data_2m1u_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2m1u _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.405 ' HG2' ' HB3' ' A' ' 87' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.133 0 N-CA-C 109.708 -0.478 . . . . 5.43 109.708 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.713 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.8 OUTLIER -67.24 -29.24 68.83 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.27 -0.423 . . . . 5.02 111.067 179.163 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.553 ' HB3' ' HG2' ' A' ' 57' ' ' PRO . 25.1 mt-30 -68.78 -31.86 71.18 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 109.177 -0.675 . . . . 6.37 109.177 177.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.469 HD23 HD21 ' A' ' 87' ' ' LEU . 0.4 OUTLIER -84.33 -10.14 57.86 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.587 -0.733 . . . . 3.69 112.166 179.032 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.713 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 7.1 mm -52.91 -18.37 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 115.345 -0.843 . . . . 5.57 112.589 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -67.91 1.07 2.86 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.366 -1.288 . . . . 6.67 112.749 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.15 -40.87 67.71 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.049 -0.523 . . . . 6.33 110.226 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -62.9 -30.09 71.27 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.364 -0.38 . . . . 7.93 110.336 178.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.573 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -115.21 78.36 1.16 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.198 -0.456 . . . . 8.9 110.446 179.686 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.573 ' CB ' ' O ' ' A' ' 33' ' ' TYR . 28.0 t30 . . . . . 0 N--CA 1.482 1.146 0 C-N-CA 124.495 1.118 . . . . 9.16 111.501 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.233 0.187 0 CA-C-O 120.709 0.29 . . . . 7.93 110.941 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.469 ' O ' ' HB ' ' A' ' 78' ' ' ILE . 7.4 p -142.84 128.66 16.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.183 -0.462 . . . . 5.91 110.728 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 77' ' ' PHE . 11.7 p -70.34 150.55 46.2 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.779 0.323 . . . . 6.83 111.271 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.658 ' CG2' HG13 ' A' ' 78' ' ' ILE . 38.3 t -57.48 -42.75 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 115.936 -0.575 . . . . 5.56 110.781 179.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.457 ' HA ' ' HD2' ' A' ' 49' ' ' ARG . 1.3 mt-10 -52.44 -50.3 62.86 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.718 -0.674 . . . . 8.18 110.931 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.19 -41.45 77.15 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.366 -0.379 . . . . 9.34 110.347 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -55.67 -43.26 76.17 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.838 -0.619 . . . . 5.8 111.386 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.457 ' HD2' ' HA ' ' A' ' 46' ' ' GLU . 58.3 mtt180 -53.74 -52.49 59.99 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.394 -0.366 . . . . 8.61 111.398 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -58.93 -42.09 96.59 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 121.151 -0.547 . . . . 8.76 112.814 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.9 mt -67.59 -47.17 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 CA-C-O 120.643 0.258 . . . . 7.65 111.101 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.46 HG22 HG12 ' A' ' 63' ' ' ILE . 4.7 mm -62.97 -36.79 77.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 116.101 -0.499 . . . . 6.94 111.917 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 19.1 mtt85 -47.59 -59.37 3.31 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.264 0.468 . . . . 11.12 112.264 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -111.81 15.1 21.02 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 111.958 0.355 . . . . 10.92 111.958 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.52 -70.67 0.63 Allowed Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.939 -0.648 . . . . 7.8 112.874 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.1 mt -104.71 116.15 61.44 Favored Pre-proline 0 CA--C 1.53 0.194 0 CA-C-O 120.554 0.216 . . . . 6.14 111.163 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.553 ' HG2' ' HB3' ' A' ' 27' ' ' GLN . 38.9 Cg_endo -66.22 97.58 0.36 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.806 2.337 . . . . 7.52 112.102 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.489 ' HB3' HG13 ' A' ' 63' ' ' ILE . 1.0 OUTLIER -138.44 144.68 40.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.536 -0.757 . . . . 7.04 110.813 -179.81 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.484 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -85.91 154.02 21.8 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.946 -0.57 . . . . 9.17 110.284 179.305 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.51 ' HA ' HD13 ' A' ' 63' ' ' ILE . 4.7 pt-20 -45.13 -52.68 8.95 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.813 0.339 . . . . 10.6 111.251 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.417 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -50.69 -20.82 1.34 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.688 0.625 . . . . 9.06 112.688 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 59' ' ' THR . 0.1 OUTLIER -95.45 -50.37 5.02 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.762 -0.458 . . . . 7.13 109.762 179.054 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.51 HD13 ' HA ' ' A' ' 60' ' ' GLU . 0.8 OUTLIER -71.52 -45.35 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 116.225 -0.443 . . . . 6.58 111.692 179.887 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.416 ' HB ' ' O ' ' A' ' 60' ' ' GLU . 17.3 m -69.53 -45.5 68.68 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.41 -0.359 . . . . 8.23 110.699 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.417 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 23.8 tt0 -64.8 -18.88 65.49 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.426 0.631 . . . . 8.97 110.491 179.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 6.2 m-30 -96.46 -31.66 12.7 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.761 -1.109 . . . . 5.31 110.316 178.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.502 ' CG ' HG12 ' A' ' 45' ' ' VAL . 2.8 m-30 -63.07 -35.86 81.67 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.415 -0.357 . . . . 5.15 110.891 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -87.88 -35.88 17.49 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.347 -0.388 . . . . 8.06 110.817 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.47 -14.57 61.26 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.403 0.519 . . . . 6.22 112.403 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.37 -38.33 11.03 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.384 -0.825 . . . . 4.43 111.124 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.445 ' HB2' ' O ' ' A' ' 77' ' ' PHE . 37.6 t0 -108.28 107.05 59.81 Favored Pre-proline 0 CA--C 1.53 0.203 0 CA-C-N 116.344 -0.389 . . . . 5.45 110.989 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -61.96 -38.14 60.2 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.709 2.272 . . . . 6.91 112.491 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -75.75 -32.74 60.1 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.331 -0.395 . . . . 6.68 111.472 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 26.8 m120 69.74 24.46 5.4 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.059 0.457 . . . . 7.35 110.37 -178.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.5 t -68.59 -16.77 63.96 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.72 -0.673 . . . . 6.16 111.043 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 111.84 17.72 8.32 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-N 116.261 -0.427 . . . . 5.83 112.659 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.445 ' O ' ' HB2' ' A' ' 71' ' ' ASP . 13.6 m-85 -116.39 164.64 14.24 Favored 'General case' 0 CA--C 1.527 0.06 0 N-CA-C 109.99 -0.374 . . . . 7.11 109.99 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.658 HG13 ' CG2' ' A' ' 45' ' ' VAL . 7.1 mt -142.09 147.64 21.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.356 0.598 . . . . 3.79 112.25 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.43 100.36 12.38 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.447 -1.316 . . . . 5.35 107.447 176.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -37.91 -40.31 0.45 Allowed 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.255 0.465 . . . . 5.81 112.255 -177.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.7 mttp -64.5 -48.51 74.89 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.758 -0.201 . . . . 8.49 110.844 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.56 -38.9 64.33 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.97 0.415 . . . . 4.83 110.314 178.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.593 ' CE1' HD12 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -75.63 -40.33 56.44 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.649 -0.705 . . . . 3.29 110.871 179.343 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.39 -33.0 74.93 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.259 -0.428 . . . . 4.77 111.523 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.22 -11.87 58.56 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.807 0.669 . . . . 6.05 112.807 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 6.3 mmt -77.12 -45.87 25.45 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.572 -0.74 . . . . 4.94 110.399 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.469 HD21 HD23 ' A' ' 28' ' ' LEU . 1.4 mp -88.2 -8.98 54.49 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.472 0.653 . . . . 5.15 112.242 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -117.04 22.75 12.35 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.606 -1.179 . . . . 7.33 111.11 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.533 0.303 0 CA-C-O 121.023 0.44 . . . . 8.25 111.051 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.737 0.303 . . . . 0.0 110.618 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.661 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -60.17 -28.27 67.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.775 -179.857 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.25 -23.96 66.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.232 0.539 . . . . 0.0 109.682 178.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -88.03 -11.32 47.61 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.257 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.661 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 10.7 mm -66.0 -14.42 17.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.92 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -77.6 2.15 17.42 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 113.9 -1.5 . . . . 0.0 111.52 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.41 -29.53 15.55 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.132 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -56.66 -22.81 37.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.155 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -97.25 29.76 3.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.129 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.902 179.902 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.837 0.351 . . . . 0.0 110.882 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.444 ' CG1' ' CE2' ' A' ' 48' ' ' PHE . 8.1 p -144.18 139.75 24.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.963 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.402 ' OG ' ' CE2' ' A' ' 77' ' ' PHE . 0.9 OUTLIER -88.9 155.16 19.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.006 -179.793 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.431 HG12 ' CD2' ' A' ' 67' ' ' PHE . 86.1 t -58.24 -55.9 19.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.058 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -46.69 -30.73 2.51 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.078 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -91.23 -28.85 17.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.476 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.444 ' CE2' ' CG1' ' A' ' 43' ' ' VAL . 0.1 OUTLIER -68.75 -38.19 79.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.74 179.716 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 26.9 mtp180 -57.6 -50.3 73.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.915 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -56.72 -25.85 52.34 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.543 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 28.5 mt -84.05 -43.81 17.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.796 0.331 . . . . 0.0 111.011 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 30.9 mm -69.72 -28.66 38.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.192 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 20.1 mtm180 -50.63 -58.22 6.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.018 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -111.75 14.9 21.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.272 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -99.0 -86.51 1.88 Allowed Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.665 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.9 mp -103.76 145.73 31.18 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.755 0.312 . . . . 0.0 111.068 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.98 112.91 3.6 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.504 2.136 . . . . 0.0 112.312 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.4 ' C ' HD13 ' A' ' 63' ' ' ILE . 1.1 ttp -154.85 138.32 15.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.721 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.452 ' O ' ' CD1' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -78.86 146.6 33.56 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.466 179.463 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.556 ' O ' ' N ' ' A' ' 64' ' ' THR . 0.6 OUTLIER -40.29 -53.21 2.58 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.288 0.566 . . . . 0.0 110.913 179.841 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.526 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -46.23 -53.08 11.28 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.045 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.437 ' O ' ' HB2' ' A' ' 66' ' ' PHE . 0.6 OUTLIER -56.04 -61.16 2.57 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 179.446 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.509 ' O ' ' N ' ' A' ' 67' ' ' PHE . 1.2 mp -59.66 -61.09 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.049 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.556 ' N ' ' O ' ' A' ' 60' ' ' GLU . 51.7 m -51.18 -51.03 57.64 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.171 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.526 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 8.6 tt0 -66.56 -15.45 63.43 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 121.683 0.754 . . . . 0.0 110.399 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.437 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.6 m-30 -96.23 -25.31 15.85 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.44 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.509 ' N ' ' O ' ' A' ' 63' ' ' ILE . 1.6 m-85 -73.74 -46.63 44.65 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.65 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.44 -26.51 58.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.153 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.53 -11.03 60.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.457 0.646 . . . . 0.0 111.844 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.3 -51.41 4.39 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.867 -1.061 . . . . 0.0 111.193 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 29.1 p-10 -105.35 118.79 54.86 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.9 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -69.14 -36.12 13.1 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.466 2.111 . . . . 0.0 112.32 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -68.42 -32.69 72.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.878 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 71.65 40.86 0.75 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.145 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.4 t -91.36 29.9 1.38 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.635 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 56.02 26.73 49.52 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.454 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.402 ' CE2' ' OG ' ' A' ' 44' ' ' SER . 2.4 m-85 -123.47 161.27 25.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.777 0.323 . . . . 0.0 110.646 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.443 HD12 ' CZ ' ' A' ' 83' ' ' PHE . 52.2 mt -139.32 148.93 23.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.247 0.546 . . . . 0.0 111.706 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.445 ' O ' ' N ' ' A' ' 82' ' ' ALA . 0.7 OUTLIER -97.49 96.28 8.22 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 176.812 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.426 ' C ' ' O ' ' A' ' 79' ' ' ASP . 39.4 t80 -28.61 -40.78 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.366 -178.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 79' ' ' ASP . 1.7 mtmp? -66.44 -54.78 20.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.567 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.445 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -52.96 -26.98 16.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.018 0.437 . . . . 0.0 110.478 179.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.443 ' CZ ' HD12 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -91.1 -31.44 16.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.884 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.65 -20.74 33.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.579 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.25 -11.23 60.43 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.423 0.63 . . . . 0.0 111.934 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 17.2 tpp -78.18 -35.34 48.82 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.57 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.9 mp -96.4 -5.86 38.82 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.831 0.824 . . . . 0.0 111.299 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -122.35 21.89 10.19 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 114.174 -1.375 . . . . 0.0 111.098 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.062 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.783 0.325 . . . . 0.0 110.688 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.669 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -63.1 -29.48 70.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.814 -179.875 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -60.6 -24.28 65.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.18 0.515 . . . . 0.0 109.701 178.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.5 tt -88.24 -11.29 47.03 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.456 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.669 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 10.8 mm -64.39 -14.59 16.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.971 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -76.92 1.83 16.49 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 114.085 -1.416 . . . . 0.0 111.543 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.54 -28.37 16.1 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.072 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -58.0 -20.81 41.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.317 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -93.97 23.82 4.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.554 -0.293 . . . . 0.0 111.182 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.052 179.957 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.848 0.356 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.426 HG12 ' CE2' ' A' ' 48' ' ' PHE . 10.2 p -122.77 125.15 72.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.042 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 52.7 p -70.49 168.43 16.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.872 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.475 ' CG2' HG13 ' A' ' 78' ' ' ILE . 41.2 t -73.06 -29.05 27.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.835 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -74.84 -53.03 9.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.711 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -58.38 -32.75 68.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.582 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.426 ' CE2' HG12 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -59.63 -35.91 75.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.76 179.715 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.72 -51.29 70.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.926 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -54.94 -25.39 37.68 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.363 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 24.6 mt -90.58 -39.94 12.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.823 0.344 . . . . 0.0 110.898 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 36.5 mm -74.26 -27.2 21.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.199 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.4 ttt85 -50.7 -58.72 5.19 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.878 0.37 . . . . 0.0 111.068 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -111.9 15.07 20.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.299 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -97.65 -86.02 1.81 Allowed Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.712 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.2 mt -101.19 135.6 19.87 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.587 0.232 . . . . 0.0 111.0 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -78.73 59.32 7.22 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.488 2.125 . . . . 0.0 112.325 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.4 ' C ' HD11 ' A' ' 63' ' ' ILE . 1.4 mtp -88.32 141.68 28.35 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.582 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.455 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -77.95 147.68 34.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.772 179.762 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.494 ' O ' ' N ' ' A' ' 64' ' ' THR . 3.0 pt-20 -38.08 -48.5 1.23 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.19 0.519 . . . . 0.0 111.094 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.515 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -50.96 -52.78 39.13 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.922 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.455 ' HG2' ' O ' ' A' ' 59' ' ' THR . 1.1 mm-40 -55.15 -61.79 2.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.007 0.432 . . . . 0.0 109.934 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.506 ' CG2' ' CE2' ' A' ' 67' ' ' PHE . 1.8 mp -57.92 -61.79 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.202 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.494 ' N ' ' O ' ' A' ' 60' ' ' GLU . 92.2 m -52.36 -52.28 54.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.291 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.515 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 1.2 tp10 -64.46 -15.58 60.95 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 121.702 0.763 . . . . 0.0 110.504 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.434 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.5 m-30 -95.07 -28.87 14.88 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.284 179.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.506 ' CE2' ' CG2' ' A' ' 63' ' ' ILE . 10.0 m-30 -79.84 -24.39 41.33 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.848 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -93.96 -27.34 16.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.85 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.77 -11.41 42.27 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.436 0.636 . . . . 0.0 111.72 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.65 -27.41 14.38 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.961 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -120.68 96.53 48.81 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.781 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.58 -29.9 70.48 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.411 2.074 . . . . 0.0 112.243 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -83.31 -27.03 30.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.828 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 73.09 40.39 0.56 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.179 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.2 t -91.47 28.71 1.63 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.621 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 47.42 31.83 7.0 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.317 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -134.04 129.19 35.7 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.849 0.357 . . . . 0.0 110.285 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.475 HG13 ' CG2' ' A' ' 45' ' ' VAL . 65.5 mt -102.75 150.57 6.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.183 0.516 . . . . 0.0 111.461 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.43 ' O ' ' N ' ' A' ' 82' ' ' ALA . 2.2 m-20 -93.76 95.64 9.27 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 176.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.423 ' C ' ' O ' ' A' ' 79' ' ' ASP . 42.4 t80 -29.67 -40.6 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.238 -177.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 79' ' ' ASP . 15.8 mtmt -66.15 -55.22 17.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.797 0.332 . . . . 0.0 110.613 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -52.72 -27.9 19.63 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.033 0.444 . . . . 0.0 110.501 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.438 ' CZ ' HD11 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -89.66 -32.78 16.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.804 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.37 -24.46 46.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.197 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.8 -11.41 60.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.446 0.641 . . . . 0.0 111.729 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 9.4 mtp -75.14 -37.88 61.23 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.743 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.1 mt -88.19 -6.88 57.59 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.854 0.835 . . . . 0.0 111.52 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -125.99 22.45 7.35 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.131 -1.395 . . . . 0.0 111.184 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.879 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.792 0.329 . . . . 0.0 110.727 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.642 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -56.76 -26.4 57.34 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.05 -179.775 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -62.89 -23.62 67.43 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -88.12 -11.48 46.87 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.362 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.642 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 12.2 mm -64.68 -14.74 16.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 114.77 -1.104 . . . . 0.0 111.946 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -77.67 2.07 17.88 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 113.907 -1.497 . . . . 0.0 111.667 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.37 -40.09 10.58 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.022 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -58.82 -29.83 67.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.95 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -98.1 28.36 4.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.954 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.767 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.783 0.325 . . . . 0.0 110.965 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.427 HG12 ' CD2' ' A' ' 48' ' ' PHE . 9.5 p -120.93 136.17 58.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.014 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.415 ' HB3' ' CD1' ' A' ' 77' ' ' PHE . 1.3 m -88.71 145.08 25.85 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.855 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.429 HG12 ' CD1' ' A' ' 67' ' ' PHE . 93.1 t -51.51 -55.69 7.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.179 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -47.95 -31.3 5.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.873 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -86.92 -30.24 21.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.413 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.427 ' CD2' HG12 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -67.08 -40.08 86.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.825 179.847 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -56.47 -50.7 70.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.911 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -56.03 -25.41 46.11 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.315 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 28.7 mt -85.51 -43.89 16.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.817 0.341 . . . . 0.0 110.924 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 34.5 mm -71.65 -26.05 25.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.147 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 10.0 mmp_? -52.48 -59.5 4.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.748 0.308 . . . . 0.0 111.118 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -111.72 14.94 21.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.361 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -98.31 -86.35 1.85 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.678 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.2 mp -105.54 146.78 33.47 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-O 120.689 0.281 . . . . 0.0 111.049 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -73.48 95.09 0.85 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.588 2.192 . . . . 0.0 112.11 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.442 ' C ' HD11 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -130.8 141.67 50.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.799 -179.81 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.482 ' O ' ' HB3' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -90.0 144.88 25.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.956 179.449 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.601 ' O ' ' N ' ' A' ' 64' ' ' THR . 6.4 pt-20 -47.33 -56.96 5.83 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 121.077 0.465 . . . . 0.0 110.49 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.428 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -50.29 -24.56 3.01 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.982 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.482 ' HB3' ' O ' ' A' ' 59' ' ' THR . 4.8 tp10 -86.67 -46.0 10.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.335 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.548 ' O ' ' N ' ' A' ' 67' ' ' PHE . 0.7 OUTLIER -82.63 -47.82 18.43 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.179 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.074 179.552 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.601 ' N ' ' O ' ' A' ' 60' ' ' GLU . 23.0 m -59.48 -46.84 87.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.202 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.428 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 0.9 OUTLIER -68.32 -16.51 63.97 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 121.755 0.788 . . . . 0.0 110.201 179.376 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.407 ' CD1' ' O ' ' A' ' 62' ' ' GLU . 3.1 m-85 -97.14 -24.0 15.94 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.31 -1.313 . . . . 0.0 110.286 178.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.548 ' N ' ' O ' ' A' ' 63' ' ' ILE . 2.1 m-85 -72.19 -41.3 67.14 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.767 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -79.85 -28.33 40.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.917 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.15 -11.26 60.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.437 0.637 . . . . 0.0 111.741 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.83 -30.59 14.14 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.041 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -120.73 120.38 29.6 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.909 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -64.36 -27.12 63.18 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.46 2.107 . . . . 0.0 112.282 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 -87.79 -32.56 19.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.886 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 71.52 38.93 0.95 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.063 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.408 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 1.6 t -89.2 42.74 1.1 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.689 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 50.87 25.03 8.93 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.636 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.415 ' CD1' ' HB3' ' A' ' 44' ' ' SER . 41.4 m-85 -122.21 159.16 27.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.905 0.383 . . . . 0.0 110.718 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.46 HD13 ' CZ ' ' A' ' 83' ' ' PHE . 50.5 mt -137.28 153.39 28.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.146 0.498 . . . . 0.0 111.593 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.425 ' O ' ' C ' ' A' ' 80' ' ' TYR . 1.0 OUTLIER -98.72 95.86 7.52 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 176.923 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.425 ' C ' ' O ' ' A' ' 79' ' ' ASP . 47.8 t80 -28.96 -41.16 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.333 -178.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 79' ' ' ASP . 22.2 mttt -68.01 -55.88 11.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.728 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -51.43 -27.46 10.29 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.961 0.41 . . . . 0.0 110.672 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.46 ' CZ ' HD13 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -91.13 -33.06 15.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.94 179.852 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.401 ' O ' ' CD2' ' A' ' 88' ' ' TYR . . . -80.56 -18.24 48.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.444 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.95 -11.69 61.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.379 0.609 . . . . 0.0 111.719 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 51.4 mtm -76.18 -38.49 56.54 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.587 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -85.94 -6.59 59.03 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 121.822 0.82 . . . . 0.0 111.365 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.401 ' CD2' ' O ' ' A' ' 84' ' ' ALA . 19.0 m-85 -125.65 22.21 7.6 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 114.142 -1.39 . . . . 0.0 111.157 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.929 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.156 0 CA-C-O 120.844 0.354 . . . . 0.0 110.587 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.666 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -65.55 -29.07 69.65 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.781 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -59.21 -23.74 62.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.278 0.561 . . . . 0.0 109.776 178.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.7 tt -88.12 -11.32 47.32 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.415 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.666 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 11.0 mm -67.19 -13.67 17.02 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-N 114.749 -1.114 . . . . 0.0 111.952 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -76.61 2.12 14.96 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 113.921 -1.491 . . . . 0.0 111.621 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.03 -33.51 14.09 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.076 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -63.73 -29.17 70.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.887 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -97.99 31.76 2.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.907 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.865 -179.982 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 78.1 t80 . . . . . 0 C--O 1.23 0.055 0 CA-C-O 120.902 0.382 . . . . 0.0 110.828 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.421 HG13 ' CD2' ' A' ' 48' ' ' PHE . 7.5 p -142.76 125.02 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.875 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.422 ' HB3' ' CD2' ' A' ' 77' ' ' PHE . 1.8 m -77.21 154.71 32.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.056 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.433 HG12 ' CD1' ' A' ' 67' ' ' PHE . 59.4 t -59.87 -52.69 58.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.759 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -50.09 -31.31 12.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.907 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.4 mm-40 -91.69 -29.22 16.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.46 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.421 ' CD2' HG13 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -64.66 -35.9 82.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.813 179.844 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 15.5 mtt180 -58.37 -49.55 76.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.859 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -57.05 -26.77 56.32 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.36 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 26.0 mt -85.29 -44.35 17.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.891 0.377 . . . . 0.0 110.991 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 37.5 mm -67.2 -29.07 44.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.107 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.09 -57.09 10.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.908 0.385 . . . . 0.0 110.925 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -111.76 14.82 21.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.312 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -99.55 -86.62 1.9 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.673 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.7 mt -100.19 139.04 20.41 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.577 0.227 . . . . 0.0 110.969 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -79.06 58.79 7.11 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.472 2.115 . . . . 0.0 112.314 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.459 ' HG2' ' HB2' ' A' ' 62' ' ' GLU . 1.4 ttp -94.5 139.9 30.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.746 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.466 ' O ' ' CD1' ' A' ' 63' ' ' ILE . 0.8 OUTLIER -75.95 142.56 41.95 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.052 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.548 ' O ' ' N ' ' A' ' 64' ' ' THR . 6.6 pt-20 -39.5 -51.79 2.16 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.276 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.442 ' O ' ' HB2' ' A' ' 65' ' ' GLU . . . -45.61 -55.52 6.24 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.182 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.459 ' HB2' ' HG2' ' A' ' 58' ' ' MET . 0.9 OUTLIER -55.07 -60.86 2.8 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.619 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.518 ' O ' ' N ' ' A' ' 67' ' ' PHE . 1.5 mp -58.94 -61.93 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.921 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.548 ' N ' ' O ' ' A' ' 60' ' ' GLU . 75.2 m -49.55 -52.45 29.81 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.218 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.442 ' HB2' ' O ' ' A' ' 61' ' ' ALA . 44.0 mt-10 -66.16 -15.75 63.4 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.701 0.762 . . . . 0.0 110.381 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.451 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.5 m-30 -94.66 -26.51 16.3 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.517 -1.22 . . . . 0.0 110.385 179.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.518 ' N ' ' O ' ' A' ' 63' ' ' ILE . 2.4 m-30 -75.16 -30.27 60.67 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.681 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -92.91 -24.93 18.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.92 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.24 -11.23 44.21 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.518 0.675 . . . . 0.0 111.856 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.46 -27.27 13.81 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.136 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -118.96 115.7 34.64 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.703 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.83 -50.51 1.67 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.44 2.093 . . . . 0.0 112.5 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -68.48 -32.55 72.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.93 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 12.6 m120 72.41 30.62 1.94 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.543 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 36.8 p -68.48 -22.71 64.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.036 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 115.08 20.64 5.55 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.568 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.44 ' CD1' ' N ' ' A' ' 77' ' ' PHE . 3.2 m-85 -137.48 150.37 47.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.671 0.272 . . . . 0.0 110.736 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.466 HG21 ' CD1' ' A' ' 83' ' ' PHE . 1.6 mt -133.36 146.55 32.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.571 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.434 ' O ' ' N ' ' A' ' 81' ' ' LYS . 8.5 m-20 -75.74 105.04 6.57 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 177.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.407 ' C ' ' O ' ' A' ' 79' ' ' ASP . 27.6 t80 -28.73 -40.19 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 79' ' ' ASP . 0.1 OUTLIER -64.64 -53.32 49.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.654 0.264 . . . . 0.0 110.854 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -51.45 -27.24 9.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.063 0.458 . . . . 0.0 110.747 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.466 ' CD1' HG21 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -93.83 -32.48 13.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.986 -179.869 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.99 -18.49 53.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.262 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -71.72 -11.61 60.91 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.427 0.632 . . . . 0.0 111.803 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.36 -41.82 62.97 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.716 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.1 mp -86.03 -6.31 59.06 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.884 0.85 . . . . 0.0 111.512 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -125.28 22.26 7.84 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.168 -1.378 . . . . 0.0 111.107 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.886 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 120.781 0.324 . . . . 0.0 110.65 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.64 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -67.15 -27.75 67.55 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.857 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -59.51 -23.75 63.07 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.6 tt -88.2 -11.31 47.09 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.563 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.64 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 11.9 mm -66.1 -14.06 16.81 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 114.695 -1.139 . . . . 0.0 111.932 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.89 1.98 15.99 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 113.915 -1.493 . . . . 0.0 111.66 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.33 -29.21 15.75 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.076 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -57.18 -25.91 59.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.098 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -95.08 42.42 1.09 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.814 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.849 179.925 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 34.0 t80 . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.852 0.358 . . . . 0.0 111.006 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.422 HG11 ' CD2' ' A' ' 48' ' ' PHE . 7.7 p -175.65 125.43 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.907 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.53 146.93 40.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.112 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.465 HG12 ' CE1' ' A' ' 67' ' ' PHE . 75.7 t -56.25 -53.23 42.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.989 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -48.0 -30.09 4.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.973 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -92.83 -30.0 15.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.467 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.422 ' CD2' HG11 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -64.6 -33.28 75.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.8 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 8.7 mtt180 -55.35 -51.72 65.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.941 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -56.15 -25.71 47.79 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.438 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 40.6 mt -81.97 -28.69 9.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.795 0.331 . . . . 0.0 111.022 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 31.6 mm -90.2 -28.32 5.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.104 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.9 mmm-85 -54.29 -55.6 26.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.346 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -111.66 14.96 21.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.638 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -103.45 -87.49 2.01 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.321 -0.943 . . . . 0.0 112.764 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.4 mp -102.54 143.79 27.31 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 120.767 0.317 . . . . 0.0 111.044 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.51 118.41 4.87 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.501 2.134 . . . . 0.0 112.226 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.433 ' C ' HD11 ' A' ' 63' ' ' ILE . 0.4 OUTLIER -158.52 137.68 11.51 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.716 -179.772 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.451 ' O ' ' CD1' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -78.27 146.06 35.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.468 179.303 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.575 ' O ' ' N ' ' A' ' 64' ' ' THR . 4.8 pt-20 -39.98 -52.79 2.44 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 121.376 0.608 . . . . 0.0 111.01 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.519 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -46.14 -53.91 9.56 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.164 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 59' ' ' THR . 1.8 mm-40 -55.27 -61.53 2.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.956 0.407 . . . . 0.0 109.95 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.512 ' CG2' ' CE2' ' A' ' 67' ' ' PHE . 1.1 mp -60.0 -61.68 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.184 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.575 ' N ' ' O ' ' A' ' 60' ' ' GLU . 61.7 m -50.16 -50.85 47.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.196 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.519 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 4.8 tp10 -64.92 -16.29 63.11 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.708 0.766 . . . . 0.0 110.453 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.424 ' CD2' ' O ' ' A' ' 62' ' ' GLU . 1.7 m-85 -96.44 -25.68 15.6 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.515 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.512 ' CE2' ' CG2' ' A' ' 63' ' ' ILE . 1.4 m-85 -73.42 -31.07 63.64 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.614 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -84.56 -28.21 26.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.971 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -81.34 -11.17 59.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.487 0.661 . . . . 0.0 111.819 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.448 ' HB1' ' CD1' ' A' ' 83' ' ' PHE . . . -97.39 -27.58 14.41 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.086 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -121.54 118.99 29.48 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.765 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -62.86 -53.93 1.42 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.578 2.186 . . . . 0.0 112.65 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -68.41 -32.82 73.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.963 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.7 m120 74.47 43.74 0.25 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.626 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 17.6 p -93.14 37.79 1.04 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.523 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 55.69 23.02 35.09 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.383 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -124.08 128.54 49.46 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -112.23 152.61 14.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.224 0.535 . . . . 0.0 111.512 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -98.88 97.57 8.74 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.159 178.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -35.2 -35.91 0.05 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.028 -178.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.72 -51.95 50.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.511 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.75 -25.12 54.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.141 0.496 . . . . 0.0 110.413 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.448 ' CD1' ' HB1' ' A' ' 70' ' ' ALA . 0.1 OUTLIER -92.59 -29.59 16.07 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.928 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.4 ' O ' ' CD2' ' A' ' 88' ' ' TYR . . . -80.09 -25.92 39.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.157 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.76 -11.46 60.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.418 0.627 . . . . 0.0 111.814 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 14.0 tpp -82.72 -36.55 25.7 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.818 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 9.7 mt -85.8 -6.43 59.1 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.845 0.831 . . . . 0.0 111.505 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.4 ' CD2' ' O ' ' A' ' 84' ' ' ALA . 12.7 m-85 -126.07 22.14 7.34 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 114.101 -1.409 . . . . 0.0 111.001 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.8 t . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.874 179.902 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.8 tttt . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.776 0.322 . . . . 0.0 110.671 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.661 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -68.36 -28.91 67.54 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.671 -179.881 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -59.45 -23.82 63.02 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 tt -88.17 -11.22 47.47 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.436 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.661 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 11.8 mm -66.57 -14.14 17.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 114.803 -1.089 . . . . 0.0 111.983 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -78.14 2.3 18.5 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 113.936 -1.484 . . . . 0.0 111.51 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.42 -32.67 14.14 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.989 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -59.26 -29.56 67.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.951 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -97.52 36.28 1.52 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.95 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.979 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.796 0.332 . . . . 0.0 110.922 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.426 HG13 ' CD2' ' A' ' 48' ' ' PHE . 7.8 p -144.92 110.83 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.92 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.423 ' HB3' ' CD2' ' A' ' 77' ' ' PHE . 1.2 m -65.83 160.69 22.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.041 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.437 HG12 ' CD2' ' A' ' 67' ' ' PHE . 72.5 t -57.89 -56.07 17.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.784 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -47.13 -41.49 17.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.989 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -78.91 -27.65 43.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.48 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.473 ' CE2' ' CD2' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -67.7 -29.47 68.73 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.96 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 34.1 mmm-85 -56.07 -56.43 20.89 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.053 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -54.9 -23.61 31.3 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.621 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 24.7 mt -84.5 -24.34 7.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.631 0.253 . . . . 0.0 111.238 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 39.9 mm -93.03 -36.19 7.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.243 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.97 -46.43 71.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.119 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -111.84 14.84 21.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.508 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -109.8 -88.87 1.95 Allowed Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.66 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.6 mp -100.38 136.82 19.91 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.587 0.232 . . . . 0.0 110.989 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -79.9 58.44 6.98 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.529 2.152 . . . . 0.0 112.493 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.437 ' C ' HD13 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -86.4 141.71 28.96 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.567 179.607 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.451 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 0.3 OUTLIER -75.78 145.59 40.64 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.606 179.632 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.544 ' O ' ' N ' ' A' ' 64' ' ' THR . 4.8 pt-20 -39.29 -52.23 2.0 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.178 0.513 . . . . 0.0 111.02 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.52 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -46.65 -53.61 11.25 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.071 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 59' ' ' THR . 1.7 mm-40 -55.16 -61.64 2.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.928 0.394 . . . . 0.0 110.039 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.527 ' CG2' ' CE2' ' A' ' 67' ' ' PHE . 1.4 mp -59.17 -61.48 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.177 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.544 ' N ' ' O ' ' A' ' 60' ' ' GLU . 68.2 m -51.35 -51.68 52.32 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.174 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.52 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 28.8 tp10 -65.8 -15.46 62.9 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.576 0.703 . . . . 0.0 110.346 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.448 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.4 m-30 -94.94 -25.93 16.33 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.387 179.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.527 ' CE2' ' CG2' ' A' ' 63' ' ' ILE . 2.6 m-30 -79.64 -28.79 40.85 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.765 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -86.64 -31.1 21.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.881 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -81.46 -11.17 59.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.486 0.66 . . . . 0.0 111.713 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -102.25 -27.41 12.88 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.028 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -123.33 107.82 32.12 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.675 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.48 -43.5 7.83 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.397 2.065 . . . . 0.0 112.339 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -68.45 -32.31 72.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.823 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 21.2 m-20 73.96 20.95 2.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.529 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -63.64 -22.38 66.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.861 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 109.21 19.75 8.29 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.502 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.423 ' CD2' ' HB3' ' A' ' 44' ' ' SER . 4.1 m-85 -132.97 146.27 51.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.776 0.322 . . . . 0.0 110.825 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.463 HG21 ' CD1' ' A' ' 83' ' ' PHE . 1.0 OUTLIER -133.38 146.09 32.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.433 179.789 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.438 ' O ' ' N ' ' A' ' 82' ' ' ALA . 0.4 OUTLIER -77.08 108.18 9.98 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 177.202 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.426 ' C ' ' O ' ' A' ' 79' ' ' ASP . 28.0 t80 -28.77 -40.75 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.428 ' N ' ' O ' ' A' ' 79' ' ' ASP . 0.2 OUTLIER -64.66 -53.13 52.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.935 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -50.21 -28.08 6.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.058 0.456 . . . . 0.0 110.771 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.473 ' CD2' ' CE2' ' A' ' 48' ' ' PHE . 0.1 OUTLIER -93.25 -35.5 13.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.041 -179.748 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.08 -22.61 55.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.313 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.68 -11.55 60.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.476 0.655 . . . . 0.0 111.849 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 9.5 mmt -72.96 -31.28 64.45 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.806 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.6 mt -100.18 -6.59 25.9 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.917 0.865 . . . . 0.0 111.58 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -126.05 22.34 7.32 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.127 -1.397 . . . . 0.0 111.173 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.857 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.778 0.323 . . . . 0.0 110.687 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.667 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -57.9 -27.31 63.2 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.828 -179.807 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -62.86 -24.03 67.6 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -88.08 -11.47 47.02 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.195 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.667 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 11.3 mm -64.98 -14.59 16.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.969 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -77.89 2.14 18.28 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 113.878 -1.51 . . . . 0.0 111.463 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.23 -31.23 14.82 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.064 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -59.54 -30.98 68.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.942 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -97.41 38.9 1.22 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.932 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.851 179.897 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.813 0.34 . . . . 0.0 110.971 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.449 ' CG1' ' CE2' ' A' ' 48' ' ' PHE . 9.4 p -131.39 127.67 60.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.976 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.1 p -78.99 162.08 26.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.906 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.435 HG12 ' CD2' ' A' ' 67' ' ' PHE . 46.5 t -64.17 -54.16 34.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.001 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -47.22 -29.75 2.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.084 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -93.32 -30.05 15.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.655 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.449 ' CE2' ' CG1' ' A' ' 43' ' ' VAL . 0.1 OUTLIER -66.02 -38.31 88.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.95 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.6 mtp85 -54.72 -51.48 65.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.0 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -57.2 -21.49 39.73 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.606 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.9 mt -93.17 -25.43 4.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.744 0.307 . . . . 0.0 111.255 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 40.6 mm -93.37 -49.39 12.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.301 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 24.7 ttp180 -46.86 -68.86 0.16 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.7 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -92.44 14.93 15.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.745 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -121.31 -89.88 1.07 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.373 -0.918 . . . . 0.0 112.914 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -80.23 132.9 58.18 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.554 0.216 . . . . 0.0 111.192 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.65 113.82 3.82 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.466 2.111 . . . . 0.0 112.256 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -155.63 137.69 14.6 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.892 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.433 ' O ' ' CD1' ' A' ' 63' ' ' ILE . 0.6 OUTLIER -74.31 145.1 44.2 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.855 179.733 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.515 ' O ' ' N ' ' A' ' 64' ' ' THR . 2.3 pt-20 -37.85 -48.65 1.14 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.169 0.509 . . . . 0.0 111.054 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.426 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -49.55 -55.74 12.38 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.835 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.444 ' O ' ' HB2' ' A' ' 66' ' ' PHE . 0.6 OUTLIER -52.18 -62.6 1.53 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.286 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.485 ' O ' ' N ' ' A' ' 67' ' ' PHE . 1.8 mp -57.35 -62.84 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.123 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.515 ' N ' ' O ' ' A' ' 60' ' ' GLU . 99.3 m -50.12 -53.09 29.85 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.405 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.426 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 2.7 mm-40 -65.31 -15.8 62.91 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-O 121.617 0.722 . . . . 0.0 110.485 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.444 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.7 m-30 -94.61 -26.57 16.31 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.423 179.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.485 ' N ' ' O ' ' A' ' 63' ' ' ILE . 4.8 m-30 -77.97 -26.58 48.8 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.801 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -91.32 -28.93 17.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.805 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.07 -11.23 47.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.535 0.683 . . . . 0.0 111.782 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -92.09 -28.53 17.07 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.113 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -126.16 119.36 23.62 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.785 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.84 -40.67 16.15 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.272 1.982 . . . . 0.0 112.279 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -76.53 -30.94 57.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.817 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.2 m120 72.35 38.83 0.8 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.171 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.5 t -89.64 41.77 1.06 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.634 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 47.94 26.94 4.64 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.523 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -128.12 129.38 46.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.819 0.342 . . . . 0.0 110.449 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.459 HG23 HD13 ' A' ' 78' ' ' ILE . 61.9 mt -102.49 153.34 5.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.19 0.519 . . . . 0.0 111.662 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.426 ' O ' ' C ' ' A' ' 80' ' ' TYR . 1.2 t0 -98.78 95.76 7.43 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 176.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.426 ' C ' ' O ' ' A' ' 79' ' ' ASP . 56.4 t80 -29.06 -41.25 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.337 -177.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -66.0 -55.85 14.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.672 0.272 . . . . 0.0 110.618 179.818 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.415 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -52.65 -27.08 15.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.965 0.412 . . . . 0.0 110.594 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.435 ' CZ ' HD12 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -90.37 -32.3 16.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.86 179.823 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.12 -28.76 48.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.165 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.82 -11.5 60.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.375 0.607 . . . . 0.0 111.708 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 14.1 tmm? -69.59 -35.12 75.04 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.913 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.0 mp -100.67 -5.97 25.8 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.816 0.817 . . . . 0.0 111.63 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -125.48 22.41 7.68 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 114.193 -1.367 . . . . 0.0 111.09 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.871 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.9 tttt . . . . . 0 N--CA 1.458 -0.04 0 CA-C-O 120.788 0.327 . . . . 0.0 110.644 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.652 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -68.08 -28.16 67.12 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.854 -179.892 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -60.3 -24.28 64.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.223 0.535 . . . . 0.0 109.562 178.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.6 tt -88.33 -11.22 46.98 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.476 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.652 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 13.5 mm -63.61 -15.45 16.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.964 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -80.56 1.95 27.52 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 113.854 -1.521 . . . . 0.0 111.345 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.45 -29.87 15.34 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.043 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -56.56 -28.16 59.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.053 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -97.65 28.3 3.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.084 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.218 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.869 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 54.3 t80 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.886 0.374 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.453 ' CG1' ' CE2' ' A' ' 48' ' ' PHE . 7.6 p -139.53 127.33 25.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.898 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.1 p -67.42 154.17 41.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.159 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.478 ' CG2' HG13 ' A' ' 78' ' ' ILE . 50.6 t -61.9 -27.8 43.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.928 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -71.91 -58.62 3.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.921 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -58.07 -29.07 65.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.802 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.453 ' CE2' ' CG1' ' A' ' 43' ' ' VAL . 0.1 OUTLIER -61.85 -36.88 82.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.904 179.816 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 16.2 mtt-85 -58.08 -50.74 72.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.951 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -57.28 -26.48 56.39 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.548 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 22.9 mt -80.87 -39.61 18.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.81 0.338 . . . . 0.0 111.087 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 37.9 mm -75.65 -28.77 19.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.248 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.6 mtp85 -51.23 -55.13 19.7 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.094 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -111.86 14.93 21.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.276 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -100.24 -86.84 1.93 Allowed Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.533 -0.841 . . . . 0.0 112.74 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.5 mt -105.47 140.05 20.77 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 120.694 0.283 . . . . 0.0 110.981 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -81.35 55.76 5.73 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.524 2.149 . . . . 0.0 112.398 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.419 ' CG ' ' HB2' ' A' ' 62' ' ' GLU . 2.7 ttp -88.2 139.22 30.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.696 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.451 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 1.7 p -69.18 140.19 54.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.03 0.443 . . . . 0.0 111.067 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.509 ' O ' ' N ' ' A' ' 64' ' ' THR . 0.1 OUTLIER -39.95 -50.36 2.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.156 179.824 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.526 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -45.92 -52.97 10.68 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.489 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.491 ' O ' ' HB2' ' A' ' 66' ' ' PHE . 0.9 OUTLIER -58.2 -60.94 2.97 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.04 179.683 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.56 ' O ' ' N ' ' A' ' 67' ' ' PHE . 1.7 mp -57.2 -60.21 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.914 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.509 ' N ' ' O ' ' A' ' 60' ' ' GLU . 36.1 m -52.32 -51.24 59.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.786 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.526 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 27.2 tt0 -65.99 -16.14 63.63 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-O 121.603 0.716 . . . . 0.0 110.344 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.491 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 2.3 m-85 -95.77 -25.95 15.86 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.277 178.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.56 ' N ' ' O ' ' A' ' 63' ' ' ILE . 1.6 m-85 -70.74 -41.37 71.92 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.564 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -84.1 -29.14 27.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.919 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -80.5 -11.14 59.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.481 0.658 . . . . 0.0 111.76 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.39 -31.65 15.96 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.018 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -115.86 121.18 34.49 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.778 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.77 -34.95 59.78 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.453 2.102 . . . . 0.0 112.245 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 14.3 m-80 -84.5 -31.63 24.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.792 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 11.5 m120 72.43 37.08 0.95 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.166 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.8 t -88.93 41.84 1.05 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.743 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 50.82 25.62 9.7 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 121.104 -0.57 . . . . 0.0 112.727 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -128.32 129.46 46.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.844 0.354 . . . . 0.0 110.662 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.478 HG13 ' CG2' ' A' ' 45' ' ' VAL . 59.8 mt -101.44 152.37 5.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.266 0.555 . . . . 0.0 111.627 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.439 ' N ' HG22 ' A' ' 78' ' ' ILE . 20.3 t0 -101.07 96.02 6.95 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 176.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.426 ' C ' ' O ' ' A' ' 79' ' ' ASP . 40.2 t80 -28.58 -41.31 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.436 -177.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 79' ' ' ASP . 0.4 OUTLIER -65.28 -55.41 18.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.689 0.28 . . . . 0.0 110.627 179.767 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -53.43 -27.58 25.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.16 0.505 . . . . 0.0 110.497 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.44 ' CZ ' HD12 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -89.43 -31.7 17.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.734 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' A' ' 80' ' ' TYR . . . -78.6 -31.12 46.97 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.108 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -74.57 -11.34 60.18 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.503 0.668 . . . . 0.0 111.823 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 4.4 mmt -74.66 -32.11 62.15 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.808 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.7 mt -97.19 -6.93 33.63 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.921 0.867 . . . . 0.0 111.579 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -126.03 22.32 7.34 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.076 -1.42 . . . . 0.0 111.112 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 60.5 p . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.914 -179.987 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.407 ' NZ ' ' CE1' ' A' ' 88' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.842 0.353 . . . . 0.0 110.685 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.655 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -66.56 -29.11 69.11 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.814 -179.937 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -60.13 -24.26 64.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.093 0.473 . . . . 0.0 109.725 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.3 tt -88.15 -11.22 47.52 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.461 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.655 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 10.8 mm -65.26 -14.3 16.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.924 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -77.04 2.04 16.17 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 114.035 -1.439 . . . . 0.0 111.585 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.46 -30.78 14.87 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.102 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -57.41 -24.34 54.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.167 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -97.05 30.41 2.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.012 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.875 179.983 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.781 0.324 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.452 ' CG1' ' CE2' ' A' ' 48' ' ' PHE . 9.2 p -116.58 122.74 70.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.017 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.421 ' HB3' ' CE2' ' A' ' 77' ' ' PHE . 0.1 OUTLIER -74.73 154.29 38.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.825 179.931 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.433 HG12 ' CD2' ' A' ' 67' ' ' PHE . 57.4 t -58.87 -53.2 50.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.859 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -48.93 -33.05 10.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.937 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -86.36 -28.93 23.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.482 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.452 ' CE2' ' CG1' ' A' ' 43' ' ' VAL . 0.1 OUTLIER -69.25 -41.99 76.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.859 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.7 mtp180 -56.27 -52.35 64.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.954 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -53.91 -25.1 29.43 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.326 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 14.1 mt -89.83 -47.05 15.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.854 0.359 . . . . 0.0 110.923 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 36.4 mm -66.06 -28.01 42.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.223 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.7 -61.53 2.15 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.904 0.383 . . . . 0.0 111.066 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -111.86 15.04 20.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.26 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -97.48 -86.05 1.81 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.591 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.1 mt -101.27 142.44 24.63 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.693 0.283 . . . . 0.0 111.065 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.32 113.49 3.69 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.533 2.155 . . . . 0.0 112.321 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -152.26 138.11 18.03 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.806 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.469 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -77.65 147.67 35.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.683 179.698 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.519 ' O ' ' N ' ' A' ' 64' ' ' THR . 4.6 pt-20 -38.76 -51.86 1.7 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.162 0.505 . . . . 0.0 110.822 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.516 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -46.77 -53.64 11.46 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.118 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 59' ' ' THR . 0.9 OUTLIER -54.91 -61.78 2.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.961 0.41 . . . . 0.0 110.02 179.478 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.49 ' CG2' ' CE2' ' A' ' 67' ' ' PHE . 1.6 mp -58.7 -61.54 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.205 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.519 ' N ' ' O ' ' A' ' 60' ' ' GLU . 62.7 m -52.02 -51.49 57.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.37 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.516 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 6.6 tt0 -65.64 -15.53 62.86 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.735 0.779 . . . . 0.0 110.497 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.443 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.6 m-30 -95.97 -25.47 15.94 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 114.449 -1.251 . . . . 0.0 110.321 179.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.49 ' CE2' ' CG2' ' A' ' 63' ' ' ILE . 4.0 m-30 -79.06 -26.57 43.07 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.748 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -91.37 -27.5 18.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.905 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.63 -11.18 43.31 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.487 0.66 . . . . 0.0 111.777 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.65 -28.39 18.41 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.016 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.53 119.25 23.02 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.829 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.31 -34.9 42.87 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.373 2.049 . . . . 0.0 112.204 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 26.2 m-20 -82.35 -31.32 29.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.9 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 12.9 m120 72.21 38.43 0.87 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.176 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.5 t -89.39 42.26 1.08 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.578 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 50.75 25.29 9.06 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.663 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.421 ' CE2' ' HB3' ' A' ' 44' ' ' SER . 1.9 m-85 -123.08 146.74 47.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.783 0.325 . . . . 0.0 110.783 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.447 HD11 HG23 ' A' ' 78' ' ' ILE . 59.4 mt -123.02 153.12 28.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.096 0.474 . . . . 0.0 111.578 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.43 ' O ' ' C ' ' A' ' 80' ' ' TYR . 0.5 OUTLIER -98.3 95.78 7.6 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 176.958 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.43 ' C ' ' O ' ' A' ' 79' ' ' ASP . 42.6 t80 -29.34 -41.23 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.036 -0.529 . . . . 0.0 112.293 -178.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.406 ' N ' ' O ' ' A' ' 79' ' ' ASP . 0.1 OUTLIER -65.81 -56.04 14.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.643 179.638 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.412 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -52.45 -27.17 15.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.944 0.402 . . . . 0.0 110.462 179.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.436 ' CZ ' HD13 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -90.76 -30.81 16.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.803 179.929 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.31 -24.64 37.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.433 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.47 -11.53 60.71 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.452 0.644 . . . . 0.0 111.895 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 23.6 mtp -79.29 -30.79 43.08 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.843 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.1 mt -100.66 -6.18 25.52 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.735 0.778 . . . . 0.0 111.534 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.407 ' CE1' ' NZ ' ' A' ' 25' ' ' LYS . 32.6 m-85 -125.83 22.37 7.46 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 114.241 -1.345 . . . . 0.0 111.186 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 6.7 t . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.874 -179.971 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.456 -0.173 0 CA-C-O 120.833 0.349 . . . . 0.0 110.702 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.638 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -68.5 -27.39 66.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.885 179.972 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -59.34 -23.72 62.75 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.0 tt -88.16 -11.41 46.93 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.449 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.638 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 12.9 mm -66.4 -14.38 17.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.908 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -78.36 2.12 19.67 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 113.895 -1.502 . . . . 0.0 111.661 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.11 -31.91 14.64 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.085 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -60.67 -29.31 69.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.964 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -96.91 38.19 1.25 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.93 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.926 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 71.1 t80 . . . . . 0 N--CA 1.457 -0.113 0 CA-C-O 120.848 0.356 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.422 ' CG1' ' CE2' ' A' ' 48' ' ' PHE . 7.1 p -141.42 137.33 32.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.949 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.426 ' HB3' ' CE2' ' A' ' 77' ' ' PHE . 13.1 p -84.99 150.13 25.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.047 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.433 HG12 ' CD2' ' A' ' 67' ' ' PHE . 91.7 t -54.92 -55.52 15.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.082 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -46.74 -30.12 2.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.079 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -91.65 -28.68 17.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.45 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.422 ' CE2' ' CG1' ' A' ' 43' ' ' VAL . 0.1 OUTLIER -67.42 -38.21 84.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.9 179.885 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 29.4 mtm180 -57.06 -50.43 72.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.907 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -56.15 -25.75 47.89 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.381 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.6 mt -85.22 -43.5 16.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.721 0.296 . . . . 0.0 110.932 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 31.0 mm -69.89 -36.21 68.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.096 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.6 ttm180 -54.36 -47.43 72.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.08 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -111.81 14.94 21.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.335 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -109.17 -88.66 1.96 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.639 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.9 mp -102.06 142.07 23.83 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.7 0.286 . . . . 0.0 111.106 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.05 111.41 3.27 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.498 2.132 . . . . 0.0 112.26 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.421 ' C ' HD12 ' A' ' 63' ' ' ILE . 0.6 OUTLIER -148.08 138.03 22.57 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.805 -179.867 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.439 ' O ' ' CD1' ' A' ' 63' ' ' ILE . 0.6 OUTLIER -75.32 144.82 42.21 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.719 179.529 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.548 ' O ' ' N ' ' A' ' 64' ' ' THR . 1.3 pm0 -37.85 -49.01 1.17 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.278 0.561 . . . . 0.0 111.156 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.421 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -49.37 -55.98 11.13 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.83 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 66' ' ' PHE . 0.7 OUTLIER -52.24 -62.22 1.77 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.886 0.374 . . . . 0.0 110.003 179.266 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.509 ' CG2' ' CE2' ' A' ' 67' ' ' PHE . 1.4 mp -58.51 -62.88 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.125 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.548 ' N ' ' O ' ' A' ' 60' ' ' GLU . 98.6 m -49.37 -53.03 24.51 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.421 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.421 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 4.9 mm-40 -65.48 -15.72 62.94 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 121.566 0.698 . . . . 0.0 110.554 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.453 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.6 m-30 -95.71 -23.99 16.73 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.56 179.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.509 ' CE2' ' CG2' ' A' ' 63' ' ' ILE . 1.9 m-30 -76.7 -31.68 57.37 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.746 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -85.73 -29.95 23.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.856 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.71 -11.1 60.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.433 0.635 . . . . 0.0 111.733 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.67 -30.26 12.2 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.061 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -121.8 116.91 30.11 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.748 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -64.85 -50.4 2.31 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.381 2.054 . . . . 0.0 112.315 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -68.63 -32.73 72.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.813 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.3 m120 75.44 53.83 0.07 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.72 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 12.6 p -98.16 28.83 3.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.703 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 59.2 26.5 61.47 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.319 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.426 ' CE2' ' HB3' ' A' ' 44' ' ' SER . 4.1 m-85 -129.06 131.69 47.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.768 0.318 . . . . 0.0 110.74 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.46 HG23 HD13 ' A' ' 78' ' ' ILE . 61.2 mt -106.17 152.46 7.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.23 0.538 . . . . 0.0 111.635 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.451 ' N ' HG22 ' A' ' 78' ' ' ILE . 1.1 m-20 -101.23 96.2 7.04 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 176.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.43 ' C ' ' O ' ' A' ' 79' ' ' ASP . 40.5 t80 -28.78 -41.14 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.035 -0.529 . . . . 0.0 112.331 -177.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 79' ' ' ASP . 5.0 mtpp -66.06 -55.16 17.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.692 0.282 . . . . 0.0 110.51 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -53.2 -28.06 24.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.003 0.43 . . . . 0.0 110.411 179.128 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.437 ' CZ ' HD12 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -88.97 -32.47 17.63 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.846 179.88 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.71 -29.6 45.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.228 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 89' ' ' SER . . . -74.32 -11.53 60.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.369 0.605 . . . . 0.0 111.619 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 2.2 mtt -68.9 -47.68 65.23 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.461 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.5 mp -82.81 -6.92 59.65 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.845 0.831 . . . . 0.0 111.107 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -119.69 21.77 11.89 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 113.982 -1.463 . . . . 0.0 111.25 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.415 ' HB2' ' O ' ' A' ' 85' ' ' ALA . 9.3 t . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.935 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.865 0.364 . . . . 0.0 110.657 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.664 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -67.1 -28.44 68.17 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.77 -179.936 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -58.95 -23.94 62.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.175 0.512 . . . . 0.0 109.751 178.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.2 tt -88.09 -11.37 47.26 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.488 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.664 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 11.6 mm -67.21 -13.73 17.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 114.71 -1.132 . . . . 0.0 111.98 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -77.89 2.29 17.83 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 113.894 -1.503 . . . . 0.0 111.499 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.22 -43.21 8.94 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.102 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -59.82 -28.62 67.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.974 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -96.12 39.79 1.14 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.994 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.018 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.858 0.361 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.1 p -128.85 139.0 53.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.068 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.405 ' HB3' ' CZ ' ' A' ' 77' ' ' PHE . 79.2 p -88.36 151.58 22.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.788 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.45 HG12 ' CD2' ' A' ' 67' ' ' PHE . 53.7 t -58.18 -50.75 77.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.826 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -51.27 -29.18 13.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.988 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -91.45 -32.32 15.66 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.601 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.13 -42.31 98.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.024 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 72.1 mtt180 -56.87 -48.27 78.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.917 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -59.58 -27.42 63.66 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.383 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.5 mt -86.27 -50.06 14.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.872 0.367 . . . . 0.0 110.916 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.0 tp -57.87 -40.32 75.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.431 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.6 ttm180 -48.39 -68.01 0.22 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.063 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -93.36 14.79 17.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.065 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -109.51 -59.76 0.52 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.614 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.4 mp -129.09 139.51 35.9 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.655 0.264 . . . . 0.0 111.143 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -79.6 58.3 6.9 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.598 2.199 . . . . 0.0 112.056 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.477 ' HG2' ' HB2' ' A' ' 62' ' ' GLU . 1.3 ttt -87.08 138.66 31.31 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.952 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.449 ' O ' ' CD1' ' A' ' 63' ' ' ILE . 1.3 p -78.27 140.59 38.86 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.883 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.511 ' O ' ' N ' ' A' ' 64' ' ' THR . 0.1 OUTLIER -37.05 -49.1 0.83 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.093 -180.0 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.525 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -48.49 -55.52 10.76 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.314 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.477 ' HB2' ' HG2' ' A' ' 58' ' ' MET . 0.7 OUTLIER -56.16 -60.28 3.72 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.287 179.833 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.519 ' O ' ' N ' ' A' ' 67' ' ' PHE . 2.3 mp -58.07 -61.12 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.163 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.511 ' N ' ' O ' ' A' ' 60' ' ' GLU . 71.8 m -52.8 -51.53 60.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.122 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.525 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 44.6 tt0 -64.93 -15.76 62.5 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.63 0.729 . . . . 0.0 110.516 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.448 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.7 m-30 -96.38 -27.87 14.73 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 114.594 -1.184 . . . . 0.0 110.434 179.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.519 ' N ' ' O ' ' A' ' 63' ' ' ILE . 3.9 m-30 -73.25 -30.1 63.22 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.651 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.75 -26.85 20.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.874 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.28 -11.2 47.19 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.482 0.658 . . . . 0.0 111.725 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.8 -29.95 13.46 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.994 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -116.74 121.38 33.0 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.787 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.08 -49.39 2.07 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.388 2.059 . . . . 0.0 112.361 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -80.5 -28.42 37.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.911 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.1 m120 75.82 51.92 0.06 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.616 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 12.6 p -96.52 31.1 2.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.87 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 59.55 29.31 66.47 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.413 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.405 ' CZ ' ' HB3' ' A' ' 44' ' ' SER . 0.2 OUTLIER -132.08 129.34 39.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.833 0.349 . . . . 0.0 110.664 179.901 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.433 HD11 ' CZ ' ' A' ' 83' ' ' PHE . 63.7 mt -104.51 152.83 6.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.235 0.541 . . . . 0.0 111.593 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.43 ' O ' ' C ' ' A' ' 80' ' ' TYR . 1.8 m-20 -97.76 95.6 7.66 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 176.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.43 ' C ' ' O ' ' A' ' 79' ' ' ASP . 40.4 t80 -28.96 -41.55 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.209 -178.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 79' ' ' ASP . 0.3 OUTLIER -66.01 -56.21 12.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.625 179.706 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -52.11 -27.6 14.74 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.998 0.428 . . . . 0.0 110.602 179.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.433 ' CZ ' HD11 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -89.84 -32.16 17.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.866 179.85 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.6 -27.88 45.67 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.258 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.68 -11.41 60.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.482 0.658 . . . . 0.0 111.814 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 1.8 mtp -77.98 -36.86 48.5 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.736 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.2 mt -86.76 -6.71 58.74 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.862 0.839 . . . . 0.0 111.501 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -126.03 22.08 7.38 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 114.139 -1.391 . . . . 0.0 111.088 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.839 -179.986 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt . . . . . 0 N--CA 1.457 -0.093 0 CA-C-O 120.804 0.335 . . . . 0.0 110.749 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.654 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -65.25 -28.88 69.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.78 179.912 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -59.71 -23.94 63.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.136 0.493 . . . . 0.0 109.677 178.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.1 tt -88.17 -11.35 47.06 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.434 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.654 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 11.4 mm -65.63 -14.39 16.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.022 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -78.26 2.3 18.82 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 113.801 -1.545 . . . . 0.0 111.596 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.16 -28.67 16.16 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.179 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -56.45 -29.06 61.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.048 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -98.39 30.56 3.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.907 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.888 -179.997 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 . . . . . 0 N--CA 1.457 -0.102 0 CA-C-O 120.829 0.347 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.447 ' CG1' ' CE2' ' A' ' 48' ' ' PHE . 8.8 p -129.49 123.96 58.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.973 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.14 160.52 30.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.941 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.448 HG12 ' CD2' ' A' ' 67' ' ' PHE . 45.8 t -63.94 -50.98 75.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.843 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -50.92 -31.37 17.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.962 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -89.07 -28.87 19.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.521 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.447 ' CE2' ' CG1' ' A' ' 43' ' ' VAL . 0.1 OUTLIER -68.22 -40.08 82.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.909 179.918 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 15.1 mtp85 -57.13 -48.33 78.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.874 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -57.57 -27.89 59.12 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.303 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.7 mt -86.65 -43.03 15.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.848 0.356 . . . . 0.0 110.843 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 35.7 mm -68.13 -29.93 46.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.023 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 6.2 tpm_? -51.89 -55.8 17.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.95 0.405 . . . . 0.0 110.9 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -111.82 14.86 21.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.195 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -99.73 -86.76 1.91 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.628 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -100.77 137.01 19.71 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 120.658 0.266 . . . . 0.0 110.966 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.88 74.48 4.92 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.406 2.071 . . . . 0.0 112.322 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 1.4 mtp -105.8 142.18 35.96 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.733 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.453 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -79.85 148.45 31.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.729 179.734 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.491 ' O ' ' N ' ' A' ' 64' ' ' THR . 1.7 pm0 -38.09 -48.82 1.26 Allowed 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.19 0.519 . . . . 0.0 111.082 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.521 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -50.86 -52.53 40.7 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.024 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 59' ' ' THR . 1.1 mm-40 -55.33 -61.71 2.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.97 0.414 . . . . 0.0 109.933 179.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.492 ' CG2' ' CE2' ' A' ' 67' ' ' PHE . 1.8 mp -57.87 -61.77 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.249 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.491 ' N ' ' O ' ' A' ' 60' ' ' GLU . 89.8 m -52.65 -52.05 57.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.419 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.521 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 51.5 tt0 -64.81 -15.58 61.95 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.625 0.726 . . . . 0.0 110.423 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.441 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.6 m-30 -95.65 -28.13 14.97 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.548 -1.205 . . . . 0.0 110.326 179.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.492 ' CE2' ' CG2' ' A' ' 63' ' ' ILE . 7.5 m-30 -77.88 -26.09 48.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.813 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -90.57 -27.62 19.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.91 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -90.73 -11.19 40.37 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 121.391 0.615 . . . . 0.0 111.752 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -93.92 -31.32 14.35 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.939 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -120.95 120.05 29.55 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.77 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -63.33 -53.87 1.28 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.467 2.112 . . . . 0.0 112.388 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -73.91 -30.22 62.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.877 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 75.35 50.57 0.08 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.509 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.9 p -95.68 31.07 2.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.822 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 62.28 30.81 77.11 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.344 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -131.37 130.17 42.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.758 0.313 . . . . 0.0 110.881 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.442 HD12 ' CZ ' ' A' ' 83' ' ' PHE . 56.1 mt -106.06 153.18 7.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.15 0.5 . . . . 0.0 111.456 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.422 ' N ' ' CG2' ' A' ' 78' ' ' ILE . 0.8 OUTLIER -98.3 95.65 7.52 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 176.923 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.417 ' C ' ' O ' ' A' ' 79' ' ' ASP . 44.4 t80 -30.66 -40.12 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.121 -178.119 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.2 mttt -66.88 -55.56 14.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.49 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -53.32 -27.77 24.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.12 0.486 . . . . 0.0 110.555 179.172 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.442 ' CZ ' HD12 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -89.02 -31.1 18.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.722 179.703 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.11 -22.46 39.11 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.312 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.33 -11.5 60.73 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 121.388 0.613 . . . . 0.0 111.708 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 33.4 mtt -70.4 -40.28 74.0 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.773 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.3 mp -91.73 -6.31 52.15 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.857 0.837 . . . . 0.0 111.513 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -124.07 22.29 8.76 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 114.123 -1.398 . . . . 0.0 111.127 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.824 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.1 ttpt . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.809 0.338 . . . . 0.0 110.733 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.645 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -56.11 -26.64 50.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.964 -179.829 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -61.66 -23.33 66.01 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -88.08 -11.63 46.54 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.375 179.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.645 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 11.3 mm -65.48 -14.25 16.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.914 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -75.59 1.88 13.24 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 113.91 -1.496 . . . . 0.0 111.819 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.27 -28.68 16.08 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.041 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.55 -24.49 56.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.0 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -96.84 30.39 2.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.987 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.858 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 . . . . . 0 N--CA 1.456 -0.134 0 CA-C-O 120.745 0.307 . . . . 0.0 110.997 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.416 HG12 ' CE2' ' A' ' 48' ' ' PHE . 12.4 p -132.35 157.96 43.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.008 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.431 ' HB2' ' CD2' ' A' ' 77' ' ' PHE . 77.9 p -108.47 150.25 27.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.89 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.433 HG12 ' CD2' ' A' ' 67' ' ' PHE . 96.2 t -56.43 -51.84 59.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.951 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -47.37 -31.0 3.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.046 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -96.37 -30.97 13.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.502 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.416 ' CE2' HG12 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -62.98 -35.25 79.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.052 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 20.9 mtt85 -55.8 -52.34 64.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.036 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -56.79 -27.87 56.41 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.397 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 21.1 mt -81.14 -25.3 10.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.848 0.356 . . . . 0.0 111.125 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 34.8 mm -93.36 -55.25 6.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.062 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.35 -34.03 68.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.319 -179.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -111.73 14.84 21.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.67 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -131.43 -89.84 0.49 Allowed Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.33 -0.938 . . . . 0.0 112.827 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.0 mp -87.02 140.82 32.83 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.681 0.276 . . . . 0.0 111.238 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -78.27 122.02 5.5 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.567 2.178 . . . . 0.0 112.325 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.411 ' C ' HD12 ' A' ' 63' ' ' ILE . 0.8 OUTLIER -155.17 137.42 14.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.778 -179.941 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.452 ' O ' ' CD1' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -72.71 145.9 46.84 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.848 179.706 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.482 ' O ' ' N ' ' A' ' 64' ' ' THR . 5.9 pt-20 -37.6 -51.79 1.2 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.29 0.567 . . . . 0.0 111.06 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.44 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -47.64 -56.11 7.93 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.867 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 66' ' ' PHE . 0.7 OUTLIER -51.16 -62.87 1.35 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.415 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.51 ' CG2' ' CE2' ' A' ' 67' ' ' PHE . 2.2 mp -56.51 -63.71 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.32 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.482 ' N ' ' O ' ' A' ' 60' ' ' GLU . 92.5 m -51.17 -52.57 42.93 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.397 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.44 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 6.4 mm-40 -65.03 -15.98 62.94 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-O 121.652 0.739 . . . . 0.0 110.377 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.3 m-30 -92.04 -27.45 17.79 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.599 -1.182 . . . . 0.0 110.3 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.51 ' CE2' ' CG2' ' A' ' 63' ' ' ILE . 4.7 m-30 -85.6 -25.53 26.61 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.921 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -94.05 -27.66 16.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.947 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.09 -11.22 44.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.39 0.614 . . . . 0.0 111.776 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.47 -28.16 13.38 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.094 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -122.51 112.14 31.23 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.681 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.08 -47.63 3.35 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.503 2.135 . . . . 0.0 112.533 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 61.8 m-80 -68.41 -31.85 71.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.971 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 71.76 31.24 2.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.569 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 46.9 p -67.57 -26.24 66.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.981 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 113.79 19.66 6.39 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.525 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.444 ' CD1' ' N ' ' A' ' 77' ' ' PHE . 3.0 m-85 -140.91 130.97 24.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.65 0.262 . . . . 0.0 110.786 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.464 HG21 ' CD1' ' A' ' 83' ' ' PHE . 2.1 mt -110.14 147.82 14.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.929 0.395 . . . . 0.0 111.468 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.436 ' O ' ' N ' ' A' ' 81' ' ' LYS . 72.6 m-20 -77.28 103.75 7.39 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 177.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.409 ' C ' ' O ' ' A' ' 79' ' ' ASP . 50.7 t80 -28.61 -40.34 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.021 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.436 ' N ' ' O ' ' A' ' 79' ' ' ASP . 10.2 mttt -62.93 -54.46 38.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.705 0.288 . . . . 0.0 110.915 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -51.79 -26.85 10.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.089 0.471 . . . . 0.0 110.743 179.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.464 ' CD1' HG21 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -93.09 -29.71 15.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.267 -179.766 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -82.4 -26.85 32.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.243 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -74.36 -11.49 60.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.438 0.637 . . . . 0.0 111.658 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 24.6 tpp -74.85 -37.71 62.16 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.713 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.7 mt -89.14 -6.52 56.93 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.86 0.838 . . . . 0.0 111.437 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -125.84 22.44 7.44 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 114.14 -1.391 . . . . 0.0 111.099 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.949 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? . . . . . 0 N--CA 1.456 -0.156 0 CA-C-O 120.842 0.353 . . . . 0.0 110.774 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.666 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -67.63 -29.07 68.29 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.786 -179.919 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -59.5 -24.27 63.49 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.7 tt -88.22 -11.3 47.07 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.406 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.666 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 11.5 mm -65.67 -14.3 16.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.921 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -77.55 2.19 17.17 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 113.887 -1.506 . . . . 0.0 111.537 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.27 -30.59 15.08 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.09 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -58.35 -25.54 62.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.116 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -96.09 38.84 1.16 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.945 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.3 p-10 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.871 179.936 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.836 0.35 . . . . 0.0 111.004 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.452 ' CG1' ' CE2' ' A' ' 48' ' ' PHE . 9.3 p -130.48 147.76 33.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.948 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 21.7 p -92.74 159.91 15.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.919 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.46 ' CG1' ' CG ' ' A' ' 67' ' ' PHE . 46.1 t -61.69 -32.81 54.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.797 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -66.69 -57.9 6.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.846 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -59.33 -31.02 68.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.826 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.452 ' CE2' ' CG1' ' A' ' 43' ' ' VAL . 0.1 OUTLIER -63.76 -40.73 97.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.962 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 10.2 mtm180 -58.6 -51.69 68.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.936 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -55.6 -25.59 43.29 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.486 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 13.0 mt -83.51 -46.11 18.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.915 0.388 . . . . 0.0 111.057 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 31.0 mm -68.52 -28.69 41.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.137 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.27 -59.34 4.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.061 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -111.88 15.02 20.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.237 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -98.06 -86.19 1.83 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.738 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.1 mt -105.96 144.7 29.44 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 120.705 0.288 . . . . 0.0 111.024 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.51 115.8 4.16 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.577 2.185 . . . . 0.0 112.235 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.411 ' C ' HD13 ' A' ' 63' ' ' ILE . 0.8 OUTLIER -153.88 138.48 16.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.726 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.463 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -76.07 147.04 38.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.646 179.592 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' A' ' 64' ' ' THR . 6.2 pt-20 -38.81 -52.13 1.72 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.214 0.53 . . . . 0.0 110.853 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.515 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -46.91 -53.31 12.49 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.09 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 59' ' ' THR . 2.0 mm-40 -55.13 -61.57 2.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.921 0.391 . . . . 0.0 110.021 179.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.504 ' CG2' ' CE2' ' A' ' 67' ' ' PHE . 1.6 mp -59.17 -61.69 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.155 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.539 ' N ' ' O ' ' A' ' 60' ' ' GLU . 69.3 m -51.39 -51.73 52.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.394 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.515 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 1.5 tp10 -65.36 -15.34 62.47 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.638 0.732 . . . . 0.0 110.412 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.428 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.6 m-30 -96.46 -25.88 15.51 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.533 -1.212 . . . . 0.0 110.415 179.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.504 ' CE2' ' CG2' ' A' ' 63' ' ' ILE . 1.7 m-85 -75.31 -30.18 60.27 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.747 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -93.18 -28.47 16.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.892 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.6 -10.96 59.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.407 0.622 . . . . 0.0 111.718 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.98 -33.4 14.87 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.067 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -120.09 116.98 32.34 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.888 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.68 -28.94 51.94 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.358 2.038 . . . . 0.0 112.185 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 53.9 m-20 -83.64 -32.09 25.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.713 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 71.79 39.94 0.81 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.118 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.5 t -90.33 39.6 0.98 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.737 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 46.55 28.67 3.61 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.463 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -132.3 129.11 39.1 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.81 0.338 . . . . 0.0 110.468 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.447 HG23 HD13 ' A' ' 78' ' ' ILE . 66.6 mt -103.11 148.77 7.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.108 0.48 . . . . 0.0 111.61 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.44 ' O ' ' N ' ' A' ' 82' ' ' ALA . 0.8 OUTLIER -96.15 95.89 8.45 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 176.698 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.437 ' C ' ' O ' ' A' ' 79' ' ' ASP . 51.2 t80 -28.56 -42.29 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.261 -177.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 79' ' ' ASP . 6.9 mmmm -63.79 -55.62 21.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.823 0.344 . . . . 0.0 110.619 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -52.32 -30.7 29.62 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.172 0.511 . . . . 0.0 110.411 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.429 ' CZ ' HD12 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -85.56 -32.59 22.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.695 179.807 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.21 -23.77 43.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.2 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.8 -11.4 60.59 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.411 0.624 . . . . 0.0 111.804 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 13.2 tpp -76.64 -32.04 57.76 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.61 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.6 mt -94.05 -6.24 45.63 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 121.885 0.85 . . . . 0.0 111.33 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -125.95 22.06 7.43 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.081 -1.418 . . . . 0.0 111.212 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.957 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.4 ttpt . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.817 0.341 . . . . 0.0 110.788 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.645 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -71.57 -28.86 64.13 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.914 -179.967 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -59.92 -24.22 64.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.215 0.531 . . . . 0.0 109.683 178.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 tt -88.3 -11.27 46.92 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.519 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.645 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 12.0 mm -63.59 -15.12 15.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.865 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -79.04 2.17 21.48 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 113.919 -1.491 . . . . 0.0 111.478 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.29 -29.35 15.71 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.107 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -56.47 -24.39 45.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.15 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -96.9 34.43 1.71 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.025 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.821 -179.932 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 9.6 t80 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.811 0.338 . . . . 0.0 110.939 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.418 HG13 ' CD2' ' A' ' 48' ' ' PHE . 10.4 p -124.37 132.92 70.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.966 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.51 147.45 25.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.854 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.443 HG12 ' CD1' ' A' ' 67' ' ' PHE . 88.8 t -53.37 -55.14 14.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.065 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -47.21 -31.98 4.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.906 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -88.3 -29.75 20.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.358 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.418 ' CD2' HG13 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -69.04 -38.15 78.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.809 179.806 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 18.7 mtt180 -58.23 -51.21 70.69 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.991 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -55.94 -25.78 46.42 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.394 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 21.8 mt -83.08 -44.54 18.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.874 0.368 . . . . 0.0 111.065 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 35.8 mm -68.07 -27.27 36.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.138 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.8 ttm180 -52.8 -58.79 5.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.993 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -111.75 14.98 21.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.344 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -99.41 -86.53 1.89 Allowed Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.632 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.9 mt -103.48 143.72 27.2 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 120.631 0.253 . . . . 0.0 110.982 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.48 85.28 1.6 Allowed 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.549 2.166 . . . . 0.0 112.166 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.413 ' C ' HD13 ' A' ' 63' ' ' ILE . 3.8 ttt -124.28 140.84 52.58 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.796 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.601 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 0.8 OUTLIER -89.32 143.41 26.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.613 179.36 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.616 ' O ' ' N ' ' A' ' 64' ' ' THR . 0.2 OUTLIER -41.99 -53.16 3.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.369 0.604 . . . . 0.0 110.637 -179.852 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.487 ' N ' ' CG ' ' A' ' 60' ' ' GLU . . . -44.68 -28.93 0.67 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.004 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.601 ' HG2' ' O ' ' A' ' 59' ' ' THR . 1.5 mm-40 -89.57 -51.43 5.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.736 0.303 . . . . 0.0 110.458 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.501 ' CG2' ' CE2' ' A' ' 67' ' ' PHE . 1.0 OUTLIER -74.35 -44.69 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.347 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.616 ' N ' ' O ' ' A' ' 60' ' ' GLU . 50.6 m -62.96 -48.92 76.82 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.024 0.44 . . . . 0.0 109.991 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.408 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 3.2 tm-20 -66.68 -16.2 64.05 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.714 0.768 . . . . 0.0 110.301 179.297 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.2 m-85 -96.78 -23.61 16.32 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.469 -1.242 . . . . 0.0 110.357 178.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.501 ' CE2' ' CG2' ' A' ' 63' ' ' ILE . 2.1 m-85 -74.52 -36.06 63.19 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.736 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -76.42 -30.36 57.39 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.861 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.28 -11.08 59.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.476 0.655 . . . . 0.0 111.653 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -95.58 -30.25 13.91 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.985 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -128.31 106.22 19.54 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.825 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.43 -30.92 43.55 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.404 2.069 . . . . 0.0 112.276 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 63.6 m-80 -76.81 -27.64 55.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.917 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 72.51 36.7 0.97 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.128 0.489 . . . . 0.0 110.13 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.1 t -85.65 13.14 7.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.975 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 69.45 26.57 74.41 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.262 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -117.39 178.48 4.36 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.701 0.286 . . . . 0.0 110.571 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.453 HG23 HD12 ' A' ' 78' ' ' ILE . 65.4 mt -153.62 153.54 8.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.206 0.527 . . . . 0.0 111.724 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.429 ' O ' ' C ' ' A' ' 80' ' ' TYR . 24.2 t0 -99.55 95.97 7.35 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 176.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.429 ' C ' ' O ' ' A' ' 79' ' ' ASP . 44.8 t80 -28.7 -41.37 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.366 -178.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.418 ' N ' ' O ' ' A' ' 79' ' ' ASP . 3.4 mtmt -66.2 -56.61 10.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.717 0.294 . . . . 0.0 110.68 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -51.9 -27.71 13.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.043 0.449 . . . . 0.0 110.614 179.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.448 ' CZ ' HD11 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -89.83 -31.91 17.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.743 179.923 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.09 -18.64 55.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.339 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -71.08 -11.56 61.02 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.366 0.603 . . . . 0.0 111.882 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.96 -34.6 62.06 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.784 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.1 mt -92.72 -6.73 48.53 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.851 0.834 . . . . 0.0 111.483 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -126.08 22.31 7.31 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.108 -1.405 . . . . 0.0 111.057 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.6 p . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.961 179.917 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.6 tttp . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.773 0.321 . . . . 0.0 110.72 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.638 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -67.63 -28.79 68.03 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.845 -179.815 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 89.3 mm-40 -61.13 -24.91 66.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.204 0.526 . . . . 0.0 109.594 178.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.0 tt -88.3 -11.28 46.88 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.539 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.638 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 11.2 mm -61.43 -15.58 13.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 114.973 -1.012 . . . . 0.0 112.03 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -77.84 1.81 19.19 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 113.983 -1.462 . . . . 0.0 111.559 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.62 -28.15 16.17 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.009 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -58.12 -20.53 40.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.315 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -93.07 24.02 3.98 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.334 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.93 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.805 0.336 . . . . 0.0 110.952 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.454 ' CG1' ' CE2' ' A' ' 48' ' ' PHE . 10.3 p -117.97 123.67 72.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.991 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.95 155.59 40.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.965 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.48 ' CG2' HG13 ' A' ' 78' ' ' ILE . 59.8 t -60.17 -32.51 50.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.806 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -65.2 -61.38 2.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.013 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -57.62 -30.66 65.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.918 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.454 ' CE2' ' CG1' ' A' ' 43' ' ' VAL . 0.1 OUTLIER -62.1 -40.73 96.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.011 -179.909 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.419 ' HG3' ' CE2' ' A' ' 67' ' ' PHE . 65.5 mtt180 -58.76 -51.73 68.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.986 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -55.91 -25.85 46.39 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.505 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 12.4 mt -82.56 -45.64 19.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.882 0.372 . . . . 0.0 111.045 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 35.6 mm -68.57 -28.4 40.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.237 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 17.9 ttp180 -48.75 -60.37 2.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.063 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -111.86 14.89 21.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.109 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -96.64 -85.68 1.76 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.606 -0.806 . . . . 0.0 112.772 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.1 mp -106.34 144.97 30.05 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.594 0.235 . . . . 0.0 111.105 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.59 113.26 3.62 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.523 2.148 . . . . 0.0 112.222 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.4 ' C ' HD11 ' A' ' 63' ' ' ILE . 0.9 OUTLIER -152.68 138.97 18.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.762 -179.97 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.454 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -77.16 147.67 36.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.529 179.57 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.55 ' O ' ' N ' ' A' ' 64' ' ' THR . 0.5 OUTLIER -38.62 -52.21 1.64 Allowed 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.271 0.558 . . . . 0.0 110.932 179.705 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 65' ' ' GLU . . . -46.76 -55.94 7.03 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.792 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 59' ' ' THR . 1.9 mm-40 -52.07 -62.26 1.75 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.945 0.402 . . . . 0.0 109.932 179.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.497 ' CG2' ' CE2' ' A' ' 67' ' ' PHE . 1.4 mp -59.04 -63.16 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.217 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.55 ' N ' ' O ' ' A' ' 60' ' ' GLU . 75.7 m -49.32 -52.31 28.73 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.475 -179.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' A' ' 61' ' ' ALA . 3.3 mm-40 -65.63 -15.6 62.91 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 121.698 0.761 . . . . 0.0 110.417 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.429 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.5 m-30 -96.17 -24.74 16.12 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.476 -1.238 . . . . 0.0 110.465 179.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.497 ' CE2' ' CG2' ' A' ' 63' ' ' ILE . 1.6 m-30 -76.44 -30.85 57.53 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.826 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.69 -26.88 16.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.092 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -82.66 -10.91 58.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.511 0.672 . . . . 0.0 111.96 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.17 -33.96 13.11 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.27 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 48.1 p-10 -110.54 122.5 38.23 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.869 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.59 -47.39 1.44 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.447 2.098 . . . . 0.0 112.479 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -68.54 -30.45 69.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.066 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.2 m120 73.84 22.06 2.56 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.413 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.2 t -66.23 -15.68 63.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.183 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.56 22.23 9.81 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.19 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -125.34 129.44 49.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.799 0.333 . . . . 0.0 110.426 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.48 HG13 ' CG2' ' A' ' 45' ' ' VAL . 66.6 mt -99.49 146.89 7.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.223 0.535 . . . . 0.0 111.794 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.44 ' N ' HG22 ' A' ' 78' ' ' ILE . 0.9 OUTLIER -91.94 96.0 10.13 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 176.598 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.426 ' C ' ' O ' ' A' ' 79' ' ' ASP . 56.4 t80 -28.55 -40.95 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -177.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.423 ' N ' ' O ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -65.19 -55.53 18.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.768 0.318 . . . . 0.0 110.718 179.644 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -51.9 -28.3 15.77 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.104 0.478 . . . . 0.0 110.6 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.435 ' CD1' HG23 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -89.71 -31.9 17.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.812 179.967 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -80.49 -20.8 42.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.324 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.12 -11.57 60.81 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.437 0.637 . . . . 0.0 111.824 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 14.4 mmt -74.03 -33.64 63.83 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.786 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.4 mt -95.58 -6.59 39.96 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.831 0.824 . . . . 0.0 111.476 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -125.91 22.18 7.44 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 114.178 -1.374 . . . . 0.0 111.041 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.877 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? . . . . . 0 N--CA 1.457 -0.119 0 CA-C-O 120.845 0.355 . . . . 0.0 110.699 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.662 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -66.91 -28.49 68.36 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.746 -179.933 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -59.3 -23.67 62.63 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.0 tt -88.0 -11.36 47.57 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.508 179.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.662 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 11.3 mm -67.59 -13.81 17.35 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.934 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -77.01 2.04 16.11 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 113.935 -1.484 . . . . 0.0 111.564 179.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.21 -30.54 15.14 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.034 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -59.58 -29.11 67.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.91 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -97.57 28.17 3.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.0 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.947 179.962 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 62.5 t80 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.946 0.403 . . . . 0.0 111.048 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.41 HG13 ' CE2' ' A' ' 48' ' ' PHE . 4.4 p -136.41 106.17 5.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.754 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.4 m -59.01 153.74 17.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.084 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.441 HG12 ' CD1' ' A' ' 67' ' ' PHE . 92.9 t -57.03 -56.84 12.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.045 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -47.41 -29.71 2.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.058 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -88.43 -29.79 19.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.602 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.41 ' CE2' HG13 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -64.68 -30.79 71.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.799 179.876 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.4 mtt-85 -56.06 -51.23 68.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.951 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -57.49 -25.03 54.39 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.452 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 34.0 mt -83.35 -27.92 7.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.754 0.312 . . . . 0.0 111.156 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 41.7 mm -90.45 -49.18 13.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.085 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.3 -35.73 62.94 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.198 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -111.81 14.72 21.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.426 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -123.24 -90.1 0.94 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.662 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.4 mp -97.8 142.93 25.34 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.645 0.26 . . . . 0.0 110.94 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -78.92 57.94 6.67 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.525 2.15 . . . . 0.0 112.439 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.409 ' C ' HD11 ' A' ' 63' ' ' ILE . 5.3 ttt -86.58 136.19 33.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.72 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.464 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 1.0 OUTLIER -81.76 142.05 32.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.789 0.328 . . . . 0.0 110.631 179.645 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.608 ' O ' ' N ' ' A' ' 64' ' ' THR . 0.2 OUTLIER -41.16 -52.92 3.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.328 0.585 . . . . 0.0 110.844 -179.844 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.483 ' N ' ' CG ' ' A' ' 60' ' ' GLU . . . -45.01 -27.09 0.5 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.938 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.48 ' O ' ' HB2' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -91.07 -51.73 5.19 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.672 0.272 . . . . 0.0 110.32 179.729 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.51 ' O ' ' N ' ' A' ' 67' ' ' PHE . 1.2 mp -73.65 -43.35 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.201 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.608 ' N ' ' O ' ' A' ' 60' ' ' GLU . 24.3 m -64.6 -47.78 77.36 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.027 0.441 . . . . 0.0 109.961 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.408 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 5.7 tt0 -65.66 -17.28 64.49 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.693 0.758 . . . . 0.0 110.188 179.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.48 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 1.0 OUTLIER -97.02 -26.92 14.84 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.243 178.829 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.51 ' N ' ' O ' ' A' ' 63' ' ' ILE . 2.0 m-85 -68.13 -47.36 68.31 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.738 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.77 -26.81 54.94 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.994 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.77 -11.06 59.92 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.445 0.64 . . . . 0.0 111.779 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -95.84 -32.78 12.5 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.006 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -119.85 120.43 30.43 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.744 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.65 -27.78 45.04 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.344 2.029 . . . . 0.0 112.222 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 30.2 m-20 -84.6 -32.35 23.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.904 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.2 m120 71.31 40.4 0.85 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.038 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.403 ' OG1' ' CE2' ' A' ' 77' ' ' PHE . 1.4 t -90.37 40.57 1.02 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.644 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 50.33 25.72 8.65 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.763 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.403 ' CE2' ' OG1' ' A' ' 75' ' ' THR . 17.5 m-85 -125.23 148.94 48.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.874 0.369 . . . . 0.0 110.779 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.446 HD12 ' CZ ' ' A' ' 83' ' ' PHE . 54.1 mt -127.14 153.12 35.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.203 0.525 . . . . 0.0 111.552 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.435 ' N ' HG22 ' A' ' 78' ' ' ILE . 1.0 OUTLIER -98.11 96.0 7.82 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 176.863 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.42 ' C ' ' O ' ' A' ' 79' ' ' ASP . 70.6 t80 -29.23 -40.86 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -178.084 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 79' ' ' ASP . 1.9 mmmm -68.72 -54.44 16.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.733 0.301 . . . . 0.0 110.699 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -52.59 -26.82 14.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.015 0.436 . . . . 0.0 110.577 179.129 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.446 ' CZ ' HD12 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -91.9 -35.27 14.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.844 -179.898 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.404 ' O ' ' CD2' ' A' ' 88' ' ' TYR . . . -76.56 -29.09 56.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.398 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -74.43 -11.33 60.21 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.396 0.617 . . . . 0.0 111.824 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 13.0 mmm -84.04 -28.97 27.26 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.942 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.5 mt -100.83 -7.09 23.93 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.778 0.799 . . . . 0.0 111.819 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.404 ' CD2' ' O ' ' A' ' 84' ' ' ALA . 10.8 m-85 -125.99 21.87 7.44 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 114.377 -1.283 . . . . 0.0 111.339 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.0 m . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.409 179.886 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.5 ttpp . . . . . 0 N--CA 1.457 -0.076 0 CA-C-O 120.883 0.373 . . . . 0.0 110.745 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.663 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -68.29 -28.58 67.31 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.8 -179.89 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -58.95 -23.92 62.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.159 0.504 . . . . 0.0 109.781 178.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 tt -88.07 -11.39 47.29 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.407 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.663 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 11.2 mm -67.26 -13.6 16.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.959 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -76.32 2.19 14.09 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 113.944 -1.48 . . . . 0.0 111.676 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.31 -29.44 16.37 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.092 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -57.23 -28.21 62.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.055 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -97.42 37.76 1.33 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.919 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.8 t30 . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.852 -179.971 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.837 0.351 . . . . 0.0 110.916 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.451 ' CG1' ' CE2' ' A' ' 48' ' ' PHE . 9.1 p -117.56 122.19 69.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.966 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.401 ' OG ' ' CE1' ' A' ' 77' ' ' PHE . 0.7 OUTLIER -74.0 155.38 38.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.839 -179.988 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.434 HG12 ' CD2' ' A' ' 67' ' ' PHE . 49.7 t -59.71 -53.13 52.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.773 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -49.14 -37.07 20.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.749 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -80.84 -29.1 35.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.439 179.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.451 ' CE2' ' CG1' ' A' ' 43' ' ' VAL . 0.1 OUTLIER -70.66 -40.05 73.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.782 179.91 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 46.0 mtm180 -56.96 -51.82 67.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.943 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -54.23 -25.41 32.73 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.327 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.0 mt -89.61 -43.68 14.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.847 0.355 . . . . 0.0 110.869 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 36.6 mm -70.7 -26.97 29.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.211 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.33 -60.22 3.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.106 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -111.87 14.92 21.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.336 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -101.84 -87.29 1.98 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.75 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.9 mp -90.92 133.4 32.22 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.509 0.195 . . . . 0.0 111.147 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -77.91 87.58 1.51 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.54 2.16 . . . . 0.0 112.289 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 1.2 mtp -125.08 141.27 52.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.774 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.464 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -77.99 148.92 34.18 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.642 179.673 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.506 ' O ' ' N ' ' A' ' 64' ' ' THR . 5.4 pt-20 -38.76 -52.0 1.7 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.258 0.551 . . . . 0.0 110.851 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.524 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -47.17 -53.2 13.63 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.038 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.464 ' HG2' ' O ' ' A' ' 59' ' ' THR . 2.2 mm-40 -55.08 -61.72 2.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.928 0.394 . . . . 0.0 109.975 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.496 ' O ' ' N ' ' A' ' 67' ' ' PHE . 1.7 mp -58.72 -61.7 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.168 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.506 ' N ' ' O ' ' A' ' 60' ' ' GLU . 58.9 m -51.8 -51.45 56.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.343 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.524 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 50.9 tt0 -65.62 -15.45 62.76 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 121.686 0.755 . . . . 0.0 110.458 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.435 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.6 m-30 -96.15 -26.52 15.44 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.519 -1.219 . . . . 0.0 110.372 179.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.496 ' N ' ' O ' ' A' ' 63' ' ' ILE . 5.1 m-30 -77.8 -26.68 49.78 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.827 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -90.75 -28.43 18.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.882 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.94 -11.2 45.13 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.459 0.647 . . . . 0.0 111.732 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -92.15 -29.72 16.34 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.078 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -125.64 119.29 24.44 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.789 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -64.85 -40.69 20.52 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.421 2.081 . . . . 0.0 112.189 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -77.4 -31.31 54.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.758 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 72.18 38.9 0.83 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.103 0.477 . . . . 0.0 110.144 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.5 t -89.7 41.27 1.03 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.529 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 50.88 25.39 9.51 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.688 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.401 ' CE1' ' OG ' ' A' ' 44' ' ' SER . 2.5 m-85 -126.06 129.5 49.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.761 0.315 . . . . 0.0 110.84 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.485 HG23 HD12 ' A' ' 78' ' ' ILE . 55.7 mt -103.13 153.27 5.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.184 0.516 . . . . 0.0 111.379 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.427 ' N ' ' CG2' ' A' ' 78' ' ' ILE . 10.1 t0 -99.41 95.66 7.18 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 176.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.417 ' C ' ' O ' ' A' ' 79' ' ' ASP . 47.3 t80 -29.35 -41.32 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.066 -0.515 . . . . 0.0 112.287 -178.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 79' ' ' ASP . 21.9 mttt -65.93 -55.82 14.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.562 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -53.05 -26.16 14.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.044 0.449 . . . . 0.0 110.574 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.432 ' CZ ' HD11 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -91.55 -30.49 16.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.895 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.05 -45.58 16.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.359 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -71.4 -11.62 60.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.412 0.625 . . . . 0.0 111.816 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 14.7 tpp -68.67 -35.44 77.23 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.656 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.2 mp -100.63 -6.76 24.74 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.777 0.798 . . . . 0.0 111.556 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -125.82 22.44 7.45 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 114.271 -1.331 . . . . 0.0 111.176 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.829 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.1 tmtm? . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.738 0.304 . . . . 0.0 110.641 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.667 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -68.03 -29.11 68.02 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.765 -179.923 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.0 mm100 -59.79 -23.93 63.7 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.15 -11.25 47.44 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.468 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.667 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 10.8 mm -66.58 -13.74 16.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.987 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -76.4 2.11 14.49 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 113.923 -1.49 . . . . 0.0 111.658 179.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.62 -29.82 15.93 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.138 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -59.76 -27.31 66.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.123 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -94.81 42.89 1.09 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.028 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.973 179.896 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.845 0.355 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.422 HG13 ' CD2' ' A' ' 48' ' ' PHE . 10.3 p -128.52 124.52 61.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.936 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 51.1 p -76.46 148.22 37.38 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.925 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.454 HG12 ' CD2' ' A' ' 67' ' ' PHE . 57.5 t -58.45 -39.56 75.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.836 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -56.06 -30.26 61.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.979 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -96.42 -31.9 12.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.886 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.422 ' CD2' HG13 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -58.77 -41.21 86.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.084 -179.757 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.54 -48.62 78.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.008 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -59.56 -28.04 64.52 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.434 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.6 mt -86.47 -49.99 14.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.95 0.405 . . . . 0.0 110.989 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 tp -57.83 -40.5 76.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.278 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 13.6 mtp85 -47.63 -68.34 0.2 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.169 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -93.3 14.66 17.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.018 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.51 -57.86 0.5 Allowed Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.592 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.4 mt -129.09 135.58 27.83 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.649 0.261 . . . . 0.0 111.015 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -78.95 97.38 1.13 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.641 2.227 . . . . 0.0 112.246 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 1.3 mtp -129.52 140.28 51.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.814 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.449 ' O ' ' CD1' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -77.88 148.12 34.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.674 179.677 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.483 ' O ' ' N ' ' A' ' 64' ' ' THR . 6.1 pt-20 -39.53 -52.22 2.17 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.166 0.508 . . . . 0.0 111.064 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.529 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -47.98 -52.45 19.73 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.949 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' A' ' 66' ' ' PHE . 0.9 OUTLIER -55.36 -62.4 1.7 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.377 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.481 ' CG2' ' CZ ' ' A' ' 67' ' ' PHE . 1.8 mp -56.59 -61.82 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.964 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.483 ' N ' ' O ' ' A' ' 60' ' ' GLU . 55.3 m -52.14 -50.4 61.81 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.061 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.529 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 2.3 tp10 -65.99 -15.87 63.39 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 121.579 0.704 . . . . 0.0 110.459 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.445 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 2.4 m-85 -96.31 -24.48 16.17 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.42 179.066 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.481 ' CZ ' ' CG2' ' A' ' 63' ' ' ILE . 8.5 m-30 -81.62 -28.92 33.47 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.797 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -94.12 -28.79 15.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.891 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.53 -11.19 54.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.402 0.62 . . . . 0.0 111.796 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -103.5 -30.2 10.68 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.015 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -119.63 95.74 49.35 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.813 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -65.04 -35.79 41.01 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.5 2.133 . . . . 0.0 112.325 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -77.36 -30.4 53.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.875 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.1 m120 74.28 49.05 0.11 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.594 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.1 p -95.2 25.27 4.39 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.815 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 53.78 23.66 22.85 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.189 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -142.8 129.24 20.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.779 0.323 . . . . 0.0 110.442 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.465 HG21 ' CD1' ' A' ' 83' ' ' PHE . 7.2 mt -105.48 156.99 6.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.051 0.453 . . . . 0.0 111.67 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.444 ' O ' ' N ' ' A' ' 82' ' ' ALA . 1.7 m-20 -85.11 97.59 9.96 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 176.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.414 ' C ' ' O ' ' A' ' 79' ' ' ASP . 50.0 t80 -28.48 -39.77 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -177.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.442 ' N ' ' O ' ' A' ' 79' ' ' ASP . 5.4 mmmm -65.11 -53.16 49.56 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.693 0.282 . . . . 0.0 110.698 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -54.11 -25.47 22.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.933 0.397 . . . . 0.0 110.594 179.198 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.465 ' CD1' HG21 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -94.15 -30.15 14.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.102 -179.67 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.34 -38.8 26.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.315 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.66 -11.45 60.42 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.392 0.615 . . . . 0.0 111.716 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 36.9 tpp -67.49 -36.16 80.55 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.74 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.8 mp -100.74 -6.78 24.5 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 121.865 0.841 . . . . 0.0 111.537 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -124.61 22.34 8.31 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 114.135 -1.393 . . . . 0.0 111.111 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.061 179.997 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.943 0.401 . . . . 0.0 110.6 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.67 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -69.09 -28.85 66.87 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.817 -179.862 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.4 -24.22 63.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.168 0.509 . . . . 0.0 109.675 178.529 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.4 tt -88.23 -11.29 47.05 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.451 179.691 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.67 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 12.4 mm -65.65 -14.48 17.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 114.794 -1.094 . . . . 0.0 112.007 -179.899 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -79.02 2.25 21.13 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 113.872 -1.513 . . . . 0.0 111.427 179.526 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.16 -30.8 15.05 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.171 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -59.05 -30.85 68.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.92 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -98.43 34.99 1.87 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.984 179.906 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.943 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.404 ' CZ ' ' O ' ' A' ' 78' ' ' ILE . 10.5 t80 . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.811 0.339 . . . . 0.0 111.017 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.439 ' CG1' ' CE2' ' A' ' 48' ' ' PHE . 8.0 p -123.67 115.93 46.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.004 179.774 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.4 p -71.69 149.38 45.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.91 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.43 HG12 ' CD2' ' A' ' 67' ' ' PHE . 82.0 t -54.51 -55.03 17.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.963 179.844 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -47.72 -30.63 4.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.971 -179.833 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -87.62 -30.04 20.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.443 179.391 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.439 ' CE2' ' CG1' ' A' ' 43' ' ' VAL . 0.1 OUTLIER -68.95 -36.16 77.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.903 179.88 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 37.5 mtt-85 -55.47 -51.54 66.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.027 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -57.03 -22.22 41.53 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.531 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 28.3 mt -89.86 -26.24 5.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.769 0.319 . . . . 0.0 111.223 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 31.2 mm -93.15 -28.65 4.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.228 -179.905 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.8 ttm-85 -56.31 -54.98 38.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.351 -179.648 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -111.76 15.08 21.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.621 -179.566 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -105.31 -87.89 2.02 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.819 -179.8 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.1 mp -99.6 139.85 21.17 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-O 120.674 0.273 . . . . 0.0 111.11 -179.725 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.0 117.78 4.79 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.478 2.119 . . . . 0.0 112.252 179.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.422 ' C ' HD12 ' A' ' 63' ' ' ILE . 0.6 OUTLIER -153.12 137.9 17.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.811 -179.881 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.443 ' O ' ' CD1' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -75.45 146.75 40.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.653 179.506 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.532 ' O ' ' N ' ' A' ' 64' ' ' THR . 0.5 OUTLIER -39.07 -52.45 1.85 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.299 0.571 . . . . 0.0 111.011 179.744 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.511 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -46.34 -53.21 11.29 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.105 179.63 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 66' ' ' PHE . 0.5 OUTLIER -55.67 -61.33 2.43 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.872 0.368 . . . . 0.0 110.077 179.439 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.523 ' CG2' ' CE2' ' A' ' 67' ' ' PHE . 1.5 mp -59.39 -61.3 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.115 179.776 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.532 ' N ' ' O ' ' A' ' 60' ' ' GLU . 65.2 m -51.59 -51.67 53.67 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.232 -179.844 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.511 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 6.7 tt0 -65.75 -15.42 62.83 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-O 121.623 0.725 . . . . 0.0 110.389 179.778 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.446 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.4 m-30 -95.25 -25.49 16.33 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.537 -1.211 . . . . 0.0 110.389 179.114 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.523 ' CE2' ' CG2' ' A' ' 63' ' ' ILE . 2.6 m-30 -80.15 -28.94 38.79 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.719 179.942 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.42 -30.24 22.24 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.859 179.918 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.12 -11.13 59.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.503 0.668 . . . . 0.0 111.691 180.0 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.02 -29.9 12.64 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.836 -1.074 . . . . 0.0 111.035 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -124.43 117.06 26.65 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.755 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.37 -50.28 2.05 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.372 2.048 . . . . 0.0 112.301 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -68.48 -32.77 73.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.852 179.911 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 6.1 m120 75.38 52.36 0.07 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.644 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 13.6 p -97.6 30.04 3.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.649 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 58.75 25.89 59.49 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.287 -179.717 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -127.75 131.13 49.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.802 0.334 . . . . 0.0 110.77 179.876 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.468 HG23 HD11 ' A' ' 78' ' ' ILE . 58.2 mt -105.05 152.64 6.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.233 0.539 . . . . 0.0 111.594 -179.764 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.43 ' N ' HG22 ' A' ' 78' ' ' ILE . 0.5 OUTLIER -99.01 95.58 7.23 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 176.912 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.422 ' C ' ' O ' ' A' ' 79' ' ' ASP . 38.6 t80 -28.93 -41.63 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.312 -178.081 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' A' ' 79' ' ' ASP . 4.4 mptt -65.86 -56.13 13.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.655 179.781 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.41 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -52.81 -26.83 15.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.944 0.402 . . . . 0.0 110.59 179.221 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.446 ' CZ ' HD13 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -90.47 -31.98 16.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.813 179.956 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.46 ' O ' ' CD2' ' A' ' 88' ' ' TYR . . . -75.61 -41.38 54.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.225 179.946 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.451 ' HA ' ' CE2' ' A' ' 88' ' ' TYR . . . -61.97 -12.06 16.49 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.333 0.587 . . . . 0.0 112.035 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 8.8 mmt -79.27 -21.25 46.35 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.205 179.884 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 19.9 mt -100.6 -15.57 17.75 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 121.677 0.751 . . . . 0.0 112.366 -179.593 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.46 ' CD2' ' O ' ' A' ' 84' ' ' ALA . 33.1 p90 -127.93 21.62 6.34 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.33 179.017 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.829 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.3 tpt . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 120.669 0.271 . . . . 16.34 111.35 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -63.12 131.46 42.37 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 121.108 -0.568 . . . . 14.78 112.552 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 55.2 m 59.5 52.56 5.68 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.019 0.438 . . . . 13.61 110.927 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.5 m -80.45 -32.47 37.2 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.016 -0.538 . . . . 13.05 111.443 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -76.8 68.03 2.95 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 121.044 0.45 . . . . 13.58 110.908 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.475 ' HA ' ' CD2' ' A' ' 10' ' ' HIS . 80.7 t60 -176.32 -60.81 0.01 OUTLIER 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.831 -0.622 . . . . 11.9 110.647 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 -105.34 -48.36 3.71 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.143 -0.48 . . . . 11.16 111.026 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -62.13 -71.39 0.15 Allowed 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.468 -0.333 . . . . 11.12 111.041 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 6.4 m170 -156.55 121.59 4.65 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.798 0.332 . . . . 11.11 111.379 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.475 ' CD2' ' HA ' ' A' ' 6' ' ' HIS . 0.2 OUTLIER -90.77 -157.24 0.48 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.951 -0.568 . . . . 11.14 109.988 179.271 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.8 p -47.7 -42.19 24.47 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.751 0.31 . . . . 10.13 110.494 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 57.8 m -111.16 139.57 46.43 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.972 -0.558 . . . . 9.84 109.976 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.25 81.03 0.6 Allowed Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.914 -0.66 . . . . 10.27 112.787 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 49.47 56.86 7.18 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.001 0.429 . . . . 11.66 110.83 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.2 t -112.43 96.36 35.62 Favored Pre-proline 0 C--O 1.233 0.222 0 CA-C-N 115.951 -0.568 . . . . 11.67 111.453 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.05 -33.59 25.11 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.648 2.232 . . . . 11.66 112.176 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 37.0 ptt85 -67.29 171.36 5.95 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.24 -0.436 . . . . 13.05 111.087 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.32 -65.08 2.21 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.95 -0.643 . . . . 9.84 111.909 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 74.6 m -105.9 31.11 5.28 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 120.836 0.351 . . . . 9.69 110.737 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -92.44 -161.91 0.88 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.155 -0.475 . . . . 11.31 110.609 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -78.18 75.13 4.72 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.046 0.45 . . . . 10.3 110.9 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.7 m -98.61 5.28 47.91 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.954 -0.566 . . . . 7.22 111.768 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.447 ' HA ' ' OG1' ' A' ' 26' ' ' THR . 12.9 m-20 -95.32 -15.61 23.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.153 -0.476 . . . . 6.47 112.167 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -62.28 -19.51 63.33 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.469 -0.787 . . . . 6.87 111.287 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.405 ' HG2' ' HB3' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -89.46 -42.11 11.68 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.959 -1.019 . . . . 5.43 109.708 178.253 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.713 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.8 OUTLIER -67.24 -29.24 68.83 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.27 -0.423 . . . . 5.02 111.067 179.163 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.553 ' HB3' ' HG2' ' A' ' 57' ' ' PRO . 25.1 mt-30 -68.78 -31.86 71.18 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 109.177 -0.675 . . . . 6.37 109.177 177.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.469 HD23 HD21 ' A' ' 87' ' ' LEU . 0.4 OUTLIER -84.33 -10.14 57.86 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.587 -0.733 . . . . 3.69 112.166 179.032 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.713 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 7.1 mm -52.91 -18.37 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 115.345 -0.843 . . . . 5.57 112.589 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -67.91 1.07 2.86 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.366 -1.288 . . . . 6.67 112.749 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.15 -40.87 67.71 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.049 -0.523 . . . . 6.33 110.226 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.415 ' HA ' ' HB2' ' A' ' 36' ' ' ASP . 62.1 m-85 -62.9 -30.09 71.27 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.364 -0.38 . . . . 7.93 110.336 178.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.573 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -115.21 78.36 1.16 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.198 -0.456 . . . . 8.9 110.446 179.686 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.573 ' CB ' ' O ' ' A' ' 33' ' ' TYR . 28.0 t30 127.8 18.95 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.495 1.118 . . . . 9.16 111.501 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -176.75 39.92 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.841 0.353 . . . . 8.13 110.965 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.415 ' HB2' ' HA ' ' A' ' 32' ' ' PHE . 0.7 OUTLIER -159.28 44.91 0.26 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.885 0.374 . . . . 10.54 111.08 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -88.19 -66.17 1.31 Allowed Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.987 -0.625 . . . . 11.84 112.19 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -150.16 66.02 0.97 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.023 0.439 . . . . 12.49 110.572 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -130.27 140.57 50.67 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.924 -0.58 . . . . 14.37 111.085 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.4 -162.38 0.5 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.098 -0.501 . . . . 9.62 110.775 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -85.82 43.15 3.21 Favored Glycine 0 C--N 1.337 0.605 0 C-N-CA 120.945 -0.645 . . . . 7.91 112.961 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -155.23 123.84 6.04 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.709 0.29 . . . . 7.93 110.941 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.469 ' O ' ' HB ' ' A' ' 78' ' ' ILE . 7.4 p -142.84 128.66 16.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.183 -0.462 . . . . 5.91 110.728 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 77' ' ' PHE . 11.7 p -70.34 150.55 46.2 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.779 0.323 . . . . 6.83 111.271 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.658 ' CG2' HG13 ' A' ' 78' ' ' ILE . 38.3 t -57.48 -42.75 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 115.936 -0.575 . . . . 5.56 110.781 179.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.457 ' HA ' ' HD2' ' A' ' 49' ' ' ARG . 1.3 mt-10 -52.44 -50.3 62.86 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.718 -0.674 . . . . 8.18 110.931 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.19 -41.45 77.15 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.366 -0.379 . . . . 9.34 110.347 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -55.67 -43.26 76.17 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.838 -0.619 . . . . 5.8 111.386 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.457 ' HD2' ' HA ' ' A' ' 46' ' ' GLU . 58.3 mtt180 -53.74 -52.49 59.99 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.394 -0.366 . . . . 8.61 111.398 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -58.93 -42.09 96.59 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 121.151 -0.547 . . . . 8.76 112.814 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.9 mt -67.59 -47.17 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 CA-C-O 120.643 0.258 . . . . 7.65 111.101 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.46 HG22 HG12 ' A' ' 63' ' ' ILE . 4.7 mm -62.97 -36.79 77.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 116.101 -0.499 . . . . 6.94 111.917 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 19.1 mtt85 -47.59 -59.37 3.31 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.264 0.468 . . . . 11.12 112.264 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -111.81 15.1 21.02 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 111.958 0.355 . . . . 10.92 111.958 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.52 -70.67 0.63 Allowed Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.939 -0.648 . . . . 7.8 112.874 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.1 mt -104.71 116.15 61.44 Favored Pre-proline 0 CA--C 1.53 0.194 0 CA-C-O 120.554 0.216 . . . . 6.14 111.163 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.553 ' HG2' ' HB3' ' A' ' 27' ' ' GLN . 38.9 Cg_endo -66.22 97.58 0.36 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.806 2.337 . . . . 7.52 112.102 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.489 ' HB3' HG13 ' A' ' 63' ' ' ILE . 1.0 OUTLIER -138.44 144.68 40.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.536 -0.757 . . . . 7.04 110.813 -179.81 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.484 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -85.91 154.02 21.8 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.946 -0.57 . . . . 9.17 110.284 179.305 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.51 ' HA ' HD13 ' A' ' 63' ' ' ILE . 4.7 pt-20 -45.13 -52.68 8.95 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.813 0.339 . . . . 10.6 111.251 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.417 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -50.69 -20.82 1.34 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.688 0.625 . . . . 9.06 112.688 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 59' ' ' THR . 0.1 OUTLIER -95.45 -50.37 5.02 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.762 -0.458 . . . . 7.13 109.762 179.054 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.51 HD13 ' HA ' ' A' ' 60' ' ' GLU . 0.8 OUTLIER -71.52 -45.35 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 116.225 -0.443 . . . . 6.58 111.692 179.887 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.416 ' HB ' ' O ' ' A' ' 60' ' ' GLU . 17.3 m -69.53 -45.5 68.68 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.41 -0.359 . . . . 8.23 110.699 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.417 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 23.8 tt0 -64.8 -18.88 65.49 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.426 0.631 . . . . 8.97 110.491 179.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 6.2 m-30 -96.46 -31.66 12.7 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.761 -1.109 . . . . 5.31 110.316 178.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.502 ' CG ' HG12 ' A' ' 45' ' ' VAL . 2.8 m-30 -63.07 -35.86 81.67 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.415 -0.357 . . . . 5.15 110.891 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -87.88 -35.88 17.49 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.347 -0.388 . . . . 8.06 110.817 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.47 -14.57 61.26 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.403 0.519 . . . . 6.22 112.403 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.37 -38.33 11.03 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.384 -0.825 . . . . 4.43 111.124 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.445 ' HB2' ' O ' ' A' ' 77' ' ' PHE . 37.6 t0 -108.28 107.05 59.81 Favored Pre-proline 0 CA--C 1.53 0.203 0 CA-C-N 116.344 -0.389 . . . . 5.45 110.989 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -61.96 -38.14 60.2 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.709 2.272 . . . . 6.91 112.491 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -75.75 -32.74 60.1 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.331 -0.395 . . . . 6.68 111.472 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 26.8 m120 69.74 24.46 5.4 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.059 0.457 . . . . 7.35 110.37 -178.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.5 t -68.59 -16.77 63.96 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.72 -0.673 . . . . 6.16 111.043 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 111.84 17.72 8.32 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-N 116.261 -0.427 . . . . 5.83 112.659 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.445 ' O ' ' HB2' ' A' ' 71' ' ' ASP . 13.6 m-85 -116.39 164.64 14.24 Favored 'General case' 0 CA--C 1.527 0.06 0 N-CA-C 109.99 -0.374 . . . . 7.11 109.99 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.658 HG13 ' CG2' ' A' ' 45' ' ' VAL . 7.1 mt -142.09 147.64 21.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.356 0.598 . . . . 3.79 112.25 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.43 100.36 12.38 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.447 -1.316 . . . . 5.35 107.447 176.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -37.91 -40.31 0.45 Allowed 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.255 0.465 . . . . 5.81 112.255 -177.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.7 mttp -64.5 -48.51 74.89 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.758 -0.201 . . . . 8.49 110.844 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.56 -38.9 64.33 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.97 0.415 . . . . 4.83 110.314 178.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.593 ' CE1' HD12 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -75.63 -40.33 56.44 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.649 -0.705 . . . . 3.29 110.871 179.343 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.39 -33.0 74.93 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.259 -0.428 . . . . 4.77 111.523 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.22 -11.87 58.56 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.807 0.669 . . . . 6.05 112.807 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 6.3 mmt -77.12 -45.87 25.45 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.572 -0.74 . . . . 4.94 110.399 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.469 HD21 HD23 ' A' ' 28' ' ' LEU . 1.4 mp -88.2 -8.98 54.49 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.472 0.653 . . . . 5.15 112.242 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -117.04 22.75 12.35 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.606 -1.179 . . . . 7.33 111.11 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.6 58.67 3.81 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.023 0.44 . . . . 8.25 111.051 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.2 t -129.98 27.2 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 116.053 -0.521 . . . . 10.05 110.872 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -141.58 95.82 2.88 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.241 -0.436 . . . . 11.61 110.425 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -87.98 135.7 33.29 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.137 -0.483 . . . . 12.45 110.991 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.015 -0.993 . . . . 14.04 111.275 -179.95 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.9 mtt . . . . . 0 N--CA 1.488 1.429 0 CA-C-O 120.793 0.33 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -105.35 -148.06 16.73 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.443 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.1 m -146.38 -64.93 0.3 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.865 0.364 . . . . 0.0 110.901 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.1 t -161.6 34.61 0.13 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.936 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 22.9 m170 -123.7 134.65 53.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.881 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -78.34 79.98 4.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.864 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 60.8 m80 -146.13 165.78 28.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.864 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -176.28 147.72 0.72 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.889 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -60.32 -61.02 2.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.877 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 60.49 161.09 0.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.944 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 68.04 -70.2 0.13 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.906 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.3 m -142.86 99.95 3.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.91 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -63.58 -124.29 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.42 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -140.32 31.18 1.93 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.799 0.333 . . . . 0.0 110.939 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.5 m -159.08 79.82 2.82 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.081 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.51 163.85 1.62 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.59 2.193 . . . . 0.0 112.361 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 8.3 tpp85 -150.57 -66.76 0.2 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.83 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.6 -138.16 49.34 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.558 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.9 p 58.5 -170.04 0.12 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.835 0.35 . . . . 0.0 110.989 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 32.9 p-80 -91.06 118.89 30.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.962 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.36 34.26 4.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.888 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.3 m -101.6 5.44 41.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.594 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.14 -14.52 61.39 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.572 0.701 . . . . 0.0 111.477 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -65.53 -15.98 63.23 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 114.843 -1.072 . . . . 0.0 111.263 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.72 -29.36 16.87 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.618 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.661 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -60.17 -28.27 67.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.775 -179.857 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.25 -23.96 66.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.232 0.539 . . . . 0.0 109.682 178.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -88.03 -11.32 47.61 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.257 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.661 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 10.7 mm -66.0 -14.42 17.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.92 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -77.6 2.15 17.42 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 113.9 -1.5 . . . . 0.0 111.52 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.41 -29.53 15.55 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.132 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -56.66 -22.81 37.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.155 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -97.25 29.76 3.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.129 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -179.16 38.75 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.902 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.449 ' CZ ' ' CG2' ' A' ' 51' ' ' ILE . 11.6 m-85 -154.5 31.77 0.42 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.951 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -108.13 31.36 5.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.864 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -171.79 64.35 0.15 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.527 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.7 p30 -136.82 31.27 2.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.833 0.349 . . . . 0.0 110.89 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 60.49 84.1 0.13 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.903 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 60.74 -170.49 0.15 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.897 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.412 ' HA3' ' CD2' ' A' ' 80' ' ' TYR . . . -77.79 -27.57 58.49 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.469 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -59.7 123.81 18.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.837 0.351 . . . . 0.0 110.882 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.444 ' CG1' ' CE2' ' A' ' 48' ' ' PHE . 8.1 p -144.18 139.75 24.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.963 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.402 ' OG ' ' CE2' ' A' ' 77' ' ' PHE . 0.9 OUTLIER -88.9 155.16 19.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.006 -179.793 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.431 HG12 ' CD2' ' A' ' 67' ' ' PHE . 86.1 t -58.24 -55.9 19.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.058 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -46.69 -30.73 2.51 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.078 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -91.23 -28.85 17.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.476 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.444 ' CE2' ' CG1' ' A' ' 43' ' ' VAL . 0.1 OUTLIER -68.75 -38.19 79.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.74 179.716 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 26.9 mtp180 -57.6 -50.3 73.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.915 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -56.72 -25.85 52.34 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.543 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.449 ' CG2' ' CZ ' ' A' ' 35' ' ' PHE . 28.5 mt -84.05 -43.81 17.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.796 0.331 . . . . 0.0 111.011 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 30.9 mm -69.72 -28.66 38.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.192 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 20.1 mtm180 -50.63 -58.22 6.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.018 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -111.75 14.9 21.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.272 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -99.0 -86.51 1.88 Allowed Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.665 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.9 mp -103.76 145.73 31.18 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.755 0.312 . . . . 0.0 111.068 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.98 112.91 3.6 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.504 2.136 . . . . 0.0 112.312 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.4 ' C ' HD13 ' A' ' 63' ' ' ILE . 1.1 ttp -154.85 138.32 15.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.721 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.452 ' O ' ' CD1' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -78.86 146.6 33.56 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.466 179.463 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.556 ' O ' ' N ' ' A' ' 64' ' ' THR . 0.6 OUTLIER -40.29 -53.21 2.58 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.288 0.566 . . . . 0.0 110.913 179.841 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.526 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -46.23 -53.08 11.28 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.045 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.437 ' O ' ' HB2' ' A' ' 66' ' ' PHE . 0.6 OUTLIER -56.04 -61.16 2.57 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 179.446 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.509 ' O ' ' N ' ' A' ' 67' ' ' PHE . 1.2 mp -59.66 -61.09 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.049 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.556 ' N ' ' O ' ' A' ' 60' ' ' GLU . 51.7 m -51.18 -51.03 57.64 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.171 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.526 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 8.6 tt0 -66.56 -15.45 63.43 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 121.683 0.754 . . . . 0.0 110.399 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.437 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.6 m-30 -96.23 -25.31 15.85 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.44 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.509 ' N ' ' O ' ' A' ' 63' ' ' ILE . 1.6 m-85 -73.74 -46.63 44.65 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.65 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.44 -26.51 58.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.153 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.53 -11.03 60.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.457 0.646 . . . . 0.0 111.844 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.3 -51.41 4.39 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.867 -1.061 . . . . 0.0 111.193 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 29.1 p-10 -105.35 118.79 54.86 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.9 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -69.14 -36.12 13.1 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.466 2.111 . . . . 0.0 112.32 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -68.42 -32.69 72.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.878 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 71.65 40.86 0.75 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.145 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.4 t -91.36 29.9 1.38 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.635 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 56.02 26.73 49.52 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.454 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.402 ' CE2' ' OG ' ' A' ' 44' ' ' SER . 2.4 m-85 -123.47 161.27 25.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.777 0.323 . . . . 0.0 110.646 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.443 HD12 ' CZ ' ' A' ' 83' ' ' PHE . 52.2 mt -139.32 148.93 23.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.247 0.546 . . . . 0.0 111.706 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.445 ' O ' ' N ' ' A' ' 82' ' ' ALA . 0.7 OUTLIER -97.49 96.28 8.22 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 176.812 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.426 ' C ' ' O ' ' A' ' 79' ' ' ASP . 39.4 t80 -28.61 -40.78 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.366 -178.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 79' ' ' ASP . 1.7 mtmp? -66.44 -54.78 20.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.567 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.445 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -52.96 -26.98 16.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.018 0.437 . . . . 0.0 110.478 179.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.443 ' CZ ' HD12 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -91.1 -31.44 16.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.884 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.65 -20.74 33.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.579 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.25 -11.23 60.43 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.423 0.63 . . . . 0.0 111.934 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 17.2 tpp -78.18 -35.34 48.82 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.57 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.9 mp -96.4 -5.86 38.82 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.831 0.824 . . . . 0.0 111.299 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -122.35 21.89 10.19 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 114.174 -1.375 . . . . 0.0 111.098 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.05 29.63 2.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.062 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.7 p -138.21 36.84 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.962 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -156.21 37.33 0.34 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.898 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -125.52 138.0 53.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.943 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.155 -0.926 . . . . 0.0 110.826 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.3 mtm . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 120.939 0.399 . . . . 0.0 111.259 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 96.81 39.13 4.2 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.447 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.2 p -63.08 -175.35 0.1 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.794 0.331 . . . . 0.0 110.878 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.5 m -75.28 -65.67 0.86 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.948 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -172.93 -179.02 1.95 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.939 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 -141.32 167.71 21.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.948 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 60.54 -174.38 0.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.845 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 25.9 p80 -132.21 -176.2 3.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.91 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 23.8 t-80 60.66 109.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.914 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -176.48 -40.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.895 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.4 m -143.13 -47.57 0.31 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.893 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.8 m -146.43 113.58 6.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.814 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -88.58 -47.19 4.36 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.506 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -76.17 83.53 2.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.934 0.397 . . . . 0.0 110.976 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.5 t 60.47 88.18 0.12 Allowed Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.127 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.07 -178.22 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.626 2.217 . . . . 0.0 112.276 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.5 tpp85 -61.28 -67.79 0.37 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.896 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.11 173.75 0.57 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.526 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.24 31.46 0.17 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.853 0.359 . . . . 0.0 110.936 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -176.37 37.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.826 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.36 -60.85 1.59 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.906 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.4 t -100.91 5.3 43.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.528 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.84 -14.44 61.5 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.594 0.711 . . . . 0.0 111.589 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.82 -16.28 63.67 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.855 -1.066 . . . . 0.0 111.124 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.83 -28.29 17.43 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.688 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.669 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -63.1 -29.48 70.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.814 -179.875 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -60.6 -24.28 65.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.18 0.515 . . . . 0.0 109.701 178.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.5 tt -88.24 -11.29 47.03 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.456 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.669 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 10.8 mm -64.39 -14.59 16.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.971 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -76.92 1.83 16.49 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 114.085 -1.416 . . . . 0.0 111.543 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.54 -28.37 16.1 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.072 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -58.0 -20.81 41.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.317 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -93.97 23.82 4.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.554 -0.293 . . . . 0.0 111.182 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -176.66 34.15 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.052 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 17.1 t80 179.74 77.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.742 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -98.46 24.14 7.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.139 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 93.24 -24.34 25.53 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.652 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.5 t0 62.4 27.68 16.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.813 0.339 . . . . 0.0 110.97 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 57.02 73.6 0.45 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.946 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -177.54 -40.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.94 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.15 27.46 57.98 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.546 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -152.61 123.88 7.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.848 0.356 . . . . 0.0 110.904 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.426 HG12 ' CE2' ' A' ' 48' ' ' PHE . 10.2 p -122.77 125.15 72.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.042 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 52.7 p -70.49 168.43 16.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.872 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.475 ' CG2' HG13 ' A' ' 78' ' ' ILE . 41.2 t -73.06 -29.05 27.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.835 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -74.84 -53.03 9.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.711 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -58.38 -32.75 68.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.582 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.426 ' CE2' HG12 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -59.63 -35.91 75.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.76 179.715 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.72 -51.29 70.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.926 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -54.94 -25.39 37.68 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.363 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 24.6 mt -90.58 -39.94 12.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.823 0.344 . . . . 0.0 110.898 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 36.5 mm -74.26 -27.2 21.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.199 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.4 ttt85 -50.7 -58.72 5.19 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.878 0.37 . . . . 0.0 111.068 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -111.9 15.07 20.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.299 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -97.65 -86.02 1.81 Allowed Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.712 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.2 mt -101.19 135.6 19.87 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.587 0.232 . . . . 0.0 111.0 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -78.73 59.32 7.22 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.488 2.125 . . . . 0.0 112.325 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.4 ' C ' HD11 ' A' ' 63' ' ' ILE . 1.4 mtp -88.32 141.68 28.35 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.582 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.455 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -77.95 147.68 34.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.772 179.762 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.494 ' O ' ' N ' ' A' ' 64' ' ' THR . 3.0 pt-20 -38.08 -48.5 1.23 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.19 0.519 . . . . 0.0 111.094 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.515 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -50.96 -52.78 39.13 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.922 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.455 ' HG2' ' O ' ' A' ' 59' ' ' THR . 1.1 mm-40 -55.15 -61.79 2.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.007 0.432 . . . . 0.0 109.934 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.506 ' CG2' ' CE2' ' A' ' 67' ' ' PHE . 1.8 mp -57.92 -61.79 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.202 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.494 ' N ' ' O ' ' A' ' 60' ' ' GLU . 92.2 m -52.36 -52.28 54.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.291 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.515 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 1.2 tp10 -64.46 -15.58 60.95 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 121.702 0.763 . . . . 0.0 110.504 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.434 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.5 m-30 -95.07 -28.87 14.88 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.284 179.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.506 ' CE2' ' CG2' ' A' ' 63' ' ' ILE . 10.0 m-30 -79.84 -24.39 41.33 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.848 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -93.96 -27.34 16.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.85 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.77 -11.41 42.27 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.436 0.636 . . . . 0.0 111.72 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.65 -27.41 14.38 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.961 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -120.68 96.53 48.81 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.781 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.58 -29.9 70.48 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.411 2.074 . . . . 0.0 112.243 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -83.31 -27.03 30.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.828 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 73.09 40.39 0.56 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.179 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.2 t -91.47 28.71 1.63 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.621 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 47.42 31.83 7.0 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.317 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -134.04 129.19 35.7 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.849 0.357 . . . . 0.0 110.285 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.475 HG13 ' CG2' ' A' ' 45' ' ' VAL . 65.5 mt -102.75 150.57 6.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.183 0.516 . . . . 0.0 111.461 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.43 ' O ' ' N ' ' A' ' 82' ' ' ALA . 2.2 m-20 -93.76 95.64 9.27 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 176.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.423 ' C ' ' O ' ' A' ' 79' ' ' ASP . 42.4 t80 -29.67 -40.6 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.238 -177.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 79' ' ' ASP . 15.8 mtmt -66.15 -55.22 17.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.797 0.332 . . . . 0.0 110.613 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -52.72 -27.9 19.63 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.033 0.444 . . . . 0.0 110.501 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.438 ' CZ ' HD11 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -89.66 -32.78 16.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.804 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.37 -24.46 46.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.197 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.8 -11.41 60.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.446 0.641 . . . . 0.0 111.729 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 9.4 mtp -75.14 -37.88 61.23 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.743 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.1 mt -88.19 -6.88 57.59 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.854 0.835 . . . . 0.0 111.52 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -125.99 22.45 7.35 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.131 -1.395 . . . . 0.0 111.184 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.16 97.87 2.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.879 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.0 p -153.43 49.41 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.069 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -169.92 155.26 5.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.935 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -168.16 -56.05 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.902 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.909 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 120.705 0.288 . . . . 0.0 111.183 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 64.25 136.09 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.461 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 78.3 p -97.17 -176.32 3.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.749 0.309 . . . . 0.0 110.906 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 62.7 p -104.4 -74.58 0.64 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.844 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 5.6 m80 60.61 110.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.901 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -131.57 -178.04 4.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.871 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -170.73 35.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.916 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 13.6 p80 -131.43 36.67 3.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.823 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 2.5 m80 64.1 -79.13 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.973 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 16.7 m80 -140.68 -75.92 0.32 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.827 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.8 m -176.86 37.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.922 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 59.84 -169.93 0.14 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.93 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 138.18 -85.51 0.23 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.515 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.0 tp -60.49 -67.01 0.44 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.813 0.34 . . . . 0.0 110.874 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.4 m -134.89 88.78 26.5 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.173 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -51.97 -61.67 0.48 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.534 2.156 . . . . 0.0 112.373 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.82 37.0 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.864 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.17 56.62 14.82 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.546 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.9 t -86.91 132.86 33.69 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.781 0.324 . . . . 0.0 110.925 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -129.1 31.52 4.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.914 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 17.3 ptp -124.21 5.99 8.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.331 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.9 p -101.78 5.49 41.23 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.072 0.463 . . . . 0.0 111.565 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -71.74 -14.24 61.95 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.57 0.7 . . . . 0.0 111.658 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -65.1 -16.79 63.87 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.306 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.02 -32.23 15.29 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.727 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.642 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -56.76 -26.4 57.34 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.05 -179.775 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -62.89 -23.62 67.43 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -88.12 -11.48 46.87 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.362 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.642 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 12.2 mm -64.68 -14.74 16.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 114.77 -1.104 . . . . 0.0 111.946 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -77.67 2.07 17.88 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 113.907 -1.497 . . . . 0.0 111.667 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.37 -40.09 10.58 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.022 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -58.82 -29.83 67.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.95 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -98.1 28.36 4.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.954 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -179.08 41.18 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.767 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -178.13 78.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.91 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 61.93 69.15 0.65 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.866 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -59.28 -27.85 63.56 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.581 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -157.62 39.5 0.28 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.902 0.382 . . . . 0.0 110.971 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -171.98 87.34 0.09 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.92 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.41 ' HB2' ' CE1' ' A' ' 80' ' ' TYR . 1.4 p30 -128.51 -178.03 4.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.91 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 175.31 -61.05 0.11 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.489 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -152.04 123.89 7.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.783 0.325 . . . . 0.0 110.965 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.427 HG12 ' CD2' ' A' ' 48' ' ' PHE . 9.5 p -120.93 136.17 58.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.014 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.415 ' HB3' ' CD1' ' A' ' 77' ' ' PHE . 1.3 m -88.71 145.08 25.85 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.855 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.429 HG12 ' CD1' ' A' ' 67' ' ' PHE . 93.1 t -51.51 -55.69 7.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.179 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -47.95 -31.3 5.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.873 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -86.92 -30.24 21.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.413 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.427 ' CD2' HG12 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -67.08 -40.08 86.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.825 179.847 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -56.47 -50.7 70.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.911 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -56.03 -25.41 46.11 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.315 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 28.7 mt -85.51 -43.89 16.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.817 0.341 . . . . 0.0 110.924 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 34.5 mm -71.65 -26.05 25.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.147 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 10.0 mmp_? -52.48 -59.5 4.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.748 0.308 . . . . 0.0 111.118 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -111.72 14.94 21.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.361 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -98.31 -86.35 1.85 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.678 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.2 mp -105.54 146.78 33.47 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-O 120.689 0.281 . . . . 0.0 111.049 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -73.48 95.09 0.85 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.588 2.192 . . . . 0.0 112.11 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.442 ' C ' HD11 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -130.8 141.67 50.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.799 -179.81 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.482 ' O ' ' HB3' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -90.0 144.88 25.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.956 179.449 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.601 ' O ' ' N ' ' A' ' 64' ' ' THR . 6.4 pt-20 -47.33 -56.96 5.83 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 121.077 0.465 . . . . 0.0 110.49 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.428 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -50.29 -24.56 3.01 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.982 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.482 ' HB3' ' O ' ' A' ' 59' ' ' THR . 4.8 tp10 -86.67 -46.0 10.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.335 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.548 ' O ' ' N ' ' A' ' 67' ' ' PHE . 0.7 OUTLIER -82.63 -47.82 18.43 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.179 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.074 179.552 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.601 ' N ' ' O ' ' A' ' 60' ' ' GLU . 23.0 m -59.48 -46.84 87.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.202 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.428 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 0.9 OUTLIER -68.32 -16.51 63.97 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 121.755 0.788 . . . . 0.0 110.201 179.376 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.407 ' CD1' ' O ' ' A' ' 62' ' ' GLU . 3.1 m-85 -97.14 -24.0 15.94 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.31 -1.313 . . . . 0.0 110.286 178.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.548 ' N ' ' O ' ' A' ' 63' ' ' ILE . 2.1 m-85 -72.19 -41.3 67.14 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.767 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -79.85 -28.33 40.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.917 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.15 -11.26 60.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.437 0.637 . . . . 0.0 111.741 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.83 -30.59 14.14 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.041 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -120.73 120.38 29.6 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.909 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -64.36 -27.12 63.18 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.46 2.107 . . . . 0.0 112.282 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 -87.79 -32.56 19.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.886 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 71.52 38.93 0.95 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.063 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.408 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 1.6 t -89.2 42.74 1.1 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.689 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 50.87 25.03 8.93 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.636 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.415 ' CD1' ' HB3' ' A' ' 44' ' ' SER . 41.4 m-85 -122.21 159.16 27.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.905 0.383 . . . . 0.0 110.718 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.46 HD13 ' CZ ' ' A' ' 83' ' ' PHE . 50.5 mt -137.28 153.39 28.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.146 0.498 . . . . 0.0 111.593 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.425 ' O ' ' C ' ' A' ' 80' ' ' TYR . 1.0 OUTLIER -98.72 95.86 7.52 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 176.923 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.425 ' C ' ' O ' ' A' ' 79' ' ' ASP . 47.8 t80 -28.96 -41.16 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.333 -178.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 79' ' ' ASP . 22.2 mttt -68.01 -55.88 11.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.728 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -51.43 -27.46 10.29 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.961 0.41 . . . . 0.0 110.672 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.46 ' CZ ' HD13 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -91.13 -33.06 15.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.94 179.852 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.401 ' O ' ' CD2' ' A' ' 88' ' ' TYR . . . -80.56 -18.24 48.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.444 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.95 -11.69 61.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.379 0.609 . . . . 0.0 111.719 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 51.4 mtm -76.18 -38.49 56.54 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.587 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -85.94 -6.59 59.03 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 121.822 0.82 . . . . 0.0 111.365 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.401 ' CD2' ' O ' ' A' ' 84' ' ' ALA . 19.0 m-85 -125.65 22.21 7.6 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 114.142 -1.39 . . . . 0.0 111.157 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -97.41 30.38 2.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.929 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 30.6 m -104.22 30.99 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.136 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -145.04 31.96 1.12 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.856 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -153.78 -46.96 0.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.819 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.0 m . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.971 180.0 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 mmt . . . . . 0 N--CA 1.485 1.303 0 CA-C-O 120.754 0.311 . . . . 0.0 111.267 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -165.9 32.26 0.22 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.488 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.7 t -147.24 150.09 34.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.834 0.349 . . . . 0.0 110.916 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.52 177.33 1.45 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.922 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 13.7 m80 60.7 32.86 20.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.896 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -176.49 -68.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.891 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 12.5 t60 -141.44 161.56 37.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.931 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 10.7 p-80 -161.12 82.48 0.63 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.972 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -108.32 129.54 55.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.858 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 12.8 p80 -177.71 -39.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.024 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.2 t 63.65 147.89 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.949 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.75 -52.7 64.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.946 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 59.79 -153.98 32.54 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.45 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 60.22 -165.72 0.2 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.785 0.326 . . . . 0.0 110.807 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.4 m -53.47 160.09 2.03 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.185 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -50.12 166.15 0.3 Allowed 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.526 2.151 . . . . 0.0 112.44 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.7 mtt85 -59.37 128.27 36.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.963 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -107.11 28.08 14.0 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.47 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.0 t -134.77 92.42 2.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.734 0.302 . . . . 0.0 110.879 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 15.5 p80 -60.02 152.18 24.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.94 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.4 ttt -60.46 176.34 0.37 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.86 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 29.1 p -98.33 5.28 48.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.508 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -91.66 -14.49 30.02 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.518 0.675 . . . . 0.0 111.539 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -65.21 -16.38 63.46 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.203 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.89 -28.38 17.32 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.587 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.666 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -65.55 -29.07 69.65 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.781 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -59.21 -23.74 62.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.278 0.561 . . . . 0.0 109.776 178.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.7 tt -88.12 -11.32 47.32 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.415 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.666 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 11.0 mm -67.19 -13.67 17.02 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-N 114.749 -1.114 . . . . 0.0 111.952 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -76.61 2.12 14.96 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 113.921 -1.491 . . . . 0.0 111.621 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.03 -33.51 14.09 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.076 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -63.73 -29.17 70.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.887 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -97.99 31.76 2.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.907 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -167.94 33.59 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.865 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.421 ' CE1' HD12 ' A' ' 51' ' ' ILE . 20.9 t80 -158.5 38.72 0.24 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.892 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -105.95 36.4 2.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.905 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -165.15 53.79 0.27 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.435 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -176.94 78.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.903 0.382 . . . . 0.0 110.876 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 60.64 170.62 0.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.966 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -132.59 139.89 48.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.91 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.419 ' HA2' ' CD2' ' A' ' 80' ' ' TYR . . . 66.21 -86.3 0.11 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.471 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -60.06 123.72 18.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.902 0.382 . . . . 0.0 110.828 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.421 HG13 ' CD2' ' A' ' 48' ' ' PHE . 7.5 p -142.76 125.02 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.875 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.422 ' HB3' ' CD2' ' A' ' 77' ' ' PHE . 1.8 m -77.21 154.71 32.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.056 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.433 HG12 ' CD1' ' A' ' 67' ' ' PHE . 59.4 t -59.87 -52.69 58.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.759 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -50.09 -31.31 12.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.907 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.4 mm-40 -91.69 -29.22 16.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.46 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.421 ' CD2' HG13 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -64.66 -35.9 82.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.813 179.844 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 15.5 mtt180 -58.37 -49.55 76.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.859 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -57.05 -26.77 56.32 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.36 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.421 HD12 ' CE1' ' A' ' 35' ' ' PHE . 26.0 mt -85.29 -44.35 17.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.891 0.377 . . . . 0.0 110.991 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 37.5 mm -67.2 -29.07 44.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.107 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.09 -57.09 10.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.908 0.385 . . . . 0.0 110.925 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -111.76 14.82 21.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.312 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -99.55 -86.62 1.9 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.673 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.7 mt -100.19 139.04 20.41 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.577 0.227 . . . . 0.0 110.969 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -79.06 58.79 7.11 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.472 2.115 . . . . 0.0 112.314 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.459 ' HG2' ' HB2' ' A' ' 62' ' ' GLU . 1.4 ttp -94.5 139.9 30.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.746 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.466 ' O ' ' CD1' ' A' ' 63' ' ' ILE . 0.8 OUTLIER -75.95 142.56 41.95 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.052 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.548 ' O ' ' N ' ' A' ' 64' ' ' THR . 6.6 pt-20 -39.5 -51.79 2.16 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.276 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.442 ' O ' ' HB2' ' A' ' 65' ' ' GLU . . . -45.61 -55.52 6.24 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.182 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.459 ' HB2' ' HG2' ' A' ' 58' ' ' MET . 0.9 OUTLIER -55.07 -60.86 2.8 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.619 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.518 ' O ' ' N ' ' A' ' 67' ' ' PHE . 1.5 mp -58.94 -61.93 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.921 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.548 ' N ' ' O ' ' A' ' 60' ' ' GLU . 75.2 m -49.55 -52.45 29.81 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.218 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.442 ' HB2' ' O ' ' A' ' 61' ' ' ALA . 44.0 mt-10 -66.16 -15.75 63.4 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.701 0.762 . . . . 0.0 110.381 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.451 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.5 m-30 -94.66 -26.51 16.3 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.517 -1.22 . . . . 0.0 110.385 179.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.518 ' N ' ' O ' ' A' ' 63' ' ' ILE . 2.4 m-30 -75.16 -30.27 60.67 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.681 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -92.91 -24.93 18.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.92 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.24 -11.23 44.21 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.518 0.675 . . . . 0.0 111.856 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.46 -27.27 13.81 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.136 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -118.96 115.7 34.64 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.703 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.83 -50.51 1.67 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.44 2.093 . . . . 0.0 112.5 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -68.48 -32.55 72.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.93 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 12.6 m120 72.41 30.62 1.94 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.543 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 36.8 p -68.48 -22.71 64.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.036 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 115.08 20.64 5.55 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.568 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.44 ' CD1' ' N ' ' A' ' 77' ' ' PHE . 3.2 m-85 -137.48 150.37 47.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.671 0.272 . . . . 0.0 110.736 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.466 HG21 ' CD1' ' A' ' 83' ' ' PHE . 1.6 mt -133.36 146.55 32.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.571 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.434 ' O ' ' N ' ' A' ' 81' ' ' LYS . 8.5 m-20 -75.74 105.04 6.57 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 177.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.419 ' CD2' ' HA2' ' A' ' 41' ' ' GLY . 27.6 t80 -28.73 -40.19 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 79' ' ' ASP . 0.1 OUTLIER -64.64 -53.32 49.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.654 0.264 . . . . 0.0 110.854 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -51.45 -27.24 9.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.063 0.458 . . . . 0.0 110.747 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.466 ' CD1' HG21 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -93.83 -32.48 13.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.986 -179.869 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.99 -18.49 53.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.262 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -71.72 -11.61 60.91 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.427 0.632 . . . . 0.0 111.803 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.36 -41.82 62.97 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.716 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.1 mp -86.03 -6.31 59.06 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.884 0.85 . . . . 0.0 111.512 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -125.28 22.26 7.84 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.168 -1.378 . . . . 0.0 111.107 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.81 71.3 6.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.886 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.9 t -145.55 30.85 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.028 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -176.82 124.99 0.16 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.847 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -78.89 136.44 37.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.888 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.925 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.2 mmm . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.868 0.366 . . . . 0.0 111.123 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -140.37 85.48 0.21 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.424 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.2 m -170.06 35.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.811 0.338 . . . . 0.0 110.88 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.96 133.51 28.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.862 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 17.9 t-160 -172.17 -68.92 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.934 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 60.18 168.01 0.08 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.892 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -176.72 132.95 0.2 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.862 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -150.76 36.78 0.63 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.855 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -99.03 32.21 2.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.952 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 27.5 p80 -148.17 31.57 0.84 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.877 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.3 p -176.55 83.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.866 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.3 p -60.74 109.58 1.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.897 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -95.78 37.8 3.31 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.519 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.6 mt -99.67 31.12 3.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.817 0.341 . . . . 0.0 110.878 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.1 m -158.81 68.98 3.49 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.082 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.02 -58.43 1.49 Allowed 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.471 2.114 . . . . 0.0 112.346 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.07 130.51 45.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.962 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -99.98 28.49 15.4 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.473 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 m -86.43 -169.32 2.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.803 0.335 . . . . 0.0 110.871 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.8 t60 61.23 79.75 0.24 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.894 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 17.8 mtt -145.57 169.74 17.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.934 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.3 p -100.88 5.22 43.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.595 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -90.03 -14.53 33.7 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.514 0.673 . . . . 0.0 111.533 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -65.2 -16.61 63.71 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.122 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.02 -27.69 17.66 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.779 -1.1 . . . . 0.0 110.65 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.64 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -67.15 -27.75 67.55 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.857 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -59.51 -23.75 63.07 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.6 tt -88.2 -11.31 47.09 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.563 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.64 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 11.9 mm -66.1 -14.06 16.81 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 114.695 -1.139 . . . . 0.0 111.932 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.89 1.98 15.99 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 113.915 -1.493 . . . . 0.0 111.66 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.33 -29.21 15.75 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.076 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -57.18 -25.91 59.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.098 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -95.08 42.42 1.09 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.814 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -171.49 35.24 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.849 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.417 ' CE2' HD11 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -169.67 40.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.794 179.934 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.0 p30 -106.02 30.71 5.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.043 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -67.2 -35.13 87.87 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.482 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -176.81 37.54 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.787 0.327 . . . . 0.0 110.843 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 62.28 -81.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.936 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.4 t0 54.74 -169.13 0.07 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.157 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.403 ' O ' ' CG ' ' A' ' 80' ' ' TYR . . . -150.65 -67.77 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.396 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -59.43 165.89 2.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.852 0.358 . . . . 0.0 111.006 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.422 HG11 ' CD2' ' A' ' 48' ' ' PHE . 7.7 p -175.65 125.43 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.907 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.53 146.93 40.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.112 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.465 HG12 ' CE1' ' A' ' 67' ' ' PHE . 75.7 t -56.25 -53.23 42.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.989 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -48.0 -30.09 4.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.973 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -92.83 -30.0 15.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.467 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.422 ' CD2' HG11 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -64.6 -33.28 75.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.8 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 8.7 mtt180 -55.35 -51.72 65.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.941 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -56.15 -25.71 47.79 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.438 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.417 HD11 ' CE2' ' A' ' 35' ' ' PHE . 40.6 mt -81.97 -28.69 9.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.795 0.331 . . . . 0.0 111.022 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 31.6 mm -90.2 -28.32 5.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.104 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.9 mmm-85 -54.29 -55.6 26.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.346 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -111.66 14.96 21.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.638 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -103.45 -87.49 2.01 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.321 -0.943 . . . . 0.0 112.764 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.4 mp -102.54 143.79 27.31 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 120.767 0.317 . . . . 0.0 111.044 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.51 118.41 4.87 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.501 2.134 . . . . 0.0 112.226 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.433 ' C ' HD11 ' A' ' 63' ' ' ILE . 0.4 OUTLIER -158.52 137.68 11.51 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.716 -179.772 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.451 ' O ' ' CD1' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -78.27 146.06 35.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.468 179.303 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.575 ' O ' ' N ' ' A' ' 64' ' ' THR . 4.8 pt-20 -39.98 -52.79 2.44 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 121.376 0.608 . . . . 0.0 111.01 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.519 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -46.14 -53.91 9.56 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.164 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 59' ' ' THR . 1.8 mm-40 -55.27 -61.53 2.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.956 0.407 . . . . 0.0 109.95 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.512 ' CG2' ' CE2' ' A' ' 67' ' ' PHE . 1.1 mp -60.0 -61.68 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.184 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.575 ' N ' ' O ' ' A' ' 60' ' ' GLU . 61.7 m -50.16 -50.85 47.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.196 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.519 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 4.8 tp10 -64.92 -16.29 63.11 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.708 0.766 . . . . 0.0 110.453 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.424 ' CD2' ' O ' ' A' ' 62' ' ' GLU . 1.7 m-85 -96.44 -25.68 15.6 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.515 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.512 ' CE2' ' CG2' ' A' ' 63' ' ' ILE . 1.4 m-85 -73.42 -31.07 63.64 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.614 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -84.56 -28.21 26.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.971 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -81.34 -11.17 59.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.487 0.661 . . . . 0.0 111.819 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.448 ' HB1' ' CD1' ' A' ' 83' ' ' PHE . . . -97.39 -27.58 14.41 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.086 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -121.54 118.99 29.48 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.765 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -62.86 -53.93 1.42 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.578 2.186 . . . . 0.0 112.65 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -68.41 -32.82 73.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.963 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.7 m120 74.47 43.74 0.25 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.626 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 17.6 p -93.14 37.79 1.04 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.523 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 55.69 23.02 35.09 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.383 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -124.08 128.54 49.46 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -112.23 152.61 14.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.224 0.535 . . . . 0.0 111.512 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -98.88 97.57 8.74 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.159 178.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.403 ' CG ' ' O ' ' A' ' 41' ' ' GLY . 80.8 t80 -35.2 -35.91 0.05 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.028 -178.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.72 -51.95 50.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.511 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.75 -25.12 54.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.141 0.496 . . . . 0.0 110.413 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.448 ' CD1' ' HB1' ' A' ' 70' ' ' ALA . 0.1 OUTLIER -92.59 -29.59 16.07 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.928 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.4 ' O ' ' CD2' ' A' ' 88' ' ' TYR . . . -80.09 -25.92 39.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.157 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.76 -11.46 60.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.418 0.627 . . . . 0.0 111.814 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 14.0 tpp -82.72 -36.55 25.7 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.818 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 9.7 mt -85.8 -6.43 59.1 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.845 0.831 . . . . 0.0 111.505 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.4 ' CD2' ' O ' ' A' ' 84' ' ' ALA . 12.7 m-85 -126.07 22.14 7.34 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 114.101 -1.409 . . . . 0.0 111.001 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.8 t -83.17 75.33 9.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.874 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.0 t -134.54 32.38 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.143 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -122.1 84.64 2.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.882 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.1 pm0 -60.31 136.45 58.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.877 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.849 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 ptp . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.722 0.296 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 59.86 39.43 95.45 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.553 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.8 m -141.28 35.84 1.7 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.832 0.348 . . . . 0.0 110.953 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.24 87.05 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.988 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 25.7 p80 -101.17 -31.66 10.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.922 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 60.53 -169.48 0.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.909 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -167.94 90.21 0.3 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.902 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -78.06 145.58 35.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.908 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 34.2 m80 -109.92 -66.0 1.1 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.872 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -176.3 80.06 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.886 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.4 t -80.89 83.31 6.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.001 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.8 m -85.03 -72.29 0.48 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.926 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 59.91 92.24 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.493 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.89 -66.54 0.98 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.894 0.378 . . . . 0.0 110.928 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.4 m -158.53 149.72 16.49 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.084 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.35 -61.59 0.48 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.532 2.155 . . . . 0.0 112.301 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.31 -74.57 0.24 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.833 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 150.6 -70.59 0.31 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.521 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -162.19 -54.88 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.824 0.345 . . . . 0.0 110.884 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -83.9 128.0 34.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.952 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 66.3 mtm -88.44 150.62 23.05 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.893 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.3 p -99.96 5.31 45.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.996 0.427 . . . . 0.0 111.576 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -96.5 -14.64 22.18 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.497 0.665 . . . . 0.0 111.517 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -65.25 -16.49 63.6 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.13 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.8 tttt -91.9 -26.75 18.31 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.671 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.661 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -68.36 -28.91 67.54 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.671 -179.881 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -59.45 -23.82 63.02 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 tt -88.17 -11.22 47.47 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.436 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.661 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 11.8 mm -66.57 -14.14 17.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 114.803 -1.089 . . . . 0.0 111.983 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -78.14 2.3 18.5 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 113.936 -1.484 . . . . 0.0 111.51 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.42 -32.67 14.14 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.989 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -59.26 -29.56 67.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.951 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -97.52 36.28 1.52 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.95 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -165.96 32.26 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.979 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.4 ' CE1' HD12 ' A' ' 51' ' ' ILE . 20.5 t80 -177.07 40.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.889 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -132.99 56.55 1.84 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.95 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -96.03 27.58 16.02 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.626 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.6 t70 60.66 68.07 0.78 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.915 0.388 . . . . 0.0 110.974 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -122.71 -76.71 0.59 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.907 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -178.16 -177.84 0.62 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.929 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.404 ' O ' ' CG ' ' A' ' 80' ' ' TYR . . . -95.95 -37.97 4.77 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.417 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -61.85 123.73 18.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.796 0.332 . . . . 0.0 110.922 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.426 HG13 ' CD2' ' A' ' 48' ' ' PHE . 7.8 p -144.92 110.83 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.92 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.423 ' HB3' ' CD2' ' A' ' 77' ' ' PHE . 1.2 m -65.83 160.69 22.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.041 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.437 HG12 ' CD2' ' A' ' 67' ' ' PHE . 72.5 t -57.89 -56.07 17.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.784 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -47.13 -41.49 17.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.989 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -78.91 -27.65 43.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.48 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.473 ' CE2' ' CD2' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -67.7 -29.47 68.73 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.96 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 34.1 mmm-85 -56.07 -56.43 20.89 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.053 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -54.9 -23.61 31.3 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.621 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.4 HD12 ' CE1' ' A' ' 35' ' ' PHE . 24.7 mt -84.5 -24.34 7.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.631 0.253 . . . . 0.0 111.238 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 39.9 mm -93.03 -36.19 7.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.243 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.97 -46.43 71.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.119 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -111.84 14.84 21.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.508 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -109.8 -88.87 1.95 Allowed Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.66 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.6 mp -100.38 136.82 19.91 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.587 0.232 . . . . 0.0 110.989 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -79.9 58.44 6.98 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.529 2.152 . . . . 0.0 112.493 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.437 ' C ' HD13 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -86.4 141.71 28.96 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.567 179.607 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.451 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 0.3 OUTLIER -75.78 145.59 40.64 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.606 179.632 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.544 ' O ' ' N ' ' A' ' 64' ' ' THR . 4.8 pt-20 -39.29 -52.23 2.0 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.178 0.513 . . . . 0.0 111.02 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.52 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -46.65 -53.61 11.25 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.071 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 59' ' ' THR . 1.7 mm-40 -55.16 -61.64 2.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.928 0.394 . . . . 0.0 110.039 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.527 ' CG2' ' CE2' ' A' ' 67' ' ' PHE . 1.4 mp -59.17 -61.48 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.177 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.544 ' N ' ' O ' ' A' ' 60' ' ' GLU . 68.2 m -51.35 -51.68 52.32 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.174 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.52 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 28.8 tp10 -65.8 -15.46 62.9 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.576 0.703 . . . . 0.0 110.346 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.448 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.4 m-30 -94.94 -25.93 16.33 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.387 179.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.527 ' CE2' ' CG2' ' A' ' 63' ' ' ILE . 2.6 m-30 -79.64 -28.79 40.85 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.765 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -86.64 -31.1 21.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.881 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -81.46 -11.17 59.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.486 0.66 . . . . 0.0 111.713 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -102.25 -27.41 12.88 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.028 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -123.33 107.82 32.12 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.675 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.48 -43.5 7.83 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.397 2.065 . . . . 0.0 112.339 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -68.45 -32.31 72.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.823 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 21.2 m-20 73.96 20.95 2.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.529 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -63.64 -22.38 66.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.861 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 109.21 19.75 8.29 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.502 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.423 ' CD2' ' HB3' ' A' ' 44' ' ' SER . 4.1 m-85 -132.97 146.27 51.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.776 0.322 . . . . 0.0 110.825 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.463 HG21 ' CD1' ' A' ' 83' ' ' PHE . 1.0 OUTLIER -133.38 146.09 32.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.433 179.789 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.438 ' O ' ' N ' ' A' ' 82' ' ' ALA . 0.4 OUTLIER -77.08 108.18 9.98 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 177.202 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.426 ' C ' ' O ' ' A' ' 79' ' ' ASP . 28.0 t80 -28.77 -40.75 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.428 ' N ' ' O ' ' A' ' 79' ' ' ASP . 0.2 OUTLIER -64.66 -53.13 52.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.935 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -50.21 -28.08 6.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.058 0.456 . . . . 0.0 110.771 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.473 ' CD2' ' CE2' ' A' ' 48' ' ' PHE . 0.1 OUTLIER -93.25 -35.5 13.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.041 -179.748 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.08 -22.61 55.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.313 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.68 -11.55 60.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.476 0.655 . . . . 0.0 111.849 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 9.5 mmt -72.96 -31.28 64.45 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.806 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.6 mt -100.18 -6.59 25.9 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.917 0.865 . . . . 0.0 111.58 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -126.05 22.34 7.32 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.127 -1.397 . . . . 0.0 111.173 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.49 95.01 7.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.857 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.8 t -135.31 32.4 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.08 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -61.65 121.95 14.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.932 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -72.6 -68.83 0.45 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.899 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.0 t . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.179 -0.915 . . . . 0.0 110.94 -179.989 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mtt . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.799 0.333 . . . . 0.0 111.264 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -108.44 -110.74 3.42 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.515 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.0 p -96.22 43.21 1.08 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.958 0.409 . . . . 0.0 110.885 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.57 141.53 54.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.96 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -96.64 -172.2 2.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.861 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 22.6 m80 -127.48 116.76 20.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.923 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -176.53 -40.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.863 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -81.55 -171.18 3.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.908 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 8.1 m170 60.64 110.67 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.852 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -153.4 -67.92 0.15 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.965 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 27.1 t -176.56 164.5 2.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.888 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.1 m 60.31 170.1 0.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.818 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 106.22 -117.89 5.55 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.515 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.434 ' CD1' ' N ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -158.31 42.7 0.28 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.807 0.337 . . . . 0.0 110.826 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.3 m -114.05 88.3 14.45 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.148 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -52.05 -32.75 50.1 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.566 2.177 . . . . 0.0 112.313 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -99.51 123.69 44.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.897 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -102.86 -74.48 1.03 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.494 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.1 94.0 5.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.75 0.309 . . . . 0.0 111.01 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -110.62 31.5 5.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.921 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 2.8 mpt? -111.19 155.13 23.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.886 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -100.36 5.28 44.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.382 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -91.66 -14.26 30.4 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.611 0.719 . . . . 0.0 111.621 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -65.67 -16.33 63.64 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.251 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -91.96 -30.56 16.03 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.687 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.667 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -57.9 -27.31 63.2 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.828 -179.807 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -62.86 -24.03 67.6 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -88.08 -11.47 47.02 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.195 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.667 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 11.3 mm -64.98 -14.59 16.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.969 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -77.89 2.14 18.28 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 113.878 -1.51 . . . . 0.0 111.463 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.23 -31.23 14.82 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.064 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -59.54 -30.98 68.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.942 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -97.41 38.9 1.22 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.932 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -176.87 38.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.851 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -176.58 78.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.903 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -161.73 71.23 0.36 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.004 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -107.11 27.9 14.54 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.559 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 60.03 36.94 21.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.844 0.354 . . . . 0.0 110.952 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -73.38 -175.55 1.97 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.88 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.1 p-10 -98.59 33.81 2.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.93 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 60.34 43.94 98.07 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.53 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -150.4 123.9 9.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.813 0.34 . . . . 0.0 110.971 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.449 ' CG1' ' CE2' ' A' ' 48' ' ' PHE . 9.4 p -131.39 127.67 60.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.976 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.1 p -78.99 162.08 26.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.906 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.435 HG12 ' CD2' ' A' ' 67' ' ' PHE . 46.5 t -64.17 -54.16 34.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.001 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -47.22 -29.75 2.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.084 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -93.32 -30.05 15.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.655 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.449 ' CE2' ' CG1' ' A' ' 43' ' ' VAL . 0.1 OUTLIER -66.02 -38.31 88.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.95 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.6 mtp85 -54.72 -51.48 65.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.0 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -57.2 -21.49 39.73 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.606 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.9 mt -93.17 -25.43 4.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.744 0.307 . . . . 0.0 111.255 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 40.6 mm -93.37 -49.39 12.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.301 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 24.7 ttp180 -46.86 -68.86 0.16 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.7 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -92.44 14.93 15.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.745 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -121.31 -89.88 1.07 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.373 -0.918 . . . . 0.0 112.914 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -80.23 132.9 58.18 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.554 0.216 . . . . 0.0 111.192 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.65 113.82 3.82 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.466 2.111 . . . . 0.0 112.256 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -155.63 137.69 14.6 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.892 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.433 ' O ' ' CD1' ' A' ' 63' ' ' ILE . 0.6 OUTLIER -74.31 145.1 44.2 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.855 179.733 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.515 ' O ' ' N ' ' A' ' 64' ' ' THR . 2.3 pt-20 -37.85 -48.65 1.14 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.169 0.509 . . . . 0.0 111.054 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.426 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -49.55 -55.74 12.38 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.835 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.444 ' O ' ' HB2' ' A' ' 66' ' ' PHE . 0.6 OUTLIER -52.18 -62.6 1.53 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.286 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.485 ' O ' ' N ' ' A' ' 67' ' ' PHE . 1.8 mp -57.35 -62.84 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.123 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.515 ' N ' ' O ' ' A' ' 60' ' ' GLU . 99.3 m -50.12 -53.09 29.85 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.405 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.426 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 2.7 mm-40 -65.31 -15.8 62.91 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-O 121.617 0.722 . . . . 0.0 110.485 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.444 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.7 m-30 -94.61 -26.57 16.31 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.423 179.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.485 ' N ' ' O ' ' A' ' 63' ' ' ILE . 4.8 m-30 -77.97 -26.58 48.8 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.801 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -91.32 -28.93 17.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.805 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.07 -11.23 47.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.535 0.683 . . . . 0.0 111.782 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -92.09 -28.53 17.07 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.113 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -126.16 119.36 23.62 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.785 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.84 -40.67 16.15 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.272 1.982 . . . . 0.0 112.279 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -76.53 -30.94 57.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.817 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.2 m120 72.35 38.83 0.8 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.171 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.5 t -89.64 41.77 1.06 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.634 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 47.94 26.94 4.64 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.523 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -128.12 129.38 46.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.819 0.342 . . . . 0.0 110.449 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.459 HG23 HD13 ' A' ' 78' ' ' ILE . 61.9 mt -102.49 153.34 5.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.19 0.519 . . . . 0.0 111.662 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.426 ' O ' ' C ' ' A' ' 80' ' ' TYR . 1.2 t0 -98.78 95.76 7.43 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 176.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.426 ' C ' ' O ' ' A' ' 79' ' ' ASP . 56.4 t80 -29.06 -41.25 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.337 -177.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -66.0 -55.85 14.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.672 0.272 . . . . 0.0 110.618 179.818 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.415 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -52.65 -27.08 15.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.965 0.412 . . . . 0.0 110.594 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.435 ' CZ ' HD12 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -90.37 -32.3 16.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.86 179.823 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.12 -28.76 48.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.165 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.82 -11.5 60.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.375 0.607 . . . . 0.0 111.708 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 14.1 tmm? -69.59 -35.12 75.04 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.913 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.0 mp -100.67 -5.97 25.8 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.816 0.817 . . . . 0.0 111.63 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -125.48 22.41 7.68 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 114.193 -1.367 . . . . 0.0 111.09 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -65.54 79.55 0.06 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.871 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.0 t -143.19 35.77 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.026 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -123.6 175.93 6.52 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.92 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 68.4 -69.29 0.15 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.009 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.873 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 ttp . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.852 0.358 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -158.65 95.89 0.15 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.492 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.7 m -84.77 -66.71 0.86 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.723 0.297 . . . . 0.0 110.862 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 t 60.42 84.56 0.12 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.899 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 15.4 m170 -125.81 35.82 4.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.902 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 64.6 m-70 -127.79 -169.87 2.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.862 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 6.0 m170 61.85 114.98 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.87 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 18.7 m170 60.56 84.12 0.13 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.893 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -88.51 177.46 6.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.98 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 13.8 p80 -107.51 -45.79 3.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.931 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.3 t 60.67 168.16 0.09 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.887 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.9 p -103.97 105.82 16.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.88 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -176.95 -38.3 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.448 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.7 tp -82.39 -31.53 29.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.778 0.323 . . . . 0.0 110.907 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.5 m -119.45 150.49 49.84 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.153 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.43 -172.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.53 2.153 . . . . 0.0 112.279 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 11.1 mmt85 61.28 155.32 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.885 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 146.87 88.24 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.519 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.404 ' O ' ' CD2' ' A' ' 20' ' ' HIS . 0.8 OUTLIER -117.07 -178.44 3.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.879 0.371 . . . . 0.0 110.848 -179.981 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.404 ' CD2' ' O ' ' A' ' 19' ' ' SER . 6.4 m170 -163.29 174.03 12.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.896 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.7 mtt -67.13 149.66 50.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.887 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 36.6 p -101.58 5.31 41.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.54 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.79 -14.65 44.49 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.579 0.704 . . . . 0.0 111.574 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -65.31 -16.54 63.68 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.129 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.9 tttt -91.91 -27.24 18.03 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.644 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.652 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -68.08 -28.16 67.12 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.854 -179.892 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -60.3 -24.28 64.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.223 0.535 . . . . 0.0 109.562 178.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.6 tt -88.33 -11.22 46.98 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.476 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.652 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 13.5 mm -63.61 -15.45 16.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.964 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -80.56 1.95 27.52 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 113.854 -1.521 . . . . 0.0 111.345 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.45 -29.87 15.34 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.043 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -56.56 -28.16 59.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.053 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -97.65 28.3 3.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.084 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -178.33 37.46 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.869 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.403 ' CG ' ' O ' ' A' ' 35' ' ' PHE . 19.8 t80 -177.14 37.76 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.957 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.1 p-10 -145.04 45.62 1.34 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.862 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -82.62 -80.27 0.97 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.484 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -177.63 78.27 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.839 0.352 . . . . 0.0 110.965 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -146.14 34.64 0.99 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.995 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 60.69 -175.25 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.95 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.403 ' O ' ' CD1' ' A' ' 80' ' ' TYR . . . -100.36 -37.1 3.89 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.588 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -60.07 123.8 18.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.886 0.374 . . . . 0.0 110.88 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.453 ' CG1' ' CE2' ' A' ' 48' ' ' PHE . 7.6 p -139.53 127.33 25.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.898 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.1 p -67.42 154.17 41.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.159 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.478 ' CG2' HG13 ' A' ' 78' ' ' ILE . 50.6 t -61.9 -27.8 43.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.928 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -71.91 -58.62 3.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.921 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -58.07 -29.07 65.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.802 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.453 ' CE2' ' CG1' ' A' ' 43' ' ' VAL . 0.1 OUTLIER -61.85 -36.88 82.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.904 179.816 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 16.2 mtt-85 -58.08 -50.74 72.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.951 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -57.28 -26.48 56.39 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.548 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 22.9 mt -80.87 -39.61 18.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.81 0.338 . . . . 0.0 111.087 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 37.9 mm -75.65 -28.77 19.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.248 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.6 mtp85 -51.23 -55.13 19.7 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.094 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -111.86 14.93 21.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.276 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -100.24 -86.84 1.93 Allowed Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.533 -0.841 . . . . 0.0 112.74 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.5 mt -105.47 140.05 20.77 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 120.694 0.283 . . . . 0.0 110.981 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -81.35 55.76 5.73 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.524 2.149 . . . . 0.0 112.398 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.419 ' CG ' ' HB2' ' A' ' 62' ' ' GLU . 2.7 ttp -88.2 139.22 30.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.696 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.451 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 1.7 p -69.18 140.19 54.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.03 0.443 . . . . 0.0 111.067 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.509 ' O ' ' N ' ' A' ' 64' ' ' THR . 0.1 OUTLIER -39.95 -50.36 2.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.156 179.824 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.526 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -45.92 -52.97 10.68 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.489 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.491 ' O ' ' HB2' ' A' ' 66' ' ' PHE . 0.9 OUTLIER -58.2 -60.94 2.97 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.04 179.683 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.56 ' O ' ' N ' ' A' ' 67' ' ' PHE . 1.7 mp -57.2 -60.21 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.914 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.509 ' N ' ' O ' ' A' ' 60' ' ' GLU . 36.1 m -52.32 -51.24 59.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.786 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.526 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 27.2 tt0 -65.99 -16.14 63.63 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-O 121.603 0.716 . . . . 0.0 110.344 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.491 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 2.3 m-85 -95.77 -25.95 15.86 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.277 178.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.56 ' N ' ' O ' ' A' ' 63' ' ' ILE . 1.6 m-85 -70.74 -41.37 71.92 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.564 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -84.1 -29.14 27.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.919 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -80.5 -11.14 59.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.481 0.658 . . . . 0.0 111.76 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.39 -31.65 15.96 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.018 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -115.86 121.18 34.49 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.778 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.77 -34.95 59.78 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.453 2.102 . . . . 0.0 112.245 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 14.3 m-80 -84.5 -31.63 24.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.792 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 11.5 m120 72.43 37.08 0.95 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.166 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.8 t -88.93 41.84 1.05 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.743 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 50.82 25.62 9.7 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 121.104 -0.57 . . . . 0.0 112.727 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -128.32 129.46 46.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.844 0.354 . . . . 0.0 110.662 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.478 HG13 ' CG2' ' A' ' 45' ' ' VAL . 59.8 mt -101.44 152.37 5.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.266 0.555 . . . . 0.0 111.627 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.439 ' N ' HG22 ' A' ' 78' ' ' ILE . 20.3 t0 -101.07 96.02 6.95 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 176.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.426 ' C ' ' O ' ' A' ' 79' ' ' ASP . 40.2 t80 -28.58 -41.31 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.436 -177.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 79' ' ' ASP . 0.4 OUTLIER -65.28 -55.41 18.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.689 0.28 . . . . 0.0 110.627 179.767 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -53.43 -27.58 25.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.16 0.505 . . . . 0.0 110.497 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.44 ' CZ ' HD12 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -89.43 -31.7 17.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.734 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' A' ' 80' ' ' TYR . . . -78.6 -31.12 46.97 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.108 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -74.57 -11.34 60.18 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.503 0.668 . . . . 0.0 111.823 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 4.4 mmt -74.66 -32.11 62.15 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.808 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.7 mt -97.19 -6.93 33.63 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.921 0.867 . . . . 0.0 111.579 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -126.03 22.32 7.34 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.076 -1.42 . . . . 0.0 111.112 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 60.5 p -68.44 94.93 0.58 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.914 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.7 m -130.42 31.16 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.159 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -147.23 116.98 7.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.001 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -139.02 169.36 17.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.931 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.2 p . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.943 179.99 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ttm . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.759 0.314 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -136.67 51.95 0.79 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.576 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.0 p -100.53 -35.63 9.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.795 0.331 . . . . 0.0 110.831 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.1 m -60.69 129.93 43.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.918 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -95.06 87.09 4.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.979 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -66.07 154.55 39.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.828 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 9.9 p-80 -131.69 80.19 1.91 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.904 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 -134.45 31.61 3.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.925 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -154.28 -171.04 3.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.854 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -60.17 -54.71 42.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.875 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 60.2 p -176.22 -74.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.92 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.8 m -175.24 -57.91 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.971 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 103.68 100.2 2.58 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.504 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.0 -45.42 61.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.836 0.351 . . . . 0.0 110.9 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.7 t 62.84 88.18 0.12 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.095 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -56.29 -165.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.667 2.244 . . . . 0.0 112.25 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.4 mtp-105 69.09 -66.88 0.23 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.035 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -59.28 130.42 50.54 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.496 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 46.9 t -85.34 158.6 20.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.86 0.362 . . . . 0.0 110.856 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 57.2 m-70 -108.72 -41.89 4.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.965 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.3 ptp -60.24 102.56 0.18 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.92 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.4 t -101.71 5.36 41.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.067 0.46 . . . . 0.0 111.583 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.38 -14.75 62.27 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.496 0.665 . . . . 0.0 111.572 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -65.73 -16.1 63.46 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.216 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.407 ' NZ ' ' CE1' ' A' ' 88' ' ' TYR . 0.2 OUTLIER -91.69 -25.68 18.99 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 114.704 -1.134 . . . . 0.0 110.685 179.421 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.655 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -66.56 -29.11 69.11 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.814 -179.937 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -60.13 -24.26 64.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.093 0.473 . . . . 0.0 109.725 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.3 tt -88.15 -11.22 47.52 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.461 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.655 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 10.8 mm -65.26 -14.3 16.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.924 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -77.04 2.04 16.17 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 114.035 -1.439 . . . . 0.0 111.585 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.46 -30.78 14.87 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.102 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -57.41 -24.34 54.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.167 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -97.05 30.41 2.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.012 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -173.29 35.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.875 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -176.98 78.26 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.868 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -104.14 41.45 1.3 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.859 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.02 -83.32 1.29 Allowed Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.566 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 43.89 31.33 0.48 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.809 0.338 . . . . 0.0 111.523 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.481 ' CD1' ' N ' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -51.3 -100.43 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.35 -179.723 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -62.5 -28.14 69.63 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.774 0.321 . . . . 0.0 111.001 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.58 25.58 6.53 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.436 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -143.79 123.79 13.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.781 0.324 . . . . 0.0 110.92 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.452 ' CG1' ' CE2' ' A' ' 48' ' ' PHE . 9.2 p -116.58 122.74 70.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.017 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.421 ' HB3' ' CE2' ' A' ' 77' ' ' PHE . 0.1 OUTLIER -74.73 154.29 38.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.825 179.931 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.433 HG12 ' CD2' ' A' ' 67' ' ' PHE . 57.4 t -58.87 -53.2 50.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.859 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -48.93 -33.05 10.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.937 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -86.36 -28.93 23.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.482 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.452 ' CE2' ' CG1' ' A' ' 43' ' ' VAL . 0.1 OUTLIER -69.25 -41.99 76.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.859 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.7 mtp180 -56.27 -52.35 64.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.954 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -53.91 -25.1 29.43 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.326 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 14.1 mt -89.83 -47.05 15.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.854 0.359 . . . . 0.0 110.923 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 36.4 mm -66.06 -28.01 42.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.223 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.7 -61.53 2.15 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.904 0.383 . . . . 0.0 111.066 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -111.86 15.04 20.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.26 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -97.48 -86.05 1.81 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.591 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.1 mt -101.27 142.44 24.63 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.693 0.283 . . . . 0.0 111.065 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.32 113.49 3.69 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.533 2.155 . . . . 0.0 112.321 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -152.26 138.11 18.03 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.806 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.469 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -77.65 147.67 35.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.683 179.698 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.519 ' O ' ' N ' ' A' ' 64' ' ' THR . 4.6 pt-20 -38.76 -51.86 1.7 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.162 0.505 . . . . 0.0 110.822 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.516 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -46.77 -53.64 11.46 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.118 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 59' ' ' THR . 0.9 OUTLIER -54.91 -61.78 2.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.961 0.41 . . . . 0.0 110.02 179.478 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.49 ' CG2' ' CE2' ' A' ' 67' ' ' PHE . 1.6 mp -58.7 -61.54 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.205 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.519 ' N ' ' O ' ' A' ' 60' ' ' GLU . 62.7 m -52.02 -51.49 57.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.37 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.516 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 6.6 tt0 -65.64 -15.53 62.86 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.735 0.779 . . . . 0.0 110.497 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.443 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.6 m-30 -95.97 -25.47 15.94 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 114.449 -1.251 . . . . 0.0 110.321 179.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.49 ' CE2' ' CG2' ' A' ' 63' ' ' ILE . 4.0 m-30 -79.06 -26.57 43.07 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.748 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -91.37 -27.5 18.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.905 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.63 -11.18 43.31 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.487 0.66 . . . . 0.0 111.777 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.65 -28.39 18.41 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.016 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.53 119.25 23.02 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.829 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.31 -34.9 42.87 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.373 2.049 . . . . 0.0 112.204 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 26.2 m-20 -82.35 -31.32 29.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.9 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 12.9 m120 72.21 38.43 0.87 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.176 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.5 t -89.39 42.26 1.08 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.578 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 50.75 25.29 9.06 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.663 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.421 ' CE2' ' HB3' ' A' ' 44' ' ' SER . 1.9 m-85 -123.08 146.74 47.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.783 0.325 . . . . 0.0 110.783 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.447 HD11 HG23 ' A' ' 78' ' ' ILE . 59.4 mt -123.02 153.12 28.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.096 0.474 . . . . 0.0 111.578 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.43 ' O ' ' C ' ' A' ' 80' ' ' TYR . 0.5 OUTLIER -98.3 95.78 7.6 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 176.958 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.43 ' C ' ' O ' ' A' ' 79' ' ' ASP . 42.6 t80 -29.34 -41.23 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.036 -0.529 . . . . 0.0 112.293 -178.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.406 ' N ' ' O ' ' A' ' 79' ' ' ASP . 0.1 OUTLIER -65.81 -56.04 14.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.643 179.638 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.412 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -52.45 -27.17 15.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.944 0.402 . . . . 0.0 110.462 179.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.436 ' CZ ' HD13 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -90.76 -30.81 16.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.803 179.929 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.31 -24.64 37.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.433 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.47 -11.53 60.71 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.452 0.644 . . . . 0.0 111.895 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 23.6 mtp -79.29 -30.79 43.08 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.843 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.1 mt -100.66 -6.18 25.52 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.735 0.778 . . . . 0.0 111.534 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.407 ' CE1' ' NZ ' ' A' ' 25' ' ' LYS . 32.6 m-85 -125.83 22.37 7.46 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 114.241 -1.345 . . . . 0.0 111.186 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.401 ' O ' ' CG2' ' A' ' 90' ' ' VAL . 6.7 t -63.94 82.3 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.874 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.401 ' CG2' ' O ' ' A' ' 89' ' ' SER . 35.4 m 42.84 32.66 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.748 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -73.19 174.02 8.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.862 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -105.73 -33.24 8.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.92 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.2 t . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.909 179.999 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 ptp . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.77 0.319 . . . . 0.0 111.141 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -123.72 50.85 0.83 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.541 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -162.02 127.59 3.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.894 0.378 . . . . 0.0 110.837 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.55 31.78 4.74 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.922 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 30.9 m80 68.5 -68.13 0.18 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.971 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -159.62 -51.06 0.06 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.858 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 5.4 t60 60.54 35.61 20.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.939 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -83.8 154.49 23.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.92 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 4.7 t60 60.75 110.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.853 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -72.09 -62.64 1.36 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.901 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -176.23 -40.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.909 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.0 t 60.69 -169.81 0.16 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.929 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -133.7 -59.76 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.475 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.3 tp -60.49 147.71 40.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.837 0.351 . . . . 0.0 110.857 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.5 p -59.86 139.34 90.35 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.001 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -52.15 -60.52 0.73 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.429 2.086 . . . . 0.0 112.368 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.4 mtt85 -130.4 -179.27 5.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.959 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.47 88.52 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.416 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.1 p -60.73 141.34 57.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.839 0.352 . . . . 0.0 110.856 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 20.3 p80 -101.88 32.05 3.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.854 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -136.58 92.53 2.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.848 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 84.4 p -89.62 5.35 46.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.454 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -71.32 -14.58 62.25 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.54 0.686 . . . . 0.0 111.532 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -64.97 -16.67 63.64 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.084 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.91 -27.29 18.0 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.702 179.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.638 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -68.5 -27.39 66.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.885 179.972 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -59.34 -23.72 62.75 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.0 tt -88.16 -11.41 46.93 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.449 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.638 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 12.9 mm -66.4 -14.38 17.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.908 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -78.36 2.12 19.67 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 113.895 -1.502 . . . . 0.0 111.661 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.11 -31.91 14.64 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.085 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -60.67 -29.31 69.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.964 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -96.91 38.19 1.25 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.93 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -161.39 30.26 0.13 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.926 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -176.68 37.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.827 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -110.87 37.8 2.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.909 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -96.07 35.95 4.09 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.442 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.4 t70 61.51 68.77 0.69 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.919 0.39 . . . . 0.0 110.915 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -134.9 150.36 50.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.883 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -61.72 159.09 14.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.924 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.409 ' HA3' ' CD2' ' A' ' 80' ' ' TYR . . . -69.39 -30.67 71.25 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.475 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -64.04 123.76 19.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.848 0.356 . . . . 0.0 110.879 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.422 ' CG1' ' CE2' ' A' ' 48' ' ' PHE . 7.1 p -141.42 137.33 32.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.949 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.426 ' HB3' ' CE2' ' A' ' 77' ' ' PHE . 13.1 p -84.99 150.13 25.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.047 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.433 HG12 ' CD2' ' A' ' 67' ' ' PHE . 91.7 t -54.92 -55.52 15.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.082 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -46.74 -30.12 2.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.079 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -91.65 -28.68 17.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.45 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.422 ' CE2' ' CG1' ' A' ' 43' ' ' VAL . 0.1 OUTLIER -67.42 -38.21 84.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.9 179.885 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 29.4 mtm180 -57.06 -50.43 72.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.907 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -56.15 -25.75 47.89 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.381 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.6 mt -85.22 -43.5 16.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.721 0.296 . . . . 0.0 110.932 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 31.0 mm -69.89 -36.21 68.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.096 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.6 ttm180 -54.36 -47.43 72.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.08 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -111.81 14.94 21.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.335 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -109.17 -88.66 1.96 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.639 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.9 mp -102.06 142.07 23.83 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.7 0.286 . . . . 0.0 111.106 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.05 111.41 3.27 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.498 2.132 . . . . 0.0 112.26 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.421 ' C ' HD12 ' A' ' 63' ' ' ILE . 0.6 OUTLIER -148.08 138.03 22.57 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.805 -179.867 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.439 ' O ' ' CD1' ' A' ' 63' ' ' ILE . 0.6 OUTLIER -75.32 144.82 42.21 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.719 179.529 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.548 ' O ' ' N ' ' A' ' 64' ' ' THR . 1.3 pm0 -37.85 -49.01 1.17 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.278 0.561 . . . . 0.0 111.156 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.421 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -49.37 -55.98 11.13 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.83 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 66' ' ' PHE . 0.7 OUTLIER -52.24 -62.22 1.77 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.886 0.374 . . . . 0.0 110.003 179.266 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.509 ' CG2' ' CE2' ' A' ' 67' ' ' PHE . 1.4 mp -58.51 -62.88 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.125 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.548 ' N ' ' O ' ' A' ' 60' ' ' GLU . 98.6 m -49.37 -53.03 24.51 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.421 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.421 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 4.9 mm-40 -65.48 -15.72 62.94 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 121.566 0.698 . . . . 0.0 110.554 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.453 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.6 m-30 -95.71 -23.99 16.73 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.56 179.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.509 ' CE2' ' CG2' ' A' ' 63' ' ' ILE . 1.9 m-30 -76.7 -31.68 57.37 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.746 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -85.73 -29.95 23.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.856 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.71 -11.1 60.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.433 0.635 . . . . 0.0 111.733 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.67 -30.26 12.2 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.061 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -121.8 116.91 30.11 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.748 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -64.85 -50.4 2.31 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.381 2.054 . . . . 0.0 112.315 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -68.63 -32.73 72.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.813 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.3 m120 75.44 53.83 0.07 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.72 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 12.6 p -98.16 28.83 3.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.703 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 59.2 26.5 61.47 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.319 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.426 ' CE2' ' HB3' ' A' ' 44' ' ' SER . 4.1 m-85 -129.06 131.69 47.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.768 0.318 . . . . 0.0 110.74 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.46 HG23 HD13 ' A' ' 78' ' ' ILE . 61.2 mt -106.17 152.46 7.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.23 0.538 . . . . 0.0 111.635 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.451 ' N ' HG22 ' A' ' 78' ' ' ILE . 1.1 m-20 -101.23 96.2 7.04 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 176.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.43 ' C ' ' O ' ' A' ' 79' ' ' ASP . 40.5 t80 -28.78 -41.14 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.035 -0.529 . . . . 0.0 112.331 -177.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 79' ' ' ASP . 5.0 mtpp -66.06 -55.16 17.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.692 0.282 . . . . 0.0 110.51 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -53.2 -28.06 24.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.003 0.43 . . . . 0.0 110.411 179.128 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.437 ' CZ ' HD12 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -88.97 -32.47 17.63 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.846 179.88 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.71 -29.6 45.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.228 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 89' ' ' SER . . . -74.32 -11.53 60.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.369 0.605 . . . . 0.0 111.619 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 2.2 mtt -68.9 -47.68 65.23 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.461 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.5 mp -82.81 -6.92 59.65 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.845 0.831 . . . . 0.0 111.107 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -119.69 21.77 11.89 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 113.982 -1.463 . . . . 0.0 111.25 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.415 ' HB2' ' O ' ' A' ' 85' ' ' ALA . 9.3 t -95.54 23.5 6.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.935 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.8 t 53.35 29.33 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.257 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.47 163.82 21.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.995 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -157.42 -46.15 0.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.825 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.347 -0.835 . . . . 0.0 110.852 -179.973 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.485 1.305 0 CA-C-O 120.839 0.352 . . . . 0.0 111.262 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -59.76 -72.53 0.6 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.468 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.7 m -84.39 143.41 29.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.863 0.363 . . . . 0.0 110.892 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.3 t -131.56 35.39 3.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.837 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -102.63 -38.94 7.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.955 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 4.5 p-80 -106.58 176.24 5.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.97 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -106.42 -175.16 2.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.891 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -98.74 34.7 2.0 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.886 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -134.67 170.97 15.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.919 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -71.82 174.21 7.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.915 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 26.2 m -145.35 95.25 2.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.903 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m -106.49 133.2 51.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.896 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.48 157.82 33.38 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.476 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.6 mp -131.92 -171.3 2.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.764 0.316 . . . . 0.0 110.89 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.49 ' N ' ' CD ' ' A' ' 16' ' ' PRO . 6.6 t -79.94 -45.74 1.48 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.386 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.49 ' CD ' ' N ' ' A' ' 15' ' ' VAL . 70.7 Cg_exo -50.82 179.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.34 2.026 . . . . 0.0 112.348 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 60.68 96.45 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.876 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -70.44 -120.51 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.491 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.2 t -141.05 95.19 2.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.679 0.276 . . . . 0.0 110.831 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.4 -177.85 0.08 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.903 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.7 -176.23 5.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.887 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.8 m -93.45 5.43 51.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.512 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -72.01 -14.62 61.94 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.506 0.669 . . . . 0.0 111.509 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -65.35 -16.39 63.55 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.182 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.86 -27.34 18.0 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.657 179.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.664 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -67.1 -28.44 68.17 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.77 -179.936 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -58.95 -23.94 62.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.175 0.512 . . . . 0.0 109.751 178.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.2 tt -88.09 -11.37 47.26 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.488 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.664 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 11.6 mm -67.21 -13.73 17.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 114.71 -1.132 . . . . 0.0 111.98 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -77.89 2.29 17.83 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 113.894 -1.503 . . . . 0.0 111.499 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.22 -43.21 8.94 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.102 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -59.82 -28.62 67.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.974 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -96.12 39.79 1.14 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.994 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -161.55 30.01 0.13 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.018 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -177.2 76.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.908 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -120.32 48.14 1.64 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.951 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -96.23 27.6 16.29 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.595 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 60.98 68.29 0.75 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.863 0.363 . . . . 0.0 110.826 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -105.01 147.1 28.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.94 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -67.34 -173.46 0.29 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.919 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -93.53 42.15 2.6 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.586 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -154.58 123.82 6.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.858 0.361 . . . . 0.0 110.854 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.1 p -128.85 139.0 53.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.068 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.405 ' HB3' ' CZ ' ' A' ' 77' ' ' PHE . 79.2 p -88.36 151.58 22.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.788 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.45 HG12 ' CD2' ' A' ' 67' ' ' PHE . 53.7 t -58.18 -50.75 77.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.826 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -51.27 -29.18 13.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.988 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -91.45 -32.32 15.66 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.601 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.13 -42.31 98.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.024 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 72.1 mtt180 -56.87 -48.27 78.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.917 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -59.58 -27.42 63.66 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.383 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.5 mt -86.27 -50.06 14.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.872 0.367 . . . . 0.0 110.916 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.0 tp -57.87 -40.32 75.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.431 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.6 ttm180 -48.39 -68.01 0.22 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.063 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -93.36 14.79 17.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.065 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -109.51 -59.76 0.52 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.614 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.4 mp -129.09 139.51 35.9 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.655 0.264 . . . . 0.0 111.143 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -79.6 58.3 6.9 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.598 2.199 . . . . 0.0 112.056 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.477 ' HG2' ' HB2' ' A' ' 62' ' ' GLU . 1.3 ttt -87.08 138.66 31.31 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.952 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.449 ' O ' ' CD1' ' A' ' 63' ' ' ILE . 1.3 p -78.27 140.59 38.86 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.883 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.511 ' O ' ' N ' ' A' ' 64' ' ' THR . 0.1 OUTLIER -37.05 -49.1 0.83 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.093 -180.0 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.525 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -48.49 -55.52 10.76 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.314 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.477 ' HB2' ' HG2' ' A' ' 58' ' ' MET . 0.7 OUTLIER -56.16 -60.28 3.72 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.287 179.833 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.519 ' O ' ' N ' ' A' ' 67' ' ' PHE . 2.3 mp -58.07 -61.12 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.163 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.511 ' N ' ' O ' ' A' ' 60' ' ' GLU . 71.8 m -52.8 -51.53 60.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.122 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.525 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 44.6 tt0 -64.93 -15.76 62.5 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.63 0.729 . . . . 0.0 110.516 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.448 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.7 m-30 -96.38 -27.87 14.73 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 114.594 -1.184 . . . . 0.0 110.434 179.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.519 ' N ' ' O ' ' A' ' 63' ' ' ILE . 3.9 m-30 -73.25 -30.1 63.22 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.651 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.75 -26.85 20.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.874 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.28 -11.2 47.19 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.482 0.658 . . . . 0.0 111.725 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.8 -29.95 13.46 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.994 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -116.74 121.38 33.0 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.787 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.08 -49.39 2.07 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.388 2.059 . . . . 0.0 112.361 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -80.5 -28.42 37.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.911 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.1 m120 75.82 51.92 0.06 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.616 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 12.6 p -96.52 31.1 2.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.87 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 59.55 29.31 66.47 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.413 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.405 ' CZ ' ' HB3' ' A' ' 44' ' ' SER . 0.2 OUTLIER -132.08 129.34 39.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.833 0.349 . . . . 0.0 110.664 179.901 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.433 HD11 ' CZ ' ' A' ' 83' ' ' PHE . 63.7 mt -104.51 152.83 6.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.235 0.541 . . . . 0.0 111.593 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.43 ' O ' ' C ' ' A' ' 80' ' ' TYR . 1.8 m-20 -97.76 95.6 7.66 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 176.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.43 ' C ' ' O ' ' A' ' 79' ' ' ASP . 40.4 t80 -28.96 -41.55 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.209 -178.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 79' ' ' ASP . 0.3 OUTLIER -66.01 -56.21 12.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.625 179.706 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -52.11 -27.6 14.74 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.998 0.428 . . . . 0.0 110.602 179.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.433 ' CZ ' HD11 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -89.84 -32.16 17.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.866 179.85 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.6 -27.88 45.67 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.258 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.68 -11.41 60.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.482 0.658 . . . . 0.0 111.814 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 1.8 mtp -77.98 -36.86 48.5 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.736 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.2 mt -86.76 -6.71 58.74 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.862 0.839 . . . . 0.0 111.501 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -126.03 22.08 7.38 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 114.139 -1.391 . . . . 0.0 111.088 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.3 m -73.81 83.38 1.65 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.839 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 31.2 m -135.1 31.33 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.138 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -165.53 155.99 13.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.902 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -84.46 -61.51 1.78 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.929 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.28 -0.866 . . . . 0.0 110.891 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.3 tpt . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.751 0.31 . . . . 0.0 111.206 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -103.42 111.58 3.97 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.519 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.5 m -79.0 97.38 6.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.842 0.353 . . . . 0.0 110.845 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.5 t 60.39 167.46 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.854 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 21.9 p80 -62.14 118.53 7.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.958 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -155.64 -64.58 0.12 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.948 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 19.4 t-80 -169.1 150.15 4.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.923 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -76.89 150.03 36.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.856 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 77.5 m-70 60.43 -171.88 0.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.91 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.61 152.7 44.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.906 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.5 t -106.48 -71.2 0.76 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.932 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.4 p 49.97 35.61 10.05 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.17 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -97.68 88.43 0.93 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.503 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -163.61 35.03 0.09 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.854 0.359 . . . . 0.0 110.939 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.2 m -60.97 158.38 34.55 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.134 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -52.37 -51.26 11.53 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.614 2.21 . . . . 0.0 112.284 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -137.92 -62.72 0.59 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.861 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.6 -33.25 5.81 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.533 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.4 p -95.08 119.11 33.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.841 0.353 . . . . 0.0 110.885 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -61.63 172.75 1.14 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.907 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 2.4 mmt -99.14 30.81 3.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.008 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 17.8 m -101.58 5.34 41.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.535 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -81.81 -14.57 56.17 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.531 0.681 . . . . 0.0 111.553 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -65.41 -16.15 63.32 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.781 -1.1 . . . . 0.0 111.315 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -91.76 -26.51 18.53 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.7 -1.137 . . . . 0.0 110.749 179.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.654 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -65.25 -28.88 69.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.78 179.912 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -59.71 -23.94 63.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.136 0.493 . . . . 0.0 109.677 178.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.1 tt -88.17 -11.35 47.06 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.434 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.654 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 11.4 mm -65.63 -14.39 16.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.022 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -78.26 2.3 18.82 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 113.801 -1.545 . . . . 0.0 111.596 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.16 -28.67 16.16 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.179 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -56.45 -29.06 61.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.048 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -98.39 30.56 3.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.907 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -178.02 55.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.888 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.73 36.01 1.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.918 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.0 t70 59.68 29.4 18.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.981 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 57.59 25.33 55.21 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.662 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 58.32 45.16 17.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.872 0.368 . . . . 0.0 110.941 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -59.49 -66.17 0.55 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.997 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -105.34 166.07 10.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.962 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -100.23 30.36 10.32 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.465 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -149.98 123.8 9.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.829 0.347 . . . . 0.0 110.915 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.447 ' CG1' ' CE2' ' A' ' 48' ' ' PHE . 8.8 p -129.49 123.96 58.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.973 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.14 160.52 30.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.941 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.448 HG12 ' CD2' ' A' ' 67' ' ' PHE . 45.8 t -63.94 -50.98 75.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.843 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -50.92 -31.37 17.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.962 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -89.07 -28.87 19.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.521 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.447 ' CE2' ' CG1' ' A' ' 43' ' ' VAL . 0.1 OUTLIER -68.22 -40.08 82.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.909 179.918 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 15.1 mtp85 -57.13 -48.33 78.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.874 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -57.57 -27.89 59.12 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.303 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.7 mt -86.65 -43.03 15.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.848 0.356 . . . . 0.0 110.843 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 35.7 mm -68.13 -29.93 46.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.023 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 6.2 tpm_? -51.89 -55.8 17.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.95 0.405 . . . . 0.0 110.9 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -111.82 14.86 21.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.195 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -99.73 -86.76 1.91 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.628 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -100.77 137.01 19.71 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 120.658 0.266 . . . . 0.0 110.966 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.88 74.48 4.92 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.406 2.071 . . . . 0.0 112.322 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 1.4 mtp -105.8 142.18 35.96 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.733 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.453 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -79.85 148.45 31.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.729 179.734 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.491 ' O ' ' N ' ' A' ' 64' ' ' THR . 1.7 pm0 -38.09 -48.82 1.26 Allowed 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.19 0.519 . . . . 0.0 111.082 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.521 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -50.86 -52.53 40.7 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.024 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 59' ' ' THR . 1.1 mm-40 -55.33 -61.71 2.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.97 0.414 . . . . 0.0 109.933 179.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.492 ' CG2' ' CE2' ' A' ' 67' ' ' PHE . 1.8 mp -57.87 -61.77 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.249 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.491 ' N ' ' O ' ' A' ' 60' ' ' GLU . 89.8 m -52.65 -52.05 57.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.419 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.521 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 51.5 tt0 -64.81 -15.58 61.95 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.625 0.726 . . . . 0.0 110.423 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.441 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.6 m-30 -95.65 -28.13 14.97 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.548 -1.205 . . . . 0.0 110.326 179.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.492 ' CE2' ' CG2' ' A' ' 63' ' ' ILE . 7.5 m-30 -77.88 -26.09 48.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.813 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -90.57 -27.62 19.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.91 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -90.73 -11.19 40.37 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 121.391 0.615 . . . . 0.0 111.752 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -93.92 -31.32 14.35 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.939 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -120.95 120.05 29.55 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.77 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -63.33 -53.87 1.28 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.467 2.112 . . . . 0.0 112.388 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -73.91 -30.22 62.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.877 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 75.35 50.57 0.08 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.509 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.9 p -95.68 31.07 2.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.822 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 62.28 30.81 77.11 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.344 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -131.37 130.17 42.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.758 0.313 . . . . 0.0 110.881 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.442 HD12 ' CZ ' ' A' ' 83' ' ' PHE . 56.1 mt -106.06 153.18 7.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.15 0.5 . . . . 0.0 111.456 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.422 ' N ' ' CG2' ' A' ' 78' ' ' ILE . 0.8 OUTLIER -98.3 95.65 7.52 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 176.923 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.417 ' C ' ' O ' ' A' ' 79' ' ' ASP . 44.4 t80 -30.66 -40.12 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.121 -178.119 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.2 mttt -66.88 -55.56 14.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.49 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -53.32 -27.77 24.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.12 0.486 . . . . 0.0 110.555 179.172 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.442 ' CZ ' HD12 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -89.02 -31.1 18.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.722 179.703 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.11 -22.46 39.11 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.312 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.33 -11.5 60.73 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 121.388 0.613 . . . . 0.0 111.708 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 33.4 mtt -70.4 -40.28 74.0 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.773 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.3 mp -91.73 -6.31 52.15 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.857 0.837 . . . . 0.0 111.513 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -124.07 22.29 8.76 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 114.123 -1.398 . . . . 0.0 111.127 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.81 88.41 7.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.824 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 35.9 m 42.82 31.8 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.674 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -71.22 161.26 31.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.886 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -176.83 -56.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.945 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.5 t . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.865 179.995 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 mtm . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 120.785 0.326 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -88.29 -74.16 1.28 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.45 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.32 -36.68 29.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.829 0.347 . . . . 0.0 110.922 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.9 m -81.84 138.05 35.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.891 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -134.5 176.63 8.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.848 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 60.55 36.87 19.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.944 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -60.04 -69.55 0.21 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.974 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 59.86 -170.68 0.14 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.956 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -109.26 144.26 37.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.013 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -99.92 152.51 20.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.91 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 72.4 p -176.37 141.88 0.43 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.863 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 79.5 p -136.35 125.82 25.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.831 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.99 65.99 1.91 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.513 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.21 125.17 29.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.769 0.319 . . . . 0.0 110.942 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.1 p -145.93 83.9 8.44 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.07 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_exo -52.13 115.26 2.05 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.639 2.226 . . . . 0.0 112.252 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.87 143.31 31.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.878 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 133.02 -24.65 3.78 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.615 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.8 t 62.31 103.26 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.853 0.359 . . . . 0.0 110.885 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -139.55 -46.89 0.46 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.957 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 14.5 mmt 59.04 29.84 19.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.01 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.1 p -100.43 5.54 44.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.509 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.59 -15.02 63.43 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.539 0.685 . . . . 0.0 111.737 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -65.56 -16.13 63.39 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 114.944 -1.026 . . . . 0.0 111.253 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.1 ttpt -91.94 -31.93 15.46 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.733 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.645 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -56.11 -26.64 50.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.964 -179.829 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -61.66 -23.33 66.01 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -88.08 -11.63 46.54 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.375 179.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.645 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 11.3 mm -65.48 -14.25 16.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.914 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -75.59 1.88 13.24 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 113.91 -1.496 . . . . 0.0 111.819 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.27 -28.68 16.08 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.041 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.55 -24.49 56.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.0 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -96.84 30.39 2.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.987 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -177.65 38.02 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.858 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.408 ' CD1' HD12 ' A' ' 51' ' ' ILE . 14.0 t80 -172.16 41.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.929 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -167.47 73.92 0.13 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.787 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -86.19 -58.24 2.01 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.6 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -124.54 39.43 3.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.791 0.329 . . . . 0.0 110.993 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 62.64 141.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.93 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.3 p30 -178.17 127.75 0.12 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.937 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -110.73 23.23 20.23 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.56 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -154.73 123.82 6.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.745 0.307 . . . . 0.0 110.997 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.416 HG12 ' CE2' ' A' ' 48' ' ' PHE . 12.4 p -132.35 157.96 43.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.008 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.431 ' HB2' ' CD2' ' A' ' 77' ' ' PHE . 77.9 p -108.47 150.25 27.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.89 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.433 HG12 ' CD2' ' A' ' 67' ' ' PHE . 96.2 t -56.43 -51.84 59.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.951 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -47.37 -31.0 3.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.046 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -96.37 -30.97 13.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.502 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.416 ' CE2' HG12 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -62.98 -35.25 79.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.052 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 20.9 mtt85 -55.8 -52.34 64.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.036 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -56.79 -27.87 56.41 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.397 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.408 HD12 ' CD1' ' A' ' 35' ' ' PHE . 21.1 mt -81.14 -25.3 10.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.848 0.356 . . . . 0.0 111.125 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 34.8 mm -93.36 -55.25 6.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.062 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.35 -34.03 68.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.319 -179.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -111.73 14.84 21.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.67 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -131.43 -89.84 0.49 Allowed Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.33 -0.938 . . . . 0.0 112.827 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.0 mp -87.02 140.82 32.83 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.681 0.276 . . . . 0.0 111.238 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -78.27 122.02 5.5 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.567 2.178 . . . . 0.0 112.325 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.411 ' C ' HD12 ' A' ' 63' ' ' ILE . 0.8 OUTLIER -155.17 137.42 14.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.778 -179.941 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.452 ' O ' ' CD1' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -72.71 145.9 46.84 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.848 179.706 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.482 ' O ' ' N ' ' A' ' 64' ' ' THR . 5.9 pt-20 -37.6 -51.79 1.2 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.29 0.567 . . . . 0.0 111.06 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.44 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -47.64 -56.11 7.93 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.867 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 66' ' ' PHE . 0.7 OUTLIER -51.16 -62.87 1.35 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.415 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.51 ' CG2' ' CE2' ' A' ' 67' ' ' PHE . 2.2 mp -56.51 -63.71 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.32 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.482 ' N ' ' O ' ' A' ' 60' ' ' GLU . 92.5 m -51.17 -52.57 42.93 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.397 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.44 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 6.4 mm-40 -65.03 -15.98 62.94 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-O 121.652 0.739 . . . . 0.0 110.377 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.3 m-30 -92.04 -27.45 17.79 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.599 -1.182 . . . . 0.0 110.3 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.51 ' CE2' ' CG2' ' A' ' 63' ' ' ILE . 4.7 m-30 -85.6 -25.53 26.61 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.921 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -94.05 -27.66 16.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.947 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.09 -11.22 44.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.39 0.614 . . . . 0.0 111.776 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.47 -28.16 13.38 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.094 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -122.51 112.14 31.23 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.681 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.08 -47.63 3.35 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.503 2.135 . . . . 0.0 112.533 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 61.8 m-80 -68.41 -31.85 71.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.971 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 71.76 31.24 2.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.569 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 46.9 p -67.57 -26.24 66.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.981 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 113.79 19.66 6.39 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.525 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.444 ' CD1' ' N ' ' A' ' 77' ' ' PHE . 3.0 m-85 -140.91 130.97 24.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.65 0.262 . . . . 0.0 110.786 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.464 HG21 ' CD1' ' A' ' 83' ' ' PHE . 2.1 mt -110.14 147.82 14.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.929 0.395 . . . . 0.0 111.468 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.436 ' O ' ' N ' ' A' ' 81' ' ' LYS . 72.6 m-20 -77.28 103.75 7.39 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 177.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.409 ' C ' ' O ' ' A' ' 79' ' ' ASP . 50.7 t80 -28.61 -40.34 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.021 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.436 ' N ' ' O ' ' A' ' 79' ' ' ASP . 10.2 mttt -62.93 -54.46 38.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.705 0.288 . . . . 0.0 110.915 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -51.79 -26.85 10.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.089 0.471 . . . . 0.0 110.743 179.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.464 ' CD1' HG21 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -93.09 -29.71 15.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.267 -179.766 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -82.4 -26.85 32.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.243 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -74.36 -11.49 60.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.438 0.637 . . . . 0.0 111.658 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 24.6 tpp -74.85 -37.71 62.16 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.713 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.7 mt -89.14 -6.52 56.93 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.86 0.838 . . . . 0.0 111.437 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -125.84 22.44 7.44 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 114.14 -1.391 . . . . 0.0 111.099 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.06 66.51 0.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.949 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 13.8 t 57.86 30.8 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.139 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 58.8 31.61 21.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.932 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 61.2 155.43 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.963 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.914 179.99 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 mtt . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.821 0.343 . . . . 0.0 111.216 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.91 -139.94 2.82 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.401 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.4 m -60.17 140.6 56.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.847 0.356 . . . . 0.0 110.878 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 66.0 p -108.32 -41.43 4.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.879 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 62.1 m170 -63.0 -74.83 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.924 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 60.15 176.3 0.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.864 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 13.5 t-160 60.49 106.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.905 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -176.39 109.67 0.09 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.956 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -69.44 83.79 0.4 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.91 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -143.47 -51.1 0.33 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.876 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.8 p -132.33 -57.14 0.96 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.86 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.2 t -143.87 95.03 2.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.811 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -166.87 -129.1 1.03 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.485 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.6 tp -71.1 90.27 0.85 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.799 0.333 . . . . 0.0 110.917 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.504 ' N ' ' CD ' ' A' ' 16' ' ' PRO . 11.2 t -78.38 -45.22 2.1 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.442 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.504 ' CD ' ' N ' ' A' ' 15' ' ' VAL . 77.6 Cg_exo -50.12 177.99 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.402 2.068 . . . . 0.0 112.355 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.79 136.48 49.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.898 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 156.72 54.27 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.482 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.0 m -154.81 35.38 0.4 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.824 0.345 . . . . 0.0 110.856 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 45.7 t60 -104.16 -66.0 0.99 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.798 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 29.8 ttp -102.57 31.27 4.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.928 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.6 t -101.47 5.2 41.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.083 0.468 . . . . 0.0 111.695 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -94.31 -14.61 25.23 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.585 0.707 . . . . 0.0 111.582 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -65.45 -16.43 63.63 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.148 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -91.86 -26.69 18.37 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.774 179.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.666 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -67.63 -29.07 68.29 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.786 -179.919 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -59.5 -24.27 63.49 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.7 tt -88.22 -11.3 47.07 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.406 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.666 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 11.5 mm -65.67 -14.3 16.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.921 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -77.55 2.19 17.17 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 113.887 -1.506 . . . . 0.0 111.537 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.27 -30.59 15.08 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.09 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -58.35 -25.54 62.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.116 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -96.09 38.84 1.16 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.945 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.3 p-10 -178.18 38.36 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.871 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.411 ' CE2' HD11 ' A' ' 51' ' ' ILE . 2.0 t80 -152.63 55.33 0.8 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.87 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.0 t0 60.54 30.27 19.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.985 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 59.14 50.22 70.14 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.532 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.0 t0 60.32 37.01 20.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.93 0.395 . . . . 0.0 110.883 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -118.08 90.71 3.39 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.886 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -176.0 126.25 0.21 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.963 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -105.88 -19.64 10.07 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.599 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -150.71 123.8 8.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.836 0.35 . . . . 0.0 111.004 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.452 ' CG1' ' CE2' ' A' ' 48' ' ' PHE . 9.3 p -130.48 147.76 33.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.948 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 21.7 p -92.74 159.91 15.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.919 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.46 ' CG1' ' CG ' ' A' ' 67' ' ' PHE . 46.1 t -61.69 -32.81 54.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.797 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -66.69 -57.9 6.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.846 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -59.33 -31.02 68.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.826 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.452 ' CE2' ' CG1' ' A' ' 43' ' ' VAL . 0.1 OUTLIER -63.76 -40.73 97.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.962 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 10.2 mtm180 -58.6 -51.69 68.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.936 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -55.6 -25.59 43.29 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.486 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.411 HD11 ' CE2' ' A' ' 35' ' ' PHE . 13.0 mt -83.51 -46.11 18.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.915 0.388 . . . . 0.0 111.057 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 31.0 mm -68.52 -28.69 41.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.137 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.27 -59.34 4.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.061 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -111.88 15.02 20.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.237 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -98.06 -86.19 1.83 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.738 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.1 mt -105.96 144.7 29.44 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 120.705 0.288 . . . . 0.0 111.024 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.51 115.8 4.16 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.577 2.185 . . . . 0.0 112.235 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.411 ' C ' HD13 ' A' ' 63' ' ' ILE . 0.8 OUTLIER -153.88 138.48 16.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.726 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.463 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -76.07 147.04 38.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.646 179.592 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' A' ' 64' ' ' THR . 6.2 pt-20 -38.81 -52.13 1.72 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.214 0.53 . . . . 0.0 110.853 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.515 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -46.91 -53.31 12.49 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.09 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 59' ' ' THR . 2.0 mm-40 -55.13 -61.57 2.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.921 0.391 . . . . 0.0 110.021 179.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.504 ' CG2' ' CE2' ' A' ' 67' ' ' PHE . 1.6 mp -59.17 -61.69 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.155 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.539 ' N ' ' O ' ' A' ' 60' ' ' GLU . 69.3 m -51.39 -51.73 52.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.394 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.515 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 1.5 tp10 -65.36 -15.34 62.47 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.638 0.732 . . . . 0.0 110.412 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.428 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.6 m-30 -96.46 -25.88 15.51 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.533 -1.212 . . . . 0.0 110.415 179.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.504 ' CE2' ' CG2' ' A' ' 63' ' ' ILE . 1.7 m-85 -75.31 -30.18 60.27 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.747 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -93.18 -28.47 16.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.892 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.6 -10.96 59.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.407 0.622 . . . . 0.0 111.718 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.98 -33.4 14.87 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.067 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -120.09 116.98 32.34 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.888 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.68 -28.94 51.94 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.358 2.038 . . . . 0.0 112.185 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 53.9 m-20 -83.64 -32.09 25.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.713 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 71.79 39.94 0.81 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.118 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.5 t -90.33 39.6 0.98 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.737 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 46.55 28.67 3.61 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.463 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -132.3 129.11 39.1 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.81 0.338 . . . . 0.0 110.468 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.447 HG23 HD13 ' A' ' 78' ' ' ILE . 66.6 mt -103.11 148.77 7.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.108 0.48 . . . . 0.0 111.61 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.44 ' O ' ' N ' ' A' ' 82' ' ' ALA . 0.8 OUTLIER -96.15 95.89 8.45 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 176.698 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.437 ' C ' ' O ' ' A' ' 79' ' ' ASP . 51.2 t80 -28.56 -42.29 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.261 -177.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 79' ' ' ASP . 6.9 mmmm -63.79 -55.62 21.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.823 0.344 . . . . 0.0 110.619 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -52.32 -30.7 29.62 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.172 0.511 . . . . 0.0 110.411 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.429 ' CZ ' HD12 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -85.56 -32.59 22.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.695 179.807 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.21 -23.77 43.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.2 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.8 -11.4 60.59 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.411 0.624 . . . . 0.0 111.804 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 13.2 tpp -76.64 -32.04 57.76 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.61 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.6 mt -94.05 -6.24 45.63 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 121.885 0.85 . . . . 0.0 111.33 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -125.95 22.06 7.43 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.081 -1.418 . . . . 0.0 111.212 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.35 31.78 2.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.957 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.8 m -102.18 27.44 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.267 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 56.14 30.41 16.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.964 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -150.46 -50.98 0.13 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.926 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 27.4 t . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.188 -0.91 . . . . 0.0 110.978 -179.908 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.883 0.373 . . . . 0.0 111.146 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -106.39 -132.16 7.04 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.488 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.8 t -89.49 -72.39 0.56 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.835 0.35 . . . . 0.0 110.934 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.51 37.46 19.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.929 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 60.86 80.03 0.23 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.918 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -143.22 -47.61 0.31 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.884 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -170.11 178.8 3.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.952 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -152.84 106.83 3.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.905 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -140.54 30.77 1.9 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.936 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 22.9 t60 60.42 89.79 0.07 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.89 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.1 m -116.74 -69.09 0.87 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.901 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -164.74 78.85 0.35 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.912 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -112.51 -28.41 3.51 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.578 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -60.14 -71.25 0.14 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.761 0.315 . . . . 0.0 110.942 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.2 m -138.19 149.86 64.95 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.14 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -52.42 -60.73 0.65 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.558 2.172 . . . . 0.0 112.353 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 21.3 ttm180 -165.75 -44.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.878 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -174.54 -82.33 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.54 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 17.1 m -60.22 153.65 21.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.756 0.312 . . . . 0.0 110.878 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 41.3 m170 -81.59 -79.32 0.17 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.83 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 39.4 mmm -156.23 -79.16 0.08 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.919 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.9 p -101.9 5.35 40.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.95 0.405 . . . . 0.0 111.532 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.48 -14.8 34.49 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.492 0.663 . . . . 0.0 111.541 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.3 -16.49 63.62 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.17 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.4 ttpt -91.85 -23.4 19.67 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.788 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.645 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -71.57 -28.86 64.13 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.914 -179.967 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -59.92 -24.22 64.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.215 0.531 . . . . 0.0 109.683 178.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 tt -88.3 -11.27 46.92 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.519 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.645 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 12.0 mm -63.59 -15.12 15.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.865 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -79.04 2.17 21.48 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 113.919 -1.491 . . . . 0.0 111.478 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.29 -29.35 15.71 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.107 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -56.47 -24.39 45.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.15 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -96.9 34.43 1.71 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.025 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -177.22 37.62 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.821 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -176.44 37.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.892 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -106.62 38.45 2.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.949 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -62.24 -63.71 4.5 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.603 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -177.2 49.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.92 0.39 . . . . 0.0 110.944 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 60.55 101.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.806 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -83.0 133.8 35.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.966 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -100.22 -23.68 10.27 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.678 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -153.89 123.79 6.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.811 0.338 . . . . 0.0 110.939 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.418 HG13 ' CD2' ' A' ' 48' ' ' PHE . 10.4 p -124.37 132.92 70.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.966 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.51 147.45 25.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.854 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.443 HG12 ' CD1' ' A' ' 67' ' ' PHE . 88.8 t -53.37 -55.14 14.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.065 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -47.21 -31.98 4.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.906 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -88.3 -29.75 20.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.358 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.418 ' CD2' HG13 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -69.04 -38.15 78.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.809 179.806 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 18.7 mtt180 -58.23 -51.21 70.69 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.991 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -55.94 -25.78 46.42 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.394 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 21.8 mt -83.08 -44.54 18.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.874 0.368 . . . . 0.0 111.065 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 35.8 mm -68.07 -27.27 36.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.138 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.8 ttm180 -52.8 -58.79 5.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.993 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -111.75 14.98 21.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.344 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -99.41 -86.53 1.89 Allowed Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.632 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.9 mt -103.48 143.72 27.2 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 120.631 0.253 . . . . 0.0 110.982 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.48 85.28 1.6 Allowed 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.549 2.166 . . . . 0.0 112.166 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.413 ' C ' HD13 ' A' ' 63' ' ' ILE . 3.8 ttt -124.28 140.84 52.58 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.796 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.601 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 0.8 OUTLIER -89.32 143.41 26.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.613 179.36 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.616 ' O ' ' N ' ' A' ' 64' ' ' THR . 0.2 OUTLIER -41.99 -53.16 3.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.369 0.604 . . . . 0.0 110.637 -179.852 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.487 ' N ' ' CG ' ' A' ' 60' ' ' GLU . . . -44.68 -28.93 0.67 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.004 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.601 ' HG2' ' O ' ' A' ' 59' ' ' THR . 1.5 mm-40 -89.57 -51.43 5.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.736 0.303 . . . . 0.0 110.458 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.501 ' CG2' ' CE2' ' A' ' 67' ' ' PHE . 1.0 OUTLIER -74.35 -44.69 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.347 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.616 ' N ' ' O ' ' A' ' 60' ' ' GLU . 50.6 m -62.96 -48.92 76.82 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.024 0.44 . . . . 0.0 109.991 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.408 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 3.2 tm-20 -66.68 -16.2 64.05 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.714 0.768 . . . . 0.0 110.301 179.297 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.2 m-85 -96.78 -23.61 16.32 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.469 -1.242 . . . . 0.0 110.357 178.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.501 ' CE2' ' CG2' ' A' ' 63' ' ' ILE . 2.1 m-85 -74.52 -36.06 63.19 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.736 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -76.42 -30.36 57.39 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.861 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.28 -11.08 59.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.476 0.655 . . . . 0.0 111.653 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -95.58 -30.25 13.91 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.985 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -128.31 106.22 19.54 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.825 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.43 -30.92 43.55 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.404 2.069 . . . . 0.0 112.276 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 63.6 m-80 -76.81 -27.64 55.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.917 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 72.51 36.7 0.97 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.128 0.489 . . . . 0.0 110.13 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.1 t -85.65 13.14 7.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.975 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 69.45 26.57 74.41 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.262 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -117.39 178.48 4.36 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.701 0.286 . . . . 0.0 110.571 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.453 HG23 HD12 ' A' ' 78' ' ' ILE . 65.4 mt -153.62 153.54 8.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.206 0.527 . . . . 0.0 111.724 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.429 ' O ' ' C ' ' A' ' 80' ' ' TYR . 24.2 t0 -99.55 95.97 7.35 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 176.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.429 ' C ' ' O ' ' A' ' 79' ' ' ASP . 44.8 t80 -28.7 -41.37 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.366 -178.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.418 ' N ' ' O ' ' A' ' 79' ' ' ASP . 3.4 mtmt -66.2 -56.61 10.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.717 0.294 . . . . 0.0 110.68 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -51.9 -27.71 13.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.043 0.449 . . . . 0.0 110.614 179.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.448 ' CZ ' HD11 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -89.83 -31.91 17.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.743 179.923 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.09 -18.64 55.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.339 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -71.08 -11.56 61.02 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.366 0.603 . . . . 0.0 111.882 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.96 -34.6 62.06 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.784 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.1 mt -92.72 -6.73 48.53 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.851 0.834 . . . . 0.0 111.483 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -126.08 22.31 7.31 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.108 -1.405 . . . . 0.0 111.057 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.6 p -75.56 73.15 2.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.961 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 17.3 m -157.06 68.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.131 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 60.67 79.49 0.24 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.955 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -151.13 -47.4 0.12 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.903 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.7 t . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.954 179.995 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.475 0 CA-C-O 120.687 0.279 . . . . 0.0 111.352 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -164.97 42.31 0.29 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.529 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.9 p -135.99 32.12 2.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.893 0.378 . . . . 0.0 110.913 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 93.0 p -145.77 128.89 16.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.889 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -61.05 -169.71 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.838 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -155.35 32.84 0.38 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.966 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -77.3 79.29 3.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.883 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -111.82 -62.54 1.55 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.93 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 47.3 p-80 -144.34 -175.28 4.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.899 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 60.28 171.01 0.09 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.942 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.4 t -92.35 79.82 4.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.915 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.0 p -106.74 31.8 5.01 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.968 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 177.84 -177.19 48.33 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.473 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 62.74 30.66 16.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.843 0.354 . . . . 0.0 110.948 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.1 t -153.0 84.41 4.49 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.101 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.29 138.57 55.31 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.612 2.208 . . . . 0.0 112.249 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 62.28 118.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.874 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -59.09 -166.81 0.17 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.568 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.17 -74.92 0.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.74 0.305 . . . . 0.0 110.893 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.3 m170 65.47 -76.19 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.959 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 2.6 tpt 63.19 120.43 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.843 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -100.78 5.46 43.56 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.626 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -70.87 -14.7 62.49 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.572 0.701 . . . . 0.0 111.552 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -65.62 -16.38 63.66 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.117 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.6 tttp -91.98 -26.41 18.4 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.72 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.638 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -67.63 -28.79 68.03 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.845 -179.815 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 89.3 mm-40 -61.13 -24.91 66.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.204 0.526 . . . . 0.0 109.594 178.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.0 tt -88.3 -11.28 46.88 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.539 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.638 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 11.2 mm -61.43 -15.58 13.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 114.973 -1.012 . . . . 0.0 112.03 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -77.84 1.81 19.19 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 113.983 -1.462 . . . . 0.0 111.559 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.62 -28.15 16.17 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.009 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -58.12 -20.53 40.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.315 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -93.07 24.02 3.98 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.334 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -174.31 33.43 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.93 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER 178.57 39.46 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.78 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -137.13 58.77 1.7 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.948 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 153.63 69.36 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.539 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -151.03 23.87 0.75 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.723 0.297 . . . . 0.0 111.047 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 52.34 -178.55 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.887 0.375 . . . . 0.0 111.204 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 60.31 160.63 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.065 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -135.37 34.16 2.34 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.43 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -142.76 123.93 14.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.805 0.336 . . . . 0.0 110.952 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.454 ' CG1' ' CE2' ' A' ' 48' ' ' PHE . 10.3 p -117.97 123.67 72.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.991 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.95 155.59 40.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.965 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.48 ' CG2' HG13 ' A' ' 78' ' ' ILE . 59.8 t -60.17 -32.51 50.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.806 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -65.2 -61.38 2.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.013 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -57.62 -30.66 65.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.918 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.454 ' CE2' ' CG1' ' A' ' 43' ' ' VAL . 0.1 OUTLIER -62.1 -40.73 96.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.011 -179.909 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.419 ' HG3' ' CE2' ' A' ' 67' ' ' PHE . 65.5 mtt180 -58.76 -51.73 68.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.986 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -55.91 -25.85 46.39 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.505 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 12.4 mt -82.56 -45.64 19.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.882 0.372 . . . . 0.0 111.045 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 35.6 mm -68.57 -28.4 40.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.237 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 17.9 ttp180 -48.75 -60.37 2.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.063 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -111.86 14.89 21.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.109 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -96.64 -85.68 1.76 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.606 -0.806 . . . . 0.0 112.772 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.1 mp -106.34 144.97 30.05 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.594 0.235 . . . . 0.0 111.105 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.59 113.26 3.62 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.523 2.148 . . . . 0.0 112.222 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.4 ' C ' HD11 ' A' ' 63' ' ' ILE . 0.9 OUTLIER -152.68 138.97 18.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.762 -179.97 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.454 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -77.16 147.67 36.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.529 179.57 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.55 ' O ' ' N ' ' A' ' 64' ' ' THR . 0.5 OUTLIER -38.62 -52.21 1.64 Allowed 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.271 0.558 . . . . 0.0 110.932 179.705 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 65' ' ' GLU . . . -46.76 -55.94 7.03 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.792 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 59' ' ' THR . 1.9 mm-40 -52.07 -62.26 1.75 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.945 0.402 . . . . 0.0 109.932 179.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.497 ' CG2' ' CE2' ' A' ' 67' ' ' PHE . 1.4 mp -59.04 -63.16 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.217 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.55 ' N ' ' O ' ' A' ' 60' ' ' GLU . 75.7 m -49.32 -52.31 28.73 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.475 -179.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' A' ' 61' ' ' ALA . 3.3 mm-40 -65.63 -15.6 62.91 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 121.698 0.761 . . . . 0.0 110.417 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.429 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.5 m-30 -96.17 -24.74 16.12 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.476 -1.238 . . . . 0.0 110.465 179.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.497 ' CE2' ' CG2' ' A' ' 63' ' ' ILE . 1.6 m-30 -76.44 -30.85 57.53 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.826 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.69 -26.88 16.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.092 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -82.66 -10.91 58.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.511 0.672 . . . . 0.0 111.96 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.17 -33.96 13.11 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.27 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 48.1 p-10 -110.54 122.5 38.23 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.869 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.59 -47.39 1.44 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.447 2.098 . . . . 0.0 112.479 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -68.54 -30.45 69.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.066 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.2 m120 73.84 22.06 2.56 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.413 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.2 t -66.23 -15.68 63.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.183 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.56 22.23 9.81 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.19 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -125.34 129.44 49.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.799 0.333 . . . . 0.0 110.426 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.48 HG13 ' CG2' ' A' ' 45' ' ' VAL . 66.6 mt -99.49 146.89 7.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.223 0.535 . . . . 0.0 111.794 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.44 ' N ' HG22 ' A' ' 78' ' ' ILE . 0.9 OUTLIER -91.94 96.0 10.13 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 176.598 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.426 ' C ' ' O ' ' A' ' 79' ' ' ASP . 56.4 t80 -28.55 -40.95 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -177.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.423 ' N ' ' O ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -65.19 -55.53 18.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.768 0.318 . . . . 0.0 110.718 179.644 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -51.9 -28.3 15.77 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.104 0.478 . . . . 0.0 110.6 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.435 ' CD1' HG23 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -89.71 -31.9 17.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.812 179.967 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -80.49 -20.8 42.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.324 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.12 -11.57 60.81 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.437 0.637 . . . . 0.0 111.824 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 14.4 mmt -74.03 -33.64 63.83 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.786 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.4 mt -95.58 -6.59 39.96 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.831 0.824 . . . . 0.0 111.476 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -125.91 22.18 7.44 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 114.178 -1.374 . . . . 0.0 111.041 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.93 76.63 10.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.877 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 22.2 t -152.39 66.81 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.02 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -59.63 164.83 3.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.92 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -60.01 149.79 31.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.889 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.3 t . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.146 -0.93 . . . . 0.0 111.011 179.935 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 mtm . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.792 0.329 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 136.25 65.74 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.532 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.6 t -106.01 71.9 0.92 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.857 0.36 . . . . 0.0 110.884 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.3 m -116.03 -38.4 3.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.877 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 21.0 m170 60.71 30.6 19.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.003 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 40.7 t60 59.32 94.04 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.034 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 4.4 m80 -170.61 -75.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.876 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.0 t60 59.9 176.84 0.09 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.921 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 10.8 m80 -155.59 123.68 5.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.82 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -94.67 163.0 13.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.871 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -160.33 35.73 0.17 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.814 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.42 104.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.897 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -96.51 92.54 1.39 Allowed Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.536 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.7 mt -150.52 -51.68 0.14 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.809 0.338 . . . . 0.0 110.852 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.1 p -178.63 87.57 0.22 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.007 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -52.06 122.72 11.06 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.531 2.154 . . . . 0.0 112.289 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -134.16 153.93 51.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.88 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.91 173.68 17.39 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.557 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 60.03 83.5 0.14 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.799 0.333 . . . . 0.0 110.944 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.74 -73.98 0.22 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.899 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.0 tpt -162.11 147.22 12.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.927 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.4 m -101.29 5.42 42.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.517 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -70.47 -14.68 62.63 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.554 0.692 . . . . 0.0 111.579 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -64.91 -16.5 63.35 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.187 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -91.87 -27.84 17.68 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.699 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.662 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -66.91 -28.49 68.36 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.746 -179.933 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -59.3 -23.67 62.63 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.0 tt -88.0 -11.36 47.57 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.508 179.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.662 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 11.3 mm -67.59 -13.81 17.35 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.934 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -77.01 2.04 16.11 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 113.935 -1.484 . . . . 0.0 111.564 179.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.21 -30.54 15.14 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.034 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -59.58 -29.11 67.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.91 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -97.57 28.17 3.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.0 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -169.97 33.41 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.947 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.417 ' CE1' HD12 ' A' ' 51' ' ' ILE . 16.7 t80 -178.1 76.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.787 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -154.36 67.6 0.72 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.849 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -102.88 -87.62 2.01 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.419 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -178.59 75.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.819 0.342 . . . . 0.0 110.876 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -111.32 22.96 14.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.109 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 22.3 t70 53.82 24.96 4.8 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.182 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.18 -57.21 4.87 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.541 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -54.97 123.98 15.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.946 0.403 . . . . 0.0 111.048 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.41 HG13 ' CE2' ' A' ' 48' ' ' PHE . 4.4 p -136.41 106.17 5.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.754 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.4 m -59.01 153.74 17.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.084 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.441 HG12 ' CD1' ' A' ' 67' ' ' PHE . 92.9 t -57.03 -56.84 12.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.045 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -47.41 -29.71 2.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.058 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -88.43 -29.79 19.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.602 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.41 ' CE2' HG13 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -64.68 -30.79 71.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.799 179.876 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.4 mtt-85 -56.06 -51.23 68.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.951 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -57.49 -25.03 54.39 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.452 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.417 HD12 ' CE1' ' A' ' 35' ' ' PHE . 34.0 mt -83.35 -27.92 7.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.754 0.312 . . . . 0.0 111.156 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 41.7 mm -90.45 -49.18 13.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.085 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.3 -35.73 62.94 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.198 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -111.81 14.72 21.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.426 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -123.24 -90.1 0.94 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.662 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.4 mp -97.8 142.93 25.34 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.645 0.26 . . . . 0.0 110.94 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -78.92 57.94 6.67 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.525 2.15 . . . . 0.0 112.439 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.409 ' C ' HD11 ' A' ' 63' ' ' ILE . 5.3 ttt -86.58 136.19 33.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.72 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.464 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 1.0 OUTLIER -81.76 142.05 32.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.789 0.328 . . . . 0.0 110.631 179.645 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.608 ' O ' ' N ' ' A' ' 64' ' ' THR . 0.2 OUTLIER -41.16 -52.92 3.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.328 0.585 . . . . 0.0 110.844 -179.844 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.483 ' N ' ' CG ' ' A' ' 60' ' ' GLU . . . -45.01 -27.09 0.5 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.938 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.48 ' O ' ' HB2' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -91.07 -51.73 5.19 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.672 0.272 . . . . 0.0 110.32 179.729 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.51 ' O ' ' N ' ' A' ' 67' ' ' PHE . 1.2 mp -73.65 -43.35 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.201 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.608 ' N ' ' O ' ' A' ' 60' ' ' GLU . 24.3 m -64.6 -47.78 77.36 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.027 0.441 . . . . 0.0 109.961 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.408 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 5.7 tt0 -65.66 -17.28 64.49 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.693 0.758 . . . . 0.0 110.188 179.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.48 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 1.0 OUTLIER -97.02 -26.92 14.84 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.243 178.829 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.51 ' N ' ' O ' ' A' ' 63' ' ' ILE . 2.0 m-85 -68.13 -47.36 68.31 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.738 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.77 -26.81 54.94 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.994 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.77 -11.06 59.92 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.445 0.64 . . . . 0.0 111.779 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -95.84 -32.78 12.5 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.006 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -119.85 120.43 30.43 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.744 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.65 -27.78 45.04 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.344 2.029 . . . . 0.0 112.222 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 30.2 m-20 -84.6 -32.35 23.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.904 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.2 m120 71.31 40.4 0.85 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.038 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.403 ' OG1' ' CE2' ' A' ' 77' ' ' PHE . 1.4 t -90.37 40.57 1.02 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.644 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 50.33 25.72 8.65 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.763 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.403 ' CE2' ' OG1' ' A' ' 75' ' ' THR . 17.5 m-85 -125.23 148.94 48.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.874 0.369 . . . . 0.0 110.779 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.446 HD12 ' CZ ' ' A' ' 83' ' ' PHE . 54.1 mt -127.14 153.12 35.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.203 0.525 . . . . 0.0 111.552 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.435 ' N ' HG22 ' A' ' 78' ' ' ILE . 1.0 OUTLIER -98.11 96.0 7.82 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 176.863 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.42 ' C ' ' O ' ' A' ' 79' ' ' ASP . 70.6 t80 -29.23 -40.86 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -178.084 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 79' ' ' ASP . 1.9 mmmm -68.72 -54.44 16.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.733 0.301 . . . . 0.0 110.699 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -52.59 -26.82 14.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.015 0.436 . . . . 0.0 110.577 179.129 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.446 ' CZ ' HD12 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -91.9 -35.27 14.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.844 -179.898 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.404 ' O ' ' CD2' ' A' ' 88' ' ' TYR . . . -76.56 -29.09 56.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.398 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -74.43 -11.33 60.21 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.396 0.617 . . . . 0.0 111.824 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 13.0 mmm -84.04 -28.97 27.26 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.942 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.5 mt -100.83 -7.09 23.93 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.778 0.799 . . . . 0.0 111.819 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.404 ' CD2' ' O ' ' A' ' 84' ' ' ALA . 10.8 m-85 -125.99 21.87 7.44 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 114.377 -1.283 . . . . 0.0 111.339 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.0 m 45.15 33.11 1.04 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.409 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.0 t 67.52 37.24 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.097 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.9 t70 61.09 111.71 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.915 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -121.5 165.25 15.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.799 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 42.4 t . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.878 179.993 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.0 ttp . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.884 0.373 . . . . 0.0 111.141 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 154.66 87.04 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.489 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.3 t -93.55 154.0 18.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.85 0.357 . . . . 0.0 110.876 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.9 p -166.67 -66.15 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.893 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 13.7 m80 -91.02 143.03 27.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.996 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -101.9 80.04 1.97 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.875 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 17.3 t60 -91.28 -66.31 0.94 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.912 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 60.16 -170.0 0.15 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.907 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -131.11 -57.39 1.02 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.933 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 73.8 m-70 -108.57 80.71 1.37 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.955 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 46.0 t -175.98 -71.2 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.87 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.8 t -79.66 170.93 15.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.941 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 171.87 78.76 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.504 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -148.11 45.79 1.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.916 0.389 . . . . 0.0 110.817 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.665 ' N ' ' CD ' ' A' ' 16' ' ' PRO . 13.5 p -79.26 -27.95 0.53 Allowed Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.665 ' CD ' ' N ' ' A' ' 15' ' ' VAL . 51.5 Cg_exo -53.45 -47.48 27.11 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 121.917 1.744 . . . . 0.0 112.34 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.9 tpp85 -62.62 141.66 58.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.865 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 105.26 86.35 1.91 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.737 -0.745 . . . . 0.0 112.501 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.64 -177.4 0.81 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.77 0.319 . . . . 0.0 110.893 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 61.0 112.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.846 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 19.3 mmt -108.04 77.88 1.14 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.872 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -101.64 5.33 41.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.043 0.449 . . . . 0.0 111.569 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.07 -14.62 62.38 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.493 0.663 . . . . 0.0 111.559 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.03 -16.57 63.6 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 114.823 -1.08 . . . . 0.0 111.171 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.5 ttpp -91.83 -26.98 18.26 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.745 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.663 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -68.29 -28.58 67.31 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.8 -179.89 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -58.95 -23.92 62.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.159 0.504 . . . . 0.0 109.781 178.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 tt -88.07 -11.39 47.29 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.407 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.663 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 11.2 mm -67.26 -13.6 16.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.959 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -76.32 2.19 14.09 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 113.944 -1.48 . . . . 0.0 111.676 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.31 -29.44 16.37 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.092 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -57.23 -28.21 62.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.055 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -97.42 37.76 1.33 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.919 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -173.32 37.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.852 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.401 ' CD2' ' O ' ' A' ' 35' ' ' PHE . 78.1 t80 -163.27 72.02 0.28 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -140.53 42.12 1.88 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.861 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -59.32 -64.46 4.24 Favored Glycine 0 N--CA 1.453 -0.195 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.495 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -165.14 38.94 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.861 0.362 . . . . 0.0 110.926 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 1.4 t80 60.74 89.16 0.08 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.892 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.36 148.88 22.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.858 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -108.39 -24.36 6.23 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.577 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -143.68 123.82 13.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.837 0.351 . . . . 0.0 110.916 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.451 ' CG1' ' CE2' ' A' ' 48' ' ' PHE . 9.1 p -117.56 122.19 69.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.966 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.401 ' OG ' ' CE1' ' A' ' 77' ' ' PHE . 0.7 OUTLIER -74.0 155.38 38.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.839 -179.988 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.434 HG12 ' CD2' ' A' ' 67' ' ' PHE . 49.7 t -59.71 -53.13 52.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.773 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -49.14 -37.07 20.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.749 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -80.84 -29.1 35.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.439 179.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.451 ' CE2' ' CG1' ' A' ' 43' ' ' VAL . 0.1 OUTLIER -70.66 -40.05 73.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.782 179.91 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 46.0 mtm180 -56.96 -51.82 67.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.943 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -54.23 -25.41 32.73 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.327 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.0 mt -89.61 -43.68 14.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.847 0.355 . . . . 0.0 110.869 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 36.6 mm -70.7 -26.97 29.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.211 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.33 -60.22 3.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.106 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -111.87 14.92 21.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.336 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -101.84 -87.29 1.98 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.75 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.9 mp -90.92 133.4 32.22 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.509 0.195 . . . . 0.0 111.147 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -77.91 87.58 1.51 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.54 2.16 . . . . 0.0 112.289 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 1.2 mtp -125.08 141.27 52.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.774 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.464 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -77.99 148.92 34.18 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.642 179.673 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.506 ' O ' ' N ' ' A' ' 64' ' ' THR . 5.4 pt-20 -38.76 -52.0 1.7 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.258 0.551 . . . . 0.0 110.851 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.524 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -47.17 -53.2 13.63 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.038 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.464 ' HG2' ' O ' ' A' ' 59' ' ' THR . 2.2 mm-40 -55.08 -61.72 2.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.928 0.394 . . . . 0.0 109.975 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.496 ' O ' ' N ' ' A' ' 67' ' ' PHE . 1.7 mp -58.72 -61.7 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.168 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.506 ' N ' ' O ' ' A' ' 60' ' ' GLU . 58.9 m -51.8 -51.45 56.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.343 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.524 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 50.9 tt0 -65.62 -15.45 62.76 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 121.686 0.755 . . . . 0.0 110.458 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.435 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.6 m-30 -96.15 -26.52 15.44 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.519 -1.219 . . . . 0.0 110.372 179.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.496 ' N ' ' O ' ' A' ' 63' ' ' ILE . 5.1 m-30 -77.8 -26.68 49.78 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.827 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -90.75 -28.43 18.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.882 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.94 -11.2 45.13 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.459 0.647 . . . . 0.0 111.732 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -92.15 -29.72 16.34 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.078 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -125.64 119.29 24.44 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.789 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -64.85 -40.69 20.52 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.421 2.081 . . . . 0.0 112.189 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -77.4 -31.31 54.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.758 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 72.18 38.9 0.83 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.103 0.477 . . . . 0.0 110.144 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.5 t -89.7 41.27 1.03 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.529 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 50.88 25.39 9.51 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.688 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.401 ' CE1' ' OG ' ' A' ' 44' ' ' SER . 2.5 m-85 -126.06 129.5 49.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.761 0.315 . . . . 0.0 110.84 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.485 HG23 HD12 ' A' ' 78' ' ' ILE . 55.7 mt -103.13 153.27 5.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.184 0.516 . . . . 0.0 111.379 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.427 ' N ' ' CG2' ' A' ' 78' ' ' ILE . 10.1 t0 -99.41 95.66 7.18 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 176.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.417 ' C ' ' O ' ' A' ' 79' ' ' ASP . 47.3 t80 -29.35 -41.32 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.066 -0.515 . . . . 0.0 112.287 -178.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 79' ' ' ASP . 21.9 mttt -65.93 -55.82 14.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.562 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -53.05 -26.16 14.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.044 0.449 . . . . 0.0 110.574 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.432 ' CZ ' HD11 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -91.55 -30.49 16.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.895 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.05 -45.58 16.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.359 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -71.4 -11.62 60.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.412 0.625 . . . . 0.0 111.816 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 14.7 tpp -68.67 -35.44 77.23 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.656 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.2 mp -100.63 -6.76 24.74 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.777 0.798 . . . . 0.0 111.556 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -125.82 22.44 7.45 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 114.271 -1.331 . . . . 0.0 111.176 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.23 78.53 0.09 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.829 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 26.5 m -150.88 30.69 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.151 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -135.05 146.54 49.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.892 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -131.71 155.52 47.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.865 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.6 m . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.141 -0.933 . . . . 0.0 110.913 -179.964 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 mtm . . . . . 0 N--CA 1.487 1.423 0 CA-C-O 120.811 0.338 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 160.26 -88.88 0.11 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.569 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.1 m 60.55 100.96 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.786 0.327 . . . . 0.0 110.92 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.3 m -154.61 97.86 2.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.936 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 22.3 p80 -175.59 -40.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.913 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -131.47 101.23 5.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.885 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 60.62 110.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.899 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.5 p80 -162.64 83.35 0.53 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.926 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 -79.64 126.24 30.66 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.89 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -146.06 179.28 7.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.87 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.6 p -84.63 -53.9 5.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.894 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.0 m -72.86 166.5 22.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.925 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 140.09 -160.13 26.22 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.565 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.46 -75.45 0.45 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.776 0.322 . . . . 0.0 111.007 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.6 m -149.92 157.13 38.17 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.218 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.21 -61.68 0.47 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.577 2.185 . . . . 0.0 112.312 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.82 -71.88 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.914 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.96 39.34 38.47 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.555 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.9 t -177.11 165.72 2.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.839 0.352 . . . . 0.0 110.912 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -166.49 -68.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.866 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.09 30.81 0.3 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.802 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.0 m -94.75 5.36 52.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.561 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.29 -14.55 62.25 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.588 0.709 . . . . 0.0 111.654 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -65.07 -16.51 63.55 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.087 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.1 tmtm? -92.01 -26.94 18.13 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 114.781 -1.1 . . . . 0.0 110.641 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.667 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -68.03 -29.11 68.02 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.765 -179.923 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.0 mm100 -59.79 -23.93 63.7 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.15 -11.25 47.44 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.468 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.667 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 10.8 mm -66.58 -13.74 16.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.987 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -76.4 2.11 14.49 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 113.923 -1.49 . . . . 0.0 111.658 179.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.62 -29.82 15.93 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.138 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -59.76 -27.31 66.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.123 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -94.81 42.89 1.09 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.028 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -178.07 37.06 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.973 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -177.35 76.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.912 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -177.18 78.15 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.91 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -128.22 -42.41 0.25 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.552 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -177.05 78.3 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.909 0.385 . . . . 0.0 110.812 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -130.79 165.45 22.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.806 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -102.43 31.4 4.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.936 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.57 41.88 99.02 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.543 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -152.25 123.96 7.9 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.845 0.355 . . . . 0.0 110.923 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.422 HG13 ' CD2' ' A' ' 48' ' ' PHE . 10.3 p -128.52 124.52 61.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.936 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 51.1 p -76.46 148.22 37.38 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.925 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.454 HG12 ' CD2' ' A' ' 67' ' ' PHE . 57.5 t -58.45 -39.56 75.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.836 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -56.06 -30.26 61.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.979 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -96.42 -31.9 12.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.886 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.422 ' CD2' HG13 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -58.77 -41.21 86.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.084 -179.757 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.54 -48.62 78.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.008 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -59.56 -28.04 64.52 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.434 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.6 mt -86.47 -49.99 14.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.95 0.405 . . . . 0.0 110.989 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 tp -57.83 -40.5 76.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.278 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 13.6 mtp85 -47.63 -68.34 0.2 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.169 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -93.3 14.66 17.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.018 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.51 -57.86 0.5 Allowed Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.592 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.4 mt -129.09 135.58 27.83 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.649 0.261 . . . . 0.0 111.015 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -78.95 97.38 1.13 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.641 2.227 . . . . 0.0 112.246 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 1.3 mtp -129.52 140.28 51.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.814 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.449 ' O ' ' CD1' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -77.88 148.12 34.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.674 179.677 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.483 ' O ' ' N ' ' A' ' 64' ' ' THR . 6.1 pt-20 -39.53 -52.22 2.17 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.166 0.508 . . . . 0.0 111.064 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.529 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -47.98 -52.45 19.73 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.949 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' A' ' 66' ' ' PHE . 0.9 OUTLIER -55.36 -62.4 1.7 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.377 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.481 ' CG2' ' CZ ' ' A' ' 67' ' ' PHE . 1.8 mp -56.59 -61.82 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.964 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.483 ' N ' ' O ' ' A' ' 60' ' ' GLU . 55.3 m -52.14 -50.4 61.81 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.061 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.529 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 2.3 tp10 -65.99 -15.87 63.39 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 121.579 0.704 . . . . 0.0 110.459 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.445 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 2.4 m-85 -96.31 -24.48 16.17 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.42 179.066 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.481 ' CZ ' ' CG2' ' A' ' 63' ' ' ILE . 8.5 m-30 -81.62 -28.92 33.47 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.797 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -94.12 -28.79 15.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.891 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.53 -11.19 54.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.402 0.62 . . . . 0.0 111.796 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -103.5 -30.2 10.68 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.015 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -119.63 95.74 49.35 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.813 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -65.04 -35.79 41.01 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.5 2.133 . . . . 0.0 112.325 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -77.36 -30.4 53.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.875 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.1 m120 74.28 49.05 0.11 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.594 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.1 p -95.2 25.27 4.39 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.815 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 53.78 23.66 22.85 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.189 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -142.8 129.24 20.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.779 0.323 . . . . 0.0 110.442 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.465 HG21 ' CD1' ' A' ' 83' ' ' PHE . 7.2 mt -105.48 156.99 6.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.051 0.453 . . . . 0.0 111.67 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.444 ' O ' ' N ' ' A' ' 82' ' ' ALA . 1.7 m-20 -85.11 97.59 9.96 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 176.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.414 ' C ' ' O ' ' A' ' 79' ' ' ASP . 50.0 t80 -28.48 -39.77 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -177.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.442 ' N ' ' O ' ' A' ' 79' ' ' ASP . 5.4 mmmm -65.11 -53.16 49.56 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.693 0.282 . . . . 0.0 110.698 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -54.11 -25.47 22.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.933 0.397 . . . . 0.0 110.594 179.198 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.465 ' CD1' HG21 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -94.15 -30.15 14.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.102 -179.67 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.34 -38.8 26.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.315 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.66 -11.45 60.42 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.392 0.615 . . . . 0.0 111.716 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 36.9 tpp -67.49 -36.16 80.55 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.74 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.8 mp -100.74 -6.78 24.5 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 121.865 0.841 . . . . 0.0 111.537 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -124.61 22.34 8.31 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 114.135 -1.393 . . . . 0.0 111.111 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.5 m -58.24 89.26 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.061 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.8 p -165.53 47.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.105 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -134.1 81.39 1.91 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.926 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -154.96 -178.2 7.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.851 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.935 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 ptp . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.728 0.299 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -103.22 28.0 17.61 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.515 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.9 m 59.97 31.48 20.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.771 0.32 . . . . 0.0 110.888 -179.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -108.63 73.81 0.89 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.855 -179.947 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 5.4 m170 59.77 31.3 20.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.889 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 8.8 m80 -77.19 -38.06 52.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.932 179.917 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 60.07 108.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.998 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -152.79 -53.57 0.11 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.943 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -177.25 73.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.829 179.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -177.0 134.66 0.2 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.863 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.2 m 60.31 110.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.86 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.8 p -168.14 123.78 1.01 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.961 179.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.78 -142.98 0.5 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.47 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -106.68 36.55 2.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.803 0.335 . . . . 0.0 110.909 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.5 p -123.43 139.28 31.6 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.949 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.33 146.78 30.91 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.506 2.137 . . . . 0.0 112.35 179.871 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 12.5 mtm105 -105.62 154.78 19.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.871 -179.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 131.23 42.76 0.19 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.497 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 59.8 m 59.55 31.28 20.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.77 0.319 . . . . 0.0 110.92 -179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -119.66 34.55 5.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.833 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 5.0 ptm -123.67 -43.02 2.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.967 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.0 m -89.15 5.34 45.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.608 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -73.03 -14.53 61.44 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.525 0.679 . . . . 0.0 111.509 179.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -64.88 -16.62 63.44 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.095 179.638 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.67 -27.38 18.14 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.6 179.456 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.67 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -69.09 -28.85 66.87 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.817 -179.862 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.4 -24.22 63.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.168 0.509 . . . . 0.0 109.675 178.529 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.4 tt -88.23 -11.29 47.05 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.451 179.691 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.67 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 12.4 mm -65.65 -14.48 17.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 114.794 -1.094 . . . . 0.0 112.007 -179.899 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -79.02 2.25 21.13 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 113.872 -1.513 . . . . 0.0 111.427 179.526 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.16 -30.8 15.05 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.171 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -59.05 -30.85 68.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.92 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -98.43 34.99 1.87 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.984 179.906 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -176.76 38.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.943 -179.999 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -166.72 73.7 0.15 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.952 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -169.97 75.03 0.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.866 -179.914 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -94.23 -44.18 3.58 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.551 179.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -167.96 74.15 0.12 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.956 0.408 . . . . 0.0 110.911 -179.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 60.92 111.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.928 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -102.42 105.2 15.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.92 179.925 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -112.85 -24.61 4.84 Favored Glycine 0 C--N 1.33 0.203 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.562 -179.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.404 ' CZ ' ' O ' ' A' ' 78' ' ' ILE . 10.5 t80 -152.96 123.83 7.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.811 0.339 . . . . 0.0 111.017 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.439 ' CG1' ' CE2' ' A' ' 48' ' ' PHE . 8.0 p -123.67 115.93 46.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.004 179.774 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.4 p -71.69 149.38 45.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.91 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.43 HG12 ' CD2' ' A' ' 67' ' ' PHE . 82.0 t -54.51 -55.03 17.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.963 179.844 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -47.72 -30.63 4.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.971 -179.833 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -87.62 -30.04 20.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.443 179.391 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.439 ' CE2' ' CG1' ' A' ' 43' ' ' VAL . 0.1 OUTLIER -68.95 -36.16 77.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.903 179.88 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 37.5 mtt-85 -55.47 -51.54 66.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.027 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -57.03 -22.22 41.53 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.531 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 28.3 mt -89.86 -26.24 5.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.769 0.319 . . . . 0.0 111.223 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 31.2 mm -93.15 -28.65 4.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.228 -179.905 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.8 ttm-85 -56.31 -54.98 38.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.351 -179.648 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -111.76 15.08 21.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.621 -179.566 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -105.31 -87.89 2.02 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.819 -179.8 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.1 mp -99.6 139.85 21.17 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-O 120.674 0.273 . . . . 0.0 111.11 -179.725 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.0 117.78 4.79 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.478 2.119 . . . . 0.0 112.252 179.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.422 ' C ' HD12 ' A' ' 63' ' ' ILE . 0.6 OUTLIER -153.12 137.9 17.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.811 -179.881 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.443 ' O ' ' CD1' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -75.45 146.75 40.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.653 179.506 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.532 ' O ' ' N ' ' A' ' 64' ' ' THR . 0.5 OUTLIER -39.07 -52.45 1.85 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.299 0.571 . . . . 0.0 111.011 179.744 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.511 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -46.34 -53.21 11.29 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.105 179.63 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 66' ' ' PHE . 0.5 OUTLIER -55.67 -61.33 2.43 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.872 0.368 . . . . 0.0 110.077 179.439 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.523 ' CG2' ' CE2' ' A' ' 67' ' ' PHE . 1.5 mp -59.39 -61.3 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.115 179.776 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.532 ' N ' ' O ' ' A' ' 60' ' ' GLU . 65.2 m -51.59 -51.67 53.67 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.232 -179.844 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.511 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 6.7 tt0 -65.75 -15.42 62.83 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-O 121.623 0.725 . . . . 0.0 110.389 179.778 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.446 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.4 m-30 -95.25 -25.49 16.33 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.537 -1.211 . . . . 0.0 110.389 179.114 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.523 ' CE2' ' CG2' ' A' ' 63' ' ' ILE . 2.6 m-30 -80.15 -28.94 38.79 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.719 179.942 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.42 -30.24 22.24 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.859 179.918 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.12 -11.13 59.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.503 0.668 . . . . 0.0 111.691 180.0 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.02 -29.9 12.64 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.836 -1.074 . . . . 0.0 111.035 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -124.43 117.06 26.65 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.755 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.37 -50.28 2.05 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.372 2.048 . . . . 0.0 112.301 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -68.48 -32.77 73.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.852 179.911 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 6.1 m120 75.38 52.36 0.07 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.644 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 13.6 p -97.6 30.04 3.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.649 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 58.75 25.89 59.49 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.287 -179.717 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -127.75 131.13 49.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.802 0.334 . . . . 0.0 110.77 179.876 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.468 HG23 HD11 ' A' ' 78' ' ' ILE . 58.2 mt -105.05 152.64 6.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.233 0.539 . . . . 0.0 111.594 -179.764 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.43 ' N ' HG22 ' A' ' 78' ' ' ILE . 0.5 OUTLIER -99.01 95.58 7.23 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 176.912 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.422 ' C ' ' O ' ' A' ' 79' ' ' ASP . 38.6 t80 -28.93 -41.63 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.312 -178.081 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' A' ' 79' ' ' ASP . 4.4 mptt -65.86 -56.13 13.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.655 179.781 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.41 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -52.81 -26.83 15.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.944 0.402 . . . . 0.0 110.59 179.221 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.446 ' CZ ' HD13 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -90.47 -31.98 16.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.813 179.956 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.46 ' O ' ' CD2' ' A' ' 88' ' ' TYR . . . -75.61 -41.38 54.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.225 179.946 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.451 ' HA ' ' CE2' ' A' ' 88' ' ' TYR . . . -61.97 -12.06 16.49 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.333 0.587 . . . . 0.0 112.035 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 8.8 mmt -79.27 -21.25 46.35 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.205 179.884 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 19.9 mt -100.6 -15.57 17.75 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 121.677 0.751 . . . . 0.0 112.366 -179.593 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.46 ' CD2' ' O ' ' A' ' 84' ' ' ALA . 33.1 p90 -127.93 21.62 6.34 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.33 179.017 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.44 84.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.829 179.797 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 13.1 p -178.05 45.64 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.985 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -64.84 152.64 42.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.854 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -92.11 167.34 12.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.862 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.1 m . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.895 179.997 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.439 ' HE3' HD22 ' A' ' 87' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.133 0 N-CA-C 109.708 -0.478 . . . . 5.0499999999999998 109.708 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.726 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.8 OUTLIER -67.24 -29.24 68.83 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.27 -0.423 . . . . 4.79 111.067 179.163 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.586 ' HB3' ' HG2' ' A' ' 57' ' ' PRO . 25.1 mt-30 -68.78 -31.86 71.18 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 109.177 -0.675 . . . . 6.1600000000000001 109.177 177.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.828 ' HG ' HD13 ' A' ' 56' ' ' LEU . 0.4 OUTLIER -84.33 -10.14 57.86 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.587 -0.733 . . . . 3.6899999999999999 112.166 179.032 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.726 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 7.1 mm -52.91 -18.37 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 115.345 -0.843 . . . . 5.46 112.589 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -67.91 1.07 2.86 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.366 -1.288 . . . . 6.6699999999999999 112.749 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.15 -40.87 67.71 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.049 -0.523 . . . . 6.3300000000000001 110.226 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -62.9 -30.09 71.27 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.364 -0.38 . . . . 7.9299999999999997 110.336 178.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.573 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -115.21 78.36 1.16 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.198 -0.456 . . . . 8.8599999999999994 110.446 179.686 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.573 ' CB ' ' O ' ' A' ' 33' ' ' TYR . 28.0 t30 . . . . . 0 N--CA 1.482 1.146 0 C-N-CA 124.495 1.118 . . . . 8.7899999999999991 111.501 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.233 0.187 0 CA-C-O 120.709 0.29 . . . . 7.3399999999999999 110.941 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.493 ' O ' ' HB ' ' A' ' 78' ' ' ILE . 7.4 p -142.84 128.66 16.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.183 -0.462 . . . . 5.2699999999999996 110.728 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.427 ' HA ' ' HA ' ' A' ' 77' ' ' PHE . 11.7 p -70.34 150.55 46.2 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.779 0.323 . . . . 6.3700000000000001 111.271 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.92 HG22 HG13 ' A' ' 78' ' ' ILE . 38.3 t -57.48 -42.75 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 115.936 -0.575 . . . . 5.5599999999999996 110.781 179.428 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.481 ' HA ' ' HD2' ' A' ' 49' ' ' ARG . 1.3 mt-10 -52.44 -50.3 62.86 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.718 -0.674 . . . . 8.1799999999999997 110.931 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.19 -41.45 77.15 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.366 -0.379 . . . . 9.3399999999999999 110.347 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.411 ' HA ' HD12 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -55.67 -43.26 76.17 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.838 -0.619 . . . . 5.7999999999999998 111.386 179.72 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.481 ' HD2' ' HA ' ' A' ' 46' ' ' GLU . 58.3 mtt180 -53.74 -52.49 59.99 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.394 -0.366 . . . . 8.2100000000000009 111.398 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -58.93 -42.09 96.59 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 121.151 -0.547 . . . . 8.5999999999999996 112.814 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.411 HD12 ' HA ' ' A' ' 48' ' ' PHE . 7.9 mt -67.59 -47.17 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 CA-C-O 120.643 0.258 . . . . 7.3300000000000001 111.101 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.713 HD13 HD12 ' A' ' 56' ' ' LEU . 4.7 mm -62.97 -36.79 77.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 116.101 -0.499 . . . . 6.9400000000000004 111.917 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 19.1 mtt85 -47.59 -59.37 3.31 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.264 0.468 . . . . 10.77 112.264 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -111.81 15.1 21.02 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 111.958 0.355 . . . . 10.92 111.958 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.52 -70.67 0.63 Allowed Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.939 -0.648 . . . . 7.7999999999999998 112.874 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.828 HD13 ' HG ' ' A' ' 28' ' ' LEU . 7.1 mt -104.71 116.15 61.44 Favored Pre-proline 0 CA--C 1.53 0.194 0 CA-C-O 120.554 0.216 . . . . 6.1399999999999997 111.163 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.586 ' HG2' ' HB3' ' A' ' 27' ' ' GLN . 38.9 Cg_endo -66.22 97.58 0.36 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.806 2.337 . . . . 7.0099999999999998 112.102 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.634 ' O ' HD11 ' A' ' 63' ' ' ILE . 1.0 OUTLIER -138.44 144.68 40.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.536 -0.757 . . . . 7.04 110.813 -179.81 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.67 ' O ' HD12 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -85.91 154.02 21.8 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.946 -0.57 . . . . 8.9100000000000001 110.284 179.305 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.445 ' O ' ' HB ' ' A' ' 64' ' ' THR . 4.7 pt-20 -45.13 -52.68 8.95 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.813 0.339 . . . . 10.6 111.251 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.417 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -50.69 -20.82 1.34 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.688 0.625 . . . . 8.7200000000000006 112.688 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.493 ' HG2' ' O ' ' A' ' 59' ' ' THR . 0.1 OUTLIER -95.45 -50.37 5.02 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.762 -0.458 . . . . 7.0999999999999996 109.762 179.054 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.67 HD12 ' O ' ' A' ' 59' ' ' THR . 0.8 OUTLIER -71.52 -45.35 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 116.225 -0.443 . . . . 6.2400000000000002 111.692 179.887 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.445 ' HB ' ' O ' ' A' ' 60' ' ' GLU . 17.3 m -69.53 -45.5 68.68 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.41 -0.359 . . . . 7.6200000000000001 110.699 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.417 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 23.8 tt0 -64.8 -18.88 65.49 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.426 0.631 . . . . 8.9700000000000006 110.491 179.088 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 6.2 m-30 -96.46 -31.66 12.7 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.761 -1.109 . . . . 5.2400000000000002 110.316 178.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.682 ' CD1' HD11 ' A' ' 78' ' ' ILE . 2.8 m-30 -63.07 -35.86 81.67 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.415 -0.357 . . . . 4.6600000000000001 110.891 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -87.88 -35.88 17.49 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.347 -0.388 . . . . 8.0600000000000005 110.817 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.47 -14.57 61.26 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.403 0.519 . . . . 5.9299999999999997 112.403 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.37 -38.33 11.03 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.384 -0.825 . . . . 4.4299999999999997 111.124 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' ' 77' ' ' PHE . 37.6 t0 -108.28 107.05 59.81 Favored Pre-proline 0 CA--C 1.53 0.203 0 CA-C-N 116.344 -0.389 . . . . 5.4500000000000002 110.989 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -61.96 -38.14 60.2 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.709 2.272 . . . . 6.8300000000000001 112.491 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -75.75 -32.74 60.1 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.331 -0.395 . . . . 6.6799999999999997 111.472 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 26.8 m120 69.74 24.46 5.4 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.059 0.457 . . . . 7.0800000000000001 110.37 -178.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.5 t -68.59 -16.77 63.96 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.72 -0.673 . . . . 5.7199999999999998 111.043 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 111.84 17.72 8.32 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-N 116.261 -0.427 . . . . 5.4299999999999997 112.659 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.443 ' O ' ' HB2' ' A' ' 71' ' ' ASP . 13.6 m-85 -116.39 164.64 14.24 Favored 'General case' 0 CA--C 1.527 0.06 0 N-CA-C 109.99 -0.374 . . . . 6.4500000000000002 109.99 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.92 HG13 HG22 ' A' ' 45' ' ' VAL . 7.1 mt -142.09 147.64 21.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.356 0.598 . . . . 3.79 112.25 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.43 100.36 12.38 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.447 -1.316 . . . . 5.3499999999999996 107.447 176.496 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -37.91 -40.31 0.45 Allowed 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.255 0.465 . . . . 5.6100000000000003 112.255 -177.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.7 mttp -64.5 -48.51 74.89 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.758 -0.201 . . . . 8.0299999999999994 110.844 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.56 -38.9 64.33 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.97 0.415 . . . . 4.4400000000000004 110.314 178.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.566 ' CE1' HD13 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -75.63 -40.33 56.44 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.649 -0.705 . . . . 3.1699999999999999 110.871 179.343 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.39 -33.0 74.93 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.259 -0.428 . . . . 4.5199999999999996 111.523 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.22 -11.87 58.56 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.807 0.669 . . . . 5.7699999999999996 112.807 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 6.3 mmt -77.12 -45.87 25.45 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.572 -0.74 . . . . 4.7599999999999998 110.399 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.788 HD21 HD13 ' A' ' 28' ' ' LEU . 1.4 mp -88.2 -8.98 54.49 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.472 0.653 . . . . 5.1500000000000004 112.242 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -117.04 22.75 12.35 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.606 -1.179 . . . . 7.3300000000000001 111.11 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.533 0.303 0 CA-C-O 121.023 0.44 . . . . 8.25 111.051 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.733 ' HG2' HD23 ' A' ' 87' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.737 0.303 . . . . 0.0 110.618 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.674 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -60.17 -28.27 67.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.775 -179.857 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.25 -23.96 66.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.232 0.539 . . . . 0.0 109.682 178.48 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.745 ' O ' HD13 ' A' ' 28' ' ' LEU . 2.7 tm? -88.03 -11.32 47.61 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.257 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.674 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 10.7 mm -66.0 -14.42 17.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.92 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -77.6 2.15 17.42 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 113.9 -1.5 . . . . 0.0 111.52 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.435 ' HA ' HD11 ' A' ' 56' ' ' LEU . . . -93.41 -29.53 15.55 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.132 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -56.66 -22.81 37.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.155 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -97.25 29.76 3.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.129 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.902 179.902 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.837 0.351 . . . . 0.0 110.882 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.468 HG11 ' CE2' ' A' ' 48' ' ' PHE . 8.1 p -144.18 139.75 24.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.963 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -88.9 155.16 19.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.006 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.452 HG13 ' CZ ' ' A' ' 67' ' ' PHE . 86.1 t -58.24 -55.9 19.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.058 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -46.69 -30.73 2.51 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.078 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -91.23 -28.85 17.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.476 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.474 ' HA ' HD12 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -68.75 -38.19 79.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.74 179.716 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 26.9 mtp180 -57.6 -50.3 73.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.915 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -56.72 -25.85 52.34 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.543 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.474 HD12 ' HA ' ' A' ' 48' ' ' PHE . 28.5 mt -84.05 -43.81 17.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.796 0.331 . . . . 0.0 111.011 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.481 HG21 HG12 ' A' ' 63' ' ' ILE . 30.9 mm -69.72 -28.66 38.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.192 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 20.1 mtm180 -50.63 -58.22 6.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.018 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -111.75 14.9 21.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.272 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -99.0 -86.51 1.88 Allowed Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.665 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.435 HD11 ' HA ' ' A' ' 31' ' ' ALA . 7.9 mp -103.76 145.73 31.18 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.755 0.312 . . . . 0.0 111.068 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.98 112.91 3.6 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.504 2.136 . . . . 0.0 112.312 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.554 ' O ' HD11 ' A' ' 63' ' ' ILE . 1.1 ttp -154.85 138.32 15.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.721 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.87 ' O ' HD12 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -78.86 146.6 33.56 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.466 179.463 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.556 ' O ' ' N ' ' A' ' 64' ' ' THR . 0.6 OUTLIER -40.29 -53.21 2.58 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.288 0.566 . . . . 0.0 110.913 179.841 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.526 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -46.23 -53.08 11.28 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.045 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.443 ' HB2' ' HE3' ' A' ' 58' ' ' MET . 0.6 OUTLIER -56.04 -61.16 2.57 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 179.446 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.87 HD12 ' O ' ' A' ' 59' ' ' THR . 1.2 mp -59.66 -61.09 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.049 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.556 ' N ' ' O ' ' A' ' 60' ' ' GLU . 51.7 m -51.18 -51.03 57.64 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.171 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.526 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 8.6 tt0 -66.56 -15.45 63.43 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 121.683 0.754 . . . . 0.0 110.399 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.426 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.6 m-30 -96.23 -25.31 15.85 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.44 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.766 ' CE2' HG22 ' A' ' 63' ' ' ILE . 1.6 m-85 -73.74 -46.63 44.65 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.65 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.44 -26.51 58.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.153 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.53 -11.03 60.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.457 0.646 . . . . 0.0 111.844 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.433 ' HB2' ' CE1' ' A' ' 83' ' ' PHE . . . -96.3 -51.41 4.39 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.867 -1.061 . . . . 0.0 111.193 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 29.1 p-10 -105.35 118.79 54.86 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.9 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -69.14 -36.12 13.1 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.466 2.111 . . . . 0.0 112.32 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -68.42 -32.69 72.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.878 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 71.65 40.86 0.75 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.145 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.538 HG23 ' HB2' ' A' ' 77' ' ' PHE . 1.4 t -91.36 29.9 1.38 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.635 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 56.02 26.73 49.52 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.454 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.538 ' HB2' HG23 ' A' ' 75' ' ' THR . 2.4 m-85 -123.47 161.27 25.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.777 0.323 . . . . 0.0 110.646 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.712 HD11 ' HD1' ' A' ' 67' ' ' PHE . 52.2 mt -139.32 148.93 23.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.247 0.546 . . . . 0.0 111.706 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.445 ' O ' ' N ' ' A' ' 82' ' ' ALA . 0.7 OUTLIER -97.49 96.28 8.22 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 176.812 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.426 ' C ' ' O ' ' A' ' 79' ' ' ASP . 39.4 t80 -28.61 -40.78 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.366 -178.002 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 79' ' ' ASP . 1.7 mtmp? -66.44 -54.78 20.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.567 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.445 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -52.96 -26.98 16.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.018 0.437 . . . . 0.0 110.478 179.109 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.552 ' CE1' HD13 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -91.1 -31.44 16.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.884 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.65 -20.74 33.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.579 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.25 -11.23 60.43 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.423 0.63 . . . . 0.0 111.934 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.493 ' HB3' HD12 ' A' ' 87' ' ' LEU . 17.2 tpp -78.18 -35.34 48.82 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.57 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.733 HD23 ' HG2' ' A' ' 25' ' ' LYS . 6.9 mp -96.4 -5.86 38.82 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.831 0.824 . . . . 0.0 111.299 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -122.35 21.89 10.19 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 114.174 -1.375 . . . . 0.0 111.098 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.062 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.572 ' HG2' HD22 ' A' ' 87' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.783 0.325 . . . . 0.0 110.688 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.683 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -63.1 -29.48 70.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.814 -179.875 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -60.6 -24.28 65.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.18 0.515 . . . . 0.0 109.701 178.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.978 HD13 HD21 ' A' ' 87' ' ' LEU . 5.5 tt -88.24 -11.29 47.03 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.456 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.683 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 10.8 mm -64.39 -14.59 16.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.971 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -76.92 1.83 16.49 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 114.085 -1.416 . . . . 0.0 111.543 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.54 -28.37 16.1 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.072 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -58.0 -20.81 41.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.317 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -93.97 23.82 4.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.554 -0.293 . . . . 0.0 111.182 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.052 179.957 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.848 0.356 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.429 ' O ' HG13 ' A' ' 43' ' ' VAL . 10.2 p -122.77 125.15 72.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.042 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 52.7 p -70.49 168.43 16.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.872 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.827 HG22 HG13 ' A' ' 78' ' ' ILE . 41.2 t -73.06 -29.05 27.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.835 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -74.84 -53.03 9.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.711 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -58.38 -32.75 68.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.582 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.751 ' HD2' HD12 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -59.63 -35.91 75.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.76 179.715 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.72 -51.29 70.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.926 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -54.94 -25.39 37.68 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.363 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 24.6 mt -90.58 -39.94 12.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.823 0.344 . . . . 0.0 110.898 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.415 HG21 HG12 ' A' ' 63' ' ' ILE . 36.5 mm -74.26 -27.2 21.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.199 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.4 ttt85 -50.7 -58.72 5.19 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.878 0.37 . . . . 0.0 111.068 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -111.9 15.07 20.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.299 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -97.65 -86.02 1.81 Allowed Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.712 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.607 HD22 ' HA ' ' A' ' 28' ' ' LEU . 11.2 mt -101.19 135.6 19.87 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.587 0.232 . . . . 0.0 111.0 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -78.73 59.32 7.22 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.488 2.125 . . . . 0.0 112.325 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.629 ' O ' HD11 ' A' ' 63' ' ' ILE . 1.4 mtp -88.32 141.68 28.35 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.582 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.911 ' O ' HD12 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -77.95 147.68 34.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.772 179.762 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.494 ' O ' ' N ' ' A' ' 64' ' ' THR . 3.0 pt-20 -38.08 -48.5 1.23 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.19 0.519 . . . . 0.0 111.094 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.515 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -50.96 -52.78 39.13 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.922 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.478 ' HB2' ' HE2' ' A' ' 58' ' ' MET . 1.1 mm-40 -55.15 -61.79 2.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.007 0.432 . . . . 0.0 109.934 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.911 HD12 ' O ' ' A' ' 59' ' ' THR . 1.8 mp -57.92 -61.79 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.202 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.494 ' N ' ' O ' ' A' ' 60' ' ' GLU . 92.2 m -52.36 -52.28 54.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.291 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.515 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 1.2 tp10 -64.46 -15.58 60.95 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 121.702 0.763 . . . . 0.0 110.504 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.428 ' CD1' ' O ' ' A' ' 62' ' ' GLU . 3.5 m-30 -95.07 -28.87 14.88 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.284 179.168 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.742 ' CD1' HD11 ' A' ' 78' ' ' ILE . 10.0 m-30 -79.84 -24.39 41.33 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.848 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -93.96 -27.34 16.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.85 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.77 -11.41 42.27 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.436 0.636 . . . . 0.0 111.72 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.65 -27.41 14.38 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.961 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.401 ' HA ' ' HD2' ' A' ' 72' ' ' PRO . 14.6 t0 -120.68 96.53 48.81 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.781 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 71' ' ' ASP . 30.1 Cg_endo -63.58 -29.9 70.48 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.411 2.074 . . . . 0.0 112.243 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -83.31 -27.03 30.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.828 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 73.09 40.39 0.56 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.179 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.2 t -91.47 28.71 1.63 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.621 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.483 ' C ' HG23 ' A' ' 45' ' ' VAL . . . 47.42 31.83 7.0 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.317 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.636 ' N ' HG23 ' A' ' 45' ' ' VAL . 1.2 t80 -134.04 129.19 35.7 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.849 0.357 . . . . 0.0 110.285 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.827 HG13 HG22 ' A' ' 45' ' ' VAL . 65.5 mt -102.75 150.57 6.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.183 0.516 . . . . 0.0 111.461 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.43 ' O ' ' N ' ' A' ' 82' ' ' ALA . 2.2 m-20 -93.76 95.64 9.27 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 176.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.423 ' C ' ' O ' ' A' ' 79' ' ' ASP . 42.4 t80 -29.67 -40.6 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.238 -177.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 79' ' ' ASP . 15.8 mtmt -66.15 -55.22 17.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.797 0.332 . . . . 0.0 110.613 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -52.72 -27.9 19.63 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.033 0.444 . . . . 0.0 110.501 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.591 ' CE1' HD13 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -89.66 -32.78 16.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.804 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.37 -24.46 46.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.197 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.8 -11.41 60.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.446 0.641 . . . . 0.0 111.729 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 9.4 mtp -75.14 -37.88 61.23 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.743 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.978 HD21 HD13 ' A' ' 28' ' ' LEU . 4.1 mt -88.19 -6.88 57.59 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.854 0.835 . . . . 0.0 111.52 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -125.99 22.45 7.35 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.131 -1.395 . . . . 0.0 111.184 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.879 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.593 ' HE3' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.792 0.329 . . . . 0.0 110.727 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.655 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -56.76 -26.4 57.34 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.05 -179.775 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -62.89 -23.62 67.43 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.243 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.751 ' O ' HD13 ' A' ' 28' ' ' LEU . 2.7 tm? -88.12 -11.48 46.87 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.362 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.655 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 12.2 mm -64.68 -14.74 16.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 114.77 -1.104 . . . . 0.0 111.946 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -77.67 2.07 17.88 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 113.907 -1.497 . . . . 0.0 111.667 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.585 ' N ' HD21 ' A' ' 56' ' ' LEU . . . -93.37 -40.09 10.58 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.022 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -58.82 -29.83 67.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.95 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -98.1 28.36 4.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.954 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.767 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.401 ' CE2' ' HA ' ' A' ' 79' ' ' ASP . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.783 0.325 . . . . 0.0 110.965 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.5 p -120.93 136.17 58.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.014 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.4 ' HB3' ' CD1' ' A' ' 77' ' ' PHE . 1.3 m -88.71 145.08 25.85 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.855 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 93.1 t -51.51 -55.69 7.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.179 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -47.95 -31.3 5.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.873 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -86.92 -30.24 21.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.413 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.567 ' HD2' HD12 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -67.08 -40.08 86.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.825 179.847 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -56.47 -50.7 70.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.911 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -56.03 -25.41 46.11 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.315 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.436 HD12 ' HA ' ' A' ' 48' ' ' PHE . 28.7 mt -85.51 -43.89 16.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.817 0.341 . . . . 0.0 110.924 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 34.5 mm -71.65 -26.05 25.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.147 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 10.0 mmp_? -52.48 -59.5 4.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.748 0.308 . . . . 0.0 111.118 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -111.72 14.94 21.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.361 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -98.31 -86.35 1.85 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.678 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.585 HD21 ' N ' ' A' ' 31' ' ' ALA . 3.2 mp -105.54 146.78 33.47 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-O 120.689 0.281 . . . . 0.0 111.049 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -73.48 95.09 0.85 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.588 2.192 . . . . 0.0 112.11 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.425 ' HE2' ' HG3' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -130.8 141.67 50.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.799 -179.81 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.702 ' O ' HD12 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -90.0 144.88 25.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.956 179.449 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.601 ' O ' ' N ' ' A' ' 64' ' ' THR . 6.4 pt-20 -47.33 -56.96 5.83 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 121.077 0.465 . . . . 0.0 110.49 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.428 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -50.29 -24.56 3.01 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.982 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.49 ' HB3' ' O ' ' A' ' 59' ' ' THR . 4.8 tp10 -86.67 -46.0 10.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.335 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.722 HG22 ' CE2' ' A' ' 67' ' ' PHE . 0.7 OUTLIER -82.63 -47.82 18.43 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.179 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.074 179.552 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.601 ' N ' ' O ' ' A' ' 60' ' ' GLU . 23.0 m -59.48 -46.84 87.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.202 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.428 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 0.9 OUTLIER -68.32 -16.51 63.97 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 121.755 0.788 . . . . 0.0 110.201 179.376 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.407 ' CD1' ' O ' ' A' ' 62' ' ' GLU . 3.1 m-85 -97.14 -24.0 15.94 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.31 -1.313 . . . . 0.0 110.286 178.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.736 ' CD1' HD11 ' A' ' 78' ' ' ILE . 2.1 m-85 -72.19 -41.3 67.14 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.767 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -79.85 -28.33 40.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.917 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.15 -11.26 60.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.437 0.637 . . . . 0.0 111.741 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.405 ' HB2' ' HE1' ' A' ' 83' ' ' PHE . . . -94.83 -30.59 14.14 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.041 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.484 ' OD2' HG22 ' A' ' 75' ' ' THR . 22.2 t70 -120.73 120.38 29.6 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.909 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -64.36 -27.12 63.18 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.46 2.107 . . . . 0.0 112.282 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 -87.79 -32.56 19.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.886 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 71.52 38.93 0.95 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.063 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.484 HG22 ' OD2' ' A' ' 71' ' ' ASP . 1.6 t -89.2 42.74 1.1 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.689 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 50.87 25.03 8.93 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.636 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.425 ' HB2' HG23 ' A' ' 75' ' ' THR . 41.4 m-85 -122.21 159.16 27.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.905 0.383 . . . . 0.0 110.718 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.736 HD11 ' CD1' ' A' ' 67' ' ' PHE . 50.5 mt -137.28 153.39 28.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.146 0.498 . . . . 0.0 111.593 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.449 ' N ' HG22 ' A' ' 78' ' ' ILE . 1.0 OUTLIER -98.72 95.86 7.52 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 176.923 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.425 ' C ' ' O ' ' A' ' 79' ' ' ASP . 47.8 t80 -28.96 -41.16 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.333 -178.062 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 79' ' ' ASP . 22.2 mttt -68.01 -55.88 11.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.728 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -51.43 -27.46 10.29 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.961 0.41 . . . . 0.0 110.672 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.509 ' CE1' HD13 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -91.13 -33.06 15.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.94 179.852 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.401 ' O ' ' CD2' ' A' ' 88' ' ' TYR . . . -80.56 -18.24 48.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.444 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.95 -11.69 61.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.379 0.609 . . . . 0.0 111.719 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 51.4 mtm -76.18 -38.49 56.54 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.587 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.597 ' N ' HD22 ' A' ' 87' ' ' LEU . 2.7 mm? -85.94 -6.59 59.03 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 121.822 0.82 . . . . 0.0 111.365 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.401 ' CD2' ' O ' ' A' ' 84' ' ' ALA . 19.0 m-85 -125.65 22.21 7.6 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 114.142 -1.39 . . . . 0.0 111.157 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.929 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.711 ' HD3' HD23 ' A' ' 87' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.156 0 CA-C-O 120.844 0.354 . . . . 0.0 110.587 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.681 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -65.55 -29.07 69.65 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.781 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -59.21 -23.74 62.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.278 0.561 . . . . 0.0 109.776 178.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.839 HD13 HD21 ' A' ' 87' ' ' LEU . 5.7 tt -88.12 -11.32 47.32 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.415 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.681 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 11.0 mm -67.19 -13.67 17.02 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-N 114.749 -1.114 . . . . 0.0 111.952 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -76.61 2.12 14.96 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 113.921 -1.491 . . . . 0.0 111.621 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 1.091 ' HB2' HD21 ' A' ' 56' ' ' LEU . . . -93.03 -33.51 14.09 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.076 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -63.73 -29.17 70.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.887 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -97.99 31.76 2.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.907 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.865 -179.982 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 78.1 t80 . . . . . 0 C--O 1.23 0.055 0 CA-C-O 120.902 0.382 . . . . 0.0 110.828 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.413 HG11 ' CE2' ' A' ' 48' ' ' PHE . 7.5 p -142.76 125.02 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.875 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.407 ' HB3' ' CD2' ' A' ' 77' ' ' PHE . 1.8 m -77.21 154.71 32.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.056 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.521 HG13 ' CZ ' ' A' ' 67' ' ' PHE . 59.4 t -59.87 -52.69 58.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.759 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -50.09 -31.31 12.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.907 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.4 mm-40 -91.69 -29.22 16.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.46 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.413 ' CE2' HG11 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -64.66 -35.9 82.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.813 179.844 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 15.5 mtt180 -58.37 -49.55 76.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.859 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -57.05 -26.77 56.32 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.36 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 26.0 mt -85.29 -44.35 17.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.891 0.377 . . . . 0.0 110.991 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 37.5 mm -67.2 -29.07 44.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.107 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.09 -57.09 10.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.908 0.385 . . . . 0.0 110.925 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -111.76 14.82 21.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.312 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -99.55 -86.62 1.9 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.673 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 1.091 HD21 ' HB2' ' A' ' 31' ' ' ALA . 6.7 mt -100.19 139.04 20.41 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.577 0.227 . . . . 0.0 110.969 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -79.06 58.79 7.11 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.472 2.115 . . . . 0.0 112.314 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.484 ' O ' HD11 ' A' ' 63' ' ' ILE . 1.4 ttp -94.5 139.9 30.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.746 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.902 ' O ' HD12 ' A' ' 63' ' ' ILE . 0.8 OUTLIER -75.95 142.56 41.95 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.052 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.548 ' O ' ' N ' ' A' ' 64' ' ' THR . 6.6 pt-20 -39.5 -51.79 2.16 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.276 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.434 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -45.61 -55.52 6.24 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.182 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.476 ' HB2' ' HG2' ' A' ' 58' ' ' MET . 0.9 OUTLIER -55.07 -60.86 2.8 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.619 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.902 HD12 ' O ' ' A' ' 59' ' ' THR . 1.5 mp -58.94 -61.93 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.921 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.548 ' N ' ' O ' ' A' ' 60' ' ' GLU . 75.2 m -49.55 -52.45 29.81 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.218 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.434 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 44.0 mt-10 -66.16 -15.75 63.4 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.701 0.762 . . . . 0.0 110.381 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.44 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.5 m-30 -94.66 -26.51 16.3 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.517 -1.22 . . . . 0.0 110.385 179.071 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.731 ' CE2' HG22 ' A' ' 63' ' ' ILE . 2.4 m-30 -75.16 -30.27 60.67 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.681 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -92.91 -24.93 18.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.92 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.24 -11.23 44.21 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.518 0.675 . . . . 0.0 111.856 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.426 ' HB1' ' CG2' ' A' ' 78' ' ' ILE . . . -99.46 -27.27 13.81 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.136 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -118.96 115.7 34.64 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.703 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.83 -50.51 1.67 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.44 2.093 . . . . 0.0 112.5 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -68.48 -32.55 72.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.93 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 12.6 m120 72.41 30.62 1.94 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.543 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 36.8 p -68.48 -22.71 64.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.036 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 115.08 20.64 5.55 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.568 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.44 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 3.2 m-85 -137.48 150.37 47.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.671 0.272 . . . . 0.0 110.736 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.519 HD11 HG22 ' A' ' 45' ' ' VAL . 1.6 mt -133.36 146.55 32.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.571 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.434 ' O ' ' N ' ' A' ' 81' ' ' LYS . 8.5 m-20 -75.74 105.04 6.57 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 177.23 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.407 ' C ' ' O ' ' A' ' 79' ' ' ASP . 27.6 t80 -28.73 -40.19 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.102 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 79' ' ' ASP . 0.1 OUTLIER -64.64 -53.32 49.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.654 0.264 . . . . 0.0 110.854 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -51.45 -27.24 9.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.063 0.458 . . . . 0.0 110.747 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.49 ' CD1' HG21 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -93.83 -32.48 13.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.986 -179.869 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.99 -18.49 53.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.262 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -71.72 -11.61 60.91 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.427 0.632 . . . . 0.0 111.803 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.36 -41.82 62.97 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.716 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.839 HD21 HD13 ' A' ' 28' ' ' LEU . 7.1 mp -86.03 -6.31 59.06 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.884 0.85 . . . . 0.0 111.512 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -125.28 22.26 7.84 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.168 -1.378 . . . . 0.0 111.107 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.886 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.479 ' HE2' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 120.781 0.324 . . . . 0.0 110.65 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.657 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -67.15 -27.75 67.55 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.857 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -59.51 -23.75 63.07 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.978 HD13 HD21 ' A' ' 87' ' ' LEU . 5.6 tt -88.2 -11.31 47.09 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.563 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.657 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 11.9 mm -66.1 -14.06 16.81 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 114.695 -1.139 . . . . 0.0 111.932 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.89 1.98 15.99 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 113.915 -1.493 . . . . 0.0 111.66 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.858 ' HB2' HD11 ' A' ' 56' ' ' LEU . . . -93.33 -29.21 15.75 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.076 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -57.18 -25.91 59.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.098 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -95.08 42.42 1.09 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.814 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.849 179.925 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 34.0 t80 . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.852 0.358 . . . . 0.0 111.006 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.501 HG11 ' CE2' ' A' ' 48' ' ' PHE . 7.7 p -175.65 125.43 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.907 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.53 146.93 40.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.112 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.512 HG22 ' CD1' ' A' ' 67' ' ' PHE . 75.7 t -56.25 -53.23 42.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.989 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -48.0 -30.09 4.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.973 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -92.83 -30.0 15.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.467 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.501 ' CE2' HG11 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -64.6 -33.28 75.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.8 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 8.7 mtt180 -55.35 -51.72 65.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.941 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -56.15 -25.71 47.79 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.438 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 40.6 mt -81.97 -28.69 9.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.795 0.331 . . . . 0.0 111.022 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 31.6 mm -90.2 -28.32 5.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.104 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.9 mmm-85 -54.29 -55.6 26.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.346 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -111.66 14.96 21.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.638 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -103.45 -87.49 2.01 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.321 -0.943 . . . . 0.0 112.764 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.858 HD11 ' HB2' ' A' ' 31' ' ' ALA . 4.4 mp -102.54 143.79 27.31 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 120.767 0.317 . . . . 0.0 111.044 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.51 118.41 4.87 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.501 2.134 . . . . 0.0 112.226 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.572 ' O ' HD11 ' A' ' 63' ' ' ILE . 0.4 OUTLIER -158.52 137.68 11.51 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.716 -179.772 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.868 ' O ' HD12 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -78.27 146.06 35.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.468 179.303 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.575 ' O ' ' N ' ' A' ' 64' ' ' THR . 4.8 pt-20 -39.98 -52.79 2.44 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 121.376 0.608 . . . . 0.0 111.01 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.519 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -46.14 -53.91 9.56 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.164 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.461 ' HB2' ' HE2' ' A' ' 58' ' ' MET . 1.8 mm-40 -55.27 -61.53 2.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.956 0.407 . . . . 0.0 109.95 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.868 HD12 ' O ' ' A' ' 59' ' ' THR . 1.1 mp -60.0 -61.68 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.184 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.575 ' N ' ' O ' ' A' ' 60' ' ' GLU . 61.7 m -50.16 -50.85 47.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.196 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.519 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 4.8 tp10 -64.92 -16.29 63.11 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.708 0.766 . . . . 0.0 110.453 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.424 ' CD2' ' O ' ' A' ' 62' ' ' GLU . 1.7 m-85 -96.44 -25.68 15.6 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.515 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.762 ' CE2' HG22 ' A' ' 63' ' ' ILE . 1.4 m-85 -73.42 -31.07 63.64 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.614 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -84.56 -28.21 26.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.971 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -81.34 -11.17 59.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.487 0.661 . . . . 0.0 111.819 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.518 ' HB2' ' CE1' ' A' ' 83' ' ' PHE . . . -97.39 -27.58 14.41 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.086 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -121.54 118.99 29.48 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.765 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -62.86 -53.93 1.42 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.578 2.186 . . . . 0.0 112.65 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.627 ' OD1' HG23 ' A' ' 75' ' ' THR . 14.8 p30 -68.41 -32.82 73.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.963 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.7 m120 74.47 43.74 0.25 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.626 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.627 HG23 ' OD1' ' A' ' 73' ' ' ASN . 17.6 p -93.14 37.79 1.04 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.523 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 55.69 23.02 35.09 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.383 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -124.08 128.54 49.46 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.42 HD11 ' HA ' ' A' ' 67' ' ' PHE . 0.4 OUTLIER -112.23 152.61 14.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.224 0.535 . . . . 0.0 111.512 -179.22 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -98.88 97.57 8.74 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.159 178.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -35.2 -35.91 0.05 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.028 -178.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.72 -51.95 50.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.511 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.75 -25.12 54.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.141 0.496 . . . . 0.0 110.413 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.518 ' CE1' ' HB2' ' A' ' 70' ' ' ALA . 0.1 OUTLIER -92.59 -29.59 16.07 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.928 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.4 ' O ' ' CD2' ' A' ' 88' ' ' TYR . . . -80.09 -25.92 39.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.157 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.76 -11.46 60.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.418 0.627 . . . . 0.0 111.814 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 14.0 tpp -82.72 -36.55 25.7 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.818 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.978 HD21 HD13 ' A' ' 28' ' ' LEU . 9.7 mt -85.8 -6.43 59.1 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.845 0.831 . . . . 0.0 111.505 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.4 ' CD2' ' O ' ' A' ' 84' ' ' ALA . 12.7 m-85 -126.07 22.14 7.34 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 114.101 -1.409 . . . . 0.0 111.001 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.8 t . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.874 179.902 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.8 tttt . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.776 0.322 . . . . 0.0 110.671 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.676 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -68.36 -28.91 67.54 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.671 -179.881 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -59.45 -23.82 63.02 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 1.118 HD13 HD21 ' A' ' 87' ' ' LEU . 4.1 tt -88.17 -11.22 47.47 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.436 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.735 HD13 ' HE2' ' A' ' 32' ' ' PHE . 11.8 mm -66.57 -14.14 17.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 114.803 -1.089 . . . . 0.0 111.983 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -78.14 2.3 18.5 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 113.936 -1.484 . . . . 0.0 111.51 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.868 ' HB2' HD21 ' A' ' 56' ' ' LEU . . . -93.42 -32.67 14.14 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.989 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.735 ' HE2' HD13 ' A' ' 29' ' ' ILE . 93.3 m-85 -59.26 -29.56 67.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.951 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -97.52 36.28 1.52 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.95 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.979 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.796 0.332 . . . . 0.0 110.922 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.563 ' O ' HG13 ' A' ' 43' ' ' VAL . 7.8 p -144.92 110.83 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.92 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.414 ' HB3' ' CD2' ' A' ' 77' ' ' PHE . 1.2 m -65.83 160.69 22.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.041 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.729 HG22 HD11 ' A' ' 78' ' ' ILE . 72.5 t -57.89 -56.07 17.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.784 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -47.13 -41.49 17.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.989 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -78.91 -27.65 43.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.48 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.473 ' CE2' ' CD2' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -67.7 -29.47 68.73 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.96 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 34.1 mmm-85 -56.07 -56.43 20.89 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.053 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -54.9 -23.61 31.3 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.621 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 24.7 mt -84.5 -24.34 7.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.631 0.253 . . . . 0.0 111.238 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 39.9 mm -93.03 -36.19 7.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.243 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.97 -46.43 71.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.119 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -111.84 14.84 21.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.508 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -109.8 -88.87 1.95 Allowed Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.66 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.868 HD21 ' HB2' ' A' ' 31' ' ' ALA . 1.6 mp -100.38 136.82 19.91 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.587 0.232 . . . . 0.0 110.989 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -79.9 58.44 6.98 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.529 2.152 . . . . 0.0 112.493 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.647 ' O ' HD11 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -86.4 141.71 28.96 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.567 179.607 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.896 ' O ' HD12 ' A' ' 63' ' ' ILE . 0.3 OUTLIER -75.78 145.59 40.64 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.606 179.632 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.544 ' O ' ' N ' ' A' ' 64' ' ' THR . 4.8 pt-20 -39.29 -52.23 2.0 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.178 0.513 . . . . 0.0 111.02 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.52 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -46.65 -53.61 11.25 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.071 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.525 ' HB2' ' HE2' ' A' ' 58' ' ' MET . 1.7 mm-40 -55.16 -61.64 2.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.928 0.394 . . . . 0.0 110.039 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.896 HD12 ' O ' ' A' ' 59' ' ' THR . 1.4 mp -59.17 -61.48 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.177 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.544 ' N ' ' O ' ' A' ' 60' ' ' GLU . 68.2 m -51.35 -51.68 52.32 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.174 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.52 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 28.8 tp10 -65.8 -15.46 62.9 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.576 0.703 . . . . 0.0 110.346 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.437 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.4 m-30 -94.94 -25.93 16.33 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.387 179.16 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.754 ' CE2' HG22 ' A' ' 63' ' ' ILE . 2.6 m-30 -79.64 -28.79 40.85 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.765 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -86.64 -31.1 21.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.881 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -81.46 -11.17 59.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.486 0.66 . . . . 0.0 111.713 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.564 ' HB1' ' CG2' ' A' ' 78' ' ' ILE . . . -102.25 -27.41 12.88 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.028 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -123.33 107.82 32.12 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.675 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.48 -43.5 7.83 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.397 2.065 . . . . 0.0 112.339 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -68.45 -32.31 72.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.823 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 21.2 m-20 73.96 20.95 2.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.529 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.415 HG22 ' H ' ' A' ' 75' ' ' THR . 0.9 OUTLIER -63.64 -22.38 66.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.861 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 109.21 19.75 8.29 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.502 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.414 ' CD2' ' HB3' ' A' ' 44' ' ' SER . 4.1 m-85 -132.97 146.27 51.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.776 0.322 . . . . 0.0 110.825 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.729 HD11 HG22 ' A' ' 45' ' ' VAL . 1.0 OUTLIER -133.38 146.09 32.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.433 179.789 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.438 ' O ' ' N ' ' A' ' 82' ' ' ALA . 0.4 OUTLIER -77.08 108.18 9.98 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 177.202 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.426 ' C ' ' O ' ' A' ' 79' ' ' ASP . 28.0 t80 -28.77 -40.75 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.244 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.428 ' N ' ' O ' ' A' ' 79' ' ' ASP . 0.2 OUTLIER -64.66 -53.13 52.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.935 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -50.21 -28.08 6.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.058 0.456 . . . . 0.0 110.771 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.538 ' CD1' HG21 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -93.25 -35.5 13.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.041 -179.748 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.08 -22.61 55.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.313 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.68 -11.55 60.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.476 0.655 . . . . 0.0 111.849 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 9.5 mmt -72.96 -31.28 64.45 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.806 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 1.118 HD21 HD13 ' A' ' 28' ' ' LEU . 2.6 mt -100.18 -6.59 25.9 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.917 0.865 . . . . 0.0 111.58 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -126.05 22.34 7.32 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.127 -1.397 . . . . 0.0 111.173 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.857 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.778 0.323 . . . . 0.0 110.687 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.683 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -57.9 -27.31 63.2 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.828 -179.807 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -62.86 -24.03 67.6 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.789 ' O ' HD13 ' A' ' 28' ' ' LEU . 2.9 tm? -88.08 -11.47 47.02 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.195 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.683 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 11.3 mm -64.98 -14.59 16.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.969 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -77.89 2.14 18.28 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 113.878 -1.51 . . . . 0.0 111.463 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.23 -31.23 14.82 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.064 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -59.54 -30.98 68.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.942 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -97.41 38.9 1.22 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.932 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.851 179.897 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.813 0.34 . . . . 0.0 110.971 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.449 ' CG1' ' CE2' ' A' ' 48' ' ' PHE . 9.4 p -131.39 127.67 60.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.976 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.1 p -78.99 162.08 26.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.906 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.668 HG22 HG13 ' A' ' 78' ' ' ILE . 46.5 t -64.17 -54.16 34.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.001 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -47.22 -29.75 2.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.084 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -93.32 -30.05 15.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.655 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.855 ' CD2' HD12 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -66.02 -38.31 88.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.95 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.6 mtp85 -54.72 -51.48 65.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.0 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -57.2 -21.49 39.73 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.606 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.9 mt -93.17 -25.43 4.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.744 0.307 . . . . 0.0 111.255 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.467 HG21 HG12 ' A' ' 63' ' ' ILE . 40.6 mm -93.37 -49.39 12.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.301 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 24.7 ttp180 -46.86 -68.86 0.16 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.7 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -92.44 14.93 15.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.745 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -121.31 -89.88 1.07 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.373 -0.918 . . . . 0.0 112.914 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -80.23 132.9 58.18 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.554 0.216 . . . . 0.0 111.192 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.65 113.82 3.82 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.466 2.111 . . . . 0.0 112.256 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.659 ' O ' HD11 ' A' ' 63' ' ' ILE . 0.7 OUTLIER -155.63 137.69 14.6 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.892 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.894 ' O ' HD12 ' A' ' 63' ' ' ILE . 0.6 OUTLIER -74.31 145.1 44.2 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.855 179.733 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.515 ' O ' ' N ' ' A' ' 64' ' ' THR . 2.3 pt-20 -37.85 -48.65 1.14 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.169 0.509 . . . . 0.0 111.054 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.426 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -49.55 -55.74 12.38 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.835 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.489 ' HB2' ' HE2' ' A' ' 58' ' ' MET . 0.6 OUTLIER -52.18 -62.6 1.53 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.286 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.894 HD12 ' O ' ' A' ' 59' ' ' THR . 1.8 mp -57.35 -62.84 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.123 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.515 ' N ' ' O ' ' A' ' 60' ' ' GLU . 99.3 m -50.12 -53.09 29.85 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.405 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.426 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 2.7 mm-40 -65.31 -15.8 62.91 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-O 121.617 0.722 . . . . 0.0 110.485 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.432 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.7 m-30 -94.61 -26.57 16.31 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.423 179.048 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.708 ' CE2' HG22 ' A' ' 63' ' ' ILE . 4.8 m-30 -77.97 -26.58 48.8 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.801 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -91.32 -28.93 17.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.805 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.07 -11.23 47.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.535 0.683 . . . . 0.0 111.782 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -92.09 -28.53 17.07 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.113 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -126.16 119.36 23.62 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.785 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.84 -40.67 16.15 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.272 1.982 . . . . 0.0 112.279 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -76.53 -30.94 57.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.817 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.2 m120 72.35 38.83 0.8 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.171 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.508 HG23 ' HB3' ' A' ' 77' ' ' PHE . 1.5 t -89.64 41.77 1.06 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.634 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.401 ' C ' HG23 ' A' ' 45' ' ' VAL . . . 47.94 26.94 4.64 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.523 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.508 ' HB3' HG23 ' A' ' 75' ' ' THR . 0.6 OUTLIER -128.12 129.38 46.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.819 0.342 . . . . 0.0 110.449 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.855 HD12 ' CD2' ' A' ' 48' ' ' PHE . 61.9 mt -102.49 153.34 5.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.19 0.519 . . . . 0.0 111.662 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.445 ' N ' HG22 ' A' ' 78' ' ' ILE . 1.2 t0 -98.78 95.76 7.43 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 176.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.426 ' C ' ' O ' ' A' ' 79' ' ' ASP . 56.4 t80 -29.06 -41.25 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.337 -177.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -66.0 -55.85 14.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.672 0.272 . . . . 0.0 110.618 179.818 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.415 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -52.65 -27.08 15.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.965 0.412 . . . . 0.0 110.594 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.621 ' CE1' HD13 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -90.37 -32.3 16.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.86 179.823 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.12 -28.76 48.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.165 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.82 -11.5 60.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.375 0.607 . . . . 0.0 111.708 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 14.1 tmm? -69.59 -35.12 75.04 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.913 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.54 HD21 ' HG ' ' A' ' 28' ' ' LEU . 3.0 mp -100.67 -5.97 25.8 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.816 0.817 . . . . 0.0 111.63 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -125.48 22.41 7.68 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 114.193 -1.367 . . . . 0.0 111.09 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.871 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.9 tttt . . . . . 0 N--CA 1.458 -0.04 0 CA-C-O 120.788 0.327 . . . . 0.0 110.644 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.668 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -68.08 -28.16 67.12 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.854 -179.892 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -60.3 -24.28 64.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.223 0.535 . . . . 0.0 109.562 178.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.925 HD13 HD21 ' A' ' 87' ' ' LEU . 5.6 tt -88.33 -11.22 46.98 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.476 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.668 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 13.5 mm -63.61 -15.45 16.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.964 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -80.56 1.95 27.52 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 113.854 -1.521 . . . . 0.0 111.345 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.491 ' HB2' HD21 ' A' ' 56' ' ' LEU . . . -93.45 -29.87 15.34 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.043 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -56.56 -28.16 59.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.053 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -97.65 28.3 3.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.084 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.218 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.869 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 54.3 t80 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.886 0.374 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.457 HG11 ' CE2' ' A' ' 48' ' ' PHE . 7.6 p -139.53 127.33 25.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.898 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.1 p -67.42 154.17 41.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.159 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.992 HG13 ' CD1' ' A' ' 67' ' ' PHE . 50.6 t -61.9 -27.8 43.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.928 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -71.91 -58.62 3.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.921 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -58.07 -29.07 65.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.802 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.835 ' CD2' HD12 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -61.85 -36.88 82.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.904 179.816 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 16.2 mtt-85 -58.08 -50.74 72.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.951 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -57.28 -26.48 56.39 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.548 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.641 HD12 ' HA ' ' A' ' 48' ' ' PHE . 22.9 mt -80.87 -39.61 18.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.81 0.338 . . . . 0.0 111.087 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 37.9 mm -75.65 -28.77 19.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.248 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.6 mtp85 -51.23 -55.13 19.7 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.094 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -111.86 14.93 21.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.276 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -100.24 -86.84 1.93 Allowed Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.533 -0.841 . . . . 0.0 112.74 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.491 HD21 ' HB2' ' A' ' 31' ' ' ALA . 3.5 mt -105.47 140.05 20.77 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 120.694 0.283 . . . . 0.0 110.981 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -81.35 55.76 5.73 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.524 2.149 . . . . 0.0 112.398 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.606 ' O ' HD11 ' A' ' 63' ' ' ILE . 2.7 ttp -88.2 139.22 30.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.696 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.884 ' O ' HD12 ' A' ' 63' ' ' ILE . 1.7 p -69.18 140.19 54.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.03 0.443 . . . . 0.0 111.067 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.509 ' O ' ' N ' ' A' ' 64' ' ' THR . 0.1 OUTLIER -39.95 -50.36 2.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.156 179.824 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.526 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -45.92 -52.97 10.68 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.489 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.482 ' O ' ' HB2' ' A' ' 66' ' ' PHE . 0.9 OUTLIER -58.2 -60.94 2.97 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.04 179.683 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.884 HD12 ' O ' ' A' ' 59' ' ' THR . 1.7 mp -57.2 -60.21 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.914 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.509 ' N ' ' O ' ' A' ' 60' ' ' GLU . 36.1 m -52.32 -51.24 59.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.786 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.526 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 27.2 tt0 -65.99 -16.14 63.63 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-O 121.603 0.716 . . . . 0.0 110.344 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.482 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 2.3 m-85 -95.77 -25.95 15.86 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.277 178.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.992 ' CD1' HG13 ' A' ' 45' ' ' VAL . 1.6 m-85 -70.74 -41.37 71.92 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.564 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -84.1 -29.14 27.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.919 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -80.5 -11.14 59.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.481 0.658 . . . . 0.0 111.76 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.39 -31.65 15.96 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.018 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -115.86 121.18 34.49 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.778 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.77 -34.95 59.78 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.453 2.102 . . . . 0.0 112.245 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 14.3 m-80 -84.5 -31.63 24.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.792 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 72.43 37.08 0.95 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.166 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.8 t -88.93 41.84 1.05 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.743 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.427 ' C ' HG23 ' A' ' 45' ' ' VAL . . . 50.82 25.62 9.7 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 121.104 -0.57 . . . . 0.0 112.727 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.51 ' N ' HG23 ' A' ' 45' ' ' VAL . 23.4 m-85 -128.32 129.46 46.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.844 0.354 . . . . 0.0 110.662 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.835 HD12 ' CD2' ' A' ' 48' ' ' PHE . 59.8 mt -101.44 152.37 5.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.266 0.555 . . . . 0.0 111.627 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.448 ' N ' HG22 ' A' ' 78' ' ' ILE . 20.3 t0 -101.07 96.02 6.95 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 176.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.426 ' C ' ' O ' ' A' ' 79' ' ' ASP . 40.2 t80 -28.58 -41.31 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.436 -177.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 79' ' ' ASP . 0.4 OUTLIER -65.28 -55.41 18.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.689 0.28 . . . . 0.0 110.627 179.767 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -53.43 -27.58 25.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.16 0.505 . . . . 0.0 110.497 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.636 ' CE1' HD13 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -89.43 -31.7 17.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.734 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.6 -31.12 46.97 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.108 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -74.57 -11.34 60.18 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.503 0.668 . . . . 0.0 111.823 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 4.4 mmt -74.66 -32.11 62.15 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.808 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.925 HD21 HD13 ' A' ' 28' ' ' LEU . 2.7 mt -97.19 -6.93 33.63 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.921 0.867 . . . . 0.0 111.579 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -126.03 22.32 7.34 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.076 -1.42 . . . . 0.0 111.112 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 60.5 p . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.914 -179.987 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.407 ' NZ ' ' CE1' ' A' ' 88' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.842 0.353 . . . . 0.0 110.685 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.667 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -66.56 -29.11 69.11 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.814 -179.937 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -60.13 -24.26 64.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.093 0.473 . . . . 0.0 109.725 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.796 HD22 HD13 ' A' ' 87' ' ' LEU . 1.3 tt -88.15 -11.22 47.52 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.461 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.667 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 10.8 mm -65.26 -14.3 16.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.924 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -77.04 2.04 16.17 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 114.035 -1.439 . . . . 0.0 111.585 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.915 ' HB2' HD21 ' A' ' 56' ' ' LEU . . . -93.46 -30.78 14.87 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.102 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -57.41 -24.34 54.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.167 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -97.05 30.41 2.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.012 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.875 179.983 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.781 0.324 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.534 HG11 ' CE2' ' A' ' 48' ' ' PHE . 9.2 p -116.58 122.74 70.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.017 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.423 ' HB3' ' CE2' ' A' ' 77' ' ' PHE . 0.1 OUTLIER -74.73 154.29 38.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.825 179.931 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.563 HG22 HG13 ' A' ' 78' ' ' ILE . 57.4 t -58.87 -53.2 50.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.859 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -48.93 -33.05 10.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.937 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -86.36 -28.93 23.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.482 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.751 ' HD2' HD12 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -69.25 -41.99 76.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.859 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.445 ' HD2' HG12 ' A' ' 45' ' ' VAL . 13.7 mtp180 -56.27 -52.35 64.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.954 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -53.91 -25.1 29.43 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.326 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.447 HD12 ' HA ' ' A' ' 48' ' ' PHE . 14.1 mt -89.83 -47.05 15.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.854 0.359 . . . . 0.0 110.923 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.45 HG21 HG12 ' A' ' 63' ' ' ILE . 36.4 mm -66.06 -28.01 42.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.223 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.7 -61.53 2.15 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.904 0.383 . . . . 0.0 111.066 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -111.86 15.04 20.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.26 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -97.48 -86.05 1.81 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.591 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.915 HD21 ' HB2' ' A' ' 31' ' ' ALA . 14.1 mt -101.27 142.44 24.63 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.693 0.283 . . . . 0.0 111.065 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.32 113.49 3.69 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.533 2.155 . . . . 0.0 112.321 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.591 ' O ' HD11 ' A' ' 63' ' ' ILE . 0.8 OUTLIER -152.26 138.11 18.03 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.806 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.901 ' O ' HD12 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -77.65 147.67 35.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.683 179.698 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.519 ' O ' ' N ' ' A' ' 64' ' ' THR . 4.6 pt-20 -38.76 -51.86 1.7 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.162 0.505 . . . . 0.0 110.822 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.516 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -46.77 -53.64 11.46 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.118 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.491 ' HB2' ' HE2' ' A' ' 58' ' ' MET . 0.9 OUTLIER -54.91 -61.78 2.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.961 0.41 . . . . 0.0 110.02 179.478 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.901 HD12 ' O ' ' A' ' 59' ' ' THR . 1.6 mp -58.7 -61.54 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.205 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.519 ' N ' ' O ' ' A' ' 60' ' ' GLU . 62.7 m -52.02 -51.49 57.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.37 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.516 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 6.6 tt0 -65.64 -15.53 62.86 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.735 0.779 . . . . 0.0 110.497 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.431 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.6 m-30 -95.97 -25.47 15.94 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 114.449 -1.251 . . . . 0.0 110.321 179.219 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.718 ' CE2' HG22 ' A' ' 63' ' ' ILE . 4.0 m-30 -79.06 -26.57 43.07 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.748 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -91.37 -27.5 18.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.905 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.63 -11.18 43.31 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.487 0.66 . . . . 0.0 111.777 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.65 -28.39 18.41 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.016 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.53 119.25 23.02 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.829 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.31 -34.9 42.87 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.373 2.049 . . . . 0.0 112.204 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 26.2 m-20 -82.35 -31.32 29.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.9 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 72.21 38.43 0.87 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.176 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.534 HG23 ' HB2' ' A' ' 77' ' ' PHE . 1.5 t -89.39 42.26 1.08 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.578 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 50.75 25.29 9.06 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.663 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.534 ' HB2' HG23 ' A' ' 75' ' ' THR . 1.9 m-85 -123.08 146.74 47.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.783 0.325 . . . . 0.0 110.783 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.751 HD12 ' HD2' ' A' ' 48' ' ' PHE . 59.4 mt -123.02 153.12 28.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.096 0.474 . . . . 0.0 111.578 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.447 ' N ' HG22 ' A' ' 78' ' ' ILE . 0.5 OUTLIER -98.3 95.78 7.6 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 176.958 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.43 ' C ' ' O ' ' A' ' 79' ' ' ASP . 42.6 t80 -29.34 -41.23 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.036 -0.529 . . . . 0.0 112.293 -178.057 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.406 ' N ' ' O ' ' A' ' 79' ' ' ASP . 0.1 OUTLIER -65.81 -56.04 14.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.643 179.638 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.412 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -52.45 -27.17 15.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.944 0.402 . . . . 0.0 110.462 179.262 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.607 ' CE1' HD13 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -90.76 -30.81 16.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.803 179.929 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.31 -24.64 37.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.433 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.47 -11.53 60.71 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.452 0.644 . . . . 0.0 111.895 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 23.6 mtp -79.29 -30.79 43.08 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.843 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.796 HD13 HD22 ' A' ' 28' ' ' LEU . 5.1 mt -100.66 -6.18 25.52 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.735 0.778 . . . . 0.0 111.534 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.407 ' CE1' ' NZ ' ' A' ' 25' ' ' LYS . 32.6 m-85 -125.83 22.37 7.46 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 114.241 -1.345 . . . . 0.0 111.186 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 6.7 t . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.874 -179.971 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.441 ' CG ' HD23 ' A' ' 87' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.456 -0.173 0 CA-C-O 120.833 0.349 . . . . 0.0 110.702 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.651 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -68.5 -27.39 66.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.885 179.972 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -59.34 -23.72 62.75 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.707 HD13 HD21 ' A' ' 87' ' ' LEU . 7.0 tt -88.16 -11.41 46.93 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.449 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.651 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 12.9 mm -66.4 -14.38 17.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.908 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -78.36 2.12 19.67 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 113.895 -1.502 . . . . 0.0 111.661 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.656 ' HB2' HD11 ' A' ' 56' ' ' LEU . . . -93.11 -31.91 14.64 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.085 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -60.67 -29.31 69.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.964 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -96.91 38.19 1.25 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.93 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.926 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 71.1 t80 . . . . . 0 N--CA 1.457 -0.113 0 CA-C-O 120.848 0.356 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.473 HG11 ' CE2' ' A' ' 48' ' ' PHE . 7.1 p -141.42 137.33 32.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.949 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.451 ' HB3' ' CE2' ' A' ' 77' ' ' PHE . 13.1 p -84.99 150.13 25.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.047 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.472 HG13 ' CZ ' ' A' ' 67' ' ' PHE . 91.7 t -54.92 -55.52 15.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.082 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -46.74 -30.12 2.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.079 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -91.65 -28.68 17.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.45 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.576 ' CD2' HD12 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -67.42 -38.21 84.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.9 179.885 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 29.4 mtm180 -57.06 -50.43 72.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.907 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -56.15 -25.75 47.89 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.381 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.571 HD12 ' HA ' ' A' ' 48' ' ' PHE . 20.6 mt -85.22 -43.5 16.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.721 0.296 . . . . 0.0 110.932 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.464 HG21 HG12 ' A' ' 63' ' ' ILE . 31.0 mm -69.89 -36.21 68.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.096 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.6 ttm180 -54.36 -47.43 72.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.08 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -111.81 14.94 21.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.335 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -109.17 -88.66 1.96 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.639 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.656 HD11 ' HB2' ' A' ' 31' ' ' ALA . 3.9 mp -102.06 142.07 23.83 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.7 0.286 . . . . 0.0 111.106 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.05 111.41 3.27 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.498 2.132 . . . . 0.0 112.26 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.637 ' O ' HD11 ' A' ' 63' ' ' ILE . 0.6 OUTLIER -148.08 138.03 22.57 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.805 -179.867 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.889 ' O ' HD12 ' A' ' 63' ' ' ILE . 0.6 OUTLIER -75.32 144.82 42.21 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.719 179.529 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.548 ' O ' ' N ' ' A' ' 64' ' ' THR . 1.3 pm0 -37.85 -49.01 1.17 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.278 0.561 . . . . 0.0 111.156 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.421 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -49.37 -55.98 11.13 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.83 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.44 ' O ' ' HB2' ' A' ' 66' ' ' PHE . 0.7 OUTLIER -52.24 -62.22 1.77 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.886 0.374 . . . . 0.0 110.003 179.266 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.889 HD12 ' O ' ' A' ' 59' ' ' THR . 1.4 mp -58.51 -62.88 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.125 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.548 ' N ' ' O ' ' A' ' 60' ' ' GLU . 98.6 m -49.37 -53.03 24.51 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.421 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.421 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 4.9 mm-40 -65.48 -15.72 62.94 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 121.566 0.698 . . . . 0.0 110.554 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.44 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.6 m-30 -95.71 -23.99 16.73 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.56 179.166 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.764 ' CE2' HG22 ' A' ' 63' ' ' ILE . 1.9 m-30 -76.7 -31.68 57.37 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.746 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -85.73 -29.95 23.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.856 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.71 -11.1 60.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.433 0.635 . . . . 0.0 111.733 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.417 ' HB2' ' CE1' ' A' ' 83' ' ' PHE . . . -99.67 -30.26 12.2 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.061 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -121.8 116.91 30.11 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.748 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -64.85 -50.4 2.31 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.381 2.054 . . . . 0.0 112.315 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.582 ' CG ' HG23 ' A' ' 75' ' ' THR . 9.6 p30 -68.63 -32.73 72.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.813 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.3 m120 75.44 53.83 0.07 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.72 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.582 HG23 ' CG ' ' A' ' 73' ' ' ASN . 12.6 p -98.16 28.83 3.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.703 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 59.2 26.5 61.47 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.319 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.451 ' CE2' ' HB3' ' A' ' 44' ' ' SER . 4.1 m-85 -129.06 131.69 47.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.768 0.318 . . . . 0.0 110.74 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.654 HD13 ' CE1' ' A' ' 83' ' ' PHE . 61.2 mt -106.17 152.46 7.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.23 0.538 . . . . 0.0 111.635 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.442 ' N ' HG22 ' A' ' 78' ' ' ILE . 1.1 m-20 -101.23 96.2 7.04 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 176.853 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.43 ' C ' ' O ' ' A' ' 79' ' ' ASP . 40.5 t80 -28.78 -41.14 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.035 -0.529 . . . . 0.0 112.331 -177.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 79' ' ' ASP . 5.0 mtpp -66.06 -55.16 17.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.692 0.282 . . . . 0.0 110.51 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -53.2 -28.06 24.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.003 0.43 . . . . 0.0 110.411 179.128 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.654 ' CE1' HD13 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -88.97 -32.47 17.63 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.846 179.88 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.71 -29.6 45.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.228 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.44 ' O ' ' HB2' ' A' ' 89' ' ' SER . . . -74.32 -11.53 60.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.369 0.605 . . . . 0.0 111.619 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 2.2 mtt -68.9 -47.68 65.23 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.461 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.707 HD21 HD13 ' A' ' 28' ' ' LEU . 4.5 mp -82.81 -6.92 59.65 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.845 0.831 . . . . 0.0 111.107 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -119.69 21.77 11.89 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 113.982 -1.463 . . . . 0.0 111.25 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.44 ' HB2' ' O ' ' A' ' 85' ' ' ALA . 9.3 t . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.935 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.865 0.364 . . . . 0.0 110.657 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.681 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -67.1 -28.44 68.17 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.77 -179.936 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -58.95 -23.94 62.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.175 0.512 . . . . 0.0 109.751 178.451 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.741 HD13 HD21 ' A' ' 87' ' ' LEU . 3.2 tt -88.09 -11.37 47.26 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.488 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.681 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 11.6 mm -67.21 -13.73 17.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 114.71 -1.132 . . . . 0.0 111.98 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -77.89 2.29 17.83 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 113.894 -1.503 . . . . 0.0 111.499 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.826 ' HB2' HD11 ' A' ' 56' ' ' LEU . . . -93.22 -43.21 8.94 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.102 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -59.82 -28.62 67.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.974 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -96.12 39.79 1.14 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.994 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.018 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.858 0.361 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.1 p -128.85 139.0 53.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.068 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.428 ' HB3' ' CZ ' ' A' ' 77' ' ' PHE . 79.2 p -88.36 151.58 22.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.788 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.61 HG22 HG13 ' A' ' 78' ' ' ILE . 53.7 t -58.18 -50.75 77.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.826 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -51.27 -29.18 13.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.988 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -91.45 -32.32 15.66 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.601 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.748 ' HA ' HD12 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -61.13 -42.31 98.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.024 179.984 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 72.1 mtt180 -56.87 -48.27 78.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.917 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -59.58 -27.42 63.66 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.383 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.748 HD12 ' HA ' ' A' ' 48' ' ' PHE . 5.5 mt -86.27 -50.06 14.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.872 0.367 . . . . 0.0 110.916 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.0 tp -57.87 -40.32 75.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.431 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.6 ttm180 -48.39 -68.01 0.22 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.063 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -93.36 14.79 17.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.065 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -109.51 -59.76 0.52 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.614 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.826 HD11 ' HB2' ' A' ' 31' ' ' ALA . 5.4 mp -129.09 139.51 35.9 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.655 0.264 . . . . 0.0 111.143 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -79.6 58.3 6.9 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.598 2.199 . . . . 0.0 112.056 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.555 ' HB3' HD11 ' A' ' 63' ' ' ILE . 1.3 ttt -87.08 138.66 31.31 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.952 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.9 ' O ' HD12 ' A' ' 63' ' ' ILE . 1.3 p -78.27 140.59 38.86 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.883 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.511 ' O ' ' N ' ' A' ' 64' ' ' THR . 0.1 OUTLIER -37.05 -49.1 0.83 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.093 -180.0 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.525 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -48.49 -55.52 10.76 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.314 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.507 ' HB2' ' HG2' ' A' ' 58' ' ' MET . 0.7 OUTLIER -56.16 -60.28 3.72 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.287 179.833 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.9 HD12 ' O ' ' A' ' 59' ' ' THR . 2.3 mp -58.07 -61.12 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.163 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.511 ' N ' ' O ' ' A' ' 60' ' ' GLU . 71.8 m -52.8 -51.53 60.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.122 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.525 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 44.6 tt0 -64.93 -15.76 62.5 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.63 0.729 . . . . 0.0 110.516 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.435 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.7 m-30 -96.38 -27.87 14.73 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 114.594 -1.184 . . . . 0.0 110.434 179.127 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.672 ' CE2' HG22 ' A' ' 63' ' ' ILE . 3.9 m-30 -73.25 -30.1 63.22 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.651 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.75 -26.85 20.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.874 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.28 -11.2 47.19 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.482 0.658 . . . . 0.0 111.725 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.8 -29.95 13.46 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.994 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -116.74 121.38 33.0 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.787 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.08 -49.39 2.07 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.388 2.059 . . . . 0.0 112.361 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -80.5 -28.42 37.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.911 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.1 m120 75.82 51.92 0.06 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.616 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 12.6 p -96.52 31.1 2.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.87 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 59.55 29.31 66.47 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.413 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.428 ' CZ ' ' HB3' ' A' ' 44' ' ' SER . 0.2 OUTLIER -132.08 129.34 39.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.833 0.349 . . . . 0.0 110.664 179.901 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.659 HD12 ' CD2' ' A' ' 48' ' ' PHE . 63.7 mt -104.51 152.83 6.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.235 0.541 . . . . 0.0 111.593 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.431 ' N ' HG22 ' A' ' 78' ' ' ILE . 1.8 m-20 -97.76 95.6 7.66 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 176.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.43 ' C ' ' O ' ' A' ' 79' ' ' ASP . 40.4 t80 -28.96 -41.55 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.209 -178.024 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 79' ' ' ASP . 0.3 OUTLIER -66.01 -56.21 12.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.625 179.706 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -52.11 -27.6 14.74 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.998 0.428 . . . . 0.0 110.602 179.297 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.609 ' CE1' HD13 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -89.84 -32.16 17.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.866 179.85 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.6 -27.88 45.67 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.258 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.68 -11.41 60.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.482 0.658 . . . . 0.0 111.814 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 1.8 mtp -77.98 -36.86 48.5 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.736 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.741 HD21 HD13 ' A' ' 28' ' ' LEU . 4.2 mt -86.76 -6.71 58.74 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.862 0.839 . . . . 0.0 111.501 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -126.03 22.08 7.38 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 114.139 -1.391 . . . . 0.0 111.088 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.839 -179.986 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.526 ' HG2' HD23 ' A' ' 87' ' ' LEU . 3.3 ttpt . . . . . 0 N--CA 1.457 -0.093 0 CA-C-O 120.804 0.335 . . . . 0.0 110.749 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.668 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -65.25 -28.88 69.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.78 179.912 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.739 ' O ' HD12 ' A' ' 56' ' ' LEU . 4.7 tt0 -59.71 -23.94 63.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.136 0.493 . . . . 0.0 109.677 178.613 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.867 HD13 HD21 ' A' ' 87' ' ' LEU . 7.1 tt -88.17 -11.35 47.06 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.434 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.668 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 11.4 mm -65.63 -14.39 16.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.022 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -78.26 2.3 18.82 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 113.801 -1.545 . . . . 0.0 111.596 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.788 ' HB2' HD21 ' A' ' 56' ' ' LEU . . . -93.16 -28.67 16.16 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.179 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -56.45 -29.06 61.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.048 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -98.39 30.56 3.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.907 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.888 -179.997 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 . . . . . 0 N--CA 1.457 -0.102 0 CA-C-O 120.829 0.347 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.455 HG11 ' CE2' ' A' ' 48' ' ' PHE . 8.8 p -129.49 123.96 58.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.973 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.14 160.52 30.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.941 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.691 HG22 HG13 ' A' ' 78' ' ' ILE . 45.8 t -63.94 -50.98 75.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.843 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -50.92 -31.37 17.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.962 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -89.07 -28.87 19.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.521 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.816 ' CD2' HD12 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -68.22 -40.08 82.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.909 179.918 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 15.1 mtp85 -57.13 -48.33 78.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.874 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -57.57 -27.89 59.12 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.303 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.404 HD12 ' HA ' ' A' ' 48' ' ' PHE . 16.7 mt -86.65 -43.03 15.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.848 0.356 . . . . 0.0 110.843 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.492 HG21 HG12 ' A' ' 63' ' ' ILE . 35.7 mm -68.13 -29.93 46.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.023 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 6.2 tpm_? -51.89 -55.8 17.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.95 0.405 . . . . 0.0 110.9 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -111.82 14.86 21.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.195 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -99.73 -86.76 1.91 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.628 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.788 HD21 ' HB2' ' A' ' 31' ' ' ALA . 2.8 mm? -100.77 137.01 19.71 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 120.658 0.266 . . . . 0.0 110.966 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.88 74.48 4.92 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.406 2.071 . . . . 0.0 112.322 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.573 ' HE2' ' HB2' ' A' ' 62' ' ' GLU . 1.4 mtp -105.8 142.18 35.96 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.733 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.914 ' O ' HD12 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -79.85 148.45 31.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.729 179.734 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.491 ' O ' ' N ' ' A' ' 64' ' ' THR . 1.7 pm0 -38.09 -48.82 1.26 Allowed 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.19 0.519 . . . . 0.0 111.082 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.521 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -50.86 -52.53 40.7 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.024 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.573 ' HB2' ' HE2' ' A' ' 58' ' ' MET . 1.1 mm-40 -55.33 -61.71 2.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.97 0.414 . . . . 0.0 109.933 179.341 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.914 HD12 ' O ' ' A' ' 59' ' ' THR . 1.8 mp -57.87 -61.77 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.249 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.491 ' N ' ' O ' ' A' ' 60' ' ' GLU . 89.8 m -52.65 -52.05 57.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.419 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.521 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 51.5 tt0 -64.81 -15.58 61.95 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.625 0.726 . . . . 0.0 110.423 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.428 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.6 m-30 -95.65 -28.13 14.97 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.548 -1.205 . . . . 0.0 110.326 179.144 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.699 ' CE1' HD11 ' A' ' 78' ' ' ILE . 7.5 m-30 -77.88 -26.09 48.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.813 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -90.57 -27.62 19.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.91 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -90.73 -11.19 40.37 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 121.391 0.615 . . . . 0.0 111.752 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -93.92 -31.32 14.35 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.939 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -120.95 120.05 29.55 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.77 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -63.33 -53.87 1.28 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.467 2.112 . . . . 0.0 112.388 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -73.91 -30.22 62.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.877 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 75.35 50.57 0.08 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.509 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.9 p -95.68 31.07 2.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.822 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.415 ' C ' HG23 ' A' ' 45' ' ' VAL . . . 62.28 30.81 77.11 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.344 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.459 ' N ' HG23 ' A' ' 45' ' ' VAL . 5.4 m-85 -131.37 130.17 42.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.758 0.313 . . . . 0.0 110.881 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.816 HD12 ' CD2' ' A' ' 48' ' ' PHE . 56.1 mt -106.06 153.18 7.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.15 0.5 . . . . 0.0 111.456 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.441 ' N ' HG22 ' A' ' 78' ' ' ILE . 0.8 OUTLIER -98.3 95.65 7.52 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 176.923 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.417 ' C ' ' O ' ' A' ' 79' ' ' ASP . 44.4 t80 -30.66 -40.12 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.121 -178.119 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.2 mttt -66.88 -55.56 14.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.49 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -53.32 -27.77 24.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.12 0.486 . . . . 0.0 110.555 179.172 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.655 ' CE1' HD13 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -89.02 -31.1 18.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.722 179.703 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.11 -22.46 39.11 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.312 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.33 -11.5 60.73 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 121.388 0.613 . . . . 0.0 111.708 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 33.4 mtt -70.4 -40.28 74.0 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.773 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.867 HD21 HD13 ' A' ' 28' ' ' LEU . 6.3 mp -91.73 -6.31 52.15 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.857 0.837 . . . . 0.0 111.513 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -124.07 22.29 8.76 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 114.123 -1.398 . . . . 0.0 111.127 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.824 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.1 ttpt . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.809 0.338 . . . . 0.0 110.733 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.66 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -56.11 -26.64 50.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.964 -179.829 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -61.66 -23.33 66.01 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.349 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.749 ' O ' HD13 ' A' ' 28' ' ' LEU . 2.7 tm? -88.08 -11.63 46.54 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.375 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.66 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 11.3 mm -65.48 -14.25 16.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.914 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -75.59 1.88 13.24 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 113.91 -1.496 . . . . 0.0 111.819 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.458 ' HB2' HD21 ' A' ' 56' ' ' LEU . . . -93.27 -28.68 16.08 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.041 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.55 -24.49 56.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.0 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -96.84 30.39 2.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.987 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.858 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 . . . . . 0 N--CA 1.456 -0.134 0 CA-C-O 120.745 0.307 . . . . 0.0 110.997 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.47 HG22 ' N ' ' A' ' 44' ' ' SER . 12.4 p -132.35 157.96 43.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.008 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.47 ' N ' HG22 ' A' ' 43' ' ' VAL . 77.9 p -108.47 150.25 27.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.89 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.521 HG13 ' CZ ' ' A' ' 67' ' ' PHE . 96.2 t -56.43 -51.84 59.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.951 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -47.37 -31.0 3.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.046 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -96.37 -30.97 13.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.502 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -62.98 -35.25 79.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.052 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 20.9 mtt85 -55.8 -52.34 64.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.036 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -56.79 -27.87 56.41 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.397 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 21.1 mt -81.14 -25.3 10.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.848 0.356 . . . . 0.0 111.125 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 34.8 mm -93.36 -55.25 6.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.062 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.35 -34.03 68.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.319 -179.594 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -111.73 14.84 21.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.67 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -131.43 -89.84 0.49 Allowed Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.33 -0.938 . . . . 0.0 112.827 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.488 ' N ' HD12 ' A' ' 56' ' ' LEU . 7.0 mp -87.02 140.82 32.83 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.681 0.276 . . . . 0.0 111.238 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -78.27 122.02 5.5 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.567 2.178 . . . . 0.0 112.325 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.704 ' O ' HD11 ' A' ' 63' ' ' ILE . 0.8 OUTLIER -155.17 137.42 14.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.778 -179.941 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.918 ' O ' HD12 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -72.71 145.9 46.84 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.848 179.706 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.482 ' O ' ' N ' ' A' ' 64' ' ' THR . 5.9 pt-20 -37.6 -51.79 1.2 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.29 0.567 . . . . 0.0 111.06 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.44 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -47.64 -56.11 7.93 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.867 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.525 ' HB2' ' HE2' ' A' ' 58' ' ' MET . 0.7 OUTLIER -51.16 -62.87 1.35 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.415 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.918 HD12 ' O ' ' A' ' 59' ' ' THR . 2.2 mp -56.51 -63.71 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.32 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.482 ' N ' ' O ' ' A' ' 60' ' ' GLU . 92.5 m -51.17 -52.57 42.93 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.397 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.44 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 6.4 mm-40 -65.03 -15.98 62.94 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-O 121.652 0.739 . . . . 0.0 110.377 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.443 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.3 m-30 -92.04 -27.45 17.79 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.599 -1.182 . . . . 0.0 110.3 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.621 ' CE2' HG22 ' A' ' 63' ' ' ILE . 4.7 m-30 -85.6 -25.53 26.61 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.921 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -94.05 -27.66 16.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.947 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 65' ' ' GLU . . . -89.09 -11.22 44.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.39 0.614 . . . . 0.0 111.776 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.414 ' HB1' ' CG2' ' A' ' 78' ' ' ILE . . . -99.47 -28.16 13.38 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.094 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -122.51 112.14 31.23 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.681 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.08 -47.63 3.35 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.503 2.135 . . . . 0.0 112.533 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 61.8 m-80 -68.41 -31.85 71.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.971 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 12.1 m120 71.76 31.24 2.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.569 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 46.9 p -67.57 -26.24 66.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.981 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 113.79 19.66 6.39 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.525 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.459 ' CD2' ' HB2' ' A' ' 44' ' ' SER . 3.0 m-85 -140.91 130.97 24.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.65 0.262 . . . . 0.0 110.786 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.574 HD11 ' CD1' ' A' ' 67' ' ' PHE . 2.1 mt -110.14 147.82 14.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.929 0.395 . . . . 0.0 111.468 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.436 ' O ' ' N ' ' A' ' 81' ' ' LYS . 72.6 m-20 -77.28 103.75 7.39 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 177.088 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.409 ' C ' ' O ' ' A' ' 79' ' ' ASP . 50.7 t80 -28.61 -40.34 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.021 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.436 ' N ' ' O ' ' A' ' 79' ' ' ASP . 10.2 mttt -62.93 -54.46 38.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.705 0.288 . . . . 0.0 110.915 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -51.79 -26.85 10.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.089 0.471 . . . . 0.0 110.743 179.381 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.474 ' CD1' HG21 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -93.09 -29.71 15.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.267 -179.766 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -82.4 -26.85 32.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.243 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -74.36 -11.49 60.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.438 0.637 . . . . 0.0 111.658 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 24.6 tpp -74.85 -37.71 62.16 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.713 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.516 HD21 ' HG ' ' A' ' 28' ' ' LEU . 1.7 mt -89.14 -6.52 56.93 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.86 0.838 . . . . 0.0 111.437 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -125.84 22.44 7.44 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 114.14 -1.391 . . . . 0.0 111.099 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.949 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? . . . . . 0 N--CA 1.456 -0.156 0 CA-C-O 120.842 0.353 . . . . 0.0 110.774 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.683 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -67.63 -29.07 68.29 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.786 -179.919 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -59.5 -24.27 63.49 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.596 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.734 HD13 HD21 ' A' ' 87' ' ' LEU . 4.7 tt -88.22 -11.3 47.07 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.406 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.683 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 11.5 mm -65.67 -14.3 16.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.921 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -77.55 2.19 17.17 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 113.887 -1.506 . . . . 0.0 111.537 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 1.065 ' HB2' HD11 ' A' ' 56' ' ' LEU . . . -93.27 -30.59 15.08 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.09 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -58.35 -25.54 62.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.116 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -96.09 38.84 1.16 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.945 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.3 p-10 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.871 179.936 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.836 0.35 . . . . 0.0 111.004 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.54 HG11 ' CE2' ' A' ' 48' ' ' PHE . 9.3 p -130.48 147.76 33.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.948 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 21.7 p -92.74 159.91 15.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.919 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.96 HG13 ' CD1' ' A' ' 67' ' ' PHE . 46.1 t -61.69 -32.81 54.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.797 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -66.69 -57.9 6.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.846 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -59.33 -31.02 68.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.826 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.903 ' CD2' HD12 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -63.76 -40.73 97.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.962 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 10.2 mtm180 -58.6 -51.69 68.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.936 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -55.6 -25.59 43.29 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.486 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.698 HD12 ' HA ' ' A' ' 48' ' ' PHE . 13.0 mt -83.51 -46.11 18.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.915 0.388 . . . . 0.0 111.057 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.535 HG21 HG12 ' A' ' 63' ' ' ILE . 31.0 mm -68.52 -28.69 41.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.137 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.27 -59.34 4.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.061 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -111.88 15.02 20.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.237 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -98.06 -86.19 1.83 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.738 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 1.065 HD11 ' HB2' ' A' ' 31' ' ' ALA . 7.1 mt -105.96 144.7 29.44 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 120.705 0.288 . . . . 0.0 111.024 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.51 115.8 4.16 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.577 2.185 . . . . 0.0 112.235 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.636 ' O ' HD11 ' A' ' 63' ' ' ILE . 0.8 OUTLIER -153.88 138.48 16.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.726 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.898 ' O ' HD12 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -76.07 147.04 38.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.646 179.592 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' A' ' 64' ' ' THR . 6.2 pt-20 -38.81 -52.13 1.72 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.214 0.53 . . . . 0.0 110.853 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.515 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -46.91 -53.31 12.49 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.09 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.464 ' HG2' ' O ' ' A' ' 59' ' ' THR . 2.0 mm-40 -55.13 -61.57 2.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.921 0.391 . . . . 0.0 110.021 179.387 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.898 HD12 ' O ' ' A' ' 59' ' ' THR . 1.6 mp -59.17 -61.69 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.155 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.539 ' N ' ' O ' ' A' ' 60' ' ' GLU . 69.3 m -51.39 -51.73 52.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.394 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.515 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 1.5 tp10 -65.36 -15.34 62.47 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.638 0.732 . . . . 0.0 110.412 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.416 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.6 m-30 -96.46 -25.88 15.51 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.533 -1.212 . . . . 0.0 110.415 179.17 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.96 ' CD1' HG13 ' A' ' 45' ' ' VAL . 1.7 m-85 -75.31 -30.18 60.27 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.747 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -93.18 -28.47 16.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.892 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.6 -10.96 59.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.407 0.622 . . . . 0.0 111.718 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.98 -33.4 14.87 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.067 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.498 ' OD2' HG22 ' A' ' 75' ' ' THR . 7.1 t0 -120.09 116.98 32.34 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.888 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.68 -28.94 51.94 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.358 2.038 . . . . 0.0 112.185 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 53.9 m-20 -83.64 -32.09 25.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.713 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 71.79 39.94 0.81 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.118 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.498 HG22 ' OD2' ' A' ' 71' ' ' ASP . 1.5 t -90.33 39.6 0.98 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.737 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.406 ' C ' HG23 ' A' ' 45' ' ' VAL . . . 46.55 28.67 3.61 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.463 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.568 ' N ' HG23 ' A' ' 45' ' ' VAL . 1.2 t80 -132.3 129.11 39.1 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.81 0.338 . . . . 0.0 110.468 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.903 HD12 ' CD2' ' A' ' 48' ' ' PHE . 66.6 mt -103.11 148.77 7.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.108 0.48 . . . . 0.0 111.61 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.44 ' O ' ' N ' ' A' ' 82' ' ' ALA . 0.8 OUTLIER -96.15 95.89 8.45 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 176.698 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.437 ' C ' ' O ' ' A' ' 79' ' ' ASP . 51.2 t80 -28.56 -42.29 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.261 -177.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 79' ' ' ASP . 6.9 mmmm -63.79 -55.62 21.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.823 0.344 . . . . 0.0 110.619 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -52.32 -30.7 29.62 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.172 0.511 . . . . 0.0 110.411 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.661 ' CE1' HD13 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -85.56 -32.59 22.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.695 179.807 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.21 -23.77 43.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.2 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.8 -11.4 60.59 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.411 0.624 . . . . 0.0 111.804 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 13.2 tpp -76.64 -32.04 57.76 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.61 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.734 HD21 HD13 ' A' ' 28' ' ' LEU . 4.6 mt -94.05 -6.24 45.63 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 121.885 0.85 . . . . 0.0 111.33 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -125.95 22.06 7.43 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.081 -1.418 . . . . 0.0 111.212 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.957 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.4 ttpt . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.817 0.341 . . . . 0.0 110.788 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.66 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -71.57 -28.86 64.13 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.914 -179.967 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -59.92 -24.22 64.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.215 0.531 . . . . 0.0 109.683 178.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.968 HD13 HD21 ' A' ' 87' ' ' LEU . 4.2 tt -88.3 -11.27 46.92 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.519 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.66 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 12.0 mm -63.59 -15.12 15.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.865 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -79.04 2.17 21.48 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 113.919 -1.491 . . . . 0.0 111.478 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.758 ' HB2' HD21 ' A' ' 56' ' ' LEU . . . -93.29 -29.35 15.71 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.107 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -56.47 -24.39 45.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.15 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -96.9 34.43 1.71 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.025 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.821 -179.932 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 9.6 t80 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.811 0.338 . . . . 0.0 110.939 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.577 HG11 ' CE2' ' A' ' 48' ' ' PHE . 10.4 p -124.37 132.92 70.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.966 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.51 147.45 25.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.854 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.423 HG13 ' CE1' ' A' ' 67' ' ' PHE . 88.8 t -53.37 -55.14 14.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.065 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -47.21 -31.98 4.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.906 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -88.3 -29.75 20.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.358 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.629 ' HA ' HD12 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -69.04 -38.15 78.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.809 179.806 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 18.7 mtt180 -58.23 -51.21 70.69 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.991 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -55.94 -25.78 46.42 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.394 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.629 HD12 ' HA ' ' A' ' 48' ' ' PHE . 21.8 mt -83.08 -44.54 18.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.874 0.368 . . . . 0.0 111.065 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 35.8 mm -68.07 -27.27 36.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.138 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.8 ttm180 -52.8 -58.79 5.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.993 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -111.75 14.98 21.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.344 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -99.41 -86.53 1.89 Allowed Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.632 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.758 HD21 ' HB2' ' A' ' 31' ' ' ALA . 3.9 mt -103.48 143.72 27.2 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 120.631 0.253 . . . . 0.0 110.982 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.48 85.28 1.6 Allowed 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.549 2.166 . . . . 0.0 112.166 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.604 ' HB3' HD11 ' A' ' 63' ' ' ILE . 3.8 ttt -124.28 140.84 52.58 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.796 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.835 ' O ' HD12 ' A' ' 63' ' ' ILE . 0.8 OUTLIER -89.32 143.41 26.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.613 179.36 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.616 ' O ' ' N ' ' A' ' 64' ' ' THR . 0.2 OUTLIER -41.99 -53.16 3.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.369 0.604 . . . . 0.0 110.637 -179.852 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.487 ' N ' ' CG ' ' A' ' 60' ' ' GLU . . . -44.68 -28.93 0.67 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.004 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.601 ' HG2' ' O ' ' A' ' 59' ' ' THR . 1.5 mm-40 -89.57 -51.43 5.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.736 0.303 . . . . 0.0 110.458 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.835 HD12 ' O ' ' A' ' 59' ' ' THR . 1.0 OUTLIER -74.35 -44.69 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.347 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.616 ' N ' ' O ' ' A' ' 60' ' ' GLU . 50.6 m -62.96 -48.92 76.82 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.024 0.44 . . . . 0.0 109.991 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.408 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 3.2 tm-20 -66.68 -16.2 64.05 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.714 0.768 . . . . 0.0 110.301 179.297 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.443 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.2 m-85 -96.78 -23.61 16.32 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.469 -1.242 . . . . 0.0 110.357 178.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.783 ' CE2' HG22 ' A' ' 63' ' ' ILE . 2.1 m-85 -74.52 -36.06 63.19 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.736 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -76.42 -30.36 57.39 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.861 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.28 -11.08 59.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.476 0.655 . . . . 0.0 111.653 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -95.58 -30.25 13.91 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.985 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.565 ' OD2' HG22 ' A' ' 75' ' ' THR . 7.0 t70 -128.31 106.22 19.54 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.825 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 71' ' ' ASP . 37.9 Cg_endo -66.43 -30.92 43.55 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.404 2.069 . . . . 0.0 112.276 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 63.6 m-80 -76.81 -27.64 55.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.917 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 72.51 36.7 0.97 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.128 0.489 . . . . 0.0 110.13 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.565 HG22 ' OD2' ' A' ' 71' ' ' ASP . 1.1 t -85.65 13.14 7.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.975 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 69.45 26.57 74.41 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.262 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.468 ' HB2' HG23 ' A' ' 75' ' ' THR . 5.2 m-85 -117.39 178.48 4.36 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.701 0.286 . . . . 0.0 110.571 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.621 HD12 ' HD2' ' A' ' 48' ' ' PHE . 65.4 mt -153.62 153.54 8.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.206 0.527 . . . . 0.0 111.724 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.464 ' N ' HG22 ' A' ' 78' ' ' ILE . 24.2 t0 -99.55 95.97 7.35 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 176.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.429 ' C ' ' O ' ' A' ' 79' ' ' ASP . 44.8 t80 -28.7 -41.37 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.366 -178.049 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.418 ' N ' ' O ' ' A' ' 79' ' ' ASP . 3.4 mtmt -66.2 -56.61 10.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.717 0.294 . . . . 0.0 110.68 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -51.9 -27.71 13.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.043 0.449 . . . . 0.0 110.614 179.354 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.519 ' CE1' HD13 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -89.83 -31.91 17.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.743 179.923 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.09 -18.64 55.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.339 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -71.08 -11.56 61.02 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.366 0.603 . . . . 0.0 111.882 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.96 -34.6 62.06 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.784 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.968 HD21 HD13 ' A' ' 28' ' ' LEU . 4.1 mt -92.72 -6.73 48.53 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.851 0.834 . . . . 0.0 111.483 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -126.08 22.31 7.31 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.108 -1.405 . . . . 0.0 111.057 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.6 p . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.961 179.917 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.6 tttp . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.773 0.321 . . . . 0.0 110.72 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.651 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -67.63 -28.79 68.03 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.845 -179.815 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 89.3 mm-40 -61.13 -24.91 66.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.204 0.526 . . . . 0.0 109.594 178.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.804 HD13 HD21 ' A' ' 87' ' ' LEU . 3.0 tt -88.3 -11.28 46.88 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.539 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.651 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 11.2 mm -61.43 -15.58 13.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 114.973 -1.012 . . . . 0.0 112.03 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -77.84 1.81 19.19 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 113.983 -1.462 . . . . 0.0 111.559 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.646 ' HB2' HD21 ' A' ' 56' ' ' LEU . . . -93.62 -28.15 16.17 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.009 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -58.12 -20.53 40.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.315 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -93.07 24.02 3.98 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.334 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.93 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.805 0.336 . . . . 0.0 110.952 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.538 HG11 ' CE2' ' A' ' 48' ' ' PHE . 10.3 p -117.97 123.67 72.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.991 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.95 155.59 40.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.965 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.93 HG13 ' CD1' ' A' ' 67' ' ' PHE . 59.8 t -60.17 -32.51 50.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.806 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -65.2 -61.38 2.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.013 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -57.62 -30.66 65.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.918 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.876 ' CD2' HD12 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -62.1 -40.73 96.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.011 -179.909 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.445 ' HG3' ' CE2' ' A' ' 67' ' ' PHE . 65.5 mtt180 -58.76 -51.73 68.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.986 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -55.91 -25.85 46.39 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.505 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.74 HD12 ' HA ' ' A' ' 48' ' ' PHE . 12.4 mt -82.56 -45.64 19.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.882 0.372 . . . . 0.0 111.045 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.543 HG21 HG12 ' A' ' 63' ' ' ILE . 35.6 mm -68.57 -28.4 40.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.237 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 17.9 ttp180 -48.75 -60.37 2.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.063 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -111.86 14.89 21.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.109 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -96.64 -85.68 1.76 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.606 -0.806 . . . . 0.0 112.772 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.646 HD21 ' HB2' ' A' ' 31' ' ' ALA . 2.1 mp -106.34 144.97 30.05 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.594 0.235 . . . . 0.0 111.105 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.59 113.26 3.62 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.523 2.148 . . . . 0.0 112.222 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.608 ' O ' HD11 ' A' ' 63' ' ' ILE . 0.9 OUTLIER -152.68 138.97 18.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.762 -179.97 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.894 ' O ' HD12 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -77.16 147.67 36.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.529 179.57 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.55 ' O ' ' N ' ' A' ' 64' ' ' THR . 0.5 OUTLIER -38.62 -52.21 1.64 Allowed 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.271 0.558 . . . . 0.0 110.932 179.705 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.419 ' O ' ' HB2' ' A' ' 65' ' ' GLU . . . -46.76 -55.94 7.03 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.792 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.456 ' HG2' ' O ' ' A' ' 59' ' ' THR . 1.9 mm-40 -52.07 -62.26 1.75 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.945 0.402 . . . . 0.0 109.932 179.398 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.894 HD12 ' O ' ' A' ' 59' ' ' THR . 1.4 mp -59.04 -63.16 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.217 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.55 ' N ' ' O ' ' A' ' 60' ' ' GLU . 75.7 m -49.32 -52.31 28.73 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.475 -179.692 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.419 ' HB2' ' O ' ' A' ' 61' ' ' ALA . 3.3 mm-40 -65.63 -15.6 62.91 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 121.698 0.761 . . . . 0.0 110.417 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.418 ' CD1' ' O ' ' A' ' 62' ' ' GLU . 3.5 m-30 -96.17 -24.74 16.12 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.476 -1.238 . . . . 0.0 110.465 179.231 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.93 ' CD1' HG13 ' A' ' 45' ' ' VAL . 1.6 m-30 -76.44 -30.85 57.53 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.826 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.69 -26.88 16.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.092 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -82.66 -10.91 58.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.511 0.672 . . . . 0.0 111.96 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.17 -33.96 13.11 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.27 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 48.1 p-10 -110.54 122.5 38.23 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.869 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.59 -47.39 1.44 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.447 2.098 . . . . 0.0 112.479 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -68.54 -30.45 69.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.066 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.2 m120 73.84 22.06 2.56 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.413 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.2 t -66.23 -15.68 63.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.183 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.429 ' C ' HG23 ' A' ' 45' ' ' VAL . . . 102.56 22.23 9.81 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.19 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -125.34 129.44 49.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.799 0.333 . . . . 0.0 110.426 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.876 HD12 ' CD2' ' A' ' 48' ' ' PHE . 66.6 mt -99.49 146.89 7.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.223 0.535 . . . . 0.0 111.794 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.429 ' O ' ' N ' ' A' ' 82' ' ' ALA . 0.9 OUTLIER -91.94 96.0 10.13 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 176.598 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.426 ' C ' ' O ' ' A' ' 79' ' ' ASP . 56.4 t80 -28.55 -40.95 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -177.701 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.423 ' N ' ' O ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -65.19 -55.53 18.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.768 0.318 . . . . 0.0 110.718 179.644 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -51.9 -28.3 15.77 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.104 0.478 . . . . 0.0 110.6 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.645 ' CE1' HD13 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -89.71 -31.9 17.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.812 179.967 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -80.49 -20.8 42.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.324 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.12 -11.57 60.81 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.437 0.637 . . . . 0.0 111.824 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 14.4 mmt -74.03 -33.64 63.83 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.786 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.804 HD21 HD13 ' A' ' 28' ' ' LEU . 5.4 mt -95.58 -6.59 39.96 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.831 0.824 . . . . 0.0 111.476 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -125.91 22.18 7.44 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 114.178 -1.374 . . . . 0.0 111.041 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.877 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.526 ' NZ ' HD11 ' A' ' 29' ' ' ILE . 9.8 tmtt? . . . . . 0 N--CA 1.457 -0.119 0 CA-C-O 120.845 0.355 . . . . 0.0 110.699 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.674 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -66.91 -28.49 68.36 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.746 -179.933 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -59.3 -23.67 62.63 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.948 HD13 HD21 ' A' ' 87' ' ' LEU . 6.0 tt -88.0 -11.36 47.57 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.508 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.674 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 11.3 mm -67.59 -13.81 17.35 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.934 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -77.01 2.04 16.11 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 113.935 -1.484 . . . . 0.0 111.564 179.588 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.499 ' HB2' HD11 ' A' ' 56' ' ' LEU . . . -93.21 -30.54 15.14 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.034 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -59.58 -29.11 67.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.91 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -97.57 28.17 3.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.0 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.947 179.962 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 62.5 t80 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.946 0.403 . . . . 0.0 111.048 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.506 ' O ' HG13 ' A' ' 43' ' ' VAL . 4.4 p -136.41 106.17 5.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.754 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.4 m -59.01 153.74 17.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.084 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.437 HG13 ' CE1' ' A' ' 67' ' ' PHE . 92.9 t -57.03 -56.84 12.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.045 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -47.41 -29.71 2.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.058 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -88.43 -29.79 19.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.602 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.41 ' CD2' HD12 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -64.68 -30.79 71.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.799 179.876 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.4 mtt-85 -56.06 -51.23 68.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.951 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -57.49 -25.03 54.39 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.452 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 34.0 mt -83.35 -27.92 7.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.754 0.312 . . . . 0.0 111.156 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 41.7 mm -90.45 -49.18 13.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.085 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.3 -35.73 62.94 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.198 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -111.81 14.72 21.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.426 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -123.24 -90.1 0.94 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.662 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.499 HD11 ' HB2' ' A' ' 31' ' ' ALA . 2.4 mp -97.8 142.93 25.34 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.645 0.26 . . . . 0.0 110.94 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -78.92 57.94 6.67 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.525 2.15 . . . . 0.0 112.439 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.657 ' C ' HD11 ' A' ' 63' ' ' ILE . 5.3 ttt -86.58 136.19 33.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.72 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.836 ' O ' HD12 ' A' ' 63' ' ' ILE . 1.0 OUTLIER -81.76 142.05 32.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.789 0.328 . . . . 0.0 110.631 179.645 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.557 ' O ' ' N ' ' A' ' 64' ' ' THR . 0.2 OUTLIER -41.16 -52.92 3.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.328 0.585 . . . . 0.0 110.844 -179.844 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.483 ' N ' ' CG ' ' A' ' 60' ' ' GLU . . . -45.01 -27.09 0.5 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.938 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.483 ' HG3' ' O ' ' A' ' 59' ' ' THR . 0.0 OUTLIER -91.07 -51.73 5.19 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.672 0.272 . . . . 0.0 110.32 179.729 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.836 HD12 ' O ' ' A' ' 59' ' ' THR . 1.2 mp -73.65 -43.35 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.201 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.557 ' N ' ' O ' ' A' ' 60' ' ' GLU . 24.3 m -64.6 -47.78 77.36 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.027 0.441 . . . . 0.0 109.961 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.408 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 5.7 tt0 -65.66 -17.28 64.49 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.693 0.758 . . . . 0.0 110.188 179.324 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.47 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 1.0 OUTLIER -97.02 -26.92 14.84 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.243 178.829 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.755 ' CE2' HG22 ' A' ' 63' ' ' ILE . 2.0 m-85 -68.13 -47.36 68.31 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.738 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.77 -26.81 54.94 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.994 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.77 -11.06 59.92 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.445 0.64 . . . . 0.0 111.779 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.433 ' HB2' ' CE1' ' A' ' 83' ' ' PHE . . . -95.84 -32.78 12.5 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.006 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.484 ' OD2' HG22 ' A' ' 75' ' ' THR . 5.9 t70 -119.85 120.43 30.43 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.744 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.65 -27.78 45.04 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.344 2.029 . . . . 0.0 112.222 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 30.2 m-20 -84.6 -32.35 23.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.904 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.2 m120 71.31 40.4 0.85 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.038 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.484 HG22 ' OD2' ' A' ' 71' ' ' ASP . 1.4 t -90.37 40.57 1.02 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.644 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 50.33 25.72 8.65 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.763 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -125.23 148.94 48.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.874 0.369 . . . . 0.0 110.779 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.737 HD11 ' CD1' ' A' ' 67' ' ' PHE . 54.1 mt -127.14 153.12 35.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.203 0.525 . . . . 0.0 111.552 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.443 ' N ' HG22 ' A' ' 78' ' ' ILE . 1.0 OUTLIER -98.11 96.0 7.82 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 176.863 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.42 ' C ' ' O ' ' A' ' 79' ' ' ASP . 70.6 t80 -29.23 -40.86 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -178.084 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 79' ' ' ASP . 1.9 mmmm -68.72 -54.44 16.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.733 0.301 . . . . 0.0 110.699 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -52.59 -26.82 14.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.015 0.436 . . . . 0.0 110.577 179.129 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.555 ' CE1' HD13 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -91.9 -35.27 14.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.844 -179.898 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.404 ' O ' ' CD2' ' A' ' 88' ' ' TYR . . . -76.56 -29.09 56.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.398 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -74.43 -11.33 60.21 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.396 0.617 . . . . 0.0 111.824 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 13.0 mmm -84.04 -28.97 27.26 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.942 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.948 HD21 HD13 ' A' ' 28' ' ' LEU . 4.5 mt -100.83 -7.09 23.93 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.778 0.799 . . . . 0.0 111.819 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.404 ' CD2' ' O ' ' A' ' 84' ' ' ALA . 10.8 m-85 -125.99 21.87 7.44 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 114.377 -1.283 . . . . 0.0 111.339 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.0 m . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.409 179.886 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.493 ' CG ' HD23 ' A' ' 87' ' ' LEU . 1.5 ttpp . . . . . 0 N--CA 1.457 -0.076 0 CA-C-O 120.883 0.373 . . . . 0.0 110.745 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.679 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -68.29 -28.58 67.31 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.8 -179.89 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -58.95 -23.92 62.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.159 0.504 . . . . 0.0 109.781 178.501 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.973 HD22 HD22 ' A' ' 87' ' ' LEU . 3.8 tt -88.07 -11.39 47.29 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.407 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.679 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 11.2 mm -67.26 -13.6 16.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.959 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -76.32 2.19 14.09 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 113.944 -1.48 . . . . 0.0 111.676 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 1.106 ' HB2' HD21 ' A' ' 56' ' ' LEU . . . -92.31 -29.44 16.37 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.092 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -57.23 -28.21 62.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.055 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -97.42 37.76 1.33 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.919 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.8 t30 . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.852 -179.971 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.837 0.351 . . . . 0.0 110.916 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.541 HG11 ' CE2' ' A' ' 48' ' ' PHE . 9.1 p -117.56 122.19 69.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.966 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.0 155.38 38.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.839 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.698 HG22 HG13 ' A' ' 78' ' ' ILE . 49.7 t -59.71 -53.13 52.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.773 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -49.14 -37.07 20.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.749 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -80.84 -29.1 35.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.439 179.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.789 ' CD2' HD12 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -70.66 -40.05 73.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.782 179.91 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 46.0 mtm180 -56.96 -51.82 67.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.943 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -54.23 -25.41 32.73 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.327 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.0 mt -89.61 -43.68 14.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.847 0.355 . . . . 0.0 110.869 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.688 ' CD1' HD13 ' A' ' 56' ' ' LEU . 36.6 mm -70.7 -26.97 29.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.211 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.33 -60.22 3.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.106 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -111.87 14.92 21.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.336 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -101.84 -87.29 1.98 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.75 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 1.106 HD21 ' HB2' ' A' ' 31' ' ' ALA . 3.9 mp -90.92 133.4 32.22 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.509 0.195 . . . . 0.0 111.147 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -77.91 87.58 1.51 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.54 2.16 . . . . 0.0 112.289 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.613 ' O ' HD11 ' A' ' 63' ' ' ILE . 1.2 mtp -125.08 141.27 52.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.774 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.888 ' O ' HD12 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -77.99 148.92 34.18 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.642 179.673 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.506 ' O ' ' N ' ' A' ' 64' ' ' THR . 5.4 pt-20 -38.76 -52.0 1.7 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.258 0.551 . . . . 0.0 110.851 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.524 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -47.17 -53.2 13.63 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.038 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.568 ' HB2' ' HE2' ' A' ' 58' ' ' MET . 2.2 mm-40 -55.08 -61.72 2.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.928 0.394 . . . . 0.0 109.975 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.888 HD12 ' O ' ' A' ' 59' ' ' THR . 1.7 mp -58.72 -61.7 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.168 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.506 ' N ' ' O ' ' A' ' 60' ' ' GLU . 58.9 m -51.8 -51.45 56.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.343 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.524 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 50.9 tt0 -65.62 -15.45 62.76 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 121.686 0.755 . . . . 0.0 110.458 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.426 ' CD1' ' O ' ' A' ' 62' ' ' GLU . 3.6 m-30 -96.15 -26.52 15.44 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.519 -1.219 . . . . 0.0 110.372 179.145 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.699 ' CE2' HG22 ' A' ' 63' ' ' ILE . 5.1 m-30 -77.8 -26.68 49.78 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.827 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -90.75 -28.43 18.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.882 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.94 -11.2 45.13 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.459 0.647 . . . . 0.0 111.732 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -92.15 -29.72 16.34 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.078 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -125.64 119.29 24.44 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.789 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -64.85 -40.69 20.52 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.421 2.081 . . . . 0.0 112.189 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -77.4 -31.31 54.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.758 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 72.18 38.9 0.83 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.103 0.477 . . . . 0.0 110.144 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.497 HG23 ' HB2' ' A' ' 77' ' ' PHE . 1.5 t -89.7 41.27 1.03 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.529 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.422 ' C ' HG23 ' A' ' 45' ' ' VAL . . . 50.88 25.39 9.51 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.688 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.497 ' HB2' HG23 ' A' ' 75' ' ' THR . 2.5 m-85 -126.06 129.5 49.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.761 0.315 . . . . 0.0 110.84 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.789 HD12 ' CD2' ' A' ' 48' ' ' PHE . 55.7 mt -103.13 153.27 5.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.184 0.516 . . . . 0.0 111.379 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.453 ' N ' HG22 ' A' ' 78' ' ' ILE . 10.1 t0 -99.41 95.66 7.18 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 176.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.417 ' C ' ' O ' ' A' ' 79' ' ' ASP . 47.3 t80 -29.35 -41.32 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.066 -0.515 . . . . 0.0 112.287 -178.008 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 79' ' ' ASP . 21.9 mttt -65.93 -55.82 14.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.562 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -53.05 -26.16 14.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.044 0.449 . . . . 0.0 110.574 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.635 ' CE1' HD13 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -91.55 -30.49 16.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.895 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.05 -45.58 16.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.359 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -71.4 -11.62 60.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.412 0.625 . . . . 0.0 111.816 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 14.7 tpp -68.67 -35.44 77.23 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.656 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.973 HD22 HD22 ' A' ' 28' ' ' LEU . 4.2 mp -100.63 -6.76 24.74 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.777 0.798 . . . . 0.0 111.556 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -125.82 22.44 7.45 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 114.271 -1.331 . . . . 0.0 111.176 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.829 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.1 tmtm? . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.738 0.304 . . . . 0.0 110.641 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.68 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -68.03 -29.11 68.02 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.765 -179.923 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.0 mm100 -59.79 -23.93 63.7 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.829 HD22 HD22 ' A' ' 87' ' ' LEU . 0.6 OUTLIER -88.15 -11.25 47.44 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.468 179.636 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.68 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 10.8 mm -66.58 -13.74 16.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.987 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -76.4 2.11 14.49 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 113.923 -1.49 . . . . 0.0 111.658 179.664 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.666 ' HB2' HD11 ' A' ' 56' ' ' LEU . . . -92.62 -29.82 15.93 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.138 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -59.76 -27.31 66.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.123 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -94.81 42.89 1.09 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.028 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.973 179.896 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.845 0.355 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.46 HG11 ' CE2' ' A' ' 48' ' ' PHE . 10.3 p -128.52 124.52 61.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.936 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 51.1 p -76.46 148.22 37.38 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.925 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.682 HG13 ' CZ ' ' A' ' 67' ' ' PHE . 57.5 t -58.45 -39.56 75.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.836 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -56.06 -30.26 61.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.979 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -96.42 -31.9 12.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.886 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.698 ' HA ' HD12 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -58.77 -41.21 86.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.084 -179.757 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.472 ' HD2' HG12 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -57.54 -48.62 78.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.008 -179.909 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -59.56 -28.04 64.52 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.434 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.698 HD12 ' HA ' ' A' ' 48' ' ' PHE . 4.6 mt -86.47 -49.99 14.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.95 0.405 . . . . 0.0 110.989 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 tp -57.83 -40.5 76.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.278 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 13.6 mtp85 -47.63 -68.34 0.2 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.169 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -93.3 14.66 17.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.018 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.545 ' O ' HD23 ' A' ' 56' ' ' LEU . . . -110.51 -57.86 0.5 Allowed Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.592 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.666 HD11 ' HB2' ' A' ' 31' ' ' ALA . 10.4 mt -129.09 135.58 27.83 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.649 0.261 . . . . 0.0 111.015 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -78.95 97.38 1.13 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.641 2.227 . . . . 0.0 112.246 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.597 ' O ' HD11 ' A' ' 63' ' ' ILE . 1.3 mtp -129.52 140.28 51.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.814 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.898 ' O ' HD12 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -77.88 148.12 34.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.674 179.677 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.483 ' O ' ' N ' ' A' ' 64' ' ' THR . 6.1 pt-20 -39.53 -52.22 2.17 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.166 0.508 . . . . 0.0 111.064 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.529 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -47.98 -52.45 19.73 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.949 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.454 ' HB2' ' HE3' ' A' ' 58' ' ' MET . 0.9 OUTLIER -55.36 -62.4 1.7 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.377 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.898 HD12 ' O ' ' A' ' 59' ' ' THR . 1.8 mp -56.59 -61.82 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.964 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.483 ' N ' ' O ' ' A' ' 60' ' ' GLU . 55.3 m -52.14 -50.4 61.81 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.061 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.529 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 2.3 tp10 -65.99 -15.87 63.39 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 121.579 0.704 . . . . 0.0 110.459 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.441 ' CD2' ' O ' ' A' ' 62' ' ' GLU . 2.4 m-85 -96.31 -24.48 16.17 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.42 179.066 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.682 ' CZ ' HG13 ' A' ' 45' ' ' VAL . 8.5 m-30 -81.62 -28.92 33.47 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.797 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -94.12 -28.79 15.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.891 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.53 -11.19 54.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.402 0.62 . . . . 0.0 111.796 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.547 ' HB1' HG23 ' A' ' 78' ' ' ILE . . . -103.5 -30.2 10.68 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.015 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.407 ' HA ' ' HD2' ' A' ' 72' ' ' PRO . 10.8 t0 -119.63 95.74 49.35 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.813 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 71' ' ' ASP . 35.1 Cg_endo -65.04 -35.79 41.01 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.5 2.133 . . . . 0.0 112.325 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.725 ' OD1' HG23 ' A' ' 75' ' ' THR . 15.8 p30 -77.36 -30.4 53.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.875 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.1 m120 74.28 49.05 0.11 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.594 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.725 HG23 ' OD1' ' A' ' 73' ' ' ASN . 18.1 p -95.2 25.27 4.39 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.815 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 53.78 23.66 22.85 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.189 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -142.8 129.24 20.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.779 0.323 . . . . 0.0 110.442 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.547 HG23 ' HB1' ' A' ' 70' ' ' ALA . 7.2 mt -105.48 156.99 6.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.051 0.453 . . . . 0.0 111.67 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.526 ' N ' HG22 ' A' ' 78' ' ' ILE . 1.7 m-20 -85.11 97.59 9.96 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 176.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.414 ' C ' ' O ' ' A' ' 79' ' ' ASP . 50.0 t80 -28.48 -39.77 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -177.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.442 ' N ' ' O ' ' A' ' 79' ' ' ASP . 5.4 mmmm -65.11 -53.16 49.56 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.693 0.282 . . . . 0.0 110.698 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -54.11 -25.47 22.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.933 0.397 . . . . 0.0 110.594 179.198 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.497 ' CZ ' HD13 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -94.15 -30.15 14.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.102 -179.67 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.34 -38.8 26.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.315 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.66 -11.45 60.42 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.392 0.615 . . . . 0.0 111.716 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 36.9 tpp -67.49 -36.16 80.55 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.74 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.829 HD22 HD22 ' A' ' 28' ' ' LEU . 2.8 mp -100.74 -6.78 24.5 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 121.865 0.841 . . . . 0.0 111.537 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -124.61 22.34 8.31 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 114.135 -1.393 . . . . 0.0 111.111 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.061 179.997 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.561 ' HD3' HD22 ' A' ' 87' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.943 0.401 . . . . 0.0 110.6 . . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.685 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -69.09 -28.85 66.87 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.817 -179.862 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.572 ' O ' HD23 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -59.4 -24.22 63.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.168 0.509 . . . . 0.0 109.675 178.529 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.712 HD13 HD21 ' A' ' 87' ' ' LEU . 5.4 tt -88.23 -11.29 47.05 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.451 179.691 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.685 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 12.4 mm -65.65 -14.48 17.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 114.794 -1.094 . . . . 0.0 112.007 -179.899 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -79.02 2.25 21.13 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 113.872 -1.513 . . . . 0.0 111.427 179.526 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.16 -30.8 15.05 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.171 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -59.05 -30.85 68.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.92 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -98.43 34.99 1.87 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.984 179.906 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.943 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.404 ' CZ ' ' O ' ' A' ' 78' ' ' ILE . 10.5 t80 . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.811 0.339 . . . . 0.0 111.017 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.565 HG11 ' CE2' ' A' ' 48' ' ' PHE . 8.0 p -123.67 115.93 46.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.004 179.774 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.4 p -71.69 149.38 45.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.91 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.483 HG13 ' CZ ' ' A' ' 67' ' ' PHE . 82.0 t -54.51 -55.03 17.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.963 179.844 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -47.72 -30.63 4.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.971 -179.833 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -87.62 -30.04 20.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.443 179.391 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.609 ' CD2' HD12 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -68.95 -36.16 77.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.903 179.88 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.445 ' CZ ' HG12 ' A' ' 45' ' ' VAL . 37.5 mtt-85 -55.47 -51.54 66.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.027 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -57.03 -22.22 41.53 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.531 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 28.3 mt -89.86 -26.24 5.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.769 0.319 . . . . 0.0 111.223 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.442 HG21 HG12 ' A' ' 63' ' ' ILE . 31.2 mm -93.15 -28.65 4.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.228 -179.905 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.8 ttm-85 -56.31 -54.98 38.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.351 -179.648 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -111.76 15.08 21.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.621 -179.566 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -105.31 -87.89 2.02 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.819 -179.8 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.617 ' N ' HD12 ' A' ' 56' ' ' LEU . 4.1 mp -99.6 139.85 21.17 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-O 120.674 0.273 . . . . 0.0 111.11 -179.725 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.0 117.78 4.79 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.478 2.119 . . . . 0.0 112.252 179.869 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.645 ' O ' HD11 ' A' ' 63' ' ' ILE . 0.6 OUTLIER -153.12 137.9 17.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.811 -179.881 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.897 ' O ' HD12 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -75.45 146.75 40.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.653 179.506 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.532 ' O ' ' N ' ' A' ' 64' ' ' THR . 0.5 OUTLIER -39.07 -52.45 1.85 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.299 0.571 . . . . 0.0 111.011 179.744 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.511 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -46.34 -53.21 11.29 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.105 179.63 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.531 ' HB2' ' HE2' ' A' ' 58' ' ' MET . 0.5 OUTLIER -55.67 -61.33 2.43 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.872 0.368 . . . . 0.0 110.077 179.439 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.897 HD12 ' O ' ' A' ' 59' ' ' THR . 1.5 mp -59.39 -61.3 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.115 179.776 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.532 ' N ' ' O ' ' A' ' 60' ' ' GLU . 65.2 m -51.59 -51.67 53.67 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.232 -179.844 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.511 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 6.7 tt0 -65.75 -15.42 62.83 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-O 121.623 0.725 . . . . 0.0 110.389 179.778 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.435 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.4 m-30 -95.25 -25.49 16.33 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.537 -1.211 . . . . 0.0 110.389 179.114 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.751 ' CE2' HG22 ' A' ' 63' ' ' ILE . 2.6 m-30 -80.15 -28.94 38.79 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.719 179.942 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.42 -30.24 22.24 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.859 179.918 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.12 -11.13 59.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.503 0.668 . . . . 0.0 111.691 180.0 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.02 -29.9 12.64 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.836 -1.074 . . . . 0.0 111.035 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -124.43 117.06 26.65 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.755 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.37 -50.28 2.05 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.372 2.048 . . . . 0.0 112.301 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.602 ' CG ' HG23 ' A' ' 75' ' ' THR . 10.1 p30 -68.48 -32.77 73.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.852 179.911 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 6.1 m120 75.38 52.36 0.07 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.644 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.602 HG23 ' CG ' ' A' ' 73' ' ' ASN . 13.6 p -97.6 30.04 3.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.649 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 58.75 25.89 59.49 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.287 -179.717 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -127.75 131.13 49.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.802 0.334 . . . . 0.0 110.77 179.876 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.645 HD13 ' CE1' ' A' ' 83' ' ' PHE . 58.2 mt -105.05 152.64 6.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.233 0.539 . . . . 0.0 111.594 -179.764 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.435 ' N ' HG22 ' A' ' 78' ' ' ILE . 0.5 OUTLIER -99.01 95.58 7.23 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 176.912 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.422 ' C ' ' O ' ' A' ' 79' ' ' ASP . 38.6 t80 -28.93 -41.63 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.312 -178.081 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' A' ' 79' ' ' ASP . 4.4 mptt -65.86 -56.13 13.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.655 179.781 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.41 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -52.81 -26.83 15.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.944 0.402 . . . . 0.0 110.59 179.221 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.645 ' CE1' HD13 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -90.47 -31.98 16.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.813 179.956 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.46 ' O ' ' CD2' ' A' ' 88' ' ' TYR . . . -75.61 -41.38 54.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.225 179.946 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.467 ' HA ' ' CE2' ' A' ' 88' ' ' TYR . . . -61.97 -12.06 16.49 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.333 0.587 . . . . 0.0 112.035 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 8.8 mmt -79.27 -21.25 46.35 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.205 179.884 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.712 HD21 HD13 ' A' ' 28' ' ' LEU . 19.9 mt -100.6 -15.57 17.75 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 121.677 0.751 . . . . 0.0 112.366 -179.593 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.467 ' CE2' ' HA ' ' A' ' 85' ' ' ALA . 33.1 p90 -127.93 21.62 6.34 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.33 179.017 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.829 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.3 tpt . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 120.669 0.271 . . . . 16.050000000000001 111.35 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -63.12 131.46 42.37 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 121.108 -0.568 . . . . 14.67 112.552 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 55.2 m 59.5 52.56 5.68 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.019 0.438 . . . . 13.460000000000001 110.927 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.5 m -80.45 -32.47 37.2 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.016 -0.538 . . . . 12.91 111.443 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -76.8 68.03 2.95 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 121.044 0.45 . . . . 13.1 110.908 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.479 ' HA ' ' CD2' ' A' ' 10' ' ' HIS . 80.7 t60 -176.32 -60.81 0.01 OUTLIER 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.831 -0.622 . . . . 11.49 110.647 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 -105.34 -48.36 3.71 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.143 -0.48 . . . . 10.609999999999999 111.026 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -62.13 -71.39 0.15 Allowed 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.468 -0.333 . . . . 10.58 111.041 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -156.55 121.59 4.65 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.798 0.332 . . . . 10.6 111.379 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.479 ' CD2' ' HA ' ' A' ' 6' ' ' HIS . 0.2 OUTLIER -90.77 -157.24 0.48 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.951 -0.568 . . . . 10.59 109.988 179.271 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.8 p -47.7 -42.19 24.47 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.751 0.31 . . . . 9.8800000000000008 110.494 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 57.8 m -111.16 139.57 46.43 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.972 -0.558 . . . . 9.6799999999999997 109.976 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.25 81.03 0.6 Allowed Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.914 -0.66 . . . . 10.27 112.787 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 49.47 56.86 7.18 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.001 0.429 . . . . 11.4 110.83 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.2 t -112.43 96.36 35.62 Favored Pre-proline 0 C--O 1.233 0.222 0 CA-C-N 115.951 -0.568 . . . . 11.09 111.453 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.05 -33.59 25.11 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.648 2.232 . . . . 11.27 112.176 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 37.0 ptt85 -67.29 171.36 5.95 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.24 -0.436 . . . . 12.710000000000001 111.087 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.32 -65.08 2.21 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.95 -0.643 . . . . 9.6999999999999993 111.909 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 74.6 m -105.9 31.11 5.28 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 120.836 0.351 . . . . 9.4900000000000002 110.737 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -92.44 -161.91 0.88 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.155 -0.475 . . . . 10.69 110.609 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -78.18 75.13 4.72 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.046 0.45 . . . . 9.9700000000000006 110.9 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.7 m -98.61 5.28 47.91 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.954 -0.566 . . . . 7.04 111.768 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.463 ' HA ' ' OG1' ' A' ' 26' ' ' THR . 12.9 m-20 -95.32 -15.61 23.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.153 -0.476 . . . . 6.4699999999999998 112.167 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -62.28 -19.51 63.33 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.469 -0.787 . . . . 6.8700000000000001 111.287 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.439 ' HE3' HD22 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -89.46 -42.11 11.68 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.959 -1.019 . . . . 5.0499999999999998 109.708 178.253 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.726 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.8 OUTLIER -67.24 -29.24 68.83 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.27 -0.423 . . . . 4.79 111.067 179.163 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.586 ' HB3' ' HG2' ' A' ' 57' ' ' PRO . 25.1 mt-30 -68.78 -31.86 71.18 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 109.177 -0.675 . . . . 6.1600000000000001 109.177 177.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.828 ' HG ' HD13 ' A' ' 56' ' ' LEU . 0.4 OUTLIER -84.33 -10.14 57.86 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.587 -0.733 . . . . 3.6899999999999999 112.166 179.032 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.726 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 7.1 mm -52.91 -18.37 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 115.345 -0.843 . . . . 5.46 112.589 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -67.91 1.07 2.86 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.366 -1.288 . . . . 6.6699999999999999 112.749 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.15 -40.87 67.71 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.049 -0.523 . . . . 6.3300000000000001 110.226 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.42 ' HA ' ' HB2' ' A' ' 36' ' ' ASP . 62.1 m-85 -62.9 -30.09 71.27 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.364 -0.38 . . . . 7.9299999999999997 110.336 178.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.573 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -115.21 78.36 1.16 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.198 -0.456 . . . . 8.8599999999999994 110.446 179.686 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.573 ' CB ' ' O ' ' A' ' 33' ' ' TYR . 28.0 t30 127.8 18.95 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.495 1.118 . . . . 8.7899999999999991 111.501 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.636 ' CE1' HD13 ' A' ' 51' ' ' ILE . 13.3 t80 -176.75 39.92 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.841 0.353 . . . . 7.9400000000000004 110.965 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.42 ' HB2' ' HA ' ' A' ' 32' ' ' PHE . 0.7 OUTLIER -159.28 44.91 0.26 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.885 0.374 . . . . 10.539999999999999 111.08 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -88.19 -66.17 1.31 Allowed Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.987 -0.625 . . . . 11.84 112.19 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -150.16 66.02 0.97 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.023 0.439 . . . . 12.49 110.572 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -130.27 140.57 50.67 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.924 -0.58 . . . . 13.99 111.085 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.4 -162.38 0.5 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.098 -0.501 . . . . 9.6199999999999992 110.775 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -85.82 43.15 3.21 Favored Glycine 0 C--N 1.337 0.605 0 C-N-CA 120.945 -0.645 . . . . 7.71 112.961 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -155.23 123.84 6.04 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.709 0.29 . . . . 7.3399999999999999 110.941 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.493 ' O ' ' HB ' ' A' ' 78' ' ' ILE . 7.4 p -142.84 128.66 16.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.183 -0.462 . . . . 5.2699999999999996 110.728 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.427 ' HA ' ' HA ' ' A' ' 77' ' ' PHE . 11.7 p -70.34 150.55 46.2 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.779 0.323 . . . . 6.3700000000000001 111.271 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.92 HG22 HG13 ' A' ' 78' ' ' ILE . 38.3 t -57.48 -42.75 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 115.936 -0.575 . . . . 5.5599999999999996 110.781 179.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.481 ' HA ' ' HD2' ' A' ' 49' ' ' ARG . 1.3 mt-10 -52.44 -50.3 62.86 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.718 -0.674 . . . . 8.1799999999999997 110.931 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.19 -41.45 77.15 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.366 -0.379 . . . . 9.3399999999999999 110.347 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.411 ' HA ' HD12 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -55.67 -43.26 76.17 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.838 -0.619 . . . . 5.7999999999999998 111.386 179.72 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.481 ' HD2' ' HA ' ' A' ' 46' ' ' GLU . 58.3 mtt180 -53.74 -52.49 59.99 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.394 -0.366 . . . . 8.2100000000000009 111.398 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -58.93 -42.09 96.59 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 121.151 -0.547 . . . . 8.5999999999999996 112.814 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.636 HD13 ' CE1' ' A' ' 35' ' ' PHE . 7.9 mt -67.59 -47.17 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 CA-C-O 120.643 0.258 . . . . 7.3300000000000001 111.101 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.713 HD13 HD12 ' A' ' 56' ' ' LEU . 4.7 mm -62.97 -36.79 77.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 116.101 -0.499 . . . . 6.9400000000000004 111.917 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 19.1 mtt85 -47.59 -59.37 3.31 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.264 0.468 . . . . 10.77 112.264 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -111.81 15.1 21.02 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 111.958 0.355 . . . . 10.92 111.958 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.52 -70.67 0.63 Allowed Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.939 -0.648 . . . . 7.7999999999999998 112.874 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.828 HD13 ' HG ' ' A' ' 28' ' ' LEU . 7.1 mt -104.71 116.15 61.44 Favored Pre-proline 0 CA--C 1.53 0.194 0 CA-C-O 120.554 0.216 . . . . 6.1399999999999997 111.163 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.586 ' HG2' ' HB3' ' A' ' 27' ' ' GLN . 38.9 Cg_endo -66.22 97.58 0.36 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.806 2.337 . . . . 7.0099999999999998 112.102 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.634 ' O ' HD11 ' A' ' 63' ' ' ILE . 1.0 OUTLIER -138.44 144.68 40.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.536 -0.757 . . . . 7.04 110.813 -179.81 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.67 ' O ' HD12 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -85.91 154.02 21.8 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.946 -0.57 . . . . 8.9100000000000001 110.284 179.305 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.445 ' O ' ' HB ' ' A' ' 64' ' ' THR . 4.7 pt-20 -45.13 -52.68 8.95 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.813 0.339 . . . . 10.6 111.251 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.417 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -50.69 -20.82 1.34 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.688 0.625 . . . . 8.7200000000000006 112.688 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.493 ' HG2' ' O ' ' A' ' 59' ' ' THR . 0.1 OUTLIER -95.45 -50.37 5.02 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.762 -0.458 . . . . 7.0999999999999996 109.762 179.054 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.67 HD12 ' O ' ' A' ' 59' ' ' THR . 0.8 OUTLIER -71.52 -45.35 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 116.225 -0.443 . . . . 6.2400000000000002 111.692 179.887 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.445 ' HB ' ' O ' ' A' ' 60' ' ' GLU . 17.3 m -69.53 -45.5 68.68 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.41 -0.359 . . . . 7.6200000000000001 110.699 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.417 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 23.8 tt0 -64.8 -18.88 65.49 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.426 0.631 . . . . 8.9700000000000006 110.491 179.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 6.2 m-30 -96.46 -31.66 12.7 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.761 -1.109 . . . . 5.2400000000000002 110.316 178.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.682 ' CD1' HD11 ' A' ' 78' ' ' ILE . 2.8 m-30 -63.07 -35.86 81.67 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.415 -0.357 . . . . 4.6600000000000001 110.891 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -87.88 -35.88 17.49 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.347 -0.388 . . . . 8.0600000000000005 110.817 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.47 -14.57 61.26 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.403 0.519 . . . . 5.9299999999999997 112.403 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.37 -38.33 11.03 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.384 -0.825 . . . . 4.4299999999999997 111.124 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' ' 77' ' ' PHE . 37.6 t0 -108.28 107.05 59.81 Favored Pre-proline 0 CA--C 1.53 0.203 0 CA-C-N 116.344 -0.389 . . . . 5.4500000000000002 110.989 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -61.96 -38.14 60.2 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.709 2.272 . . . . 6.8300000000000001 112.491 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -75.75 -32.74 60.1 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.331 -0.395 . . . . 6.6799999999999997 111.472 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 26.8 m120 69.74 24.46 5.4 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.059 0.457 . . . . 7.0800000000000001 110.37 -178.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.5 t -68.59 -16.77 63.96 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.72 -0.673 . . . . 5.7199999999999998 111.043 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 111.84 17.72 8.32 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-N 116.261 -0.427 . . . . 5.4299999999999997 112.659 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.443 ' O ' ' HB2' ' A' ' 71' ' ' ASP . 13.6 m-85 -116.39 164.64 14.24 Favored 'General case' 0 CA--C 1.527 0.06 0 N-CA-C 109.99 -0.374 . . . . 6.4500000000000002 109.99 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.92 HG13 HG22 ' A' ' 45' ' ' VAL . 7.1 mt -142.09 147.64 21.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.356 0.598 . . . . 3.79 112.25 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.43 100.36 12.38 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.447 -1.316 . . . . 5.3499999999999996 107.447 176.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -37.91 -40.31 0.45 Allowed 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.255 0.465 . . . . 5.6100000000000003 112.255 -177.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.7 mttp -64.5 -48.51 74.89 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.758 -0.201 . . . . 8.0299999999999994 110.844 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.56 -38.9 64.33 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.97 0.415 . . . . 4.4400000000000004 110.314 178.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.566 ' CE1' HD13 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -75.63 -40.33 56.44 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.649 -0.705 . . . . 3.1699999999999999 110.871 179.343 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.39 -33.0 74.93 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.259 -0.428 . . . . 4.5199999999999996 111.523 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.22 -11.87 58.56 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.807 0.669 . . . . 5.7699999999999996 112.807 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 6.3 mmt -77.12 -45.87 25.45 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.572 -0.74 . . . . 4.7599999999999998 110.399 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.788 HD21 HD13 ' A' ' 28' ' ' LEU . 1.4 mp -88.2 -8.98 54.49 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.472 0.653 . . . . 5.1500000000000004 112.242 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -117.04 22.75 12.35 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.606 -1.179 . . . . 7.3300000000000001 111.11 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.6 58.67 3.81 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.023 0.44 . . . . 8.25 111.051 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.2 t -129.98 27.2 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 116.053 -0.521 . . . . 10.050000000000001 110.872 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -141.58 95.82 2.88 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.241 -0.436 . . . . 11.609999999999999 110.425 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -87.98 135.7 33.29 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.137 -0.483 . . . . 12.449999999999999 110.991 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.015 -0.993 . . . . 13.869999999999999 111.275 -179.95 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.9 mtt . . . . . 0 N--CA 1.488 1.429 0 CA-C-O 120.793 0.33 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -105.35 -148.06 16.73 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.443 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.1 m -146.38 -64.93 0.3 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.865 0.364 . . . . 0.0 110.901 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.1 t -161.6 34.61 0.13 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.936 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 22.9 m170 -123.7 134.65 53.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.881 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -78.34 79.98 4.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.864 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 60.8 m80 -146.13 165.78 28.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.864 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -176.28 147.72 0.72 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.889 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -60.32 -61.02 2.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.877 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 60.49 161.09 0.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.944 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 68.04 -70.2 0.13 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.906 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.3 m -142.86 99.95 3.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.91 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -63.58 -124.29 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.42 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.537 ' O ' HG13 ' A' ' 15' ' ' VAL . 1.0 OUTLIER -140.32 31.18 1.93 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.799 0.333 . . . . 0.0 110.939 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.537 HG13 ' O ' ' A' ' 14' ' ' LEU . 5.5 m -159.08 79.82 2.82 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.081 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.51 163.85 1.62 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.59 2.193 . . . . 0.0 112.361 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 8.3 tpp85 -150.57 -66.76 0.2 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.83 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.6 -138.16 49.34 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.558 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.9 p 58.5 -170.04 0.12 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.835 0.35 . . . . 0.0 110.989 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 32.9 p-80 -91.06 118.89 30.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.962 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.36 34.26 4.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.888 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.3 m -101.6 5.44 41.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.594 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.14 -14.52 61.39 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.572 0.701 . . . . 0.0 111.477 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -65.53 -15.98 63.23 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 114.843 -1.072 . . . . 0.0 111.263 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.733 ' HG2' HD23 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -91.72 -29.36 16.87 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.618 179.493 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.674 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -60.17 -28.27 67.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.775 -179.857 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.25 -23.96 66.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.232 0.539 . . . . 0.0 109.682 178.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.745 ' O ' HD13 ' A' ' 28' ' ' LEU . 2.7 tm? -88.03 -11.32 47.61 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.257 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.674 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 10.7 mm -66.0 -14.42 17.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.92 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -77.6 2.15 17.42 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 113.9 -1.5 . . . . 0.0 111.52 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.435 ' HA ' HD11 ' A' ' 56' ' ' LEU . . . -93.41 -29.53 15.55 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.132 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -56.66 -22.81 37.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.155 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -97.25 29.76 3.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.129 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -179.16 38.75 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.902 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.769 ' CZ ' HG21 ' A' ' 51' ' ' ILE . 11.6 m-85 -154.5 31.77 0.42 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.951 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -108.13 31.36 5.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.864 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -171.79 64.35 0.15 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.527 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.7 p30 -136.82 31.27 2.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.833 0.349 . . . . 0.0 110.89 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 60.49 84.1 0.13 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.903 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 60.74 -170.49 0.15 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.897 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.422 ' HA3' ' CD2' ' A' ' 80' ' ' TYR . . . -77.79 -27.57 58.49 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.469 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -59.7 123.81 18.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.837 0.351 . . . . 0.0 110.882 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.468 HG11 ' CE2' ' A' ' 48' ' ' PHE . 8.1 p -144.18 139.75 24.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.963 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -88.9 155.16 19.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.006 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.452 HG13 ' CZ ' ' A' ' 67' ' ' PHE . 86.1 t -58.24 -55.9 19.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.058 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -46.69 -30.73 2.51 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.078 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -91.23 -28.85 17.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.476 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.474 ' HA ' HD12 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -68.75 -38.19 79.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.74 179.716 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 26.9 mtp180 -57.6 -50.3 73.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.915 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -56.72 -25.85 52.34 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.543 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.769 HG21 ' CZ ' ' A' ' 35' ' ' PHE . 28.5 mt -84.05 -43.81 17.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.796 0.331 . . . . 0.0 111.011 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.481 HG21 HG12 ' A' ' 63' ' ' ILE . 30.9 mm -69.72 -28.66 38.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.192 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 20.1 mtm180 -50.63 -58.22 6.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.018 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -111.75 14.9 21.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.272 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -99.0 -86.51 1.88 Allowed Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.665 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.435 HD11 ' HA ' ' A' ' 31' ' ' ALA . 7.9 mp -103.76 145.73 31.18 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.755 0.312 . . . . 0.0 111.068 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.98 112.91 3.6 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.504 2.136 . . . . 0.0 112.312 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.554 ' O ' HD11 ' A' ' 63' ' ' ILE . 1.1 ttp -154.85 138.32 15.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.721 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.87 ' O ' HD12 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -78.86 146.6 33.56 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.466 179.463 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.556 ' O ' ' N ' ' A' ' 64' ' ' THR . 0.6 OUTLIER -40.29 -53.21 2.58 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.288 0.566 . . . . 0.0 110.913 179.841 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.526 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -46.23 -53.08 11.28 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.045 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.443 ' HB2' ' HE3' ' A' ' 58' ' ' MET . 0.6 OUTLIER -56.04 -61.16 2.57 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 179.446 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.87 HD12 ' O ' ' A' ' 59' ' ' THR . 1.2 mp -59.66 -61.09 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.049 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.556 ' N ' ' O ' ' A' ' 60' ' ' GLU . 51.7 m -51.18 -51.03 57.64 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.171 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.526 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 8.6 tt0 -66.56 -15.45 63.43 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 121.683 0.754 . . . . 0.0 110.399 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.426 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.6 m-30 -96.23 -25.31 15.85 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.44 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.766 ' CE2' HG22 ' A' ' 63' ' ' ILE . 1.6 m-85 -73.74 -46.63 44.65 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.65 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.44 -26.51 58.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.153 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.53 -11.03 60.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.457 0.646 . . . . 0.0 111.844 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.433 ' HB2' ' CE1' ' A' ' 83' ' ' PHE . . . -96.3 -51.41 4.39 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.867 -1.061 . . . . 0.0 111.193 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 29.1 p-10 -105.35 118.79 54.86 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.9 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -69.14 -36.12 13.1 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.466 2.111 . . . . 0.0 112.32 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -68.42 -32.69 72.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.878 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 71.65 40.86 0.75 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.145 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.538 HG23 ' HB2' ' A' ' 77' ' ' PHE . 1.4 t -91.36 29.9 1.38 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.635 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 56.02 26.73 49.52 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.454 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.538 ' HB2' HG23 ' A' ' 75' ' ' THR . 2.4 m-85 -123.47 161.27 25.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.777 0.323 . . . . 0.0 110.646 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.712 HD11 ' HD1' ' A' ' 67' ' ' PHE . 52.2 mt -139.32 148.93 23.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.247 0.546 . . . . 0.0 111.706 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.445 ' O ' ' N ' ' A' ' 82' ' ' ALA . 0.7 OUTLIER -97.49 96.28 8.22 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 176.812 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.426 ' C ' ' O ' ' A' ' 79' ' ' ASP . 39.4 t80 -28.61 -40.78 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.366 -178.002 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 79' ' ' ASP . 1.7 mtmp? -66.44 -54.78 20.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.567 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.445 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -52.96 -26.98 16.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.018 0.437 . . . . 0.0 110.478 179.109 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.552 ' CE1' HD13 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -91.1 -31.44 16.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.884 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.65 -20.74 33.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.579 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.25 -11.23 60.43 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.423 0.63 . . . . 0.0 111.934 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.493 ' HB3' HD12 ' A' ' 87' ' ' LEU . 17.2 tpp -78.18 -35.34 48.82 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.57 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.733 HD23 ' HG2' ' A' ' 25' ' ' LYS . 6.9 mp -96.4 -5.86 38.82 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.831 0.824 . . . . 0.0 111.299 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -122.35 21.89 10.19 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 114.174 -1.375 . . . . 0.0 111.098 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.05 29.63 2.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.062 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.623 ' O ' HG22 ' A' ' 90' ' ' VAL . 14.7 p -138.21 36.84 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.962 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -156.21 37.33 0.34 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.898 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -125.52 138.0 53.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.943 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.155 -0.926 . . . . 0.0 110.826 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.3 mtm . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 120.939 0.399 . . . . 0.0 111.259 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 96.81 39.13 4.2 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.447 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.2 p -63.08 -175.35 0.1 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.794 0.331 . . . . 0.0 110.878 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.5 m -75.28 -65.67 0.86 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.948 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -172.93 -179.02 1.95 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.939 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 -141.32 167.71 21.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.948 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 60.54 -174.38 0.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.845 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 25.9 p80 -132.21 -176.2 3.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.91 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 23.8 t-80 60.66 109.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.914 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -176.48 -40.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.895 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.4 m -143.13 -47.57 0.31 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.893 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.8 m -146.43 113.58 6.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.814 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -88.58 -47.19 4.36 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.506 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.531 HD22 ' N ' ' A' ' 14' ' ' LEU . 3.2 mm? -76.17 83.53 2.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.934 0.397 . . . . 0.0 110.976 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.5 t 60.47 88.18 0.12 Allowed Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.127 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.07 -178.22 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.626 2.217 . . . . 0.0 112.276 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.5 tpp85 -61.28 -67.79 0.37 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.896 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.11 173.75 0.57 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.526 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.24 31.46 0.17 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.853 0.359 . . . . 0.0 110.936 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -176.37 37.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.826 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.36 -60.85 1.59 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.906 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.4 t -100.91 5.3 43.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.528 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.84 -14.44 61.5 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.594 0.711 . . . . 0.0 111.589 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.82 -16.28 63.67 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.855 -1.066 . . . . 0.0 111.124 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.572 ' HG2' HD22 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -91.83 -28.29 17.43 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.688 179.504 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.683 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -63.1 -29.48 70.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.814 -179.875 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -60.6 -24.28 65.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.18 0.515 . . . . 0.0 109.701 178.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.978 HD13 HD21 ' A' ' 87' ' ' LEU . 5.5 tt -88.24 -11.29 47.03 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.456 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.683 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 10.8 mm -64.39 -14.59 16.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.971 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -76.92 1.83 16.49 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 114.085 -1.416 . . . . 0.0 111.543 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.54 -28.37 16.1 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.072 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -58.0 -20.81 41.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.317 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -93.97 23.82 4.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.554 -0.293 . . . . 0.0 111.182 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -176.66 34.15 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.052 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 17.1 t80 179.74 77.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.742 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -98.46 24.14 7.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.139 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 93.24 -24.34 25.53 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.652 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.5 t0 62.4 27.68 16.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.813 0.339 . . . . 0.0 110.97 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 57.02 73.6 0.45 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.946 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -177.54 -40.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.94 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.15 27.46 57.98 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.546 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -152.61 123.88 7.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.848 0.356 . . . . 0.0 110.904 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.429 ' O ' HG13 ' A' ' 43' ' ' VAL . 10.2 p -122.77 125.15 72.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.042 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 52.7 p -70.49 168.43 16.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.872 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.827 HG22 HG13 ' A' ' 78' ' ' ILE . 41.2 t -73.06 -29.05 27.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.835 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -74.84 -53.03 9.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.711 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -58.38 -32.75 68.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.582 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.751 ' HD2' HD12 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -59.63 -35.91 75.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.76 179.715 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.72 -51.29 70.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.926 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -54.94 -25.39 37.68 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.363 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 24.6 mt -90.58 -39.94 12.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.823 0.344 . . . . 0.0 110.898 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.415 HG21 HG12 ' A' ' 63' ' ' ILE . 36.5 mm -74.26 -27.2 21.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.199 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.4 ttt85 -50.7 -58.72 5.19 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.878 0.37 . . . . 0.0 111.068 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -111.9 15.07 20.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.299 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -97.65 -86.02 1.81 Allowed Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.712 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.607 HD22 ' HA ' ' A' ' 28' ' ' LEU . 11.2 mt -101.19 135.6 19.87 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.587 0.232 . . . . 0.0 111.0 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -78.73 59.32 7.22 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.488 2.125 . . . . 0.0 112.325 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.629 ' O ' HD11 ' A' ' 63' ' ' ILE . 1.4 mtp -88.32 141.68 28.35 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.582 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.911 ' O ' HD12 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -77.95 147.68 34.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.772 179.762 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.494 ' O ' ' N ' ' A' ' 64' ' ' THR . 3.0 pt-20 -38.08 -48.5 1.23 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.19 0.519 . . . . 0.0 111.094 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.515 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -50.96 -52.78 39.13 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.922 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.478 ' HB2' ' HE2' ' A' ' 58' ' ' MET . 1.1 mm-40 -55.15 -61.79 2.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.007 0.432 . . . . 0.0 109.934 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.911 HD12 ' O ' ' A' ' 59' ' ' THR . 1.8 mp -57.92 -61.79 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.202 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.494 ' N ' ' O ' ' A' ' 60' ' ' GLU . 92.2 m -52.36 -52.28 54.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.291 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.515 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 1.2 tp10 -64.46 -15.58 60.95 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 121.702 0.763 . . . . 0.0 110.504 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.428 ' CD1' ' O ' ' A' ' 62' ' ' GLU . 3.5 m-30 -95.07 -28.87 14.88 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.284 179.168 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.742 ' CD1' HD11 ' A' ' 78' ' ' ILE . 10.0 m-30 -79.84 -24.39 41.33 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.848 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -93.96 -27.34 16.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.85 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.77 -11.41 42.27 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.436 0.636 . . . . 0.0 111.72 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.65 -27.41 14.38 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.961 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.401 ' HA ' ' HD2' ' A' ' 72' ' ' PRO . 14.6 t0 -120.68 96.53 48.81 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.781 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 71' ' ' ASP . 30.1 Cg_endo -63.58 -29.9 70.48 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.411 2.074 . . . . 0.0 112.243 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -83.31 -27.03 30.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.828 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 73.09 40.39 0.56 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.179 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.2 t -91.47 28.71 1.63 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.621 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.483 ' C ' HG23 ' A' ' 45' ' ' VAL . . . 47.42 31.83 7.0 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.317 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.636 ' N ' HG23 ' A' ' 45' ' ' VAL . 1.2 t80 -134.04 129.19 35.7 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.849 0.357 . . . . 0.0 110.285 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.827 HG13 HG22 ' A' ' 45' ' ' VAL . 65.5 mt -102.75 150.57 6.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.183 0.516 . . . . 0.0 111.461 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.43 ' O ' ' N ' ' A' ' 82' ' ' ALA . 2.2 m-20 -93.76 95.64 9.27 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 176.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.423 ' C ' ' O ' ' A' ' 79' ' ' ASP . 42.4 t80 -29.67 -40.6 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.238 -177.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 79' ' ' ASP . 15.8 mtmt -66.15 -55.22 17.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.797 0.332 . . . . 0.0 110.613 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -52.72 -27.9 19.63 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.033 0.444 . . . . 0.0 110.501 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.591 ' CE1' HD13 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -89.66 -32.78 16.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.804 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.37 -24.46 46.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.197 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.8 -11.41 60.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.446 0.641 . . . . 0.0 111.729 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 9.4 mtp -75.14 -37.88 61.23 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.743 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.978 HD21 HD13 ' A' ' 28' ' ' LEU . 4.1 mt -88.19 -6.88 57.59 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.854 0.835 . . . . 0.0 111.52 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -125.99 22.45 7.35 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.131 -1.395 . . . . 0.0 111.184 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.16 97.87 2.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.879 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.577 ' O ' HG22 ' A' ' 90' ' ' VAL . 12.0 p -153.43 49.41 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.069 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -169.92 155.26 5.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.935 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -168.16 -56.05 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.902 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.909 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 120.705 0.288 . . . . 0.0 111.183 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 64.25 136.09 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.461 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 78.3 p -97.17 -176.32 3.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.749 0.309 . . . . 0.0 110.906 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 62.7 p -104.4 -74.58 0.64 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.844 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 5.6 m80 60.61 110.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.901 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 19.8 p-80 -131.57 -178.04 4.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.871 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -170.73 35.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.916 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 13.6 p80 -131.43 36.67 3.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.823 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 2.5 m80 64.1 -79.13 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.973 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 16.7 m80 -140.68 -75.92 0.32 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.827 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.8 m -176.86 37.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.922 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 59.84 -169.93 0.14 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.93 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 138.18 -85.51 0.23 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.515 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.448 HD12 ' HA ' ' A' ' 14' ' ' LEU . 8.0 tp -60.49 -67.01 0.44 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.813 0.34 . . . . 0.0 110.874 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.439 ' O ' HG23 ' A' ' 15' ' ' VAL . 6.4 m -134.89 88.78 26.5 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.173 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -51.97 -61.67 0.48 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.534 2.156 . . . . 0.0 112.373 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.82 37.0 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.864 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.17 56.62 14.82 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.546 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.9 t -86.91 132.86 33.69 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.781 0.324 . . . . 0.0 110.925 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -129.1 31.52 4.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.914 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 17.3 ptp -124.21 5.99 8.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.331 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.9 p -101.78 5.49 41.23 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.072 0.463 . . . . 0.0 111.565 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -71.74 -14.24 61.95 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.57 0.7 . . . . 0.0 111.658 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -65.1 -16.79 63.87 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.306 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.593 ' HE3' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -92.02 -32.23 15.29 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.727 179.603 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.655 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -56.76 -26.4 57.34 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.05 -179.775 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -62.89 -23.62 67.43 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.243 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.751 ' O ' HD13 ' A' ' 28' ' ' LEU . 2.7 tm? -88.12 -11.48 46.87 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.362 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.655 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 12.2 mm -64.68 -14.74 16.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 114.77 -1.104 . . . . 0.0 111.946 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -77.67 2.07 17.88 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 113.907 -1.497 . . . . 0.0 111.667 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.585 ' N ' HD21 ' A' ' 56' ' ' LEU . . . -93.37 -40.09 10.58 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.022 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -58.82 -29.83 67.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.95 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -98.1 28.36 4.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.954 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -179.08 41.18 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.767 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -178.13 78.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.91 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 61.93 69.15 0.65 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.866 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -59.28 -27.85 63.56 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.581 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -157.62 39.5 0.28 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.902 0.382 . . . . 0.0 110.971 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -171.98 87.34 0.09 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.92 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.422 ' HB2' ' CE1' ' A' ' 80' ' ' TYR . 1.4 p30 -128.51 -178.03 4.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.91 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 175.31 -61.05 0.11 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.489 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.401 ' CE2' ' HA ' ' A' ' 79' ' ' ASP . 1.0 OUTLIER -152.04 123.89 7.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.783 0.325 . . . . 0.0 110.965 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.5 p -120.93 136.17 58.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.014 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.4 ' HB3' ' CD1' ' A' ' 77' ' ' PHE . 1.3 m -88.71 145.08 25.85 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.855 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 93.1 t -51.51 -55.69 7.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.179 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -47.95 -31.3 5.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.873 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -86.92 -30.24 21.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.413 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.567 ' HD2' HD12 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -67.08 -40.08 86.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.825 179.847 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -56.47 -50.7 70.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.911 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -56.03 -25.41 46.11 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.315 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.436 HD12 ' HA ' ' A' ' 48' ' ' PHE . 28.7 mt -85.51 -43.89 16.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.817 0.341 . . . . 0.0 110.924 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 34.5 mm -71.65 -26.05 25.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.147 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 10.0 mmp_? -52.48 -59.5 4.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.748 0.308 . . . . 0.0 111.118 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -111.72 14.94 21.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.361 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -98.31 -86.35 1.85 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.678 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.585 HD21 ' N ' ' A' ' 31' ' ' ALA . 3.2 mp -105.54 146.78 33.47 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-O 120.689 0.281 . . . . 0.0 111.049 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -73.48 95.09 0.85 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.588 2.192 . . . . 0.0 112.11 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.425 ' HE2' ' HG3' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -130.8 141.67 50.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.799 -179.81 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.702 ' O ' HD12 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -90.0 144.88 25.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.956 179.449 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.601 ' O ' ' N ' ' A' ' 64' ' ' THR . 6.4 pt-20 -47.33 -56.96 5.83 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 121.077 0.465 . . . . 0.0 110.49 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.428 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -50.29 -24.56 3.01 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.982 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.49 ' HB3' ' O ' ' A' ' 59' ' ' THR . 4.8 tp10 -86.67 -46.0 10.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.335 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.722 HG22 ' CE2' ' A' ' 67' ' ' PHE . 0.7 OUTLIER -82.63 -47.82 18.43 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.179 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.074 179.552 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.601 ' N ' ' O ' ' A' ' 60' ' ' GLU . 23.0 m -59.48 -46.84 87.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.202 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.428 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 0.9 OUTLIER -68.32 -16.51 63.97 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 121.755 0.788 . . . . 0.0 110.201 179.376 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.407 ' CD1' ' O ' ' A' ' 62' ' ' GLU . 3.1 m-85 -97.14 -24.0 15.94 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.31 -1.313 . . . . 0.0 110.286 178.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.736 ' CD1' HD11 ' A' ' 78' ' ' ILE . 2.1 m-85 -72.19 -41.3 67.14 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.767 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -79.85 -28.33 40.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.917 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.15 -11.26 60.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.437 0.637 . . . . 0.0 111.741 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.405 ' HB2' ' HE1' ' A' ' 83' ' ' PHE . . . -94.83 -30.59 14.14 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.041 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.484 ' OD2' HG22 ' A' ' 75' ' ' THR . 22.2 t70 -120.73 120.38 29.6 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.909 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -64.36 -27.12 63.18 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.46 2.107 . . . . 0.0 112.282 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 -87.79 -32.56 19.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.886 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 71.52 38.93 0.95 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.063 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.484 HG22 ' OD2' ' A' ' 71' ' ' ASP . 1.6 t -89.2 42.74 1.1 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.689 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 50.87 25.03 8.93 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.636 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.425 ' HB2' HG23 ' A' ' 75' ' ' THR . 41.4 m-85 -122.21 159.16 27.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.905 0.383 . . . . 0.0 110.718 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.736 HD11 ' CD1' ' A' ' 67' ' ' PHE . 50.5 mt -137.28 153.39 28.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.146 0.498 . . . . 0.0 111.593 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.449 ' N ' HG22 ' A' ' 78' ' ' ILE . 1.0 OUTLIER -98.72 95.86 7.52 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 176.923 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.425 ' C ' ' O ' ' A' ' 79' ' ' ASP . 47.8 t80 -28.96 -41.16 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.333 -178.062 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 79' ' ' ASP . 22.2 mttt -68.01 -55.88 11.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.728 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -51.43 -27.46 10.29 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.961 0.41 . . . . 0.0 110.672 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.509 ' CE1' HD13 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -91.13 -33.06 15.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.94 179.852 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.401 ' O ' ' CD2' ' A' ' 88' ' ' TYR . . . -80.56 -18.24 48.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.444 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.95 -11.69 61.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.379 0.609 . . . . 0.0 111.719 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 51.4 mtm -76.18 -38.49 56.54 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.587 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.597 ' N ' HD22 ' A' ' 87' ' ' LEU . 2.7 mm? -85.94 -6.59 59.03 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 121.822 0.82 . . . . 0.0 111.365 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.401 ' CD2' ' O ' ' A' ' 84' ' ' ALA . 19.0 m-85 -125.65 22.21 7.6 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 114.142 -1.39 . . . . 0.0 111.157 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -97.41 30.38 2.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.929 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 30.6 m -104.22 30.99 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.136 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -145.04 31.96 1.12 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.856 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -153.78 -46.96 0.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.819 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.0 m . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.971 180.0 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 mmt . . . . . 0 N--CA 1.485 1.303 0 CA-C-O 120.754 0.311 . . . . 0.0 111.267 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -165.9 32.26 0.22 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.488 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.7 t -147.24 150.09 34.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.834 0.349 . . . . 0.0 110.916 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.52 177.33 1.45 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.922 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 13.7 m80 60.7 32.86 20.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.896 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -176.49 -68.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.891 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 12.5 t60 -141.44 161.56 37.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.931 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 10.7 p-80 -161.12 82.48 0.63 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.972 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -108.32 129.54 55.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.858 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 12.8 p80 -177.71 -39.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.024 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.2 t 63.65 147.89 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.949 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.75 -52.7 64.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.946 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 59.79 -153.98 32.54 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.45 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 60.22 -165.72 0.2 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.785 0.326 . . . . 0.0 110.807 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.4 m -53.47 160.09 2.03 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.185 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -50.12 166.15 0.3 Allowed 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.526 2.151 . . . . 0.0 112.44 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.7 mtt85 -59.37 128.27 36.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.963 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -107.11 28.08 14.0 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.47 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.0 t -134.77 92.42 2.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.734 0.302 . . . . 0.0 110.879 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 15.5 p80 -60.02 152.18 24.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.94 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.4 ttt -60.46 176.34 0.37 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.86 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 29.1 p -98.33 5.28 48.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.508 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -91.66 -14.49 30.02 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.518 0.675 . . . . 0.0 111.539 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -65.21 -16.38 63.46 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.203 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.711 ' HD3' HD23 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -91.89 -28.38 17.32 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.587 179.477 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.681 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -65.55 -29.07 69.65 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.781 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -59.21 -23.74 62.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.278 0.561 . . . . 0.0 109.776 178.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.839 HD13 HD21 ' A' ' 87' ' ' LEU . 5.7 tt -88.12 -11.32 47.32 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.415 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.681 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 11.0 mm -67.19 -13.67 17.02 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-N 114.749 -1.114 . . . . 0.0 111.952 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -76.61 2.12 14.96 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 113.921 -1.491 . . . . 0.0 111.621 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 1.091 ' HB2' HD21 ' A' ' 56' ' ' LEU . . . -93.03 -33.51 14.09 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.076 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -63.73 -29.17 70.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.887 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -97.99 31.76 2.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.907 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -167.94 33.59 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.865 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.407 ' CG ' ' O ' ' A' ' 35' ' ' PHE . 20.9 t80 -158.5 38.72 0.24 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.892 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -105.95 36.4 2.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.905 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -165.15 53.79 0.27 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.435 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -176.94 78.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.903 0.382 . . . . 0.0 110.876 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 60.64 170.62 0.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.966 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -132.59 139.89 48.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.91 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.432 ' HA2' ' CD2' ' A' ' 80' ' ' TYR . . . 66.21 -86.3 0.11 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.471 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -60.06 123.72 18.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.902 0.382 . . . . 0.0 110.828 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.413 HG11 ' CE2' ' A' ' 48' ' ' PHE . 7.5 p -142.76 125.02 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.875 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.407 ' HB3' ' CD2' ' A' ' 77' ' ' PHE . 1.8 m -77.21 154.71 32.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.056 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.521 HG13 ' CZ ' ' A' ' 67' ' ' PHE . 59.4 t -59.87 -52.69 58.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.759 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -50.09 -31.31 12.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.907 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.4 mm-40 -91.69 -29.22 16.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.46 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.413 ' CE2' HG11 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -64.66 -35.9 82.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.813 179.844 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 15.5 mtt180 -58.37 -49.55 76.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.859 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -57.05 -26.77 56.32 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.36 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 26.0 mt -85.29 -44.35 17.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.891 0.377 . . . . 0.0 110.991 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 37.5 mm -67.2 -29.07 44.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.107 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.09 -57.09 10.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.908 0.385 . . . . 0.0 110.925 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -111.76 14.82 21.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.312 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -99.55 -86.62 1.9 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.673 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 1.091 HD21 ' HB2' ' A' ' 31' ' ' ALA . 6.7 mt -100.19 139.04 20.41 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.577 0.227 . . . . 0.0 110.969 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -79.06 58.79 7.11 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.472 2.115 . . . . 0.0 112.314 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.484 ' O ' HD11 ' A' ' 63' ' ' ILE . 1.4 ttp -94.5 139.9 30.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.746 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.902 ' O ' HD12 ' A' ' 63' ' ' ILE . 0.8 OUTLIER -75.95 142.56 41.95 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.052 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.548 ' O ' ' N ' ' A' ' 64' ' ' THR . 6.6 pt-20 -39.5 -51.79 2.16 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.276 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.434 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -45.61 -55.52 6.24 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.182 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.476 ' HB2' ' HG2' ' A' ' 58' ' ' MET . 0.9 OUTLIER -55.07 -60.86 2.8 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.619 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.902 HD12 ' O ' ' A' ' 59' ' ' THR . 1.5 mp -58.94 -61.93 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.921 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.548 ' N ' ' O ' ' A' ' 60' ' ' GLU . 75.2 m -49.55 -52.45 29.81 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.218 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.434 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 44.0 mt-10 -66.16 -15.75 63.4 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.701 0.762 . . . . 0.0 110.381 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.44 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.5 m-30 -94.66 -26.51 16.3 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.517 -1.22 . . . . 0.0 110.385 179.071 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.731 ' CE2' HG22 ' A' ' 63' ' ' ILE . 2.4 m-30 -75.16 -30.27 60.67 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.681 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -92.91 -24.93 18.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.92 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.24 -11.23 44.21 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.518 0.675 . . . . 0.0 111.856 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.426 ' HB1' ' CG2' ' A' ' 78' ' ' ILE . . . -99.46 -27.27 13.81 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.136 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -118.96 115.7 34.64 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.703 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.83 -50.51 1.67 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.44 2.093 . . . . 0.0 112.5 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -68.48 -32.55 72.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.93 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 12.6 m120 72.41 30.62 1.94 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.543 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 36.8 p -68.48 -22.71 64.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.036 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 115.08 20.64 5.55 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.568 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.44 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 3.2 m-85 -137.48 150.37 47.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.671 0.272 . . . . 0.0 110.736 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.519 HD11 HG22 ' A' ' 45' ' ' VAL . 1.6 mt -133.36 146.55 32.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.571 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.434 ' O ' ' N ' ' A' ' 81' ' ' LYS . 8.5 m-20 -75.74 105.04 6.57 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 177.23 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.432 ' CD2' ' HA2' ' A' ' 41' ' ' GLY . 27.6 t80 -28.73 -40.19 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.102 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 79' ' ' ASP . 0.1 OUTLIER -64.64 -53.32 49.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.654 0.264 . . . . 0.0 110.854 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -51.45 -27.24 9.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.063 0.458 . . . . 0.0 110.747 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.49 ' CD1' HG21 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -93.83 -32.48 13.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.986 -179.869 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.99 -18.49 53.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.262 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -71.72 -11.61 60.91 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.427 0.632 . . . . 0.0 111.803 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.36 -41.82 62.97 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.716 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.839 HD21 HD13 ' A' ' 28' ' ' LEU . 7.1 mp -86.03 -6.31 59.06 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.884 0.85 . . . . 0.0 111.512 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -125.28 22.26 7.84 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.168 -1.378 . . . . 0.0 111.107 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.81 71.3 6.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.886 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.592 ' O ' HG12 ' A' ' 90' ' ' VAL . 15.9 t -145.55 30.85 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.028 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -176.82 124.99 0.16 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.847 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -78.89 136.44 37.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.888 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.925 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.2 mmm . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.868 0.366 . . . . 0.0 111.123 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -140.37 85.48 0.21 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.424 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.2 m -170.06 35.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.811 0.338 . . . . 0.0 110.88 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.96 133.51 28.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.862 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -172.17 -68.92 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.934 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 60.18 168.01 0.08 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.892 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -176.72 132.95 0.2 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.862 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -150.76 36.78 0.63 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.855 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -99.03 32.21 2.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.952 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 27.5 p80 -148.17 31.57 0.84 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.877 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.3 p -176.55 83.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.866 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.3 p -60.74 109.58 1.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.897 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -95.78 37.8 3.31 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.519 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.539 ' O ' HG13 ' A' ' 15' ' ' VAL . 11.6 mt -99.67 31.12 3.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.817 0.341 . . . . 0.0 110.878 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.539 HG13 ' O ' ' A' ' 14' ' ' LEU . 6.1 m -158.81 68.98 3.49 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.082 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.02 -58.43 1.49 Allowed 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.471 2.114 . . . . 0.0 112.346 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.07 130.51 45.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.962 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -99.98 28.49 15.4 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.473 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 m -86.43 -169.32 2.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.803 0.335 . . . . 0.0 110.871 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.8 t60 61.23 79.75 0.24 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.894 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 17.8 mtt -145.57 169.74 17.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.934 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.3 p -100.88 5.22 43.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.595 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -90.03 -14.53 33.7 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.514 0.673 . . . . 0.0 111.533 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -65.2 -16.61 63.71 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.122 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.479 ' HE2' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -92.02 -27.69 17.66 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.779 -1.1 . . . . 0.0 110.65 179.459 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.657 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -67.15 -27.75 67.55 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.857 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -59.51 -23.75 63.07 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.978 HD13 HD21 ' A' ' 87' ' ' LEU . 5.6 tt -88.2 -11.31 47.09 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.563 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.657 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 11.9 mm -66.1 -14.06 16.81 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 114.695 -1.139 . . . . 0.0 111.932 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.89 1.98 15.99 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 113.915 -1.493 . . . . 0.0 111.66 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.858 ' HB2' HD11 ' A' ' 56' ' ' LEU . . . -93.33 -29.21 15.75 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.076 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -57.18 -25.91 59.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.098 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -95.08 42.42 1.09 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.814 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -171.49 35.24 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.849 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.487 ' CE2' HD13 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -169.67 40.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.794 179.934 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.0 p30 -106.02 30.71 5.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.043 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -67.2 -35.13 87.87 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.482 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -176.81 37.54 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.787 0.327 . . . . 0.0 110.843 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 62.28 -81.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.936 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.4 t0 54.74 -169.13 0.07 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.157 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.403 ' O ' ' CG ' ' A' ' 80' ' ' TYR . . . -150.65 -67.77 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.396 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -59.43 165.89 2.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.852 0.358 . . . . 0.0 111.006 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.501 HG11 ' CE2' ' A' ' 48' ' ' PHE . 7.7 p -175.65 125.43 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.907 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.53 146.93 40.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.112 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.512 HG22 ' CD1' ' A' ' 67' ' ' PHE . 75.7 t -56.25 -53.23 42.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.989 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -48.0 -30.09 4.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.973 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -92.83 -30.0 15.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.467 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.501 ' CE2' HG11 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -64.6 -33.28 75.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.8 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 8.7 mtt180 -55.35 -51.72 65.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.941 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -56.15 -25.71 47.79 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.438 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.487 HD13 ' CE2' ' A' ' 35' ' ' PHE . 40.6 mt -81.97 -28.69 9.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.795 0.331 . . . . 0.0 111.022 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 31.6 mm -90.2 -28.32 5.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.104 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.9 mmm-85 -54.29 -55.6 26.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.346 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -111.66 14.96 21.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.638 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -103.45 -87.49 2.01 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.321 -0.943 . . . . 0.0 112.764 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.858 HD11 ' HB2' ' A' ' 31' ' ' ALA . 4.4 mp -102.54 143.79 27.31 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 120.767 0.317 . . . . 0.0 111.044 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.51 118.41 4.87 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.501 2.134 . . . . 0.0 112.226 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.572 ' O ' HD11 ' A' ' 63' ' ' ILE . 0.4 OUTLIER -158.52 137.68 11.51 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.716 -179.772 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.868 ' O ' HD12 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -78.27 146.06 35.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.468 179.303 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.575 ' O ' ' N ' ' A' ' 64' ' ' THR . 4.8 pt-20 -39.98 -52.79 2.44 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 121.376 0.608 . . . . 0.0 111.01 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.519 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -46.14 -53.91 9.56 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.164 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.461 ' HB2' ' HE2' ' A' ' 58' ' ' MET . 1.8 mm-40 -55.27 -61.53 2.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.956 0.407 . . . . 0.0 109.95 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.868 HD12 ' O ' ' A' ' 59' ' ' THR . 1.1 mp -60.0 -61.68 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.184 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.575 ' N ' ' O ' ' A' ' 60' ' ' GLU . 61.7 m -50.16 -50.85 47.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.196 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.519 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 4.8 tp10 -64.92 -16.29 63.11 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.708 0.766 . . . . 0.0 110.453 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.424 ' CD2' ' O ' ' A' ' 62' ' ' GLU . 1.7 m-85 -96.44 -25.68 15.6 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.515 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.762 ' CE2' HG22 ' A' ' 63' ' ' ILE . 1.4 m-85 -73.42 -31.07 63.64 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.614 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -84.56 -28.21 26.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.971 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -81.34 -11.17 59.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.487 0.661 . . . . 0.0 111.819 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.518 ' HB2' ' CE1' ' A' ' 83' ' ' PHE . . . -97.39 -27.58 14.41 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.086 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -121.54 118.99 29.48 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.765 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -62.86 -53.93 1.42 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.578 2.186 . . . . 0.0 112.65 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.627 ' OD1' HG23 ' A' ' 75' ' ' THR . 14.8 p30 -68.41 -32.82 73.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.963 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.7 m120 74.47 43.74 0.25 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.626 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.627 HG23 ' OD1' ' A' ' 73' ' ' ASN . 17.6 p -93.14 37.79 1.04 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.523 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 55.69 23.02 35.09 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.383 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -124.08 128.54 49.46 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.42 HD11 ' HA ' ' A' ' 67' ' ' PHE . 0.4 OUTLIER -112.23 152.61 14.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.224 0.535 . . . . 0.0 111.512 -179.22 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -98.88 97.57 8.74 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.159 178.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.403 ' CG ' ' O ' ' A' ' 41' ' ' GLY . 80.8 t80 -35.2 -35.91 0.05 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.028 -178.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.72 -51.95 50.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.511 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.75 -25.12 54.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.141 0.496 . . . . 0.0 110.413 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.518 ' CE1' ' HB2' ' A' ' 70' ' ' ALA . 0.1 OUTLIER -92.59 -29.59 16.07 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.928 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.4 ' O ' ' CD2' ' A' ' 88' ' ' TYR . . . -80.09 -25.92 39.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.157 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.76 -11.46 60.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.418 0.627 . . . . 0.0 111.814 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 14.0 tpp -82.72 -36.55 25.7 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.818 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.978 HD21 HD13 ' A' ' 28' ' ' LEU . 9.7 mt -85.8 -6.43 59.1 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.845 0.831 . . . . 0.0 111.505 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.4 ' CD2' ' O ' ' A' ' 84' ' ' ALA . 12.7 m-85 -126.07 22.14 7.34 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 114.101 -1.409 . . . . 0.0 111.001 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.8 t -83.17 75.33 9.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.874 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.579 ' O ' HG12 ' A' ' 90' ' ' VAL . 16.0 t -134.54 32.38 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.143 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -122.1 84.64 2.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.882 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.1 pm0 -60.31 136.45 58.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.877 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.849 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 ptp . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.722 0.296 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 59.86 39.43 95.45 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.553 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.8 m -141.28 35.84 1.7 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.832 0.348 . . . . 0.0 110.953 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.24 87.05 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.988 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 25.7 p80 -101.17 -31.66 10.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.922 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 60.53 -169.48 0.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.909 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -167.94 90.21 0.3 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.902 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -78.06 145.58 35.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.908 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 34.2 m80 -109.92 -66.0 1.1 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.872 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -176.3 80.06 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.886 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.4 t -80.89 83.31 6.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.001 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.8 m -85.03 -72.29 0.48 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.926 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 59.91 92.24 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.493 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.515 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.2 OUTLIER -105.89 -66.54 0.98 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.894 0.378 . . . . 0.0 110.928 179.998 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.515 HG13 ' O ' ' A' ' 14' ' ' LEU . 6.4 m -158.53 149.72 16.49 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.084 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.35 -61.59 0.48 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.532 2.155 . . . . 0.0 112.301 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.31 -74.57 0.24 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.833 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.468 ' HA2' HG23 ' A' ' 15' ' ' VAL . . . 150.6 -70.59 0.31 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.521 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -162.19 -54.88 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.824 0.345 . . . . 0.0 110.884 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -83.9 128.0 34.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.952 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 66.3 mtm -88.44 150.62 23.05 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.893 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.3 p -99.96 5.31 45.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.996 0.427 . . . . 0.0 111.576 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -96.5 -14.64 22.18 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.497 0.665 . . . . 0.0 111.517 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -65.25 -16.49 63.6 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.13 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.8 tttt -91.9 -26.75 18.31 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.671 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.676 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -68.36 -28.91 67.54 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.671 -179.881 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -59.45 -23.82 63.02 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 1.118 HD13 HD21 ' A' ' 87' ' ' LEU . 4.1 tt -88.17 -11.22 47.47 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.436 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.735 HD13 ' HE2' ' A' ' 32' ' ' PHE . 11.8 mm -66.57 -14.14 17.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 114.803 -1.089 . . . . 0.0 111.983 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -78.14 2.3 18.5 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 113.936 -1.484 . . . . 0.0 111.51 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.868 ' HB2' HD21 ' A' ' 56' ' ' LEU . . . -93.42 -32.67 14.14 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.989 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.735 ' HE2' HD13 ' A' ' 29' ' ' ILE . 93.3 m-85 -59.26 -29.56 67.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.951 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -97.52 36.28 1.52 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.95 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -165.96 32.26 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.979 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -177.07 40.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.889 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -132.99 56.55 1.84 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.95 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -96.03 27.58 16.02 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.626 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.6 t70 60.66 68.07 0.78 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.915 0.388 . . . . 0.0 110.974 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -122.71 -76.71 0.59 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.907 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -178.16 -177.84 0.62 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.929 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.404 ' O ' ' CG ' ' A' ' 80' ' ' TYR . . . -95.95 -37.97 4.77 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.417 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -61.85 123.73 18.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.796 0.332 . . . . 0.0 110.922 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.563 ' O ' HG13 ' A' ' 43' ' ' VAL . 7.8 p -144.92 110.83 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.92 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.414 ' HB3' ' CD2' ' A' ' 77' ' ' PHE . 1.2 m -65.83 160.69 22.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.041 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.729 HG22 HD11 ' A' ' 78' ' ' ILE . 72.5 t -57.89 -56.07 17.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.784 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -47.13 -41.49 17.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.989 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -78.91 -27.65 43.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.48 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.473 ' CE2' ' CD2' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -67.7 -29.47 68.73 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.96 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 34.1 mmm-85 -56.07 -56.43 20.89 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.053 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -54.9 -23.61 31.3 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.621 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 24.7 mt -84.5 -24.34 7.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.631 0.253 . . . . 0.0 111.238 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 39.9 mm -93.03 -36.19 7.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.243 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.97 -46.43 71.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.119 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -111.84 14.84 21.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.508 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -109.8 -88.87 1.95 Allowed Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.66 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.868 HD21 ' HB2' ' A' ' 31' ' ' ALA . 1.6 mp -100.38 136.82 19.91 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.587 0.232 . . . . 0.0 110.989 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -79.9 58.44 6.98 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.529 2.152 . . . . 0.0 112.493 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.647 ' O ' HD11 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -86.4 141.71 28.96 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.567 179.607 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.896 ' O ' HD12 ' A' ' 63' ' ' ILE . 0.3 OUTLIER -75.78 145.59 40.64 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.606 179.632 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.544 ' O ' ' N ' ' A' ' 64' ' ' THR . 4.8 pt-20 -39.29 -52.23 2.0 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.178 0.513 . . . . 0.0 111.02 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.52 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -46.65 -53.61 11.25 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.071 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.525 ' HB2' ' HE2' ' A' ' 58' ' ' MET . 1.7 mm-40 -55.16 -61.64 2.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.928 0.394 . . . . 0.0 110.039 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.896 HD12 ' O ' ' A' ' 59' ' ' THR . 1.4 mp -59.17 -61.48 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.177 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.544 ' N ' ' O ' ' A' ' 60' ' ' GLU . 68.2 m -51.35 -51.68 52.32 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.174 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.52 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 28.8 tp10 -65.8 -15.46 62.9 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.576 0.703 . . . . 0.0 110.346 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.437 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.4 m-30 -94.94 -25.93 16.33 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.387 179.16 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.754 ' CE2' HG22 ' A' ' 63' ' ' ILE . 2.6 m-30 -79.64 -28.79 40.85 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.765 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -86.64 -31.1 21.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.881 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -81.46 -11.17 59.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.486 0.66 . . . . 0.0 111.713 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.564 ' HB1' ' CG2' ' A' ' 78' ' ' ILE . . . -102.25 -27.41 12.88 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.028 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -123.33 107.82 32.12 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.675 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.48 -43.5 7.83 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.397 2.065 . . . . 0.0 112.339 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -68.45 -32.31 72.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.823 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 21.2 m-20 73.96 20.95 2.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.529 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.415 HG22 ' H ' ' A' ' 75' ' ' THR . 0.9 OUTLIER -63.64 -22.38 66.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.861 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 109.21 19.75 8.29 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.502 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.414 ' CD2' ' HB3' ' A' ' 44' ' ' SER . 4.1 m-85 -132.97 146.27 51.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.776 0.322 . . . . 0.0 110.825 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.729 HD11 HG22 ' A' ' 45' ' ' VAL . 1.0 OUTLIER -133.38 146.09 32.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.433 179.789 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.438 ' O ' ' N ' ' A' ' 82' ' ' ALA . 0.4 OUTLIER -77.08 108.18 9.98 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 177.202 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.426 ' C ' ' O ' ' A' ' 79' ' ' ASP . 28.0 t80 -28.77 -40.75 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.244 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.428 ' N ' ' O ' ' A' ' 79' ' ' ASP . 0.2 OUTLIER -64.66 -53.13 52.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.935 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -50.21 -28.08 6.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.058 0.456 . . . . 0.0 110.771 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.538 ' CD1' HG21 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -93.25 -35.5 13.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.041 -179.748 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.08 -22.61 55.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.313 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.68 -11.55 60.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.476 0.655 . . . . 0.0 111.849 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 9.5 mmt -72.96 -31.28 64.45 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.806 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 1.118 HD21 HD13 ' A' ' 28' ' ' LEU . 2.6 mt -100.18 -6.59 25.9 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.917 0.865 . . . . 0.0 111.58 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -126.05 22.34 7.32 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.127 -1.397 . . . . 0.0 111.173 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.49 95.01 7.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.857 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.57 ' O ' HG12 ' A' ' 90' ' ' VAL . 15.8 t -135.31 32.4 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.08 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -61.65 121.95 14.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.932 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -72.6 -68.83 0.45 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.899 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.0 t . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.179 -0.915 . . . . 0.0 110.94 -179.989 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mtt . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.799 0.333 . . . . 0.0 111.264 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -108.44 -110.74 3.42 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.515 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.0 p -96.22 43.21 1.08 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.958 0.409 . . . . 0.0 110.885 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.57 141.53 54.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.96 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -96.64 -172.2 2.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.861 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 22.6 m80 -127.48 116.76 20.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.923 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -176.53 -40.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.863 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -81.55 -171.18 3.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.908 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 8.1 m170 60.64 110.67 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.852 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -153.4 -67.92 0.15 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.965 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 27.1 t -176.56 164.5 2.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.888 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.1 m 60.31 170.1 0.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.818 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.668 ' C ' HD13 ' A' ' 14' ' ' LEU . . . 106.22 -117.89 5.55 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.515 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.679 HD13 ' N ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -158.31 42.7 0.28 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.807 0.337 . . . . 0.0 110.826 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.465 ' O ' HG23 ' A' ' 15' ' ' VAL . 7.3 m -114.05 88.3 14.45 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.148 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -52.05 -32.75 50.1 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.566 2.177 . . . . 0.0 112.313 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -99.51 123.69 44.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.897 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -102.86 -74.48 1.03 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.494 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.1 94.0 5.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.75 0.309 . . . . 0.0 111.01 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 42.3 p-80 -110.62 31.5 5.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.921 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 2.8 mpt? -111.19 155.13 23.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.886 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -100.36 5.28 44.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.382 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -91.66 -14.26 30.4 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.611 0.719 . . . . 0.0 111.621 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -65.67 -16.33 63.64 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.251 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -91.96 -30.56 16.03 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.687 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.683 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -57.9 -27.31 63.2 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.828 -179.807 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -62.86 -24.03 67.6 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.789 ' O ' HD13 ' A' ' 28' ' ' LEU . 2.9 tm? -88.08 -11.47 47.02 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.195 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.683 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 11.3 mm -64.98 -14.59 16.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.969 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -77.89 2.14 18.28 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 113.878 -1.51 . . . . 0.0 111.463 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.23 -31.23 14.82 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.064 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -59.54 -30.98 68.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.942 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -97.41 38.9 1.22 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.932 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -176.87 38.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.851 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -176.58 78.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.903 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -161.73 71.23 0.36 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.004 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -107.11 27.9 14.54 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.559 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 60.03 36.94 21.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.844 0.354 . . . . 0.0 110.952 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -73.38 -175.55 1.97 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.88 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.1 p-10 -98.59 33.81 2.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.93 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 60.34 43.94 98.07 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.53 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -150.4 123.9 9.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.813 0.34 . . . . 0.0 110.971 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.449 ' CG1' ' CE2' ' A' ' 48' ' ' PHE . 9.4 p -131.39 127.67 60.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.976 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.1 p -78.99 162.08 26.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.906 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.668 HG22 HG13 ' A' ' 78' ' ' ILE . 46.5 t -64.17 -54.16 34.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.001 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -47.22 -29.75 2.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.084 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -93.32 -30.05 15.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.655 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.855 ' CD2' HD12 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -66.02 -38.31 88.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.95 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.6 mtp85 -54.72 -51.48 65.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.0 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -57.2 -21.49 39.73 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.606 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.9 mt -93.17 -25.43 4.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.744 0.307 . . . . 0.0 111.255 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.467 HG21 HG12 ' A' ' 63' ' ' ILE . 40.6 mm -93.37 -49.39 12.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.301 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 24.7 ttp180 -46.86 -68.86 0.16 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.7 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -92.44 14.93 15.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.745 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -121.31 -89.88 1.07 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.373 -0.918 . . . . 0.0 112.914 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -80.23 132.9 58.18 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.554 0.216 . . . . 0.0 111.192 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.65 113.82 3.82 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.466 2.111 . . . . 0.0 112.256 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.659 ' O ' HD11 ' A' ' 63' ' ' ILE . 0.7 OUTLIER -155.63 137.69 14.6 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.892 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.894 ' O ' HD12 ' A' ' 63' ' ' ILE . 0.6 OUTLIER -74.31 145.1 44.2 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.855 179.733 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.515 ' O ' ' N ' ' A' ' 64' ' ' THR . 2.3 pt-20 -37.85 -48.65 1.14 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.169 0.509 . . . . 0.0 111.054 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.426 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -49.55 -55.74 12.38 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.835 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.489 ' HB2' ' HE2' ' A' ' 58' ' ' MET . 0.6 OUTLIER -52.18 -62.6 1.53 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.286 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.894 HD12 ' O ' ' A' ' 59' ' ' THR . 1.8 mp -57.35 -62.84 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.123 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.515 ' N ' ' O ' ' A' ' 60' ' ' GLU . 99.3 m -50.12 -53.09 29.85 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.405 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.426 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 2.7 mm-40 -65.31 -15.8 62.91 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-O 121.617 0.722 . . . . 0.0 110.485 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.432 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.7 m-30 -94.61 -26.57 16.31 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.423 179.048 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.708 ' CE2' HG22 ' A' ' 63' ' ' ILE . 4.8 m-30 -77.97 -26.58 48.8 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.801 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -91.32 -28.93 17.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.805 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.07 -11.23 47.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.535 0.683 . . . . 0.0 111.782 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -92.09 -28.53 17.07 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.113 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -126.16 119.36 23.62 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.785 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.84 -40.67 16.15 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.272 1.982 . . . . 0.0 112.279 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -76.53 -30.94 57.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.817 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.2 m120 72.35 38.83 0.8 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.171 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.508 HG23 ' HB3' ' A' ' 77' ' ' PHE . 1.5 t -89.64 41.77 1.06 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.634 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.401 ' C ' HG23 ' A' ' 45' ' ' VAL . . . 47.94 26.94 4.64 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.523 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.508 ' HB3' HG23 ' A' ' 75' ' ' THR . 0.6 OUTLIER -128.12 129.38 46.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.819 0.342 . . . . 0.0 110.449 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.855 HD12 ' CD2' ' A' ' 48' ' ' PHE . 61.9 mt -102.49 153.34 5.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.19 0.519 . . . . 0.0 111.662 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.445 ' N ' HG22 ' A' ' 78' ' ' ILE . 1.2 t0 -98.78 95.76 7.43 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 176.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.426 ' C ' ' O ' ' A' ' 79' ' ' ASP . 56.4 t80 -29.06 -41.25 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.337 -177.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -66.0 -55.85 14.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.672 0.272 . . . . 0.0 110.618 179.818 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.415 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -52.65 -27.08 15.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.965 0.412 . . . . 0.0 110.594 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.621 ' CE1' HD13 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -90.37 -32.3 16.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.86 179.823 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.12 -28.76 48.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.165 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.82 -11.5 60.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.375 0.607 . . . . 0.0 111.708 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 14.1 tmm? -69.59 -35.12 75.04 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.913 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.54 HD21 ' HG ' ' A' ' 28' ' ' LEU . 3.0 mp -100.67 -5.97 25.8 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.816 0.817 . . . . 0.0 111.63 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -125.48 22.41 7.68 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 114.193 -1.367 . . . . 0.0 111.09 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -65.54 79.55 0.06 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.871 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.547 ' O ' HG12 ' A' ' 90' ' ' VAL . 15.0 t -143.19 35.77 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.026 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -123.6 175.93 6.52 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.92 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 68.4 -69.29 0.15 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.009 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.873 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 ttp . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.852 0.358 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -158.65 95.89 0.15 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.492 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.7 m -84.77 -66.71 0.86 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.723 0.297 . . . . 0.0 110.862 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 t 60.42 84.56 0.12 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.899 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 15.4 m170 -125.81 35.82 4.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.902 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 64.6 m-70 -127.79 -169.87 2.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.862 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 6.0 m170 61.85 114.98 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.87 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 18.7 m170 60.56 84.12 0.13 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.893 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -88.51 177.46 6.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.98 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 13.8 p80 -107.51 -45.79 3.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.931 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.3 t 60.67 168.16 0.09 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.887 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.9 p -103.97 105.82 16.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.88 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -176.95 -38.3 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.448 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.7 tp -82.39 -31.53 29.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.778 0.323 . . . . 0.0 110.907 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.5 m -119.45 150.49 49.84 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.153 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.43 -172.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.53 2.153 . . . . 0.0 112.279 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 11.1 mmt85 61.28 155.32 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.885 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 146.87 88.24 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.519 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -117.07 -178.44 3.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.879 0.371 . . . . 0.0 110.848 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -163.29 174.03 12.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.896 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.7 mtt -67.13 149.66 50.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.887 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 36.6 p -101.58 5.31 41.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.54 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.79 -14.65 44.49 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.579 0.704 . . . . 0.0 111.574 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -65.31 -16.54 63.68 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.129 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.9 tttt -91.91 -27.24 18.03 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.644 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.668 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -68.08 -28.16 67.12 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.854 -179.892 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -60.3 -24.28 64.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.223 0.535 . . . . 0.0 109.562 178.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.925 HD13 HD21 ' A' ' 87' ' ' LEU . 5.6 tt -88.33 -11.22 46.98 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.476 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.668 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 13.5 mm -63.61 -15.45 16.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.964 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -80.56 1.95 27.52 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 113.854 -1.521 . . . . 0.0 111.345 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.491 ' HB2' HD21 ' A' ' 56' ' ' LEU . . . -93.45 -29.87 15.34 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.043 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -56.56 -28.16 59.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.053 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -97.65 28.3 3.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.084 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -178.33 37.46 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.869 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.403 ' CG ' ' O ' ' A' ' 35' ' ' PHE . 19.8 t80 -177.14 37.76 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.957 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.1 p-10 -145.04 45.62 1.34 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.862 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -82.62 -80.27 0.97 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.484 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -177.63 78.27 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.839 0.352 . . . . 0.0 110.965 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -146.14 34.64 0.99 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.995 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 60.69 -175.25 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.95 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.403 ' O ' ' CD1' ' A' ' 80' ' ' TYR . . . -100.36 -37.1 3.89 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.588 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -60.07 123.8 18.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.886 0.374 . . . . 0.0 110.88 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.457 HG11 ' CE2' ' A' ' 48' ' ' PHE . 7.6 p -139.53 127.33 25.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.898 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.1 p -67.42 154.17 41.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.159 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.992 HG13 ' CD1' ' A' ' 67' ' ' PHE . 50.6 t -61.9 -27.8 43.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.928 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -71.91 -58.62 3.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.921 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -58.07 -29.07 65.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.802 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.835 ' CD2' HD12 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -61.85 -36.88 82.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.904 179.816 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 16.2 mtt-85 -58.08 -50.74 72.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.951 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -57.28 -26.48 56.39 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.548 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.641 HD12 ' HA ' ' A' ' 48' ' ' PHE . 22.9 mt -80.87 -39.61 18.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.81 0.338 . . . . 0.0 111.087 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 37.9 mm -75.65 -28.77 19.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.248 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.6 mtp85 -51.23 -55.13 19.7 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.094 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -111.86 14.93 21.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.276 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -100.24 -86.84 1.93 Allowed Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.533 -0.841 . . . . 0.0 112.74 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.491 HD21 ' HB2' ' A' ' 31' ' ' ALA . 3.5 mt -105.47 140.05 20.77 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 120.694 0.283 . . . . 0.0 110.981 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -81.35 55.76 5.73 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.524 2.149 . . . . 0.0 112.398 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.606 ' O ' HD11 ' A' ' 63' ' ' ILE . 2.7 ttp -88.2 139.22 30.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.696 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.884 ' O ' HD12 ' A' ' 63' ' ' ILE . 1.7 p -69.18 140.19 54.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.03 0.443 . . . . 0.0 111.067 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.509 ' O ' ' N ' ' A' ' 64' ' ' THR . 0.1 OUTLIER -39.95 -50.36 2.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.156 179.824 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.526 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -45.92 -52.97 10.68 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.489 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.482 ' O ' ' HB2' ' A' ' 66' ' ' PHE . 0.9 OUTLIER -58.2 -60.94 2.97 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.04 179.683 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.884 HD12 ' O ' ' A' ' 59' ' ' THR . 1.7 mp -57.2 -60.21 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.914 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.509 ' N ' ' O ' ' A' ' 60' ' ' GLU . 36.1 m -52.32 -51.24 59.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.786 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.526 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 27.2 tt0 -65.99 -16.14 63.63 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-O 121.603 0.716 . . . . 0.0 110.344 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.482 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 2.3 m-85 -95.77 -25.95 15.86 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.277 178.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.992 ' CD1' HG13 ' A' ' 45' ' ' VAL . 1.6 m-85 -70.74 -41.37 71.92 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.564 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -84.1 -29.14 27.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.919 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -80.5 -11.14 59.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.481 0.658 . . . . 0.0 111.76 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.39 -31.65 15.96 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.018 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -115.86 121.18 34.49 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.778 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.77 -34.95 59.78 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.453 2.102 . . . . 0.0 112.245 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 14.3 m-80 -84.5 -31.63 24.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.792 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 72.43 37.08 0.95 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.166 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.8 t -88.93 41.84 1.05 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.743 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.427 ' C ' HG23 ' A' ' 45' ' ' VAL . . . 50.82 25.62 9.7 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 121.104 -0.57 . . . . 0.0 112.727 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.51 ' N ' HG23 ' A' ' 45' ' ' VAL . 23.4 m-85 -128.32 129.46 46.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.844 0.354 . . . . 0.0 110.662 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.835 HD12 ' CD2' ' A' ' 48' ' ' PHE . 59.8 mt -101.44 152.37 5.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.266 0.555 . . . . 0.0 111.627 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.448 ' N ' HG22 ' A' ' 78' ' ' ILE . 20.3 t0 -101.07 96.02 6.95 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 176.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.426 ' C ' ' O ' ' A' ' 79' ' ' ASP . 40.2 t80 -28.58 -41.31 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.436 -177.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 79' ' ' ASP . 0.4 OUTLIER -65.28 -55.41 18.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.689 0.28 . . . . 0.0 110.627 179.767 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -53.43 -27.58 25.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.16 0.505 . . . . 0.0 110.497 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.636 ' CE1' HD13 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -89.43 -31.7 17.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.734 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.6 -31.12 46.97 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.108 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -74.57 -11.34 60.18 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.503 0.668 . . . . 0.0 111.823 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 4.4 mmt -74.66 -32.11 62.15 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.808 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.925 HD21 HD13 ' A' ' 28' ' ' LEU . 2.7 mt -97.19 -6.93 33.63 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.921 0.867 . . . . 0.0 111.579 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -126.03 22.32 7.34 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.076 -1.42 . . . . 0.0 111.112 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 60.5 p -68.44 94.93 0.58 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.914 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.7 m -130.42 31.16 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.159 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -147.23 116.98 7.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.001 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -139.02 169.36 17.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.931 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.2 p . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.943 179.99 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ttm . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.759 0.314 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -136.67 51.95 0.79 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.576 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.0 p -100.53 -35.63 9.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.795 0.331 . . . . 0.0 110.831 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.1 m -60.69 129.93 43.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.918 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -95.06 87.09 4.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.979 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -66.07 154.55 39.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.828 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 14.1 p80 -131.69 80.19 1.91 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.904 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 -134.45 31.61 3.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.925 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -154.28 -171.04 3.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.854 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -60.17 -54.71 42.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.875 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 60.2 p -176.22 -74.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.92 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.8 m -175.24 -57.91 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.971 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 103.68 100.2 2.58 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.504 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.0 -45.42 61.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.836 0.351 . . . . 0.0 110.9 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.7 t 62.84 88.18 0.12 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.095 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -56.29 -165.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.667 2.244 . . . . 0.0 112.25 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.4 mtp-105 69.09 -66.88 0.23 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.035 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -59.28 130.42 50.54 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.496 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 46.9 t -85.34 158.6 20.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.86 0.362 . . . . 0.0 110.856 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 57.2 m-70 -108.72 -41.89 4.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.965 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.3 ptp -60.24 102.56 0.18 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.92 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.4 t -101.71 5.36 41.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.067 0.46 . . . . 0.0 111.583 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.38 -14.75 62.27 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.496 0.665 . . . . 0.0 111.572 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -65.73 -16.1 63.46 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.216 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.407 ' NZ ' ' CE1' ' A' ' 88' ' ' TYR . 0.2 OUTLIER -91.69 -25.68 18.99 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 114.704 -1.134 . . . . 0.0 110.685 179.421 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.667 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -66.56 -29.11 69.11 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.814 -179.937 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -60.13 -24.26 64.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.093 0.473 . . . . 0.0 109.725 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.796 HD22 HD13 ' A' ' 87' ' ' LEU . 1.3 tt -88.15 -11.22 47.52 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.461 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.667 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 10.8 mm -65.26 -14.3 16.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.924 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -77.04 2.04 16.17 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 114.035 -1.439 . . . . 0.0 111.585 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.915 ' HB2' HD21 ' A' ' 56' ' ' LEU . . . -93.46 -30.78 14.87 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.102 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -57.41 -24.34 54.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.167 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -97.05 30.41 2.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.012 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -173.29 35.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.875 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -176.98 78.26 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.868 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -104.14 41.45 1.3 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.859 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.02 -83.32 1.29 Allowed Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.566 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 43.89 31.33 0.48 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.809 0.338 . . . . 0.0 111.523 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.481 ' N ' ' CD1' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -51.3 -100.43 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.35 -179.723 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -62.5 -28.14 69.63 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.774 0.321 . . . . 0.0 111.001 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.58 25.58 6.53 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.436 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -143.79 123.79 13.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.781 0.324 . . . . 0.0 110.92 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.534 HG11 ' CE2' ' A' ' 48' ' ' PHE . 9.2 p -116.58 122.74 70.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.017 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.423 ' HB3' ' CE2' ' A' ' 77' ' ' PHE . 0.1 OUTLIER -74.73 154.29 38.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.825 179.931 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.563 HG22 HG13 ' A' ' 78' ' ' ILE . 57.4 t -58.87 -53.2 50.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.859 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -48.93 -33.05 10.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.937 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -86.36 -28.93 23.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.482 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.751 ' HD2' HD12 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -69.25 -41.99 76.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.859 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.445 ' HD2' HG12 ' A' ' 45' ' ' VAL . 13.7 mtp180 -56.27 -52.35 64.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.954 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -53.91 -25.1 29.43 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.326 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.447 HD12 ' HA ' ' A' ' 48' ' ' PHE . 14.1 mt -89.83 -47.05 15.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.854 0.359 . . . . 0.0 110.923 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.45 HG21 HG12 ' A' ' 63' ' ' ILE . 36.4 mm -66.06 -28.01 42.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.223 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.7 -61.53 2.15 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.904 0.383 . . . . 0.0 111.066 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -111.86 15.04 20.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.26 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -97.48 -86.05 1.81 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.591 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.915 HD21 ' HB2' ' A' ' 31' ' ' ALA . 14.1 mt -101.27 142.44 24.63 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.693 0.283 . . . . 0.0 111.065 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.32 113.49 3.69 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.533 2.155 . . . . 0.0 112.321 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.591 ' O ' HD11 ' A' ' 63' ' ' ILE . 0.8 OUTLIER -152.26 138.11 18.03 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.806 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.901 ' O ' HD12 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -77.65 147.67 35.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.683 179.698 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.519 ' O ' ' N ' ' A' ' 64' ' ' THR . 4.6 pt-20 -38.76 -51.86 1.7 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.162 0.505 . . . . 0.0 110.822 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.516 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -46.77 -53.64 11.46 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.118 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.491 ' HB2' ' HE2' ' A' ' 58' ' ' MET . 0.9 OUTLIER -54.91 -61.78 2.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.961 0.41 . . . . 0.0 110.02 179.478 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.901 HD12 ' O ' ' A' ' 59' ' ' THR . 1.6 mp -58.7 -61.54 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.205 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.519 ' N ' ' O ' ' A' ' 60' ' ' GLU . 62.7 m -52.02 -51.49 57.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.37 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.516 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 6.6 tt0 -65.64 -15.53 62.86 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.735 0.779 . . . . 0.0 110.497 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.431 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.6 m-30 -95.97 -25.47 15.94 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 114.449 -1.251 . . . . 0.0 110.321 179.219 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.718 ' CE2' HG22 ' A' ' 63' ' ' ILE . 4.0 m-30 -79.06 -26.57 43.07 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.748 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -91.37 -27.5 18.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.905 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.63 -11.18 43.31 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.487 0.66 . . . . 0.0 111.777 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.65 -28.39 18.41 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.016 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.53 119.25 23.02 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.829 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.31 -34.9 42.87 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.373 2.049 . . . . 0.0 112.204 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 26.2 m-20 -82.35 -31.32 29.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.9 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 72.21 38.43 0.87 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.176 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.534 HG23 ' HB2' ' A' ' 77' ' ' PHE . 1.5 t -89.39 42.26 1.08 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.578 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 50.75 25.29 9.06 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.663 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.534 ' HB2' HG23 ' A' ' 75' ' ' THR . 1.9 m-85 -123.08 146.74 47.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.783 0.325 . . . . 0.0 110.783 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.751 HD12 ' HD2' ' A' ' 48' ' ' PHE . 59.4 mt -123.02 153.12 28.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.096 0.474 . . . . 0.0 111.578 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.447 ' N ' HG22 ' A' ' 78' ' ' ILE . 0.5 OUTLIER -98.3 95.78 7.6 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 176.958 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.43 ' C ' ' O ' ' A' ' 79' ' ' ASP . 42.6 t80 -29.34 -41.23 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.036 -0.529 . . . . 0.0 112.293 -178.057 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.406 ' N ' ' O ' ' A' ' 79' ' ' ASP . 0.1 OUTLIER -65.81 -56.04 14.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.643 179.638 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.412 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -52.45 -27.17 15.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.944 0.402 . . . . 0.0 110.462 179.262 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.607 ' CE1' HD13 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -90.76 -30.81 16.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.803 179.929 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.31 -24.64 37.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.433 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.47 -11.53 60.71 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.452 0.644 . . . . 0.0 111.895 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 23.6 mtp -79.29 -30.79 43.08 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.843 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.796 HD13 HD22 ' A' ' 28' ' ' LEU . 5.1 mt -100.66 -6.18 25.52 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.735 0.778 . . . . 0.0 111.534 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.407 ' CE1' ' NZ ' ' A' ' 25' ' ' LYS . 32.6 m-85 -125.83 22.37 7.46 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 114.241 -1.345 . . . . 0.0 111.186 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.401 ' O ' ' CG2' ' A' ' 90' ' ' VAL . 6.7 t -63.94 82.3 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.874 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.401 ' CG2' ' O ' ' A' ' 89' ' ' SER . 35.4 m 42.84 32.66 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.748 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -73.19 174.02 8.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.862 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -105.73 -33.24 8.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.92 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.2 t . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.909 179.999 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 ptp . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.77 0.319 . . . . 0.0 111.141 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -123.72 50.85 0.83 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.541 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -162.02 127.59 3.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.894 0.378 . . . . 0.0 110.837 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.55 31.78 4.74 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.922 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 30.9 m80 68.5 -68.13 0.18 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.971 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -159.62 -51.06 0.06 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.858 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 5.4 t60 60.54 35.61 20.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.939 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -83.8 154.49 23.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.92 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 4.7 t60 60.75 110.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.853 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -72.09 -62.64 1.36 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.901 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -176.23 -40.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.909 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.0 t 60.69 -169.81 0.16 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.929 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -133.7 -59.76 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.475 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.3 tp -60.49 147.71 40.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.837 0.351 . . . . 0.0 110.857 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.5 p -59.86 139.34 90.35 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.001 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -52.15 -60.52 0.73 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.429 2.086 . . . . 0.0 112.368 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.4 mtt85 -130.4 -179.27 5.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.959 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.47 88.52 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.416 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.1 p -60.73 141.34 57.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.839 0.352 . . . . 0.0 110.856 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 20.3 p80 -101.88 32.05 3.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.854 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -136.58 92.53 2.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.848 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 84.4 p -89.62 5.35 46.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.454 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -71.32 -14.58 62.25 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.54 0.686 . . . . 0.0 111.532 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -64.97 -16.67 63.64 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.084 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.441 ' CG ' HD23 ' A' ' 87' ' ' LEU . 0.3 OUTLIER -91.91 -27.29 18.0 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.702 179.352 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.651 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -68.5 -27.39 66.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.885 179.972 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -59.34 -23.72 62.75 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.707 HD13 HD21 ' A' ' 87' ' ' LEU . 7.0 tt -88.16 -11.41 46.93 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.449 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.651 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 12.9 mm -66.4 -14.38 17.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.908 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -78.36 2.12 19.67 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 113.895 -1.502 . . . . 0.0 111.661 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.656 ' HB2' HD11 ' A' ' 56' ' ' LEU . . . -93.11 -31.91 14.64 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.085 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -60.67 -29.31 69.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.964 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -96.91 38.19 1.25 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.93 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -161.39 30.26 0.13 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.926 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -176.68 37.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.827 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -110.87 37.8 2.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.909 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -96.07 35.95 4.09 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.442 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.4 t70 61.51 68.77 0.69 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.919 0.39 . . . . 0.0 110.915 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -134.9 150.36 50.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.883 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -61.72 159.09 14.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.924 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.419 ' HA3' ' CD2' ' A' ' 80' ' ' TYR . . . -69.39 -30.67 71.25 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.475 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -64.04 123.76 19.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.848 0.356 . . . . 0.0 110.879 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.473 HG11 ' CE2' ' A' ' 48' ' ' PHE . 7.1 p -141.42 137.33 32.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.949 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.451 ' HB3' ' CE2' ' A' ' 77' ' ' PHE . 13.1 p -84.99 150.13 25.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.047 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.472 HG13 ' CZ ' ' A' ' 67' ' ' PHE . 91.7 t -54.92 -55.52 15.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.082 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -46.74 -30.12 2.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.079 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -91.65 -28.68 17.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.45 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.576 ' CD2' HD12 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -67.42 -38.21 84.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.9 179.885 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 29.4 mtm180 -57.06 -50.43 72.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.907 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -56.15 -25.75 47.89 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.381 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.571 HD12 ' HA ' ' A' ' 48' ' ' PHE . 20.6 mt -85.22 -43.5 16.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.721 0.296 . . . . 0.0 110.932 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.464 HG21 HG12 ' A' ' 63' ' ' ILE . 31.0 mm -69.89 -36.21 68.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.096 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.6 ttm180 -54.36 -47.43 72.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.08 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -111.81 14.94 21.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.335 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -109.17 -88.66 1.96 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.639 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.656 HD11 ' HB2' ' A' ' 31' ' ' ALA . 3.9 mp -102.06 142.07 23.83 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.7 0.286 . . . . 0.0 111.106 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.05 111.41 3.27 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.498 2.132 . . . . 0.0 112.26 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.637 ' O ' HD11 ' A' ' 63' ' ' ILE . 0.6 OUTLIER -148.08 138.03 22.57 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.805 -179.867 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.889 ' O ' HD12 ' A' ' 63' ' ' ILE . 0.6 OUTLIER -75.32 144.82 42.21 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.719 179.529 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.548 ' O ' ' N ' ' A' ' 64' ' ' THR . 1.3 pm0 -37.85 -49.01 1.17 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.278 0.561 . . . . 0.0 111.156 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.421 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -49.37 -55.98 11.13 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.83 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.44 ' O ' ' HB2' ' A' ' 66' ' ' PHE . 0.7 OUTLIER -52.24 -62.22 1.77 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.886 0.374 . . . . 0.0 110.003 179.266 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.889 HD12 ' O ' ' A' ' 59' ' ' THR . 1.4 mp -58.51 -62.88 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.125 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.548 ' N ' ' O ' ' A' ' 60' ' ' GLU . 98.6 m -49.37 -53.03 24.51 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.421 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.421 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 4.9 mm-40 -65.48 -15.72 62.94 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 121.566 0.698 . . . . 0.0 110.554 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.44 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.6 m-30 -95.71 -23.99 16.73 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.56 179.166 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.764 ' CE2' HG22 ' A' ' 63' ' ' ILE . 1.9 m-30 -76.7 -31.68 57.37 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.746 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -85.73 -29.95 23.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.856 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.71 -11.1 60.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.433 0.635 . . . . 0.0 111.733 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.417 ' HB2' ' CE1' ' A' ' 83' ' ' PHE . . . -99.67 -30.26 12.2 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.061 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -121.8 116.91 30.11 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.748 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -64.85 -50.4 2.31 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.381 2.054 . . . . 0.0 112.315 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.582 ' CG ' HG23 ' A' ' 75' ' ' THR . 9.6 p30 -68.63 -32.73 72.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.813 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.3 m120 75.44 53.83 0.07 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.72 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.582 HG23 ' CG ' ' A' ' 73' ' ' ASN . 12.6 p -98.16 28.83 3.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.703 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 59.2 26.5 61.47 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.319 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.451 ' CE2' ' HB3' ' A' ' 44' ' ' SER . 4.1 m-85 -129.06 131.69 47.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.768 0.318 . . . . 0.0 110.74 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.654 HD13 ' CE1' ' A' ' 83' ' ' PHE . 61.2 mt -106.17 152.46 7.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.23 0.538 . . . . 0.0 111.635 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.442 ' N ' HG22 ' A' ' 78' ' ' ILE . 1.1 m-20 -101.23 96.2 7.04 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 176.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.43 ' C ' ' O ' ' A' ' 79' ' ' ASP . 40.5 t80 -28.78 -41.14 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.035 -0.529 . . . . 0.0 112.331 -177.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 79' ' ' ASP . 5.0 mtpp -66.06 -55.16 17.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.692 0.282 . . . . 0.0 110.51 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -53.2 -28.06 24.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.003 0.43 . . . . 0.0 110.411 179.128 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.654 ' CE1' HD13 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -88.97 -32.47 17.63 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.846 179.88 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.71 -29.6 45.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.228 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.44 ' O ' ' HB2' ' A' ' 89' ' ' SER . . . -74.32 -11.53 60.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.369 0.605 . . . . 0.0 111.619 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 2.2 mtt -68.9 -47.68 65.23 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.461 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.707 HD21 HD13 ' A' ' 28' ' ' LEU . 4.5 mp -82.81 -6.92 59.65 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.845 0.831 . . . . 0.0 111.107 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -119.69 21.77 11.89 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 113.982 -1.463 . . . . 0.0 111.25 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.44 ' HB2' ' O ' ' A' ' 85' ' ' ALA . 9.3 t -95.54 23.5 6.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.935 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.593 ' O ' HG12 ' A' ' 90' ' ' VAL . 14.8 t 53.35 29.33 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.257 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.47 163.82 21.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.995 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -157.42 -46.15 0.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.825 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.347 -0.835 . . . . 0.0 110.852 -179.973 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.485 1.305 0 CA-C-O 120.839 0.352 . . . . 0.0 111.262 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -59.76 -72.53 0.6 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.468 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.7 m -84.39 143.41 29.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.863 0.363 . . . . 0.0 110.892 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.3 t -131.56 35.39 3.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.837 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -102.63 -38.94 7.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.955 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 4.5 p-80 -106.58 176.24 5.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.97 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -106.42 -175.16 2.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.891 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -98.74 34.7 2.0 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.886 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -134.67 170.97 15.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.919 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -71.82 174.21 7.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.915 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 26.2 m -145.35 95.25 2.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.903 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m -106.49 133.2 51.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.896 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.48 157.82 33.38 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.476 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.6 mp -131.92 -171.3 2.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.764 0.316 . . . . 0.0 110.89 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.49 ' N ' ' CD ' ' A' ' 16' ' ' PRO . 6.6 t -79.94 -45.74 1.48 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.386 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.49 ' CD ' ' N ' ' A' ' 15' ' ' VAL . 70.7 Cg_exo -50.82 179.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.34 2.026 . . . . 0.0 112.348 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 60.68 96.45 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.876 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -70.44 -120.51 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.491 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.2 t -141.05 95.19 2.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.679 0.276 . . . . 0.0 110.831 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.4 -177.85 0.08 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.903 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.7 -176.23 5.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.887 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.8 m -93.45 5.43 51.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.512 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -72.01 -14.62 61.94 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.506 0.669 . . . . 0.0 111.509 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -65.35 -16.39 63.55 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.182 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.86 -27.34 18.0 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.657 179.418 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.681 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -67.1 -28.44 68.17 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.77 -179.936 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -58.95 -23.94 62.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.175 0.512 . . . . 0.0 109.751 178.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.741 HD13 HD21 ' A' ' 87' ' ' LEU . 3.2 tt -88.09 -11.37 47.26 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.488 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.681 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 11.6 mm -67.21 -13.73 17.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 114.71 -1.132 . . . . 0.0 111.98 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -77.89 2.29 17.83 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 113.894 -1.503 . . . . 0.0 111.499 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.826 ' HB2' HD11 ' A' ' 56' ' ' LEU . . . -93.22 -43.21 8.94 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.102 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -59.82 -28.62 67.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.974 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -96.12 39.79 1.14 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.994 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -161.55 30.01 0.13 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.018 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -177.2 76.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.908 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -120.32 48.14 1.64 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.951 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -96.23 27.6 16.29 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.595 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 60.98 68.29 0.75 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.863 0.363 . . . . 0.0 110.826 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -105.01 147.1 28.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.94 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -67.34 -173.46 0.29 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.919 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -93.53 42.15 2.6 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.586 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -154.58 123.82 6.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.858 0.361 . . . . 0.0 110.854 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.1 p -128.85 139.0 53.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.068 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.428 ' HB3' ' CZ ' ' A' ' 77' ' ' PHE . 79.2 p -88.36 151.58 22.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.788 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.61 HG22 HG13 ' A' ' 78' ' ' ILE . 53.7 t -58.18 -50.75 77.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.826 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -51.27 -29.18 13.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.988 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -91.45 -32.32 15.66 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.601 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.748 ' HA ' HD12 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -61.13 -42.31 98.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.024 179.984 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 72.1 mtt180 -56.87 -48.27 78.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.917 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -59.58 -27.42 63.66 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.383 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.748 HD12 ' HA ' ' A' ' 48' ' ' PHE . 5.5 mt -86.27 -50.06 14.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.872 0.367 . . . . 0.0 110.916 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.0 tp -57.87 -40.32 75.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.431 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.6 ttm180 -48.39 -68.01 0.22 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.063 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -93.36 14.79 17.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.065 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -109.51 -59.76 0.52 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.614 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.826 HD11 ' HB2' ' A' ' 31' ' ' ALA . 5.4 mp -129.09 139.51 35.9 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.655 0.264 . . . . 0.0 111.143 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -79.6 58.3 6.9 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.598 2.199 . . . . 0.0 112.056 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.555 ' HB3' HD11 ' A' ' 63' ' ' ILE . 1.3 ttt -87.08 138.66 31.31 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.952 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.9 ' O ' HD12 ' A' ' 63' ' ' ILE . 1.3 p -78.27 140.59 38.86 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.883 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.511 ' O ' ' N ' ' A' ' 64' ' ' THR . 0.1 OUTLIER -37.05 -49.1 0.83 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.093 -180.0 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.525 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -48.49 -55.52 10.76 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.314 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.507 ' HB2' ' HG2' ' A' ' 58' ' ' MET . 0.7 OUTLIER -56.16 -60.28 3.72 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.287 179.833 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.9 HD12 ' O ' ' A' ' 59' ' ' THR . 2.3 mp -58.07 -61.12 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.163 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.511 ' N ' ' O ' ' A' ' 60' ' ' GLU . 71.8 m -52.8 -51.53 60.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.122 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.525 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 44.6 tt0 -64.93 -15.76 62.5 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.63 0.729 . . . . 0.0 110.516 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.435 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.7 m-30 -96.38 -27.87 14.73 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 114.594 -1.184 . . . . 0.0 110.434 179.127 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.672 ' CE2' HG22 ' A' ' 63' ' ' ILE . 3.9 m-30 -73.25 -30.1 63.22 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.651 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.75 -26.85 20.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.874 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.28 -11.2 47.19 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.482 0.658 . . . . 0.0 111.725 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.8 -29.95 13.46 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.994 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -116.74 121.38 33.0 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.787 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.08 -49.39 2.07 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.388 2.059 . . . . 0.0 112.361 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -80.5 -28.42 37.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.911 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.1 m120 75.82 51.92 0.06 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.616 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 12.6 p -96.52 31.1 2.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.87 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 59.55 29.31 66.47 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.413 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.428 ' CZ ' ' HB3' ' A' ' 44' ' ' SER . 0.2 OUTLIER -132.08 129.34 39.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.833 0.349 . . . . 0.0 110.664 179.901 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.659 HD12 ' CD2' ' A' ' 48' ' ' PHE . 63.7 mt -104.51 152.83 6.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.235 0.541 . . . . 0.0 111.593 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.431 ' N ' HG22 ' A' ' 78' ' ' ILE . 1.8 m-20 -97.76 95.6 7.66 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 176.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.43 ' C ' ' O ' ' A' ' 79' ' ' ASP . 40.4 t80 -28.96 -41.55 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.209 -178.024 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 79' ' ' ASP . 0.3 OUTLIER -66.01 -56.21 12.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.625 179.706 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -52.11 -27.6 14.74 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.998 0.428 . . . . 0.0 110.602 179.297 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.609 ' CE1' HD13 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -89.84 -32.16 17.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.866 179.85 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.6 -27.88 45.67 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.258 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.68 -11.41 60.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.482 0.658 . . . . 0.0 111.814 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 1.8 mtp -77.98 -36.86 48.5 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.736 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.741 HD21 HD13 ' A' ' 28' ' ' LEU . 4.2 mt -86.76 -6.71 58.74 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.862 0.839 . . . . 0.0 111.501 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -126.03 22.08 7.38 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 114.139 -1.391 . . . . 0.0 111.088 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.3 m -73.81 83.38 1.65 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.839 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 31.2 m -135.1 31.33 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.138 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -165.53 155.99 13.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.902 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -84.46 -61.51 1.78 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.929 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.28 -0.866 . . . . 0.0 110.891 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.3 tpt . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.751 0.31 . . . . 0.0 111.206 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -103.42 111.58 3.97 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.519 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.5 m -79.0 97.38 6.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.842 0.353 . . . . 0.0 110.845 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.5 t 60.39 167.46 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.854 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 21.9 p80 -62.14 118.53 7.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.958 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -155.64 -64.58 0.12 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.948 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 19.4 t-80 -169.1 150.15 4.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.923 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -76.89 150.03 36.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.856 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 77.5 m-70 60.43 -171.88 0.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.91 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.61 152.7 44.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.906 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.5 t -106.48 -71.2 0.76 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.932 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.4 p 49.97 35.61 10.05 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.17 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -97.68 88.43 0.93 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.503 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -163.61 35.03 0.09 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.854 0.359 . . . . 0.0 110.939 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.2 m -60.97 158.38 34.55 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.134 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -52.37 -51.26 11.53 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.614 2.21 . . . . 0.0 112.284 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -137.92 -62.72 0.59 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.861 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.6 -33.25 5.81 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.533 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.4 p -95.08 119.11 33.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.841 0.353 . . . . 0.0 110.885 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.514 ' CE1' ' HG ' ' A' ' 93' ' ' SER . 0.7 OUTLIER -61.63 172.75 1.14 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.907 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 2.4 mmt -99.14 30.81 3.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.008 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 17.8 m -101.58 5.34 41.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.535 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -81.81 -14.57 56.17 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.531 0.681 . . . . 0.0 111.553 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -65.41 -16.15 63.32 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.781 -1.1 . . . . 0.0 111.315 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.526 ' HG2' HD23 ' A' ' 87' ' ' LEU . 3.3 ttpt -91.76 -26.51 18.53 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.7 -1.137 . . . . 0.0 110.749 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.668 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -65.25 -28.88 69.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.78 179.912 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.739 ' O ' HD12 ' A' ' 56' ' ' LEU . 4.7 tt0 -59.71 -23.94 63.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.136 0.493 . . . . 0.0 109.677 178.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.867 HD13 HD21 ' A' ' 87' ' ' LEU . 7.1 tt -88.17 -11.35 47.06 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.434 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.668 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 11.4 mm -65.63 -14.39 16.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.022 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -78.26 2.3 18.82 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 113.801 -1.545 . . . . 0.0 111.596 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.788 ' HB2' HD21 ' A' ' 56' ' ' LEU . . . -93.16 -28.67 16.16 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.179 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -56.45 -29.06 61.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.048 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -98.39 30.56 3.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.907 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -178.02 55.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.888 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.73 36.01 1.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.918 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.0 t70 59.68 29.4 18.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.981 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 57.59 25.33 55.21 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.662 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 58.32 45.16 17.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.872 0.368 . . . . 0.0 110.941 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -59.49 -66.17 0.55 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.997 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -105.34 166.07 10.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.962 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -100.23 30.36 10.32 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.465 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -149.98 123.8 9.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.829 0.347 . . . . 0.0 110.915 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.455 HG11 ' CE2' ' A' ' 48' ' ' PHE . 8.8 p -129.49 123.96 58.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.973 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.14 160.52 30.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.941 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.691 HG22 HG13 ' A' ' 78' ' ' ILE . 45.8 t -63.94 -50.98 75.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.843 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -50.92 -31.37 17.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.962 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -89.07 -28.87 19.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.521 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.816 ' CD2' HD12 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -68.22 -40.08 82.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.909 179.918 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 15.1 mtp85 -57.13 -48.33 78.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.874 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -57.57 -27.89 59.12 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.303 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.404 HD12 ' HA ' ' A' ' 48' ' ' PHE . 16.7 mt -86.65 -43.03 15.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.848 0.356 . . . . 0.0 110.843 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.492 HG21 HG12 ' A' ' 63' ' ' ILE . 35.7 mm -68.13 -29.93 46.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.023 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 6.2 tpm_? -51.89 -55.8 17.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.95 0.405 . . . . 0.0 110.9 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -111.82 14.86 21.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.195 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -99.73 -86.76 1.91 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.628 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.788 HD21 ' HB2' ' A' ' 31' ' ' ALA . 2.8 mm? -100.77 137.01 19.71 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 120.658 0.266 . . . . 0.0 110.966 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.88 74.48 4.92 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.406 2.071 . . . . 0.0 112.322 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.573 ' HE2' ' HB2' ' A' ' 62' ' ' GLU . 1.4 mtp -105.8 142.18 35.96 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.733 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.914 ' O ' HD12 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -79.85 148.45 31.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.729 179.734 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.491 ' O ' ' N ' ' A' ' 64' ' ' THR . 1.7 pm0 -38.09 -48.82 1.26 Allowed 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.19 0.519 . . . . 0.0 111.082 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.521 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -50.86 -52.53 40.7 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.024 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.573 ' HB2' ' HE2' ' A' ' 58' ' ' MET . 1.1 mm-40 -55.33 -61.71 2.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.97 0.414 . . . . 0.0 109.933 179.341 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.914 HD12 ' O ' ' A' ' 59' ' ' THR . 1.8 mp -57.87 -61.77 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.249 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.491 ' N ' ' O ' ' A' ' 60' ' ' GLU . 89.8 m -52.65 -52.05 57.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.419 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.521 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 51.5 tt0 -64.81 -15.58 61.95 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.625 0.726 . . . . 0.0 110.423 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.428 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.6 m-30 -95.65 -28.13 14.97 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.548 -1.205 . . . . 0.0 110.326 179.144 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.699 ' CE1' HD11 ' A' ' 78' ' ' ILE . 7.5 m-30 -77.88 -26.09 48.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.813 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -90.57 -27.62 19.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.91 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -90.73 -11.19 40.37 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 121.391 0.615 . . . . 0.0 111.752 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -93.92 -31.32 14.35 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.939 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -120.95 120.05 29.55 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.77 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -63.33 -53.87 1.28 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.467 2.112 . . . . 0.0 112.388 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -73.91 -30.22 62.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.877 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 75.35 50.57 0.08 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.509 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.9 p -95.68 31.07 2.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.822 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.415 ' C ' HG23 ' A' ' 45' ' ' VAL . . . 62.28 30.81 77.11 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.344 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.459 ' N ' HG23 ' A' ' 45' ' ' VAL . 5.4 m-85 -131.37 130.17 42.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.758 0.313 . . . . 0.0 110.881 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.816 HD12 ' CD2' ' A' ' 48' ' ' PHE . 56.1 mt -106.06 153.18 7.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.15 0.5 . . . . 0.0 111.456 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.441 ' N ' HG22 ' A' ' 78' ' ' ILE . 0.8 OUTLIER -98.3 95.65 7.52 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 176.923 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.417 ' C ' ' O ' ' A' ' 79' ' ' ASP . 44.4 t80 -30.66 -40.12 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.121 -178.119 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.2 mttt -66.88 -55.56 14.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.49 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -53.32 -27.77 24.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.12 0.486 . . . . 0.0 110.555 179.172 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.655 ' CE1' HD13 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -89.02 -31.1 18.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.722 179.703 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.11 -22.46 39.11 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.312 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.33 -11.5 60.73 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 121.388 0.613 . . . . 0.0 111.708 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 33.4 mtt -70.4 -40.28 74.0 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.773 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.867 HD21 HD13 ' A' ' 28' ' ' LEU . 6.3 mp -91.73 -6.31 52.15 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.857 0.837 . . . . 0.0 111.513 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -124.07 22.29 8.76 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 114.123 -1.398 . . . . 0.0 111.127 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.81 88.41 7.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.824 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 35.9 m 42.82 31.8 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.674 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -71.22 161.26 31.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.886 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -176.83 -56.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.945 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.514 ' HG ' ' CE1' ' A' ' 20' ' ' HIS . 8.5 t . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.865 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 mtm . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 120.785 0.326 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -88.29 -74.16 1.28 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.45 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.32 -36.68 29.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.829 0.347 . . . . 0.0 110.922 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.9 m -81.84 138.05 35.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.891 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -134.5 176.63 8.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.848 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 60.55 36.87 19.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.944 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -60.04 -69.55 0.21 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.974 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 59.86 -170.68 0.14 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.956 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -109.26 144.26 37.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.013 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -99.92 152.51 20.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.91 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 72.4 p -176.37 141.88 0.43 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.863 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 79.5 p -136.35 125.82 25.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.831 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.99 65.99 1.91 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.513 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.586 HD23 ' HD3' ' A' ' 16' ' ' PRO . 0.7 OUTLIER -79.21 125.17 29.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.769 0.319 . . . . 0.0 110.942 -179.997 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.62 HG13 ' O ' ' A' ' 15' ' ' VAL . 7.1 p -145.93 83.9 8.44 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.07 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.586 ' HD3' HD23 ' A' ' 14' ' ' LEU . 55.2 Cg_exo -52.13 115.26 2.05 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.639 2.226 . . . . 0.0 112.252 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.87 143.31 31.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.878 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 133.02 -24.65 3.78 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.615 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.8 t 62.31 103.26 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.853 0.359 . . . . 0.0 110.885 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -139.55 -46.89 0.46 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.957 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 14.5 mmt 59.04 29.84 19.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.01 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.1 p -100.43 5.54 44.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.509 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.59 -15.02 63.43 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.539 0.685 . . . . 0.0 111.737 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -65.56 -16.13 63.39 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 114.944 -1.026 . . . . 0.0 111.253 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.1 ttpt -91.94 -31.93 15.46 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.733 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.66 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -56.11 -26.64 50.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.964 -179.829 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -61.66 -23.33 66.01 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.749 ' O ' HD13 ' A' ' 28' ' ' LEU . 2.7 tm? -88.08 -11.63 46.54 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.375 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.66 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 11.3 mm -65.48 -14.25 16.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.914 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -75.59 1.88 13.24 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 113.91 -1.496 . . . . 0.0 111.819 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.458 ' HB2' HD21 ' A' ' 56' ' ' LEU . . . -93.27 -28.68 16.08 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.041 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.55 -24.49 56.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.0 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -96.84 30.39 2.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.987 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -177.65 38.02 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.858 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.53 ' CD1' HD13 ' A' ' 51' ' ' ILE . 14.0 t80 -172.16 41.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.929 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -167.47 73.92 0.13 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.787 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -86.19 -58.24 2.01 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.6 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -124.54 39.43 3.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.791 0.329 . . . . 0.0 110.993 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 62.64 141.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.93 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.3 p30 -178.17 127.75 0.12 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.937 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -110.73 23.23 20.23 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.56 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -154.73 123.82 6.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.745 0.307 . . . . 0.0 110.997 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.47 HG22 ' N ' ' A' ' 44' ' ' SER . 12.4 p -132.35 157.96 43.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.008 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.47 ' N ' HG22 ' A' ' 43' ' ' VAL . 77.9 p -108.47 150.25 27.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.89 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.521 HG13 ' CZ ' ' A' ' 67' ' ' PHE . 96.2 t -56.43 -51.84 59.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.951 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -47.37 -31.0 3.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.046 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -96.37 -30.97 13.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.502 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -62.98 -35.25 79.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.052 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 20.9 mtt85 -55.8 -52.34 64.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.036 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -56.79 -27.87 56.41 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.397 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.53 HD13 ' CD1' ' A' ' 35' ' ' PHE . 21.1 mt -81.14 -25.3 10.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.848 0.356 . . . . 0.0 111.125 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 34.8 mm -93.36 -55.25 6.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.062 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.35 -34.03 68.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.319 -179.594 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -111.73 14.84 21.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.67 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -131.43 -89.84 0.49 Allowed Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.33 -0.938 . . . . 0.0 112.827 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.488 ' N ' HD12 ' A' ' 56' ' ' LEU . 7.0 mp -87.02 140.82 32.83 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.681 0.276 . . . . 0.0 111.238 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -78.27 122.02 5.5 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.567 2.178 . . . . 0.0 112.325 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.704 ' O ' HD11 ' A' ' 63' ' ' ILE . 0.8 OUTLIER -155.17 137.42 14.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.778 -179.941 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.918 ' O ' HD12 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -72.71 145.9 46.84 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.848 179.706 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.482 ' O ' ' N ' ' A' ' 64' ' ' THR . 5.9 pt-20 -37.6 -51.79 1.2 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.29 0.567 . . . . 0.0 111.06 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.44 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -47.64 -56.11 7.93 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.867 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.525 ' HB2' ' HE2' ' A' ' 58' ' ' MET . 0.7 OUTLIER -51.16 -62.87 1.35 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.415 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.918 HD12 ' O ' ' A' ' 59' ' ' THR . 2.2 mp -56.51 -63.71 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.32 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.482 ' N ' ' O ' ' A' ' 60' ' ' GLU . 92.5 m -51.17 -52.57 42.93 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.397 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.44 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 6.4 mm-40 -65.03 -15.98 62.94 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-O 121.652 0.739 . . . . 0.0 110.377 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.443 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.3 m-30 -92.04 -27.45 17.79 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.599 -1.182 . . . . 0.0 110.3 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.621 ' CE2' HG22 ' A' ' 63' ' ' ILE . 4.7 m-30 -85.6 -25.53 26.61 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.921 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -94.05 -27.66 16.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.947 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 65' ' ' GLU . . . -89.09 -11.22 44.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.39 0.614 . . . . 0.0 111.776 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.414 ' HB1' ' CG2' ' A' ' 78' ' ' ILE . . . -99.47 -28.16 13.38 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.094 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -122.51 112.14 31.23 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.681 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.08 -47.63 3.35 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.503 2.135 . . . . 0.0 112.533 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 61.8 m-80 -68.41 -31.85 71.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.971 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 12.1 m120 71.76 31.24 2.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.569 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 46.9 p -67.57 -26.24 66.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.981 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 113.79 19.66 6.39 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.525 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.459 ' CD2' ' HB2' ' A' ' 44' ' ' SER . 3.0 m-85 -140.91 130.97 24.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.65 0.262 . . . . 0.0 110.786 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.574 HD11 ' CD1' ' A' ' 67' ' ' PHE . 2.1 mt -110.14 147.82 14.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.929 0.395 . . . . 0.0 111.468 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.436 ' O ' ' N ' ' A' ' 81' ' ' LYS . 72.6 m-20 -77.28 103.75 7.39 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 177.088 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.409 ' C ' ' O ' ' A' ' 79' ' ' ASP . 50.7 t80 -28.61 -40.34 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.021 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.436 ' N ' ' O ' ' A' ' 79' ' ' ASP . 10.2 mttt -62.93 -54.46 38.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.705 0.288 . . . . 0.0 110.915 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -51.79 -26.85 10.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.089 0.471 . . . . 0.0 110.743 179.381 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.474 ' CD1' HG21 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -93.09 -29.71 15.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.267 -179.766 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -82.4 -26.85 32.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.243 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -74.36 -11.49 60.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.438 0.637 . . . . 0.0 111.658 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 24.6 tpp -74.85 -37.71 62.16 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.713 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.516 HD21 ' HG ' ' A' ' 28' ' ' LEU . 1.7 mt -89.14 -6.52 56.93 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.86 0.838 . . . . 0.0 111.437 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -125.84 22.44 7.44 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 114.14 -1.391 . . . . 0.0 111.099 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.06 66.51 0.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.949 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.564 ' O ' HG12 ' A' ' 90' ' ' VAL . 13.8 t 57.86 30.8 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.139 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 58.8 31.61 21.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.932 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 61.2 155.43 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.963 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.914 179.99 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 mtt . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.821 0.343 . . . . 0.0 111.216 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.91 -139.94 2.82 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.401 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.4 m -60.17 140.6 56.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.847 0.356 . . . . 0.0 110.878 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 66.0 p -108.32 -41.43 4.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.879 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 62.1 m170 -63.0 -74.83 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.924 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 60.15 176.3 0.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.864 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 13.5 t-160 60.49 106.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.905 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -176.39 109.67 0.09 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.956 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.44 83.79 0.4 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.91 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -143.47 -51.1 0.33 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.876 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.8 p -132.33 -57.14 0.96 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.86 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.2 t -143.87 95.03 2.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.811 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -166.87 -129.1 1.03 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.485 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.6 tp -71.1 90.27 0.85 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.799 0.333 . . . . 0.0 110.917 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.504 ' N ' ' CD ' ' A' ' 16' ' ' PRO . 11.2 t -78.38 -45.22 2.1 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.442 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.504 ' CD ' ' N ' ' A' ' 15' ' ' VAL . 77.6 Cg_exo -50.12 177.99 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.402 2.068 . . . . 0.0 112.355 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.79 136.48 49.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.898 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 156.72 54.27 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.482 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.0 m -154.81 35.38 0.4 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.824 0.345 . . . . 0.0 110.856 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 45.7 t60 -104.16 -66.0 0.99 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.798 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 29.8 ttp -102.57 31.27 4.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.928 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.6 t -101.47 5.2 41.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.083 0.468 . . . . 0.0 111.695 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -94.31 -14.61 25.23 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.585 0.707 . . . . 0.0 111.582 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -65.45 -16.43 63.63 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.148 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -91.86 -26.69 18.37 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.774 179.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.683 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -67.63 -29.07 68.29 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.786 -179.919 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -59.5 -24.27 63.49 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.734 HD13 HD21 ' A' ' 87' ' ' LEU . 4.7 tt -88.22 -11.3 47.07 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.406 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.683 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 11.5 mm -65.67 -14.3 16.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.921 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -77.55 2.19 17.17 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 113.887 -1.506 . . . . 0.0 111.537 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 1.065 ' HB2' HD11 ' A' ' 56' ' ' LEU . . . -93.27 -30.59 15.08 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.09 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -58.35 -25.54 62.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.116 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -96.09 38.84 1.16 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.945 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.3 p-10 -178.18 38.36 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.871 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.86 ' CE2' HD13 ' A' ' 51' ' ' ILE . 2.0 t80 -152.63 55.33 0.8 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.87 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.0 t0 60.54 30.27 19.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.985 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 59.14 50.22 70.14 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.532 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.0 t0 60.32 37.01 20.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.93 0.395 . . . . 0.0 110.883 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -118.08 90.71 3.39 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.886 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -176.0 126.25 0.21 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.963 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -105.88 -19.64 10.07 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.599 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -150.71 123.8 8.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.836 0.35 . . . . 0.0 111.004 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.54 HG11 ' CE2' ' A' ' 48' ' ' PHE . 9.3 p -130.48 147.76 33.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.948 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 21.7 p -92.74 159.91 15.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.919 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.96 HG13 ' CD1' ' A' ' 67' ' ' PHE . 46.1 t -61.69 -32.81 54.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.797 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -66.69 -57.9 6.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.846 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -59.33 -31.02 68.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.826 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.903 ' CD2' HD12 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -63.76 -40.73 97.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.962 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 10.2 mtm180 -58.6 -51.69 68.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.936 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -55.6 -25.59 43.29 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.486 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.86 HD13 ' CE2' ' A' ' 35' ' ' PHE . 13.0 mt -83.51 -46.11 18.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.915 0.388 . . . . 0.0 111.057 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.535 HG21 HG12 ' A' ' 63' ' ' ILE . 31.0 mm -68.52 -28.69 41.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.137 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.27 -59.34 4.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.061 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -111.88 15.02 20.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.237 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -98.06 -86.19 1.83 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.738 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 1.065 HD11 ' HB2' ' A' ' 31' ' ' ALA . 7.1 mt -105.96 144.7 29.44 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 120.705 0.288 . . . . 0.0 111.024 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.51 115.8 4.16 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.577 2.185 . . . . 0.0 112.235 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.636 ' O ' HD11 ' A' ' 63' ' ' ILE . 0.8 OUTLIER -153.88 138.48 16.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.726 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.898 ' O ' HD12 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -76.07 147.04 38.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.646 179.592 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' A' ' 64' ' ' THR . 6.2 pt-20 -38.81 -52.13 1.72 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.214 0.53 . . . . 0.0 110.853 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.515 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -46.91 -53.31 12.49 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.09 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.464 ' HG2' ' O ' ' A' ' 59' ' ' THR . 2.0 mm-40 -55.13 -61.57 2.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.921 0.391 . . . . 0.0 110.021 179.387 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.898 HD12 ' O ' ' A' ' 59' ' ' THR . 1.6 mp -59.17 -61.69 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.155 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.539 ' N ' ' O ' ' A' ' 60' ' ' GLU . 69.3 m -51.39 -51.73 52.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.394 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.515 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 1.5 tp10 -65.36 -15.34 62.47 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.638 0.732 . . . . 0.0 110.412 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.416 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.6 m-30 -96.46 -25.88 15.51 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.533 -1.212 . . . . 0.0 110.415 179.17 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.96 ' CD1' HG13 ' A' ' 45' ' ' VAL . 1.7 m-85 -75.31 -30.18 60.27 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.747 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -93.18 -28.47 16.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.892 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.6 -10.96 59.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.407 0.622 . . . . 0.0 111.718 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.98 -33.4 14.87 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.067 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.498 ' OD2' HG22 ' A' ' 75' ' ' THR . 7.1 t0 -120.09 116.98 32.34 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.888 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.68 -28.94 51.94 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.358 2.038 . . . . 0.0 112.185 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 53.9 m-20 -83.64 -32.09 25.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.713 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 71.79 39.94 0.81 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.118 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.498 HG22 ' OD2' ' A' ' 71' ' ' ASP . 1.5 t -90.33 39.6 0.98 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.737 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.406 ' C ' HG23 ' A' ' 45' ' ' VAL . . . 46.55 28.67 3.61 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.463 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.568 ' N ' HG23 ' A' ' 45' ' ' VAL . 1.2 t80 -132.3 129.11 39.1 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.81 0.338 . . . . 0.0 110.468 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.903 HD12 ' CD2' ' A' ' 48' ' ' PHE . 66.6 mt -103.11 148.77 7.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.108 0.48 . . . . 0.0 111.61 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.44 ' O ' ' N ' ' A' ' 82' ' ' ALA . 0.8 OUTLIER -96.15 95.89 8.45 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 176.698 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.437 ' C ' ' O ' ' A' ' 79' ' ' ASP . 51.2 t80 -28.56 -42.29 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.261 -177.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 79' ' ' ASP . 6.9 mmmm -63.79 -55.62 21.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.823 0.344 . . . . 0.0 110.619 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -52.32 -30.7 29.62 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.172 0.511 . . . . 0.0 110.411 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.661 ' CE1' HD13 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -85.56 -32.59 22.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.695 179.807 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.21 -23.77 43.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.2 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.8 -11.4 60.59 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.411 0.624 . . . . 0.0 111.804 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 13.2 tpp -76.64 -32.04 57.76 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.61 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.734 HD21 HD13 ' A' ' 28' ' ' LEU . 4.6 mt -94.05 -6.24 45.63 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 121.885 0.85 . . . . 0.0 111.33 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -125.95 22.06 7.43 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.081 -1.418 . . . . 0.0 111.212 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.35 31.78 2.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.957 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.8 m -102.18 27.44 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.267 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 56.14 30.41 16.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.964 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -150.46 -50.98 0.13 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.926 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 27.4 t . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.188 -0.91 . . . . 0.0 110.978 -179.908 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.883 0.373 . . . . 0.0 111.146 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -106.39 -132.16 7.04 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.488 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.8 t -89.49 -72.39 0.56 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.835 0.35 . . . . 0.0 110.934 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.51 37.46 19.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.929 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 60.86 80.03 0.23 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.918 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -143.22 -47.61 0.31 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.884 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -170.11 178.8 3.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.952 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -152.84 106.83 3.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.905 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -140.54 30.77 1.9 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.936 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 22.9 t60 60.42 89.79 0.07 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.89 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.1 m -116.74 -69.09 0.87 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.901 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -164.74 78.85 0.35 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.912 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -112.51 -28.41 3.51 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.578 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -60.14 -71.25 0.14 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.761 0.315 . . . . 0.0 110.942 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.2 m -138.19 149.86 64.95 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.14 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -52.42 -60.73 0.65 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.558 2.172 . . . . 0.0 112.353 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 21.3 ttm180 -165.75 -44.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.878 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -174.54 -82.33 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.54 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 17.1 m -60.22 153.65 21.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.756 0.312 . . . . 0.0 110.878 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 41.3 m170 -81.59 -79.32 0.17 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.83 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 39.4 mmm -156.23 -79.16 0.08 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.919 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.9 p -101.9 5.35 40.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.95 0.405 . . . . 0.0 111.532 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.48 -14.8 34.49 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.492 0.663 . . . . 0.0 111.541 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.3 -16.49 63.62 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.17 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.4 ttpt -91.85 -23.4 19.67 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.788 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.66 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -71.57 -28.86 64.13 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.914 -179.967 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -59.92 -24.22 64.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.215 0.531 . . . . 0.0 109.683 178.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.968 HD13 HD21 ' A' ' 87' ' ' LEU . 4.2 tt -88.3 -11.27 46.92 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.519 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.66 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 12.0 mm -63.59 -15.12 15.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.865 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -79.04 2.17 21.48 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 113.919 -1.491 . . . . 0.0 111.478 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.758 ' HB2' HD21 ' A' ' 56' ' ' LEU . . . -93.29 -29.35 15.71 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.107 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -56.47 -24.39 45.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.15 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -96.9 34.43 1.71 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.025 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -177.22 37.62 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.821 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -176.44 37.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.892 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -106.62 38.45 2.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.949 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -62.24 -63.71 4.5 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.603 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -177.2 49.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.92 0.39 . . . . 0.0 110.944 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 60.55 101.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.806 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -83.0 133.8 35.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.966 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -100.22 -23.68 10.27 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.678 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -153.89 123.79 6.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.811 0.338 . . . . 0.0 110.939 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.577 HG11 ' CE2' ' A' ' 48' ' ' PHE . 10.4 p -124.37 132.92 70.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.966 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.51 147.45 25.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.854 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.423 HG13 ' CE1' ' A' ' 67' ' ' PHE . 88.8 t -53.37 -55.14 14.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.065 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -47.21 -31.98 4.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.906 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -88.3 -29.75 20.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.358 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.629 ' HA ' HD12 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -69.04 -38.15 78.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.809 179.806 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 18.7 mtt180 -58.23 -51.21 70.69 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.991 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -55.94 -25.78 46.42 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.394 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.629 HD12 ' HA ' ' A' ' 48' ' ' PHE . 21.8 mt -83.08 -44.54 18.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.874 0.368 . . . . 0.0 111.065 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 35.8 mm -68.07 -27.27 36.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.138 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.8 ttm180 -52.8 -58.79 5.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.993 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -111.75 14.98 21.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.344 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -99.41 -86.53 1.89 Allowed Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.632 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.758 HD21 ' HB2' ' A' ' 31' ' ' ALA . 3.9 mt -103.48 143.72 27.2 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 120.631 0.253 . . . . 0.0 110.982 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.48 85.28 1.6 Allowed 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.549 2.166 . . . . 0.0 112.166 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.604 ' HB3' HD11 ' A' ' 63' ' ' ILE . 3.8 ttt -124.28 140.84 52.58 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.796 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.835 ' O ' HD12 ' A' ' 63' ' ' ILE . 0.8 OUTLIER -89.32 143.41 26.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.613 179.36 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.616 ' O ' ' N ' ' A' ' 64' ' ' THR . 0.2 OUTLIER -41.99 -53.16 3.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.369 0.604 . . . . 0.0 110.637 -179.852 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.487 ' N ' ' CG ' ' A' ' 60' ' ' GLU . . . -44.68 -28.93 0.67 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.004 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.601 ' HG2' ' O ' ' A' ' 59' ' ' THR . 1.5 mm-40 -89.57 -51.43 5.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.736 0.303 . . . . 0.0 110.458 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.835 HD12 ' O ' ' A' ' 59' ' ' THR . 1.0 OUTLIER -74.35 -44.69 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.347 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.616 ' N ' ' O ' ' A' ' 60' ' ' GLU . 50.6 m -62.96 -48.92 76.82 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.024 0.44 . . . . 0.0 109.991 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.408 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 3.2 tm-20 -66.68 -16.2 64.05 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.714 0.768 . . . . 0.0 110.301 179.297 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.443 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.2 m-85 -96.78 -23.61 16.32 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.469 -1.242 . . . . 0.0 110.357 178.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.783 ' CE2' HG22 ' A' ' 63' ' ' ILE . 2.1 m-85 -74.52 -36.06 63.19 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.736 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -76.42 -30.36 57.39 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.861 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.28 -11.08 59.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.476 0.655 . . . . 0.0 111.653 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -95.58 -30.25 13.91 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.985 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.565 ' OD2' HG22 ' A' ' 75' ' ' THR . 7.0 t70 -128.31 106.22 19.54 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.825 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 71' ' ' ASP . 37.9 Cg_endo -66.43 -30.92 43.55 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.404 2.069 . . . . 0.0 112.276 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 63.6 m-80 -76.81 -27.64 55.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.917 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 72.51 36.7 0.97 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.128 0.489 . . . . 0.0 110.13 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.565 HG22 ' OD2' ' A' ' 71' ' ' ASP . 1.1 t -85.65 13.14 7.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.975 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 69.45 26.57 74.41 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.262 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.468 ' HB2' HG23 ' A' ' 75' ' ' THR . 5.2 m-85 -117.39 178.48 4.36 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.701 0.286 . . . . 0.0 110.571 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.621 HD12 ' HD2' ' A' ' 48' ' ' PHE . 65.4 mt -153.62 153.54 8.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.206 0.527 . . . . 0.0 111.724 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.464 ' N ' HG22 ' A' ' 78' ' ' ILE . 24.2 t0 -99.55 95.97 7.35 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 176.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.429 ' C ' ' O ' ' A' ' 79' ' ' ASP . 44.8 t80 -28.7 -41.37 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.366 -178.049 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.418 ' N ' ' O ' ' A' ' 79' ' ' ASP . 3.4 mtmt -66.2 -56.61 10.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.717 0.294 . . . . 0.0 110.68 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -51.9 -27.71 13.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.043 0.449 . . . . 0.0 110.614 179.354 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.519 ' CE1' HD13 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -89.83 -31.91 17.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.743 179.923 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.09 -18.64 55.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.339 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -71.08 -11.56 61.02 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.366 0.603 . . . . 0.0 111.882 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.96 -34.6 62.06 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.784 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.968 HD21 HD13 ' A' ' 28' ' ' LEU . 4.1 mt -92.72 -6.73 48.53 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.851 0.834 . . . . 0.0 111.483 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -126.08 22.31 7.31 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.108 -1.405 . . . . 0.0 111.057 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.443 ' O ' HG13 ' A' ' 90' ' ' VAL . 1.6 p -75.56 73.15 2.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.961 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 90' ' ' VAL . 17.3 m -157.06 68.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.131 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 60.67 79.49 0.24 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.955 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -151.13 -47.4 0.12 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.903 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.7 t . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.954 179.995 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.475 0 CA-C-O 120.687 0.279 . . . . 0.0 111.352 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -164.97 42.31 0.29 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.529 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.9 p -135.99 32.12 2.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.893 0.378 . . . . 0.0 110.913 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 93.0 p -145.77 128.89 16.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.889 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -61.05 -169.71 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.838 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 70.4 m80 -155.35 32.84 0.38 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.966 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -77.3 79.29 3.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.883 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -111.82 -62.54 1.55 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.93 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 47.3 p-80 -144.34 -175.28 4.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.899 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 60.28 171.01 0.09 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.942 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.4 t -92.35 79.82 4.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.915 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.0 p -106.74 31.8 5.01 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.968 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 177.84 -177.19 48.33 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.473 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 62.74 30.66 16.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.843 0.354 . . . . 0.0 110.948 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.1 t -153.0 84.41 4.49 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.101 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.29 138.57 55.31 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.612 2.208 . . . . 0.0 112.249 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 62.28 118.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.874 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -59.09 -166.81 0.17 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.568 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.17 -74.92 0.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.74 0.305 . . . . 0.0 110.893 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.3 m170 65.47 -76.19 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.959 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 2.6 tpt 63.19 120.43 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.843 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -100.78 5.46 43.56 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.626 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -70.87 -14.7 62.49 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.572 0.701 . . . . 0.0 111.552 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -65.62 -16.38 63.66 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.117 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.6 tttp -91.98 -26.41 18.4 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.72 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.651 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -67.63 -28.79 68.03 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.845 -179.815 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 89.3 mm-40 -61.13 -24.91 66.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.204 0.526 . . . . 0.0 109.594 178.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.804 HD13 HD21 ' A' ' 87' ' ' LEU . 3.0 tt -88.3 -11.28 46.88 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.539 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.651 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 11.2 mm -61.43 -15.58 13.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 114.973 -1.012 . . . . 0.0 112.03 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -77.84 1.81 19.19 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 113.983 -1.462 . . . . 0.0 111.559 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.646 ' HB2' HD21 ' A' ' 56' ' ' LEU . . . -93.62 -28.15 16.17 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.009 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -58.12 -20.53 40.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.315 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -93.07 24.02 3.98 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.334 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -174.31 33.43 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.93 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER 178.57 39.46 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.78 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -137.13 58.77 1.7 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.948 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 153.63 69.36 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.539 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -151.03 23.87 0.75 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.723 0.297 . . . . 0.0 111.047 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 52.34 -178.55 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.887 0.375 . . . . 0.0 111.204 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 60.31 160.63 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.065 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -135.37 34.16 2.34 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.43 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -142.76 123.93 14.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.805 0.336 . . . . 0.0 110.952 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.538 HG11 ' CE2' ' A' ' 48' ' ' PHE . 10.3 p -117.97 123.67 72.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.991 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.95 155.59 40.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.965 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.93 HG13 ' CD1' ' A' ' 67' ' ' PHE . 59.8 t -60.17 -32.51 50.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.806 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -65.2 -61.38 2.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.013 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -57.62 -30.66 65.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.918 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.876 ' CD2' HD12 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -62.1 -40.73 96.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.011 -179.909 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.445 ' HG3' ' CE2' ' A' ' 67' ' ' PHE . 65.5 mtt180 -58.76 -51.73 68.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.986 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -55.91 -25.85 46.39 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.505 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.74 HD12 ' HA ' ' A' ' 48' ' ' PHE . 12.4 mt -82.56 -45.64 19.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.882 0.372 . . . . 0.0 111.045 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.543 HG21 HG12 ' A' ' 63' ' ' ILE . 35.6 mm -68.57 -28.4 40.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.237 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 17.9 ttp180 -48.75 -60.37 2.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.063 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -111.86 14.89 21.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.109 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -96.64 -85.68 1.76 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.606 -0.806 . . . . 0.0 112.772 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.646 HD21 ' HB2' ' A' ' 31' ' ' ALA . 2.1 mp -106.34 144.97 30.05 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.594 0.235 . . . . 0.0 111.105 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.59 113.26 3.62 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.523 2.148 . . . . 0.0 112.222 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.608 ' O ' HD11 ' A' ' 63' ' ' ILE . 0.9 OUTLIER -152.68 138.97 18.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.762 -179.97 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.894 ' O ' HD12 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -77.16 147.67 36.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.529 179.57 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.55 ' O ' ' N ' ' A' ' 64' ' ' THR . 0.5 OUTLIER -38.62 -52.21 1.64 Allowed 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.271 0.558 . . . . 0.0 110.932 179.705 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.419 ' O ' ' HB2' ' A' ' 65' ' ' GLU . . . -46.76 -55.94 7.03 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.792 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.456 ' HG2' ' O ' ' A' ' 59' ' ' THR . 1.9 mm-40 -52.07 -62.26 1.75 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.945 0.402 . . . . 0.0 109.932 179.398 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.894 HD12 ' O ' ' A' ' 59' ' ' THR . 1.4 mp -59.04 -63.16 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.217 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.55 ' N ' ' O ' ' A' ' 60' ' ' GLU . 75.7 m -49.32 -52.31 28.73 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.475 -179.692 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.419 ' HB2' ' O ' ' A' ' 61' ' ' ALA . 3.3 mm-40 -65.63 -15.6 62.91 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 121.698 0.761 . . . . 0.0 110.417 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.418 ' CD1' ' O ' ' A' ' 62' ' ' GLU . 3.5 m-30 -96.17 -24.74 16.12 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.476 -1.238 . . . . 0.0 110.465 179.231 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.93 ' CD1' HG13 ' A' ' 45' ' ' VAL . 1.6 m-30 -76.44 -30.85 57.53 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.826 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.69 -26.88 16.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.092 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -82.66 -10.91 58.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.511 0.672 . . . . 0.0 111.96 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.17 -33.96 13.11 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.27 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 48.1 p-10 -110.54 122.5 38.23 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.869 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.59 -47.39 1.44 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.447 2.098 . . . . 0.0 112.479 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -68.54 -30.45 69.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.066 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.2 m120 73.84 22.06 2.56 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.413 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.2 t -66.23 -15.68 63.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.183 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.429 ' C ' HG23 ' A' ' 45' ' ' VAL . . . 102.56 22.23 9.81 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.19 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -125.34 129.44 49.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.799 0.333 . . . . 0.0 110.426 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.876 HD12 ' CD2' ' A' ' 48' ' ' PHE . 66.6 mt -99.49 146.89 7.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.223 0.535 . . . . 0.0 111.794 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.429 ' O ' ' N ' ' A' ' 82' ' ' ALA . 0.9 OUTLIER -91.94 96.0 10.13 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 176.598 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.426 ' C ' ' O ' ' A' ' 79' ' ' ASP . 56.4 t80 -28.55 -40.95 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -177.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.423 ' N ' ' O ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -65.19 -55.53 18.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.768 0.318 . . . . 0.0 110.718 179.644 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -51.9 -28.3 15.77 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.104 0.478 . . . . 0.0 110.6 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.645 ' CE1' HD13 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -89.71 -31.9 17.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.812 179.967 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -80.49 -20.8 42.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.324 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.12 -11.57 60.81 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.437 0.637 . . . . 0.0 111.824 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 14.4 mmt -74.03 -33.64 63.83 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.786 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.804 HD21 HD13 ' A' ' 28' ' ' LEU . 5.4 mt -95.58 -6.59 39.96 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.831 0.824 . . . . 0.0 111.476 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -125.91 22.18 7.44 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 114.178 -1.374 . . . . 0.0 111.041 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.93 76.63 10.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.877 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 22.2 t -152.39 66.81 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.02 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -59.63 164.83 3.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.92 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -60.01 149.79 31.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.889 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.3 t . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.146 -0.93 . . . . 0.0 111.011 179.935 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 mtm . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.792 0.329 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 136.25 65.74 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.532 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.6 t -106.01 71.9 0.92 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.857 0.36 . . . . 0.0 110.884 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.3 m -116.03 -38.4 3.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.877 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 21.0 m170 60.71 30.6 19.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.003 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 40.7 t60 59.32 94.04 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.034 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 4.4 m80 -170.61 -75.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.876 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.0 t60 59.9 176.84 0.09 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.921 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 10.8 m80 -155.59 123.68 5.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.82 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -94.67 163.0 13.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.871 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -160.33 35.73 0.17 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.814 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.42 104.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.897 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -96.51 92.54 1.39 Allowed Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.536 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.7 mt -150.52 -51.68 0.14 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.809 0.338 . . . . 0.0 110.852 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.625 HG13 ' O ' ' A' ' 15' ' ' VAL . 7.1 p -178.63 87.57 0.22 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.007 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -52.06 122.72 11.06 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.531 2.154 . . . . 0.0 112.289 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -134.16 153.93 51.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.88 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.91 173.68 17.39 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.557 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 60.03 83.5 0.14 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.799 0.333 . . . . 0.0 110.944 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.74 -73.98 0.22 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.899 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.0 tpt -162.11 147.22 12.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.927 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.4 m -101.29 5.42 42.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.517 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -70.47 -14.68 62.63 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.554 0.692 . . . . 0.0 111.579 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -64.91 -16.5 63.35 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.187 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.526 ' NZ ' HD11 ' A' ' 29' ' ' ILE . 9.8 tmtt? -91.87 -27.84 17.68 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.699 179.382 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.674 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -66.91 -28.49 68.36 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.746 -179.933 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -59.3 -23.67 62.63 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.948 HD13 HD21 ' A' ' 87' ' ' LEU . 6.0 tt -88.0 -11.36 47.57 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.508 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.674 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 11.3 mm -67.59 -13.81 17.35 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.934 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -77.01 2.04 16.11 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 113.935 -1.484 . . . . 0.0 111.564 179.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.499 ' HB2' HD11 ' A' ' 56' ' ' LEU . . . -93.21 -30.54 15.14 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.034 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -59.58 -29.11 67.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.91 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -97.57 28.17 3.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.0 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -169.97 33.41 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.947 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.458 ' CE1' HD13 ' A' ' 51' ' ' ILE . 16.7 t80 -178.1 76.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.787 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -154.36 67.6 0.72 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.849 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -102.88 -87.62 2.01 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.419 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -178.59 75.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.819 0.342 . . . . 0.0 110.876 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -111.32 22.96 14.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.109 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 22.3 t70 53.82 24.96 4.8 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.182 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.18 -57.21 4.87 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.541 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -54.97 123.98 15.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.946 0.403 . . . . 0.0 111.048 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.506 ' O ' HG13 ' A' ' 43' ' ' VAL . 4.4 p -136.41 106.17 5.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.754 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.4 m -59.01 153.74 17.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.084 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.437 HG13 ' CE1' ' A' ' 67' ' ' PHE . 92.9 t -57.03 -56.84 12.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.045 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -47.41 -29.71 2.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.058 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -88.43 -29.79 19.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.602 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.41 ' CD2' HD12 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -64.68 -30.79 71.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.799 179.876 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.4 mtt-85 -56.06 -51.23 68.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.951 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -57.49 -25.03 54.39 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.452 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.458 HD13 ' CE1' ' A' ' 35' ' ' PHE . 34.0 mt -83.35 -27.92 7.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.754 0.312 . . . . 0.0 111.156 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 41.7 mm -90.45 -49.18 13.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.085 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.3 -35.73 62.94 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.198 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -111.81 14.72 21.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.426 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -123.24 -90.1 0.94 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.662 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.499 HD11 ' HB2' ' A' ' 31' ' ' ALA . 2.4 mp -97.8 142.93 25.34 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.645 0.26 . . . . 0.0 110.94 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -78.92 57.94 6.67 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.525 2.15 . . . . 0.0 112.439 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.657 ' C ' HD11 ' A' ' 63' ' ' ILE . 5.3 ttt -86.58 136.19 33.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.72 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.836 ' O ' HD12 ' A' ' 63' ' ' ILE . 1.0 OUTLIER -81.76 142.05 32.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.789 0.328 . . . . 0.0 110.631 179.645 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.557 ' O ' ' N ' ' A' ' 64' ' ' THR . 0.2 OUTLIER -41.16 -52.92 3.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.328 0.585 . . . . 0.0 110.844 -179.844 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.483 ' N ' ' CG ' ' A' ' 60' ' ' GLU . . . -45.01 -27.09 0.5 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.938 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.483 ' HG3' ' O ' ' A' ' 59' ' ' THR . 0.0 OUTLIER -91.07 -51.73 5.19 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.672 0.272 . . . . 0.0 110.32 179.729 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.836 HD12 ' O ' ' A' ' 59' ' ' THR . 1.2 mp -73.65 -43.35 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.201 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.557 ' N ' ' O ' ' A' ' 60' ' ' GLU . 24.3 m -64.6 -47.78 77.36 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.027 0.441 . . . . 0.0 109.961 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.408 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 5.7 tt0 -65.66 -17.28 64.49 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.693 0.758 . . . . 0.0 110.188 179.324 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.47 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 1.0 OUTLIER -97.02 -26.92 14.84 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.243 178.829 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.755 ' CE2' HG22 ' A' ' 63' ' ' ILE . 2.0 m-85 -68.13 -47.36 68.31 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.738 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.77 -26.81 54.94 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.994 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.77 -11.06 59.92 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.445 0.64 . . . . 0.0 111.779 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.433 ' HB2' ' CE1' ' A' ' 83' ' ' PHE . . . -95.84 -32.78 12.5 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.006 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.484 ' OD2' HG22 ' A' ' 75' ' ' THR . 5.9 t70 -119.85 120.43 30.43 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.744 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.65 -27.78 45.04 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.344 2.029 . . . . 0.0 112.222 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 30.2 m-20 -84.6 -32.35 23.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.904 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.2 m120 71.31 40.4 0.85 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.038 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.484 HG22 ' OD2' ' A' ' 71' ' ' ASP . 1.4 t -90.37 40.57 1.02 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.644 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 50.33 25.72 8.65 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.763 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -125.23 148.94 48.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.874 0.369 . . . . 0.0 110.779 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.737 HD11 ' CD1' ' A' ' 67' ' ' PHE . 54.1 mt -127.14 153.12 35.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.203 0.525 . . . . 0.0 111.552 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.443 ' N ' HG22 ' A' ' 78' ' ' ILE . 1.0 OUTLIER -98.11 96.0 7.82 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 176.863 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.42 ' C ' ' O ' ' A' ' 79' ' ' ASP . 70.6 t80 -29.23 -40.86 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -178.084 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 79' ' ' ASP . 1.9 mmmm -68.72 -54.44 16.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.733 0.301 . . . . 0.0 110.699 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -52.59 -26.82 14.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.015 0.436 . . . . 0.0 110.577 179.129 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.555 ' CE1' HD13 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -91.9 -35.27 14.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.844 -179.898 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.404 ' O ' ' CD2' ' A' ' 88' ' ' TYR . . . -76.56 -29.09 56.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.398 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.737 ' HB1' HG22 ' A' ' 90' ' ' VAL . . . -74.43 -11.33 60.21 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.396 0.617 . . . . 0.0 111.824 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 13.0 mmm -84.04 -28.97 27.26 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.942 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.948 HD21 HD13 ' A' ' 28' ' ' LEU . 4.5 mt -100.83 -7.09 23.93 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.778 0.799 . . . . 0.0 111.819 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.404 ' CD2' ' O ' ' A' ' 84' ' ' ALA . 10.8 m-85 -125.99 21.87 7.44 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 114.377 -1.283 . . . . 0.0 111.339 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.0 m 45.15 33.11 1.04 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.409 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.737 HG22 ' HB1' ' A' ' 85' ' ' ALA . 14.0 t 67.52 37.24 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.097 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.9 t70 61.09 111.71 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.915 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -121.5 165.25 15.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.799 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 42.4 t . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.878 179.993 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.0 ttp . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.884 0.373 . . . . 0.0 111.141 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 154.66 87.04 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.489 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.3 t -93.55 154.0 18.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.85 0.357 . . . . 0.0 110.876 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.9 p -166.67 -66.15 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.893 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 13.7 m80 -91.02 143.03 27.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.996 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -101.9 80.04 1.97 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.875 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 17.3 t60 -91.28 -66.31 0.94 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.912 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 60.16 -170.0 0.15 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.907 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -131.11 -57.39 1.02 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.933 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 73.8 m-70 -108.57 80.71 1.37 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.955 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 46.0 t -175.98 -71.2 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.87 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.8 t -79.66 170.93 15.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.941 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.472 ' H ' HD23 ' A' ' 14' ' ' LEU . . . 171.87 78.76 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.504 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.472 HD23 ' H ' ' A' ' 13' ' ' GLY . 0.6 OUTLIER -148.11 45.79 1.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.916 0.389 . . . . 0.0 110.817 -179.954 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.665 ' N ' ' CD ' ' A' ' 16' ' ' PRO . 13.5 p -79.26 -27.95 0.53 Allowed Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.665 ' CD ' ' N ' ' A' ' 15' ' ' VAL . 51.5 Cg_exo -53.45 -47.48 27.11 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 121.917 1.744 . . . . 0.0 112.34 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.9 tpp85 -62.62 141.66 58.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.865 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 105.26 86.35 1.91 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.737 -0.745 . . . . 0.0 112.501 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.64 -177.4 0.81 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.77 0.319 . . . . 0.0 110.893 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 61.0 112.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.846 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 19.3 mmt -108.04 77.88 1.14 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.872 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -101.64 5.33 41.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.043 0.449 . . . . 0.0 111.569 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.07 -14.62 62.38 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.493 0.663 . . . . 0.0 111.559 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.03 -16.57 63.6 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 114.823 -1.08 . . . . 0.0 111.171 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.493 ' CG ' HD23 ' A' ' 87' ' ' LEU . 1.5 ttpp -91.83 -26.98 18.26 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.745 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.679 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -68.29 -28.58 67.31 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.8 -179.89 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -58.95 -23.92 62.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.159 0.504 . . . . 0.0 109.781 178.501 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.973 HD22 HD22 ' A' ' 87' ' ' LEU . 3.8 tt -88.07 -11.39 47.29 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.407 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.679 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 11.2 mm -67.26 -13.6 16.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.959 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -76.32 2.19 14.09 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 113.944 -1.48 . . . . 0.0 111.676 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 1.106 ' HB2' HD21 ' A' ' 56' ' ' LEU . . . -92.31 -29.44 16.37 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.092 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -57.23 -28.21 62.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.055 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -97.42 37.76 1.33 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.919 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -173.32 37.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.852 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.401 ' CD2' ' O ' ' A' ' 35' ' ' PHE . 78.1 t80 -163.27 72.02 0.28 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -140.53 42.12 1.88 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.861 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -59.32 -64.46 4.24 Favored Glycine 0 N--CA 1.453 -0.195 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.495 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -165.14 38.94 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.861 0.362 . . . . 0.0 110.926 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 1.4 t80 60.74 89.16 0.08 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.892 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.36 148.88 22.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.858 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -108.39 -24.36 6.23 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.577 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -143.68 123.82 13.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.837 0.351 . . . . 0.0 110.916 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.541 HG11 ' CE2' ' A' ' 48' ' ' PHE . 9.1 p -117.56 122.19 69.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.966 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.0 155.38 38.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.839 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.698 HG22 HG13 ' A' ' 78' ' ' ILE . 49.7 t -59.71 -53.13 52.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.773 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -49.14 -37.07 20.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.749 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -80.84 -29.1 35.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.439 179.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.789 ' CD2' HD12 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -70.66 -40.05 73.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.782 179.91 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 46.0 mtm180 -56.96 -51.82 67.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.943 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -54.23 -25.41 32.73 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.327 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.0 mt -89.61 -43.68 14.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.847 0.355 . . . . 0.0 110.869 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.688 ' CD1' HD13 ' A' ' 56' ' ' LEU . 36.6 mm -70.7 -26.97 29.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.211 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.33 -60.22 3.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.106 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -111.87 14.92 21.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.336 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -101.84 -87.29 1.98 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.75 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 1.106 HD21 ' HB2' ' A' ' 31' ' ' ALA . 3.9 mp -90.92 133.4 32.22 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.509 0.195 . . . . 0.0 111.147 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -77.91 87.58 1.51 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.54 2.16 . . . . 0.0 112.289 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.613 ' O ' HD11 ' A' ' 63' ' ' ILE . 1.2 mtp -125.08 141.27 52.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.774 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.888 ' O ' HD12 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -77.99 148.92 34.18 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.642 179.673 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.506 ' O ' ' N ' ' A' ' 64' ' ' THR . 5.4 pt-20 -38.76 -52.0 1.7 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.258 0.551 . . . . 0.0 110.851 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.524 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -47.17 -53.2 13.63 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.038 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.568 ' HB2' ' HE2' ' A' ' 58' ' ' MET . 2.2 mm-40 -55.08 -61.72 2.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.928 0.394 . . . . 0.0 109.975 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.888 HD12 ' O ' ' A' ' 59' ' ' THR . 1.7 mp -58.72 -61.7 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.168 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.506 ' N ' ' O ' ' A' ' 60' ' ' GLU . 58.9 m -51.8 -51.45 56.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.343 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.524 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 50.9 tt0 -65.62 -15.45 62.76 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 121.686 0.755 . . . . 0.0 110.458 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.426 ' CD1' ' O ' ' A' ' 62' ' ' GLU . 3.6 m-30 -96.15 -26.52 15.44 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.519 -1.219 . . . . 0.0 110.372 179.145 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.699 ' CE2' HG22 ' A' ' 63' ' ' ILE . 5.1 m-30 -77.8 -26.68 49.78 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.827 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -90.75 -28.43 18.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.882 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.94 -11.2 45.13 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.459 0.647 . . . . 0.0 111.732 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -92.15 -29.72 16.34 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.078 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -125.64 119.29 24.44 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.789 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -64.85 -40.69 20.52 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.421 2.081 . . . . 0.0 112.189 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -77.4 -31.31 54.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.758 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 72.18 38.9 0.83 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.103 0.477 . . . . 0.0 110.144 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.497 HG23 ' HB2' ' A' ' 77' ' ' PHE . 1.5 t -89.7 41.27 1.03 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.529 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.422 ' C ' HG23 ' A' ' 45' ' ' VAL . . . 50.88 25.39 9.51 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.688 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.497 ' HB2' HG23 ' A' ' 75' ' ' THR . 2.5 m-85 -126.06 129.5 49.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.761 0.315 . . . . 0.0 110.84 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.789 HD12 ' CD2' ' A' ' 48' ' ' PHE . 55.7 mt -103.13 153.27 5.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.184 0.516 . . . . 0.0 111.379 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.453 ' N ' HG22 ' A' ' 78' ' ' ILE . 10.1 t0 -99.41 95.66 7.18 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 176.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.417 ' C ' ' O ' ' A' ' 79' ' ' ASP . 47.3 t80 -29.35 -41.32 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.066 -0.515 . . . . 0.0 112.287 -178.008 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 79' ' ' ASP . 21.9 mttt -65.93 -55.82 14.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.562 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -53.05 -26.16 14.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.044 0.449 . . . . 0.0 110.574 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.635 ' CE1' HD13 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -91.55 -30.49 16.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.895 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.05 -45.58 16.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.359 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -71.4 -11.62 60.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.412 0.625 . . . . 0.0 111.816 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 14.7 tpp -68.67 -35.44 77.23 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.656 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.973 HD22 HD22 ' A' ' 28' ' ' LEU . 4.2 mp -100.63 -6.76 24.74 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.777 0.798 . . . . 0.0 111.556 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -125.82 22.44 7.45 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 114.271 -1.331 . . . . 0.0 111.176 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.23 78.53 0.09 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.829 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 26.5 m -150.88 30.69 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.151 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -135.05 146.54 49.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.892 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -131.71 155.52 47.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.865 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.6 m . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.141 -0.933 . . . . 0.0 110.913 -179.964 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 mtm . . . . . 0 N--CA 1.487 1.423 0 CA-C-O 120.811 0.338 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 160.26 -88.88 0.11 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.569 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.1 m 60.55 100.96 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.786 0.327 . . . . 0.0 110.92 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.3 m -154.61 97.86 2.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.936 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 22.3 p80 -175.59 -40.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.913 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -131.47 101.23 5.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.885 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 60.62 110.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.899 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.5 p80 -162.64 83.35 0.53 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.926 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 -79.64 126.24 30.66 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.89 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -146.06 179.28 7.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.87 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.6 p -84.63 -53.9 5.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.894 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.0 m -72.86 166.5 22.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.925 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 140.09 -160.13 26.22 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.565 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.46 -75.45 0.45 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.776 0.322 . . . . 0.0 111.007 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.6 m -149.92 157.13 38.17 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.218 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.21 -61.68 0.47 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.577 2.185 . . . . 0.0 112.312 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.82 -71.88 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.914 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.96 39.34 38.47 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.555 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.9 t -177.11 165.72 2.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.839 0.352 . . . . 0.0 110.912 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -166.49 -68.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.866 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.09 30.81 0.3 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.802 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.0 m -94.75 5.36 52.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.561 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.29 -14.55 62.25 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.588 0.709 . . . . 0.0 111.654 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -65.07 -16.51 63.55 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.087 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.1 tmtm? -92.01 -26.94 18.13 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 114.781 -1.1 . . . . 0.0 110.641 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.68 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -68.03 -29.11 68.02 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.765 -179.923 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.0 mm100 -59.79 -23.93 63.7 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.829 HD22 HD22 ' A' ' 87' ' ' LEU . 0.6 OUTLIER -88.15 -11.25 47.44 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.468 179.636 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.68 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 10.8 mm -66.58 -13.74 16.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.987 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -76.4 2.11 14.49 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 113.923 -1.49 . . . . 0.0 111.658 179.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.666 ' HB2' HD11 ' A' ' 56' ' ' LEU . . . -92.62 -29.82 15.93 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.138 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -59.76 -27.31 66.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.123 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -94.81 42.89 1.09 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.028 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -178.07 37.06 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.973 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -177.35 76.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.912 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -177.18 78.15 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.91 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -128.22 -42.41 0.25 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.552 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -177.05 78.3 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.909 0.385 . . . . 0.0 110.812 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -130.79 165.45 22.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.806 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -102.43 31.4 4.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.936 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.57 41.88 99.02 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.543 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -152.25 123.96 7.9 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.845 0.355 . . . . 0.0 110.923 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.46 HG11 ' CE2' ' A' ' 48' ' ' PHE . 10.3 p -128.52 124.52 61.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.936 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 51.1 p -76.46 148.22 37.38 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.925 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.682 HG13 ' CZ ' ' A' ' 67' ' ' PHE . 57.5 t -58.45 -39.56 75.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.836 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -56.06 -30.26 61.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.979 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -96.42 -31.9 12.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.886 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.698 ' HA ' HD12 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -58.77 -41.21 86.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.084 -179.757 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.472 ' HD2' HG12 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -57.54 -48.62 78.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.008 -179.909 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -59.56 -28.04 64.52 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.434 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.698 HD12 ' HA ' ' A' ' 48' ' ' PHE . 4.6 mt -86.47 -49.99 14.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.95 0.405 . . . . 0.0 110.989 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 tp -57.83 -40.5 76.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.278 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 13.6 mtp85 -47.63 -68.34 0.2 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.169 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -93.3 14.66 17.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.018 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.545 ' O ' HD23 ' A' ' 56' ' ' LEU . . . -110.51 -57.86 0.5 Allowed Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.592 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.666 HD11 ' HB2' ' A' ' 31' ' ' ALA . 10.4 mt -129.09 135.58 27.83 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.649 0.261 . . . . 0.0 111.015 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -78.95 97.38 1.13 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.641 2.227 . . . . 0.0 112.246 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.597 ' O ' HD11 ' A' ' 63' ' ' ILE . 1.3 mtp -129.52 140.28 51.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.814 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.898 ' O ' HD12 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -77.88 148.12 34.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.674 179.677 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.483 ' O ' ' N ' ' A' ' 64' ' ' THR . 6.1 pt-20 -39.53 -52.22 2.17 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.166 0.508 . . . . 0.0 111.064 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.529 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -47.98 -52.45 19.73 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.949 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.454 ' HB2' ' HE3' ' A' ' 58' ' ' MET . 0.9 OUTLIER -55.36 -62.4 1.7 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.377 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.898 HD12 ' O ' ' A' ' 59' ' ' THR . 1.8 mp -56.59 -61.82 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.964 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.483 ' N ' ' O ' ' A' ' 60' ' ' GLU . 55.3 m -52.14 -50.4 61.81 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.061 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.529 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 2.3 tp10 -65.99 -15.87 63.39 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 121.579 0.704 . . . . 0.0 110.459 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.441 ' CD2' ' O ' ' A' ' 62' ' ' GLU . 2.4 m-85 -96.31 -24.48 16.17 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.42 179.066 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.682 ' CZ ' HG13 ' A' ' 45' ' ' VAL . 8.5 m-30 -81.62 -28.92 33.47 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.797 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -94.12 -28.79 15.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.891 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.53 -11.19 54.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.402 0.62 . . . . 0.0 111.796 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.547 ' HB1' HG23 ' A' ' 78' ' ' ILE . . . -103.5 -30.2 10.68 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.015 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.407 ' HA ' ' HD2' ' A' ' 72' ' ' PRO . 10.8 t0 -119.63 95.74 49.35 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.813 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 71' ' ' ASP . 35.1 Cg_endo -65.04 -35.79 41.01 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.5 2.133 . . . . 0.0 112.325 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.725 ' OD1' HG23 ' A' ' 75' ' ' THR . 15.8 p30 -77.36 -30.4 53.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.875 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.1 m120 74.28 49.05 0.11 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.594 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.725 HG23 ' OD1' ' A' ' 73' ' ' ASN . 18.1 p -95.2 25.27 4.39 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.815 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 53.78 23.66 22.85 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.189 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -142.8 129.24 20.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.779 0.323 . . . . 0.0 110.442 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.547 HG23 ' HB1' ' A' ' 70' ' ' ALA . 7.2 mt -105.48 156.99 6.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.051 0.453 . . . . 0.0 111.67 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.526 ' N ' HG22 ' A' ' 78' ' ' ILE . 1.7 m-20 -85.11 97.59 9.96 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 176.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.414 ' C ' ' O ' ' A' ' 79' ' ' ASP . 50.0 t80 -28.48 -39.77 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -177.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.442 ' N ' ' O ' ' A' ' 79' ' ' ASP . 5.4 mmmm -65.11 -53.16 49.56 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.693 0.282 . . . . 0.0 110.698 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -54.11 -25.47 22.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.933 0.397 . . . . 0.0 110.594 179.198 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.497 ' CZ ' HD13 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -94.15 -30.15 14.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.102 -179.67 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.34 -38.8 26.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.315 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.66 -11.45 60.42 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.392 0.615 . . . . 0.0 111.716 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 36.9 tpp -67.49 -36.16 80.55 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.74 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.829 HD22 HD22 ' A' ' 28' ' ' LEU . 2.8 mp -100.74 -6.78 24.5 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 121.865 0.841 . . . . 0.0 111.537 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.406 ' O ' HG12 ' A' ' 90' ' ' VAL . 3.8 m-85 -124.61 22.34 8.31 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 114.135 -1.393 . . . . 0.0 111.111 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.5 m -58.24 89.26 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.061 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.582 ' O ' HG22 ' A' ' 90' ' ' VAL . 12.8 p -165.53 47.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.105 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -134.1 81.39 1.91 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.926 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -154.96 -178.2 7.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.851 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.935 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 ptp . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.728 0.299 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -103.22 28.0 17.61 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.515 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.9 m 59.97 31.48 20.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.771 0.32 . . . . 0.0 110.888 -179.947 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -108.63 73.81 0.89 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.855 -179.947 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 5.4 m170 59.77 31.3 20.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.889 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 8.8 m80 -77.19 -38.06 52.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.932 179.917 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 60.07 108.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.998 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -152.79 -53.57 0.11 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.943 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -177.25 73.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.829 179.954 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -177.0 134.66 0.2 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.863 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.2 m 60.31 110.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.86 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.8 p -168.14 123.78 1.01 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.961 179.957 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.78 -142.98 0.5 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.47 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -106.68 36.55 2.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.803 0.335 . . . . 0.0 110.909 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.5 p -123.43 139.28 31.6 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.949 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.33 146.78 30.91 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.506 2.137 . . . . 0.0 112.35 179.871 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 12.5 mtm105 -105.62 154.78 19.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.871 -179.975 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 131.23 42.76 0.19 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.497 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 59.8 m 59.55 31.28 20.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.77 0.319 . . . . 0.0 110.92 -179.994 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -119.66 34.55 5.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.833 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 5.0 ptm -123.67 -43.02 2.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.967 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.0 m -89.15 5.34 45.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.608 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -73.03 -14.53 61.44 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.525 0.679 . . . . 0.0 111.509 179.946 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -64.88 -16.62 63.44 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.095 179.638 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.561 ' HD3' HD22 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -91.67 -27.38 18.14 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.6 179.456 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.685 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -69.09 -28.85 66.87 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.817 -179.862 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.572 ' O ' HD23 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -59.4 -24.22 63.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.168 0.509 . . . . 0.0 109.675 178.529 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.712 HD13 HD21 ' A' ' 87' ' ' LEU . 5.4 tt -88.23 -11.29 47.05 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.451 179.691 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.685 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 12.4 mm -65.65 -14.48 17.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 114.794 -1.094 . . . . 0.0 112.007 -179.899 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -79.02 2.25 21.13 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 113.872 -1.513 . . . . 0.0 111.427 179.526 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.16 -30.8 15.05 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.171 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -59.05 -30.85 68.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.92 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -98.43 34.99 1.87 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.984 179.906 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -176.76 38.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.943 -179.999 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -166.72 73.7 0.15 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.952 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -169.97 75.03 0.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.866 -179.914 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -94.23 -44.18 3.58 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.551 179.991 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -167.96 74.15 0.12 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.956 0.408 . . . . 0.0 110.911 -179.984 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 60.92 111.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.928 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -102.42 105.2 15.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.92 179.925 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -112.85 -24.61 4.84 Favored Glycine 0 C--N 1.33 0.203 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.562 -179.918 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.404 ' CZ ' ' O ' ' A' ' 78' ' ' ILE . 10.5 t80 -152.96 123.83 7.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.811 0.339 . . . . 0.0 111.017 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.565 HG11 ' CE2' ' A' ' 48' ' ' PHE . 8.0 p -123.67 115.93 46.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.004 179.774 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.4 p -71.69 149.38 45.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.91 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.483 HG13 ' CZ ' ' A' ' 67' ' ' PHE . 82.0 t -54.51 -55.03 17.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.963 179.844 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -47.72 -30.63 4.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.971 -179.833 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -87.62 -30.04 20.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.443 179.391 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.609 ' CD2' HD12 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -68.95 -36.16 77.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.903 179.88 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.445 ' CZ ' HG12 ' A' ' 45' ' ' VAL . 37.5 mtt-85 -55.47 -51.54 66.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.027 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -57.03 -22.22 41.53 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.531 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 28.3 mt -89.86 -26.24 5.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.769 0.319 . . . . 0.0 111.223 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.442 HG21 HG12 ' A' ' 63' ' ' ILE . 31.2 mm -93.15 -28.65 4.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.228 -179.905 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.8 ttm-85 -56.31 -54.98 38.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.351 -179.648 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -111.76 15.08 21.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.621 -179.566 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -105.31 -87.89 2.02 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.819 -179.8 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.617 ' N ' HD12 ' A' ' 56' ' ' LEU . 4.1 mp -99.6 139.85 21.17 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-O 120.674 0.273 . . . . 0.0 111.11 -179.725 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.0 117.78 4.79 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.478 2.119 . . . . 0.0 112.252 179.869 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.645 ' O ' HD11 ' A' ' 63' ' ' ILE . 0.6 OUTLIER -153.12 137.9 17.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.811 -179.881 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.897 ' O ' HD12 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -75.45 146.75 40.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.653 179.506 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.532 ' O ' ' N ' ' A' ' 64' ' ' THR . 0.5 OUTLIER -39.07 -52.45 1.85 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.299 0.571 . . . . 0.0 111.011 179.744 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.511 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -46.34 -53.21 11.29 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.105 179.63 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.531 ' HB2' ' HE2' ' A' ' 58' ' ' MET . 0.5 OUTLIER -55.67 -61.33 2.43 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.872 0.368 . . . . 0.0 110.077 179.439 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.897 HD12 ' O ' ' A' ' 59' ' ' THR . 1.5 mp -59.39 -61.3 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.115 179.776 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.532 ' N ' ' O ' ' A' ' 60' ' ' GLU . 65.2 m -51.59 -51.67 53.67 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.232 -179.844 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.511 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 6.7 tt0 -65.75 -15.42 62.83 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-O 121.623 0.725 . . . . 0.0 110.389 179.778 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.435 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.4 m-30 -95.25 -25.49 16.33 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.537 -1.211 . . . . 0.0 110.389 179.114 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.751 ' CE2' HG22 ' A' ' 63' ' ' ILE . 2.6 m-30 -80.15 -28.94 38.79 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.719 179.942 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.42 -30.24 22.24 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.859 179.918 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.12 -11.13 59.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.503 0.668 . . . . 0.0 111.691 180.0 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.02 -29.9 12.64 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.836 -1.074 . . . . 0.0 111.035 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -124.43 117.06 26.65 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.755 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.37 -50.28 2.05 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.372 2.048 . . . . 0.0 112.301 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.602 ' CG ' HG23 ' A' ' 75' ' ' THR . 10.1 p30 -68.48 -32.77 73.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.852 179.911 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 6.1 m120 75.38 52.36 0.07 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.644 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.602 HG23 ' CG ' ' A' ' 73' ' ' ASN . 13.6 p -97.6 30.04 3.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.649 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 58.75 25.89 59.49 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.287 -179.717 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -127.75 131.13 49.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.802 0.334 . . . . 0.0 110.77 179.876 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.645 HD13 ' CE1' ' A' ' 83' ' ' PHE . 58.2 mt -105.05 152.64 6.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.233 0.539 . . . . 0.0 111.594 -179.764 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.435 ' N ' HG22 ' A' ' 78' ' ' ILE . 0.5 OUTLIER -99.01 95.58 7.23 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 176.912 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.422 ' C ' ' O ' ' A' ' 79' ' ' ASP . 38.6 t80 -28.93 -41.63 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.312 -178.081 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' A' ' 79' ' ' ASP . 4.4 mptt -65.86 -56.13 13.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.655 179.781 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.41 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -52.81 -26.83 15.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.944 0.402 . . . . 0.0 110.59 179.221 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.645 ' CE1' HD13 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -90.47 -31.98 16.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.813 179.956 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.46 ' O ' ' CD2' ' A' ' 88' ' ' TYR . . . -75.61 -41.38 54.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.225 179.946 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.467 ' HA ' ' CE2' ' A' ' 88' ' ' TYR . . . -61.97 -12.06 16.49 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.333 0.587 . . . . 0.0 112.035 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 8.8 mmt -79.27 -21.25 46.35 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.205 179.884 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.712 HD21 HD13 ' A' ' 28' ' ' LEU . 19.9 mt -100.6 -15.57 17.75 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 121.677 0.751 . . . . 0.0 112.366 -179.593 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.467 ' CE2' ' HA ' ' A' ' 85' ' ' ALA . 33.1 p90 -127.93 21.62 6.34 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.33 179.017 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.44 84.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.829 179.797 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.59 ' O ' HG22 ' A' ' 90' ' ' VAL . 13.1 p -178.05 45.64 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.985 179.947 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -64.84 152.64 42.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.854 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -92.11 167.34 12.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.862 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.1 m . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.895 179.997 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.439 ' HE3' HD22 ' A' ' 87' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.133 0 N-CA-C 109.708 -0.478 . . . . 5.0499999999999998 109.708 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.726 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.8 OUTLIER -67.24 -29.24 68.83 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.27 -0.423 . . . . 4.79 111.067 179.163 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.586 ' HB3' ' HG2' ' A' ' 57' ' ' PRO . 25.1 mt-30 -68.78 -31.86 71.18 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 109.177 -0.675 . . . . 6.1600000000000001 109.177 177.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.828 ' HG ' HD13 ' A' ' 56' ' ' LEU . 0.4 OUTLIER -84.33 -10.14 57.86 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.587 -0.733 . . . . 3.6899999999999999 112.166 179.032 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.726 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 7.1 mm -52.91 -18.37 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 115.345 -0.843 . . . . 5.46 112.589 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -67.91 1.07 2.86 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.366 -1.288 . . . . 6.6699999999999999 112.749 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.15 -40.87 67.71 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.049 -0.523 . . . . 6.3300000000000001 110.226 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -62.9 -30.09 71.27 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.364 -0.38 . . . . 7.9299999999999997 110.336 178.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.573 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -115.21 78.36 1.16 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.198 -0.456 . . . . 8.8599999999999994 110.446 179.686 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.573 ' CB ' ' O ' ' A' ' 33' ' ' TYR . 28.0 t30 . . . . . 0 N--CA 1.482 1.146 0 C-N-CA 124.495 1.118 . . . . 8.7899999999999991 111.501 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.233 0.187 0 CA-C-O 120.709 0.29 . . . . 7.3399999999999999 110.941 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.493 ' O ' ' HB ' ' A' ' 78' ' ' ILE . 7.4 p -142.84 128.66 16.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.183 -0.462 . . . . 5.2699999999999996 110.728 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.427 ' HA ' ' HA ' ' A' ' 77' ' ' PHE . 11.7 p -70.34 150.55 46.2 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.779 0.323 . . . . 6.3700000000000001 111.271 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.92 HG22 HG13 ' A' ' 78' ' ' ILE . 38.3 t -57.48 -42.75 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 115.936 -0.575 . . . . 5.5599999999999996 110.781 179.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.481 ' HA ' ' HD2' ' A' ' 49' ' ' ARG . 1.3 mt-10 -52.44 -50.3 62.86 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.718 -0.674 . . . . 8.1799999999999997 110.931 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.19 -41.45 77.15 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.366 -0.379 . . . . 9.3399999999999999 110.347 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.411 ' HA ' HD12 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -55.67 -43.26 76.17 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.838 -0.619 . . . . 5.7999999999999998 111.386 179.72 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.481 ' HD2' ' HA ' ' A' ' 46' ' ' GLU . 58.3 mtt180 -53.74 -52.49 59.99 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.394 -0.366 . . . . 8.2100000000000009 111.398 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -58.93 -42.09 96.59 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 121.151 -0.547 . . . . 8.5999999999999996 112.814 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.411 HD12 ' HA ' ' A' ' 48' ' ' PHE . 7.9 mt -67.59 -47.17 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 CA-C-O 120.643 0.258 . . . . 7.3300000000000001 111.101 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.713 HD13 HD12 ' A' ' 56' ' ' LEU . 4.7 mm -62.97 -36.79 77.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 116.101 -0.499 . . . . 6.9400000000000004 111.917 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 19.1 mtt85 -47.59 -59.37 3.31 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.264 0.468 . . . . 10.77 112.264 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -111.81 15.1 21.02 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 111.958 0.355 . . . . 10.92 111.958 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.52 -70.67 0.63 Allowed Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.939 -0.648 . . . . 7.7999999999999998 112.874 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.828 HD13 ' HG ' ' A' ' 28' ' ' LEU . 7.1 mt -104.71 116.15 61.44 Favored Pre-proline 0 CA--C 1.53 0.194 0 CA-C-O 120.554 0.216 . . . . 6.1399999999999997 111.163 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.586 ' HG2' ' HB3' ' A' ' 27' ' ' GLN . 38.9 Cg_endo -66.22 97.58 0.36 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.806 2.337 . . . . 7.0099999999999998 112.102 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.634 ' O ' HD11 ' A' ' 63' ' ' ILE . 1.0 OUTLIER -138.44 144.68 40.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.536 -0.757 . . . . 7.04 110.813 -179.81 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.67 ' O ' HD12 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -85.91 154.02 21.8 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.946 -0.57 . . . . 8.9100000000000001 110.284 179.305 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.445 ' O ' ' HB ' ' A' ' 64' ' ' THR . 4.7 pt-20 -45.13 -52.68 8.95 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.813 0.339 . . . . 10.6 111.251 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.417 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -50.69 -20.82 1.34 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.688 0.625 . . . . 8.7200000000000006 112.688 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.493 ' HG2' ' O ' ' A' ' 59' ' ' THR . 0.1 OUTLIER -95.45 -50.37 5.02 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.762 -0.458 . . . . 7.0999999999999996 109.762 179.054 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.67 HD12 ' O ' ' A' ' 59' ' ' THR . 0.8 OUTLIER -71.52 -45.35 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 116.225 -0.443 . . . . 6.2400000000000002 111.692 179.887 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.445 ' HB ' ' O ' ' A' ' 60' ' ' GLU . 17.3 m -69.53 -45.5 68.68 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.41 -0.359 . . . . 7.6200000000000001 110.699 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.417 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 23.8 tt0 -64.8 -18.88 65.49 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.426 0.631 . . . . 8.9700000000000006 110.491 179.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 6.2 m-30 -96.46 -31.66 12.7 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.761 -1.109 . . . . 5.2400000000000002 110.316 178.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.682 ' CD1' HD11 ' A' ' 78' ' ' ILE . 2.8 m-30 -63.07 -35.86 81.67 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.415 -0.357 . . . . 4.6600000000000001 110.891 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -87.88 -35.88 17.49 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.347 -0.388 . . . . 8.0600000000000005 110.817 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.47 -14.57 61.26 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.403 0.519 . . . . 5.9299999999999997 112.403 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.37 -38.33 11.03 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.384 -0.825 . . . . 4.4299999999999997 111.124 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' ' 77' ' ' PHE . 37.6 t0 -108.28 107.05 59.81 Favored Pre-proline 0 CA--C 1.53 0.203 0 CA-C-N 116.344 -0.389 . . . . 5.4500000000000002 110.989 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -61.96 -38.14 60.2 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.709 2.272 . . . . 6.8300000000000001 112.491 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -75.75 -32.74 60.1 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.331 -0.395 . . . . 6.6799999999999997 111.472 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 26.8 m120 69.74 24.46 5.4 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.059 0.457 . . . . 7.0800000000000001 110.37 -178.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.5 t -68.59 -16.77 63.96 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.72 -0.673 . . . . 5.7199999999999998 111.043 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 111.84 17.72 8.32 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-N 116.261 -0.427 . . . . 5.4299999999999997 112.659 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.443 ' O ' ' HB2' ' A' ' 71' ' ' ASP . 13.6 m-85 -116.39 164.64 14.24 Favored 'General case' 0 CA--C 1.527 0.06 0 N-CA-C 109.99 -0.374 . . . . 6.4500000000000002 109.99 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.92 HG13 HG22 ' A' ' 45' ' ' VAL . 7.1 mt -142.09 147.64 21.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.356 0.598 . . . . 3.79 112.25 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.43 100.36 12.38 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.447 -1.316 . . . . 5.3499999999999996 107.447 176.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -37.91 -40.31 0.45 Allowed 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.255 0.465 . . . . 5.6100000000000003 112.255 -177.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.7 mttp -64.5 -48.51 74.89 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.758 -0.201 . . . . 8.0299999999999994 110.844 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.56 -38.9 64.33 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.97 0.415 . . . . 4.4400000000000004 110.314 178.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.566 ' CE1' HD13 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -75.63 -40.33 56.44 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.649 -0.705 . . . . 3.1699999999999999 110.871 179.343 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.39 -33.0 74.93 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.259 -0.428 . . . . 4.5199999999999996 111.523 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.22 -11.87 58.56 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.807 0.669 . . . . 5.7699999999999996 112.807 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 6.3 mmt -77.12 -45.87 25.45 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.572 -0.74 . . . . 4.7599999999999998 110.399 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.788 HD21 HD13 ' A' ' 28' ' ' LEU . 1.4 mp -88.2 -8.98 54.49 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.472 0.653 . . . . 5.1500000000000004 112.242 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -117.04 22.75 12.35 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.606 -1.179 . . . . 7.3300000000000001 111.11 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.533 0.303 0 CA-C-O 121.023 0.44 . . . . 8.25 111.051 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.733 ' HG2' HD23 ' A' ' 87' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.737 0.303 . . . . 0.0 110.618 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.674 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -60.17 -28.27 67.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.775 -179.857 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.25 -23.96 66.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.232 0.539 . . . . 0.0 109.682 178.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.745 ' O ' HD13 ' A' ' 28' ' ' LEU . 2.7 tm? -88.03 -11.32 47.61 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.257 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.674 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 10.7 mm -66.0 -14.42 17.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.92 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -77.6 2.15 17.42 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 113.9 -1.5 . . . . 0.0 111.52 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.435 ' HA ' HD11 ' A' ' 56' ' ' LEU . . . -93.41 -29.53 15.55 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.132 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -56.66 -22.81 37.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.155 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -97.25 29.76 3.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.129 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.902 179.902 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.837 0.351 . . . . 0.0 110.882 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.468 HG11 ' CE2' ' A' ' 48' ' ' PHE . 8.1 p -144.18 139.75 24.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.963 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -88.9 155.16 19.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.006 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.452 HG13 ' CZ ' ' A' ' 67' ' ' PHE . 86.1 t -58.24 -55.9 19.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.058 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -46.69 -30.73 2.51 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.078 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -91.23 -28.85 17.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.476 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.474 ' HA ' HD12 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -68.75 -38.19 79.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.74 179.716 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 26.9 mtp180 -57.6 -50.3 73.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.915 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -56.72 -25.85 52.34 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.543 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.474 HD12 ' HA ' ' A' ' 48' ' ' PHE . 28.5 mt -84.05 -43.81 17.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.796 0.331 . . . . 0.0 111.011 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.481 HG21 HG12 ' A' ' 63' ' ' ILE . 30.9 mm -69.72 -28.66 38.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.192 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 20.1 mtm180 -50.63 -58.22 6.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.018 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -111.75 14.9 21.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.272 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -99.0 -86.51 1.88 Allowed Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.665 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.435 HD11 ' HA ' ' A' ' 31' ' ' ALA . 7.9 mp -103.76 145.73 31.18 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.755 0.312 . . . . 0.0 111.068 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.98 112.91 3.6 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.504 2.136 . . . . 0.0 112.312 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.554 ' O ' HD11 ' A' ' 63' ' ' ILE . 1.1 ttp -154.85 138.32 15.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.721 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.87 ' O ' HD12 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -78.86 146.6 33.56 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.466 179.463 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.556 ' O ' ' N ' ' A' ' 64' ' ' THR . 0.6 OUTLIER -40.29 -53.21 2.58 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.288 0.566 . . . . 0.0 110.913 179.841 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.526 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -46.23 -53.08 11.28 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.045 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.443 ' HB2' ' HE3' ' A' ' 58' ' ' MET . 0.6 OUTLIER -56.04 -61.16 2.57 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 179.446 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.87 HD12 ' O ' ' A' ' 59' ' ' THR . 1.2 mp -59.66 -61.09 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.049 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.556 ' N ' ' O ' ' A' ' 60' ' ' GLU . 51.7 m -51.18 -51.03 57.64 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.171 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.526 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 8.6 tt0 -66.56 -15.45 63.43 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 121.683 0.754 . . . . 0.0 110.399 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.426 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.6 m-30 -96.23 -25.31 15.85 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.44 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.766 ' CE2' HG22 ' A' ' 63' ' ' ILE . 1.6 m-85 -73.74 -46.63 44.65 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.65 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.44 -26.51 58.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.153 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.53 -11.03 60.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.457 0.646 . . . . 0.0 111.844 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.433 ' HB2' ' CE1' ' A' ' 83' ' ' PHE . . . -96.3 -51.41 4.39 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.867 -1.061 . . . . 0.0 111.193 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 29.1 p-10 -105.35 118.79 54.86 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.9 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -69.14 -36.12 13.1 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.466 2.111 . . . . 0.0 112.32 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -68.42 -32.69 72.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.878 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 71.65 40.86 0.75 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.145 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.538 HG23 ' HB2' ' A' ' 77' ' ' PHE . 1.4 t -91.36 29.9 1.38 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.635 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 56.02 26.73 49.52 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.454 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.538 ' HB2' HG23 ' A' ' 75' ' ' THR . 2.4 m-85 -123.47 161.27 25.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.777 0.323 . . . . 0.0 110.646 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.712 HD11 ' HD1' ' A' ' 67' ' ' PHE . 52.2 mt -139.32 148.93 23.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.247 0.546 . . . . 0.0 111.706 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.445 ' O ' ' N ' ' A' ' 82' ' ' ALA . 0.7 OUTLIER -97.49 96.28 8.22 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 176.812 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.426 ' C ' ' O ' ' A' ' 79' ' ' ASP . 39.4 t80 -28.61 -40.78 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.366 -178.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 79' ' ' ASP . 1.7 mtmp? -66.44 -54.78 20.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.567 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.445 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -52.96 -26.98 16.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.018 0.437 . . . . 0.0 110.478 179.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.552 ' CE1' HD13 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -91.1 -31.44 16.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.884 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.65 -20.74 33.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.579 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.25 -11.23 60.43 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.423 0.63 . . . . 0.0 111.934 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.493 ' HB3' HD12 ' A' ' 87' ' ' LEU . 17.2 tpp -78.18 -35.34 48.82 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.57 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.733 HD23 ' HG2' ' A' ' 25' ' ' LYS . 6.9 mp -96.4 -5.86 38.82 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.831 0.824 . . . . 0.0 111.299 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -122.35 21.89 10.19 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 114.174 -1.375 . . . . 0.0 111.098 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.062 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.572 ' HG2' HD22 ' A' ' 87' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.783 0.325 . . . . 0.0 110.688 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.683 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -63.1 -29.48 70.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.814 -179.875 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -60.6 -24.28 65.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.18 0.515 . . . . 0.0 109.701 178.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.978 HD13 HD21 ' A' ' 87' ' ' LEU . 5.5 tt -88.24 -11.29 47.03 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.456 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.683 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 10.8 mm -64.39 -14.59 16.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.971 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -76.92 1.83 16.49 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 114.085 -1.416 . . . . 0.0 111.543 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.54 -28.37 16.1 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.072 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -58.0 -20.81 41.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.317 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -93.97 23.82 4.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.554 -0.293 . . . . 0.0 111.182 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.052 179.957 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.848 0.356 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.429 ' O ' HG13 ' A' ' 43' ' ' VAL . 10.2 p -122.77 125.15 72.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.042 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 52.7 p -70.49 168.43 16.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.872 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.827 HG22 HG13 ' A' ' 78' ' ' ILE . 41.2 t -73.06 -29.05 27.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.835 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -74.84 -53.03 9.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.711 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -58.38 -32.75 68.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.582 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.751 ' HD2' HD12 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -59.63 -35.91 75.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.76 179.715 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.72 -51.29 70.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.926 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -54.94 -25.39 37.68 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.363 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 24.6 mt -90.58 -39.94 12.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.823 0.344 . . . . 0.0 110.898 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.415 HG21 HG12 ' A' ' 63' ' ' ILE . 36.5 mm -74.26 -27.2 21.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.199 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.4 ttt85 -50.7 -58.72 5.19 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.878 0.37 . . . . 0.0 111.068 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -111.9 15.07 20.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.299 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -97.65 -86.02 1.81 Allowed Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.712 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.607 HD22 ' HA ' ' A' ' 28' ' ' LEU . 11.2 mt -101.19 135.6 19.87 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.587 0.232 . . . . 0.0 111.0 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -78.73 59.32 7.22 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.488 2.125 . . . . 0.0 112.325 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.629 ' O ' HD11 ' A' ' 63' ' ' ILE . 1.4 mtp -88.32 141.68 28.35 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.582 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.911 ' O ' HD12 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -77.95 147.68 34.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.772 179.762 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.494 ' O ' ' N ' ' A' ' 64' ' ' THR . 3.0 pt-20 -38.08 -48.5 1.23 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.19 0.519 . . . . 0.0 111.094 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.515 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -50.96 -52.78 39.13 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.922 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.478 ' HB2' ' HE2' ' A' ' 58' ' ' MET . 1.1 mm-40 -55.15 -61.79 2.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.007 0.432 . . . . 0.0 109.934 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.911 HD12 ' O ' ' A' ' 59' ' ' THR . 1.8 mp -57.92 -61.79 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.202 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.494 ' N ' ' O ' ' A' ' 60' ' ' GLU . 92.2 m -52.36 -52.28 54.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.291 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.515 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 1.2 tp10 -64.46 -15.58 60.95 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 121.702 0.763 . . . . 0.0 110.504 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.428 ' CD1' ' O ' ' A' ' 62' ' ' GLU . 3.5 m-30 -95.07 -28.87 14.88 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.284 179.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.742 ' CD1' HD11 ' A' ' 78' ' ' ILE . 10.0 m-30 -79.84 -24.39 41.33 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.848 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -93.96 -27.34 16.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.85 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.77 -11.41 42.27 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.436 0.636 . . . . 0.0 111.72 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.65 -27.41 14.38 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.961 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.401 ' HA ' ' HD2' ' A' ' 72' ' ' PRO . 14.6 t0 -120.68 96.53 48.81 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.781 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 71' ' ' ASP . 30.1 Cg_endo -63.58 -29.9 70.48 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.411 2.074 . . . . 0.0 112.243 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -83.31 -27.03 30.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.828 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 73.09 40.39 0.56 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.179 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.2 t -91.47 28.71 1.63 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.621 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.483 ' C ' HG23 ' A' ' 45' ' ' VAL . . . 47.42 31.83 7.0 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.317 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.636 ' N ' HG23 ' A' ' 45' ' ' VAL . 1.2 t80 -134.04 129.19 35.7 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.849 0.357 . . . . 0.0 110.285 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.827 HG13 HG22 ' A' ' 45' ' ' VAL . 65.5 mt -102.75 150.57 6.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.183 0.516 . . . . 0.0 111.461 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.43 ' O ' ' N ' ' A' ' 82' ' ' ALA . 2.2 m-20 -93.76 95.64 9.27 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 176.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.423 ' C ' ' O ' ' A' ' 79' ' ' ASP . 42.4 t80 -29.67 -40.6 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.238 -177.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 79' ' ' ASP . 15.8 mtmt -66.15 -55.22 17.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.797 0.332 . . . . 0.0 110.613 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -52.72 -27.9 19.63 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.033 0.444 . . . . 0.0 110.501 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.591 ' CE1' HD13 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -89.66 -32.78 16.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.804 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.37 -24.46 46.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.197 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.8 -11.41 60.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.446 0.641 . . . . 0.0 111.729 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 9.4 mtp -75.14 -37.88 61.23 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.743 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.978 HD21 HD13 ' A' ' 28' ' ' LEU . 4.1 mt -88.19 -6.88 57.59 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.854 0.835 . . . . 0.0 111.52 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -125.99 22.45 7.35 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.131 -1.395 . . . . 0.0 111.184 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.879 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.593 ' HE3' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.792 0.329 . . . . 0.0 110.727 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.655 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -56.76 -26.4 57.34 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.05 -179.775 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -62.89 -23.62 67.43 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.751 ' O ' HD13 ' A' ' 28' ' ' LEU . 2.7 tm? -88.12 -11.48 46.87 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.362 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.655 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 12.2 mm -64.68 -14.74 16.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 114.77 -1.104 . . . . 0.0 111.946 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -77.67 2.07 17.88 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 113.907 -1.497 . . . . 0.0 111.667 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.585 ' N ' HD21 ' A' ' 56' ' ' LEU . . . -93.37 -40.09 10.58 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.022 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -58.82 -29.83 67.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.95 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -98.1 28.36 4.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.954 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.767 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.401 ' CE2' ' HA ' ' A' ' 79' ' ' ASP . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.783 0.325 . . . . 0.0 110.965 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.5 p -120.93 136.17 58.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.014 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.4 ' HB3' ' CD1' ' A' ' 77' ' ' PHE . 1.3 m -88.71 145.08 25.85 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.855 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 93.1 t -51.51 -55.69 7.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.179 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -47.95 -31.3 5.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.873 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -86.92 -30.24 21.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.413 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.567 ' HD2' HD12 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -67.08 -40.08 86.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.825 179.847 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -56.47 -50.7 70.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.911 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -56.03 -25.41 46.11 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.315 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.436 HD12 ' HA ' ' A' ' 48' ' ' PHE . 28.7 mt -85.51 -43.89 16.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.817 0.341 . . . . 0.0 110.924 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 34.5 mm -71.65 -26.05 25.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.147 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 10.0 mmp_? -52.48 -59.5 4.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.748 0.308 . . . . 0.0 111.118 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -111.72 14.94 21.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.361 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -98.31 -86.35 1.85 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.678 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.585 HD21 ' N ' ' A' ' 31' ' ' ALA . 3.2 mp -105.54 146.78 33.47 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-O 120.689 0.281 . . . . 0.0 111.049 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -73.48 95.09 0.85 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.588 2.192 . . . . 0.0 112.11 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.425 ' HE2' ' HG3' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -130.8 141.67 50.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.799 -179.81 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.702 ' O ' HD12 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -90.0 144.88 25.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.956 179.449 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.601 ' O ' ' N ' ' A' ' 64' ' ' THR . 6.4 pt-20 -47.33 -56.96 5.83 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 121.077 0.465 . . . . 0.0 110.49 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.428 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -50.29 -24.56 3.01 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.982 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.49 ' HB3' ' O ' ' A' ' 59' ' ' THR . 4.8 tp10 -86.67 -46.0 10.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.335 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.722 HG22 ' CE2' ' A' ' 67' ' ' PHE . 0.7 OUTLIER -82.63 -47.82 18.43 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.179 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.074 179.552 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.601 ' N ' ' O ' ' A' ' 60' ' ' GLU . 23.0 m -59.48 -46.84 87.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.202 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.428 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 0.9 OUTLIER -68.32 -16.51 63.97 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 121.755 0.788 . . . . 0.0 110.201 179.376 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.407 ' CD1' ' O ' ' A' ' 62' ' ' GLU . 3.1 m-85 -97.14 -24.0 15.94 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.31 -1.313 . . . . 0.0 110.286 178.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.736 ' CD1' HD11 ' A' ' 78' ' ' ILE . 2.1 m-85 -72.19 -41.3 67.14 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.767 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -79.85 -28.33 40.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.917 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.15 -11.26 60.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.437 0.637 . . . . 0.0 111.741 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.405 ' HB2' ' HE1' ' A' ' 83' ' ' PHE . . . -94.83 -30.59 14.14 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.041 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.484 ' OD2' HG22 ' A' ' 75' ' ' THR . 22.2 t70 -120.73 120.38 29.6 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.909 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -64.36 -27.12 63.18 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.46 2.107 . . . . 0.0 112.282 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 -87.79 -32.56 19.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.886 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 71.52 38.93 0.95 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.063 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.484 HG22 ' OD2' ' A' ' 71' ' ' ASP . 1.6 t -89.2 42.74 1.1 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.689 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 50.87 25.03 8.93 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.636 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.425 ' HB2' HG23 ' A' ' 75' ' ' THR . 41.4 m-85 -122.21 159.16 27.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.905 0.383 . . . . 0.0 110.718 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.736 HD11 ' CD1' ' A' ' 67' ' ' PHE . 50.5 mt -137.28 153.39 28.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.146 0.498 . . . . 0.0 111.593 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.449 ' N ' HG22 ' A' ' 78' ' ' ILE . 1.0 OUTLIER -98.72 95.86 7.52 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 176.923 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.425 ' C ' ' O ' ' A' ' 79' ' ' ASP . 47.8 t80 -28.96 -41.16 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.333 -178.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 79' ' ' ASP . 22.2 mttt -68.01 -55.88 11.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.728 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -51.43 -27.46 10.29 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.961 0.41 . . . . 0.0 110.672 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.509 ' CE1' HD13 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -91.13 -33.06 15.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.94 179.852 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.401 ' O ' ' CD2' ' A' ' 88' ' ' TYR . . . -80.56 -18.24 48.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.444 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.95 -11.69 61.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.379 0.609 . . . . 0.0 111.719 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 51.4 mtm -76.18 -38.49 56.54 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.587 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.597 ' N ' HD22 ' A' ' 87' ' ' LEU . 2.7 mm? -85.94 -6.59 59.03 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 121.822 0.82 . . . . 0.0 111.365 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.401 ' CD2' ' O ' ' A' ' 84' ' ' ALA . 19.0 m-85 -125.65 22.21 7.6 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 114.142 -1.39 . . . . 0.0 111.157 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.929 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.711 ' HD3' HD23 ' A' ' 87' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.156 0 CA-C-O 120.844 0.354 . . . . 0.0 110.587 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.681 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -65.55 -29.07 69.65 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.781 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -59.21 -23.74 62.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.278 0.561 . . . . 0.0 109.776 178.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.839 HD13 HD21 ' A' ' 87' ' ' LEU . 5.7 tt -88.12 -11.32 47.32 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.415 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.681 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 11.0 mm -67.19 -13.67 17.02 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-N 114.749 -1.114 . . . . 0.0 111.952 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -76.61 2.12 14.96 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 113.921 -1.491 . . . . 0.0 111.621 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 1.091 ' HB2' HD21 ' A' ' 56' ' ' LEU . . . -93.03 -33.51 14.09 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.076 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -63.73 -29.17 70.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.887 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -97.99 31.76 2.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.907 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.865 -179.982 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 78.1 t80 . . . . . 0 C--O 1.23 0.055 0 CA-C-O 120.902 0.382 . . . . 0.0 110.828 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.413 HG11 ' CE2' ' A' ' 48' ' ' PHE . 7.5 p -142.76 125.02 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.875 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.407 ' HB3' ' CD2' ' A' ' 77' ' ' PHE . 1.8 m -77.21 154.71 32.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.056 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.521 HG13 ' CZ ' ' A' ' 67' ' ' PHE . 59.4 t -59.87 -52.69 58.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.759 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -50.09 -31.31 12.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.907 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.4 mm-40 -91.69 -29.22 16.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.46 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.413 ' CE2' HG11 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -64.66 -35.9 82.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.813 179.844 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 15.5 mtt180 -58.37 -49.55 76.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.859 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -57.05 -26.77 56.32 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.36 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 26.0 mt -85.29 -44.35 17.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.891 0.377 . . . . 0.0 110.991 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 37.5 mm -67.2 -29.07 44.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.107 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.09 -57.09 10.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.908 0.385 . . . . 0.0 110.925 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -111.76 14.82 21.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.312 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -99.55 -86.62 1.9 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.673 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 1.091 HD21 ' HB2' ' A' ' 31' ' ' ALA . 6.7 mt -100.19 139.04 20.41 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.577 0.227 . . . . 0.0 110.969 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -79.06 58.79 7.11 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.472 2.115 . . . . 0.0 112.314 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.484 ' O ' HD11 ' A' ' 63' ' ' ILE . 1.4 ttp -94.5 139.9 30.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.746 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.902 ' O ' HD12 ' A' ' 63' ' ' ILE . 0.8 OUTLIER -75.95 142.56 41.95 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.052 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.548 ' O ' ' N ' ' A' ' 64' ' ' THR . 6.6 pt-20 -39.5 -51.79 2.16 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.276 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.434 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -45.61 -55.52 6.24 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.182 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.476 ' HB2' ' HG2' ' A' ' 58' ' ' MET . 0.9 OUTLIER -55.07 -60.86 2.8 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.619 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.902 HD12 ' O ' ' A' ' 59' ' ' THR . 1.5 mp -58.94 -61.93 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.921 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.548 ' N ' ' O ' ' A' ' 60' ' ' GLU . 75.2 m -49.55 -52.45 29.81 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.218 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.434 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 44.0 mt-10 -66.16 -15.75 63.4 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.701 0.762 . . . . 0.0 110.381 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.44 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.5 m-30 -94.66 -26.51 16.3 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.517 -1.22 . . . . 0.0 110.385 179.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.731 ' CE2' HG22 ' A' ' 63' ' ' ILE . 2.4 m-30 -75.16 -30.27 60.67 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.681 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -92.91 -24.93 18.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.92 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.24 -11.23 44.21 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.518 0.675 . . . . 0.0 111.856 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.426 ' HB1' ' CG2' ' A' ' 78' ' ' ILE . . . -99.46 -27.27 13.81 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.136 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -118.96 115.7 34.64 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.703 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.83 -50.51 1.67 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.44 2.093 . . . . 0.0 112.5 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -68.48 -32.55 72.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.93 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 12.6 m120 72.41 30.62 1.94 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.543 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 36.8 p -68.48 -22.71 64.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.036 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 115.08 20.64 5.55 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.568 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.44 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 3.2 m-85 -137.48 150.37 47.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.671 0.272 . . . . 0.0 110.736 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.519 HD11 HG22 ' A' ' 45' ' ' VAL . 1.6 mt -133.36 146.55 32.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.571 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.434 ' O ' ' N ' ' A' ' 81' ' ' LYS . 8.5 m-20 -75.74 105.04 6.57 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 177.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.407 ' C ' ' O ' ' A' ' 79' ' ' ASP . 27.6 t80 -28.73 -40.19 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 79' ' ' ASP . 0.1 OUTLIER -64.64 -53.32 49.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.654 0.264 . . . . 0.0 110.854 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -51.45 -27.24 9.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.063 0.458 . . . . 0.0 110.747 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.49 ' CD1' HG21 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -93.83 -32.48 13.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.986 -179.869 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.99 -18.49 53.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.262 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -71.72 -11.61 60.91 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.427 0.632 . . . . 0.0 111.803 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.36 -41.82 62.97 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.716 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.839 HD21 HD13 ' A' ' 28' ' ' LEU . 7.1 mp -86.03 -6.31 59.06 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.884 0.85 . . . . 0.0 111.512 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -125.28 22.26 7.84 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.168 -1.378 . . . . 0.0 111.107 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.886 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.479 ' HE2' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 120.781 0.324 . . . . 0.0 110.65 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.657 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -67.15 -27.75 67.55 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.857 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -59.51 -23.75 63.07 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.978 HD13 HD21 ' A' ' 87' ' ' LEU . 5.6 tt -88.2 -11.31 47.09 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.563 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.657 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 11.9 mm -66.1 -14.06 16.81 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 114.695 -1.139 . . . . 0.0 111.932 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.89 1.98 15.99 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 113.915 -1.493 . . . . 0.0 111.66 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.858 ' HB2' HD11 ' A' ' 56' ' ' LEU . . . -93.33 -29.21 15.75 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.076 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -57.18 -25.91 59.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.098 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -95.08 42.42 1.09 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.814 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.849 179.925 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 34.0 t80 . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.852 0.358 . . . . 0.0 111.006 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.501 HG11 ' CE2' ' A' ' 48' ' ' PHE . 7.7 p -175.65 125.43 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.907 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.53 146.93 40.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.112 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.512 HG22 ' CD1' ' A' ' 67' ' ' PHE . 75.7 t -56.25 -53.23 42.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.989 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -48.0 -30.09 4.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.973 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -92.83 -30.0 15.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.467 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.501 ' CE2' HG11 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -64.6 -33.28 75.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.8 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 8.7 mtt180 -55.35 -51.72 65.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.941 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -56.15 -25.71 47.79 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.438 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 40.6 mt -81.97 -28.69 9.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.795 0.331 . . . . 0.0 111.022 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 31.6 mm -90.2 -28.32 5.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.104 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.9 mmm-85 -54.29 -55.6 26.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.346 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -111.66 14.96 21.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.638 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -103.45 -87.49 2.01 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.321 -0.943 . . . . 0.0 112.764 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.858 HD11 ' HB2' ' A' ' 31' ' ' ALA . 4.4 mp -102.54 143.79 27.31 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 120.767 0.317 . . . . 0.0 111.044 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.51 118.41 4.87 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.501 2.134 . . . . 0.0 112.226 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.572 ' O ' HD11 ' A' ' 63' ' ' ILE . 0.4 OUTLIER -158.52 137.68 11.51 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.716 -179.772 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.868 ' O ' HD12 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -78.27 146.06 35.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.468 179.303 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.575 ' O ' ' N ' ' A' ' 64' ' ' THR . 4.8 pt-20 -39.98 -52.79 2.44 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 121.376 0.608 . . . . 0.0 111.01 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.519 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -46.14 -53.91 9.56 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.164 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.461 ' HB2' ' HE2' ' A' ' 58' ' ' MET . 1.8 mm-40 -55.27 -61.53 2.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.956 0.407 . . . . 0.0 109.95 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.868 HD12 ' O ' ' A' ' 59' ' ' THR . 1.1 mp -60.0 -61.68 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.184 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.575 ' N ' ' O ' ' A' ' 60' ' ' GLU . 61.7 m -50.16 -50.85 47.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.196 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.519 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 4.8 tp10 -64.92 -16.29 63.11 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.708 0.766 . . . . 0.0 110.453 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.424 ' CD2' ' O ' ' A' ' 62' ' ' GLU . 1.7 m-85 -96.44 -25.68 15.6 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.515 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.762 ' CE2' HG22 ' A' ' 63' ' ' ILE . 1.4 m-85 -73.42 -31.07 63.64 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.614 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -84.56 -28.21 26.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.971 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -81.34 -11.17 59.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.487 0.661 . . . . 0.0 111.819 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.518 ' HB2' ' CE1' ' A' ' 83' ' ' PHE . . . -97.39 -27.58 14.41 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.086 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -121.54 118.99 29.48 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.765 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -62.86 -53.93 1.42 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.578 2.186 . . . . 0.0 112.65 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.627 ' OD1' HG23 ' A' ' 75' ' ' THR . 14.8 p30 -68.41 -32.82 73.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.963 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.7 m120 74.47 43.74 0.25 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.626 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.627 HG23 ' OD1' ' A' ' 73' ' ' ASN . 17.6 p -93.14 37.79 1.04 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.523 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 55.69 23.02 35.09 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.383 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -124.08 128.54 49.46 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.42 HD11 ' HA ' ' A' ' 67' ' ' PHE . 0.4 OUTLIER -112.23 152.61 14.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.224 0.535 . . . . 0.0 111.512 -179.22 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -98.88 97.57 8.74 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.159 178.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -35.2 -35.91 0.05 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.028 -178.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.72 -51.95 50.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.511 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.75 -25.12 54.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.141 0.496 . . . . 0.0 110.413 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.518 ' CE1' ' HB2' ' A' ' 70' ' ' ALA . 0.1 OUTLIER -92.59 -29.59 16.07 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.928 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.4 ' O ' ' CD2' ' A' ' 88' ' ' TYR . . . -80.09 -25.92 39.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.157 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.76 -11.46 60.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.418 0.627 . . . . 0.0 111.814 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 14.0 tpp -82.72 -36.55 25.7 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.818 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.978 HD21 HD13 ' A' ' 28' ' ' LEU . 9.7 mt -85.8 -6.43 59.1 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.845 0.831 . . . . 0.0 111.505 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.4 ' CD2' ' O ' ' A' ' 84' ' ' ALA . 12.7 m-85 -126.07 22.14 7.34 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 114.101 -1.409 . . . . 0.0 111.001 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.8 t . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.874 179.902 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.8 tttt . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.776 0.322 . . . . 0.0 110.671 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.676 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -68.36 -28.91 67.54 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.671 -179.881 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -59.45 -23.82 63.02 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 1.118 HD13 HD21 ' A' ' 87' ' ' LEU . 4.1 tt -88.17 -11.22 47.47 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.436 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.735 HD13 ' HE2' ' A' ' 32' ' ' PHE . 11.8 mm -66.57 -14.14 17.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 114.803 -1.089 . . . . 0.0 111.983 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -78.14 2.3 18.5 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 113.936 -1.484 . . . . 0.0 111.51 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.868 ' HB2' HD21 ' A' ' 56' ' ' LEU . . . -93.42 -32.67 14.14 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.989 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.735 ' HE2' HD13 ' A' ' 29' ' ' ILE . 93.3 m-85 -59.26 -29.56 67.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.951 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -97.52 36.28 1.52 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.95 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.979 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.796 0.332 . . . . 0.0 110.922 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.563 ' O ' HG13 ' A' ' 43' ' ' VAL . 7.8 p -144.92 110.83 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.92 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.414 ' HB3' ' CD2' ' A' ' 77' ' ' PHE . 1.2 m -65.83 160.69 22.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.041 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.729 HG22 HD11 ' A' ' 78' ' ' ILE . 72.5 t -57.89 -56.07 17.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.784 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -47.13 -41.49 17.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.989 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -78.91 -27.65 43.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.48 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.473 ' CE2' ' CD2' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -67.7 -29.47 68.73 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.96 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 34.1 mmm-85 -56.07 -56.43 20.89 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.053 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -54.9 -23.61 31.3 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.621 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 24.7 mt -84.5 -24.34 7.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.631 0.253 . . . . 0.0 111.238 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 39.9 mm -93.03 -36.19 7.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.243 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.97 -46.43 71.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.119 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -111.84 14.84 21.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.508 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -109.8 -88.87 1.95 Allowed Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.66 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.868 HD21 ' HB2' ' A' ' 31' ' ' ALA . 1.6 mp -100.38 136.82 19.91 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.587 0.232 . . . . 0.0 110.989 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -79.9 58.44 6.98 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.529 2.152 . . . . 0.0 112.493 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.647 ' O ' HD11 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -86.4 141.71 28.96 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.567 179.607 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.896 ' O ' HD12 ' A' ' 63' ' ' ILE . 0.3 OUTLIER -75.78 145.59 40.64 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.606 179.632 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.544 ' O ' ' N ' ' A' ' 64' ' ' THR . 4.8 pt-20 -39.29 -52.23 2.0 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.178 0.513 . . . . 0.0 111.02 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.52 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -46.65 -53.61 11.25 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.071 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.525 ' HB2' ' HE2' ' A' ' 58' ' ' MET . 1.7 mm-40 -55.16 -61.64 2.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.928 0.394 . . . . 0.0 110.039 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.896 HD12 ' O ' ' A' ' 59' ' ' THR . 1.4 mp -59.17 -61.48 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.177 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.544 ' N ' ' O ' ' A' ' 60' ' ' GLU . 68.2 m -51.35 -51.68 52.32 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.174 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.52 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 28.8 tp10 -65.8 -15.46 62.9 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.576 0.703 . . . . 0.0 110.346 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.437 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.4 m-30 -94.94 -25.93 16.33 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.387 179.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.754 ' CE2' HG22 ' A' ' 63' ' ' ILE . 2.6 m-30 -79.64 -28.79 40.85 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.765 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -86.64 -31.1 21.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.881 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -81.46 -11.17 59.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.486 0.66 . . . . 0.0 111.713 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.564 ' HB1' ' CG2' ' A' ' 78' ' ' ILE . . . -102.25 -27.41 12.88 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.028 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -123.33 107.82 32.12 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.675 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.48 -43.5 7.83 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.397 2.065 . . . . 0.0 112.339 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -68.45 -32.31 72.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.823 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 21.2 m-20 73.96 20.95 2.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.529 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.415 HG22 ' H ' ' A' ' 75' ' ' THR . 0.9 OUTLIER -63.64 -22.38 66.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.861 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 109.21 19.75 8.29 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.502 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.414 ' CD2' ' HB3' ' A' ' 44' ' ' SER . 4.1 m-85 -132.97 146.27 51.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.776 0.322 . . . . 0.0 110.825 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.729 HD11 HG22 ' A' ' 45' ' ' VAL . 1.0 OUTLIER -133.38 146.09 32.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.433 179.789 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.438 ' O ' ' N ' ' A' ' 82' ' ' ALA . 0.4 OUTLIER -77.08 108.18 9.98 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 177.202 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.426 ' C ' ' O ' ' A' ' 79' ' ' ASP . 28.0 t80 -28.77 -40.75 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.428 ' N ' ' O ' ' A' ' 79' ' ' ASP . 0.2 OUTLIER -64.66 -53.13 52.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.935 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -50.21 -28.08 6.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.058 0.456 . . . . 0.0 110.771 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.538 ' CD1' HG21 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -93.25 -35.5 13.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.041 -179.748 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.08 -22.61 55.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.313 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.68 -11.55 60.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.476 0.655 . . . . 0.0 111.849 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 9.5 mmt -72.96 -31.28 64.45 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.806 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 1.118 HD21 HD13 ' A' ' 28' ' ' LEU . 2.6 mt -100.18 -6.59 25.9 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.917 0.865 . . . . 0.0 111.58 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -126.05 22.34 7.32 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.127 -1.397 . . . . 0.0 111.173 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.857 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.778 0.323 . . . . 0.0 110.687 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.683 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -57.9 -27.31 63.2 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.828 -179.807 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -62.86 -24.03 67.6 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.789 ' O ' HD13 ' A' ' 28' ' ' LEU . 2.9 tm? -88.08 -11.47 47.02 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.195 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.683 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 11.3 mm -64.98 -14.59 16.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.969 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -77.89 2.14 18.28 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 113.878 -1.51 . . . . 0.0 111.463 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.23 -31.23 14.82 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.064 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -59.54 -30.98 68.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.942 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -97.41 38.9 1.22 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.932 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.851 179.897 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.813 0.34 . . . . 0.0 110.971 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.449 ' CG1' ' CE2' ' A' ' 48' ' ' PHE . 9.4 p -131.39 127.67 60.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.976 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.1 p -78.99 162.08 26.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.906 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.668 HG22 HG13 ' A' ' 78' ' ' ILE . 46.5 t -64.17 -54.16 34.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.001 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -47.22 -29.75 2.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.084 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -93.32 -30.05 15.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.655 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.855 ' CD2' HD12 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -66.02 -38.31 88.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.95 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.6 mtp85 -54.72 -51.48 65.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.0 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -57.2 -21.49 39.73 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.606 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.9 mt -93.17 -25.43 4.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.744 0.307 . . . . 0.0 111.255 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.467 HG21 HG12 ' A' ' 63' ' ' ILE . 40.6 mm -93.37 -49.39 12.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.301 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 24.7 ttp180 -46.86 -68.86 0.16 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.7 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -92.44 14.93 15.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.745 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -121.31 -89.88 1.07 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.373 -0.918 . . . . 0.0 112.914 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -80.23 132.9 58.18 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.554 0.216 . . . . 0.0 111.192 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.65 113.82 3.82 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.466 2.111 . . . . 0.0 112.256 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.659 ' O ' HD11 ' A' ' 63' ' ' ILE . 0.7 OUTLIER -155.63 137.69 14.6 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.892 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.894 ' O ' HD12 ' A' ' 63' ' ' ILE . 0.6 OUTLIER -74.31 145.1 44.2 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.855 179.733 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.515 ' O ' ' N ' ' A' ' 64' ' ' THR . 2.3 pt-20 -37.85 -48.65 1.14 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.169 0.509 . . . . 0.0 111.054 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.426 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -49.55 -55.74 12.38 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.835 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.489 ' HB2' ' HE2' ' A' ' 58' ' ' MET . 0.6 OUTLIER -52.18 -62.6 1.53 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.286 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.894 HD12 ' O ' ' A' ' 59' ' ' THR . 1.8 mp -57.35 -62.84 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.123 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.515 ' N ' ' O ' ' A' ' 60' ' ' GLU . 99.3 m -50.12 -53.09 29.85 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.405 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.426 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 2.7 mm-40 -65.31 -15.8 62.91 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-O 121.617 0.722 . . . . 0.0 110.485 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.432 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.7 m-30 -94.61 -26.57 16.31 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.423 179.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.708 ' CE2' HG22 ' A' ' 63' ' ' ILE . 4.8 m-30 -77.97 -26.58 48.8 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.801 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -91.32 -28.93 17.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.805 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.07 -11.23 47.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.535 0.683 . . . . 0.0 111.782 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -92.09 -28.53 17.07 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.113 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -126.16 119.36 23.62 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.785 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.84 -40.67 16.15 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.272 1.982 . . . . 0.0 112.279 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -76.53 -30.94 57.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.817 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.2 m120 72.35 38.83 0.8 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.171 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.508 HG23 ' HB3' ' A' ' 77' ' ' PHE . 1.5 t -89.64 41.77 1.06 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.634 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.401 ' C ' HG23 ' A' ' 45' ' ' VAL . . . 47.94 26.94 4.64 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.523 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.508 ' HB3' HG23 ' A' ' 75' ' ' THR . 0.6 OUTLIER -128.12 129.38 46.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.819 0.342 . . . . 0.0 110.449 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.855 HD12 ' CD2' ' A' ' 48' ' ' PHE . 61.9 mt -102.49 153.34 5.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.19 0.519 . . . . 0.0 111.662 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.445 ' N ' HG22 ' A' ' 78' ' ' ILE . 1.2 t0 -98.78 95.76 7.43 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 176.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.426 ' C ' ' O ' ' A' ' 79' ' ' ASP . 56.4 t80 -29.06 -41.25 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.337 -177.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -66.0 -55.85 14.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.672 0.272 . . . . 0.0 110.618 179.818 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.415 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -52.65 -27.08 15.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.965 0.412 . . . . 0.0 110.594 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.621 ' CE1' HD13 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -90.37 -32.3 16.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.86 179.823 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.12 -28.76 48.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.165 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.82 -11.5 60.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.375 0.607 . . . . 0.0 111.708 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 14.1 tmm? -69.59 -35.12 75.04 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.913 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.54 HD21 ' HG ' ' A' ' 28' ' ' LEU . 3.0 mp -100.67 -5.97 25.8 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.816 0.817 . . . . 0.0 111.63 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -125.48 22.41 7.68 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 114.193 -1.367 . . . . 0.0 111.09 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.871 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.9 tttt . . . . . 0 N--CA 1.458 -0.04 0 CA-C-O 120.788 0.327 . . . . 0.0 110.644 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.668 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -68.08 -28.16 67.12 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.854 -179.892 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -60.3 -24.28 64.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.223 0.535 . . . . 0.0 109.562 178.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.925 HD13 HD21 ' A' ' 87' ' ' LEU . 5.6 tt -88.33 -11.22 46.98 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.476 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.668 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 13.5 mm -63.61 -15.45 16.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.964 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -80.56 1.95 27.52 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 113.854 -1.521 . . . . 0.0 111.345 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.491 ' HB2' HD21 ' A' ' 56' ' ' LEU . . . -93.45 -29.87 15.34 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.043 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -56.56 -28.16 59.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.053 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -97.65 28.3 3.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.084 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.218 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.869 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 54.3 t80 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.886 0.374 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.457 HG11 ' CE2' ' A' ' 48' ' ' PHE . 7.6 p -139.53 127.33 25.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.898 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.1 p -67.42 154.17 41.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.159 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.992 HG13 ' CD1' ' A' ' 67' ' ' PHE . 50.6 t -61.9 -27.8 43.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.928 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -71.91 -58.62 3.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.921 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -58.07 -29.07 65.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.802 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.835 ' CD2' HD12 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -61.85 -36.88 82.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.904 179.816 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 16.2 mtt-85 -58.08 -50.74 72.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.951 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -57.28 -26.48 56.39 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.548 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.641 HD12 ' HA ' ' A' ' 48' ' ' PHE . 22.9 mt -80.87 -39.61 18.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.81 0.338 . . . . 0.0 111.087 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 37.9 mm -75.65 -28.77 19.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.248 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.6 mtp85 -51.23 -55.13 19.7 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.094 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -111.86 14.93 21.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.276 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -100.24 -86.84 1.93 Allowed Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.533 -0.841 . . . . 0.0 112.74 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.491 HD21 ' HB2' ' A' ' 31' ' ' ALA . 3.5 mt -105.47 140.05 20.77 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 120.694 0.283 . . . . 0.0 110.981 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -81.35 55.76 5.73 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.524 2.149 . . . . 0.0 112.398 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.606 ' O ' HD11 ' A' ' 63' ' ' ILE . 2.7 ttp -88.2 139.22 30.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.696 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.884 ' O ' HD12 ' A' ' 63' ' ' ILE . 1.7 p -69.18 140.19 54.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.03 0.443 . . . . 0.0 111.067 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.509 ' O ' ' N ' ' A' ' 64' ' ' THR . 0.1 OUTLIER -39.95 -50.36 2.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.156 179.824 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.526 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -45.92 -52.97 10.68 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.489 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.482 ' O ' ' HB2' ' A' ' 66' ' ' PHE . 0.9 OUTLIER -58.2 -60.94 2.97 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.04 179.683 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.884 HD12 ' O ' ' A' ' 59' ' ' THR . 1.7 mp -57.2 -60.21 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.914 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.509 ' N ' ' O ' ' A' ' 60' ' ' GLU . 36.1 m -52.32 -51.24 59.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.786 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.526 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 27.2 tt0 -65.99 -16.14 63.63 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-O 121.603 0.716 . . . . 0.0 110.344 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.482 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 2.3 m-85 -95.77 -25.95 15.86 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.277 178.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.992 ' CD1' HG13 ' A' ' 45' ' ' VAL . 1.6 m-85 -70.74 -41.37 71.92 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.564 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -84.1 -29.14 27.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.919 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -80.5 -11.14 59.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.481 0.658 . . . . 0.0 111.76 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.39 -31.65 15.96 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.018 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -115.86 121.18 34.49 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.778 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.77 -34.95 59.78 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.453 2.102 . . . . 0.0 112.245 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 14.3 m-80 -84.5 -31.63 24.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.792 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 11.5 m120 72.43 37.08 0.95 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.166 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.8 t -88.93 41.84 1.05 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.743 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.427 ' C ' HG23 ' A' ' 45' ' ' VAL . . . 50.82 25.62 9.7 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 121.104 -0.57 . . . . 0.0 112.727 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.51 ' N ' HG23 ' A' ' 45' ' ' VAL . 23.4 m-85 -128.32 129.46 46.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.844 0.354 . . . . 0.0 110.662 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.835 HD12 ' CD2' ' A' ' 48' ' ' PHE . 59.8 mt -101.44 152.37 5.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.266 0.555 . . . . 0.0 111.627 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.448 ' N ' HG22 ' A' ' 78' ' ' ILE . 20.3 t0 -101.07 96.02 6.95 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 176.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.426 ' C ' ' O ' ' A' ' 79' ' ' ASP . 40.2 t80 -28.58 -41.31 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.436 -177.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 79' ' ' ASP . 0.4 OUTLIER -65.28 -55.41 18.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.689 0.28 . . . . 0.0 110.627 179.767 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -53.43 -27.58 25.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.16 0.505 . . . . 0.0 110.497 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.636 ' CE1' HD13 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -89.43 -31.7 17.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.734 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.6 -31.12 46.97 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.108 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -74.57 -11.34 60.18 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.503 0.668 . . . . 0.0 111.823 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 4.4 mmt -74.66 -32.11 62.15 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.808 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.925 HD21 HD13 ' A' ' 28' ' ' LEU . 2.7 mt -97.19 -6.93 33.63 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.921 0.867 . . . . 0.0 111.579 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -126.03 22.32 7.34 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.076 -1.42 . . . . 0.0 111.112 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 60.5 p . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.914 -179.987 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.407 ' NZ ' ' CE1' ' A' ' 88' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.842 0.353 . . . . 0.0 110.685 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.667 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -66.56 -29.11 69.11 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.814 -179.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -60.13 -24.26 64.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.093 0.473 . . . . 0.0 109.725 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.796 HD22 HD13 ' A' ' 87' ' ' LEU . 1.3 tt -88.15 -11.22 47.52 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.461 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.667 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 10.8 mm -65.26 -14.3 16.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.924 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -77.04 2.04 16.17 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 114.035 -1.439 . . . . 0.0 111.585 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.915 ' HB2' HD21 ' A' ' 56' ' ' LEU . . . -93.46 -30.78 14.87 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.102 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -57.41 -24.34 54.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.167 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -97.05 30.41 2.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.012 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.875 179.983 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.781 0.324 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.534 HG11 ' CE2' ' A' ' 48' ' ' PHE . 9.2 p -116.58 122.74 70.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.017 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.423 ' HB3' ' CE2' ' A' ' 77' ' ' PHE . 0.1 OUTLIER -74.73 154.29 38.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.825 179.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.563 HG22 HG13 ' A' ' 78' ' ' ILE . 57.4 t -58.87 -53.2 50.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.859 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -48.93 -33.05 10.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.937 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -86.36 -28.93 23.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.482 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.751 ' HD2' HD12 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -69.25 -41.99 76.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.859 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.445 ' HD2' HG12 ' A' ' 45' ' ' VAL . 13.7 mtp180 -56.27 -52.35 64.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.954 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -53.91 -25.1 29.43 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.326 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.447 HD12 ' HA ' ' A' ' 48' ' ' PHE . 14.1 mt -89.83 -47.05 15.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.854 0.359 . . . . 0.0 110.923 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.45 HG21 HG12 ' A' ' 63' ' ' ILE . 36.4 mm -66.06 -28.01 42.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.223 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.7 -61.53 2.15 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.904 0.383 . . . . 0.0 111.066 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -111.86 15.04 20.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.26 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -97.48 -86.05 1.81 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.591 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.915 HD21 ' HB2' ' A' ' 31' ' ' ALA . 14.1 mt -101.27 142.44 24.63 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.693 0.283 . . . . 0.0 111.065 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.32 113.49 3.69 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.533 2.155 . . . . 0.0 112.321 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.591 ' O ' HD11 ' A' ' 63' ' ' ILE . 0.8 OUTLIER -152.26 138.11 18.03 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.806 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.901 ' O ' HD12 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -77.65 147.67 35.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.683 179.698 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.519 ' O ' ' N ' ' A' ' 64' ' ' THR . 4.6 pt-20 -38.76 -51.86 1.7 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.162 0.505 . . . . 0.0 110.822 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.516 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -46.77 -53.64 11.46 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.118 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.491 ' HB2' ' HE2' ' A' ' 58' ' ' MET . 0.9 OUTLIER -54.91 -61.78 2.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.961 0.41 . . . . 0.0 110.02 179.478 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.901 HD12 ' O ' ' A' ' 59' ' ' THR . 1.6 mp -58.7 -61.54 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.205 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.519 ' N ' ' O ' ' A' ' 60' ' ' GLU . 62.7 m -52.02 -51.49 57.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.37 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.516 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 6.6 tt0 -65.64 -15.53 62.86 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.735 0.779 . . . . 0.0 110.497 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.431 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.6 m-30 -95.97 -25.47 15.94 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 114.449 -1.251 . . . . 0.0 110.321 179.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.718 ' CE2' HG22 ' A' ' 63' ' ' ILE . 4.0 m-30 -79.06 -26.57 43.07 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.748 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -91.37 -27.5 18.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.905 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.63 -11.18 43.31 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.487 0.66 . . . . 0.0 111.777 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.65 -28.39 18.41 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.016 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.53 119.25 23.02 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.829 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.31 -34.9 42.87 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.373 2.049 . . . . 0.0 112.204 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 26.2 m-20 -82.35 -31.32 29.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.9 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 12.9 m120 72.21 38.43 0.87 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.176 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.534 HG23 ' HB2' ' A' ' 77' ' ' PHE . 1.5 t -89.39 42.26 1.08 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.578 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 50.75 25.29 9.06 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.663 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.534 ' HB2' HG23 ' A' ' 75' ' ' THR . 1.9 m-85 -123.08 146.74 47.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.783 0.325 . . . . 0.0 110.783 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.751 HD12 ' HD2' ' A' ' 48' ' ' PHE . 59.4 mt -123.02 153.12 28.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.096 0.474 . . . . 0.0 111.578 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.447 ' N ' HG22 ' A' ' 78' ' ' ILE . 0.5 OUTLIER -98.3 95.78 7.6 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 176.958 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.43 ' C ' ' O ' ' A' ' 79' ' ' ASP . 42.6 t80 -29.34 -41.23 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.036 -0.529 . . . . 0.0 112.293 -178.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.406 ' N ' ' O ' ' A' ' 79' ' ' ASP . 0.1 OUTLIER -65.81 -56.04 14.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.643 179.638 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.412 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -52.45 -27.17 15.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.944 0.402 . . . . 0.0 110.462 179.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.607 ' CE1' HD13 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -90.76 -30.81 16.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.803 179.929 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.31 -24.64 37.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.433 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.47 -11.53 60.71 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.452 0.644 . . . . 0.0 111.895 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 23.6 mtp -79.29 -30.79 43.08 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.843 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.796 HD13 HD22 ' A' ' 28' ' ' LEU . 5.1 mt -100.66 -6.18 25.52 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.735 0.778 . . . . 0.0 111.534 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.407 ' CE1' ' NZ ' ' A' ' 25' ' ' LYS . 32.6 m-85 -125.83 22.37 7.46 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 114.241 -1.345 . . . . 0.0 111.186 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 6.7 t . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.874 -179.971 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.441 ' CG ' HD23 ' A' ' 87' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.456 -0.173 0 CA-C-O 120.833 0.349 . . . . 0.0 110.702 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.651 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -68.5 -27.39 66.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.885 179.972 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -59.34 -23.72 62.75 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.707 HD13 HD21 ' A' ' 87' ' ' LEU . 7.0 tt -88.16 -11.41 46.93 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.449 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.651 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 12.9 mm -66.4 -14.38 17.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.908 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -78.36 2.12 19.67 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 113.895 -1.502 . . . . 0.0 111.661 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.656 ' HB2' HD11 ' A' ' 56' ' ' LEU . . . -93.11 -31.91 14.64 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.085 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -60.67 -29.31 69.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.964 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -96.91 38.19 1.25 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.93 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.926 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 71.1 t80 . . . . . 0 N--CA 1.457 -0.113 0 CA-C-O 120.848 0.356 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.473 HG11 ' CE2' ' A' ' 48' ' ' PHE . 7.1 p -141.42 137.33 32.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.949 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.451 ' HB3' ' CE2' ' A' ' 77' ' ' PHE . 13.1 p -84.99 150.13 25.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.047 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.472 HG13 ' CZ ' ' A' ' 67' ' ' PHE . 91.7 t -54.92 -55.52 15.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.082 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -46.74 -30.12 2.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.079 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -91.65 -28.68 17.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.45 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.576 ' CD2' HD12 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -67.42 -38.21 84.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.9 179.885 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 29.4 mtm180 -57.06 -50.43 72.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.907 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -56.15 -25.75 47.89 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.381 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.571 HD12 ' HA ' ' A' ' 48' ' ' PHE . 20.6 mt -85.22 -43.5 16.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.721 0.296 . . . . 0.0 110.932 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.464 HG21 HG12 ' A' ' 63' ' ' ILE . 31.0 mm -69.89 -36.21 68.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.096 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.6 ttm180 -54.36 -47.43 72.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.08 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -111.81 14.94 21.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.335 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -109.17 -88.66 1.96 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.639 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.656 HD11 ' HB2' ' A' ' 31' ' ' ALA . 3.9 mp -102.06 142.07 23.83 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.7 0.286 . . . . 0.0 111.106 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.05 111.41 3.27 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.498 2.132 . . . . 0.0 112.26 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.637 ' O ' HD11 ' A' ' 63' ' ' ILE . 0.6 OUTLIER -148.08 138.03 22.57 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.805 -179.867 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.889 ' O ' HD12 ' A' ' 63' ' ' ILE . 0.6 OUTLIER -75.32 144.82 42.21 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.719 179.529 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.548 ' O ' ' N ' ' A' ' 64' ' ' THR . 1.3 pm0 -37.85 -49.01 1.17 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.278 0.561 . . . . 0.0 111.156 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.421 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -49.37 -55.98 11.13 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.83 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.44 ' O ' ' HB2' ' A' ' 66' ' ' PHE . 0.7 OUTLIER -52.24 -62.22 1.77 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.886 0.374 . . . . 0.0 110.003 179.266 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.889 HD12 ' O ' ' A' ' 59' ' ' THR . 1.4 mp -58.51 -62.88 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.125 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.548 ' N ' ' O ' ' A' ' 60' ' ' GLU . 98.6 m -49.37 -53.03 24.51 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.421 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.421 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 4.9 mm-40 -65.48 -15.72 62.94 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 121.566 0.698 . . . . 0.0 110.554 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.44 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.6 m-30 -95.71 -23.99 16.73 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.56 179.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.764 ' CE2' HG22 ' A' ' 63' ' ' ILE . 1.9 m-30 -76.7 -31.68 57.37 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.746 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -85.73 -29.95 23.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.856 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.71 -11.1 60.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.433 0.635 . . . . 0.0 111.733 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.417 ' HB2' ' CE1' ' A' ' 83' ' ' PHE . . . -99.67 -30.26 12.2 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.061 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -121.8 116.91 30.11 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.748 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -64.85 -50.4 2.31 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.381 2.054 . . . . 0.0 112.315 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.582 ' CG ' HG23 ' A' ' 75' ' ' THR . 9.6 p30 -68.63 -32.73 72.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.813 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.3 m120 75.44 53.83 0.07 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.72 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.582 HG23 ' CG ' ' A' ' 73' ' ' ASN . 12.6 p -98.16 28.83 3.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.703 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 59.2 26.5 61.47 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.319 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.451 ' CE2' ' HB3' ' A' ' 44' ' ' SER . 4.1 m-85 -129.06 131.69 47.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.768 0.318 . . . . 0.0 110.74 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.654 HD13 ' CE1' ' A' ' 83' ' ' PHE . 61.2 mt -106.17 152.46 7.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.23 0.538 . . . . 0.0 111.635 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.442 ' N ' HG22 ' A' ' 78' ' ' ILE . 1.1 m-20 -101.23 96.2 7.04 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 176.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.43 ' C ' ' O ' ' A' ' 79' ' ' ASP . 40.5 t80 -28.78 -41.14 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.035 -0.529 . . . . 0.0 112.331 -177.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 79' ' ' ASP . 5.0 mtpp -66.06 -55.16 17.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.692 0.282 . . . . 0.0 110.51 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -53.2 -28.06 24.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.003 0.43 . . . . 0.0 110.411 179.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.654 ' CE1' HD13 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -88.97 -32.47 17.63 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.846 179.88 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.71 -29.6 45.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.228 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.44 ' O ' ' HB2' ' A' ' 89' ' ' SER . . . -74.32 -11.53 60.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.369 0.605 . . . . 0.0 111.619 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 2.2 mtt -68.9 -47.68 65.23 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.461 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.707 HD21 HD13 ' A' ' 28' ' ' LEU . 4.5 mp -82.81 -6.92 59.65 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.845 0.831 . . . . 0.0 111.107 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -119.69 21.77 11.89 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 113.982 -1.463 . . . . 0.0 111.25 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.44 ' HB2' ' O ' ' A' ' 85' ' ' ALA . 9.3 t . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.935 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.865 0.364 . . . . 0.0 110.657 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.681 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -67.1 -28.44 68.17 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.77 -179.936 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -58.95 -23.94 62.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.175 0.512 . . . . 0.0 109.751 178.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.741 HD13 HD21 ' A' ' 87' ' ' LEU . 3.2 tt -88.09 -11.37 47.26 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.488 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.681 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 11.6 mm -67.21 -13.73 17.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 114.71 -1.132 . . . . 0.0 111.98 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -77.89 2.29 17.83 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 113.894 -1.503 . . . . 0.0 111.499 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.826 ' HB2' HD11 ' A' ' 56' ' ' LEU . . . -93.22 -43.21 8.94 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.102 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -59.82 -28.62 67.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.974 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -96.12 39.79 1.14 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.994 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.018 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.858 0.361 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.1 p -128.85 139.0 53.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.068 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.428 ' HB3' ' CZ ' ' A' ' 77' ' ' PHE . 79.2 p -88.36 151.58 22.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.788 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.61 HG22 HG13 ' A' ' 78' ' ' ILE . 53.7 t -58.18 -50.75 77.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.826 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -51.27 -29.18 13.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.988 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -91.45 -32.32 15.66 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.601 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.748 ' HA ' HD12 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -61.13 -42.31 98.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.024 179.984 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 72.1 mtt180 -56.87 -48.27 78.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.917 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -59.58 -27.42 63.66 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.383 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.748 HD12 ' HA ' ' A' ' 48' ' ' PHE . 5.5 mt -86.27 -50.06 14.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.872 0.367 . . . . 0.0 110.916 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.0 tp -57.87 -40.32 75.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.431 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.6 ttm180 -48.39 -68.01 0.22 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.063 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -93.36 14.79 17.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.065 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -109.51 -59.76 0.52 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.614 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.826 HD11 ' HB2' ' A' ' 31' ' ' ALA . 5.4 mp -129.09 139.51 35.9 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.655 0.264 . . . . 0.0 111.143 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -79.6 58.3 6.9 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.598 2.199 . . . . 0.0 112.056 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.555 ' HB3' HD11 ' A' ' 63' ' ' ILE . 1.3 ttt -87.08 138.66 31.31 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.952 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.9 ' O ' HD12 ' A' ' 63' ' ' ILE . 1.3 p -78.27 140.59 38.86 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.883 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.511 ' O ' ' N ' ' A' ' 64' ' ' THR . 0.1 OUTLIER -37.05 -49.1 0.83 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.093 -180.0 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.525 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -48.49 -55.52 10.76 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.314 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.507 ' HB2' ' HG2' ' A' ' 58' ' ' MET . 0.7 OUTLIER -56.16 -60.28 3.72 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.287 179.833 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.9 HD12 ' O ' ' A' ' 59' ' ' THR . 2.3 mp -58.07 -61.12 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.163 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.511 ' N ' ' O ' ' A' ' 60' ' ' GLU . 71.8 m -52.8 -51.53 60.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.122 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.525 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 44.6 tt0 -64.93 -15.76 62.5 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.63 0.729 . . . . 0.0 110.516 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.435 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.7 m-30 -96.38 -27.87 14.73 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 114.594 -1.184 . . . . 0.0 110.434 179.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.672 ' CE2' HG22 ' A' ' 63' ' ' ILE . 3.9 m-30 -73.25 -30.1 63.22 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.651 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.75 -26.85 20.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.874 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.28 -11.2 47.19 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.482 0.658 . . . . 0.0 111.725 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.8 -29.95 13.46 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.994 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -116.74 121.38 33.0 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.787 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.08 -49.39 2.07 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.388 2.059 . . . . 0.0 112.361 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -80.5 -28.42 37.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.911 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.1 m120 75.82 51.92 0.06 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.616 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 12.6 p -96.52 31.1 2.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.87 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 59.55 29.31 66.47 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.413 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.428 ' CZ ' ' HB3' ' A' ' 44' ' ' SER . 0.2 OUTLIER -132.08 129.34 39.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.833 0.349 . . . . 0.0 110.664 179.901 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.659 HD12 ' CD2' ' A' ' 48' ' ' PHE . 63.7 mt -104.51 152.83 6.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.235 0.541 . . . . 0.0 111.593 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.431 ' N ' HG22 ' A' ' 78' ' ' ILE . 1.8 m-20 -97.76 95.6 7.66 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 176.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.43 ' C ' ' O ' ' A' ' 79' ' ' ASP . 40.4 t80 -28.96 -41.55 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.209 -178.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 79' ' ' ASP . 0.3 OUTLIER -66.01 -56.21 12.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.625 179.706 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -52.11 -27.6 14.74 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.998 0.428 . . . . 0.0 110.602 179.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.609 ' CE1' HD13 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -89.84 -32.16 17.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.866 179.85 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.6 -27.88 45.67 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.258 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.68 -11.41 60.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.482 0.658 . . . . 0.0 111.814 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 1.8 mtp -77.98 -36.86 48.5 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.736 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.741 HD21 HD13 ' A' ' 28' ' ' LEU . 4.2 mt -86.76 -6.71 58.74 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.862 0.839 . . . . 0.0 111.501 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -126.03 22.08 7.38 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 114.139 -1.391 . . . . 0.0 111.088 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.839 -179.986 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.526 ' HG2' HD23 ' A' ' 87' ' ' LEU . 3.3 ttpt . . . . . 0 N--CA 1.457 -0.093 0 CA-C-O 120.804 0.335 . . . . 0.0 110.749 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.668 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -65.25 -28.88 69.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.78 179.912 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.739 ' O ' HD12 ' A' ' 56' ' ' LEU . 4.7 tt0 -59.71 -23.94 63.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.136 0.493 . . . . 0.0 109.677 178.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.867 HD13 HD21 ' A' ' 87' ' ' LEU . 7.1 tt -88.17 -11.35 47.06 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.434 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.668 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 11.4 mm -65.63 -14.39 16.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.022 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -78.26 2.3 18.82 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 113.801 -1.545 . . . . 0.0 111.596 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.788 ' HB2' HD21 ' A' ' 56' ' ' LEU . . . -93.16 -28.67 16.16 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.179 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -56.45 -29.06 61.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.048 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -98.39 30.56 3.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.907 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.888 -179.997 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 . . . . . 0 N--CA 1.457 -0.102 0 CA-C-O 120.829 0.347 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.455 HG11 ' CE2' ' A' ' 48' ' ' PHE . 8.8 p -129.49 123.96 58.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.973 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.14 160.52 30.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.941 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.691 HG22 HG13 ' A' ' 78' ' ' ILE . 45.8 t -63.94 -50.98 75.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.843 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -50.92 -31.37 17.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.962 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -89.07 -28.87 19.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.521 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.816 ' CD2' HD12 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -68.22 -40.08 82.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.909 179.918 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 15.1 mtp85 -57.13 -48.33 78.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.874 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -57.57 -27.89 59.12 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.303 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.404 HD12 ' HA ' ' A' ' 48' ' ' PHE . 16.7 mt -86.65 -43.03 15.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.848 0.356 . . . . 0.0 110.843 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.492 HG21 HG12 ' A' ' 63' ' ' ILE . 35.7 mm -68.13 -29.93 46.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.023 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 6.2 tpm_? -51.89 -55.8 17.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.95 0.405 . . . . 0.0 110.9 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -111.82 14.86 21.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.195 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -99.73 -86.76 1.91 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.628 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.788 HD21 ' HB2' ' A' ' 31' ' ' ALA . 2.8 mm? -100.77 137.01 19.71 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 120.658 0.266 . . . . 0.0 110.966 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.88 74.48 4.92 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.406 2.071 . . . . 0.0 112.322 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.573 ' HE2' ' HB2' ' A' ' 62' ' ' GLU . 1.4 mtp -105.8 142.18 35.96 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.733 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.914 ' O ' HD12 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -79.85 148.45 31.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.729 179.734 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.491 ' O ' ' N ' ' A' ' 64' ' ' THR . 1.7 pm0 -38.09 -48.82 1.26 Allowed 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.19 0.519 . . . . 0.0 111.082 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.521 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -50.86 -52.53 40.7 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.024 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.573 ' HB2' ' HE2' ' A' ' 58' ' ' MET . 1.1 mm-40 -55.33 -61.71 2.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.97 0.414 . . . . 0.0 109.933 179.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.914 HD12 ' O ' ' A' ' 59' ' ' THR . 1.8 mp -57.87 -61.77 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.249 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.491 ' N ' ' O ' ' A' ' 60' ' ' GLU . 89.8 m -52.65 -52.05 57.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.419 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.521 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 51.5 tt0 -64.81 -15.58 61.95 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.625 0.726 . . . . 0.0 110.423 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.428 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.6 m-30 -95.65 -28.13 14.97 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.548 -1.205 . . . . 0.0 110.326 179.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.699 ' CE1' HD11 ' A' ' 78' ' ' ILE . 7.5 m-30 -77.88 -26.09 48.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.813 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -90.57 -27.62 19.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.91 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -90.73 -11.19 40.37 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 121.391 0.615 . . . . 0.0 111.752 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -93.92 -31.32 14.35 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.939 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -120.95 120.05 29.55 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.77 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -63.33 -53.87 1.28 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.467 2.112 . . . . 0.0 112.388 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -73.91 -30.22 62.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.877 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 75.35 50.57 0.08 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.509 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.9 p -95.68 31.07 2.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.822 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.415 ' C ' HG23 ' A' ' 45' ' ' VAL . . . 62.28 30.81 77.11 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.344 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.459 ' N ' HG23 ' A' ' 45' ' ' VAL . 5.4 m-85 -131.37 130.17 42.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.758 0.313 . . . . 0.0 110.881 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.816 HD12 ' CD2' ' A' ' 48' ' ' PHE . 56.1 mt -106.06 153.18 7.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.15 0.5 . . . . 0.0 111.456 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.441 ' N ' HG22 ' A' ' 78' ' ' ILE . 0.8 OUTLIER -98.3 95.65 7.52 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 176.923 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.417 ' C ' ' O ' ' A' ' 79' ' ' ASP . 44.4 t80 -30.66 -40.12 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.121 -178.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.2 mttt -66.88 -55.56 14.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.49 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -53.32 -27.77 24.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.12 0.486 . . . . 0.0 110.555 179.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.655 ' CE1' HD13 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -89.02 -31.1 18.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.722 179.703 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.11 -22.46 39.11 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.312 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.33 -11.5 60.73 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 121.388 0.613 . . . . 0.0 111.708 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 33.4 mtt -70.4 -40.28 74.0 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.773 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.867 HD21 HD13 ' A' ' 28' ' ' LEU . 6.3 mp -91.73 -6.31 52.15 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.857 0.837 . . . . 0.0 111.513 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -124.07 22.29 8.76 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 114.123 -1.398 . . . . 0.0 111.127 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.824 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.1 ttpt . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.809 0.338 . . . . 0.0 110.733 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.66 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -56.11 -26.64 50.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.964 -179.829 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -61.66 -23.33 66.01 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.749 ' O ' HD13 ' A' ' 28' ' ' LEU . 2.7 tm? -88.08 -11.63 46.54 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.375 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.66 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 11.3 mm -65.48 -14.25 16.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.914 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -75.59 1.88 13.24 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 113.91 -1.496 . . . . 0.0 111.819 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.458 ' HB2' HD21 ' A' ' 56' ' ' LEU . . . -93.27 -28.68 16.08 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.041 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.55 -24.49 56.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.0 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -96.84 30.39 2.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.987 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.858 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 . . . . . 0 N--CA 1.456 -0.134 0 CA-C-O 120.745 0.307 . . . . 0.0 110.997 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.47 HG22 ' N ' ' A' ' 44' ' ' SER . 12.4 p -132.35 157.96 43.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.008 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.47 ' N ' HG22 ' A' ' 43' ' ' VAL . 77.9 p -108.47 150.25 27.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.89 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.521 HG13 ' CZ ' ' A' ' 67' ' ' PHE . 96.2 t -56.43 -51.84 59.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.951 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -47.37 -31.0 3.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.046 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -96.37 -30.97 13.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.502 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -62.98 -35.25 79.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.052 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 20.9 mtt85 -55.8 -52.34 64.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.036 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -56.79 -27.87 56.41 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.397 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 21.1 mt -81.14 -25.3 10.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.848 0.356 . . . . 0.0 111.125 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 34.8 mm -93.36 -55.25 6.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.062 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.35 -34.03 68.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.319 -179.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -111.73 14.84 21.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.67 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -131.43 -89.84 0.49 Allowed Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.33 -0.938 . . . . 0.0 112.827 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.488 ' N ' HD12 ' A' ' 56' ' ' LEU . 7.0 mp -87.02 140.82 32.83 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.681 0.276 . . . . 0.0 111.238 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -78.27 122.02 5.5 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.567 2.178 . . . . 0.0 112.325 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.704 ' O ' HD11 ' A' ' 63' ' ' ILE . 0.8 OUTLIER -155.17 137.42 14.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.778 -179.941 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.918 ' O ' HD12 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -72.71 145.9 46.84 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.848 179.706 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.482 ' O ' ' N ' ' A' ' 64' ' ' THR . 5.9 pt-20 -37.6 -51.79 1.2 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.29 0.567 . . . . 0.0 111.06 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.44 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -47.64 -56.11 7.93 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.867 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.525 ' HB2' ' HE2' ' A' ' 58' ' ' MET . 0.7 OUTLIER -51.16 -62.87 1.35 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.415 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.918 HD12 ' O ' ' A' ' 59' ' ' THR . 2.2 mp -56.51 -63.71 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.32 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.482 ' N ' ' O ' ' A' ' 60' ' ' GLU . 92.5 m -51.17 -52.57 42.93 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.397 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.44 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 6.4 mm-40 -65.03 -15.98 62.94 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-O 121.652 0.739 . . . . 0.0 110.377 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.443 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.3 m-30 -92.04 -27.45 17.79 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.599 -1.182 . . . . 0.0 110.3 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.621 ' CE2' HG22 ' A' ' 63' ' ' ILE . 4.7 m-30 -85.6 -25.53 26.61 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.921 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -94.05 -27.66 16.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.947 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 65' ' ' GLU . . . -89.09 -11.22 44.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.39 0.614 . . . . 0.0 111.776 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.414 ' HB1' ' CG2' ' A' ' 78' ' ' ILE . . . -99.47 -28.16 13.38 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.094 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -122.51 112.14 31.23 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.681 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.08 -47.63 3.35 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.503 2.135 . . . . 0.0 112.533 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 61.8 m-80 -68.41 -31.85 71.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.971 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 71.76 31.24 2.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.569 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 46.9 p -67.57 -26.24 66.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.981 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 113.79 19.66 6.39 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.525 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.459 ' CD2' ' HB2' ' A' ' 44' ' ' SER . 3.0 m-85 -140.91 130.97 24.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.65 0.262 . . . . 0.0 110.786 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.574 HD11 ' CD1' ' A' ' 67' ' ' PHE . 2.1 mt -110.14 147.82 14.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.929 0.395 . . . . 0.0 111.468 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.436 ' O ' ' N ' ' A' ' 81' ' ' LYS . 72.6 m-20 -77.28 103.75 7.39 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 177.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.409 ' C ' ' O ' ' A' ' 79' ' ' ASP . 50.7 t80 -28.61 -40.34 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.436 ' N ' ' O ' ' A' ' 79' ' ' ASP . 10.2 mttt -62.93 -54.46 38.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.705 0.288 . . . . 0.0 110.915 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -51.79 -26.85 10.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.089 0.471 . . . . 0.0 110.743 179.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.474 ' CD1' HG21 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -93.09 -29.71 15.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.267 -179.766 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -82.4 -26.85 32.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.243 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -74.36 -11.49 60.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.438 0.637 . . . . 0.0 111.658 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 24.6 tpp -74.85 -37.71 62.16 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.713 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.516 HD21 ' HG ' ' A' ' 28' ' ' LEU . 1.7 mt -89.14 -6.52 56.93 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.86 0.838 . . . . 0.0 111.437 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -125.84 22.44 7.44 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 114.14 -1.391 . . . . 0.0 111.099 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.949 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? . . . . . 0 N--CA 1.456 -0.156 0 CA-C-O 120.842 0.353 . . . . 0.0 110.774 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.683 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -67.63 -29.07 68.29 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.786 -179.919 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -59.5 -24.27 63.49 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.734 HD13 HD21 ' A' ' 87' ' ' LEU . 4.7 tt -88.22 -11.3 47.07 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.406 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.683 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 11.5 mm -65.67 -14.3 16.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.921 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -77.55 2.19 17.17 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 113.887 -1.506 . . . . 0.0 111.537 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 1.065 ' HB2' HD11 ' A' ' 56' ' ' LEU . . . -93.27 -30.59 15.08 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.09 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -58.35 -25.54 62.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.116 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -96.09 38.84 1.16 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.945 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.3 p-10 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.871 179.936 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.836 0.35 . . . . 0.0 111.004 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.54 HG11 ' CE2' ' A' ' 48' ' ' PHE . 9.3 p -130.48 147.76 33.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.948 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 21.7 p -92.74 159.91 15.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.919 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.96 HG13 ' CD1' ' A' ' 67' ' ' PHE . 46.1 t -61.69 -32.81 54.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.797 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -66.69 -57.9 6.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.846 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -59.33 -31.02 68.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.826 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.903 ' CD2' HD12 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -63.76 -40.73 97.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.962 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 10.2 mtm180 -58.6 -51.69 68.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.936 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -55.6 -25.59 43.29 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.486 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.698 HD12 ' HA ' ' A' ' 48' ' ' PHE . 13.0 mt -83.51 -46.11 18.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.915 0.388 . . . . 0.0 111.057 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.535 HG21 HG12 ' A' ' 63' ' ' ILE . 31.0 mm -68.52 -28.69 41.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.137 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.27 -59.34 4.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.061 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -111.88 15.02 20.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.237 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -98.06 -86.19 1.83 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.738 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 1.065 HD11 ' HB2' ' A' ' 31' ' ' ALA . 7.1 mt -105.96 144.7 29.44 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 120.705 0.288 . . . . 0.0 111.024 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.51 115.8 4.16 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.577 2.185 . . . . 0.0 112.235 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.636 ' O ' HD11 ' A' ' 63' ' ' ILE . 0.8 OUTLIER -153.88 138.48 16.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.726 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.898 ' O ' HD12 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -76.07 147.04 38.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.646 179.592 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' A' ' 64' ' ' THR . 6.2 pt-20 -38.81 -52.13 1.72 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.214 0.53 . . . . 0.0 110.853 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.515 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -46.91 -53.31 12.49 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.09 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.464 ' HG2' ' O ' ' A' ' 59' ' ' THR . 2.0 mm-40 -55.13 -61.57 2.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.921 0.391 . . . . 0.0 110.021 179.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.898 HD12 ' O ' ' A' ' 59' ' ' THR . 1.6 mp -59.17 -61.69 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.155 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.539 ' N ' ' O ' ' A' ' 60' ' ' GLU . 69.3 m -51.39 -51.73 52.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.394 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.515 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 1.5 tp10 -65.36 -15.34 62.47 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.638 0.732 . . . . 0.0 110.412 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.416 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.6 m-30 -96.46 -25.88 15.51 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.533 -1.212 . . . . 0.0 110.415 179.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.96 ' CD1' HG13 ' A' ' 45' ' ' VAL . 1.7 m-85 -75.31 -30.18 60.27 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.747 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -93.18 -28.47 16.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.892 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.6 -10.96 59.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.407 0.622 . . . . 0.0 111.718 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.98 -33.4 14.87 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.067 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.498 ' OD2' HG22 ' A' ' 75' ' ' THR . 7.1 t0 -120.09 116.98 32.34 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.888 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.68 -28.94 51.94 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.358 2.038 . . . . 0.0 112.185 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 53.9 m-20 -83.64 -32.09 25.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.713 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 71.79 39.94 0.81 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.118 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.498 HG22 ' OD2' ' A' ' 71' ' ' ASP . 1.5 t -90.33 39.6 0.98 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.737 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.406 ' C ' HG23 ' A' ' 45' ' ' VAL . . . 46.55 28.67 3.61 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.463 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.568 ' N ' HG23 ' A' ' 45' ' ' VAL . 1.2 t80 -132.3 129.11 39.1 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.81 0.338 . . . . 0.0 110.468 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.903 HD12 ' CD2' ' A' ' 48' ' ' PHE . 66.6 mt -103.11 148.77 7.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.108 0.48 . . . . 0.0 111.61 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.44 ' O ' ' N ' ' A' ' 82' ' ' ALA . 0.8 OUTLIER -96.15 95.89 8.45 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 176.698 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.437 ' C ' ' O ' ' A' ' 79' ' ' ASP . 51.2 t80 -28.56 -42.29 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.261 -177.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 79' ' ' ASP . 6.9 mmmm -63.79 -55.62 21.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.823 0.344 . . . . 0.0 110.619 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -52.32 -30.7 29.62 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.172 0.511 . . . . 0.0 110.411 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.661 ' CE1' HD13 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -85.56 -32.59 22.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.695 179.807 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.21 -23.77 43.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.2 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.8 -11.4 60.59 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.411 0.624 . . . . 0.0 111.804 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 13.2 tpp -76.64 -32.04 57.76 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.61 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.734 HD21 HD13 ' A' ' 28' ' ' LEU . 4.6 mt -94.05 -6.24 45.63 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 121.885 0.85 . . . . 0.0 111.33 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -125.95 22.06 7.43 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.081 -1.418 . . . . 0.0 111.212 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.957 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.4 ttpt . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.817 0.341 . . . . 0.0 110.788 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.66 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -71.57 -28.86 64.13 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.914 -179.967 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -59.92 -24.22 64.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.215 0.531 . . . . 0.0 109.683 178.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.968 HD13 HD21 ' A' ' 87' ' ' LEU . 4.2 tt -88.3 -11.27 46.92 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.519 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.66 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 12.0 mm -63.59 -15.12 15.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.865 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -79.04 2.17 21.48 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 113.919 -1.491 . . . . 0.0 111.478 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.758 ' HB2' HD21 ' A' ' 56' ' ' LEU . . . -93.29 -29.35 15.71 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.107 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -56.47 -24.39 45.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.15 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -96.9 34.43 1.71 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.025 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.821 -179.932 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 9.6 t80 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.811 0.338 . . . . 0.0 110.939 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.577 HG11 ' CE2' ' A' ' 48' ' ' PHE . 10.4 p -124.37 132.92 70.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.966 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.51 147.45 25.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.854 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.423 HG13 ' CE1' ' A' ' 67' ' ' PHE . 88.8 t -53.37 -55.14 14.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.065 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -47.21 -31.98 4.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.906 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -88.3 -29.75 20.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.358 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.629 ' HA ' HD12 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -69.04 -38.15 78.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.809 179.806 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 18.7 mtt180 -58.23 -51.21 70.69 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.991 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -55.94 -25.78 46.42 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.394 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.629 HD12 ' HA ' ' A' ' 48' ' ' PHE . 21.8 mt -83.08 -44.54 18.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.874 0.368 . . . . 0.0 111.065 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 35.8 mm -68.07 -27.27 36.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.138 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.8 ttm180 -52.8 -58.79 5.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.993 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -111.75 14.98 21.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.344 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -99.41 -86.53 1.89 Allowed Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.632 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.758 HD21 ' HB2' ' A' ' 31' ' ' ALA . 3.9 mt -103.48 143.72 27.2 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 120.631 0.253 . . . . 0.0 110.982 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.48 85.28 1.6 Allowed 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.549 2.166 . . . . 0.0 112.166 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.604 ' HB3' HD11 ' A' ' 63' ' ' ILE . 3.8 ttt -124.28 140.84 52.58 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.796 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.835 ' O ' HD12 ' A' ' 63' ' ' ILE . 0.8 OUTLIER -89.32 143.41 26.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.613 179.36 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.616 ' O ' ' N ' ' A' ' 64' ' ' THR . 0.2 OUTLIER -41.99 -53.16 3.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.369 0.604 . . . . 0.0 110.637 -179.852 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.487 ' N ' ' CG ' ' A' ' 60' ' ' GLU . . . -44.68 -28.93 0.67 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.004 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.601 ' HG2' ' O ' ' A' ' 59' ' ' THR . 1.5 mm-40 -89.57 -51.43 5.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.736 0.303 . . . . 0.0 110.458 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.835 HD12 ' O ' ' A' ' 59' ' ' THR . 1.0 OUTLIER -74.35 -44.69 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.347 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.616 ' N ' ' O ' ' A' ' 60' ' ' GLU . 50.6 m -62.96 -48.92 76.82 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.024 0.44 . . . . 0.0 109.991 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.408 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 3.2 tm-20 -66.68 -16.2 64.05 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.714 0.768 . . . . 0.0 110.301 179.297 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.443 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.2 m-85 -96.78 -23.61 16.32 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.469 -1.242 . . . . 0.0 110.357 178.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.783 ' CE2' HG22 ' A' ' 63' ' ' ILE . 2.1 m-85 -74.52 -36.06 63.19 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.736 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -76.42 -30.36 57.39 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.861 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.28 -11.08 59.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.476 0.655 . . . . 0.0 111.653 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -95.58 -30.25 13.91 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.985 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.565 ' OD2' HG22 ' A' ' 75' ' ' THR . 7.0 t70 -128.31 106.22 19.54 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.825 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 71' ' ' ASP . 37.9 Cg_endo -66.43 -30.92 43.55 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.404 2.069 . . . . 0.0 112.276 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 63.6 m-80 -76.81 -27.64 55.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.917 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 72.51 36.7 0.97 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.128 0.489 . . . . 0.0 110.13 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.565 HG22 ' OD2' ' A' ' 71' ' ' ASP . 1.1 t -85.65 13.14 7.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.975 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 69.45 26.57 74.41 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.262 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.468 ' HB2' HG23 ' A' ' 75' ' ' THR . 5.2 m-85 -117.39 178.48 4.36 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.701 0.286 . . . . 0.0 110.571 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.621 HD12 ' HD2' ' A' ' 48' ' ' PHE . 65.4 mt -153.62 153.54 8.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.206 0.527 . . . . 0.0 111.724 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.464 ' N ' HG22 ' A' ' 78' ' ' ILE . 24.2 t0 -99.55 95.97 7.35 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 176.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.429 ' C ' ' O ' ' A' ' 79' ' ' ASP . 44.8 t80 -28.7 -41.37 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.366 -178.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.418 ' N ' ' O ' ' A' ' 79' ' ' ASP . 3.4 mtmt -66.2 -56.61 10.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.717 0.294 . . . . 0.0 110.68 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -51.9 -27.71 13.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.043 0.449 . . . . 0.0 110.614 179.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.519 ' CE1' HD13 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -89.83 -31.91 17.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.743 179.923 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.09 -18.64 55.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.339 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -71.08 -11.56 61.02 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.366 0.603 . . . . 0.0 111.882 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.96 -34.6 62.06 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.784 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.968 HD21 HD13 ' A' ' 28' ' ' LEU . 4.1 mt -92.72 -6.73 48.53 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.851 0.834 . . . . 0.0 111.483 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -126.08 22.31 7.31 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.108 -1.405 . . . . 0.0 111.057 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.6 p . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.961 179.917 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.6 tttp . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.773 0.321 . . . . 0.0 110.72 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.651 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -67.63 -28.79 68.03 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.845 -179.815 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 89.3 mm-40 -61.13 -24.91 66.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.204 0.526 . . . . 0.0 109.594 178.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.804 HD13 HD21 ' A' ' 87' ' ' LEU . 3.0 tt -88.3 -11.28 46.88 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.539 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.651 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 11.2 mm -61.43 -15.58 13.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 114.973 -1.012 . . . . 0.0 112.03 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -77.84 1.81 19.19 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 113.983 -1.462 . . . . 0.0 111.559 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.646 ' HB2' HD21 ' A' ' 56' ' ' LEU . . . -93.62 -28.15 16.17 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.009 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -58.12 -20.53 40.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.315 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -93.07 24.02 3.98 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.334 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.93 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.805 0.336 . . . . 0.0 110.952 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.538 HG11 ' CE2' ' A' ' 48' ' ' PHE . 10.3 p -117.97 123.67 72.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.991 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.95 155.59 40.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.965 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.93 HG13 ' CD1' ' A' ' 67' ' ' PHE . 59.8 t -60.17 -32.51 50.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.806 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -65.2 -61.38 2.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.013 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -57.62 -30.66 65.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.918 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.876 ' CD2' HD12 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -62.1 -40.73 96.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.011 -179.909 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.445 ' HG3' ' CE2' ' A' ' 67' ' ' PHE . 65.5 mtt180 -58.76 -51.73 68.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.986 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -55.91 -25.85 46.39 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.505 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.74 HD12 ' HA ' ' A' ' 48' ' ' PHE . 12.4 mt -82.56 -45.64 19.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.882 0.372 . . . . 0.0 111.045 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.543 HG21 HG12 ' A' ' 63' ' ' ILE . 35.6 mm -68.57 -28.4 40.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.237 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 17.9 ttp180 -48.75 -60.37 2.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.063 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -111.86 14.89 21.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.109 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -96.64 -85.68 1.76 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.606 -0.806 . . . . 0.0 112.772 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.646 HD21 ' HB2' ' A' ' 31' ' ' ALA . 2.1 mp -106.34 144.97 30.05 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.594 0.235 . . . . 0.0 111.105 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.59 113.26 3.62 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.523 2.148 . . . . 0.0 112.222 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.608 ' O ' HD11 ' A' ' 63' ' ' ILE . 0.9 OUTLIER -152.68 138.97 18.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.762 -179.97 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.894 ' O ' HD12 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -77.16 147.67 36.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.529 179.57 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.55 ' O ' ' N ' ' A' ' 64' ' ' THR . 0.5 OUTLIER -38.62 -52.21 1.64 Allowed 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.271 0.558 . . . . 0.0 110.932 179.705 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.419 ' O ' ' HB2' ' A' ' 65' ' ' GLU . . . -46.76 -55.94 7.03 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.792 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.456 ' HG2' ' O ' ' A' ' 59' ' ' THR . 1.9 mm-40 -52.07 -62.26 1.75 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.945 0.402 . . . . 0.0 109.932 179.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.894 HD12 ' O ' ' A' ' 59' ' ' THR . 1.4 mp -59.04 -63.16 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.217 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.55 ' N ' ' O ' ' A' ' 60' ' ' GLU . 75.7 m -49.32 -52.31 28.73 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.475 -179.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.419 ' HB2' ' O ' ' A' ' 61' ' ' ALA . 3.3 mm-40 -65.63 -15.6 62.91 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 121.698 0.761 . . . . 0.0 110.417 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.418 ' CD1' ' O ' ' A' ' 62' ' ' GLU . 3.5 m-30 -96.17 -24.74 16.12 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.476 -1.238 . . . . 0.0 110.465 179.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.93 ' CD1' HG13 ' A' ' 45' ' ' VAL . 1.6 m-30 -76.44 -30.85 57.53 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.826 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.69 -26.88 16.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.092 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -82.66 -10.91 58.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.511 0.672 . . . . 0.0 111.96 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.17 -33.96 13.11 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.27 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 48.1 p-10 -110.54 122.5 38.23 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.869 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.59 -47.39 1.44 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.447 2.098 . . . . 0.0 112.479 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -68.54 -30.45 69.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.066 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.2 m120 73.84 22.06 2.56 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.413 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.2 t -66.23 -15.68 63.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.183 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.429 ' C ' HG23 ' A' ' 45' ' ' VAL . . . 102.56 22.23 9.81 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.19 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -125.34 129.44 49.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.799 0.333 . . . . 0.0 110.426 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.876 HD12 ' CD2' ' A' ' 48' ' ' PHE . 66.6 mt -99.49 146.89 7.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.223 0.535 . . . . 0.0 111.794 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.429 ' O ' ' N ' ' A' ' 82' ' ' ALA . 0.9 OUTLIER -91.94 96.0 10.13 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 176.598 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.426 ' C ' ' O ' ' A' ' 79' ' ' ASP . 56.4 t80 -28.55 -40.95 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -177.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.423 ' N ' ' O ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -65.19 -55.53 18.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.768 0.318 . . . . 0.0 110.718 179.644 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -51.9 -28.3 15.77 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.104 0.478 . . . . 0.0 110.6 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.645 ' CE1' HD13 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -89.71 -31.9 17.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.812 179.967 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -80.49 -20.8 42.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.324 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.12 -11.57 60.81 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.437 0.637 . . . . 0.0 111.824 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 14.4 mmt -74.03 -33.64 63.83 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.786 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.804 HD21 HD13 ' A' ' 28' ' ' LEU . 5.4 mt -95.58 -6.59 39.96 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.831 0.824 . . . . 0.0 111.476 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -125.91 22.18 7.44 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 114.178 -1.374 . . . . 0.0 111.041 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.877 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.526 ' NZ ' HD11 ' A' ' 29' ' ' ILE . 9.8 tmtt? . . . . . 0 N--CA 1.457 -0.119 0 CA-C-O 120.845 0.355 . . . . 0.0 110.699 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.674 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -66.91 -28.49 68.36 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.746 -179.933 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -59.3 -23.67 62.63 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.948 HD13 HD21 ' A' ' 87' ' ' LEU . 6.0 tt -88.0 -11.36 47.57 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.508 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.674 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 11.3 mm -67.59 -13.81 17.35 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.934 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -77.01 2.04 16.11 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 113.935 -1.484 . . . . 0.0 111.564 179.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.499 ' HB2' HD11 ' A' ' 56' ' ' LEU . . . -93.21 -30.54 15.14 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.034 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -59.58 -29.11 67.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.91 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -97.57 28.17 3.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.0 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.947 179.962 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 62.5 t80 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.946 0.403 . . . . 0.0 111.048 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.506 ' O ' HG13 ' A' ' 43' ' ' VAL . 4.4 p -136.41 106.17 5.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.754 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.4 m -59.01 153.74 17.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.084 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.437 HG13 ' CE1' ' A' ' 67' ' ' PHE . 92.9 t -57.03 -56.84 12.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.045 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -47.41 -29.71 2.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.058 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -88.43 -29.79 19.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.602 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.41 ' CD2' HD12 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -64.68 -30.79 71.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.799 179.876 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.4 mtt-85 -56.06 -51.23 68.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.951 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -57.49 -25.03 54.39 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.452 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 34.0 mt -83.35 -27.92 7.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.754 0.312 . . . . 0.0 111.156 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 41.7 mm -90.45 -49.18 13.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.085 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.3 -35.73 62.94 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.198 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -111.81 14.72 21.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.426 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -123.24 -90.1 0.94 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.662 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.499 HD11 ' HB2' ' A' ' 31' ' ' ALA . 2.4 mp -97.8 142.93 25.34 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.645 0.26 . . . . 0.0 110.94 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -78.92 57.94 6.67 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.525 2.15 . . . . 0.0 112.439 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.657 ' C ' HD11 ' A' ' 63' ' ' ILE . 5.3 ttt -86.58 136.19 33.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.72 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.836 ' O ' HD12 ' A' ' 63' ' ' ILE . 1.0 OUTLIER -81.76 142.05 32.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.789 0.328 . . . . 0.0 110.631 179.645 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.557 ' O ' ' N ' ' A' ' 64' ' ' THR . 0.2 OUTLIER -41.16 -52.92 3.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.328 0.585 . . . . 0.0 110.844 -179.844 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.483 ' N ' ' CG ' ' A' ' 60' ' ' GLU . . . -45.01 -27.09 0.5 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.938 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.483 ' HG3' ' O ' ' A' ' 59' ' ' THR . 0.0 OUTLIER -91.07 -51.73 5.19 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.672 0.272 . . . . 0.0 110.32 179.729 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.836 HD12 ' O ' ' A' ' 59' ' ' THR . 1.2 mp -73.65 -43.35 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.201 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.557 ' N ' ' O ' ' A' ' 60' ' ' GLU . 24.3 m -64.6 -47.78 77.36 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.027 0.441 . . . . 0.0 109.961 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.408 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 5.7 tt0 -65.66 -17.28 64.49 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.693 0.758 . . . . 0.0 110.188 179.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.47 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 1.0 OUTLIER -97.02 -26.92 14.84 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.243 178.829 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.755 ' CE2' HG22 ' A' ' 63' ' ' ILE . 2.0 m-85 -68.13 -47.36 68.31 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.738 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.77 -26.81 54.94 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.994 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.77 -11.06 59.92 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.445 0.64 . . . . 0.0 111.779 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.433 ' HB2' ' CE1' ' A' ' 83' ' ' PHE . . . -95.84 -32.78 12.5 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.006 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.484 ' OD2' HG22 ' A' ' 75' ' ' THR . 5.9 t70 -119.85 120.43 30.43 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.744 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.65 -27.78 45.04 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.344 2.029 . . . . 0.0 112.222 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 30.2 m-20 -84.6 -32.35 23.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.904 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.2 m120 71.31 40.4 0.85 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.038 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.484 HG22 ' OD2' ' A' ' 71' ' ' ASP . 1.4 t -90.37 40.57 1.02 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.644 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 50.33 25.72 8.65 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.763 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -125.23 148.94 48.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.874 0.369 . . . . 0.0 110.779 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.737 HD11 ' CD1' ' A' ' 67' ' ' PHE . 54.1 mt -127.14 153.12 35.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.203 0.525 . . . . 0.0 111.552 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.443 ' N ' HG22 ' A' ' 78' ' ' ILE . 1.0 OUTLIER -98.11 96.0 7.82 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 176.863 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.42 ' C ' ' O ' ' A' ' 79' ' ' ASP . 70.6 t80 -29.23 -40.86 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -178.084 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 79' ' ' ASP . 1.9 mmmm -68.72 -54.44 16.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.733 0.301 . . . . 0.0 110.699 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -52.59 -26.82 14.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.015 0.436 . . . . 0.0 110.577 179.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.555 ' CE1' HD13 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -91.9 -35.27 14.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.844 -179.898 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.404 ' O ' ' CD2' ' A' ' 88' ' ' TYR . . . -76.56 -29.09 56.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.398 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -74.43 -11.33 60.21 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.396 0.617 . . . . 0.0 111.824 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 13.0 mmm -84.04 -28.97 27.26 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.942 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.948 HD21 HD13 ' A' ' 28' ' ' LEU . 4.5 mt -100.83 -7.09 23.93 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.778 0.799 . . . . 0.0 111.819 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.404 ' CD2' ' O ' ' A' ' 84' ' ' ALA . 10.8 m-85 -125.99 21.87 7.44 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 114.377 -1.283 . . . . 0.0 111.339 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.0 m . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.409 179.886 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.493 ' CG ' HD23 ' A' ' 87' ' ' LEU . 1.5 ttpp . . . . . 0 N--CA 1.457 -0.076 0 CA-C-O 120.883 0.373 . . . . 0.0 110.745 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.679 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -68.29 -28.58 67.31 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.8 -179.89 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -58.95 -23.92 62.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.159 0.504 . . . . 0.0 109.781 178.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.973 HD22 HD22 ' A' ' 87' ' ' LEU . 3.8 tt -88.07 -11.39 47.29 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.407 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.679 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 11.2 mm -67.26 -13.6 16.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.959 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -76.32 2.19 14.09 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 113.944 -1.48 . . . . 0.0 111.676 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 1.106 ' HB2' HD21 ' A' ' 56' ' ' LEU . . . -92.31 -29.44 16.37 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.092 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -57.23 -28.21 62.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.055 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -97.42 37.76 1.33 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.919 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.8 t30 . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.852 -179.971 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.837 0.351 . . . . 0.0 110.916 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.541 HG11 ' CE2' ' A' ' 48' ' ' PHE . 9.1 p -117.56 122.19 69.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.966 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.0 155.38 38.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.839 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.698 HG22 HG13 ' A' ' 78' ' ' ILE . 49.7 t -59.71 -53.13 52.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.773 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -49.14 -37.07 20.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.749 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -80.84 -29.1 35.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.439 179.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.789 ' CD2' HD12 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -70.66 -40.05 73.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.782 179.91 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 46.0 mtm180 -56.96 -51.82 67.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.943 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -54.23 -25.41 32.73 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.327 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.0 mt -89.61 -43.68 14.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.847 0.355 . . . . 0.0 110.869 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.688 ' CD1' HD13 ' A' ' 56' ' ' LEU . 36.6 mm -70.7 -26.97 29.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.211 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.33 -60.22 3.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.106 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -111.87 14.92 21.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.336 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -101.84 -87.29 1.98 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.75 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 1.106 HD21 ' HB2' ' A' ' 31' ' ' ALA . 3.9 mp -90.92 133.4 32.22 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.509 0.195 . . . . 0.0 111.147 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -77.91 87.58 1.51 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.54 2.16 . . . . 0.0 112.289 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.613 ' O ' HD11 ' A' ' 63' ' ' ILE . 1.2 mtp -125.08 141.27 52.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.774 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.888 ' O ' HD12 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -77.99 148.92 34.18 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.642 179.673 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.506 ' O ' ' N ' ' A' ' 64' ' ' THR . 5.4 pt-20 -38.76 -52.0 1.7 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.258 0.551 . . . . 0.0 110.851 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.524 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -47.17 -53.2 13.63 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.038 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.568 ' HB2' ' HE2' ' A' ' 58' ' ' MET . 2.2 mm-40 -55.08 -61.72 2.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.928 0.394 . . . . 0.0 109.975 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.888 HD12 ' O ' ' A' ' 59' ' ' THR . 1.7 mp -58.72 -61.7 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.168 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.506 ' N ' ' O ' ' A' ' 60' ' ' GLU . 58.9 m -51.8 -51.45 56.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.343 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.524 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 50.9 tt0 -65.62 -15.45 62.76 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 121.686 0.755 . . . . 0.0 110.458 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.426 ' CD1' ' O ' ' A' ' 62' ' ' GLU . 3.6 m-30 -96.15 -26.52 15.44 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.519 -1.219 . . . . 0.0 110.372 179.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.699 ' CE2' HG22 ' A' ' 63' ' ' ILE . 5.1 m-30 -77.8 -26.68 49.78 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.827 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -90.75 -28.43 18.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.882 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.94 -11.2 45.13 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.459 0.647 . . . . 0.0 111.732 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -92.15 -29.72 16.34 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.078 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -125.64 119.29 24.44 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.789 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -64.85 -40.69 20.52 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.421 2.081 . . . . 0.0 112.189 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -77.4 -31.31 54.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.758 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 72.18 38.9 0.83 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.103 0.477 . . . . 0.0 110.144 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.497 HG23 ' HB2' ' A' ' 77' ' ' PHE . 1.5 t -89.7 41.27 1.03 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.529 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.422 ' C ' HG23 ' A' ' 45' ' ' VAL . . . 50.88 25.39 9.51 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.688 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.497 ' HB2' HG23 ' A' ' 75' ' ' THR . 2.5 m-85 -126.06 129.5 49.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.761 0.315 . . . . 0.0 110.84 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.789 HD12 ' CD2' ' A' ' 48' ' ' PHE . 55.7 mt -103.13 153.27 5.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.184 0.516 . . . . 0.0 111.379 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.453 ' N ' HG22 ' A' ' 78' ' ' ILE . 10.1 t0 -99.41 95.66 7.18 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 176.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.417 ' C ' ' O ' ' A' ' 79' ' ' ASP . 47.3 t80 -29.35 -41.32 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.066 -0.515 . . . . 0.0 112.287 -178.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 79' ' ' ASP . 21.9 mttt -65.93 -55.82 14.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.562 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -53.05 -26.16 14.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.044 0.449 . . . . 0.0 110.574 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.635 ' CE1' HD13 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -91.55 -30.49 16.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.895 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.05 -45.58 16.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.359 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -71.4 -11.62 60.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.412 0.625 . . . . 0.0 111.816 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 14.7 tpp -68.67 -35.44 77.23 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.656 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.973 HD22 HD22 ' A' ' 28' ' ' LEU . 4.2 mp -100.63 -6.76 24.74 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.777 0.798 . . . . 0.0 111.556 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -125.82 22.44 7.45 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 114.271 -1.331 . . . . 0.0 111.176 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.829 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.1 tmtm? . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.738 0.304 . . . . 0.0 110.641 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.68 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -68.03 -29.11 68.02 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.765 -179.923 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.0 mm100 -59.79 -23.93 63.7 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.829 HD22 HD22 ' A' ' 87' ' ' LEU . 0.6 OUTLIER -88.15 -11.25 47.44 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.468 179.636 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.68 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 10.8 mm -66.58 -13.74 16.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.987 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -76.4 2.11 14.49 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 113.923 -1.49 . . . . 0.0 111.658 179.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.666 ' HB2' HD11 ' A' ' 56' ' ' LEU . . . -92.62 -29.82 15.93 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.138 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -59.76 -27.31 66.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.123 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -94.81 42.89 1.09 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.028 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.973 179.896 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.845 0.355 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.46 HG11 ' CE2' ' A' ' 48' ' ' PHE . 10.3 p -128.52 124.52 61.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.936 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 51.1 p -76.46 148.22 37.38 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.925 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.682 HG13 ' CZ ' ' A' ' 67' ' ' PHE . 57.5 t -58.45 -39.56 75.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.836 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -56.06 -30.26 61.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.979 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -96.42 -31.9 12.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.886 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.698 ' HA ' HD12 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -58.77 -41.21 86.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.084 -179.757 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.472 ' HD2' HG12 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -57.54 -48.62 78.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.008 -179.909 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -59.56 -28.04 64.52 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.434 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.698 HD12 ' HA ' ' A' ' 48' ' ' PHE . 4.6 mt -86.47 -49.99 14.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.95 0.405 . . . . 0.0 110.989 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 tp -57.83 -40.5 76.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.278 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 13.6 mtp85 -47.63 -68.34 0.2 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.169 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -93.3 14.66 17.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.018 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.545 ' O ' HD23 ' A' ' 56' ' ' LEU . . . -110.51 -57.86 0.5 Allowed Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.592 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.666 HD11 ' HB2' ' A' ' 31' ' ' ALA . 10.4 mt -129.09 135.58 27.83 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.649 0.261 . . . . 0.0 111.015 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -78.95 97.38 1.13 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.641 2.227 . . . . 0.0 112.246 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.597 ' O ' HD11 ' A' ' 63' ' ' ILE . 1.3 mtp -129.52 140.28 51.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.814 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.898 ' O ' HD12 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -77.88 148.12 34.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.674 179.677 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.483 ' O ' ' N ' ' A' ' 64' ' ' THR . 6.1 pt-20 -39.53 -52.22 2.17 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.166 0.508 . . . . 0.0 111.064 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.529 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -47.98 -52.45 19.73 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.949 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.454 ' HB2' ' HE3' ' A' ' 58' ' ' MET . 0.9 OUTLIER -55.36 -62.4 1.7 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.377 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.898 HD12 ' O ' ' A' ' 59' ' ' THR . 1.8 mp -56.59 -61.82 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.964 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.483 ' N ' ' O ' ' A' ' 60' ' ' GLU . 55.3 m -52.14 -50.4 61.81 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.061 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.529 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 2.3 tp10 -65.99 -15.87 63.39 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 121.579 0.704 . . . . 0.0 110.459 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.441 ' CD2' ' O ' ' A' ' 62' ' ' GLU . 2.4 m-85 -96.31 -24.48 16.17 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.42 179.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.682 ' CZ ' HG13 ' A' ' 45' ' ' VAL . 8.5 m-30 -81.62 -28.92 33.47 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.797 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -94.12 -28.79 15.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.891 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.53 -11.19 54.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.402 0.62 . . . . 0.0 111.796 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.547 ' HB1' HG23 ' A' ' 78' ' ' ILE . . . -103.5 -30.2 10.68 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.015 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.407 ' HA ' ' HD2' ' A' ' 72' ' ' PRO . 10.8 t0 -119.63 95.74 49.35 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.813 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 71' ' ' ASP . 35.1 Cg_endo -65.04 -35.79 41.01 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.5 2.133 . . . . 0.0 112.325 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.725 ' OD1' HG23 ' A' ' 75' ' ' THR . 15.8 p30 -77.36 -30.4 53.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.875 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.1 m120 74.28 49.05 0.11 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.594 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.725 HG23 ' OD1' ' A' ' 73' ' ' ASN . 18.1 p -95.2 25.27 4.39 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.815 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 53.78 23.66 22.85 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.189 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -142.8 129.24 20.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.779 0.323 . . . . 0.0 110.442 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.547 HG23 ' HB1' ' A' ' 70' ' ' ALA . 7.2 mt -105.48 156.99 6.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.051 0.453 . . . . 0.0 111.67 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.526 ' N ' HG22 ' A' ' 78' ' ' ILE . 1.7 m-20 -85.11 97.59 9.96 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 176.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.414 ' C ' ' O ' ' A' ' 79' ' ' ASP . 50.0 t80 -28.48 -39.77 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -177.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.442 ' N ' ' O ' ' A' ' 79' ' ' ASP . 5.4 mmmm -65.11 -53.16 49.56 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.693 0.282 . . . . 0.0 110.698 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -54.11 -25.47 22.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.933 0.397 . . . . 0.0 110.594 179.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.497 ' CZ ' HD13 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -94.15 -30.15 14.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.102 -179.67 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.34 -38.8 26.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.315 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.66 -11.45 60.42 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.392 0.615 . . . . 0.0 111.716 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 36.9 tpp -67.49 -36.16 80.55 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.74 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.829 HD22 HD22 ' A' ' 28' ' ' LEU . 2.8 mp -100.74 -6.78 24.5 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 121.865 0.841 . . . . 0.0 111.537 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -124.61 22.34 8.31 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 114.135 -1.393 . . . . 0.0 111.111 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.061 179.997 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.561 ' HD3' HD22 ' A' ' 87' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.943 0.401 . . . . 0.0 110.6 . . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.685 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -69.09 -28.85 66.87 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.817 -179.862 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.572 ' O ' HD23 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -59.4 -24.22 63.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.168 0.509 . . . . 0.0 109.675 178.529 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.712 HD13 HD21 ' A' ' 87' ' ' LEU . 5.4 tt -88.23 -11.29 47.05 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.451 179.691 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.685 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 12.4 mm -65.65 -14.48 17.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 114.794 -1.094 . . . . 0.0 112.007 -179.899 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -79.02 2.25 21.13 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 113.872 -1.513 . . . . 0.0 111.427 179.526 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.16 -30.8 15.05 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.171 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -59.05 -30.85 68.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.92 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -98.43 34.99 1.87 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.984 179.906 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.943 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.404 ' CZ ' ' O ' ' A' ' 78' ' ' ILE . 10.5 t80 . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.811 0.339 . . . . 0.0 111.017 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.565 HG11 ' CE2' ' A' ' 48' ' ' PHE . 8.0 p -123.67 115.93 46.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.004 179.774 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.4 p -71.69 149.38 45.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.91 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.483 HG13 ' CZ ' ' A' ' 67' ' ' PHE . 82.0 t -54.51 -55.03 17.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.963 179.844 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -47.72 -30.63 4.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.971 -179.833 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -87.62 -30.04 20.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.443 179.391 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.609 ' CD2' HD12 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -68.95 -36.16 77.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.903 179.88 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.445 ' CZ ' HG12 ' A' ' 45' ' ' VAL . 37.5 mtt-85 -55.47 -51.54 66.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.027 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -57.03 -22.22 41.53 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.531 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 28.3 mt -89.86 -26.24 5.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.769 0.319 . . . . 0.0 111.223 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.442 HG21 HG12 ' A' ' 63' ' ' ILE . 31.2 mm -93.15 -28.65 4.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.228 -179.905 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.8 ttm-85 -56.31 -54.98 38.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.351 -179.648 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -111.76 15.08 21.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.621 -179.566 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -105.31 -87.89 2.02 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.819 -179.8 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.617 ' N ' HD12 ' A' ' 56' ' ' LEU . 4.1 mp -99.6 139.85 21.17 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-O 120.674 0.273 . . . . 0.0 111.11 -179.725 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.0 117.78 4.79 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.478 2.119 . . . . 0.0 112.252 179.869 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.645 ' O ' HD11 ' A' ' 63' ' ' ILE . 0.6 OUTLIER -153.12 137.9 17.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.811 -179.881 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.897 ' O ' HD12 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -75.45 146.75 40.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.653 179.506 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.532 ' O ' ' N ' ' A' ' 64' ' ' THR . 0.5 OUTLIER -39.07 -52.45 1.85 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.299 0.571 . . . . 0.0 111.011 179.744 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.511 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -46.34 -53.21 11.29 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.105 179.63 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.531 ' HB2' ' HE2' ' A' ' 58' ' ' MET . 0.5 OUTLIER -55.67 -61.33 2.43 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.872 0.368 . . . . 0.0 110.077 179.439 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.897 HD12 ' O ' ' A' ' 59' ' ' THR . 1.5 mp -59.39 -61.3 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.115 179.776 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.532 ' N ' ' O ' ' A' ' 60' ' ' GLU . 65.2 m -51.59 -51.67 53.67 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.232 -179.844 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.511 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 6.7 tt0 -65.75 -15.42 62.83 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-O 121.623 0.725 . . . . 0.0 110.389 179.778 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.435 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.4 m-30 -95.25 -25.49 16.33 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.537 -1.211 . . . . 0.0 110.389 179.114 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.751 ' CE2' HG22 ' A' ' 63' ' ' ILE . 2.6 m-30 -80.15 -28.94 38.79 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.719 179.942 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.42 -30.24 22.24 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.859 179.918 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.12 -11.13 59.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.503 0.668 . . . . 0.0 111.691 180.0 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.02 -29.9 12.64 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.836 -1.074 . . . . 0.0 111.035 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -124.43 117.06 26.65 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.755 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.37 -50.28 2.05 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.372 2.048 . . . . 0.0 112.301 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.602 ' CG ' HG23 ' A' ' 75' ' ' THR . 10.1 p30 -68.48 -32.77 73.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.852 179.911 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 6.1 m120 75.38 52.36 0.07 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.644 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.602 HG23 ' CG ' ' A' ' 73' ' ' ASN . 13.6 p -97.6 30.04 3.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.649 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 58.75 25.89 59.49 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.287 -179.717 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -127.75 131.13 49.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.802 0.334 . . . . 0.0 110.77 179.876 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.645 HD13 ' CE1' ' A' ' 83' ' ' PHE . 58.2 mt -105.05 152.64 6.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.233 0.539 . . . . 0.0 111.594 -179.764 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.435 ' N ' HG22 ' A' ' 78' ' ' ILE . 0.5 OUTLIER -99.01 95.58 7.23 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 176.912 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.422 ' C ' ' O ' ' A' ' 79' ' ' ASP . 38.6 t80 -28.93 -41.63 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.312 -178.081 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' A' ' 79' ' ' ASP . 4.4 mptt -65.86 -56.13 13.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.655 179.781 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.41 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -52.81 -26.83 15.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.944 0.402 . . . . 0.0 110.59 179.221 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.645 ' CE1' HD13 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -90.47 -31.98 16.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.813 179.956 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.46 ' O ' ' CD2' ' A' ' 88' ' ' TYR . . . -75.61 -41.38 54.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.225 179.946 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.467 ' HA ' ' CE2' ' A' ' 88' ' ' TYR . . . -61.97 -12.06 16.49 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.333 0.587 . . . . 0.0 112.035 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 8.8 mmt -79.27 -21.25 46.35 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.205 179.884 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.712 HD21 HD13 ' A' ' 28' ' ' LEU . 19.9 mt -100.6 -15.57 17.75 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 121.677 0.751 . . . . 0.0 112.366 -179.593 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.467 ' CE2' ' HA ' ' A' ' 85' ' ' ALA . 33.1 p90 -127.93 21.62 6.34 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.33 179.017 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.829 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.3 tpt . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 120.669 0.271 . . . . 16.050000000000001 111.35 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -63.12 131.46 42.37 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 121.108 -0.568 . . . . 14.67 112.552 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 55.2 m 59.5 52.56 5.68 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.019 0.438 . . . . 13.460000000000001 110.927 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.5 m -80.45 -32.47 37.2 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.016 -0.538 . . . . 12.91 111.443 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -76.8 68.03 2.95 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 121.044 0.45 . . . . 13.1 110.908 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.479 ' HA ' ' CD2' ' A' ' 10' ' ' HIS . 80.7 t60 -176.32 -60.81 0.01 OUTLIER 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.831 -0.622 . . . . 11.49 110.647 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 -105.34 -48.36 3.71 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.143 -0.48 . . . . 10.609999999999999 111.026 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -62.13 -71.39 0.15 Allowed 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.468 -0.333 . . . . 10.58 111.041 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 6.4 m170 -156.55 121.59 4.65 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.798 0.332 . . . . 10.6 111.379 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.479 ' CD2' ' HA ' ' A' ' 6' ' ' HIS . 0.2 OUTLIER -90.77 -157.24 0.48 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.951 -0.568 . . . . 10.59 109.988 179.271 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.8 p -47.7 -42.19 24.47 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.751 0.31 . . . . 9.8800000000000008 110.494 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 57.8 m -111.16 139.57 46.43 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.972 -0.558 . . . . 9.6799999999999997 109.976 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.25 81.03 0.6 Allowed Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.914 -0.66 . . . . 10.27 112.787 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 49.47 56.86 7.18 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.001 0.429 . . . . 11.4 110.83 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.2 t -112.43 96.36 35.62 Favored Pre-proline 0 C--O 1.233 0.222 0 CA-C-N 115.951 -0.568 . . . . 11.09 111.453 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.05 -33.59 25.11 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.648 2.232 . . . . 11.27 112.176 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 37.0 ptt85 -67.29 171.36 5.95 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.24 -0.436 . . . . 12.710000000000001 111.087 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.32 -65.08 2.21 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.95 -0.643 . . . . 9.6999999999999993 111.909 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 74.6 m -105.9 31.11 5.28 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 120.836 0.351 . . . . 9.4900000000000002 110.737 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -92.44 -161.91 0.88 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.155 -0.475 . . . . 10.69 110.609 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -78.18 75.13 4.72 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.046 0.45 . . . . 9.9700000000000006 110.9 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.7 m -98.61 5.28 47.91 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.954 -0.566 . . . . 7.04 111.768 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.463 ' HA ' ' OG1' ' A' ' 26' ' ' THR . 12.9 m-20 -95.32 -15.61 23.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.153 -0.476 . . . . 6.4699999999999998 112.167 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -62.28 -19.51 63.33 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.469 -0.787 . . . . 6.8700000000000001 111.287 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.439 ' HE3' HD22 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -89.46 -42.11 11.68 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.959 -1.019 . . . . 5.0499999999999998 109.708 178.253 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.726 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.8 OUTLIER -67.24 -29.24 68.83 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.27 -0.423 . . . . 4.79 111.067 179.163 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.586 ' HB3' ' HG2' ' A' ' 57' ' ' PRO . 25.1 mt-30 -68.78 -31.86 71.18 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 109.177 -0.675 . . . . 6.1600000000000001 109.177 177.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.828 ' HG ' HD13 ' A' ' 56' ' ' LEU . 0.4 OUTLIER -84.33 -10.14 57.86 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.587 -0.733 . . . . 3.6899999999999999 112.166 179.032 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.726 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 7.1 mm -52.91 -18.37 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 115.345 -0.843 . . . . 5.46 112.589 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -67.91 1.07 2.86 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.366 -1.288 . . . . 6.6699999999999999 112.749 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.15 -40.87 67.71 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.049 -0.523 . . . . 6.3300000000000001 110.226 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.42 ' HA ' ' HB2' ' A' ' 36' ' ' ASP . 62.1 m-85 -62.9 -30.09 71.27 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.364 -0.38 . . . . 7.9299999999999997 110.336 178.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.573 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -115.21 78.36 1.16 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.198 -0.456 . . . . 8.8599999999999994 110.446 179.686 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.573 ' CB ' ' O ' ' A' ' 33' ' ' TYR . 28.0 t30 127.8 18.95 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.495 1.118 . . . . 8.7899999999999991 111.501 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.636 ' CE1' HD13 ' A' ' 51' ' ' ILE . 13.3 t80 -176.75 39.92 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.841 0.353 . . . . 7.9400000000000004 110.965 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.42 ' HB2' ' HA ' ' A' ' 32' ' ' PHE . 0.7 OUTLIER -159.28 44.91 0.26 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.885 0.374 . . . . 10.539999999999999 111.08 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -88.19 -66.17 1.31 Allowed Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.987 -0.625 . . . . 11.84 112.19 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -150.16 66.02 0.97 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.023 0.439 . . . . 12.49 110.572 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -130.27 140.57 50.67 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.924 -0.58 . . . . 13.99 111.085 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.4 -162.38 0.5 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.098 -0.501 . . . . 9.6199999999999992 110.775 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -85.82 43.15 3.21 Favored Glycine 0 C--N 1.337 0.605 0 C-N-CA 120.945 -0.645 . . . . 7.71 112.961 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -155.23 123.84 6.04 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.709 0.29 . . . . 7.3399999999999999 110.941 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.493 ' O ' ' HB ' ' A' ' 78' ' ' ILE . 7.4 p -142.84 128.66 16.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.183 -0.462 . . . . 5.2699999999999996 110.728 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.427 ' HA ' ' HA ' ' A' ' 77' ' ' PHE . 11.7 p -70.34 150.55 46.2 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.779 0.323 . . . . 6.3700000000000001 111.271 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.92 HG22 HG13 ' A' ' 78' ' ' ILE . 38.3 t -57.48 -42.75 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 115.936 -0.575 . . . . 5.5599999999999996 110.781 179.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.481 ' HA ' ' HD2' ' A' ' 49' ' ' ARG . 1.3 mt-10 -52.44 -50.3 62.86 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.718 -0.674 . . . . 8.1799999999999997 110.931 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.19 -41.45 77.15 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.366 -0.379 . . . . 9.3399999999999999 110.347 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.411 ' HA ' HD12 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -55.67 -43.26 76.17 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.838 -0.619 . . . . 5.7999999999999998 111.386 179.72 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.481 ' HD2' ' HA ' ' A' ' 46' ' ' GLU . 58.3 mtt180 -53.74 -52.49 59.99 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.394 -0.366 . . . . 8.2100000000000009 111.398 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -58.93 -42.09 96.59 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 121.151 -0.547 . . . . 8.5999999999999996 112.814 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.636 HD13 ' CE1' ' A' ' 35' ' ' PHE . 7.9 mt -67.59 -47.17 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 CA-C-O 120.643 0.258 . . . . 7.3300000000000001 111.101 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.713 HD13 HD12 ' A' ' 56' ' ' LEU . 4.7 mm -62.97 -36.79 77.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 116.101 -0.499 . . . . 6.9400000000000004 111.917 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 19.1 mtt85 -47.59 -59.37 3.31 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.264 0.468 . . . . 10.77 112.264 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -111.81 15.1 21.02 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 111.958 0.355 . . . . 10.92 111.958 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.52 -70.67 0.63 Allowed Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.939 -0.648 . . . . 7.7999999999999998 112.874 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.828 HD13 ' HG ' ' A' ' 28' ' ' LEU . 7.1 mt -104.71 116.15 61.44 Favored Pre-proline 0 CA--C 1.53 0.194 0 CA-C-O 120.554 0.216 . . . . 6.1399999999999997 111.163 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.586 ' HG2' ' HB3' ' A' ' 27' ' ' GLN . 38.9 Cg_endo -66.22 97.58 0.36 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.806 2.337 . . . . 7.0099999999999998 112.102 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.634 ' O ' HD11 ' A' ' 63' ' ' ILE . 1.0 OUTLIER -138.44 144.68 40.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.536 -0.757 . . . . 7.04 110.813 -179.81 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.67 ' O ' HD12 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -85.91 154.02 21.8 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.946 -0.57 . . . . 8.9100000000000001 110.284 179.305 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.445 ' O ' ' HB ' ' A' ' 64' ' ' THR . 4.7 pt-20 -45.13 -52.68 8.95 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.813 0.339 . . . . 10.6 111.251 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.417 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -50.69 -20.82 1.34 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.688 0.625 . . . . 8.7200000000000006 112.688 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.493 ' HG2' ' O ' ' A' ' 59' ' ' THR . 0.1 OUTLIER -95.45 -50.37 5.02 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.762 -0.458 . . . . 7.0999999999999996 109.762 179.054 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.67 HD12 ' O ' ' A' ' 59' ' ' THR . 0.8 OUTLIER -71.52 -45.35 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 116.225 -0.443 . . . . 6.2400000000000002 111.692 179.887 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.445 ' HB ' ' O ' ' A' ' 60' ' ' GLU . 17.3 m -69.53 -45.5 68.68 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.41 -0.359 . . . . 7.6200000000000001 110.699 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.417 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 23.8 tt0 -64.8 -18.88 65.49 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.426 0.631 . . . . 8.9700000000000006 110.491 179.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 6.2 m-30 -96.46 -31.66 12.7 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.761 -1.109 . . . . 5.2400000000000002 110.316 178.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.682 ' CD1' HD11 ' A' ' 78' ' ' ILE . 2.8 m-30 -63.07 -35.86 81.67 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.415 -0.357 . . . . 4.6600000000000001 110.891 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -87.88 -35.88 17.49 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.347 -0.388 . . . . 8.0600000000000005 110.817 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.47 -14.57 61.26 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.403 0.519 . . . . 5.9299999999999997 112.403 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.37 -38.33 11.03 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.384 -0.825 . . . . 4.4299999999999997 111.124 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' ' 77' ' ' PHE . 37.6 t0 -108.28 107.05 59.81 Favored Pre-proline 0 CA--C 1.53 0.203 0 CA-C-N 116.344 -0.389 . . . . 5.4500000000000002 110.989 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -61.96 -38.14 60.2 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.709 2.272 . . . . 6.8300000000000001 112.491 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -75.75 -32.74 60.1 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.331 -0.395 . . . . 6.6799999999999997 111.472 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 26.8 m120 69.74 24.46 5.4 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.059 0.457 . . . . 7.0800000000000001 110.37 -178.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.5 t -68.59 -16.77 63.96 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.72 -0.673 . . . . 5.7199999999999998 111.043 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 111.84 17.72 8.32 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-N 116.261 -0.427 . . . . 5.4299999999999997 112.659 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.443 ' O ' ' HB2' ' A' ' 71' ' ' ASP . 13.6 m-85 -116.39 164.64 14.24 Favored 'General case' 0 CA--C 1.527 0.06 0 N-CA-C 109.99 -0.374 . . . . 6.4500000000000002 109.99 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.92 HG13 HG22 ' A' ' 45' ' ' VAL . 7.1 mt -142.09 147.64 21.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.356 0.598 . . . . 3.79 112.25 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.43 100.36 12.38 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.447 -1.316 . . . . 5.3499999999999996 107.447 176.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -37.91 -40.31 0.45 Allowed 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.255 0.465 . . . . 5.6100000000000003 112.255 -177.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.7 mttp -64.5 -48.51 74.89 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.758 -0.201 . . . . 8.0299999999999994 110.844 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.56 -38.9 64.33 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.97 0.415 . . . . 4.4400000000000004 110.314 178.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.566 ' CE1' HD13 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -75.63 -40.33 56.44 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.649 -0.705 . . . . 3.1699999999999999 110.871 179.343 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.39 -33.0 74.93 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.259 -0.428 . . . . 4.5199999999999996 111.523 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.22 -11.87 58.56 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.807 0.669 . . . . 5.7699999999999996 112.807 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 6.3 mmt -77.12 -45.87 25.45 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.572 -0.74 . . . . 4.7599999999999998 110.399 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.788 HD21 HD13 ' A' ' 28' ' ' LEU . 1.4 mp -88.2 -8.98 54.49 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.472 0.653 . . . . 5.1500000000000004 112.242 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -117.04 22.75 12.35 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.606 -1.179 . . . . 7.3300000000000001 111.11 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.6 58.67 3.81 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.023 0.44 . . . . 8.25 111.051 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.2 t -129.98 27.2 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 116.053 -0.521 . . . . 10.050000000000001 110.872 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -141.58 95.82 2.88 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.241 -0.436 . . . . 11.609999999999999 110.425 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -87.98 135.7 33.29 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.137 -0.483 . . . . 12.449999999999999 110.991 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.015 -0.993 . . . . 13.869999999999999 111.275 -179.95 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.9 mtt . . . . . 0 N--CA 1.488 1.429 0 CA-C-O 120.793 0.33 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -105.35 -148.06 16.73 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.443 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.1 m -146.38 -64.93 0.3 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.865 0.364 . . . . 0.0 110.901 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.1 t -161.6 34.61 0.13 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.936 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 22.9 m170 -123.7 134.65 53.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.881 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -78.34 79.98 4.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.864 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 60.8 m80 -146.13 165.78 28.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.864 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -176.28 147.72 0.72 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.889 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -60.32 -61.02 2.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.877 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 60.49 161.09 0.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.944 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 68.04 -70.2 0.13 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.906 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.3 m -142.86 99.95 3.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.91 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -63.58 -124.29 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.42 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.537 ' O ' HG13 ' A' ' 15' ' ' VAL . 1.0 OUTLIER -140.32 31.18 1.93 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.799 0.333 . . . . 0.0 110.939 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.537 HG13 ' O ' ' A' ' 14' ' ' LEU . 5.5 m -159.08 79.82 2.82 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.081 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.51 163.85 1.62 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.59 2.193 . . . . 0.0 112.361 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 8.3 tpp85 -150.57 -66.76 0.2 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.83 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.6 -138.16 49.34 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.558 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.9 p 58.5 -170.04 0.12 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.835 0.35 . . . . 0.0 110.989 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 32.9 p-80 -91.06 118.89 30.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.962 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.36 34.26 4.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.888 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.3 m -101.6 5.44 41.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.594 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.14 -14.52 61.39 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.572 0.701 . . . . 0.0 111.477 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -65.53 -15.98 63.23 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 114.843 -1.072 . . . . 0.0 111.263 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.733 ' HG2' HD23 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -91.72 -29.36 16.87 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.618 179.493 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.674 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -60.17 -28.27 67.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.775 -179.857 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.25 -23.96 66.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.232 0.539 . . . . 0.0 109.682 178.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.745 ' O ' HD13 ' A' ' 28' ' ' LEU . 2.7 tm? -88.03 -11.32 47.61 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.257 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.674 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 10.7 mm -66.0 -14.42 17.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.92 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -77.6 2.15 17.42 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 113.9 -1.5 . . . . 0.0 111.52 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.435 ' HA ' HD11 ' A' ' 56' ' ' LEU . . . -93.41 -29.53 15.55 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.132 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -56.66 -22.81 37.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.155 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -97.25 29.76 3.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.129 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -179.16 38.75 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.902 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.769 ' CZ ' HG21 ' A' ' 51' ' ' ILE . 11.6 m-85 -154.5 31.77 0.42 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.951 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -108.13 31.36 5.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.864 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -171.79 64.35 0.15 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.527 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.7 p30 -136.82 31.27 2.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.833 0.349 . . . . 0.0 110.89 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 60.49 84.1 0.13 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.903 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 60.74 -170.49 0.15 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.897 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.422 ' HA3' ' CD2' ' A' ' 80' ' ' TYR . . . -77.79 -27.57 58.49 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.469 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -59.7 123.81 18.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.837 0.351 . . . . 0.0 110.882 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.468 HG11 ' CE2' ' A' ' 48' ' ' PHE . 8.1 p -144.18 139.75 24.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.963 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -88.9 155.16 19.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.006 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.452 HG13 ' CZ ' ' A' ' 67' ' ' PHE . 86.1 t -58.24 -55.9 19.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.058 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -46.69 -30.73 2.51 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.078 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -91.23 -28.85 17.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.476 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.474 ' HA ' HD12 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -68.75 -38.19 79.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.74 179.716 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 26.9 mtp180 -57.6 -50.3 73.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.915 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -56.72 -25.85 52.34 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.543 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.769 HG21 ' CZ ' ' A' ' 35' ' ' PHE . 28.5 mt -84.05 -43.81 17.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.796 0.331 . . . . 0.0 111.011 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.481 HG21 HG12 ' A' ' 63' ' ' ILE . 30.9 mm -69.72 -28.66 38.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.192 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 20.1 mtm180 -50.63 -58.22 6.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.018 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -111.75 14.9 21.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.272 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -99.0 -86.51 1.88 Allowed Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.665 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.435 HD11 ' HA ' ' A' ' 31' ' ' ALA . 7.9 mp -103.76 145.73 31.18 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.755 0.312 . . . . 0.0 111.068 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.98 112.91 3.6 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.504 2.136 . . . . 0.0 112.312 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.554 ' O ' HD11 ' A' ' 63' ' ' ILE . 1.1 ttp -154.85 138.32 15.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.721 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.87 ' O ' HD12 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -78.86 146.6 33.56 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.466 179.463 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.556 ' O ' ' N ' ' A' ' 64' ' ' THR . 0.6 OUTLIER -40.29 -53.21 2.58 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.288 0.566 . . . . 0.0 110.913 179.841 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.526 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -46.23 -53.08 11.28 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.045 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.443 ' HB2' ' HE3' ' A' ' 58' ' ' MET . 0.6 OUTLIER -56.04 -61.16 2.57 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 179.446 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.87 HD12 ' O ' ' A' ' 59' ' ' THR . 1.2 mp -59.66 -61.09 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.049 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.556 ' N ' ' O ' ' A' ' 60' ' ' GLU . 51.7 m -51.18 -51.03 57.64 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.171 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.526 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 8.6 tt0 -66.56 -15.45 63.43 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 121.683 0.754 . . . . 0.0 110.399 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.426 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.6 m-30 -96.23 -25.31 15.85 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.44 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.766 ' CE2' HG22 ' A' ' 63' ' ' ILE . 1.6 m-85 -73.74 -46.63 44.65 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.65 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.44 -26.51 58.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.153 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.53 -11.03 60.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.457 0.646 . . . . 0.0 111.844 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.433 ' HB2' ' CE1' ' A' ' 83' ' ' PHE . . . -96.3 -51.41 4.39 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.867 -1.061 . . . . 0.0 111.193 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 29.1 p-10 -105.35 118.79 54.86 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.9 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -69.14 -36.12 13.1 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.466 2.111 . . . . 0.0 112.32 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -68.42 -32.69 72.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.878 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 71.65 40.86 0.75 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.145 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.538 HG23 ' HB2' ' A' ' 77' ' ' PHE . 1.4 t -91.36 29.9 1.38 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.635 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 56.02 26.73 49.52 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.454 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.538 ' HB2' HG23 ' A' ' 75' ' ' THR . 2.4 m-85 -123.47 161.27 25.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.777 0.323 . . . . 0.0 110.646 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.712 HD11 ' HD1' ' A' ' 67' ' ' PHE . 52.2 mt -139.32 148.93 23.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.247 0.546 . . . . 0.0 111.706 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.445 ' O ' ' N ' ' A' ' 82' ' ' ALA . 0.7 OUTLIER -97.49 96.28 8.22 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 176.812 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.426 ' C ' ' O ' ' A' ' 79' ' ' ASP . 39.4 t80 -28.61 -40.78 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.366 -178.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 79' ' ' ASP . 1.7 mtmp? -66.44 -54.78 20.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.567 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.445 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -52.96 -26.98 16.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.018 0.437 . . . . 0.0 110.478 179.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.552 ' CE1' HD13 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -91.1 -31.44 16.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.884 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.65 -20.74 33.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.579 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.25 -11.23 60.43 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.423 0.63 . . . . 0.0 111.934 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.493 ' HB3' HD12 ' A' ' 87' ' ' LEU . 17.2 tpp -78.18 -35.34 48.82 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.57 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.733 HD23 ' HG2' ' A' ' 25' ' ' LYS . 6.9 mp -96.4 -5.86 38.82 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.831 0.824 . . . . 0.0 111.299 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -122.35 21.89 10.19 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 114.174 -1.375 . . . . 0.0 111.098 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.05 29.63 2.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.062 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.623 ' O ' HG22 ' A' ' 90' ' ' VAL . 14.7 p -138.21 36.84 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.962 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -156.21 37.33 0.34 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.898 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -125.52 138.0 53.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.943 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.155 -0.926 . . . . 0.0 110.826 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.3 mtm . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 120.939 0.399 . . . . 0.0 111.259 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 96.81 39.13 4.2 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.447 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.2 p -63.08 -175.35 0.1 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.794 0.331 . . . . 0.0 110.878 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.5 m -75.28 -65.67 0.86 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.948 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -172.93 -179.02 1.95 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.939 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 -141.32 167.71 21.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.948 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 60.54 -174.38 0.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.845 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 25.9 p80 -132.21 -176.2 3.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.91 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 23.8 t-80 60.66 109.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.914 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -176.48 -40.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.895 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.4 m -143.13 -47.57 0.31 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.893 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.8 m -146.43 113.58 6.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.814 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -88.58 -47.19 4.36 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.506 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.531 HD22 ' N ' ' A' ' 14' ' ' LEU . 3.2 mm? -76.17 83.53 2.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.934 0.397 . . . . 0.0 110.976 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.5 t 60.47 88.18 0.12 Allowed Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.127 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.07 -178.22 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.626 2.217 . . . . 0.0 112.276 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.5 tpp85 -61.28 -67.79 0.37 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.896 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.11 173.75 0.57 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.526 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.24 31.46 0.17 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.853 0.359 . . . . 0.0 110.936 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -176.37 37.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.826 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.36 -60.85 1.59 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.906 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.4 t -100.91 5.3 43.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.528 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.84 -14.44 61.5 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.594 0.711 . . . . 0.0 111.589 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.82 -16.28 63.67 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.855 -1.066 . . . . 0.0 111.124 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.572 ' HG2' HD22 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -91.83 -28.29 17.43 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.688 179.504 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.683 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -63.1 -29.48 70.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.814 -179.875 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -60.6 -24.28 65.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.18 0.515 . . . . 0.0 109.701 178.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.978 HD13 HD21 ' A' ' 87' ' ' LEU . 5.5 tt -88.24 -11.29 47.03 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.456 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.683 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 10.8 mm -64.39 -14.59 16.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.971 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -76.92 1.83 16.49 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 114.085 -1.416 . . . . 0.0 111.543 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.54 -28.37 16.1 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.072 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -58.0 -20.81 41.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.317 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -93.97 23.82 4.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.554 -0.293 . . . . 0.0 111.182 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -176.66 34.15 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.052 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 17.1 t80 179.74 77.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.742 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -98.46 24.14 7.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.139 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 93.24 -24.34 25.53 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.652 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.5 t0 62.4 27.68 16.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.813 0.339 . . . . 0.0 110.97 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 57.02 73.6 0.45 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.946 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -177.54 -40.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.94 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.15 27.46 57.98 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.546 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -152.61 123.88 7.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.848 0.356 . . . . 0.0 110.904 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.429 ' O ' HG13 ' A' ' 43' ' ' VAL . 10.2 p -122.77 125.15 72.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.042 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 52.7 p -70.49 168.43 16.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.872 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.827 HG22 HG13 ' A' ' 78' ' ' ILE . 41.2 t -73.06 -29.05 27.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.835 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -74.84 -53.03 9.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.711 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -58.38 -32.75 68.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.582 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.751 ' HD2' HD12 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -59.63 -35.91 75.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.76 179.715 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.72 -51.29 70.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.926 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -54.94 -25.39 37.68 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.363 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 24.6 mt -90.58 -39.94 12.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.823 0.344 . . . . 0.0 110.898 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.415 HG21 HG12 ' A' ' 63' ' ' ILE . 36.5 mm -74.26 -27.2 21.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.199 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.4 ttt85 -50.7 -58.72 5.19 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.878 0.37 . . . . 0.0 111.068 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -111.9 15.07 20.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.299 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -97.65 -86.02 1.81 Allowed Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.712 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.607 HD22 ' HA ' ' A' ' 28' ' ' LEU . 11.2 mt -101.19 135.6 19.87 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.587 0.232 . . . . 0.0 111.0 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -78.73 59.32 7.22 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.488 2.125 . . . . 0.0 112.325 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.629 ' O ' HD11 ' A' ' 63' ' ' ILE . 1.4 mtp -88.32 141.68 28.35 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.582 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.911 ' O ' HD12 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -77.95 147.68 34.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.772 179.762 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.494 ' O ' ' N ' ' A' ' 64' ' ' THR . 3.0 pt-20 -38.08 -48.5 1.23 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.19 0.519 . . . . 0.0 111.094 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.515 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -50.96 -52.78 39.13 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.922 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.478 ' HB2' ' HE2' ' A' ' 58' ' ' MET . 1.1 mm-40 -55.15 -61.79 2.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.007 0.432 . . . . 0.0 109.934 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.911 HD12 ' O ' ' A' ' 59' ' ' THR . 1.8 mp -57.92 -61.79 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.202 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.494 ' N ' ' O ' ' A' ' 60' ' ' GLU . 92.2 m -52.36 -52.28 54.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.291 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.515 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 1.2 tp10 -64.46 -15.58 60.95 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 121.702 0.763 . . . . 0.0 110.504 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.428 ' CD1' ' O ' ' A' ' 62' ' ' GLU . 3.5 m-30 -95.07 -28.87 14.88 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.284 179.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.742 ' CD1' HD11 ' A' ' 78' ' ' ILE . 10.0 m-30 -79.84 -24.39 41.33 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.848 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -93.96 -27.34 16.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.85 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.77 -11.41 42.27 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.436 0.636 . . . . 0.0 111.72 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.65 -27.41 14.38 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.961 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.401 ' HA ' ' HD2' ' A' ' 72' ' ' PRO . 14.6 t0 -120.68 96.53 48.81 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.781 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 71' ' ' ASP . 30.1 Cg_endo -63.58 -29.9 70.48 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.411 2.074 . . . . 0.0 112.243 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -83.31 -27.03 30.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.828 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 73.09 40.39 0.56 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.179 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.2 t -91.47 28.71 1.63 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.621 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.483 ' C ' HG23 ' A' ' 45' ' ' VAL . . . 47.42 31.83 7.0 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.317 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.636 ' N ' HG23 ' A' ' 45' ' ' VAL . 1.2 t80 -134.04 129.19 35.7 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.849 0.357 . . . . 0.0 110.285 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.827 HG13 HG22 ' A' ' 45' ' ' VAL . 65.5 mt -102.75 150.57 6.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.183 0.516 . . . . 0.0 111.461 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.43 ' O ' ' N ' ' A' ' 82' ' ' ALA . 2.2 m-20 -93.76 95.64 9.27 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 176.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.423 ' C ' ' O ' ' A' ' 79' ' ' ASP . 42.4 t80 -29.67 -40.6 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.238 -177.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 79' ' ' ASP . 15.8 mtmt -66.15 -55.22 17.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.797 0.332 . . . . 0.0 110.613 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -52.72 -27.9 19.63 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.033 0.444 . . . . 0.0 110.501 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.591 ' CE1' HD13 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -89.66 -32.78 16.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.804 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.37 -24.46 46.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.197 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.8 -11.41 60.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.446 0.641 . . . . 0.0 111.729 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 9.4 mtp -75.14 -37.88 61.23 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.743 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.978 HD21 HD13 ' A' ' 28' ' ' LEU . 4.1 mt -88.19 -6.88 57.59 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.854 0.835 . . . . 0.0 111.52 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -125.99 22.45 7.35 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.131 -1.395 . . . . 0.0 111.184 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.16 97.87 2.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.879 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.577 ' O ' HG22 ' A' ' 90' ' ' VAL . 12.0 p -153.43 49.41 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.069 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -169.92 155.26 5.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.935 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -168.16 -56.05 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.902 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.909 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 120.705 0.288 . . . . 0.0 111.183 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 64.25 136.09 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.461 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 78.3 p -97.17 -176.32 3.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.749 0.309 . . . . 0.0 110.906 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 62.7 p -104.4 -74.58 0.64 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.844 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 5.6 m80 60.61 110.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.901 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -131.57 -178.04 4.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.871 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -170.73 35.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.916 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 13.6 p80 -131.43 36.67 3.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.823 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 2.5 m80 64.1 -79.13 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.973 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 16.7 m80 -140.68 -75.92 0.32 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.827 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.8 m -176.86 37.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.922 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 59.84 -169.93 0.14 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.93 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 138.18 -85.51 0.23 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.515 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.448 HD12 ' HA ' ' A' ' 14' ' ' LEU . 8.0 tp -60.49 -67.01 0.44 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.813 0.34 . . . . 0.0 110.874 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.439 ' O ' HG23 ' A' ' 15' ' ' VAL . 6.4 m -134.89 88.78 26.5 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.173 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -51.97 -61.67 0.48 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.534 2.156 . . . . 0.0 112.373 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.82 37.0 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.864 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.17 56.62 14.82 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.546 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.9 t -86.91 132.86 33.69 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.781 0.324 . . . . 0.0 110.925 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -129.1 31.52 4.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.914 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 17.3 ptp -124.21 5.99 8.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.331 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.9 p -101.78 5.49 41.23 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.072 0.463 . . . . 0.0 111.565 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -71.74 -14.24 61.95 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.57 0.7 . . . . 0.0 111.658 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -65.1 -16.79 63.87 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.306 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.593 ' HE3' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -92.02 -32.23 15.29 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.727 179.603 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.655 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -56.76 -26.4 57.34 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.05 -179.775 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -62.89 -23.62 67.43 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.751 ' O ' HD13 ' A' ' 28' ' ' LEU . 2.7 tm? -88.12 -11.48 46.87 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.362 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.655 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 12.2 mm -64.68 -14.74 16.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 114.77 -1.104 . . . . 0.0 111.946 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -77.67 2.07 17.88 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 113.907 -1.497 . . . . 0.0 111.667 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.585 ' N ' HD21 ' A' ' 56' ' ' LEU . . . -93.37 -40.09 10.58 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.022 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -58.82 -29.83 67.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.95 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -98.1 28.36 4.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.954 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -179.08 41.18 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.767 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -178.13 78.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.91 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 61.93 69.15 0.65 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.866 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -59.28 -27.85 63.56 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.581 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -157.62 39.5 0.28 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.902 0.382 . . . . 0.0 110.971 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -171.98 87.34 0.09 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.92 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.422 ' HB2' ' CE1' ' A' ' 80' ' ' TYR . 1.4 p30 -128.51 -178.03 4.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.91 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 175.31 -61.05 0.11 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.489 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.401 ' CE2' ' HA ' ' A' ' 79' ' ' ASP . 1.0 OUTLIER -152.04 123.89 7.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.783 0.325 . . . . 0.0 110.965 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.5 p -120.93 136.17 58.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.014 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.4 ' HB3' ' CD1' ' A' ' 77' ' ' PHE . 1.3 m -88.71 145.08 25.85 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.855 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 93.1 t -51.51 -55.69 7.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.179 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -47.95 -31.3 5.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.873 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -86.92 -30.24 21.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.413 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.567 ' HD2' HD12 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -67.08 -40.08 86.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.825 179.847 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -56.47 -50.7 70.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.911 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -56.03 -25.41 46.11 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.315 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.436 HD12 ' HA ' ' A' ' 48' ' ' PHE . 28.7 mt -85.51 -43.89 16.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.817 0.341 . . . . 0.0 110.924 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 34.5 mm -71.65 -26.05 25.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.147 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 10.0 mmp_? -52.48 -59.5 4.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.748 0.308 . . . . 0.0 111.118 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -111.72 14.94 21.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.361 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -98.31 -86.35 1.85 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.678 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.585 HD21 ' N ' ' A' ' 31' ' ' ALA . 3.2 mp -105.54 146.78 33.47 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-O 120.689 0.281 . . . . 0.0 111.049 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -73.48 95.09 0.85 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.588 2.192 . . . . 0.0 112.11 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.425 ' HE2' ' HG3' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -130.8 141.67 50.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.799 -179.81 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.702 ' O ' HD12 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -90.0 144.88 25.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.956 179.449 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.601 ' O ' ' N ' ' A' ' 64' ' ' THR . 6.4 pt-20 -47.33 -56.96 5.83 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 121.077 0.465 . . . . 0.0 110.49 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.428 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -50.29 -24.56 3.01 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.982 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.49 ' HB3' ' O ' ' A' ' 59' ' ' THR . 4.8 tp10 -86.67 -46.0 10.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.335 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.722 HG22 ' CE2' ' A' ' 67' ' ' PHE . 0.7 OUTLIER -82.63 -47.82 18.43 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.179 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.074 179.552 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.601 ' N ' ' O ' ' A' ' 60' ' ' GLU . 23.0 m -59.48 -46.84 87.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.202 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.428 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 0.9 OUTLIER -68.32 -16.51 63.97 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 121.755 0.788 . . . . 0.0 110.201 179.376 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.407 ' CD1' ' O ' ' A' ' 62' ' ' GLU . 3.1 m-85 -97.14 -24.0 15.94 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.31 -1.313 . . . . 0.0 110.286 178.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.736 ' CD1' HD11 ' A' ' 78' ' ' ILE . 2.1 m-85 -72.19 -41.3 67.14 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.767 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -79.85 -28.33 40.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.917 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.15 -11.26 60.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.437 0.637 . . . . 0.0 111.741 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.405 ' HB2' ' HE1' ' A' ' 83' ' ' PHE . . . -94.83 -30.59 14.14 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.041 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.484 ' OD2' HG22 ' A' ' 75' ' ' THR . 22.2 t70 -120.73 120.38 29.6 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.909 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -64.36 -27.12 63.18 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.46 2.107 . . . . 0.0 112.282 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 -87.79 -32.56 19.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.886 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 71.52 38.93 0.95 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.063 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.484 HG22 ' OD2' ' A' ' 71' ' ' ASP . 1.6 t -89.2 42.74 1.1 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.689 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 50.87 25.03 8.93 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.636 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.425 ' HB2' HG23 ' A' ' 75' ' ' THR . 41.4 m-85 -122.21 159.16 27.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.905 0.383 . . . . 0.0 110.718 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.736 HD11 ' CD1' ' A' ' 67' ' ' PHE . 50.5 mt -137.28 153.39 28.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.146 0.498 . . . . 0.0 111.593 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.449 ' N ' HG22 ' A' ' 78' ' ' ILE . 1.0 OUTLIER -98.72 95.86 7.52 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 176.923 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.425 ' C ' ' O ' ' A' ' 79' ' ' ASP . 47.8 t80 -28.96 -41.16 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.333 -178.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 79' ' ' ASP . 22.2 mttt -68.01 -55.88 11.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.728 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -51.43 -27.46 10.29 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.961 0.41 . . . . 0.0 110.672 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.509 ' CE1' HD13 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -91.13 -33.06 15.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.94 179.852 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.401 ' O ' ' CD2' ' A' ' 88' ' ' TYR . . . -80.56 -18.24 48.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.444 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.95 -11.69 61.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.379 0.609 . . . . 0.0 111.719 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 51.4 mtm -76.18 -38.49 56.54 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.587 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.597 ' N ' HD22 ' A' ' 87' ' ' LEU . 2.7 mm? -85.94 -6.59 59.03 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 121.822 0.82 . . . . 0.0 111.365 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.401 ' CD2' ' O ' ' A' ' 84' ' ' ALA . 19.0 m-85 -125.65 22.21 7.6 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 114.142 -1.39 . . . . 0.0 111.157 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -97.41 30.38 2.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.929 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 30.6 m -104.22 30.99 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.136 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -145.04 31.96 1.12 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.856 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -153.78 -46.96 0.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.819 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.0 m . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.971 180.0 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 mmt . . . . . 0 N--CA 1.485 1.303 0 CA-C-O 120.754 0.311 . . . . 0.0 111.267 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -165.9 32.26 0.22 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.488 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.7 t -147.24 150.09 34.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.834 0.349 . . . . 0.0 110.916 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.52 177.33 1.45 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.922 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 13.7 m80 60.7 32.86 20.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.896 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -176.49 -68.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.891 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 12.5 t60 -141.44 161.56 37.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.931 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 10.7 p-80 -161.12 82.48 0.63 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.972 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -108.32 129.54 55.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.858 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 12.8 p80 -177.71 -39.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.024 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.2 t 63.65 147.89 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.949 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.75 -52.7 64.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.946 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 59.79 -153.98 32.54 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.45 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 60.22 -165.72 0.2 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.785 0.326 . . . . 0.0 110.807 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.4 m -53.47 160.09 2.03 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.185 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -50.12 166.15 0.3 Allowed 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.526 2.151 . . . . 0.0 112.44 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.7 mtt85 -59.37 128.27 36.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.963 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -107.11 28.08 14.0 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.47 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.0 t -134.77 92.42 2.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.734 0.302 . . . . 0.0 110.879 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 15.5 p80 -60.02 152.18 24.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.94 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.4 ttt -60.46 176.34 0.37 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.86 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 29.1 p -98.33 5.28 48.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.508 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -91.66 -14.49 30.02 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.518 0.675 . . . . 0.0 111.539 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -65.21 -16.38 63.46 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.203 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.711 ' HD3' HD23 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -91.89 -28.38 17.32 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.587 179.477 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.681 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -65.55 -29.07 69.65 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.781 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -59.21 -23.74 62.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.278 0.561 . . . . 0.0 109.776 178.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.839 HD13 HD21 ' A' ' 87' ' ' LEU . 5.7 tt -88.12 -11.32 47.32 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.415 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.681 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 11.0 mm -67.19 -13.67 17.02 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-N 114.749 -1.114 . . . . 0.0 111.952 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -76.61 2.12 14.96 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 113.921 -1.491 . . . . 0.0 111.621 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 1.091 ' HB2' HD21 ' A' ' 56' ' ' LEU . . . -93.03 -33.51 14.09 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.076 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -63.73 -29.17 70.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.887 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -97.99 31.76 2.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.907 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -167.94 33.59 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.865 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.407 ' CG ' ' O ' ' A' ' 35' ' ' PHE . 20.9 t80 -158.5 38.72 0.24 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.892 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -105.95 36.4 2.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.905 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -165.15 53.79 0.27 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.435 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -176.94 78.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.903 0.382 . . . . 0.0 110.876 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 60.64 170.62 0.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.966 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -132.59 139.89 48.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.91 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.432 ' HA2' ' CD2' ' A' ' 80' ' ' TYR . . . 66.21 -86.3 0.11 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.471 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -60.06 123.72 18.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.902 0.382 . . . . 0.0 110.828 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.413 HG11 ' CE2' ' A' ' 48' ' ' PHE . 7.5 p -142.76 125.02 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.875 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.407 ' HB3' ' CD2' ' A' ' 77' ' ' PHE . 1.8 m -77.21 154.71 32.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.056 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.521 HG13 ' CZ ' ' A' ' 67' ' ' PHE . 59.4 t -59.87 -52.69 58.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.759 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -50.09 -31.31 12.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.907 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.4 mm-40 -91.69 -29.22 16.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.46 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.413 ' CE2' HG11 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -64.66 -35.9 82.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.813 179.844 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 15.5 mtt180 -58.37 -49.55 76.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.859 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -57.05 -26.77 56.32 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.36 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 26.0 mt -85.29 -44.35 17.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.891 0.377 . . . . 0.0 110.991 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 37.5 mm -67.2 -29.07 44.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.107 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.09 -57.09 10.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.908 0.385 . . . . 0.0 110.925 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -111.76 14.82 21.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.312 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -99.55 -86.62 1.9 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.673 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 1.091 HD21 ' HB2' ' A' ' 31' ' ' ALA . 6.7 mt -100.19 139.04 20.41 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.577 0.227 . . . . 0.0 110.969 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -79.06 58.79 7.11 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.472 2.115 . . . . 0.0 112.314 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.484 ' O ' HD11 ' A' ' 63' ' ' ILE . 1.4 ttp -94.5 139.9 30.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.746 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.902 ' O ' HD12 ' A' ' 63' ' ' ILE . 0.8 OUTLIER -75.95 142.56 41.95 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.052 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.548 ' O ' ' N ' ' A' ' 64' ' ' THR . 6.6 pt-20 -39.5 -51.79 2.16 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.276 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.434 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -45.61 -55.52 6.24 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.182 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.476 ' HB2' ' HG2' ' A' ' 58' ' ' MET . 0.9 OUTLIER -55.07 -60.86 2.8 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.619 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.902 HD12 ' O ' ' A' ' 59' ' ' THR . 1.5 mp -58.94 -61.93 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.921 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.548 ' N ' ' O ' ' A' ' 60' ' ' GLU . 75.2 m -49.55 -52.45 29.81 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.218 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.434 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 44.0 mt-10 -66.16 -15.75 63.4 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.701 0.762 . . . . 0.0 110.381 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.44 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.5 m-30 -94.66 -26.51 16.3 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.517 -1.22 . . . . 0.0 110.385 179.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.731 ' CE2' HG22 ' A' ' 63' ' ' ILE . 2.4 m-30 -75.16 -30.27 60.67 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.681 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -92.91 -24.93 18.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.92 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.24 -11.23 44.21 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.518 0.675 . . . . 0.0 111.856 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.426 ' HB1' ' CG2' ' A' ' 78' ' ' ILE . . . -99.46 -27.27 13.81 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.136 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -118.96 115.7 34.64 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.703 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.83 -50.51 1.67 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.44 2.093 . . . . 0.0 112.5 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -68.48 -32.55 72.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.93 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 12.6 m120 72.41 30.62 1.94 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.543 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 36.8 p -68.48 -22.71 64.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.036 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 115.08 20.64 5.55 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.568 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.44 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 3.2 m-85 -137.48 150.37 47.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.671 0.272 . . . . 0.0 110.736 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.519 HD11 HG22 ' A' ' 45' ' ' VAL . 1.6 mt -133.36 146.55 32.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.571 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.434 ' O ' ' N ' ' A' ' 81' ' ' LYS . 8.5 m-20 -75.74 105.04 6.57 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 177.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.432 ' CD2' ' HA2' ' A' ' 41' ' ' GLY . 27.6 t80 -28.73 -40.19 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 79' ' ' ASP . 0.1 OUTLIER -64.64 -53.32 49.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.654 0.264 . . . . 0.0 110.854 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -51.45 -27.24 9.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.063 0.458 . . . . 0.0 110.747 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.49 ' CD1' HG21 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -93.83 -32.48 13.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.986 -179.869 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.99 -18.49 53.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.262 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -71.72 -11.61 60.91 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.427 0.632 . . . . 0.0 111.803 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.36 -41.82 62.97 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.716 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.839 HD21 HD13 ' A' ' 28' ' ' LEU . 7.1 mp -86.03 -6.31 59.06 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.884 0.85 . . . . 0.0 111.512 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -125.28 22.26 7.84 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.168 -1.378 . . . . 0.0 111.107 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.81 71.3 6.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.886 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.592 ' O ' HG12 ' A' ' 90' ' ' VAL . 15.9 t -145.55 30.85 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.028 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -176.82 124.99 0.16 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.847 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -78.89 136.44 37.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.888 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.925 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.2 mmm . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.868 0.366 . . . . 0.0 111.123 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -140.37 85.48 0.21 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.424 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.2 m -170.06 35.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.811 0.338 . . . . 0.0 110.88 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.96 133.51 28.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.862 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 17.9 t-160 -172.17 -68.92 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.934 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 60.18 168.01 0.08 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.892 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -176.72 132.95 0.2 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.862 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -150.76 36.78 0.63 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.855 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -99.03 32.21 2.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.952 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 27.5 p80 -148.17 31.57 0.84 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.877 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.3 p -176.55 83.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.866 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.3 p -60.74 109.58 1.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.897 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -95.78 37.8 3.31 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.519 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.539 ' O ' HG13 ' A' ' 15' ' ' VAL . 11.6 mt -99.67 31.12 3.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.817 0.341 . . . . 0.0 110.878 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.539 HG13 ' O ' ' A' ' 14' ' ' LEU . 6.1 m -158.81 68.98 3.49 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.082 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.02 -58.43 1.49 Allowed 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.471 2.114 . . . . 0.0 112.346 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.07 130.51 45.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.962 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -99.98 28.49 15.4 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.473 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 m -86.43 -169.32 2.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.803 0.335 . . . . 0.0 110.871 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.8 t60 61.23 79.75 0.24 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.894 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 17.8 mtt -145.57 169.74 17.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.934 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.3 p -100.88 5.22 43.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.595 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -90.03 -14.53 33.7 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.514 0.673 . . . . 0.0 111.533 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -65.2 -16.61 63.71 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.122 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.479 ' HE2' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -92.02 -27.69 17.66 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.779 -1.1 . . . . 0.0 110.65 179.459 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.657 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -67.15 -27.75 67.55 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.857 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -59.51 -23.75 63.07 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.978 HD13 HD21 ' A' ' 87' ' ' LEU . 5.6 tt -88.2 -11.31 47.09 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.563 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.657 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 11.9 mm -66.1 -14.06 16.81 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 114.695 -1.139 . . . . 0.0 111.932 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.89 1.98 15.99 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 113.915 -1.493 . . . . 0.0 111.66 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.858 ' HB2' HD11 ' A' ' 56' ' ' LEU . . . -93.33 -29.21 15.75 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.076 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -57.18 -25.91 59.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.098 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -95.08 42.42 1.09 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.814 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -171.49 35.24 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.849 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.487 ' CE2' HD13 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -169.67 40.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.794 179.934 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.0 p30 -106.02 30.71 5.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.043 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -67.2 -35.13 87.87 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.482 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -176.81 37.54 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.787 0.327 . . . . 0.0 110.843 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 62.28 -81.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.936 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.4 t0 54.74 -169.13 0.07 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.157 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.403 ' O ' ' CG ' ' A' ' 80' ' ' TYR . . . -150.65 -67.77 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.396 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -59.43 165.89 2.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.852 0.358 . . . . 0.0 111.006 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.501 HG11 ' CE2' ' A' ' 48' ' ' PHE . 7.7 p -175.65 125.43 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.907 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.53 146.93 40.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.112 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.512 HG22 ' CD1' ' A' ' 67' ' ' PHE . 75.7 t -56.25 -53.23 42.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.989 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -48.0 -30.09 4.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.973 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -92.83 -30.0 15.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.467 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.501 ' CE2' HG11 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -64.6 -33.28 75.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.8 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 8.7 mtt180 -55.35 -51.72 65.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.941 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -56.15 -25.71 47.79 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.438 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.487 HD13 ' CE2' ' A' ' 35' ' ' PHE . 40.6 mt -81.97 -28.69 9.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.795 0.331 . . . . 0.0 111.022 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 31.6 mm -90.2 -28.32 5.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.104 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.9 mmm-85 -54.29 -55.6 26.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.346 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -111.66 14.96 21.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.638 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -103.45 -87.49 2.01 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.321 -0.943 . . . . 0.0 112.764 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.858 HD11 ' HB2' ' A' ' 31' ' ' ALA . 4.4 mp -102.54 143.79 27.31 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 120.767 0.317 . . . . 0.0 111.044 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.51 118.41 4.87 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.501 2.134 . . . . 0.0 112.226 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.572 ' O ' HD11 ' A' ' 63' ' ' ILE . 0.4 OUTLIER -158.52 137.68 11.51 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.716 -179.772 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.868 ' O ' HD12 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -78.27 146.06 35.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.468 179.303 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.575 ' O ' ' N ' ' A' ' 64' ' ' THR . 4.8 pt-20 -39.98 -52.79 2.44 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 121.376 0.608 . . . . 0.0 111.01 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.519 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -46.14 -53.91 9.56 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.164 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.461 ' HB2' ' HE2' ' A' ' 58' ' ' MET . 1.8 mm-40 -55.27 -61.53 2.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.956 0.407 . . . . 0.0 109.95 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.868 HD12 ' O ' ' A' ' 59' ' ' THR . 1.1 mp -60.0 -61.68 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.184 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.575 ' N ' ' O ' ' A' ' 60' ' ' GLU . 61.7 m -50.16 -50.85 47.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.196 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.519 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 4.8 tp10 -64.92 -16.29 63.11 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.708 0.766 . . . . 0.0 110.453 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.424 ' CD2' ' O ' ' A' ' 62' ' ' GLU . 1.7 m-85 -96.44 -25.68 15.6 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.515 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.762 ' CE2' HG22 ' A' ' 63' ' ' ILE . 1.4 m-85 -73.42 -31.07 63.64 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.614 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -84.56 -28.21 26.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.971 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -81.34 -11.17 59.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.487 0.661 . . . . 0.0 111.819 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.518 ' HB2' ' CE1' ' A' ' 83' ' ' PHE . . . -97.39 -27.58 14.41 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.086 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -121.54 118.99 29.48 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.765 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -62.86 -53.93 1.42 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.578 2.186 . . . . 0.0 112.65 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.627 ' OD1' HG23 ' A' ' 75' ' ' THR . 14.8 p30 -68.41 -32.82 73.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.963 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.7 m120 74.47 43.74 0.25 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.626 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.627 HG23 ' OD1' ' A' ' 73' ' ' ASN . 17.6 p -93.14 37.79 1.04 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.523 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 55.69 23.02 35.09 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.383 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -124.08 128.54 49.46 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.42 HD11 ' HA ' ' A' ' 67' ' ' PHE . 0.4 OUTLIER -112.23 152.61 14.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.224 0.535 . . . . 0.0 111.512 -179.22 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -98.88 97.57 8.74 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.159 178.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.403 ' CG ' ' O ' ' A' ' 41' ' ' GLY . 80.8 t80 -35.2 -35.91 0.05 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.028 -178.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.72 -51.95 50.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.511 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.75 -25.12 54.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.141 0.496 . . . . 0.0 110.413 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.518 ' CE1' ' HB2' ' A' ' 70' ' ' ALA . 0.1 OUTLIER -92.59 -29.59 16.07 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.928 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.4 ' O ' ' CD2' ' A' ' 88' ' ' TYR . . . -80.09 -25.92 39.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.157 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.76 -11.46 60.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.418 0.627 . . . . 0.0 111.814 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 14.0 tpp -82.72 -36.55 25.7 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.818 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.978 HD21 HD13 ' A' ' 28' ' ' LEU . 9.7 mt -85.8 -6.43 59.1 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.845 0.831 . . . . 0.0 111.505 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.4 ' CD2' ' O ' ' A' ' 84' ' ' ALA . 12.7 m-85 -126.07 22.14 7.34 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 114.101 -1.409 . . . . 0.0 111.001 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.8 t -83.17 75.33 9.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.874 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.579 ' O ' HG12 ' A' ' 90' ' ' VAL . 16.0 t -134.54 32.38 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.143 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -122.1 84.64 2.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.882 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.1 pm0 -60.31 136.45 58.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.877 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.849 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 ptp . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.722 0.296 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 59.86 39.43 95.45 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.553 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.8 m -141.28 35.84 1.7 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.832 0.348 . . . . 0.0 110.953 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.24 87.05 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.988 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 25.7 p80 -101.17 -31.66 10.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.922 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 60.53 -169.48 0.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.909 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -167.94 90.21 0.3 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.902 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -78.06 145.58 35.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.908 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 34.2 m80 -109.92 -66.0 1.1 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.872 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -176.3 80.06 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.886 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.4 t -80.89 83.31 6.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.001 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.8 m -85.03 -72.29 0.48 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.926 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 59.91 92.24 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.493 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.515 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.2 OUTLIER -105.89 -66.54 0.98 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.894 0.378 . . . . 0.0 110.928 179.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.515 HG13 ' O ' ' A' ' 14' ' ' LEU . 6.4 m -158.53 149.72 16.49 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.084 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.35 -61.59 0.48 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.532 2.155 . . . . 0.0 112.301 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.31 -74.57 0.24 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.833 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.468 ' HA2' HG23 ' A' ' 15' ' ' VAL . . . 150.6 -70.59 0.31 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.521 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -162.19 -54.88 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.824 0.345 . . . . 0.0 110.884 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -83.9 128.0 34.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.952 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 66.3 mtm -88.44 150.62 23.05 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.893 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.3 p -99.96 5.31 45.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.996 0.427 . . . . 0.0 111.576 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -96.5 -14.64 22.18 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.497 0.665 . . . . 0.0 111.517 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -65.25 -16.49 63.6 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.13 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.8 tttt -91.9 -26.75 18.31 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.671 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.676 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -68.36 -28.91 67.54 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.671 -179.881 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -59.45 -23.82 63.02 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 1.118 HD13 HD21 ' A' ' 87' ' ' LEU . 4.1 tt -88.17 -11.22 47.47 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.436 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.735 HD13 ' HE2' ' A' ' 32' ' ' PHE . 11.8 mm -66.57 -14.14 17.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 114.803 -1.089 . . . . 0.0 111.983 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -78.14 2.3 18.5 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 113.936 -1.484 . . . . 0.0 111.51 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.868 ' HB2' HD21 ' A' ' 56' ' ' LEU . . . -93.42 -32.67 14.14 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.989 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.735 ' HE2' HD13 ' A' ' 29' ' ' ILE . 93.3 m-85 -59.26 -29.56 67.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.951 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -97.52 36.28 1.52 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.95 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -165.96 32.26 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.979 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -177.07 40.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.889 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -132.99 56.55 1.84 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.95 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -96.03 27.58 16.02 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.626 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.6 t70 60.66 68.07 0.78 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.915 0.388 . . . . 0.0 110.974 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -122.71 -76.71 0.59 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.907 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -178.16 -177.84 0.62 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.929 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.404 ' O ' ' CG ' ' A' ' 80' ' ' TYR . . . -95.95 -37.97 4.77 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.417 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -61.85 123.73 18.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.796 0.332 . . . . 0.0 110.922 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.563 ' O ' HG13 ' A' ' 43' ' ' VAL . 7.8 p -144.92 110.83 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.92 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.414 ' HB3' ' CD2' ' A' ' 77' ' ' PHE . 1.2 m -65.83 160.69 22.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.041 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.729 HG22 HD11 ' A' ' 78' ' ' ILE . 72.5 t -57.89 -56.07 17.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.784 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -47.13 -41.49 17.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.989 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -78.91 -27.65 43.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.48 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.473 ' CE2' ' CD2' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -67.7 -29.47 68.73 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.96 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 34.1 mmm-85 -56.07 -56.43 20.89 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.053 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -54.9 -23.61 31.3 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.621 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 24.7 mt -84.5 -24.34 7.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.631 0.253 . . . . 0.0 111.238 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 39.9 mm -93.03 -36.19 7.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.243 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.97 -46.43 71.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.119 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -111.84 14.84 21.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.508 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -109.8 -88.87 1.95 Allowed Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.66 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.868 HD21 ' HB2' ' A' ' 31' ' ' ALA . 1.6 mp -100.38 136.82 19.91 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.587 0.232 . . . . 0.0 110.989 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -79.9 58.44 6.98 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.529 2.152 . . . . 0.0 112.493 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.647 ' O ' HD11 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -86.4 141.71 28.96 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.567 179.607 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.896 ' O ' HD12 ' A' ' 63' ' ' ILE . 0.3 OUTLIER -75.78 145.59 40.64 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.606 179.632 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.544 ' O ' ' N ' ' A' ' 64' ' ' THR . 4.8 pt-20 -39.29 -52.23 2.0 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.178 0.513 . . . . 0.0 111.02 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.52 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -46.65 -53.61 11.25 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.071 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.525 ' HB2' ' HE2' ' A' ' 58' ' ' MET . 1.7 mm-40 -55.16 -61.64 2.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.928 0.394 . . . . 0.0 110.039 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.896 HD12 ' O ' ' A' ' 59' ' ' THR . 1.4 mp -59.17 -61.48 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.177 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.544 ' N ' ' O ' ' A' ' 60' ' ' GLU . 68.2 m -51.35 -51.68 52.32 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.174 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.52 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 28.8 tp10 -65.8 -15.46 62.9 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.576 0.703 . . . . 0.0 110.346 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.437 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.4 m-30 -94.94 -25.93 16.33 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.387 179.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.754 ' CE2' HG22 ' A' ' 63' ' ' ILE . 2.6 m-30 -79.64 -28.79 40.85 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.765 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -86.64 -31.1 21.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.881 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -81.46 -11.17 59.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.486 0.66 . . . . 0.0 111.713 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.564 ' HB1' ' CG2' ' A' ' 78' ' ' ILE . . . -102.25 -27.41 12.88 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.028 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -123.33 107.82 32.12 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.675 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.48 -43.5 7.83 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.397 2.065 . . . . 0.0 112.339 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -68.45 -32.31 72.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.823 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 21.2 m-20 73.96 20.95 2.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.529 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.415 HG22 ' H ' ' A' ' 75' ' ' THR . 0.9 OUTLIER -63.64 -22.38 66.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.861 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 109.21 19.75 8.29 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.502 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.414 ' CD2' ' HB3' ' A' ' 44' ' ' SER . 4.1 m-85 -132.97 146.27 51.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.776 0.322 . . . . 0.0 110.825 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.729 HD11 HG22 ' A' ' 45' ' ' VAL . 1.0 OUTLIER -133.38 146.09 32.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.433 179.789 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.438 ' O ' ' N ' ' A' ' 82' ' ' ALA . 0.4 OUTLIER -77.08 108.18 9.98 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 177.202 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.426 ' C ' ' O ' ' A' ' 79' ' ' ASP . 28.0 t80 -28.77 -40.75 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.428 ' N ' ' O ' ' A' ' 79' ' ' ASP . 0.2 OUTLIER -64.66 -53.13 52.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.935 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -50.21 -28.08 6.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.058 0.456 . . . . 0.0 110.771 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.538 ' CD1' HG21 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -93.25 -35.5 13.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.041 -179.748 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.08 -22.61 55.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.313 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.68 -11.55 60.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.476 0.655 . . . . 0.0 111.849 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 9.5 mmt -72.96 -31.28 64.45 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.806 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 1.118 HD21 HD13 ' A' ' 28' ' ' LEU . 2.6 mt -100.18 -6.59 25.9 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.917 0.865 . . . . 0.0 111.58 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -126.05 22.34 7.32 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.127 -1.397 . . . . 0.0 111.173 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.49 95.01 7.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.857 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.57 ' O ' HG12 ' A' ' 90' ' ' VAL . 15.8 t -135.31 32.4 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.08 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -61.65 121.95 14.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.932 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -72.6 -68.83 0.45 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.899 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.0 t . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.179 -0.915 . . . . 0.0 110.94 -179.989 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mtt . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.799 0.333 . . . . 0.0 111.264 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -108.44 -110.74 3.42 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.515 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.0 p -96.22 43.21 1.08 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.958 0.409 . . . . 0.0 110.885 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.57 141.53 54.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.96 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -96.64 -172.2 2.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.861 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 22.6 m80 -127.48 116.76 20.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.923 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -176.53 -40.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.863 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -81.55 -171.18 3.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.908 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 8.1 m170 60.64 110.67 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.852 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -153.4 -67.92 0.15 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.965 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 27.1 t -176.56 164.5 2.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.888 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.1 m 60.31 170.1 0.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.818 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.668 ' C ' HD13 ' A' ' 14' ' ' LEU . . . 106.22 -117.89 5.55 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.515 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.679 HD13 ' N ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -158.31 42.7 0.28 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.807 0.337 . . . . 0.0 110.826 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.465 ' O ' HG23 ' A' ' 15' ' ' VAL . 7.3 m -114.05 88.3 14.45 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.148 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -52.05 -32.75 50.1 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.566 2.177 . . . . 0.0 112.313 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -99.51 123.69 44.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.897 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -102.86 -74.48 1.03 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.494 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.1 94.0 5.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.75 0.309 . . . . 0.0 111.01 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -110.62 31.5 5.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.921 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 2.8 mpt? -111.19 155.13 23.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.886 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -100.36 5.28 44.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.382 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -91.66 -14.26 30.4 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.611 0.719 . . . . 0.0 111.621 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -65.67 -16.33 63.64 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.251 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -91.96 -30.56 16.03 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.687 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.683 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -57.9 -27.31 63.2 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.828 -179.807 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -62.86 -24.03 67.6 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.789 ' O ' HD13 ' A' ' 28' ' ' LEU . 2.9 tm? -88.08 -11.47 47.02 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.195 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.683 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 11.3 mm -64.98 -14.59 16.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.969 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -77.89 2.14 18.28 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 113.878 -1.51 . . . . 0.0 111.463 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.23 -31.23 14.82 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.064 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -59.54 -30.98 68.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.942 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -97.41 38.9 1.22 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.932 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -176.87 38.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.851 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -176.58 78.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.903 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -161.73 71.23 0.36 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.004 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -107.11 27.9 14.54 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.559 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 60.03 36.94 21.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.844 0.354 . . . . 0.0 110.952 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -73.38 -175.55 1.97 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.88 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.1 p-10 -98.59 33.81 2.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.93 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 60.34 43.94 98.07 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.53 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -150.4 123.9 9.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.813 0.34 . . . . 0.0 110.971 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.449 ' CG1' ' CE2' ' A' ' 48' ' ' PHE . 9.4 p -131.39 127.67 60.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.976 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.1 p -78.99 162.08 26.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.906 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.668 HG22 HG13 ' A' ' 78' ' ' ILE . 46.5 t -64.17 -54.16 34.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.001 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -47.22 -29.75 2.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.084 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -93.32 -30.05 15.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.655 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.855 ' CD2' HD12 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -66.02 -38.31 88.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.95 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.6 mtp85 -54.72 -51.48 65.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.0 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -57.2 -21.49 39.73 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.606 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.9 mt -93.17 -25.43 4.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.744 0.307 . . . . 0.0 111.255 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.467 HG21 HG12 ' A' ' 63' ' ' ILE . 40.6 mm -93.37 -49.39 12.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.301 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 24.7 ttp180 -46.86 -68.86 0.16 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.7 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -92.44 14.93 15.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.745 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -121.31 -89.88 1.07 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.373 -0.918 . . . . 0.0 112.914 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -80.23 132.9 58.18 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.554 0.216 . . . . 0.0 111.192 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.65 113.82 3.82 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.466 2.111 . . . . 0.0 112.256 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.659 ' O ' HD11 ' A' ' 63' ' ' ILE . 0.7 OUTLIER -155.63 137.69 14.6 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.892 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.894 ' O ' HD12 ' A' ' 63' ' ' ILE . 0.6 OUTLIER -74.31 145.1 44.2 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.855 179.733 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.515 ' O ' ' N ' ' A' ' 64' ' ' THR . 2.3 pt-20 -37.85 -48.65 1.14 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.169 0.509 . . . . 0.0 111.054 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.426 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -49.55 -55.74 12.38 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.835 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.489 ' HB2' ' HE2' ' A' ' 58' ' ' MET . 0.6 OUTLIER -52.18 -62.6 1.53 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.286 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.894 HD12 ' O ' ' A' ' 59' ' ' THR . 1.8 mp -57.35 -62.84 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.123 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.515 ' N ' ' O ' ' A' ' 60' ' ' GLU . 99.3 m -50.12 -53.09 29.85 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.405 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.426 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 2.7 mm-40 -65.31 -15.8 62.91 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-O 121.617 0.722 . . . . 0.0 110.485 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.432 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.7 m-30 -94.61 -26.57 16.31 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.423 179.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.708 ' CE2' HG22 ' A' ' 63' ' ' ILE . 4.8 m-30 -77.97 -26.58 48.8 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.801 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -91.32 -28.93 17.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.805 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.07 -11.23 47.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.535 0.683 . . . . 0.0 111.782 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -92.09 -28.53 17.07 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.113 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -126.16 119.36 23.62 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.785 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.84 -40.67 16.15 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.272 1.982 . . . . 0.0 112.279 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -76.53 -30.94 57.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.817 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.2 m120 72.35 38.83 0.8 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.171 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.508 HG23 ' HB3' ' A' ' 77' ' ' PHE . 1.5 t -89.64 41.77 1.06 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.634 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.401 ' C ' HG23 ' A' ' 45' ' ' VAL . . . 47.94 26.94 4.64 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.523 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.508 ' HB3' HG23 ' A' ' 75' ' ' THR . 0.6 OUTLIER -128.12 129.38 46.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.819 0.342 . . . . 0.0 110.449 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.855 HD12 ' CD2' ' A' ' 48' ' ' PHE . 61.9 mt -102.49 153.34 5.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.19 0.519 . . . . 0.0 111.662 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.445 ' N ' HG22 ' A' ' 78' ' ' ILE . 1.2 t0 -98.78 95.76 7.43 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 176.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.426 ' C ' ' O ' ' A' ' 79' ' ' ASP . 56.4 t80 -29.06 -41.25 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.337 -177.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -66.0 -55.85 14.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.672 0.272 . . . . 0.0 110.618 179.818 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.415 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -52.65 -27.08 15.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.965 0.412 . . . . 0.0 110.594 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.621 ' CE1' HD13 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -90.37 -32.3 16.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.86 179.823 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.12 -28.76 48.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.165 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.82 -11.5 60.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.375 0.607 . . . . 0.0 111.708 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 14.1 tmm? -69.59 -35.12 75.04 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.913 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.54 HD21 ' HG ' ' A' ' 28' ' ' LEU . 3.0 mp -100.67 -5.97 25.8 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.816 0.817 . . . . 0.0 111.63 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -125.48 22.41 7.68 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 114.193 -1.367 . . . . 0.0 111.09 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -65.54 79.55 0.06 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.871 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.547 ' O ' HG12 ' A' ' 90' ' ' VAL . 15.0 t -143.19 35.77 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.026 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -123.6 175.93 6.52 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.92 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 68.4 -69.29 0.15 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.009 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.873 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 ttp . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.852 0.358 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -158.65 95.89 0.15 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.492 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.7 m -84.77 -66.71 0.86 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.723 0.297 . . . . 0.0 110.862 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 t 60.42 84.56 0.12 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.899 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 15.4 m170 -125.81 35.82 4.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.902 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 64.6 m-70 -127.79 -169.87 2.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.862 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 6.0 m170 61.85 114.98 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.87 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 18.7 m170 60.56 84.12 0.13 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.893 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -88.51 177.46 6.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.98 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 13.8 p80 -107.51 -45.79 3.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.931 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.3 t 60.67 168.16 0.09 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.887 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.9 p -103.97 105.82 16.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.88 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -176.95 -38.3 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.448 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.7 tp -82.39 -31.53 29.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.778 0.323 . . . . 0.0 110.907 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.5 m -119.45 150.49 49.84 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.153 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.43 -172.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.53 2.153 . . . . 0.0 112.279 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 11.1 mmt85 61.28 155.32 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.885 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 146.87 88.24 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.519 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.404 ' O ' ' CD2' ' A' ' 20' ' ' HIS . 0.8 OUTLIER -117.07 -178.44 3.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.879 0.371 . . . . 0.0 110.848 -179.981 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.404 ' CD2' ' O ' ' A' ' 19' ' ' SER . 6.4 m170 -163.29 174.03 12.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.896 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.7 mtt -67.13 149.66 50.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.887 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 36.6 p -101.58 5.31 41.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.54 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.79 -14.65 44.49 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.579 0.704 . . . . 0.0 111.574 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -65.31 -16.54 63.68 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.129 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.9 tttt -91.91 -27.24 18.03 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.644 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.668 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -68.08 -28.16 67.12 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.854 -179.892 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -60.3 -24.28 64.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.223 0.535 . . . . 0.0 109.562 178.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.925 HD13 HD21 ' A' ' 87' ' ' LEU . 5.6 tt -88.33 -11.22 46.98 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.476 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.668 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 13.5 mm -63.61 -15.45 16.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.964 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -80.56 1.95 27.52 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 113.854 -1.521 . . . . 0.0 111.345 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.491 ' HB2' HD21 ' A' ' 56' ' ' LEU . . . -93.45 -29.87 15.34 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.043 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -56.56 -28.16 59.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.053 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -97.65 28.3 3.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.084 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -178.33 37.46 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.869 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.403 ' CG ' ' O ' ' A' ' 35' ' ' PHE . 19.8 t80 -177.14 37.76 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.957 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.1 p-10 -145.04 45.62 1.34 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.862 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -82.62 -80.27 0.97 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.484 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -177.63 78.27 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.839 0.352 . . . . 0.0 110.965 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -146.14 34.64 0.99 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.995 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 60.69 -175.25 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.95 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.403 ' O ' ' CD1' ' A' ' 80' ' ' TYR . . . -100.36 -37.1 3.89 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.588 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -60.07 123.8 18.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.886 0.374 . . . . 0.0 110.88 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.457 HG11 ' CE2' ' A' ' 48' ' ' PHE . 7.6 p -139.53 127.33 25.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.898 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.1 p -67.42 154.17 41.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.159 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.992 HG13 ' CD1' ' A' ' 67' ' ' PHE . 50.6 t -61.9 -27.8 43.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.928 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -71.91 -58.62 3.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.921 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -58.07 -29.07 65.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.802 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.835 ' CD2' HD12 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -61.85 -36.88 82.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.904 179.816 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 16.2 mtt-85 -58.08 -50.74 72.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.951 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -57.28 -26.48 56.39 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.548 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.641 HD12 ' HA ' ' A' ' 48' ' ' PHE . 22.9 mt -80.87 -39.61 18.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.81 0.338 . . . . 0.0 111.087 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 37.9 mm -75.65 -28.77 19.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.248 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.6 mtp85 -51.23 -55.13 19.7 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.094 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -111.86 14.93 21.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.276 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -100.24 -86.84 1.93 Allowed Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.533 -0.841 . . . . 0.0 112.74 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.491 HD21 ' HB2' ' A' ' 31' ' ' ALA . 3.5 mt -105.47 140.05 20.77 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 120.694 0.283 . . . . 0.0 110.981 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -81.35 55.76 5.73 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.524 2.149 . . . . 0.0 112.398 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.606 ' O ' HD11 ' A' ' 63' ' ' ILE . 2.7 ttp -88.2 139.22 30.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.696 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.884 ' O ' HD12 ' A' ' 63' ' ' ILE . 1.7 p -69.18 140.19 54.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.03 0.443 . . . . 0.0 111.067 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.509 ' O ' ' N ' ' A' ' 64' ' ' THR . 0.1 OUTLIER -39.95 -50.36 2.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.156 179.824 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.526 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -45.92 -52.97 10.68 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.489 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.482 ' O ' ' HB2' ' A' ' 66' ' ' PHE . 0.9 OUTLIER -58.2 -60.94 2.97 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.04 179.683 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.884 HD12 ' O ' ' A' ' 59' ' ' THR . 1.7 mp -57.2 -60.21 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.914 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.509 ' N ' ' O ' ' A' ' 60' ' ' GLU . 36.1 m -52.32 -51.24 59.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.786 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.526 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 27.2 tt0 -65.99 -16.14 63.63 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-O 121.603 0.716 . . . . 0.0 110.344 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.482 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 2.3 m-85 -95.77 -25.95 15.86 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.277 178.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.992 ' CD1' HG13 ' A' ' 45' ' ' VAL . 1.6 m-85 -70.74 -41.37 71.92 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.564 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -84.1 -29.14 27.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.919 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -80.5 -11.14 59.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.481 0.658 . . . . 0.0 111.76 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.39 -31.65 15.96 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.018 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -115.86 121.18 34.49 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.778 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.77 -34.95 59.78 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.453 2.102 . . . . 0.0 112.245 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 14.3 m-80 -84.5 -31.63 24.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.792 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 11.5 m120 72.43 37.08 0.95 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.166 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.8 t -88.93 41.84 1.05 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.743 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.427 ' C ' HG23 ' A' ' 45' ' ' VAL . . . 50.82 25.62 9.7 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 121.104 -0.57 . . . . 0.0 112.727 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.51 ' N ' HG23 ' A' ' 45' ' ' VAL . 23.4 m-85 -128.32 129.46 46.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.844 0.354 . . . . 0.0 110.662 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.835 HD12 ' CD2' ' A' ' 48' ' ' PHE . 59.8 mt -101.44 152.37 5.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.266 0.555 . . . . 0.0 111.627 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.448 ' N ' HG22 ' A' ' 78' ' ' ILE . 20.3 t0 -101.07 96.02 6.95 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 176.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.426 ' C ' ' O ' ' A' ' 79' ' ' ASP . 40.2 t80 -28.58 -41.31 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.436 -177.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 79' ' ' ASP . 0.4 OUTLIER -65.28 -55.41 18.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.689 0.28 . . . . 0.0 110.627 179.767 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -53.43 -27.58 25.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.16 0.505 . . . . 0.0 110.497 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.636 ' CE1' HD13 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -89.43 -31.7 17.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.734 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.6 -31.12 46.97 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.108 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -74.57 -11.34 60.18 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.503 0.668 . . . . 0.0 111.823 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 4.4 mmt -74.66 -32.11 62.15 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.808 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.925 HD21 HD13 ' A' ' 28' ' ' LEU . 2.7 mt -97.19 -6.93 33.63 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.921 0.867 . . . . 0.0 111.579 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -126.03 22.32 7.34 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.076 -1.42 . . . . 0.0 111.112 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 60.5 p -68.44 94.93 0.58 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.914 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.7 m -130.42 31.16 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.159 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -147.23 116.98 7.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.001 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -139.02 169.36 17.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.931 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.2 p . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.943 179.99 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ttm . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.759 0.314 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -136.67 51.95 0.79 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.576 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.0 p -100.53 -35.63 9.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.795 0.331 . . . . 0.0 110.831 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.1 m -60.69 129.93 43.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.918 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -95.06 87.09 4.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.979 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -66.07 154.55 39.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.828 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 9.9 p-80 -131.69 80.19 1.91 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.904 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 -134.45 31.61 3.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.925 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -154.28 -171.04 3.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.854 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -60.17 -54.71 42.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.875 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 60.2 p -176.22 -74.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.92 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.8 m -175.24 -57.91 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.971 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 103.68 100.2 2.58 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.504 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.0 -45.42 61.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.836 0.351 . . . . 0.0 110.9 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.7 t 62.84 88.18 0.12 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.095 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -56.29 -165.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.667 2.244 . . . . 0.0 112.25 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.4 mtp-105 69.09 -66.88 0.23 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.035 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -59.28 130.42 50.54 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.496 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 46.9 t -85.34 158.6 20.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.86 0.362 . . . . 0.0 110.856 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 57.2 m-70 -108.72 -41.89 4.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.965 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.3 ptp -60.24 102.56 0.18 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.92 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.4 t -101.71 5.36 41.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.067 0.46 . . . . 0.0 111.583 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.38 -14.75 62.27 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.496 0.665 . . . . 0.0 111.572 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -65.73 -16.1 63.46 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.216 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.407 ' NZ ' ' CE1' ' A' ' 88' ' ' TYR . 0.2 OUTLIER -91.69 -25.68 18.99 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 114.704 -1.134 . . . . 0.0 110.685 179.421 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.667 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -66.56 -29.11 69.11 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.814 -179.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -60.13 -24.26 64.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.093 0.473 . . . . 0.0 109.725 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.796 HD22 HD13 ' A' ' 87' ' ' LEU . 1.3 tt -88.15 -11.22 47.52 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.461 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.667 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 10.8 mm -65.26 -14.3 16.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.924 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -77.04 2.04 16.17 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 114.035 -1.439 . . . . 0.0 111.585 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.915 ' HB2' HD21 ' A' ' 56' ' ' LEU . . . -93.46 -30.78 14.87 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.102 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -57.41 -24.34 54.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.167 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -97.05 30.41 2.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.012 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -173.29 35.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.875 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -176.98 78.26 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.868 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -104.14 41.45 1.3 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.859 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.02 -83.32 1.29 Allowed Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.566 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 43.89 31.33 0.48 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.809 0.338 . . . . 0.0 111.523 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.481 ' N ' ' CD1' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -51.3 -100.43 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.35 -179.723 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -62.5 -28.14 69.63 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.774 0.321 . . . . 0.0 111.001 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.58 25.58 6.53 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.436 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -143.79 123.79 13.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.781 0.324 . . . . 0.0 110.92 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.534 HG11 ' CE2' ' A' ' 48' ' ' PHE . 9.2 p -116.58 122.74 70.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.017 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.423 ' HB3' ' CE2' ' A' ' 77' ' ' PHE . 0.1 OUTLIER -74.73 154.29 38.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.825 179.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.563 HG22 HG13 ' A' ' 78' ' ' ILE . 57.4 t -58.87 -53.2 50.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.859 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -48.93 -33.05 10.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.937 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -86.36 -28.93 23.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.482 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.751 ' HD2' HD12 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -69.25 -41.99 76.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.859 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.445 ' HD2' HG12 ' A' ' 45' ' ' VAL . 13.7 mtp180 -56.27 -52.35 64.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.954 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -53.91 -25.1 29.43 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.326 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.447 HD12 ' HA ' ' A' ' 48' ' ' PHE . 14.1 mt -89.83 -47.05 15.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.854 0.359 . . . . 0.0 110.923 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.45 HG21 HG12 ' A' ' 63' ' ' ILE . 36.4 mm -66.06 -28.01 42.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.223 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.7 -61.53 2.15 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.904 0.383 . . . . 0.0 111.066 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -111.86 15.04 20.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.26 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -97.48 -86.05 1.81 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.591 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.915 HD21 ' HB2' ' A' ' 31' ' ' ALA . 14.1 mt -101.27 142.44 24.63 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.693 0.283 . . . . 0.0 111.065 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.32 113.49 3.69 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.533 2.155 . . . . 0.0 112.321 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.591 ' O ' HD11 ' A' ' 63' ' ' ILE . 0.8 OUTLIER -152.26 138.11 18.03 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.806 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.901 ' O ' HD12 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -77.65 147.67 35.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.683 179.698 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.519 ' O ' ' N ' ' A' ' 64' ' ' THR . 4.6 pt-20 -38.76 -51.86 1.7 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.162 0.505 . . . . 0.0 110.822 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.516 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -46.77 -53.64 11.46 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.118 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.491 ' HB2' ' HE2' ' A' ' 58' ' ' MET . 0.9 OUTLIER -54.91 -61.78 2.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.961 0.41 . . . . 0.0 110.02 179.478 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.901 HD12 ' O ' ' A' ' 59' ' ' THR . 1.6 mp -58.7 -61.54 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.205 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.519 ' N ' ' O ' ' A' ' 60' ' ' GLU . 62.7 m -52.02 -51.49 57.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.37 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.516 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 6.6 tt0 -65.64 -15.53 62.86 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.735 0.779 . . . . 0.0 110.497 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.431 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.6 m-30 -95.97 -25.47 15.94 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 114.449 -1.251 . . . . 0.0 110.321 179.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.718 ' CE2' HG22 ' A' ' 63' ' ' ILE . 4.0 m-30 -79.06 -26.57 43.07 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.748 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -91.37 -27.5 18.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.905 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.63 -11.18 43.31 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.487 0.66 . . . . 0.0 111.777 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.65 -28.39 18.41 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.016 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.53 119.25 23.02 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.829 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.31 -34.9 42.87 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.373 2.049 . . . . 0.0 112.204 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 26.2 m-20 -82.35 -31.32 29.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.9 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 12.9 m120 72.21 38.43 0.87 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.176 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.534 HG23 ' HB2' ' A' ' 77' ' ' PHE . 1.5 t -89.39 42.26 1.08 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.578 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 50.75 25.29 9.06 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.663 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.534 ' HB2' HG23 ' A' ' 75' ' ' THR . 1.9 m-85 -123.08 146.74 47.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.783 0.325 . . . . 0.0 110.783 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.751 HD12 ' HD2' ' A' ' 48' ' ' PHE . 59.4 mt -123.02 153.12 28.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.096 0.474 . . . . 0.0 111.578 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.447 ' N ' HG22 ' A' ' 78' ' ' ILE . 0.5 OUTLIER -98.3 95.78 7.6 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 176.958 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.43 ' C ' ' O ' ' A' ' 79' ' ' ASP . 42.6 t80 -29.34 -41.23 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.036 -0.529 . . . . 0.0 112.293 -178.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.406 ' N ' ' O ' ' A' ' 79' ' ' ASP . 0.1 OUTLIER -65.81 -56.04 14.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.643 179.638 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.412 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -52.45 -27.17 15.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.944 0.402 . . . . 0.0 110.462 179.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.607 ' CE1' HD13 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -90.76 -30.81 16.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.803 179.929 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.31 -24.64 37.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.433 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.47 -11.53 60.71 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.452 0.644 . . . . 0.0 111.895 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 23.6 mtp -79.29 -30.79 43.08 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.843 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.796 HD13 HD22 ' A' ' 28' ' ' LEU . 5.1 mt -100.66 -6.18 25.52 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.735 0.778 . . . . 0.0 111.534 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.407 ' CE1' ' NZ ' ' A' ' 25' ' ' LYS . 32.6 m-85 -125.83 22.37 7.46 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 114.241 -1.345 . . . . 0.0 111.186 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.401 ' O ' ' CG2' ' A' ' 90' ' ' VAL . 6.7 t -63.94 82.3 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.874 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.401 ' CG2' ' O ' ' A' ' 89' ' ' SER . 35.4 m 42.84 32.66 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.748 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -73.19 174.02 8.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.862 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -105.73 -33.24 8.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.92 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.2 t . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.909 179.999 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 ptp . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.77 0.319 . . . . 0.0 111.141 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -123.72 50.85 0.83 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.541 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -162.02 127.59 3.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.894 0.378 . . . . 0.0 110.837 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.55 31.78 4.74 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.922 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 30.9 m80 68.5 -68.13 0.18 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.971 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -159.62 -51.06 0.06 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.858 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 5.4 t60 60.54 35.61 20.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.939 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -83.8 154.49 23.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.92 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 4.7 t60 60.75 110.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.853 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -72.09 -62.64 1.36 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.901 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -176.23 -40.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.909 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.0 t 60.69 -169.81 0.16 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.929 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -133.7 -59.76 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.475 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.3 tp -60.49 147.71 40.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.837 0.351 . . . . 0.0 110.857 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.5 p -59.86 139.34 90.35 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.001 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -52.15 -60.52 0.73 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.429 2.086 . . . . 0.0 112.368 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.4 mtt85 -130.4 -179.27 5.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.959 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.47 88.52 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.416 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.1 p -60.73 141.34 57.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.839 0.352 . . . . 0.0 110.856 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 20.3 p80 -101.88 32.05 3.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.854 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -136.58 92.53 2.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.848 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 84.4 p -89.62 5.35 46.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.454 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -71.32 -14.58 62.25 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.54 0.686 . . . . 0.0 111.532 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -64.97 -16.67 63.64 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.084 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.441 ' CG ' HD23 ' A' ' 87' ' ' LEU . 0.3 OUTLIER -91.91 -27.29 18.0 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.702 179.352 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.651 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -68.5 -27.39 66.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.885 179.972 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -59.34 -23.72 62.75 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.707 HD13 HD21 ' A' ' 87' ' ' LEU . 7.0 tt -88.16 -11.41 46.93 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.449 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.651 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 12.9 mm -66.4 -14.38 17.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.908 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -78.36 2.12 19.67 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 113.895 -1.502 . . . . 0.0 111.661 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.656 ' HB2' HD11 ' A' ' 56' ' ' LEU . . . -93.11 -31.91 14.64 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.085 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -60.67 -29.31 69.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.964 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -96.91 38.19 1.25 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.93 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -161.39 30.26 0.13 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.926 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -176.68 37.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.827 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -110.87 37.8 2.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.909 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -96.07 35.95 4.09 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.442 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.4 t70 61.51 68.77 0.69 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.919 0.39 . . . . 0.0 110.915 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -134.9 150.36 50.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.883 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -61.72 159.09 14.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.924 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.419 ' HA3' ' CD2' ' A' ' 80' ' ' TYR . . . -69.39 -30.67 71.25 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.475 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -64.04 123.76 19.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.848 0.356 . . . . 0.0 110.879 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.473 HG11 ' CE2' ' A' ' 48' ' ' PHE . 7.1 p -141.42 137.33 32.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.949 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.451 ' HB3' ' CE2' ' A' ' 77' ' ' PHE . 13.1 p -84.99 150.13 25.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.047 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.472 HG13 ' CZ ' ' A' ' 67' ' ' PHE . 91.7 t -54.92 -55.52 15.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.082 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -46.74 -30.12 2.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.079 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -91.65 -28.68 17.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.45 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.576 ' CD2' HD12 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -67.42 -38.21 84.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.9 179.885 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 29.4 mtm180 -57.06 -50.43 72.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.907 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -56.15 -25.75 47.89 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.381 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.571 HD12 ' HA ' ' A' ' 48' ' ' PHE . 20.6 mt -85.22 -43.5 16.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.721 0.296 . . . . 0.0 110.932 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.464 HG21 HG12 ' A' ' 63' ' ' ILE . 31.0 mm -69.89 -36.21 68.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.096 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.6 ttm180 -54.36 -47.43 72.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.08 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -111.81 14.94 21.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.335 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -109.17 -88.66 1.96 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.639 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.656 HD11 ' HB2' ' A' ' 31' ' ' ALA . 3.9 mp -102.06 142.07 23.83 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.7 0.286 . . . . 0.0 111.106 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.05 111.41 3.27 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.498 2.132 . . . . 0.0 112.26 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.637 ' O ' HD11 ' A' ' 63' ' ' ILE . 0.6 OUTLIER -148.08 138.03 22.57 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.805 -179.867 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.889 ' O ' HD12 ' A' ' 63' ' ' ILE . 0.6 OUTLIER -75.32 144.82 42.21 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.719 179.529 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.548 ' O ' ' N ' ' A' ' 64' ' ' THR . 1.3 pm0 -37.85 -49.01 1.17 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.278 0.561 . . . . 0.0 111.156 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.421 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -49.37 -55.98 11.13 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.83 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.44 ' O ' ' HB2' ' A' ' 66' ' ' PHE . 0.7 OUTLIER -52.24 -62.22 1.77 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.886 0.374 . . . . 0.0 110.003 179.266 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.889 HD12 ' O ' ' A' ' 59' ' ' THR . 1.4 mp -58.51 -62.88 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.125 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.548 ' N ' ' O ' ' A' ' 60' ' ' GLU . 98.6 m -49.37 -53.03 24.51 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.421 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.421 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 4.9 mm-40 -65.48 -15.72 62.94 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 121.566 0.698 . . . . 0.0 110.554 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.44 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.6 m-30 -95.71 -23.99 16.73 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.56 179.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.764 ' CE2' HG22 ' A' ' 63' ' ' ILE . 1.9 m-30 -76.7 -31.68 57.37 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.746 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -85.73 -29.95 23.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.856 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.71 -11.1 60.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.433 0.635 . . . . 0.0 111.733 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.417 ' HB2' ' CE1' ' A' ' 83' ' ' PHE . . . -99.67 -30.26 12.2 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.061 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -121.8 116.91 30.11 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.748 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -64.85 -50.4 2.31 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.381 2.054 . . . . 0.0 112.315 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.582 ' CG ' HG23 ' A' ' 75' ' ' THR . 9.6 p30 -68.63 -32.73 72.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.813 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.3 m120 75.44 53.83 0.07 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.72 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.582 HG23 ' CG ' ' A' ' 73' ' ' ASN . 12.6 p -98.16 28.83 3.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.703 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 59.2 26.5 61.47 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.319 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.451 ' CE2' ' HB3' ' A' ' 44' ' ' SER . 4.1 m-85 -129.06 131.69 47.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.768 0.318 . . . . 0.0 110.74 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.654 HD13 ' CE1' ' A' ' 83' ' ' PHE . 61.2 mt -106.17 152.46 7.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.23 0.538 . . . . 0.0 111.635 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.442 ' N ' HG22 ' A' ' 78' ' ' ILE . 1.1 m-20 -101.23 96.2 7.04 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 176.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.43 ' C ' ' O ' ' A' ' 79' ' ' ASP . 40.5 t80 -28.78 -41.14 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.035 -0.529 . . . . 0.0 112.331 -177.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 79' ' ' ASP . 5.0 mtpp -66.06 -55.16 17.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.692 0.282 . . . . 0.0 110.51 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -53.2 -28.06 24.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.003 0.43 . . . . 0.0 110.411 179.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.654 ' CE1' HD13 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -88.97 -32.47 17.63 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.846 179.88 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.71 -29.6 45.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.228 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.44 ' O ' ' HB2' ' A' ' 89' ' ' SER . . . -74.32 -11.53 60.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.369 0.605 . . . . 0.0 111.619 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 2.2 mtt -68.9 -47.68 65.23 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.461 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.707 HD21 HD13 ' A' ' 28' ' ' LEU . 4.5 mp -82.81 -6.92 59.65 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.845 0.831 . . . . 0.0 111.107 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -119.69 21.77 11.89 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 113.982 -1.463 . . . . 0.0 111.25 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.44 ' HB2' ' O ' ' A' ' 85' ' ' ALA . 9.3 t -95.54 23.5 6.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.935 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.593 ' O ' HG12 ' A' ' 90' ' ' VAL . 14.8 t 53.35 29.33 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.257 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.47 163.82 21.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.995 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -157.42 -46.15 0.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.825 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.347 -0.835 . . . . 0.0 110.852 -179.973 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.485 1.305 0 CA-C-O 120.839 0.352 . . . . 0.0 111.262 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -59.76 -72.53 0.6 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.468 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.7 m -84.39 143.41 29.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.863 0.363 . . . . 0.0 110.892 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.3 t -131.56 35.39 3.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.837 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -102.63 -38.94 7.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.955 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 4.5 p-80 -106.58 176.24 5.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.97 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -106.42 -175.16 2.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.891 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -98.74 34.7 2.0 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.886 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -134.67 170.97 15.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.919 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -71.82 174.21 7.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.915 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 26.2 m -145.35 95.25 2.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.903 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m -106.49 133.2 51.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.896 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.48 157.82 33.38 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.476 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.6 mp -131.92 -171.3 2.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.764 0.316 . . . . 0.0 110.89 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.49 ' N ' ' CD ' ' A' ' 16' ' ' PRO . 6.6 t -79.94 -45.74 1.48 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.386 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.49 ' CD ' ' N ' ' A' ' 15' ' ' VAL . 70.7 Cg_exo -50.82 179.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.34 2.026 . . . . 0.0 112.348 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 60.68 96.45 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.876 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -70.44 -120.51 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.491 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.2 t -141.05 95.19 2.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.679 0.276 . . . . 0.0 110.831 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.4 -177.85 0.08 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.903 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.7 -176.23 5.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.887 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.8 m -93.45 5.43 51.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.512 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -72.01 -14.62 61.94 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.506 0.669 . . . . 0.0 111.509 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -65.35 -16.39 63.55 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.182 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.86 -27.34 18.0 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.657 179.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.681 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -67.1 -28.44 68.17 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.77 -179.936 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -58.95 -23.94 62.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.175 0.512 . . . . 0.0 109.751 178.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.741 HD13 HD21 ' A' ' 87' ' ' LEU . 3.2 tt -88.09 -11.37 47.26 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.488 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.681 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 11.6 mm -67.21 -13.73 17.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 114.71 -1.132 . . . . 0.0 111.98 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -77.89 2.29 17.83 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 113.894 -1.503 . . . . 0.0 111.499 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.826 ' HB2' HD11 ' A' ' 56' ' ' LEU . . . -93.22 -43.21 8.94 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.102 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -59.82 -28.62 67.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.974 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -96.12 39.79 1.14 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.994 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -161.55 30.01 0.13 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.018 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -177.2 76.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.908 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -120.32 48.14 1.64 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.951 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -96.23 27.6 16.29 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.595 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 60.98 68.29 0.75 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.863 0.363 . . . . 0.0 110.826 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -105.01 147.1 28.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.94 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -67.34 -173.46 0.29 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.919 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -93.53 42.15 2.6 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.586 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -154.58 123.82 6.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.858 0.361 . . . . 0.0 110.854 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.1 p -128.85 139.0 53.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.068 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.428 ' HB3' ' CZ ' ' A' ' 77' ' ' PHE . 79.2 p -88.36 151.58 22.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.788 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.61 HG22 HG13 ' A' ' 78' ' ' ILE . 53.7 t -58.18 -50.75 77.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.826 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -51.27 -29.18 13.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.988 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -91.45 -32.32 15.66 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.601 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.748 ' HA ' HD12 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -61.13 -42.31 98.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.024 179.984 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 72.1 mtt180 -56.87 -48.27 78.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.917 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -59.58 -27.42 63.66 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.383 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.748 HD12 ' HA ' ' A' ' 48' ' ' PHE . 5.5 mt -86.27 -50.06 14.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.872 0.367 . . . . 0.0 110.916 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.0 tp -57.87 -40.32 75.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.431 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.6 ttm180 -48.39 -68.01 0.22 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.063 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -93.36 14.79 17.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.065 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -109.51 -59.76 0.52 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.614 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.826 HD11 ' HB2' ' A' ' 31' ' ' ALA . 5.4 mp -129.09 139.51 35.9 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.655 0.264 . . . . 0.0 111.143 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -79.6 58.3 6.9 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.598 2.199 . . . . 0.0 112.056 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.555 ' HB3' HD11 ' A' ' 63' ' ' ILE . 1.3 ttt -87.08 138.66 31.31 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.952 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.9 ' O ' HD12 ' A' ' 63' ' ' ILE . 1.3 p -78.27 140.59 38.86 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.883 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.511 ' O ' ' N ' ' A' ' 64' ' ' THR . 0.1 OUTLIER -37.05 -49.1 0.83 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.093 -180.0 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.525 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -48.49 -55.52 10.76 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.314 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.507 ' HB2' ' HG2' ' A' ' 58' ' ' MET . 0.7 OUTLIER -56.16 -60.28 3.72 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.287 179.833 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.9 HD12 ' O ' ' A' ' 59' ' ' THR . 2.3 mp -58.07 -61.12 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.163 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.511 ' N ' ' O ' ' A' ' 60' ' ' GLU . 71.8 m -52.8 -51.53 60.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.122 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.525 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 44.6 tt0 -64.93 -15.76 62.5 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.63 0.729 . . . . 0.0 110.516 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.435 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.7 m-30 -96.38 -27.87 14.73 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 114.594 -1.184 . . . . 0.0 110.434 179.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.672 ' CE2' HG22 ' A' ' 63' ' ' ILE . 3.9 m-30 -73.25 -30.1 63.22 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.651 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.75 -26.85 20.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.874 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.28 -11.2 47.19 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.482 0.658 . . . . 0.0 111.725 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.8 -29.95 13.46 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.994 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -116.74 121.38 33.0 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.787 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.08 -49.39 2.07 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.388 2.059 . . . . 0.0 112.361 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -80.5 -28.42 37.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.911 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.1 m120 75.82 51.92 0.06 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.616 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 12.6 p -96.52 31.1 2.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.87 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 59.55 29.31 66.47 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.413 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.428 ' CZ ' ' HB3' ' A' ' 44' ' ' SER . 0.2 OUTLIER -132.08 129.34 39.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.833 0.349 . . . . 0.0 110.664 179.901 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.659 HD12 ' CD2' ' A' ' 48' ' ' PHE . 63.7 mt -104.51 152.83 6.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.235 0.541 . . . . 0.0 111.593 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.431 ' N ' HG22 ' A' ' 78' ' ' ILE . 1.8 m-20 -97.76 95.6 7.66 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 176.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.43 ' C ' ' O ' ' A' ' 79' ' ' ASP . 40.4 t80 -28.96 -41.55 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.209 -178.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 79' ' ' ASP . 0.3 OUTLIER -66.01 -56.21 12.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.625 179.706 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -52.11 -27.6 14.74 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.998 0.428 . . . . 0.0 110.602 179.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.609 ' CE1' HD13 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -89.84 -32.16 17.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.866 179.85 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.6 -27.88 45.67 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.258 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.68 -11.41 60.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.482 0.658 . . . . 0.0 111.814 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 1.8 mtp -77.98 -36.86 48.5 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.736 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.741 HD21 HD13 ' A' ' 28' ' ' LEU . 4.2 mt -86.76 -6.71 58.74 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.862 0.839 . . . . 0.0 111.501 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -126.03 22.08 7.38 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 114.139 -1.391 . . . . 0.0 111.088 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.3 m -73.81 83.38 1.65 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.839 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 31.2 m -135.1 31.33 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.138 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -165.53 155.99 13.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.902 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -84.46 -61.51 1.78 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.929 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.28 -0.866 . . . . 0.0 110.891 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.3 tpt . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.751 0.31 . . . . 0.0 111.206 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -103.42 111.58 3.97 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.519 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.5 m -79.0 97.38 6.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.842 0.353 . . . . 0.0 110.845 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.5 t 60.39 167.46 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.854 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 21.9 p80 -62.14 118.53 7.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.958 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -155.64 -64.58 0.12 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.948 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 19.4 t-80 -169.1 150.15 4.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.923 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -76.89 150.03 36.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.856 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 77.5 m-70 60.43 -171.88 0.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.91 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.61 152.7 44.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.906 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.5 t -106.48 -71.2 0.76 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.932 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.4 p 49.97 35.61 10.05 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.17 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -97.68 88.43 0.93 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.503 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -163.61 35.03 0.09 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.854 0.359 . . . . 0.0 110.939 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.2 m -60.97 158.38 34.55 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.134 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -52.37 -51.26 11.53 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.614 2.21 . . . . 0.0 112.284 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -137.92 -62.72 0.59 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.861 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.6 -33.25 5.81 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.533 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.4 p -95.08 119.11 33.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.841 0.353 . . . . 0.0 110.885 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.514 ' CE1' ' HG ' ' A' ' 93' ' ' SER . 0.7 OUTLIER -61.63 172.75 1.14 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.907 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 2.4 mmt -99.14 30.81 3.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.008 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 17.8 m -101.58 5.34 41.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.535 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -81.81 -14.57 56.17 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.531 0.681 . . . . 0.0 111.553 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -65.41 -16.15 63.32 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.781 -1.1 . . . . 0.0 111.315 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.526 ' HG2' HD23 ' A' ' 87' ' ' LEU . 3.3 ttpt -91.76 -26.51 18.53 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.7 -1.137 . . . . 0.0 110.749 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.668 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -65.25 -28.88 69.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.78 179.912 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.739 ' O ' HD12 ' A' ' 56' ' ' LEU . 4.7 tt0 -59.71 -23.94 63.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.136 0.493 . . . . 0.0 109.677 178.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.867 HD13 HD21 ' A' ' 87' ' ' LEU . 7.1 tt -88.17 -11.35 47.06 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.434 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.668 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 11.4 mm -65.63 -14.39 16.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.022 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -78.26 2.3 18.82 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 113.801 -1.545 . . . . 0.0 111.596 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.788 ' HB2' HD21 ' A' ' 56' ' ' LEU . . . -93.16 -28.67 16.16 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.179 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -56.45 -29.06 61.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.048 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -98.39 30.56 3.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.907 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -178.02 55.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.888 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.73 36.01 1.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.918 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.0 t70 59.68 29.4 18.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.981 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 57.59 25.33 55.21 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.662 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 58.32 45.16 17.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.872 0.368 . . . . 0.0 110.941 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -59.49 -66.17 0.55 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.997 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -105.34 166.07 10.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.962 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -100.23 30.36 10.32 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.465 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -149.98 123.8 9.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.829 0.347 . . . . 0.0 110.915 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.455 HG11 ' CE2' ' A' ' 48' ' ' PHE . 8.8 p -129.49 123.96 58.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.973 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.14 160.52 30.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.941 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.691 HG22 HG13 ' A' ' 78' ' ' ILE . 45.8 t -63.94 -50.98 75.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.843 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -50.92 -31.37 17.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.962 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -89.07 -28.87 19.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.521 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.816 ' CD2' HD12 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -68.22 -40.08 82.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.909 179.918 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 15.1 mtp85 -57.13 -48.33 78.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.874 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -57.57 -27.89 59.12 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.303 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.404 HD12 ' HA ' ' A' ' 48' ' ' PHE . 16.7 mt -86.65 -43.03 15.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.848 0.356 . . . . 0.0 110.843 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.492 HG21 HG12 ' A' ' 63' ' ' ILE . 35.7 mm -68.13 -29.93 46.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.023 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 6.2 tpm_? -51.89 -55.8 17.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.95 0.405 . . . . 0.0 110.9 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -111.82 14.86 21.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.195 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -99.73 -86.76 1.91 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.628 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.788 HD21 ' HB2' ' A' ' 31' ' ' ALA . 2.8 mm? -100.77 137.01 19.71 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 120.658 0.266 . . . . 0.0 110.966 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.88 74.48 4.92 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.406 2.071 . . . . 0.0 112.322 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.573 ' HE2' ' HB2' ' A' ' 62' ' ' GLU . 1.4 mtp -105.8 142.18 35.96 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.733 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.914 ' O ' HD12 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -79.85 148.45 31.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.729 179.734 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.491 ' O ' ' N ' ' A' ' 64' ' ' THR . 1.7 pm0 -38.09 -48.82 1.26 Allowed 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.19 0.519 . . . . 0.0 111.082 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.521 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -50.86 -52.53 40.7 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.024 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.573 ' HB2' ' HE2' ' A' ' 58' ' ' MET . 1.1 mm-40 -55.33 -61.71 2.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.97 0.414 . . . . 0.0 109.933 179.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.914 HD12 ' O ' ' A' ' 59' ' ' THR . 1.8 mp -57.87 -61.77 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.249 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.491 ' N ' ' O ' ' A' ' 60' ' ' GLU . 89.8 m -52.65 -52.05 57.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.419 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.521 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 51.5 tt0 -64.81 -15.58 61.95 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.625 0.726 . . . . 0.0 110.423 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.428 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.6 m-30 -95.65 -28.13 14.97 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.548 -1.205 . . . . 0.0 110.326 179.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.699 ' CE1' HD11 ' A' ' 78' ' ' ILE . 7.5 m-30 -77.88 -26.09 48.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.813 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -90.57 -27.62 19.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.91 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -90.73 -11.19 40.37 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 121.391 0.615 . . . . 0.0 111.752 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -93.92 -31.32 14.35 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.939 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -120.95 120.05 29.55 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.77 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -63.33 -53.87 1.28 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.467 2.112 . . . . 0.0 112.388 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -73.91 -30.22 62.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.877 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 75.35 50.57 0.08 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.509 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.9 p -95.68 31.07 2.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.822 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.415 ' C ' HG23 ' A' ' 45' ' ' VAL . . . 62.28 30.81 77.11 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.344 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.459 ' N ' HG23 ' A' ' 45' ' ' VAL . 5.4 m-85 -131.37 130.17 42.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.758 0.313 . . . . 0.0 110.881 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.816 HD12 ' CD2' ' A' ' 48' ' ' PHE . 56.1 mt -106.06 153.18 7.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.15 0.5 . . . . 0.0 111.456 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.441 ' N ' HG22 ' A' ' 78' ' ' ILE . 0.8 OUTLIER -98.3 95.65 7.52 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 176.923 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.417 ' C ' ' O ' ' A' ' 79' ' ' ASP . 44.4 t80 -30.66 -40.12 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.121 -178.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.2 mttt -66.88 -55.56 14.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.49 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -53.32 -27.77 24.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.12 0.486 . . . . 0.0 110.555 179.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.655 ' CE1' HD13 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -89.02 -31.1 18.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.722 179.703 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.11 -22.46 39.11 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.312 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.33 -11.5 60.73 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 121.388 0.613 . . . . 0.0 111.708 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 33.4 mtt -70.4 -40.28 74.0 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.773 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.867 HD21 HD13 ' A' ' 28' ' ' LEU . 6.3 mp -91.73 -6.31 52.15 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.857 0.837 . . . . 0.0 111.513 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -124.07 22.29 8.76 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 114.123 -1.398 . . . . 0.0 111.127 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.81 88.41 7.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.824 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 35.9 m 42.82 31.8 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.674 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -71.22 161.26 31.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.886 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -176.83 -56.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.945 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.514 ' HG ' ' CE1' ' A' ' 20' ' ' HIS . 8.5 t . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.865 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 mtm . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 120.785 0.326 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -88.29 -74.16 1.28 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.45 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.32 -36.68 29.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.829 0.347 . . . . 0.0 110.922 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.9 m -81.84 138.05 35.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.891 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -134.5 176.63 8.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.848 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 60.55 36.87 19.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.944 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -60.04 -69.55 0.21 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.974 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 59.86 -170.68 0.14 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.956 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -109.26 144.26 37.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.013 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -99.92 152.51 20.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.91 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 72.4 p -176.37 141.88 0.43 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.863 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 79.5 p -136.35 125.82 25.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.831 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.99 65.99 1.91 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.513 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.586 HD23 ' HD3' ' A' ' 16' ' ' PRO . 0.7 OUTLIER -79.21 125.17 29.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.769 0.319 . . . . 0.0 110.942 -179.997 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.62 HG13 ' O ' ' A' ' 15' ' ' VAL . 7.1 p -145.93 83.9 8.44 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.07 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.586 ' HD3' HD23 ' A' ' 14' ' ' LEU . 55.2 Cg_exo -52.13 115.26 2.05 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.639 2.226 . . . . 0.0 112.252 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.87 143.31 31.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.878 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 133.02 -24.65 3.78 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.615 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.8 t 62.31 103.26 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.853 0.359 . . . . 0.0 110.885 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -139.55 -46.89 0.46 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.957 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 14.5 mmt 59.04 29.84 19.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.01 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.1 p -100.43 5.54 44.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.509 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.59 -15.02 63.43 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.539 0.685 . . . . 0.0 111.737 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -65.56 -16.13 63.39 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 114.944 -1.026 . . . . 0.0 111.253 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.1 ttpt -91.94 -31.93 15.46 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.733 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.66 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -56.11 -26.64 50.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.964 -179.829 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -61.66 -23.33 66.01 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.749 ' O ' HD13 ' A' ' 28' ' ' LEU . 2.7 tm? -88.08 -11.63 46.54 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.375 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.66 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 11.3 mm -65.48 -14.25 16.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.914 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -75.59 1.88 13.24 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 113.91 -1.496 . . . . 0.0 111.819 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.458 ' HB2' HD21 ' A' ' 56' ' ' LEU . . . -93.27 -28.68 16.08 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.041 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.55 -24.49 56.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.0 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -96.84 30.39 2.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.987 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -177.65 38.02 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.858 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.53 ' CD1' HD13 ' A' ' 51' ' ' ILE . 14.0 t80 -172.16 41.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.929 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -167.47 73.92 0.13 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.787 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -86.19 -58.24 2.01 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.6 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -124.54 39.43 3.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.791 0.329 . . . . 0.0 110.993 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 62.64 141.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.93 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.3 p30 -178.17 127.75 0.12 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.937 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -110.73 23.23 20.23 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.56 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -154.73 123.82 6.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.745 0.307 . . . . 0.0 110.997 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.47 HG22 ' N ' ' A' ' 44' ' ' SER . 12.4 p -132.35 157.96 43.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.008 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.47 ' N ' HG22 ' A' ' 43' ' ' VAL . 77.9 p -108.47 150.25 27.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.89 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.521 HG13 ' CZ ' ' A' ' 67' ' ' PHE . 96.2 t -56.43 -51.84 59.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.951 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -47.37 -31.0 3.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.046 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -96.37 -30.97 13.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.502 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -62.98 -35.25 79.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.052 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 20.9 mtt85 -55.8 -52.34 64.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.036 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -56.79 -27.87 56.41 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.397 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.53 HD13 ' CD1' ' A' ' 35' ' ' PHE . 21.1 mt -81.14 -25.3 10.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.848 0.356 . . . . 0.0 111.125 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 34.8 mm -93.36 -55.25 6.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.062 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.35 -34.03 68.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.319 -179.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -111.73 14.84 21.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.67 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -131.43 -89.84 0.49 Allowed Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.33 -0.938 . . . . 0.0 112.827 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.488 ' N ' HD12 ' A' ' 56' ' ' LEU . 7.0 mp -87.02 140.82 32.83 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.681 0.276 . . . . 0.0 111.238 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -78.27 122.02 5.5 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.567 2.178 . . . . 0.0 112.325 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.704 ' O ' HD11 ' A' ' 63' ' ' ILE . 0.8 OUTLIER -155.17 137.42 14.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.778 -179.941 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.918 ' O ' HD12 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -72.71 145.9 46.84 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.848 179.706 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.482 ' O ' ' N ' ' A' ' 64' ' ' THR . 5.9 pt-20 -37.6 -51.79 1.2 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.29 0.567 . . . . 0.0 111.06 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.44 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -47.64 -56.11 7.93 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.867 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.525 ' HB2' ' HE2' ' A' ' 58' ' ' MET . 0.7 OUTLIER -51.16 -62.87 1.35 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.415 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.918 HD12 ' O ' ' A' ' 59' ' ' THR . 2.2 mp -56.51 -63.71 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.32 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.482 ' N ' ' O ' ' A' ' 60' ' ' GLU . 92.5 m -51.17 -52.57 42.93 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.397 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.44 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 6.4 mm-40 -65.03 -15.98 62.94 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-O 121.652 0.739 . . . . 0.0 110.377 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.443 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.3 m-30 -92.04 -27.45 17.79 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.599 -1.182 . . . . 0.0 110.3 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.621 ' CE2' HG22 ' A' ' 63' ' ' ILE . 4.7 m-30 -85.6 -25.53 26.61 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.921 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -94.05 -27.66 16.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.947 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 65' ' ' GLU . . . -89.09 -11.22 44.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.39 0.614 . . . . 0.0 111.776 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.414 ' HB1' ' CG2' ' A' ' 78' ' ' ILE . . . -99.47 -28.16 13.38 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.094 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -122.51 112.14 31.23 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.681 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.08 -47.63 3.35 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.503 2.135 . . . . 0.0 112.533 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 61.8 m-80 -68.41 -31.85 71.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.971 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 71.76 31.24 2.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.569 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 46.9 p -67.57 -26.24 66.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.981 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 113.79 19.66 6.39 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.525 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.459 ' CD2' ' HB2' ' A' ' 44' ' ' SER . 3.0 m-85 -140.91 130.97 24.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.65 0.262 . . . . 0.0 110.786 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.574 HD11 ' CD1' ' A' ' 67' ' ' PHE . 2.1 mt -110.14 147.82 14.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.929 0.395 . . . . 0.0 111.468 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.436 ' O ' ' N ' ' A' ' 81' ' ' LYS . 72.6 m-20 -77.28 103.75 7.39 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 177.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.409 ' C ' ' O ' ' A' ' 79' ' ' ASP . 50.7 t80 -28.61 -40.34 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.436 ' N ' ' O ' ' A' ' 79' ' ' ASP . 10.2 mttt -62.93 -54.46 38.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.705 0.288 . . . . 0.0 110.915 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -51.79 -26.85 10.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.089 0.471 . . . . 0.0 110.743 179.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.474 ' CD1' HG21 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -93.09 -29.71 15.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.267 -179.766 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -82.4 -26.85 32.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.243 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -74.36 -11.49 60.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.438 0.637 . . . . 0.0 111.658 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 24.6 tpp -74.85 -37.71 62.16 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.713 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.516 HD21 ' HG ' ' A' ' 28' ' ' LEU . 1.7 mt -89.14 -6.52 56.93 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.86 0.838 . . . . 0.0 111.437 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -125.84 22.44 7.44 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 114.14 -1.391 . . . . 0.0 111.099 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.06 66.51 0.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.949 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.564 ' O ' HG12 ' A' ' 90' ' ' VAL . 13.8 t 57.86 30.8 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.139 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 58.8 31.61 21.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.932 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 61.2 155.43 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.963 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.914 179.99 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 mtt . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.821 0.343 . . . . 0.0 111.216 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.91 -139.94 2.82 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.401 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.4 m -60.17 140.6 56.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.847 0.356 . . . . 0.0 110.878 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 66.0 p -108.32 -41.43 4.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.879 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 62.1 m170 -63.0 -74.83 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.924 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 60.15 176.3 0.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.864 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 13.5 t-160 60.49 106.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.905 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -176.39 109.67 0.09 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.956 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -69.44 83.79 0.4 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.91 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -143.47 -51.1 0.33 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.876 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.8 p -132.33 -57.14 0.96 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.86 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.2 t -143.87 95.03 2.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.811 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -166.87 -129.1 1.03 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.485 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.6 tp -71.1 90.27 0.85 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.799 0.333 . . . . 0.0 110.917 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.504 ' N ' ' CD ' ' A' ' 16' ' ' PRO . 11.2 t -78.38 -45.22 2.1 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.442 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.504 ' CD ' ' N ' ' A' ' 15' ' ' VAL . 77.6 Cg_exo -50.12 177.99 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.402 2.068 . . . . 0.0 112.355 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.79 136.48 49.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.898 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 156.72 54.27 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.482 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.0 m -154.81 35.38 0.4 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.824 0.345 . . . . 0.0 110.856 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 45.7 t60 -104.16 -66.0 0.99 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.798 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 29.8 ttp -102.57 31.27 4.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.928 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.6 t -101.47 5.2 41.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.083 0.468 . . . . 0.0 111.695 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -94.31 -14.61 25.23 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.585 0.707 . . . . 0.0 111.582 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -65.45 -16.43 63.63 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.148 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -91.86 -26.69 18.37 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.774 179.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.683 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -67.63 -29.07 68.29 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.786 -179.919 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -59.5 -24.27 63.49 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.734 HD13 HD21 ' A' ' 87' ' ' LEU . 4.7 tt -88.22 -11.3 47.07 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.406 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.683 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 11.5 mm -65.67 -14.3 16.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.921 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -77.55 2.19 17.17 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 113.887 -1.506 . . . . 0.0 111.537 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 1.065 ' HB2' HD11 ' A' ' 56' ' ' LEU . . . -93.27 -30.59 15.08 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.09 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -58.35 -25.54 62.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.116 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -96.09 38.84 1.16 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.945 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.3 p-10 -178.18 38.36 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.871 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.86 ' CE2' HD13 ' A' ' 51' ' ' ILE . 2.0 t80 -152.63 55.33 0.8 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.87 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.0 t0 60.54 30.27 19.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.985 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 59.14 50.22 70.14 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.532 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.0 t0 60.32 37.01 20.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.93 0.395 . . . . 0.0 110.883 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -118.08 90.71 3.39 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.886 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -176.0 126.25 0.21 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.963 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -105.88 -19.64 10.07 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.599 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -150.71 123.8 8.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.836 0.35 . . . . 0.0 111.004 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.54 HG11 ' CE2' ' A' ' 48' ' ' PHE . 9.3 p -130.48 147.76 33.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.948 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 21.7 p -92.74 159.91 15.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.919 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.96 HG13 ' CD1' ' A' ' 67' ' ' PHE . 46.1 t -61.69 -32.81 54.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.797 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -66.69 -57.9 6.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.846 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -59.33 -31.02 68.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.826 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.903 ' CD2' HD12 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -63.76 -40.73 97.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.962 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 10.2 mtm180 -58.6 -51.69 68.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.936 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -55.6 -25.59 43.29 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.486 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.86 HD13 ' CE2' ' A' ' 35' ' ' PHE . 13.0 mt -83.51 -46.11 18.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.915 0.388 . . . . 0.0 111.057 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.535 HG21 HG12 ' A' ' 63' ' ' ILE . 31.0 mm -68.52 -28.69 41.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.137 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.27 -59.34 4.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.061 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -111.88 15.02 20.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.237 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -98.06 -86.19 1.83 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.738 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 1.065 HD11 ' HB2' ' A' ' 31' ' ' ALA . 7.1 mt -105.96 144.7 29.44 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 120.705 0.288 . . . . 0.0 111.024 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.51 115.8 4.16 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.577 2.185 . . . . 0.0 112.235 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.636 ' O ' HD11 ' A' ' 63' ' ' ILE . 0.8 OUTLIER -153.88 138.48 16.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.726 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.898 ' O ' HD12 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -76.07 147.04 38.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.646 179.592 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' A' ' 64' ' ' THR . 6.2 pt-20 -38.81 -52.13 1.72 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.214 0.53 . . . . 0.0 110.853 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.515 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -46.91 -53.31 12.49 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.09 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.464 ' HG2' ' O ' ' A' ' 59' ' ' THR . 2.0 mm-40 -55.13 -61.57 2.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.921 0.391 . . . . 0.0 110.021 179.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.898 HD12 ' O ' ' A' ' 59' ' ' THR . 1.6 mp -59.17 -61.69 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.155 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.539 ' N ' ' O ' ' A' ' 60' ' ' GLU . 69.3 m -51.39 -51.73 52.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.394 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.515 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 1.5 tp10 -65.36 -15.34 62.47 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.638 0.732 . . . . 0.0 110.412 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.416 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.6 m-30 -96.46 -25.88 15.51 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.533 -1.212 . . . . 0.0 110.415 179.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.96 ' CD1' HG13 ' A' ' 45' ' ' VAL . 1.7 m-85 -75.31 -30.18 60.27 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.747 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -93.18 -28.47 16.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.892 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.6 -10.96 59.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.407 0.622 . . . . 0.0 111.718 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.98 -33.4 14.87 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.067 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.498 ' OD2' HG22 ' A' ' 75' ' ' THR . 7.1 t0 -120.09 116.98 32.34 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.888 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.68 -28.94 51.94 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.358 2.038 . . . . 0.0 112.185 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 53.9 m-20 -83.64 -32.09 25.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.713 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 71.79 39.94 0.81 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.118 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.498 HG22 ' OD2' ' A' ' 71' ' ' ASP . 1.5 t -90.33 39.6 0.98 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.737 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.406 ' C ' HG23 ' A' ' 45' ' ' VAL . . . 46.55 28.67 3.61 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.463 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.568 ' N ' HG23 ' A' ' 45' ' ' VAL . 1.2 t80 -132.3 129.11 39.1 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.81 0.338 . . . . 0.0 110.468 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.903 HD12 ' CD2' ' A' ' 48' ' ' PHE . 66.6 mt -103.11 148.77 7.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.108 0.48 . . . . 0.0 111.61 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.44 ' O ' ' N ' ' A' ' 82' ' ' ALA . 0.8 OUTLIER -96.15 95.89 8.45 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 176.698 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.437 ' C ' ' O ' ' A' ' 79' ' ' ASP . 51.2 t80 -28.56 -42.29 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.261 -177.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 79' ' ' ASP . 6.9 mmmm -63.79 -55.62 21.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.823 0.344 . . . . 0.0 110.619 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -52.32 -30.7 29.62 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.172 0.511 . . . . 0.0 110.411 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.661 ' CE1' HD13 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -85.56 -32.59 22.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.695 179.807 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.21 -23.77 43.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.2 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.8 -11.4 60.59 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.411 0.624 . . . . 0.0 111.804 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 13.2 tpp -76.64 -32.04 57.76 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.61 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.734 HD21 HD13 ' A' ' 28' ' ' LEU . 4.6 mt -94.05 -6.24 45.63 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 121.885 0.85 . . . . 0.0 111.33 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -125.95 22.06 7.43 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.081 -1.418 . . . . 0.0 111.212 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.35 31.78 2.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.957 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.8 m -102.18 27.44 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.267 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 56.14 30.41 16.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.964 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -150.46 -50.98 0.13 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.926 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 27.4 t . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.188 -0.91 . . . . 0.0 110.978 -179.908 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.883 0.373 . . . . 0.0 111.146 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -106.39 -132.16 7.04 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.488 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.8 t -89.49 -72.39 0.56 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.835 0.35 . . . . 0.0 110.934 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.51 37.46 19.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.929 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 60.86 80.03 0.23 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.918 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -143.22 -47.61 0.31 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.884 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -170.11 178.8 3.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.952 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -152.84 106.83 3.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.905 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -140.54 30.77 1.9 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.936 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 22.9 t60 60.42 89.79 0.07 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.89 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.1 m -116.74 -69.09 0.87 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.901 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -164.74 78.85 0.35 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.912 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -112.51 -28.41 3.51 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.578 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -60.14 -71.25 0.14 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.761 0.315 . . . . 0.0 110.942 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.2 m -138.19 149.86 64.95 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.14 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -52.42 -60.73 0.65 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.558 2.172 . . . . 0.0 112.353 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 21.3 ttm180 -165.75 -44.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.878 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -174.54 -82.33 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.54 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 17.1 m -60.22 153.65 21.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.756 0.312 . . . . 0.0 110.878 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 41.3 m170 -81.59 -79.32 0.17 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.83 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 39.4 mmm -156.23 -79.16 0.08 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.919 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.9 p -101.9 5.35 40.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.95 0.405 . . . . 0.0 111.532 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.48 -14.8 34.49 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.492 0.663 . . . . 0.0 111.541 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.3 -16.49 63.62 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.17 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.4 ttpt -91.85 -23.4 19.67 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.788 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.66 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -71.57 -28.86 64.13 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.914 -179.967 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -59.92 -24.22 64.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.215 0.531 . . . . 0.0 109.683 178.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.968 HD13 HD21 ' A' ' 87' ' ' LEU . 4.2 tt -88.3 -11.27 46.92 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.519 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.66 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 12.0 mm -63.59 -15.12 15.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.865 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -79.04 2.17 21.48 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 113.919 -1.491 . . . . 0.0 111.478 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.758 ' HB2' HD21 ' A' ' 56' ' ' LEU . . . -93.29 -29.35 15.71 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.107 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -56.47 -24.39 45.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.15 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -96.9 34.43 1.71 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.025 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -177.22 37.62 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.821 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -176.44 37.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.892 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -106.62 38.45 2.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.949 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -62.24 -63.71 4.5 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.603 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -177.2 49.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.92 0.39 . . . . 0.0 110.944 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 60.55 101.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.806 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -83.0 133.8 35.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.966 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -100.22 -23.68 10.27 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.678 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -153.89 123.79 6.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.811 0.338 . . . . 0.0 110.939 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.577 HG11 ' CE2' ' A' ' 48' ' ' PHE . 10.4 p -124.37 132.92 70.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.966 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.51 147.45 25.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.854 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.423 HG13 ' CE1' ' A' ' 67' ' ' PHE . 88.8 t -53.37 -55.14 14.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.065 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -47.21 -31.98 4.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.906 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -88.3 -29.75 20.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.358 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.629 ' HA ' HD12 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -69.04 -38.15 78.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.809 179.806 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 18.7 mtt180 -58.23 -51.21 70.69 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.991 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -55.94 -25.78 46.42 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.394 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.629 HD12 ' HA ' ' A' ' 48' ' ' PHE . 21.8 mt -83.08 -44.54 18.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.874 0.368 . . . . 0.0 111.065 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 35.8 mm -68.07 -27.27 36.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.138 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.8 ttm180 -52.8 -58.79 5.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.993 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -111.75 14.98 21.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.344 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -99.41 -86.53 1.89 Allowed Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.632 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.758 HD21 ' HB2' ' A' ' 31' ' ' ALA . 3.9 mt -103.48 143.72 27.2 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 120.631 0.253 . . . . 0.0 110.982 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.48 85.28 1.6 Allowed 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.549 2.166 . . . . 0.0 112.166 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.604 ' HB3' HD11 ' A' ' 63' ' ' ILE . 3.8 ttt -124.28 140.84 52.58 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.796 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.835 ' O ' HD12 ' A' ' 63' ' ' ILE . 0.8 OUTLIER -89.32 143.41 26.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.613 179.36 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.616 ' O ' ' N ' ' A' ' 64' ' ' THR . 0.2 OUTLIER -41.99 -53.16 3.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.369 0.604 . . . . 0.0 110.637 -179.852 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.487 ' N ' ' CG ' ' A' ' 60' ' ' GLU . . . -44.68 -28.93 0.67 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.004 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.601 ' HG2' ' O ' ' A' ' 59' ' ' THR . 1.5 mm-40 -89.57 -51.43 5.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.736 0.303 . . . . 0.0 110.458 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.835 HD12 ' O ' ' A' ' 59' ' ' THR . 1.0 OUTLIER -74.35 -44.69 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.347 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.616 ' N ' ' O ' ' A' ' 60' ' ' GLU . 50.6 m -62.96 -48.92 76.82 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.024 0.44 . . . . 0.0 109.991 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.408 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 3.2 tm-20 -66.68 -16.2 64.05 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.714 0.768 . . . . 0.0 110.301 179.297 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.443 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.2 m-85 -96.78 -23.61 16.32 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.469 -1.242 . . . . 0.0 110.357 178.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.783 ' CE2' HG22 ' A' ' 63' ' ' ILE . 2.1 m-85 -74.52 -36.06 63.19 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.736 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -76.42 -30.36 57.39 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.861 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.28 -11.08 59.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.476 0.655 . . . . 0.0 111.653 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -95.58 -30.25 13.91 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.985 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.565 ' OD2' HG22 ' A' ' 75' ' ' THR . 7.0 t70 -128.31 106.22 19.54 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.825 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 71' ' ' ASP . 37.9 Cg_endo -66.43 -30.92 43.55 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.404 2.069 . . . . 0.0 112.276 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 63.6 m-80 -76.81 -27.64 55.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.917 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 72.51 36.7 0.97 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.128 0.489 . . . . 0.0 110.13 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.565 HG22 ' OD2' ' A' ' 71' ' ' ASP . 1.1 t -85.65 13.14 7.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.975 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 69.45 26.57 74.41 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.262 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.468 ' HB2' HG23 ' A' ' 75' ' ' THR . 5.2 m-85 -117.39 178.48 4.36 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.701 0.286 . . . . 0.0 110.571 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.621 HD12 ' HD2' ' A' ' 48' ' ' PHE . 65.4 mt -153.62 153.54 8.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.206 0.527 . . . . 0.0 111.724 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.464 ' N ' HG22 ' A' ' 78' ' ' ILE . 24.2 t0 -99.55 95.97 7.35 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 176.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.429 ' C ' ' O ' ' A' ' 79' ' ' ASP . 44.8 t80 -28.7 -41.37 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.366 -178.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.418 ' N ' ' O ' ' A' ' 79' ' ' ASP . 3.4 mtmt -66.2 -56.61 10.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.717 0.294 . . . . 0.0 110.68 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -51.9 -27.71 13.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.043 0.449 . . . . 0.0 110.614 179.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.519 ' CE1' HD13 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -89.83 -31.91 17.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.743 179.923 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.09 -18.64 55.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.339 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -71.08 -11.56 61.02 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.366 0.603 . . . . 0.0 111.882 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.96 -34.6 62.06 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.784 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.968 HD21 HD13 ' A' ' 28' ' ' LEU . 4.1 mt -92.72 -6.73 48.53 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.851 0.834 . . . . 0.0 111.483 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -126.08 22.31 7.31 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.108 -1.405 . . . . 0.0 111.057 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.443 ' O ' HG13 ' A' ' 90' ' ' VAL . 1.6 p -75.56 73.15 2.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.961 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 90' ' ' VAL . 17.3 m -157.06 68.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.131 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 60.67 79.49 0.24 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.955 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -151.13 -47.4 0.12 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.903 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.7 t . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.954 179.995 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.475 0 CA-C-O 120.687 0.279 . . . . 0.0 111.352 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -164.97 42.31 0.29 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.529 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.9 p -135.99 32.12 2.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.893 0.378 . . . . 0.0 110.913 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 93.0 p -145.77 128.89 16.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.889 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -61.05 -169.71 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.838 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -155.35 32.84 0.38 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.966 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -77.3 79.29 3.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.883 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -111.82 -62.54 1.55 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.93 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 47.3 p-80 -144.34 -175.28 4.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.899 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 60.28 171.01 0.09 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.942 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.4 t -92.35 79.82 4.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.915 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.0 p -106.74 31.8 5.01 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.968 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 177.84 -177.19 48.33 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.473 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 62.74 30.66 16.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.843 0.354 . . . . 0.0 110.948 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.1 t -153.0 84.41 4.49 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.101 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.29 138.57 55.31 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.612 2.208 . . . . 0.0 112.249 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 62.28 118.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.874 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -59.09 -166.81 0.17 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.568 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.17 -74.92 0.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.74 0.305 . . . . 0.0 110.893 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.3 m170 65.47 -76.19 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.959 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 2.6 tpt 63.19 120.43 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.843 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -100.78 5.46 43.56 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.626 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -70.87 -14.7 62.49 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.572 0.701 . . . . 0.0 111.552 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -65.62 -16.38 63.66 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.117 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.6 tttp -91.98 -26.41 18.4 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.72 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.651 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -67.63 -28.79 68.03 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.845 -179.815 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 89.3 mm-40 -61.13 -24.91 66.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.204 0.526 . . . . 0.0 109.594 178.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.804 HD13 HD21 ' A' ' 87' ' ' LEU . 3.0 tt -88.3 -11.28 46.88 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.539 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.651 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 11.2 mm -61.43 -15.58 13.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 114.973 -1.012 . . . . 0.0 112.03 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -77.84 1.81 19.19 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 113.983 -1.462 . . . . 0.0 111.559 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.646 ' HB2' HD21 ' A' ' 56' ' ' LEU . . . -93.62 -28.15 16.17 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.009 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -58.12 -20.53 40.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.315 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -93.07 24.02 3.98 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.334 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -174.31 33.43 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.93 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER 178.57 39.46 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.78 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -137.13 58.77 1.7 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.948 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 153.63 69.36 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.539 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -151.03 23.87 0.75 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.723 0.297 . . . . 0.0 111.047 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 52.34 -178.55 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.887 0.375 . . . . 0.0 111.204 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 60.31 160.63 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.065 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -135.37 34.16 2.34 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.43 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -142.76 123.93 14.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.805 0.336 . . . . 0.0 110.952 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.538 HG11 ' CE2' ' A' ' 48' ' ' PHE . 10.3 p -117.97 123.67 72.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.991 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.95 155.59 40.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.965 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.93 HG13 ' CD1' ' A' ' 67' ' ' PHE . 59.8 t -60.17 -32.51 50.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.806 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -65.2 -61.38 2.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.013 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -57.62 -30.66 65.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.918 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.876 ' CD2' HD12 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -62.1 -40.73 96.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.011 -179.909 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.445 ' HG3' ' CE2' ' A' ' 67' ' ' PHE . 65.5 mtt180 -58.76 -51.73 68.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.986 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -55.91 -25.85 46.39 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.505 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.74 HD12 ' HA ' ' A' ' 48' ' ' PHE . 12.4 mt -82.56 -45.64 19.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.882 0.372 . . . . 0.0 111.045 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.543 HG21 HG12 ' A' ' 63' ' ' ILE . 35.6 mm -68.57 -28.4 40.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.237 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 17.9 ttp180 -48.75 -60.37 2.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.063 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -111.86 14.89 21.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.109 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -96.64 -85.68 1.76 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.606 -0.806 . . . . 0.0 112.772 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.646 HD21 ' HB2' ' A' ' 31' ' ' ALA . 2.1 mp -106.34 144.97 30.05 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.594 0.235 . . . . 0.0 111.105 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.59 113.26 3.62 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.523 2.148 . . . . 0.0 112.222 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.608 ' O ' HD11 ' A' ' 63' ' ' ILE . 0.9 OUTLIER -152.68 138.97 18.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.762 -179.97 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.894 ' O ' HD12 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -77.16 147.67 36.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.529 179.57 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.55 ' O ' ' N ' ' A' ' 64' ' ' THR . 0.5 OUTLIER -38.62 -52.21 1.64 Allowed 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.271 0.558 . . . . 0.0 110.932 179.705 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.419 ' O ' ' HB2' ' A' ' 65' ' ' GLU . . . -46.76 -55.94 7.03 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.792 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.456 ' HG2' ' O ' ' A' ' 59' ' ' THR . 1.9 mm-40 -52.07 -62.26 1.75 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.945 0.402 . . . . 0.0 109.932 179.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.894 HD12 ' O ' ' A' ' 59' ' ' THR . 1.4 mp -59.04 -63.16 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.217 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.55 ' N ' ' O ' ' A' ' 60' ' ' GLU . 75.7 m -49.32 -52.31 28.73 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.475 -179.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.419 ' HB2' ' O ' ' A' ' 61' ' ' ALA . 3.3 mm-40 -65.63 -15.6 62.91 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 121.698 0.761 . . . . 0.0 110.417 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.418 ' CD1' ' O ' ' A' ' 62' ' ' GLU . 3.5 m-30 -96.17 -24.74 16.12 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.476 -1.238 . . . . 0.0 110.465 179.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.93 ' CD1' HG13 ' A' ' 45' ' ' VAL . 1.6 m-30 -76.44 -30.85 57.53 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.826 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.69 -26.88 16.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.092 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -82.66 -10.91 58.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.511 0.672 . . . . 0.0 111.96 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.17 -33.96 13.11 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.27 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 48.1 p-10 -110.54 122.5 38.23 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.869 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.59 -47.39 1.44 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.447 2.098 . . . . 0.0 112.479 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -68.54 -30.45 69.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.066 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.2 m120 73.84 22.06 2.56 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.413 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.2 t -66.23 -15.68 63.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.183 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.429 ' C ' HG23 ' A' ' 45' ' ' VAL . . . 102.56 22.23 9.81 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.19 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -125.34 129.44 49.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.799 0.333 . . . . 0.0 110.426 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.876 HD12 ' CD2' ' A' ' 48' ' ' PHE . 66.6 mt -99.49 146.89 7.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.223 0.535 . . . . 0.0 111.794 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.429 ' O ' ' N ' ' A' ' 82' ' ' ALA . 0.9 OUTLIER -91.94 96.0 10.13 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 176.598 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.426 ' C ' ' O ' ' A' ' 79' ' ' ASP . 56.4 t80 -28.55 -40.95 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -177.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.423 ' N ' ' O ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -65.19 -55.53 18.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.768 0.318 . . . . 0.0 110.718 179.644 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -51.9 -28.3 15.77 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.104 0.478 . . . . 0.0 110.6 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.645 ' CE1' HD13 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -89.71 -31.9 17.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.812 179.967 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -80.49 -20.8 42.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.324 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.12 -11.57 60.81 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.437 0.637 . . . . 0.0 111.824 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 14.4 mmt -74.03 -33.64 63.83 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.786 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.804 HD21 HD13 ' A' ' 28' ' ' LEU . 5.4 mt -95.58 -6.59 39.96 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.831 0.824 . . . . 0.0 111.476 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -125.91 22.18 7.44 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 114.178 -1.374 . . . . 0.0 111.041 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.93 76.63 10.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.877 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 22.2 t -152.39 66.81 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.02 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -59.63 164.83 3.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.92 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -60.01 149.79 31.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.889 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.3 t . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.146 -0.93 . . . . 0.0 111.011 179.935 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 mtm . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.792 0.329 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 136.25 65.74 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.532 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.6 t -106.01 71.9 0.92 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.857 0.36 . . . . 0.0 110.884 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.3 m -116.03 -38.4 3.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.877 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 21.0 m170 60.71 30.6 19.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.003 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 40.7 t60 59.32 94.04 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.034 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 4.4 m80 -170.61 -75.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.876 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.0 t60 59.9 176.84 0.09 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.921 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 10.8 m80 -155.59 123.68 5.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.82 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -94.67 163.0 13.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.871 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -160.33 35.73 0.17 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.814 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.42 104.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.897 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -96.51 92.54 1.39 Allowed Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.536 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.7 mt -150.52 -51.68 0.14 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.809 0.338 . . . . 0.0 110.852 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.625 HG13 ' O ' ' A' ' 15' ' ' VAL . 7.1 p -178.63 87.57 0.22 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.007 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -52.06 122.72 11.06 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.531 2.154 . . . . 0.0 112.289 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -134.16 153.93 51.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.88 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.91 173.68 17.39 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.557 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 60.03 83.5 0.14 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.799 0.333 . . . . 0.0 110.944 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.74 -73.98 0.22 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.899 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.0 tpt -162.11 147.22 12.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.927 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.4 m -101.29 5.42 42.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.517 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -70.47 -14.68 62.63 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.554 0.692 . . . . 0.0 111.579 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -64.91 -16.5 63.35 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.187 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.526 ' NZ ' HD11 ' A' ' 29' ' ' ILE . 9.8 tmtt? -91.87 -27.84 17.68 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.699 179.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.674 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -66.91 -28.49 68.36 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.746 -179.933 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -59.3 -23.67 62.63 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.948 HD13 HD21 ' A' ' 87' ' ' LEU . 6.0 tt -88.0 -11.36 47.57 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.508 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.674 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 11.3 mm -67.59 -13.81 17.35 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.934 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -77.01 2.04 16.11 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 113.935 -1.484 . . . . 0.0 111.564 179.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.499 ' HB2' HD11 ' A' ' 56' ' ' LEU . . . -93.21 -30.54 15.14 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.034 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -59.58 -29.11 67.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.91 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -97.57 28.17 3.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.0 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -169.97 33.41 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.947 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.458 ' CE1' HD13 ' A' ' 51' ' ' ILE . 16.7 t80 -178.1 76.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.787 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -154.36 67.6 0.72 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.849 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -102.88 -87.62 2.01 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.419 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -178.59 75.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.819 0.342 . . . . 0.0 110.876 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -111.32 22.96 14.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.109 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 22.3 t70 53.82 24.96 4.8 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.182 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.18 -57.21 4.87 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.541 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -54.97 123.98 15.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.946 0.403 . . . . 0.0 111.048 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.506 ' O ' HG13 ' A' ' 43' ' ' VAL . 4.4 p -136.41 106.17 5.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.754 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.4 m -59.01 153.74 17.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.084 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.437 HG13 ' CE1' ' A' ' 67' ' ' PHE . 92.9 t -57.03 -56.84 12.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.045 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -47.41 -29.71 2.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.058 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -88.43 -29.79 19.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.602 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.41 ' CD2' HD12 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -64.68 -30.79 71.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.799 179.876 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.4 mtt-85 -56.06 -51.23 68.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.951 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -57.49 -25.03 54.39 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.452 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.458 HD13 ' CE1' ' A' ' 35' ' ' PHE . 34.0 mt -83.35 -27.92 7.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.754 0.312 . . . . 0.0 111.156 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 41.7 mm -90.45 -49.18 13.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.085 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.3 -35.73 62.94 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.198 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -111.81 14.72 21.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.426 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -123.24 -90.1 0.94 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.662 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.499 HD11 ' HB2' ' A' ' 31' ' ' ALA . 2.4 mp -97.8 142.93 25.34 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.645 0.26 . . . . 0.0 110.94 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -78.92 57.94 6.67 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.525 2.15 . . . . 0.0 112.439 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.657 ' C ' HD11 ' A' ' 63' ' ' ILE . 5.3 ttt -86.58 136.19 33.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.72 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.836 ' O ' HD12 ' A' ' 63' ' ' ILE . 1.0 OUTLIER -81.76 142.05 32.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.789 0.328 . . . . 0.0 110.631 179.645 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.557 ' O ' ' N ' ' A' ' 64' ' ' THR . 0.2 OUTLIER -41.16 -52.92 3.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.328 0.585 . . . . 0.0 110.844 -179.844 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.483 ' N ' ' CG ' ' A' ' 60' ' ' GLU . . . -45.01 -27.09 0.5 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.938 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.483 ' HG3' ' O ' ' A' ' 59' ' ' THR . 0.0 OUTLIER -91.07 -51.73 5.19 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.672 0.272 . . . . 0.0 110.32 179.729 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.836 HD12 ' O ' ' A' ' 59' ' ' THR . 1.2 mp -73.65 -43.35 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.201 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.557 ' N ' ' O ' ' A' ' 60' ' ' GLU . 24.3 m -64.6 -47.78 77.36 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.027 0.441 . . . . 0.0 109.961 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.408 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 5.7 tt0 -65.66 -17.28 64.49 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.693 0.758 . . . . 0.0 110.188 179.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.47 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 1.0 OUTLIER -97.02 -26.92 14.84 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.243 178.829 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.755 ' CE2' HG22 ' A' ' 63' ' ' ILE . 2.0 m-85 -68.13 -47.36 68.31 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.738 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.77 -26.81 54.94 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.994 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.77 -11.06 59.92 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.445 0.64 . . . . 0.0 111.779 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.433 ' HB2' ' CE1' ' A' ' 83' ' ' PHE . . . -95.84 -32.78 12.5 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.006 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.484 ' OD2' HG22 ' A' ' 75' ' ' THR . 5.9 t70 -119.85 120.43 30.43 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.744 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.65 -27.78 45.04 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.344 2.029 . . . . 0.0 112.222 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 30.2 m-20 -84.6 -32.35 23.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.904 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.2 m120 71.31 40.4 0.85 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.038 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.484 HG22 ' OD2' ' A' ' 71' ' ' ASP . 1.4 t -90.37 40.57 1.02 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.644 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 50.33 25.72 8.65 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.763 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -125.23 148.94 48.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.874 0.369 . . . . 0.0 110.779 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.737 HD11 ' CD1' ' A' ' 67' ' ' PHE . 54.1 mt -127.14 153.12 35.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.203 0.525 . . . . 0.0 111.552 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.443 ' N ' HG22 ' A' ' 78' ' ' ILE . 1.0 OUTLIER -98.11 96.0 7.82 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 176.863 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.42 ' C ' ' O ' ' A' ' 79' ' ' ASP . 70.6 t80 -29.23 -40.86 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -178.084 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 79' ' ' ASP . 1.9 mmmm -68.72 -54.44 16.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.733 0.301 . . . . 0.0 110.699 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -52.59 -26.82 14.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.015 0.436 . . . . 0.0 110.577 179.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.555 ' CE1' HD13 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -91.9 -35.27 14.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.844 -179.898 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.404 ' O ' ' CD2' ' A' ' 88' ' ' TYR . . . -76.56 -29.09 56.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.398 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.737 ' HB1' HG22 ' A' ' 90' ' ' VAL . . . -74.43 -11.33 60.21 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.396 0.617 . . . . 0.0 111.824 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 13.0 mmm -84.04 -28.97 27.26 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.942 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.948 HD21 HD13 ' A' ' 28' ' ' LEU . 4.5 mt -100.83 -7.09 23.93 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.778 0.799 . . . . 0.0 111.819 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.404 ' CD2' ' O ' ' A' ' 84' ' ' ALA . 10.8 m-85 -125.99 21.87 7.44 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 114.377 -1.283 . . . . 0.0 111.339 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.0 m 45.15 33.11 1.04 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.409 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.737 HG22 ' HB1' ' A' ' 85' ' ' ALA . 14.0 t 67.52 37.24 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.097 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.9 t70 61.09 111.71 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.915 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -121.5 165.25 15.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.799 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 42.4 t . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.878 179.993 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.0 ttp . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.884 0.373 . . . . 0.0 111.141 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 154.66 87.04 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.489 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.3 t -93.55 154.0 18.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.85 0.357 . . . . 0.0 110.876 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.9 p -166.67 -66.15 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.893 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 13.7 m80 -91.02 143.03 27.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.996 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -101.9 80.04 1.97 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.875 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 17.3 t60 -91.28 -66.31 0.94 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.912 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 60.16 -170.0 0.15 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.907 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -131.11 -57.39 1.02 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.933 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 73.8 m-70 -108.57 80.71 1.37 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.955 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 46.0 t -175.98 -71.2 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.87 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.8 t -79.66 170.93 15.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.941 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.472 ' H ' HD23 ' A' ' 14' ' ' LEU . . . 171.87 78.76 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.504 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.472 HD23 ' H ' ' A' ' 13' ' ' GLY . 0.6 OUTLIER -148.11 45.79 1.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.916 0.389 . . . . 0.0 110.817 -179.954 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.665 ' N ' ' CD ' ' A' ' 16' ' ' PRO . 13.5 p -79.26 -27.95 0.53 Allowed Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.665 ' CD ' ' N ' ' A' ' 15' ' ' VAL . 51.5 Cg_exo -53.45 -47.48 27.11 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 121.917 1.744 . . . . 0.0 112.34 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.9 tpp85 -62.62 141.66 58.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.865 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 105.26 86.35 1.91 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.737 -0.745 . . . . 0.0 112.501 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.64 -177.4 0.81 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.77 0.319 . . . . 0.0 110.893 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 61.0 112.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.846 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 19.3 mmt -108.04 77.88 1.14 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.872 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -101.64 5.33 41.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.043 0.449 . . . . 0.0 111.569 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.07 -14.62 62.38 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.493 0.663 . . . . 0.0 111.559 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.03 -16.57 63.6 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 114.823 -1.08 . . . . 0.0 111.171 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.493 ' CG ' HD23 ' A' ' 87' ' ' LEU . 1.5 ttpp -91.83 -26.98 18.26 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.745 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.679 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -68.29 -28.58 67.31 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.8 -179.89 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -58.95 -23.92 62.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.159 0.504 . . . . 0.0 109.781 178.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.973 HD22 HD22 ' A' ' 87' ' ' LEU . 3.8 tt -88.07 -11.39 47.29 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.407 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.679 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 11.2 mm -67.26 -13.6 16.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.959 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -76.32 2.19 14.09 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 113.944 -1.48 . . . . 0.0 111.676 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 1.106 ' HB2' HD21 ' A' ' 56' ' ' LEU . . . -92.31 -29.44 16.37 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.092 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -57.23 -28.21 62.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.055 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -97.42 37.76 1.33 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.919 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -173.32 37.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.852 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.401 ' CD2' ' O ' ' A' ' 35' ' ' PHE . 78.1 t80 -163.27 72.02 0.28 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -140.53 42.12 1.88 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.861 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -59.32 -64.46 4.24 Favored Glycine 0 N--CA 1.453 -0.195 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.495 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -165.14 38.94 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.861 0.362 . . . . 0.0 110.926 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 1.4 t80 60.74 89.16 0.08 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.892 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.36 148.88 22.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.858 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -108.39 -24.36 6.23 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.577 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -143.68 123.82 13.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.837 0.351 . . . . 0.0 110.916 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.541 HG11 ' CE2' ' A' ' 48' ' ' PHE . 9.1 p -117.56 122.19 69.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.966 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.0 155.38 38.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.839 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.698 HG22 HG13 ' A' ' 78' ' ' ILE . 49.7 t -59.71 -53.13 52.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.773 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -49.14 -37.07 20.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.749 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -80.84 -29.1 35.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.439 179.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.789 ' CD2' HD12 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -70.66 -40.05 73.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.782 179.91 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 46.0 mtm180 -56.96 -51.82 67.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.943 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -54.23 -25.41 32.73 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.327 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.0 mt -89.61 -43.68 14.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.847 0.355 . . . . 0.0 110.869 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.688 ' CD1' HD13 ' A' ' 56' ' ' LEU . 36.6 mm -70.7 -26.97 29.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.211 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.33 -60.22 3.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.106 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -111.87 14.92 21.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.336 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -101.84 -87.29 1.98 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.75 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 1.106 HD21 ' HB2' ' A' ' 31' ' ' ALA . 3.9 mp -90.92 133.4 32.22 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.509 0.195 . . . . 0.0 111.147 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -77.91 87.58 1.51 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.54 2.16 . . . . 0.0 112.289 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.613 ' O ' HD11 ' A' ' 63' ' ' ILE . 1.2 mtp -125.08 141.27 52.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.774 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.888 ' O ' HD12 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -77.99 148.92 34.18 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.642 179.673 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.506 ' O ' ' N ' ' A' ' 64' ' ' THR . 5.4 pt-20 -38.76 -52.0 1.7 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.258 0.551 . . . . 0.0 110.851 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.524 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -47.17 -53.2 13.63 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.038 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.568 ' HB2' ' HE2' ' A' ' 58' ' ' MET . 2.2 mm-40 -55.08 -61.72 2.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.928 0.394 . . . . 0.0 109.975 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.888 HD12 ' O ' ' A' ' 59' ' ' THR . 1.7 mp -58.72 -61.7 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.168 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.506 ' N ' ' O ' ' A' ' 60' ' ' GLU . 58.9 m -51.8 -51.45 56.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.343 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.524 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 50.9 tt0 -65.62 -15.45 62.76 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 121.686 0.755 . . . . 0.0 110.458 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.426 ' CD1' ' O ' ' A' ' 62' ' ' GLU . 3.6 m-30 -96.15 -26.52 15.44 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.519 -1.219 . . . . 0.0 110.372 179.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.699 ' CE2' HG22 ' A' ' 63' ' ' ILE . 5.1 m-30 -77.8 -26.68 49.78 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.827 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -90.75 -28.43 18.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.882 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.94 -11.2 45.13 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.459 0.647 . . . . 0.0 111.732 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -92.15 -29.72 16.34 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.078 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -125.64 119.29 24.44 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.789 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -64.85 -40.69 20.52 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.421 2.081 . . . . 0.0 112.189 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -77.4 -31.31 54.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.758 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 72.18 38.9 0.83 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.103 0.477 . . . . 0.0 110.144 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.497 HG23 ' HB2' ' A' ' 77' ' ' PHE . 1.5 t -89.7 41.27 1.03 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.529 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.422 ' C ' HG23 ' A' ' 45' ' ' VAL . . . 50.88 25.39 9.51 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.688 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.497 ' HB2' HG23 ' A' ' 75' ' ' THR . 2.5 m-85 -126.06 129.5 49.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.761 0.315 . . . . 0.0 110.84 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.789 HD12 ' CD2' ' A' ' 48' ' ' PHE . 55.7 mt -103.13 153.27 5.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.184 0.516 . . . . 0.0 111.379 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.453 ' N ' HG22 ' A' ' 78' ' ' ILE . 10.1 t0 -99.41 95.66 7.18 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 176.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.417 ' C ' ' O ' ' A' ' 79' ' ' ASP . 47.3 t80 -29.35 -41.32 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.066 -0.515 . . . . 0.0 112.287 -178.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 79' ' ' ASP . 21.9 mttt -65.93 -55.82 14.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.562 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -53.05 -26.16 14.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.044 0.449 . . . . 0.0 110.574 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.635 ' CE1' HD13 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -91.55 -30.49 16.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.895 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.05 -45.58 16.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.359 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -71.4 -11.62 60.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.412 0.625 . . . . 0.0 111.816 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 14.7 tpp -68.67 -35.44 77.23 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.656 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.973 HD22 HD22 ' A' ' 28' ' ' LEU . 4.2 mp -100.63 -6.76 24.74 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.777 0.798 . . . . 0.0 111.556 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -125.82 22.44 7.45 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 114.271 -1.331 . . . . 0.0 111.176 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.23 78.53 0.09 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.829 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 26.5 m -150.88 30.69 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.151 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -135.05 146.54 49.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.892 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -131.71 155.52 47.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.865 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.6 m . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.141 -0.933 . . . . 0.0 110.913 -179.964 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 mtm . . . . . 0 N--CA 1.487 1.423 0 CA-C-O 120.811 0.338 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 160.26 -88.88 0.11 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.569 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.1 m 60.55 100.96 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.786 0.327 . . . . 0.0 110.92 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.3 m -154.61 97.86 2.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.936 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 22.3 p80 -175.59 -40.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.913 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -131.47 101.23 5.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.885 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 60.62 110.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.899 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.5 p80 -162.64 83.35 0.53 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.926 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 -79.64 126.24 30.66 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.89 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -146.06 179.28 7.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.87 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.6 p -84.63 -53.9 5.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.894 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.0 m -72.86 166.5 22.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.925 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 140.09 -160.13 26.22 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.565 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.46 -75.45 0.45 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.776 0.322 . . . . 0.0 111.007 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.6 m -149.92 157.13 38.17 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.218 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.21 -61.68 0.47 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.577 2.185 . . . . 0.0 112.312 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.82 -71.88 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.914 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.96 39.34 38.47 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.555 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.9 t -177.11 165.72 2.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.839 0.352 . . . . 0.0 110.912 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -166.49 -68.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.866 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.09 30.81 0.3 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.802 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.0 m -94.75 5.36 52.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.561 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.29 -14.55 62.25 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.588 0.709 . . . . 0.0 111.654 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -65.07 -16.51 63.55 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.087 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.1 tmtm? -92.01 -26.94 18.13 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 114.781 -1.1 . . . . 0.0 110.641 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.68 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -68.03 -29.11 68.02 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.765 -179.923 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.0 mm100 -59.79 -23.93 63.7 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.829 HD22 HD22 ' A' ' 87' ' ' LEU . 0.6 OUTLIER -88.15 -11.25 47.44 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.468 179.636 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.68 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 10.8 mm -66.58 -13.74 16.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.987 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -76.4 2.11 14.49 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 113.923 -1.49 . . . . 0.0 111.658 179.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.666 ' HB2' HD11 ' A' ' 56' ' ' LEU . . . -92.62 -29.82 15.93 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.138 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -59.76 -27.31 66.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.123 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -94.81 42.89 1.09 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.028 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -178.07 37.06 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.973 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -177.35 76.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.912 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -177.18 78.15 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.91 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -128.22 -42.41 0.25 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.552 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -177.05 78.3 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.909 0.385 . . . . 0.0 110.812 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -130.79 165.45 22.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.806 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -102.43 31.4 4.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.936 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.57 41.88 99.02 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.543 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -152.25 123.96 7.9 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.845 0.355 . . . . 0.0 110.923 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.46 HG11 ' CE2' ' A' ' 48' ' ' PHE . 10.3 p -128.52 124.52 61.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.936 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 51.1 p -76.46 148.22 37.38 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.925 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.682 HG13 ' CZ ' ' A' ' 67' ' ' PHE . 57.5 t -58.45 -39.56 75.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.836 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -56.06 -30.26 61.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.979 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -96.42 -31.9 12.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.886 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.698 ' HA ' HD12 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -58.77 -41.21 86.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.084 -179.757 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.472 ' HD2' HG12 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -57.54 -48.62 78.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.008 -179.909 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -59.56 -28.04 64.52 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.434 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.698 HD12 ' HA ' ' A' ' 48' ' ' PHE . 4.6 mt -86.47 -49.99 14.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.95 0.405 . . . . 0.0 110.989 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 tp -57.83 -40.5 76.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.278 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 13.6 mtp85 -47.63 -68.34 0.2 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.169 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -93.3 14.66 17.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.018 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.545 ' O ' HD23 ' A' ' 56' ' ' LEU . . . -110.51 -57.86 0.5 Allowed Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.592 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.666 HD11 ' HB2' ' A' ' 31' ' ' ALA . 10.4 mt -129.09 135.58 27.83 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.649 0.261 . . . . 0.0 111.015 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -78.95 97.38 1.13 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.641 2.227 . . . . 0.0 112.246 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.597 ' O ' HD11 ' A' ' 63' ' ' ILE . 1.3 mtp -129.52 140.28 51.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.814 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.898 ' O ' HD12 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -77.88 148.12 34.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.674 179.677 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.483 ' O ' ' N ' ' A' ' 64' ' ' THR . 6.1 pt-20 -39.53 -52.22 2.17 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.166 0.508 . . . . 0.0 111.064 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.529 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -47.98 -52.45 19.73 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.949 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.454 ' HB2' ' HE3' ' A' ' 58' ' ' MET . 0.9 OUTLIER -55.36 -62.4 1.7 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.377 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.898 HD12 ' O ' ' A' ' 59' ' ' THR . 1.8 mp -56.59 -61.82 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.964 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.483 ' N ' ' O ' ' A' ' 60' ' ' GLU . 55.3 m -52.14 -50.4 61.81 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.061 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.529 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 2.3 tp10 -65.99 -15.87 63.39 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 121.579 0.704 . . . . 0.0 110.459 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.441 ' CD2' ' O ' ' A' ' 62' ' ' GLU . 2.4 m-85 -96.31 -24.48 16.17 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.42 179.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.682 ' CZ ' HG13 ' A' ' 45' ' ' VAL . 8.5 m-30 -81.62 -28.92 33.47 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.797 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -94.12 -28.79 15.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.891 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.53 -11.19 54.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.402 0.62 . . . . 0.0 111.796 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.547 ' HB1' HG23 ' A' ' 78' ' ' ILE . . . -103.5 -30.2 10.68 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.015 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.407 ' HA ' ' HD2' ' A' ' 72' ' ' PRO . 10.8 t0 -119.63 95.74 49.35 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.813 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 71' ' ' ASP . 35.1 Cg_endo -65.04 -35.79 41.01 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.5 2.133 . . . . 0.0 112.325 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.725 ' OD1' HG23 ' A' ' 75' ' ' THR . 15.8 p30 -77.36 -30.4 53.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.875 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.1 m120 74.28 49.05 0.11 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.594 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.725 HG23 ' OD1' ' A' ' 73' ' ' ASN . 18.1 p -95.2 25.27 4.39 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.815 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 53.78 23.66 22.85 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.189 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -142.8 129.24 20.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.779 0.323 . . . . 0.0 110.442 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.547 HG23 ' HB1' ' A' ' 70' ' ' ALA . 7.2 mt -105.48 156.99 6.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.051 0.453 . . . . 0.0 111.67 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.526 ' N ' HG22 ' A' ' 78' ' ' ILE . 1.7 m-20 -85.11 97.59 9.96 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 176.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.414 ' C ' ' O ' ' A' ' 79' ' ' ASP . 50.0 t80 -28.48 -39.77 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -177.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.442 ' N ' ' O ' ' A' ' 79' ' ' ASP . 5.4 mmmm -65.11 -53.16 49.56 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.693 0.282 . . . . 0.0 110.698 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -54.11 -25.47 22.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.933 0.397 . . . . 0.0 110.594 179.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.497 ' CZ ' HD13 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -94.15 -30.15 14.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.102 -179.67 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.34 -38.8 26.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.315 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.66 -11.45 60.42 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.392 0.615 . . . . 0.0 111.716 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 36.9 tpp -67.49 -36.16 80.55 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.74 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.829 HD22 HD22 ' A' ' 28' ' ' LEU . 2.8 mp -100.74 -6.78 24.5 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 121.865 0.841 . . . . 0.0 111.537 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.406 ' O ' HG12 ' A' ' 90' ' ' VAL . 3.8 m-85 -124.61 22.34 8.31 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 114.135 -1.393 . . . . 0.0 111.111 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.5 m -58.24 89.26 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.061 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.582 ' O ' HG22 ' A' ' 90' ' ' VAL . 12.8 p -165.53 47.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.105 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -134.1 81.39 1.91 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.926 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -154.96 -178.2 7.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.851 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.935 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 ptp . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.728 0.299 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -103.22 28.0 17.61 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.515 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.9 m 59.97 31.48 20.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.771 0.32 . . . . 0.0 110.888 -179.947 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -108.63 73.81 0.89 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.855 -179.947 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 5.4 m170 59.77 31.3 20.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.889 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 8.8 m80 -77.19 -38.06 52.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.932 179.917 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 60.07 108.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.998 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -152.79 -53.57 0.11 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.943 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -177.25 73.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.829 179.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -177.0 134.66 0.2 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.863 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.2 m 60.31 110.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.86 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.8 p -168.14 123.78 1.01 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.961 179.957 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.78 -142.98 0.5 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.47 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -106.68 36.55 2.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.803 0.335 . . . . 0.0 110.909 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.5 p -123.43 139.28 31.6 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.949 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.33 146.78 30.91 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.506 2.137 . . . . 0.0 112.35 179.871 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 12.5 mtm105 -105.62 154.78 19.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.871 -179.975 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 131.23 42.76 0.19 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.497 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 59.8 m 59.55 31.28 20.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.77 0.319 . . . . 0.0 110.92 -179.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -119.66 34.55 5.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.833 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 5.0 ptm -123.67 -43.02 2.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.967 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.0 m -89.15 5.34 45.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.608 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -73.03 -14.53 61.44 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.525 0.679 . . . . 0.0 111.509 179.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -64.88 -16.62 63.44 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.095 179.638 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.561 ' HD3' HD22 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -91.67 -27.38 18.14 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.6 179.456 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.685 ' HA ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -69.09 -28.85 66.87 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.817 -179.862 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.572 ' O ' HD23 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -59.4 -24.22 63.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.168 0.509 . . . . 0.0 109.675 178.529 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.712 HD13 HD21 ' A' ' 87' ' ' LEU . 5.4 tt -88.23 -11.29 47.05 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.451 179.691 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.685 ' CG1' ' HA ' ' A' ' 26' ' ' THR . 12.4 mm -65.65 -14.48 17.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 114.794 -1.094 . . . . 0.0 112.007 -179.899 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -79.02 2.25 21.13 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 113.872 -1.513 . . . . 0.0 111.427 179.526 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.16 -30.8 15.05 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.171 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -59.05 -30.85 68.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.92 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -98.43 34.99 1.87 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.984 179.906 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -176.76 38.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.943 -179.999 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -166.72 73.7 0.15 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.952 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -169.97 75.03 0.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.866 -179.914 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -94.23 -44.18 3.58 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.551 179.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -167.96 74.15 0.12 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.956 0.408 . . . . 0.0 110.911 -179.984 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 60.92 111.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.928 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -102.42 105.2 15.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.92 179.925 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -112.85 -24.61 4.84 Favored Glycine 0 C--N 1.33 0.203 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.562 -179.918 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.404 ' CZ ' ' O ' ' A' ' 78' ' ' ILE . 10.5 t80 -152.96 123.83 7.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.811 0.339 . . . . 0.0 111.017 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.565 HG11 ' CE2' ' A' ' 48' ' ' PHE . 8.0 p -123.67 115.93 46.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.004 179.774 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.4 p -71.69 149.38 45.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.91 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.483 HG13 ' CZ ' ' A' ' 67' ' ' PHE . 82.0 t -54.51 -55.03 17.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.963 179.844 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -47.72 -30.63 4.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.971 -179.833 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -87.62 -30.04 20.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.443 179.391 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.609 ' CD2' HD12 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -68.95 -36.16 77.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.903 179.88 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.445 ' CZ ' HG12 ' A' ' 45' ' ' VAL . 37.5 mtt-85 -55.47 -51.54 66.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.027 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -57.03 -22.22 41.53 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.531 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 28.3 mt -89.86 -26.24 5.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.769 0.319 . . . . 0.0 111.223 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.442 HG21 HG12 ' A' ' 63' ' ' ILE . 31.2 mm -93.15 -28.65 4.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.228 -179.905 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.8 ttm-85 -56.31 -54.98 38.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.351 -179.648 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -111.76 15.08 21.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.621 -179.566 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -105.31 -87.89 2.02 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.819 -179.8 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.617 ' N ' HD12 ' A' ' 56' ' ' LEU . 4.1 mp -99.6 139.85 21.17 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-O 120.674 0.273 . . . . 0.0 111.11 -179.725 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.0 117.78 4.79 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.478 2.119 . . . . 0.0 112.252 179.869 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.645 ' O ' HD11 ' A' ' 63' ' ' ILE . 0.6 OUTLIER -153.12 137.9 17.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.811 -179.881 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.897 ' O ' HD12 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -75.45 146.75 40.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.653 179.506 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.532 ' O ' ' N ' ' A' ' 64' ' ' THR . 0.5 OUTLIER -39.07 -52.45 1.85 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.299 0.571 . . . . 0.0 111.011 179.744 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.511 ' O ' ' CB ' ' A' ' 65' ' ' GLU . . . -46.34 -53.21 11.29 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.105 179.63 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.531 ' HB2' ' HE2' ' A' ' 58' ' ' MET . 0.5 OUTLIER -55.67 -61.33 2.43 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.872 0.368 . . . . 0.0 110.077 179.439 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.897 HD12 ' O ' ' A' ' 59' ' ' THR . 1.5 mp -59.39 -61.3 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.115 179.776 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.532 ' N ' ' O ' ' A' ' 60' ' ' GLU . 65.2 m -51.59 -51.67 53.67 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.232 -179.844 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.511 ' CB ' ' O ' ' A' ' 61' ' ' ALA . 6.7 tt0 -65.75 -15.42 62.83 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-O 121.623 0.725 . . . . 0.0 110.389 179.778 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.435 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 3.4 m-30 -95.25 -25.49 16.33 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.537 -1.211 . . . . 0.0 110.389 179.114 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.751 ' CE2' HG22 ' A' ' 63' ' ' ILE . 2.6 m-30 -80.15 -28.94 38.79 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.719 179.942 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.42 -30.24 22.24 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.859 179.918 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.12 -11.13 59.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.503 0.668 . . . . 0.0 111.691 180.0 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.02 -29.9 12.64 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.836 -1.074 . . . . 0.0 111.035 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -124.43 117.06 26.65 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.755 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.37 -50.28 2.05 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.372 2.048 . . . . 0.0 112.301 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.602 ' CG ' HG23 ' A' ' 75' ' ' THR . 10.1 p30 -68.48 -32.77 73.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.852 179.911 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 6.1 m120 75.38 52.36 0.07 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.644 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.602 HG23 ' CG ' ' A' ' 73' ' ' ASN . 13.6 p -97.6 30.04 3.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.649 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 58.75 25.89 59.49 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.287 -179.717 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -127.75 131.13 49.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.802 0.334 . . . . 0.0 110.77 179.876 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.645 HD13 ' CE1' ' A' ' 83' ' ' PHE . 58.2 mt -105.05 152.64 6.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.233 0.539 . . . . 0.0 111.594 -179.764 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.435 ' N ' HG22 ' A' ' 78' ' ' ILE . 0.5 OUTLIER -99.01 95.58 7.23 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 176.912 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.422 ' C ' ' O ' ' A' ' 79' ' ' ASP . 38.6 t80 -28.93 -41.63 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.312 -178.081 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' A' ' 79' ' ' ASP . 4.4 mptt -65.86 -56.13 13.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.655 179.781 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.41 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -52.81 -26.83 15.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.944 0.402 . . . . 0.0 110.59 179.221 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.645 ' CE1' HD13 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -90.47 -31.98 16.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.813 179.956 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.46 ' O ' ' CD2' ' A' ' 88' ' ' TYR . . . -75.61 -41.38 54.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.225 179.946 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.467 ' HA ' ' CE2' ' A' ' 88' ' ' TYR . . . -61.97 -12.06 16.49 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.333 0.587 . . . . 0.0 112.035 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 8.8 mmt -79.27 -21.25 46.35 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.205 179.884 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.712 HD21 HD13 ' A' ' 28' ' ' LEU . 19.9 mt -100.6 -15.57 17.75 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 121.677 0.751 . . . . 0.0 112.366 -179.593 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.467 ' CE2' ' HA ' ' A' ' 85' ' ' ALA . 33.1 p90 -127.93 21.62 6.34 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.33 179.017 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.44 84.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.829 179.797 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.59 ' O ' HG22 ' A' ' 90' ' ' VAL . 13.1 p -178.05 45.64 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.985 179.947 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -64.84 152.64 42.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.854 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -92.11 167.34 12.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.862 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.1 m . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.895 179.997 . . . . . . . . 0 0 . 1 stop_ save_